
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-14401-14700*
  '(".17G9" ".7E5" ".8A4" "A-1195G" "A-308G" "A-498" "A-704" "A-704-mut1"
    "A-704-mut2" "A-CM" "A-allele" "A-fiber" "A-fibers" "A-subtype" "A-type"
    "A1" "A112C" "A15T" "A161S" "A1708E" "A2A" "A375C6" "A391E" "A4" "A43T"
    "A482T" "A6" "A@K592" "A@R568" "AA-rs10787498GT" "AA-rs12247479AG" "AA1–75"
    "AA76–320" "AAAA" "AAAAA" "AACAnnnTGTTCT" "AACR" "AATK" "AAV-GFP"
    "AAV-hRheb" "AB-2992" "ABCDE" "ABCE" "ABCE1-V5" "ABSCs" "ABT-737-induced"
    "ABT-737-mediated" "AC-220" "ACCGGAAGTG" "ACEi" "ACG-family" "AChR" "AChRs"
    "AD8" "ADRB2and" "ADRs" "AFA" "AFA-I" "AFC" "AFC≤9" "AGC" "AGE-BSA"
    "AGE-BSA-mediated" "AGE-BSA-treated" "AGE-BSAs" "AGEs-induced" "AGO" "AGRE"
    "AIS" "AJCC" "AK-A" "AK23" "AK23-injection" "AKT-dependent" "AKT1-KO"
    "AKT1-dependent" "AKT1-targeted" "AKTpS473" "ALS2" "AMG232" "AMH≥1"
    "AMP+ADP" "AMPKα2" "AMPPCP" "AMZ2" "ANKRD22" "ANT-negative" "ANT-positive"
    "ANTS" "AP26113" "AP2γ" "APA5" "APOBEC3" "APOBEC3A" "APOBEC3D" "APP695"
    "AR+" "AR21" "ARAR0332" "ARF-independent" "ARF6T157N-GFP" "ARF6T27N"
    "ARFT8A" "ARFT8D" "ARK" "ARNT-like" "ARΔLBD" "ARΔNLS" "AS-PCR" "ASCO"
    "ASP133" "ASP3026" "AT-hook" "AT1R" "ATAD1" "ATCC" "ATCH" "ATF-like" "ATMi"
    "ATR-CHK1" "ATRX-null" "ATTCT" "ATXN" "ATXN10-12A-res" "ATXN10-2A-res"
    "ATXN10-3A-res" "ATXN10-S12A-res" "ATXN2" "ATau" "AUG" "AURKC" "AVAglio"
    "AVM" "AW" "AY017215.1" "AZD" "AZD-1152" "AZD-2281" "AZD1152-HQPA"
    "Abagovomab" "Abboud" "Abcam" "Abraxane" "Ac" "Ac-H3" "Ac-H3K9"
    "AcK348-EZH2" "Accelrys" "AchRα7" "Achilles" "Achuthan" "Ack" "Ad-4EBP1-5A"
    "Ad-4EBP1-5A-infected" "Ad-CAGA-Td-Tom" "Ad-Cre" "Ad-Cre-GFP"
    "Ad-Cre-induced" "Ad-Ctrl" "Ad-Empty" "Ad-GFP" "Ad-S6K1-ca" "Ad-S6K1-wt"
    "Ad-SIRT1" "Ad-SOCS3" "Ad-SOCS3-GFP" "Ad-dn-Akt" "Ad-myr-Akt" "AdCre"
    "Adam" "Addgene" "Adenoviral-Cre" "Adr" "Adr+Cbl-b" "Affymatrix"
    "Affymetrix" "African" "African-American" "Africans" "Afro-American" "Age"
    "Akhoondi" "Akirin1" "Alameda" "Albright" "Alexa" "Alexa488" "Alexa647"
    "Allen" "Almeida" "Alsin" "Alternaria" "Alzheimer" "Alzheimer’s" "America"
    "Ameziane" "Amicon" "Ammon" "An" "Andes" "Andrulis" "AngII" "Angeles" "Ann"
    "Annexin-V-Fluos" "AnnexinV-FITC" "Ap" "Aperio" "Archaeoglobus" "Arg-only"
    "Argentina" "Argonaut" "Ark5" "Arnold" "Array-CGH" "Asante"
    "Asclepiadaceae" "Asia-Pacific" "Asian" "Asians" "Assié" "Ataxin-10-S12A"
    "Ataxin-10-pS12" "Atkinson" "Attardi" "Augello" "Aur" "AuroraA" "Australia"
    "Autodock4.2" "Avanti" "Avastin" "Aviv" "Azan" "Aβ" "A–S2C" "A–S2D" "A–S3E"
    "B-Cdk1" "B-Cdk1-mediated" "B-DNA" "B-associated" "B-boxes" "B-dependent"
    "B-lymphoid" "B-lymphoma" "B-lymphomas" "B-pocket" "B-type" "B1" "B2" "B23"
    "B3" "B4" "B6" "BACMEFs" "BALB" "BAX-alone" "BAXΔC" "BAY" "BCA" "BCL-ABL1"
    "BCL-xl" "BCL2-like" "BEV" "BGT226" "BH3-in-groove" "BH3-mimetics"
    "BH3-only" "BH4-interaction" "BI2356" "BIBW2922" "BID1176" "BJ-TERT-tsLT"
    "BJ-hTERT" "BKV" "BL1" "BLBPcre" "BLR1" "BMS-936558" "BO18255" "BPTES"
    "BRACA1" "BRAF-non-V600E" "BRAFi" "BRAG1" "BRCA1-BRCT-binding" "BRCA1b"
    "BRCAness" "BRCR2" "BRCT-domains-only" "BRCT-phosphopeptide" "BRCT1-domain"
    "BRCT7" "BRD" "BRD2-4" "BRDT" "BRS" "BSAs" "BSL3" "BST" "BT-163" "BT-171"
    "BT74" "BTCs" "BUM" "BVD" "BVD-523" "BWS" "Ba" "Bachet" "Background"
    "BafA1" "Barbacid" "Barbieri" "Barrueco" "Bastiaens" "Bax1" "Bayes"
    "Bcl-Xl" "Bcl-xl" "Beckman" "Beckwith" "Beckwith-Wiedemann" "Beeser" "Begg"
    "Begg’s" "Belfiore" "Beltran" "Beltrao" "Bender" "Benjamini"
    "Benjamini–Hochberg" "Benzeno" "Berlin" "Berns" "Bertoni" "Bethyl"
    "Between-ness" "Bevazucimab" "Bienvenu" "Big-Dye" "Bigoni" "Bijani"
    "Billerica" "Bio" "Bio-Plex" "Bio-Rad" "BioBank" "BioSewoom" "Biochemicals"
    "Biosystems" "Biotech" "Bis" "Bis-anthracycline" "Bisindolylmalemide"
    "Bisson" "Björkbacka" "Blume" "Blume-Jensen" "Bmal1-driven" "Bn" "BoM"
    "BoM-1833" "Bockenheimer" "Boekholdt" "Boltzmann" "Bonferroni"
    "Bonferroni-like" "Bordoli" "Bosch" "Boston" "Botcheva" "Bothell" "Bourgo"
    "Bourke" "Boyden" "Bp" "BrPA" "Bradshaw" "Brady" "Brandl" "Braun" "Brazil"
    "Breflate" "Brenner" "Brent" "Broeks" "Broz" "Bueno" "Buizza"
    "Bunyaviridae" "Burd" "Burkitt" "Burkitt's" "Burmeister" "B–2D" "B–S6G"
    "C#2" "C-3737T" "C-CM" "C-Cdc20" "C-allele" "C-dependent" "C-lobe"
    "C-mediated" "C-nociceptors" "C-pocket" "C-potentiated" "C-site"
    "C-statistic" "C-ter" "C-terminally" "C-α" "C1-C2-C3" "C10orf81" "C2"
    "C20041018-0267" "C2159A" "C2159G" "C3" "C3C" "C3H-2K" "C3LND" "C3PO" "C4"
    "C459S" "C6" "C6–7" "C7" "C81" "C@592" "C@K567" "C@R568" "C@V564" "CA10561"
    "CA16" "CA19–9" "CAA-CM" "CACGCG" "CACGTG" "CACTTCCGGT" "CAGA-Fluc"
    "CAGA-Td-Tom" "CALS" "CARS" "CASMC" "CASP8AP" "CASSR1" "CATGTG" "CAY10561"
    "CB+CBM" "CBF-β" "CBM" "CBP-degradation" "CBP-induced" "CBP-interaction"
    "CCGGAA" "CCR10" "CCR5-tropic" "CCRT" "CCSP-rtTA" "CCdh1" "CD-specific"
    "CD135" "CD18-JQ1" "CD18-P" "CD28-Ab" "CD3-Ab" "CD3-OKT3"
    "CD4-Nav1.6-C-tail" "CD4-Nav1.6-NLuc" "CD4-Nav1.6-Nluc" "CD90" "CDC151"
    "CDK2-dependent" "CDK2AP1-shRNA1" "CDK2AP1-shRNA2" "CDK2AP1in"
    "CDK2AP1inhibited" "CDK2AP1knockdown" "CDKL5" "CDRs" "CDs" "CEGMR"
    "CFP-PC3" "CFP-cells" "CFTR-like" "CFU-G" "CG6638" "CGC" "CGI-peaks"
    "CGI-promoters" "CHCHD10" "CHIC" "CHIC-35" "CHIP–BACE1–p53"
    "CHIP–p53–BACE1" "CHK2-Cdc5s" "CHOC" "CHOP-O" "CHOP-OR" "CHOP-null" "CK-MB"
    "CK1e" "CK1ɛ" "CK1γ1" "CKD2AP1downregulation" "CKIIα" "CL21" "CL8" "CL858R"
    "CLIA" "CLOVES" "CM-AVM" "CMA" "CMML" "CMV-Td-Tom" "CMV10" "CMV9" "CN34"
    "CN34BrM" "CNBr" "CNBr-Sepharose" "CNGs" "CNKI" "CNTFRα" "CNUH" "CNVs"
    "COLO" "COLO-320" "CONDEL" "COS-1" "COUP" "COUPTF" "COUPTFs" "COX-2+8374T"
    "COX-2+8473T" "COX-2-1195G" "COX-2-765G" "COX2-1195G" "COX2-765G" "CPA-7"
    "CPN" "CPP–DNA" "CPP–siRNA" "CR208" "CRAM" "CRC-negative" "CRC-positive"
    "CRE-half" "CREDO" "CRISPR" "CRLF3" "CRYs" "CS-component" "CSC-like"
    "CTC2151-2153del" "CTCAE" "CTD-3022N7" "CTFβ" "CTFβ-99" "CUL3-mediated"
    "CVA16" "CXCL" "CXCR" "CXCR4-tropic" "CaCl" "CalbioChem" "Calmette"
    "Calmette–Guérin" "Calphstin" "Cambridge" "Canada" "Canadians" "Cantley"
    "Carba" "Carboxyl-termini" "Carboxyl-terminus" "Caris" "Carlsbad" "Carna"
    "Carney" "Carrere" "Cartharius" "Casimiro" "Caspase-1" "Caspase-3" "Casson"
    "Castiglioni" "Castro" "Castro-Sanchez" "Catalouge" "Caucasian"
    "Caucasians" "Caucasoid" "Ccnd" "Cdc20–D-box" "Cdc45-Mcm2-7-GINS" "Cdc5c"
    "Celebrex" "Celgene" "Cenci" "Cenini" "CenpF" "Cftr" "ChEMBL474807"
    "ChIP-PCR" "ChIP-qPCR" "ChIP-qPCRs" "Changzheng" "Charité"
    "Checkpoint-sensitive" "Chi-Square" "Chi-square" "Chile" "Chilean" "China"
    "Chk1" "Chk1-null" "Chk1S317A" "Chk1S345A" "Chk1degradation" "Choi" "Chou"
    "Chr5" "Christensen" "Christophorou" "Chávez" "Chávez-Sánchez" "Cip" "Cip1"
    "Cl" "Clara" "Class-I" "CldU" "Cleveland" "Click-SILAC" "Click-iT"
    "ClinicalTrials" "Clinico-pathological" "Clock" "Clontech" "ClpB" "CoTC"
    "Cobas" "Cochrane" "Cog8p" "Col2" "Col2.3Cremice" "Col2α1-Cre" "Col2α1Cre"
    "Cole" "Collagen1α1" "College" "Collins" "Colombia" "Colorado" "Columbia"
    "Comstock" "ConsensusPathDB" "Control" "Coomassie" "Corticosteroids"
    "Costa" "Costello" "Counter-regulation" "Cowden" "Cox-proportional"
    "Coxsackie" "CpG-island" "CpG-islands" "Cq" "Cramer" "Cri-du-chat" "Crm"
    "Crm-1-dependent" "Croce" "Crohn" "Crohn's" "Cross-resistance"
    "Cross-species" "Crouzon" "Cruz" "Cry-deficient" "Csibi" "Ct" "Ct-values"
    "Ctgf" "Cui" "Cullin" "Cullin-RING" "Cunningham" "Curtis" "Curtiss"
    "Cushing-like" "Cy" "CyDye" "CycE" "Cyr61" "Cys-MTSL" "CytoScan" "Cα" "Cβ"
    "Cβ–Cγ–Cδ–Cε" "Cγ" "Cε" "C–6E" "C–S1E" "D-cyclins" "D-loop" "D-serine"
    "D-type" "D17S2179E" "D1–D8" "D2" "D2357E" "D3" "D3H2LN" "D3T" "D425A"
    "D458-Luc" "D5F3" "D6" "D87" "D88" "D89" "D99-Y100" "DAKO" "DAPKs"
    "DAPKs1–3" "DAS28" "DAVID" "DBC1ΔLZ" "DBQ" "DBS" "DBZ"
    "DC-SCRIPT-expressing" "DC-SCRIPT-inducible" "DC-SCRIPT-mediated" "DC-like"
    "DCAF12L1" "DDR-signalling-cascade" "DEFA" "DEFA-T1" "DEFA1" "DEFA1-T1"
    "DENND2A" "DENV" "DENV-Fluc" "DFG-out" "DG" "DGV" "DHFR-Luc" "DIV14"
    "DIV15" "DIV8" "DME" "DN-Cas4" "DN-IκBα-expressing" "DNA-AR" "DNA-PET"
    "DNA-PKs" "DNA-damage-activated" "DNA-damage-dependent"
    "DNA-damage-induced" "DNA-damage-sensing" "DNA-protein" "DNAI1"
    "DNA–histone" "DNase1" "DNaseI" "DNaseI-seq" "DOGS-NTA-Ni"
    "DPX-encapsulated" "DR-GFP" "DRAKs1" "DRB1*1501" "DRIP+RH" "DRIP-seq"
    "DRMR" "DRP" "DT13" "DV2" "DVVEV" "DW22" "Dalmases" "Damme" "Danes" "Dangi"
    "Dangi-Garimella" "Danish" "Danshen" "Danvers" "Darby" "Dave" "Davies"
    "Dawley" "Dawson" "Dbf4-Drf1-dependent" "Dekker" "Del-carriers"
    "Deprivation-induced" "Design" "Desorption" "Detrisac" "DiGeorge" "Diao"
    "Dictyostelium" "Diego" "Diisocyanates" "Dikshit" "Dimitorvaet" "Dimitrova"
    "Dimpy" "Disse" "Dmp53" "Dose-intense" "Dose–response" "Dotap"
    "Dotap-nanoparticles" "Double-label" "Doulias" "Dox-fed" "Doyle" "DpSPVF"
    "Draviam" "Drohsa" "Drug" "Dual-color" "Dual-parametric" "Dulbecco"
    "Dulbecco’s" "Durham" "Dutch" "Dvorak" "Díaz" "D–4F" "D–S3F" "E+T" "E-box"
    "E-caherin" "E-prostanoid" "E1A" "E1b" "E2+TNFα" "E2-conjugase" "E2A-PBX1"
    "E2F-deficient" "E2F-inducible" "E2F1-3a" "E2F1-lys185" "E2F1-mediated"
    "E2F1–3A" "E2F1–5" "E2F1–6" "E2F3b" "E2F6–8" "E2f3+" "E3-ligase"
    "E3-ligases" "E369fs" "E370fs" "E371del" "E371fs" "E374X" "E378del" "E380X"
    "E381del" "E396del" "E403X" "E405del" "E5.5" "E7-infection" "E746-A750"
    "E746-A750del" "E746–A750" "E746−A750" "E83Stop" "E85-H90" "E8Nfs" "EAU"
    "EAp53" "EBM-2" "EBNA" "EC+TM" "EC-TM-A391E-JM" "EC-TM-JM" "EC-TM-JM-FP"
    "EC-TM-JM-YFP" "EC-TM-JM-mCherry" "ECOG" "ECTM" "ECTM-JM" "EDSS" "EEs"
    "EFB2" "EFGR" "EGAS00001001102" "EGF-family" "EGF-like" "EGF-receptor"
    "EGF-unstimulated" "EGFR2" "EGM-2" "EHSCC" "EKVX" "EL858R" "ELMO" "ELOB"
    "EMAN" "EMAN2" "EMAP" "EMAP-II" "EMC" "EMC-286" "EML4-AL"
    "EML4-ALK-positive" "EMT-TFs" "EMT-like" "ENDOG" "EORTC" "EPTF" "ER+ve"
    "ER-Stress" "ER-adaptive" "ER-coactivator" "ER-quality" "ER-resident"
    "ER-stress" "ER-stress-related" "ERE-DNA" "ERE-luc" "ERE1" "ERE3" "ERSE2"
    "ERα-coactivator" "ERα-status" "ERαs" "ETS-1expression" "ETSα" "EUS"
    "EUS-FNA" "EV71" "EVH1" "EVILLLDSDE" "EXIST-1" "EXIST-2" "EZH" "EZH2-8KR"
    "EZH2-T345-P" "EZH2-T487-P" "Easter" "Edfeldt" "Effect" "Egger" "Egger’s"
    "Eid" "Eighty-seven" "Eker" "Elk" "Emory" "EndMT" "EndoH" "Endohm"
    "English" "English-language" "Ensa" "Entrez" "EpiTYPER"
    "Epithelial-mesenchymal" "Erasmus" "ErbB" "ErbB2-dependent" "ErbB4" "Erk"
    "Erridge" "Esser" "Esterbauer" "Estrella" "Ets-2-DNA" "Etv" "Etv-4" "Etv-5"
    "Etv-6" "Europe" "European" "Europeans" "Eveno" "Evin" "ExAC" "Eμ-MYC"
    "Eμ-tTA" "E–3G" "E–6G" "F-FDG" "F-FDG-PET" "F-Luc" "F-MDM2" "F-actin"
    "F-actin-depolymerization" "F-fluorodeoxyglucose" "F-luc" "F1" "F114HA"
    "F3-EML4-ALK" "F508del" "F6" "F6C" "F979A" "FACPGM" "FADH" "FAM14"
    "FAT-family" "FAT2" "FAVA5" "FBN1was" "FBNI" "FBS-MEM" "FBXW" "FBXW7-KO"
    "FDG-PET" "FDG-avid" "FDG-uptake" "FEMF" "FEMFs" "FENG" "FERM" "FGF14-Nav"
    "FH-SPOP-WT" "FIGO" "FIRE-3" "FITC-BCL-2" "FITC-BIM" "FKBP12-rapamycin"
    "FLAG" "FLAG-Ataxin-10-WT" "FLAG-EZH2-K348Q" "FLAG-EZH2-K348R"
    "FLAG-LRP16-expressing" "FLAG-N" "FLAG-Polη" "FLAG-agarose"
    "FLAG-immunoblot" "FLAG-tag" "FLT3-ITD" "FLT3-T1" "FLT3-T1-3" "FLT3-T2"
    "FLT3-T2-standard" "FLT3-T3" "FMN1" "FN1EDA" "FNA" "FNs" "FOLFOX"
    "FOPFlash" "FOS-like" "FPKM" "FRA" "FRB" "FVC" "FXR1" "Fatty-fibrous" "Fc"
    "Fe" "Ferrante" "Fes" "Fifty-four" "Fifty-nine" "Fifty-one" "Figarska"
    "Filho" "Finger" "Finland" "Firefly" "First-line" "FirstDiv" "Fischer"
    "Flag" "Flag-Ski" "Flaherty" "Fluc" "Fluoromount" "Fn" "FoSTeS" "Follow-Up"
    "Follow-up" "For-1195G" "Forty-eight" "Forty-three" "Fp" "Fra-1"
    "Fractional" "France" "Francisco" "Franco" "Fratta" "Fraumeni" "Freiburg"
    "French" "French's" "French-Canadians" "Freund" "Friedman" "Fu" "Fuhrman"
    "Funaba" "Funel" "FusionSeq" "G-765C" "G-LISA" "G-MDSCs" "G-actin"
    "G-agarose" "G-allele" "G-rich" "G-to-A" "G-to-T" "G0" "G0-phase" "G1"
    "G1+S-early" "G1-S" "G1-S-G2-M" "G12" "G12D" "G13" "G15D" "G1656" "G2"
    "G2-M" "G2-to-M" "G270A-V271A-F271A" "G2M" "G3M" "G3MB" "G719X" "G@K563"
    "G@K588" "G@R568" "G@R591" "G@V564" "GA+AA" "GALNT" "GBM8" "GC+CC"
    "GC-skew" "GCN" "GCN4" "GCNs" "GCS" "GCTGAGnnn" "GDM" "GECs" "GEF-ARF"
    "GEMM" "GENCODE" "GENCs" "GFAP-Tat" "GFAP-gp120" "GFFG" "GFP-HIF-1α-S247A"
    "GFP-HIF-1α-ΔΝ" "GFP-LC3B" "GFP-PELP1-expressing" "GFP-SLX4-ΔSIM"
    "GFP-eIF2α" "GFP-eIF2αS51A" "GFP-empty" "GFP-fluorescence" "GFP-mSLX4"
    "GFP-mSLX4-enriched" "GFP-neg" "GFP-p53MT" "GFP-pos" "GFP-transgenic"
    "GG+GA" "GG+GC" "GGCA" "GIBCO" "GIC" "GIPZ" "GIR" "GISTIC2" "GLM"
    "GLOBOCAN" "GO-203-2C" "GPi" "GRCFP" "GRO-seq" "GSCKV" "GSE-781" "GSE11877"
    "GSE12276" "GSE14020" "GSE18497" "GSE2034" "GSE2603" "GSE30219" "GSE31309"
    "GSE3189" "GSE33630" "GSE5327" "GSE6344" "GSE7023" "GSE781" "GSK3-pathway"
    "GSK3βCA" "GSKβ" "GST-4E-BP1" "GST-Ataxin-10-S12A" "GST-Ataxin-10-WT"
    "GST-Aurora" "GST-FAD104N" "GST-Pin1-WW" "GST-YAP" "GST-fusion" "GTIIC"
    "GUA81" "GVD" "GVD-AAA" "GVF" "GVF-AAA" "GWASs" "GYS1B" "Gab1FF"
    "Gab1Y627F" "Gadd45β" "Gain-of-Function" "Gain-of-function" "GalNAc"
    "GalNAc-O-Ser" "GalNAc-transferase" "GalNAc-transferases" "Galbraith"
    "Galectins" "Gambino" "Garcea" "Gargiulo" "Garimella" "Gatz" "Gautschi"
    "Gb" "Gc" "Gebbia" "Gebhardt" "Geile" "GenBank" "Gender-dependent"
    "Gene-dose" "Gene-environment" "GeneBank" "GeneCards" "GeneChip" "GeneID"
    "GeneIDs" "Geng" "Genome-wide" "Gensini" "George" "German" "Germany"
    "Germinin" "Germline" "Giampieri" "Gibbs" "Gilbert" "Giorgi" "Gleason"
    "Gli1gene" "Glycyrrhizin" "Gmh1p" "Goldberg" "Goldblatt" "Gonzalez"
    "Gonzalez’s" "Google" "Gouveia" "Grabner" "Grade-II" "Grade-III" "GraphPad"
    "Grasso" "Griot" "Guangzhou" "Guérin" "Gy" "Géranton" "Gö6976" "Gαi2"
    "G–3I" "H&E" "H-Ras12v" "H-bond" "H-bonding" "H-bonds" "H-score" "H1"
    "H1-β1" "H1975" "H1N1" "H2" "H2-H3" "H2BK12" "H2Bub1" "H3" "H3.3" "H3.3S"
    "H3.3S31" "H3.3S31ph" "H3.3Ser31ph" "H3K27" "H3K9" "H3K9Ac" "H3S10" "H3Y41"
    "H3pS10" "H4" "H4K12" "H4K12ac" "H4K12ac-BRD4-RNAPII-H2Bub1" "H4K16" "H5"
    "H5N1" "H7" "H7N9" "HA-Ataxin-10-12A-res" "HA-Ataxin-10-res" "HA-Aurora"
    "HA-PCNA" "HA-PCNA-WT" "HA-Plk1" "HA-immunoprecipitation" "HA-like"
    "HA-reactive" "HA-tag" "HA0" "HA114Myc" "HAART" "HADC2" "HB-CLS-2"
    "HBEC-3KT" "HBECs" "HC-DSBs" "HCC-827" "HCC-827GR" "HCC-relevant" "HCG"
    "HCI" "HCI-H446" "HCL-v" "HCT118" "HCVcc" "HCVpp" "HCYTMAG-60K-PX41"
    "HDAC-Romidepsin" "HDAC2-V5" "HDAC6-siRNA-1" "HDAC6-siRNA-treated"
    "HDAC8–1" "HDAC8–2" "HDAC8–3" "HDAC8–Largazole" "HDF" "HDFs"
    "HER2-double-negative" "HER2amp" "HER2amp-negative" "HESN" "HFE-145" "HFF"
    "HFK" "HFKs" "HG-media" "HGMB1" "HHB" "HHD" "HI-1" "HI-1–HI-2" "HI-2"
    "HI-2-H1" "HIF-1α1-347" "HIFα" "HIFβ" "HIPPO-let-7" "HIS-SUMO2-expressing"
    "HISPANEL" "HIVE" "HL7702" "HLA-DRB*1501" "HLA-DRB1*1501" "HLMCs" "HLMVEC"
    "HME3" "HN14" "HPCS" "HPDP" "HPMECs" "HPNE" "HPS" "HQPA" "HR-HPV"
    "HR-HPV16" "HR-HPV53" "HR-α" "HRGECs" "HRmutp53" "HRs" "HSCORE" "HSCOREs"
    "HSP100" "HSP104" "HSP70-like" "HSP70-substrate-CHIP" "HSP701.3" "HSP70s"
    "HSP90B3P" "HSPB1-cDNA" "HSPB1phosphorylation" "HSQC" "HSV-1" "HT1080"
    "Haffner" "Hailey" "Hailey–Hailey" "Handra" "Hanken" "Hansson" "Hantaan"
    "Hapmap" "Hardy-Weinberg" "Harris" "Haselbauer" "Hausp-interactions"
    "Hayes" "HbA1c" "Hbond" "HeLa-mycTNKS1BP1" "HeLa-shTNKS1BP1" "Heat-shock"
    "Heatmaps" "Hebei" "Hedgehog" "Hegde" "Hegele" "Heidelberg" "Helsen"
    "Helsinki" "Hemler" "Henan" "Henry" "HepG" "HepG2-shTNKS1BP1" "Her2"
    "Her2+ve" "Hercules" "Hernesniemi" "Heuckmann" "Hhpathways" "Higashimori"
    "High-fluorescence-intensity-puncta" "High-level" "High-risk" "Higo"
    "Hippo" "Hippo-YAP" "Hirota" "His-Aurora" "His-Flag-FOXK2" "His-PCAF"
    "His-Plk1" "His-Ub" "His-Ub-PCNA" "His-Ub-PCNA-WT" "His-Ub-modified"
    "His-tRNA" "His-ub" "His-ubiquitin" "Histone-3" "Hochberg" "Hodgkin"
    "Hodgkin’s" "Hoechst" "Hollestelle" "Hornbeck" "Horton" "Host-targeting"
    "Hot-spot" "HoxA-11" "Hp53int1" "HrasV12" "Hsd3b6" "Hsp70" "HuGene" "HuMC"
    "HuMCs" "Huang" "Huarte" "Hubei" "Huber" "Humphreys" "Huntington"
    "Huntington’s" "Hurwitz" "Hwang" "Hydrogen-deuterium" "Hyper-inflammation"
    "I+II" "I-II" "I-coated" "I2" "IAVs" "IBM" "IC50" "ICAM-I" "ICAM-II"
    "ICD-O-3" "ICMD" "ICOS-L-Fc" "ICOS-Ligand" "IDs" "IE1core" "IEF"
    "IFL±bevacizumab" "IFU" "IGF-1-mediated" "IGF-1-stimulated" "IGF1R-KD"
    "IGF1R-null" "IGF1R-α" "IGHV" "IGHV-34-negative" "IGHV-34-positive" "IHC-P"
    "IHS" "IIA" "III+IV" "III-IV" "III~IV" "III + IV" "IKKs" "IKαB" "IL-10–592"
    "IL-10–819" "IL-2Rα" "IL-2Rβ" "IL-33-administration" "IL-33R" "IL-6sR"
    "IL2RA-T1" "IL2Rα" "ILC2" "ILC2s" "ILF" "ILα" "IMC" "IMC-225" "IMC-3G3"
    "IMCD" "IMT12" "IMT14" "IMT2" "IMT3" "IMT46" "IMT48" "IMT7" "IMT8" "INFβ"
    "INFβ-induced" "INFγ-induced" "INK2A" "INKc" "INSBR" "INSRA" "INSRB" "INXS"
    "IP-MS" "IPACTR001" "IPACTR004" "IPACTR013" "IPACTR019" "IPASS" "IPGTTs"
    "IPR000980" "IPR002404" "IPR006020" "IQSEQ3" "IR-B" "IR-JMTK" "IR-JMTK-Cy3"
    "IR-JMTK-Cy5" "IR-specific" "IRES-like" "ISGs" "ISRE-luciferase" "ISS"
    "IST-9" "IT" "ITCHE3" "IU" "IVIS" "Ibeawuchi" "Icells" "Ideker" "Ifgbp4"
    "IgG1κ" "Igκ" "Ikeda" "ImClone" "ImageJ" "ImageStream" "Imager" "Impedance"
    "Inc" "Indianapolis" "Indigofera" "Ing1b" "InterPro" "Interleukin-25"
    "InuA" "Invitrogen" "Ionization" "IpgB1" "IpgB2" "Irvine" "Isodalt"
    "Israel" "Iwakawa" "Izumi" "I~II" "Iα" "IκB-kinase-β" "IκBm" "IκBɑ"
    "IκBα-M" "I–II" "J-kappa" "JAK2V617F" "JAKand" "JFH1-EGFP" "JNJ"
    "JNJ-26854165" "JNJ-ROS1i-A" "JNK-IN-8" "JNK1-mediated" "JRCSF" "JS-81"
    "JS81" "Jana" "Janet" "Jang" "JapA" "JapA's" "Japan" "Japanese" "Jayaraman"
    "Jefferson" "Jegher" "Jeghers" "Jeong" "Jewish" "Jews" "Jiang" "Jiangsu"
    "Jiao" "Jiménez" "Jiménez-Díaz" "Jin" "Jirawatnotai" "Jonasch" "Joseph"
    "Ju" "Jung" "K-M" "K3326X" "K385fs" "K385fs*47" "K391X" "K5Cre" "K8" "KAc"
    "KDAC6" "KEGG" "KFERQ" "KFERQ-like" "KG" "KI-D1b" "KIT-band" "KIT-mutant"
    "KLFs" "KPS" "KRAS12" "KRAS13" "KRD" "KTC" "KTC-26" "Kamada" "Kamburov"
    "Kandoth" "Kaneshiro" "Kaplan" "Kaplan-Meier" "Kaplan–Meier" "Keane" "Keap"
    "Kedar" "Kelch-like" "Kendall" "Kendrick" "Kenzelmann" "Kesari" "Kessler"
    "Kessler's" "Khader" "Kharrat" "Ki" "Ki-67" "Ki-67-positive" "Ki67LI"
    "Kiechl" "Kim" "Kimberley" "Kimura" "Kip" "Kirshner" "Kirsten" "Kligys"
    "Klippel" "Klippel-Trenaunay" "Klosek" "Knock-down" "Knodell" "Knudsen"
    "Koike" "Kolmogorov" "Kolmogorov-Smirnov" "Korea" "Korean" "Koytiger"
    "Kraus" "Krishnamurthy" "Krisko" "Krogan" "Kruskal–Wallis" "Kumar"
    "Kurtoglu" "Kuwait" "Kwak" "Kwon" "Kyoto" "L-glucose" "L1" "L1-L2" "L1–L3"
    "L2" "L367fs" "L367fs*48" "L4" "L4-L5" "L5" "L5-L6" "L52F" "L858R"
    "L858R+T790M" "L861Q" "L9" "LABA" "LAI" "LAMP1-reactive" "LATS" "LATS1-YAP"
    "LC3-interaction" "LC31→LC3II" "LC3B-I" "LC3B-II" "LC3I" "LC3II"
    "LC3I→LC3II" "LCLs" "LE" "LESC" "LFL" "LG-media" "LGALSL" "LGPUC" "LHS"
    "LINC00290" "LIPA" "LISA" "LLVY" "LLVY-AMC" "LM-qPCR" "LMFS" "LNI" "LR"
    "LREA" "LRRFS" "LS0082" "LS141" "LS6500" "LS7785-1" "LS7785-10" "LS8107"
    "LS8313" "LS8817" "LSL-25,26" "LSL-G12D" "LSLp53" "LTL-331" "LUAD"
    "LV-cont-infected" "LV-shDUSP1" "LV-shDUSP1-infected" "LV-shDUSP1–1"
    "LV-shDUSP1–2" "LV-shDUSP1–3" "LW" "LXXLL" "LY94002" "Laakso" "Labsystems"
    "Lacombe" "Lamy" "Landis" "Langerak" "Langerhans" "Lanni" "Laplante"
    "Large-scale" "Laser-gene" "Lassa" "Latin" "Lats-null" "Lats1" "Lazo"
    "LeVine" "Leggett" "Lehmann" "Lemmon" "Lenti-GFP" "Lenti-NICD1"
    "Lenti-NICD1-4" "Lenti-NICD2" "Lenti-NICD3" "Lenti-NICD4" "Leonarduzzi"
    "Li" "Li-Fraumeni" "Li-Fraumeni-like" "Liang" "LicoA" "LicoA-Sepharose"
    "Licochalcone" "Licor" "Liddle" "Liddle’s" "Linc01092" "LincRNA-p21"
    "Lincoln" "Line-389" "Line-65" "Line-669" "Lithospermum" "Liu" "Liu's"
    "Loc554202" "Loc728606" "Log-rank" "Log2FC" "Lohr" "Lonza" "Lopez"
    "Lopez-Beltran" "Lorh" "Low-level" "LoxP" "Lu" "Luca" "Luhyan" "Luminoskan"
    "Lundgren" "LungCarta" "Lunn" "Luo" "Luxol" "Lys1030-Glu1047"
    "Lys136–Phe143" "Lysine" "M-FISH" "M-MDSCs" "M0" "M1-M5" "M6P" "MAC"
    "MACS2" "MAP1LC3B‒PE" "MAP4-MT" "MAPK-induced" "MAPK-mediated" "MATLAB"
    "MB-435" "MBP-reactive" "MC3482" "MCE" "MCF-7-2Si" "MCF-7-2si"
    "MCF7-DC-SCRIPT" "MCF7-shCtrl" "MCF7-shCtrl-tfLC3" "MCF7-shYAP"
    "MCF7-shYAP-tfLC3" "MCF7EV" "MCF7EV16" "MCF7SC" "MCF7SC29" "MCF7SC36"
    "MCF7and" "MCMC" "MD-MB-435S" "MDA-MB-231-4175" "MDA-MB-231BoM-1833"
    "MDA-MB-231BrM2a" "MDA-MB-231s" "MDA231BrM" "MDA231cells"
    "MDM2-overexpression-mediated" "MDSCs" "MED8A" "MEFS" "MEK1-CA" "MEKi"
    "MET-like" "MGC2055" "MGH131-1" "MGH131-2" "MHC-II" "MIBC" "MK-3475"
    "MK-8353" "MMECs" "MMP-activatable" "MMP-involved" "MMR-intact" "MMTS"
    "MNGC" "MOIs" "MOMA-2" "MPN-unclassified" "MREs" "MRL" "MRN" "MS" "MS-Fit"
    "MSF2" "MSF4" "MSI-H" "MSI-L" "MSKCC" "MSPL" "MSSS" "MT-PELP1"
    "MT-PELP1-expressing" "MTS" "MTSL" "MUC16-Cter" "MV4" "MVLD" "MW299" "MWAs"
    "MYCER" "MacDonald" "Mackay" "Madhusudhan" "Madin" "Madin–Darby" "Maejima"
    "Maillard" "Malats" "Malumbres" "Marburg" "Marca" "Marchesani" "Maria"
    "Marinelli" "Maroteaux" "Martinez" "MassARRAY" "Massachusetts" "Massagué"
    "Masubuchi" "Material" "Matsuura" "Maurice" "Mayer" "Mb" "McCune"
    "McCune-Albright" "McMahon" "McR2" "Mcm2-7" "Meacham" "Mediatech" "Medline"
    "Meier" "Melles" "Mendell" "Mendelsohn" "Menhaden" "Merck" "Merkel"
    "Merzbacher" "Mestizo" "Methe" "Methods" "Mevellec" "Mexican"
    "Mexican-American" "Mexicans" "Mexico" "MiR-146a" "MiR-15" "MiR-18a"
    "MiR-199a" "MiR-199a-2" "MiR-199a-5p" "MiR-199b-5p" "MiR-21is" "MiR-491-3p"
    "MiR29b" "MiRNA-10b" "MiaPaCa-1" "MiaPaCa-2-Luc-eGFP" "Michelsen"
    "Michikawa" "Michnick" "Micro-metastases" "MicroRNA-10b" "MicroRNA-34a"
    "Microsoft" "Mier" "Millipore" "Minella" "Mis-Localization"
    "Mismatch-repair" "Mismatch-repair-deficiency" "MitoTracker" "Miyamoto"
    "Mol-SHARE" "Moller" "Mologni" "Monro" "Moraceae" "Moreau" "Moreno"
    "Moreno-Bueno" "Morimoto" "Moritz" "Mothe" "Mrp" "Ms4a4b" "Mst" "Mueller"
    "Muenster" "Multiskan" "Multivariate" "Murayama" "Muro" "Musgrove" "Mutant"
    "Mutationin" "MyD88-dependent" "Myc-tag" "Myers" "MzChA1-parent" "M±SD"
    "Müllerian" "MΦ" "MΦs" "N-BAX" "N-acetylgalactosamine"
    "N-acetylgalactosaminyltransferase" "N-glycosidase" "N-linked" "N-lobe"
    "N-stage" "N0" "N4" "N7" "N=3" "NA" "NA19020" "NASH-like" "NBM" "NBNC"
    "NBT" "NC+PKCε" "NCBI" "NCBI’s" "NCI" "NCI60" "NCRN" "NCSLC" "NCT00623870"
    "ND+BafA1" "ND+CQ" "NDDs" "NDR" "NF-B" "NF-kB1" "NF-kβ" "NF-κB-dependent"
    "NF1Prx1" "NF1patient" "NFSPLARRVDR" "NFκB1" "NFκB3" "NH125" "NH2-group"
    "NHEMs" "NHK" "NIRDPBS" "NLADA" "NLCSFV3" "NMIBC" "NMIBCs" "NMSCs"
    "NOD-SCID" "NOG-hCD34" "NORE" "NORE1A-delSARAH" "NORE1A-induced" "NOTHC1-4"
    "NOTHC3" "NPI" "NPM-ALK-positive" "NR-coactivator" "NRE" "NSAID-users"
    "NSC656202" "NSTEMI" "NTUH" "NaH" "Nacaeeati" "Nakatani" "Napoles"
    "Narayan" "Nardo" "Nav1.6" "Nav1.6-C-tail" "Nec-1s" "Nephromine" "Neskey"
    "NetOGlyc4.0" "Netea" "Netherlands" "Network" "Neurosurgery" "Never-smoker"
    "Next-generation" "NextBio" "Nf1Prx1" "NfPrx1" "Ni" "Ni-NTA" "Ni-affinity"
    "Ni-pull-down" "Nicholls" "Nicotiana" "Niederst" "Nishida" "Nombre"
    "Noonan" "Notch" "Notch-mediated" "Notch-pathway-specific" "Notch-related"
    "Novi" "Nowak" "Nrf2" "Nrf2-P" "Nrf2-caveolae" "NuRD" "Nuak1" "Nucleo"
    "Nui" "Nunc" "Nε" "N–H" "O-GlcNAcylation" "O-glcNAcylation" "O-glycosite"
    "O-glycosites" "O-glycosylation" "OA" "OCT3" "OFAR1" "OFAR2" "OLINK" "OMIM"
    "ONM" "ONOO" "OPUS" "OR" "OR=0.95" "OR=0.99" "OR=1.01" "OR=1.05" "OR=1.06"
    "OR=1.08" "OR=5.68" "ORs" "Objective" "Obrdlik" "Ochoa" "Ocvirk" "Oddo"
    "Oderda" "Ogata" "Okazaki" "Oklejewicz" "Oliver" "Olsen" "OncoScan"
    "Oncogenex" "Oncology" "Oncomine" "One-hundred" "Optiview" "Ortega" "Osman"
    "Otsubo" "Ou" "Oxford" "Oxygen-glucose" "P-LC" "P0" "P1" "P1-Luc" "P16"
    "P2" "P2-Luc" "P34S" "P72" "P72A" "P75A" "P85" "P94A" "P=0.0007" "P=0.001"
    "P=0.005" "P=0.009" "P=0.01" "P=0.02" "P=0.03" "P=0.04" "P=0.059" "P=0.3"
    "P=2.83x10" "P=2.84x10" "P=2.96x10" "P=3.1x10" "P=4.10x10" "P=5x10"
    "P=7.8x10" "P=8.28x10" "PAGE" "PANTHER" "PAPS" "PAR-PARP1-dependent"
    "PARPi" "PAb240" "PBS-treatedIcos" "PBs" "PBu" "PC3AR-LBD" "PCAT1" "PCAT18"
    "PCAT8" "PCAT9" "PCGEM1" "PCMV6" "PCNA-WT" "PCR-RFLP" "PCR-SSCP" "PCT"
    "PD-L1-directed" "PD033291" "PD033299" "PD318088" "PDBID" "PDGF" "PDGF-CC"
    "PDGF-CC-induced" "PDGFRα" "PDGFRαα" "PDGFRαβ" "PDGFβ" "PDK" "PDK1i" "PDKi"
    "PDQuest" "PDSI" "PELP1-shRNA-expressing" "PELP1–MTp53" "PEST" "PET-CT"
    "PETACC3" "PF-treated" "PF878" "PFGE" "PFIgG" "PFT-α" "PG240" "PGC1-α"
    "PGH" "PI3KCA" "PI3KK" "PI3Kand" "PI3KΔp85" "PIK3R3-C10orf81" "PIKKs"
    "PISCC" "PKBβ" "PKCεA" "PKCεI" "PKH-26" "PKM2-depletion-induced"
    "PKM2-knock" "PL046" "PML-I" "PML-IV" "PML-VI" "PMP"
    "PMP22-aggregate-containing" "PMP22-like" "PMP22-positive" "PNAS" "PNGaseF"
    "POSCCE" "POSDRU" "PP2A-A" "PP2A-Cα" "PP2A-like" "PP2Acα" "PP6C-PP6R"
    "PP6R2" "PP6Rs" "PPMS" "PPXP" "PQR" "PR-positive" "PRAP" "PRC2-A" "PRC2-B"
    "PRKX" "PRNCR1" "PSA-recurrence" "PTEN-mutation-negative" "PTEN-proficient"
    "PTENWT" "PTGS" "PTP-defective" "PTPMeg2" "PVIgG" "PXXY" "PZA" "Paeoniae"
    "Paez" "Paik" "Paik’s" "Pairwise" "Pakistani" "Pan-EGFR" "Paolillo" "Paolo"
    "Papanikolaou" "Parkinson" "Parkinson’s" "Partek" "Pasini" "Pasterkamp"
    "Pathare" "Pawson" "PbR" "Pdgfa" "Pearson" "Pearson's" "Pearson’s" "PegIFN"
    "Pelizaeus" "Pelizaeus-Merzbacher" "Pennsylvania" "Percipalle" "Perez"
    "Perez-Pinera" "PeriCre" "PeriCreandNf1" "Perrimon" "Petre" "Petre-Draviam"
    "Petrucelli" "Peutz" "PfSIR2A" "Philadelphia" "Phillips" "Phiphilux"
    "Phipps" "Phosphenolpyruvate" "Phosphosite" "Piccini" "PiggyBac" "Pin1–Rb"
    "Pinera" "Pinton" "Piscataway" "Plex" "Pneumonic-type" "Poeta" "Pogue"
    "Pogue-Geile" "Poisson" "Poisson–Boltzmann" "Polyphen-2" "Polζ"
    "Polη-deficient" "Polη-mediated" "Polη-proficient" "Positron"
    "Post-Genomic" "Post-surgical" "Post-translational" "Prapinjumrune"
    "Prensner" "Promega" "Protein-fragment" "Protein-ligand" "Proteoextract"
    "Prunotto" "Ptenmice" "Puc" "Puerto" "Pull-down" "PureLink" "PyVmT"
    "Pàez-Ribes" "P = 0.001" "P = 0.003" "P = 0.009" "P = 0.022" "Q-Lab"
    "Q-rtPCR" "Q-test" "Q1200X" "Q3" "Q4" "Q61" "QI" "QI-FRET" "QUADAS-2" "QV"
    "Qiagen" "Qiang" "R-2-HG" "R-CHOP" "R-Luc" "R-enantiomer" "R-hyper-CVXD-MA"
    "R-loop" "R-loop-driven" "R-loops" "R-mediated" "R-selective" "R1" "R1443X"
    "R172H" "R2" "R4" "R68" "R92-94A" "R=0.32" "R=0.37" "R=0.42" "R=0.57"
    "RAD-001" "RAD51-dsDNA" "RAD51-ssDNA" "RAD51–DNA" "RAD54L+B" "RAD54L+B-2"
    "RAD54L+RAD54B" "RAD6-RAD18" "RAEB" "RAEB-T" "RAGE-AGE" "RAS-expressing"
    "RAS-mutant" "RAS-pathway" "RE-1" "RE-A" "RE3" "RECQ1-regulated" "RENASICA"
    "RERT" "RFC-mediated" "RG7842" "RGD" "RIP2-promoter" "RIPA" "RIPX" "RIα"
    "RLU" "RMSD" "RMSDs" "RNA" "RNAPII-PSer2" "RNAas" "RNAfold" "RNAs" "RNeasy"
    "RP11-150I16" "RP11-203M5" "RP11-251I15" "RP11-339F13" "RP11-815K24"
    "RP11-817G24" "RP11-97P11" "RP11–199F11.2" "RPA32-S4" "RRRCWWGYYY" "RSXSXP"
    "RTKs" "RTPKs" "RUFY" "RV-CTR-SPG" "RV-NDRG1" "RV-NDRG1-transfected"
    "RV-miR-199a-3p-SPG" "RV-miR-199a-5p" "RV-miR-199a-5p-SPG" "RV-miR-CTR"
    "RV-miR199a-3p-sponge" "RXR-α" "RXXL" "Rab-family" "Rab7-positive" "Rac1"
    "Rac1-GTP" "Rac1GV12" "Rad17" "Rad3" "Rad3-related" "Rad51-dsDNA"
    "Radiation-associated" "Radiation-induced" "Radio-therapy" "Radix" "Raf-1"
    "Rahuel" "Rajamohan" "Ramachandran" "Random-effect" "Random-effects"
    "Ratka" "RayBio" "Rb-null" "RbLP-2S" "RbLP-2T" "RbSP" "Rcade" "Rd8"
    "Re-expression" "Re-introduction" "Re-plating" "Redmond" "Refseq"
    "RegulomeDB" "Reifenberger" "Reincke" "Reis" "Reis-Filho" "Renilla" "Rep2a"
    "Results" "Retentates" "Rett" "Reungwetwattana" "Rev-Man" "Reynisdottir"
    "Reynold" "RhoA" "RhoGTPases" "Ribes" "Rica" "Richter" "Richter’s" "Rico"
    "Riederer" "Roche" "Rockland" "Rockville" "Rodolico" "Rodriguez"
    "Rodriguez-Barrueco" "Rodway" "Rolland" "Rosa" "Rosa26-LacZ" "Rosenfeld"
    "Rossant" "Rossmann" "Rotterdam" "Roux" "Roux-en-Y" "Rs115474585" "Rudas"
    "Rumpf" "Ryan" "Rydén" "S-Nitrosoproteome" "S-adenosyl-L-methionine"
    "S-early" "S-late" "S-late+G2" "S-like" "S-nitrosoproteome"
    "S-nitrosoproteomes" "S-pulse" "S-segment" "S-to-M" "S-transition" "S1"
    "S12AS77AT82A" "S12V" "S1655" "S16H" "S17V" "S18A" "S1981"
    "S1981-phosphorylation" "S1A–C" "S1C" "S1D" "S1E" "S1F" "S1G" "S1H" "S1I"
    "S1J" "S1–S4" "S2035T" "S2056" "S21" "S235" "S255" "S2A" "S2B" "S2C" "S2D"
    "S2E" "S2F" "S2F–S2H" "S2G" "S2I" "S2J" "S2K" "S2L–S2N" "S2iL5" "S3" "S308"
    "S308-specific" "S317" "S317-Chk1" "S33F" "S345-Chk1" "S345-phosphorylated"
    "S380-385" "S3C" "S3D" "S3E" "S3H" "S3L" "S4" "S424" "S4A" "S4A–D" "S4A–E"
    "S4B" "S4C" "S4E" "S4F" "S51A" "S52D" "S56D" "S5A" "S5C" "S5D" "S5d–f" "S6"
    "S6-positive" "S65" "S669" "S6A" "S6I" "S6K1-ca" "S6K1and" "S6pS235"
    "S6pS240" "S7" "S718del" "S77AT82A" "S7A" "S7a" "S7b" "S7c" "S8" "S807"
    "S811" "S86A" "S8A" "S8B" "S9" "SA-β-Gal-positive" "SA-β-Gal-staining"
    "SAHB" "SAHBs" "SARAH" "SATB1-mediated" "SBMs" "SC79" "SCAR" "SCEs"
    "SCF-like" "SCH900353" "SCOS3" "SCRIPT" "SCRT" "SDH-mutant"
    "SDS-polyacrylamide" "SEMD" "SERCA" "SETX-containing" "SETX-dependent"
    "SGC" "SGC-790" "SGH" "SGH-44" "SGKi" "SGKs" "SH2-domain"
    "SH2-domain-containing" "SID1574" "SID1586" "SID343" "SIE3" "SIE4" "SIEs"
    "SIFT" "SIRPA" "SIRT1-3" "SIRT1-7" "SIRT4-7" "SIRT4–7" "SIRTs" "SIT4"
    "SIVE" "SJACT003" "SJACT004" "SJACT005" "SJACT006" "SJACT009" "SJACT017"
    "SJACT023" "SJACT062" "SJACT065" "SJACT069" "SJATC004" "SKX" "SKX-cells"
    "SLX4-ΔSIM" "SMIs" "SMMC-7721cells" "SN50" "SN77734" "SNOC"
    "SNP-miR-COX2-PGE2" "SNPHAP" "SNPs" "SNVs" "SOC3" "SOCSC3" "SOLAMEN" "SONG"
    "SORT-T1" "SPOP-D1–D8" "SPOP-substrate" "SPOP-ΔBTB" "SPOP-ΔMATH" "SPPQS"
    "SPRY4-IT" "SPRY4-IT1-induced" "SPRY4-IT1-inducible"
    "SPRY4-IT1-overexpressing" "SPRY4-IT1induced" "SPRY40-IT1" "SPSS" "SR"
    "SR-α" "SRC-3a" "SRC-3b" "SRC-3s" "SRC-3ΔCID" "SRC-interaction" "SREBFs"
    "SSC02696" "SSC03276" "SSCP" "SSc" "ST-HSC" "ST-HSC-enriched" "ST-HSCs"
    "STAT1activation" "STAT3-CA" "STAT3-CA." "STAT3-DNA-binding" "STAT3-null"
    "STAT3-proficient" "STAT3CA" "STAT3DN" "STE20-like" "STEMI" "STK11-SNP"
    "SUM-190" "SUMO–SIM" "SUMO–SIM-mediated" "SUVmax " "SVneo" "SW-780"
    "Sabatini" "Sabatini's" "Sadej" "Sahara" "Saharan" "Sakata"
    "Salvador-Warts-Hippo" "Sanchez" "Sandhu" "Sartoris" "Sastre" "Sato"
    "Saudi" "Scarf-Bloom-Richardson" "Schiewer" "Schlessinger" "Schoneveld"
    "Schrodiger" "Schultz" "Schulze" "Schwann" "Schweiger" "Sdn" "Seattle"
    "Second-generation" "SecondDiv" "Seelenmeyer" "Seet" "Segger" "Segmental"
    "Self-renewal" "Self-reported" "Selleckchem" "Sen1" "Sendai" "Seneviratne"
    "Sequence-Specific" "Sequenom" "Ser-235" "Ser-9" "Ser1981" "Ser2-P"
    "Ser2056" "Ser235" "Ser240" "Ser303" "Ser32" "Ser424" "Ser641"
    "Ser65-GST-4E-BP1" "Ser807" "Serva" "Servalytes" "Setx" "Seventy-four"
    "Seventy-seven" "Seventy-two" "Sfp" "Sgk" "Sh5" "Sh6" "Shang" "Shen"
    "Shimada" "Shor" "Short-term" "Sicinski" "Sigma-Aldrich" "Singh"
    "Single-Nucleotide" "Single-cell" "Single-molecule" "Single-nucleotide"
    "SingleQuot" "SirReal-mediated" "SirReal1" "SirReal3–6" "SirReal5"
    "SirReal6" "SirReals" "Sirt" "Sirt1-HM" "Sirt1–3" "Sirt1–6"
    "Sirt2-SirReal1-OTC" "Sirt2-SirReal2-H3" "Sirt2–ADPR" "Sirt2–SirReal"
    "Sirt2–SirReal1–OTC" "Sirt2–SirReal2" "Sirt2–SirReal2-H3"
    "Sirt2–SirReal2–H3" "Sirt2–ligand" "Sirt3-HM" "Sirt4–6" "Sirt5" "Sirtuin"
    "Sixty-five" "Sk" "Sk-ChA-1" "Sk-ChA-1cells" "Ski-associated"
    "Ski-coexpressing" "Ski-expressing" "Ski-induced" "Ski-mediated" "Ski4A16"
    "SkiW274E" "Skp-Cullin-Fbox" "Skp1" "Skp1-Cul1-F" "Skp1-Cul1-F-box" "Sloan"
    "Slpi" "Smad-induced" "Smad-mediated" "Smad2" "Smad3" "Smad3-Td-Tomato"
    "Smads" "Smirnov" "Sn" "Soeda" "Sogame" "Solomon" "Songyang" "Sonoyama"
    "Sos" "Sotiropoulos" "Sottero" "Sp" "Spain" "Spanish" "Spearman"
    "Spearman's" "Spearman’s" "Spodoptera" "Spotfire" "Sprague" "Src-dependent"
    "Srikantan" "Staaf" "Stage" "Stage_TNM" "Steinberg" "Stelzl"
    "Stress-activated" "Stress-induced" "Sub-Sahara" "Sub-Saharan" "SubG"
    "Sullivan" "Sulzer" "Sutton" "Swedish" "Swift" "SwissProt" "Switch"
    "Sánchez" "Søreide" "Sγ" "S–C–C–C" "T-77C" "T-category" "T-helper"
    "T-mismatch" "T-regulatory" "T-stage" "T1" "T1-T2-T3" "T1-weighted" "T180"
    "T2" "T202" "T205-FBW7" "T205-dependent" "T2152C" "T256" "T2DM" "T3" "T3-4"
    "T315I-mutant" "T394K" "T394k" "T3M4-Luc-eGFP" "T3SS" "T4" "T421" "T5" "T7"
    "T7-L4" "T790M" "T8-T10" "T8A" "T8D" "T@R591" "TA-p73γ" "TAF-15" "TAFIa"
    "TAP-MS-based" "TAS" "TAT" "TATA" "TATA-boxes" "TATA-less" "TAZ+Ski"
    "TAZS89A" "TAp53" "TAp53α" "TAp73α" "TAp73β" "TAp73β's" "TAp73γ" "TC+CC"
    "TC+TT" "TCID" "TCPA" "TEA" "TEAD1ΔC-YAP" "TEAD1ΔC-YAP(AD)" "TEAD1ΔC–YAP"
    "TEADs" "TEFb" "TET-on" "TFGβ-SMAD" "TGACnnnGC" "TGF-β1and" "TGF1β" "TGFR"
    "TGFβRII" "TGN" "TGN1412" "TGS" "TIA" "TIRF" "TKI-naïve" "TM-JM-YFP" "TMAF"
    "TMy" "TNBCs" "TNFα-treatment" "TNKS1BP1-proficient" "TNKS1BP1did"
    "TNSK1BP1" "TNSKS1BP1" "TO-PRO3" "TOPFlash" "TOT" "TPCK-trypsin" "TPPXS"
    "TR-FRET" "TSPAN2-Y5-7F" "TSPANs" "TTAGGG" "TTS " "TURB" "TV" "TX-1918"
    "Tagged-ULK1" "Taiwan" "Taiwanese" "Takahashi" "Takamochi" "Takamochi’s"
    "Talalay" "Tamagno" "Taqman" "TargetScan" "Tat" "Tat-HA" "Tat-expressing"
    "Tat-induced" "Tat-mediated" "Tau-ΔC" "Tax-induced" "Td" "Td-Tomato"
    "Td-tomato" "Tek" "Tel-Aviv" "Telomerase-Immortalized" "Telomerase-null"
    "Ter-stalled" "Tet-off" "Tet-on" "TetOn" "TetOn-TAp73α" "TetOn-TAp73β"
    "TetOn-ΔNp73" "Tewksbury" "Texas" "Th17" "Th17-cell" "Thailand" "TheMig6"
    "Thermo" "ThinCert" "Thirty-eight" "Thirty-seven" "Thirty-six" "Thirty-two"
    "Thomas" "Thr-202" "Thr-Pro-101" "Thr-rich" "Thr180" "Thr183" "Thr202"
    "Thr37" "Thr421" "Threonine205-Proline206" "Tiacci" "Tibco" "Tim-3"
    "Time-course" "Time-lapse" "Timlip" "Tinti" "Tn" "Tn-antigens" "Tobias"
    "Tocris" "Toll-like" "Toll1like" "Topo2" "Topo2α" "Topo2β" "ToppGene"
    "Towne" "Toyoshima" "Toyoshima's" "TpG" "TpXXS" "TpXXXS" "TrJ-HA3"
    "TrJ-PMP22" "TragetScan" "Trans-well" "Transmonolayer" "Transwell" "Trask"
    "Trembler" "Trembler-J" "Trembler-J-PMP22" "Trenaunay" "Tripathi"
    "Tris–HCl" "Triton-X" "TrkA" "TrkA-C" "Tsang" "Tsc2-null" "Tseng" "TspRI"
    "Tsujino" "Tu" "Tukey" "Turkish" "Tus" "Twenty-four" "Twenty-two"
    "Two-photon" "Two-way" "Type-II" "Typhimurium" "Tyr-204" "Tyr-568" "Tyr182"
    "Tyr185" "Tyr204" "TβRs" "T→E" "T→G" "U138MG" "U20S" "U251" "U2OS-B6"
    "U373" "U73122" "U87-miR-494-3p" "UACC1940" "UACC903" "UASMC" "UBB+1"
    "UBCs" "UC" "UC23" "UCCC" "UCSC" "UDP-GalNAc"
    "UDP-glucuronosyltransferases" "ULK" "ULN" "UMUC3-L" "UMUC9" "UNC1062"
    "UNC1653" "UNC1666" "UNM" "UNMH" "USA" "USD" "UTRb" "UTRs" "UV-B" "UV-C"
    "UV-C-triggered" "UV-HCMV" "UV-HCMV-induced" "UV-HCMV-infected"
    "UV-HCMV-mediated" "UV-SNV" "UV-irradiated" "UVA" "UVB" "UVC" "UW425"
    "UW426-Myc" "Ub-G76V-GFP" "Ub-K63-modified" "Ub-aggregates" "Ub-reactive"
    "Uberti" "Ueno" "Ullrich" "Unc-51-like" "UniGene" "Uniprot"
    "Universitätsmedizin" "Upadhya" "Urology" "Uruguay" "Usingp53" "V-Ki-ras2"
    "V-Raf" "V-raf" "V0" "V177C" "V3" "V5" "V5-tagged" "V600" "V600E" "V600E2"
    "V75A" "V82-Q84" "V985A" "VARNAGUI" "VASC100" "VASC101" "VASC102" "VASC103"
    "VASC104" "VASC105" "VCO2" "VDRE" "VDREs" "VE1" "VEGFR-2-negative"
    "VEGFR-2-suppressive" "VEGRF3" "VH" "VIDVE" "VK" "VL" "VM-CUB-1" "VO2"
    "VP3" "VPl" "VS-6063" "VVA" "Vanderbilt" "Vannini" "Varga" "Veh"
    "Vehicle-treated" "Venezuela" "Venkatesan" "Ventana" "Verghese" "Verhaak"
    "Vidal" "Vietnam" "Vinayagam" "Vink" "Vlashi" "Volinia" "Volm" "W138-VA13"
    "WB-308" "WCE" "WCLC" "WGS" "WI" "WP631" "WST1" "WT-EGFR" "WT-FBW7"
    "WT-GFP-PELP1" "WT-ILC2s" "WT-PELP1" "WTPTEN" "Waal" "Waals" "Wakahara"
    "Waksman" "Walkersville" "Wallis" "Walsh" "Waltham" "Walton" "Wan-ling"
    "WanFang" "Warburg" "Warburg’s" "Washington" "Watkins" "Webgestalt" "Weill"
    "Weill-Marchesani" "Weimann" "Weinberg" "Wellcome" "Werner" "Western"
    "Weyemi" "Whitehall" "Whitney" "Whole-cell" "Whole-exome" "Whole-genome"
    "Wiedemann" "Wilcoxon" "Williams" "Wilson" "Wong" "Woodsmith" "Worseck"
    "Wortmannin-treatment" "Wt-Myc3" "Wt-PMP22" "Wt-myc3" "Wu" "Wuhan"
    "Wynsberghe" "X-31" "X-ray" "X-tile" "X-zone" "X100" "XBP1-dependent"
    "XBP1-mediated" "XIII" "XP-V" "XP2SASV3" "XTrJ" "XU" "Xiao" "Xinjiang"
    "Xp11.23" "Y-F" "Y-family" "Y-phosphorylation" "Y1068" "Y1135" "Y1136"
    "Y124" "Y182" "Y204" "Y28C" "Y28C-MTSL" "Y394" "Y395" "Y659F" "YAP-5SA"
    "YAP-let-7" "YE" "YFP-PC3" "YFP-cells" "YO" "YO-PRO-1" "YRHHY" "YUMM1.5"
    "YUMM1.9" "YZH" "Yale" "Yamada" "Yanagawa" "Yang" "Yang’s" "Yanyang" "Yao"
    "Yaoi" "Yasuhiko" "Ye-chun" "Yes" "Yki-sd" "York" "Yoshioka" "Yu"
    "Z-Asp-CH2-DCB" "Z-DEVD-FMK" "Z-axis" "ZHONG" "ZNF703is" "ZNF703plays" "ZR"
    "ZR-51-30" "ZR-75" "Zeb1" "Zeiss" "Zhang" "Zhao" "Zheng" "Zhongnan" "Zhou"
    "Zhu" "Zicao" "Zou" "Zwijsen" "Zθ" "Z–Asp–CH2–DCB" "a-KG" "a-c" "a-d" "a-e"
    "a-ketoglutarate" "aMig6" "aPKCs" "aPPT" "aPTT" "aa2-29" "aa200-300"
    "aa205" "aa336-412" "aa340-360" "ab8224" "aberrantly-expressed" "abilities"
    "above-noted" "above450" "acDDR" "accorandance" "acetamide" "acetonide"
    "acetyl-lysine" "acetyl-lysine-binding" "acetyl-lysine-containing"
    "acetyl-lysine–binding" "acetylated-H3K9" "acetylated-lysine"
    "acetylation-defective" "acetylation-deﬁcient" "acetylation–defective"
    "acetylators" "acetylcholine" "acetylgalactosamine" "acid-binding"
    "acid-treated" "acinus-like" "acneiform" "acral" "across-talk"
    "actin-cytoskeletal" "actinomyces" "activation-loop" "activators" "acyl"
    "adaptin" "adducts" "adeno" "adenoma-carcinoma" "adenomectomy"
    "adenosine-5" "adenylate" "adipose-specific" "ado-trastuzumab" "adultdhtt"
    "advanced-stage" "ae" "afamelanotide" "afferents" "after-5" "agar" "age≥60"
    "aggregate-containing" "aggregophagy" "aglycone" "agonism" "air-exchanging"
    "air-liquid" "albicans" "alcohol-fed" "algorithm" "algorithms"
    "all-hydrocarbon" "all-or-none" "allodynia" "allograft" "alpha-C"
    "alpha-helical" "alpha-helices" "alpha-methyldopa"
    "alternate-reading-frame" "alveoli" "alymphoid" "amaranth" "amd"
    "amide-nitrogen" "amino-acid" "amino-terminal" "amino-terminally"
    "amino-terminus" "aminoacids" "aminobenzamide" "amplicon" "amplicons"
    "amygdala" "analysed±PMA" "ancer" "and-4.7" "and-7" "and-7023" "and-9"
    "andBraf" "andCCSP" "andEGFR" "andFAT4" "andHrasV12" "andIcos" "andMig6"
    "andNRF1" "andPrkaa1" "andPrkaa2" "andTP53" "anddhtt" "andp53"
    "androgen-ablation" "androgen-deprivation" "androgen-independence" "andv"
    "aneuploid" "aneuploidy" "angiontensin" "angiontensinogen"
    "anilinoquinazoline" "anisotropy" "anit-miR-16-1" "annexinV-FITC" "annum"
    "antagomirs" "anterior-specific" "antiangiogenesis-induced" "antiautophagy"
    "antibody-drug" "antidepressant-like" "antigen" "antigens" "antioncogene"
    "antiparallel" "antiplatelet" "antitumour" "aorta-gonad-mesonephros"
    "apical-basolateral" "apoptotioc" "apriori" "arisen" "armamentarium"
    "around-2.3" "arrayCGH" "arrest-associated" "arteriosus" "as-9.77"
    "as-of-yet" "as-yet" "asNRAS" "ase" "aspirin-intolerant" "associated-1"
    "associated-oncogenesis" "asthma-susceptibility" "atand" "athanogene"
    "ation" "atomic-bomb" "atypia" "aureus" "authors" "auto-crine"
    "autoinhibit" "autophago" "autophago-lysosomes" "autophagy-inductor"
    "autoradiograph" "autoradiography" "autosomal-dominant" "axial"
    "axis-targeted" "axon" "axon-related1" "azidohomoalanine" "azoles" "a–c"
    "a–d" "a–f" "b-c" "b-d" "b-e" "bafilomycinA" "bardoxolene" "basal-like"
    "be-19.2" "be-9.2" "bead-mill" "begun" "benifits" "benthamiana" "benzo"
    "benzoylstaurosporine" "benzyl" "benzyl-α-GalNAc" "beta-HCG" "beta-agonist"
    "beta-glucoronidase" "beta-oxidation" "beta-strands" "betadine" "betle"
    "better-known" "betweenHrasV12" "betweenIcos" "bi" "bi-allelic"
    "bi-directional" "bi-directionally" "bi-orientation" "bi-weekly"
    "binding-affinity" "binding-competent" "bio-availability" "bio-informatic"
    "bio-safety" "biofunctions" "biolipid" "biologically-aggressive"
    "biologically-sound" "biomarker-validation" "biosafety" "biospecimen"
    "bioterms" "biotin" "biotin-HPDP" "biotin-X-SSE" "bis-anthracycline"
    "bis-intercalates" "bisindole" "bisphosphate" "bisphosphoglycerate"
    "bisphosphoryl" "bivariate" "blastocyst" "blastocysts" "blastomas"
    "blasts-1" "blockers" "blood-brain" "blood–brain" "blood–tumor"
    "blue-print" "board-line" "bodyweight" "boney" "botanicals" "both10A"
    "bothHrasV12" "bothMig6" "bp" "brainstem" "branched-dendritic" "brassica"
    "break-apart" "breakpoint" "breakpoints" "breast-like" "brefeldin-A"
    "bright-blue" "broad-range" "broad-spectrum" "broader" "bromelain"
    "bronchoscopy" "browser" "brussels" "build-up" "burn-out"
    "butylhydroxyquinone" "butyrateand" "by-products" "byIcos" "c-IAP"
    "c-IAP、XIAP" "c-Src-dependent" "c-section" "cDNA" "cFN-EDA" "cPKCs"
    "cT1-2N0" "cTanyNanyM0" "cadmium-induced" "cafe-au-lait" "café"
    "café-au-lait" "caherin" "callosum" "calorimetry" "calpain-1" "calpain-I"
    "calphostin" "camostat" "cancer-supportive" "cantenin" "cap-dependent"
    "cap-independent" "capase-3" "capsase-4" "carbinol" "carbohydrazide"
    "carbon-carbon" "carbonitriles" "carbonyl" "carbonyl-O" "carbonyls"
    "carboxy-2" "carboxyl" "carboxyl-terminal" "carboxyl-terminus"
    "carboxymethoxyphenyl" "cardia" "cardio-facio-cutaneous" "cargo-specific"
    "cargos" "carinatum" "carotid" "carriers" "cartilage-specific"
    "case-by-case" "case-cohort" "case-control" "case-only" "case-patients"
    "casepase-9" "caspase-8-dependent" "caspase-9-dependent"
    "caspase-denpendent" "castration-resistance" "catalyse" "cation-pi"
    "cause-and-effect" "ccRCC" "cecum" "cell-autonomous" "cell-autonomously"
    "cell-cycle-dependent" "cell-cycle-independent" "cell-death-1"
    "cell-intrinsic" "cell-microenvironment" "cell-permeable" "cell-to-cell"
    "cell-type-dependent" "cellgrowth" "cells" "cellulo" "cell–pathogen"
    "centromere" "cerebellum" "cerevisiae" "change-the" "chaperone-response"
    "charcoal-stripped" "charcoal-treated" "charge-charge" "checkerboard"
    "checkpoint-activating" "checkpoint-effector" "checkpoint-induced"
    "checkpoint-inhibited" "chemically-diverse" "chemo" "chemo-sensitivity"
    "chemo-therapy" "chemoattractant" "chemokine-like" "chemokine-receptor"
    "chemoradiotherapy" "chemoresistance" "chemoresistant" "chemoresponse"
    "chemotherapy-naive" "chemotherapy-only" "chemotypes" "chi-square"
    "children" "chlorophenyl" "chlroquine" "cholan" "cholan-giocytes"
    "cholesterol-rich" "chosen" "chr11" "chromaffin" "chromatid" "chromatids"
    "chromatin-immunoprecipitation" "chromatin-remodeling"
    "chromosome-associated" "chromosome-microtubule" "chun" "chylothorax"
    "circuitry" "cis-adhesion" "cis-eQTL" "cis-or" "cis-regulatory"
    "cisplatin-DNA" "cisplatin–pemetrexed-based" "cisplatn" "cistrome"
    "cistromes" "clades" "classifier" "classifiers" "clearer"
    "clinical-pathological" "clinically-available" "clinically-relevant"
    "clinicians" "clinico" "clinico-pathological" "clonogenicty" "clover-leaf"
    "coactivator-1α" "coactivator-binding" "coagulants"
    "coagulation-fibrinolysis" "cobble-stone" "cobblestone-like" "cochaperone"
    "codeletions" "codon" "codon72" "codons" "coherences" "coid" "coiled-coil"
    "colectomy" "coli" "colitis-associated" "collagens" "collectives"
    "collegues" "colony-formation" "colony-forming" "colorectum" "commensalism"
    "commonest" "compacta" "comparedwith" "compartment-specific" "complex-Ab1"
    "compound-treated" "concentrations-erlotinib" "conductance" "conformers"
    "confounder" "confounders" "consolidation-type" "constitutive-homeostatic"
    "contra-indicate" "contributed-3.2" "control-shRNA-expressing"
    "copy-neutral" "corn-oil" "coronaviruses" "cortactin-rosettes"
    "corticoserone" "corticosteroid" "cost-effective" "cosubstrate" "cotarget"
    "covariate" "covariates" "covaries" "coworkers" "cribriform" "crine"
    "cross-communication" "cross-contamination" "cross-over" "cross-peak"
    "cross-phosphorylate" "cross-reactivity" "cross-regulating"
    "cross-resistance" "cross-sectional" "cross-sections" "cross-signaling"
    "cross-species" "cross-talking" "cross-transplantation" "cross-validation"
    "cryo-EM" "cryo-microscopy" "cryptochrome" "cryptochromes" "ctnnd2b"
    "culturedIcos" "cultureware" "cut-off" "cutting-edge" "cyclesuch"
    "cyclin-complex" "cyclin-complexes" "cyclohexamide" "cyclopentyladenosine"
    "cylin" "cystectomy" "cysteine-knot-type" "cyte" "cytoarchitecture"
    "cytochemistry" "cytohesin" "cytology" "cytoplasma" "cytoplasmic-positive"
    "d-dimers" "dL" "dUTP-biotin" "damaged-DNA" "dataset" "datasets"
    "day-to-day" "day–night" "dbSNP" "dbSNP129" "dbSNP135" "dbSNPs" "ddPCR"
    "de-adhesion" "de-emphasized" "de-repressed" "de-represses" "de-repression"
    "de-stabilization" "de-ubiquitinase" "deacetylators" "decanoyl" "decouple"
    "decreasedK" "deeper" "defactinib" "defatty" "defatty-acylation" "defects"
    "degron" "degron-like" "degrons" "del-carriers" "del19" "del4" "del5"
    "del6" "del7" "del8" "delL747" "delSARAH" "deletions" "delta-2"
    "delta-like" "demyristoylate" "demyristoylates" "dendrite" "dendrite-like"
    "denitrosylates" "densa" "densitometer" "density-dependent" "deoxycitidine"
    "deoxynucleotidyl" "deoxyuridine" "deprivation-induced"
    "deprivation-mediated" "der" "derma" "desmoglein" "desmoplasia"
    "deubiquinates" "dexa" "df" "dhtt" "di-substituted" "diabetes-induced"
    "diarlyureas" "dibenzoquinoline" "dibenzoquinoline-33b" "dibenzoquinolines"
    "dichlorofluorescein" "dichloropyridyloxy" "dichroism" "diet-controlled"
    "diet-treated" "diethyl" "difficult-to-replicate" "diffuse-proliferative"
    "dihydroxyvitamin" "diindolylometan" "diisocyanate" "dimerises"
    "dimethyl-α-ketoglutarate" "dimethylbenz" "dimethylmercaptophenyl"
    "dimethylmercaptopyrimidine" "dimethylthiahiazo" "dimmers" "diolepoxide"
    "dioxygenases" "diphenolaze" "diphenylmethane" "diphosphate" "diploid"
    "dipropylxanthine" "disabilitiesand" "disatinib" "discoideum"
    "discordances" "discrepant" "discriminant" "disesquiterpenoid" "disomy"
    "dnSTAT3" "dockings" "doi" "domainprotein2" "donor-acceptor" "dormancy"
    "dosage-dependently" "dose-dependently" "dose-limiting" "dose-reduction"
    "dose-relationship" "dose-response" "dose-responsive" "dose-responsively"
    "dose–response" "dot-like" "double-blind" "double-knockdown"
    "double-knockout" "double-membrane" "double-strand" "down-expression"
    "down-modulate" "down-modulating" "down-modulation" "down-stream"
    "doxifluridine" "draw-back" "drawn" "drinkers" "droplet" "droplets"
    "drug-discovery" "drug-levels" "drug-like" "dsRNAs" "dual-color"
    "dual-epitope" "dual-labeling" "dual-targeting" "ductus" "duplexes"
    "dwarfism" "dwarfisms" "dye-binding" "dyslipidemia" "dysplasia"
    "dysplasias" "dysplastic-alveolar" "dyspnea" "e-28" "e-29" "e-43" "e-f"
    "e-mail" "e.g.JAK-STAT3-TGFB1" "eIF2·GDP" "eIF2·GTP" "eIF2·GTP·Met-tRNA"
    "eIF2α-S51A" "eIF2α-kinase" "eIF2αS51A" "eIF2αis" "eIF2αvia"
    "eIF3η-associated" "eLife" "eNOSser-1177" "eRNA" "eRNAs" "eWAT"
    "ear-containing" "early-differentiation" "early-onset" "early-response"
    "early-stage" "easy-to-use" "easyFRAP" "ectodomain" "ectodomains" "edema"
    "edge-driven" "effecter" "eight-gene" "eightfold" "elF2a" "electron-dense"
    "element-1" "element-binding" "eluates" "emboli" "emphasise" "emphasises"
    "enantiomer" "encoding-vector" "end-fusions" "end-product" "end-stage"
    "endoMT" "endolyn" "endometrial-specific" "endometrioid" "endometrium"
    "endoproteases" "endothelia" "endothelial-mesenchymal"
    "endothelial-to-mesenchymal" "endpoint" "endpoints" "endproducts"
    "energies-2.3" "energy-0.7" "energy-2.7" "energy-5.9" "energy-9.77"
    "energy-consumption" "energy-generating" "energy-inefficient"
    "energy-producing" "energy-stress-induced" "enhancer" "enhancs" "enterica"
    "enthalpy" "entropy" "environment-dependent" "enzyme-solvent-inhibitor"
    "eosin" "eosinophil" "eosinophilia" "eosinophils" "epidermoid"
    "epigenotype" "epigenotype–malignant" "epithelia" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-specific" "epithelial-to-mesenchymal"
    "epithelial-to-mesenchyme" "epithelial–mesenchymal" "epithelioid"
    "epithelium" "epitheloid" "equal-caloric" "erbB" "erythema" "erythorid"
    "erythro" "erythro-poietin" "erythrocytes" "erythrorhizon" "ester-to-amide"
    "et" "ethambutol" "ethnicity-specific" "etoposide-VP16" "et "
    "eudesmanolide-guaianolide" "eugenol" "evaluators" "evalute" "everse" "ex"
    "ex3" "ex9-12del" "execution-phase" "exercise-induced" "exmaine" "exocrine"
    "exogenously-expressed" "exome" "exomes" "exon-4-deleted" "exon-disruptive"
    "exon6" "exons" "exon–intron" "experiment-wide" "experimentally-induced"
    "expressers" "expression-only" "expressionand" "extra-capsular"
    "extracellular-signal-regulated" "factor-1" "fad158" "false-positives"
    "far-exclusively" "farnesyl" "fascicles" "fasciculata" "fast-cycling"
    "fast-growing" "fast-tracking" "fatty-acylation" "feed-back"
    "feedback-loop" "feedforward" "female-enriched" "female-specific" "ferr-1"
    "ferr-1-treatedp53" "ferroptos" "ferrostain-1" "ferrostatin-1"
    "festoon-like" "ffu" "fiber-containing" "fibro" "fibro-adipose"
    "fibro-inflammatory" "fibro-myxoid" "fibroSblasts" "fibroadipose"
    "fibroblast-like" "fibromyxoid" "fibronolytic-impairment" "filopidia"
    "filoviruses" "fine-tune" "fine-tuned" "fine-tuning" "first-degree"
    "first-generation" "first-in-field" "first-line" "first-or" "fish-oil"
    "five-residue" "five-tier" "five-year" "fixed-model" "flask-like"
    "flavonoid" "flavonoids" "flexneri" "flexure" "florouracil" "flowchart"
    "flu-like" "fluid-to-plasma" "fluorescent-condensed" "fluorimeter"
    "fluorodeoxyglucose" "fluorophore" "fndc" "foliaceus" "folic" "follicles"
    "follow-up" "follow-ups" "following–loco-regional" "fontanel" "forBRAF"
    "forCC10" "forMig6" "foramen" "forced-expression" "forelimbs"
    "fork-associated" "forkhead-box" "forty-three" "four-generation"
    "four-helix" "four-locus" "four-stranded" "four-way" "four-week"
    "frameshift" "fresh-frozen" "from-1" "fromBraf" "fromEGFR" "fromIcos"
    "fromMig6" "fromPrkaa2" "frozen" "frugiperda" "fs" "fulgidus" "full-gene"
    "full-texts" "function-or" "fusiform" "fusion-type" "fusion–driven" "g-h"
    "gain-of-c-Myc-function" "gain-of-function" "gain-of-functions"
    "gain-of-the-function" "galectin" "gallbladder" "gamma-radiation"
    "gatekeeper" "gavage" "gender-dependent" "gender-specific" "gene-1"
    "gene-dose" "gene-environment" "gene-gene" "genes" "gene–environment"
    "genic" "genome" "genome-protective" "genome-wide" "genomes"
    "genotype-phenotype" "genotype–phenotype" "germ-line" "gfp" "gifatinib"
    "giocytes" "glia" "gliobastoms" "gliomatosis-like" "gloimas"
    "glomerular-specific" "glomeruli" "glomerulosa" "glomerulus" "glucocorti"
    "glucocorti-coid" "glucose-avid" "glucose-metabolism" "glutamylcysteine"
    "glutaryl" "glycaemia" "glycans" "glyceraldehyde-3-phosphodehydrogenase"
    "glyco" "glyco-metabolism" "glyco-phenotypes" "glycosite" "glycosites" "gm"
    "go-ichi-ni-san" "goes" "gp140" "granulocyte-monocyte" "granulosum"
    "greater" "greatest" "guaianolide" "guanylate" "guglesterone" "hCDC4-α"
    "hCMEC" "hESCs" "hFINS" "hHSC" "hHtt" "hPG" "hTERT-HPNE"
    "hTert-immortalized" "haematuria" "hairpin-mediated" "half-life"
    "half-lives" "half-maximal" "half-site" "half-sites" "half-width"
    "haplotype" "haplotypes" "head-and-neck" "head-to-tail" "healthy-smoker"
    "heat-shock" "heat-shock-inducible" "heathy" "heatmap" "heavier"
    "heavy-chain" "helices" "helix" "hemimegalencaphy" "hemocytometer"
    "hepatectomy" "hepatitis-induced" "hepato" "hepato-cyte"
    "hepatocyte-specific" "hepatome" "heptapeptide" "here-to-after"
    "herpesvirus-6" "herring-bone" "hetero" "hetero-complexes" "hetero-dimers"
    "hetero-trimer" "hetero-trimers" "heterocomplex" "heterodeletions"
    "heteroduplex" "heterotrimer" "heterozygote" "heterozygousdhtt"
    "hetpatitis" "hetrodimers" "hexachlorophene" "hexahistidine" "hexanoyl"
    "hexapeptide" "hg19" "high-affinity" "high-confidence" "high-density"
    "high-dose" "high-efficiency" "high-expression" "high-fat" "high-fidelity"
    "high-fluorescence-intensity" "high-grade" "high-intensity" "high-level"
    "high-magnification" "high-mannose" "high-mobility" "high-order"
    "high-performance" "high-quality" "high-resolution" "high-risk" "high-salt"
    "high-stage" "high-titer" "higher-grade" "higher-order" "higher-risk"
    "highly-conserved" "highly-induced" "hilar" "hindlimb" "histidinol"
    "histoarchitecture" "histoculture" "histologies" "histology"
    "histology-disease" "histomorphology" "histomorphometry" "histone-3"
    "histone–DNA" "histopathology" "hnRNPM" "hnRNPM3-M4" "hnRNPQ" "hoc"
    "homo-dimer" "homo-dimers" "homo-oligomerization" "homo-trimer"
    "homo-trimers" "homolog" "homologs" "homologuos" "homologuos-recombination"
    "homozygote" "homozygotes" "homozygousatg8a" "host-specific" "host-virus"
    "hotspot" "hotspots" "hr" "hsa-miR-130a" "hsa-miR-130b" "hsa-miR-148a"
    "hsa-miR-148b" "hsa-miR-152" "hsa-miR-301" "hsa-miR130a" "hsa-miR148"
    "hsa-miR148a" "hsa-miR152" "human-ICOS-L" "human-to-human" "humanBRAF"
    "hungbuk" "hydrocortisone-like" "hydrogel" "hydrogen-bond"
    "hydrogen-deuterium" "hydrophobic-to-hydrophilic" "hydroxycholesterol"
    "hydroxyguanine" "hydroxyl" "hydroxylases" "hydroxylglutarate"
    "hydroxymethylglutaryl" "hydroxymethylglutaryl-CoA" "hydroxytryptophan"
    "hydroxyuracil" "hygroscopicus" "hyper-CVXD" "hyper-activity"
    "hyper-inflammation" "hyper-inflammatory" "hyper-pRb" "hyper-proliferation"
    "hyper-secretion" "hyperalgesia" "hypercalcaemia" "hypercorticosteronaemia"
    "hypercorticosteronemia" "hyperinsulinaemia" "hyperinsulinemia"
    "hyperinsulinemic-euglycemic" "hypermutations" "hyperphagia"
    "hyperpigmentations" "hypo-phosphorylated" "hypo-phosphorylation"
    "hypo-responsive" "hypointense" "hypopharynx" "hypothermia" "hypotonia"
    "iPOND" "iReport" "ibo" "icariside" "identifiers" "ii" "iii" "iii–viii"
    "ileum" "ill-defined" "ill-health" "imidazol-5-yl" "imidazole"
    "immediate-early" "immune-regulation" "immune-related" "immune-suppressive"
    "immuno-cytokine" "immuno-precipitation" "immuno-signals" "immunoassay"
    "immunochemistry" "immunocytochemistry" "immunoglobulin" "immunoglobulin-3"
    "immunohistochemistry" "immunophenotype" "immunophenotypes"
    "immunoprecipiate" "immunoprecitates" "immunoprofile" "immunoreactivty"
    "immunotherapy" "in-cell" "in-depth" "in-frame" "in-gel" "in-hospital"
    "in-house" "in-silico" "in-situ" "in-spite" "in-vitro" "in-vivo" "inBraf"
    "inEGFR" "inFbxw7" "inHrasV12" "inIcos" "inKras" "inPrkaa2" "inRag2"
    "inUADT" "incognita" "incompliance" "indel" "indels" "independent-ATG"
    "indhtt" "indicatedthe" "indirubin-3" "indol" "indol-3-carbinol"
    "indolizidine" "induced-interaction" "infection-induced" "infiltrant"
    "inflammation-associated" "inflammation-induced" "inflammosome" "inframe"
    "infundibula" "infusion-stimulated" "ingle" "inhibite" "inhibites"
    "inhibiton" "inhibitor-dapagliflozin" "inhibitors" "initio"
    "injury-stimulus-induced" "inocula" "ins-carriers" "insQS" "insS" "insT"
    "insertions" "insulin-blocked" "insulin-containing" "insulin-dependent"
    "insulin-induced" "insulin-like" "insulin-mediated" "insulin-sensitive"
    "insulin-stimulated" "insulin-suppressed" "int" "intention-to-treat"
    "inter-chromosomal" "inter-individual" "inter-origin" "inter-patient"
    "inter-strand" "inter-substrata" "interactes" "interactio"
    "interaction-key" "interactome" "interactomes" "intercrosses" "interdomain"
    "interface-specific" "interferon-regulatory" "interferon-λ1"
    "intermediate-1" "intermediate-2" "interspace" "interstrand" "interwoven"
    "intima" "intoRag2" "intra" "intra-abdominal" "intra-chromosomal"
    "intra-patient" "intra-rectal" "intra-strands" "intracardiac" "intron1"
    "inv2" "invaginations" "invariant" "invasion-inhibitory"
    "invasion-relevant" "invasion-supportive" "inversely-correlated" "ionic"
    "ionization-time" "ionization–time" "ionization–time-of-flight" "ipgB1"
    "iron-chelator" "irradiation-induced" "is-1.47" "is-4.21" "ischaemia" "isg"
    "isocyanates" "isomers" "isopeptide" "isopropyl" "isotype" "isotypes"
    "isozyme" "isozymes" "iswhere" "ite" "iv" "junction-associated"
    "kappa-light-chain-enhancer" "karnofsky" "karyotypes" "kataegis" "kcal"
    "kd" "kdr1" "kdrl" "keratincoytes" "ketocholesterol" "ketoglutarate" "kg"
    "kinase-2" "kinase–substrate" "kinome" "kinome-wide" "kit-8" "knock-down"
    "knock-in" "knocked-down" "knocked-out" "knockin" "knocking-down"
    "knowdown" "known-down" "kymograph" "kΩ" "laevis" "lait" "lait-spots"
    "lambda" "lambdoid" "lamina" "large-cell" "large-form" "large-scale"
    "laser-induced" "laser-mediated" "late-G1" "late-onset" "late-replicating"
    "late-stage" "late-staged" "latentKras" "lavage" "leave-one-out"
    "lectin-receptor" "left-shifted" "left-sided" "lenti-sh-4"
    "lesion-specific" "lesion-specificity" "let-7b" "let7e" "leukemogens"
    "leukoencephalopathy" "levi" "levi-AChR" "lifespan" "ligand-1"
    "ligand-receptor" "ligand–kinase" "likeHrasV12" "lincRNA-21" "lincRNA-p21"
    "lincRNA-p21-depleted" "lineage-determining" "lineage-specific"
    "lipid-laden" "lipolysis-required" "lipopolysaccharide"
    "lipopolysaccharides" "lipoproteins" "lipotoxicy" "littermate"
    "littermates" "live-cell" "live-threatening" "lncRNA-SPRY4-IT1" "lobar"
    "lobule" "lobules" "locus-locus" "log-marginals" "log10-transformed"
    "logrank" "long-acting" "long-bone" "long-chain" "long-lasting"
    "long-lived" "long-range" "long-standing" "longer-term" "loss-of"
    "loss-of-function" "loss-of-the-function" "low-affinity"
    "low-allele-burden" "low-carbohydrate" "low-complexity" "low-confidence"
    "low-copy" "low-cost" "low-density" "low-dose" "low-expression"
    "low-frequency" "low-grade" "low-level" "low-levels" "low-molecular-weight"
    "low-output" "low-risk" "lowAR" "lower-risk" "lowerK" "loxP" "lpr" "lu"
    "luciferase-reporter" "luminescence-based" "luminometer" "lymph-specific"
    "lymphadenopathy" "lymphoblastoid" "lymphopenia" "lysine-63-linked" "lysis"
    "m-PGES" "m-PGES1" "m-SUVmax" "mA" "mBRAF" "mBrEC" "mCherry"
    "mCherry-GFP-Atg8a" "mG" "mIgG-treated" "mJ" "mKRAS" "mNampt" "mPAI-1"
    "mRFP" "mRFP-GFP-tagged" "mRNA-transcripts" "mRNAa" "mSIN3A" "mSIN3a"
    "mSirt1" "mSki" "mT" "mTOR-T" "mTOR-TE" "mTORCs" "mTORpS2448" "mV"
    "machanisms" "macrosomia" "macula" "macules" "magnesium-ATP" "mainchain"
    "maleate" "malformation-arteriovenous" "malignance" "malignant-specific"
    "mammography" "mammosphere" "mammospheres" "mangabeys" "manhedan"
    "manufacturer-provided" "marginals" "markers" "mastectomy" "mean±S"
    "mean±SD" "mean±s" "mean ± S" "mechanosensors" "medial-Golgi" "median=0.55"
    "median=0.98" "mediastinoscopy" "mediastinum" "mediater" "mediatesthe"
    "mediator-induced" "medulla" "melanin" "melanogaster" "melanotropine"
    "mellitus" "members" "menses" "mesenchymal-derived"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchymal-stem-like"
    "mesenchymal-to-epithelial" "mesenchymal-type" "mesenchymally-derived"
    "mesenchyme" "mesentericartery" "meta-database" "meta-regression"
    "metabsoslsim" "metal-dependent" "metal-thiolate" "metanephrines"
    "metaphyses" "metastasectomy" "metastasis-supportive" "meth"
    "methanesulfonate" "methanesulfonothioate" "methasone"
    "methotrexate–CPP–dextran" "methoxy" "methoxyestradiol" "methylademine"
    "methyladenine" "miR-100" "miR-101" "miR-103" "miR-105"
    "miR-10b-E2F1-regulated" "miR-1307" "miR-139-5p" "miR-143" "miR-145"
    "miR-145-VDRE" "miR-145-induced" "miR-146a" "miR-15" "miR-152" "miR-155"
    "miR-15a" "miR-16-1" "miR-17" "miR-17-92" "miR-17-reduced"
    "miR-17-transfected" "miR-17–92" "miR-17∼92" "miR-181a2" "miR-181b1"
    "miR-184" "miR-18a" "miR-191" "miR-195" "miR-199-3p" "miR-199-5p"
    "miR-199a" "miR-199a-2" "miR-199b-5p" "miR-19a" "miR-19b" "miR-19b-1"
    "miR-200" "miR-200b" "miR-200s" "miR-203" "miR-204" "miR-20a" "miR-20b"
    "miR-211" "miR-218" "miR-21also" "miR-21expression" "miR-223" "miR-25"
    "miR-26a" "miR-26b" "miR-27a" "miR-30a" "miR-30c" "miR-31" "miR-328"
    "miR-338-3p" "miR-34" "miR-34–induced" "miR-375" "miR-421" "miR-424"
    "miR-484" "miR-491-3p" "miR-491–3" "miR-491–39" "miR-494" "miR-498"
    "miR-503" "miR-508-5p" "miR-509" "miR-509-3-5p" "miR-509-5p" "miR-548b-5p"
    "miR-548c-5p" "miR-548n" "miR-610" "miR-625" "miR-768-3p" "miR-802"
    "miR-874" "miR-92-1" "miR-93" "miR-98" "miR148-152" "miR199-5p" "miR199a"
    "miR199a-3p" "miR200c" "miR29" "miR30" "miR30a" "miRDB" "miRNA" "miRNA-10b"
    "miRNA-143" "miRNA-23b" "miRNA-296-5p" "miRNA-34a" "miRNA-548" "miRNAs"
    "miRWalk" "miRanda" "micrOTOF" "micrOTOF-Q" "micro-albuminuria"
    "micro-dissected" "micro-environment" "micro-irradiation" "microRNA-122"
    "microRNA-199a-5p" "microRNA-34" "microRNA-451" "microRNAs"
    "microangiopathy" "microarchitecture" "microautophagy" "microbiota"
    "microblisters" "microcon" "microdeletions" "microdomains"
    "microelectrodes" "micrographs" "microlesions" "microphages" "microplate"
    "microsatellite" "microseconds" "microvessel" "microvessels" "mid-luteal"
    "mid-somitic" "midzone" "mild-moderate" "miltiorrhiza" "mineralcorticoid"
    "mini-gene" "minichromosome" "minipumps" "minus-strand" "miofibrocytes"
    "mir" "miravirsen" "miroRNAs" "mis-localization" "misbalance"
    "mismatch-repair" "mismatch-repair-deficiency" "mismatch-repair-deficient"
    "missense" "mito-genic" "mitochondrial-dependent" "mitochondrial-mediated"
    "mitomycin" "mitotane" "mitotracker" "mmLDLs" "mmps" "mmuno"
    "mock-infected" "mock-infection" "mock-irradiated" "mock-transfected"
    "mock-treated" "mode-of-action" "moderate-scale" "moderate-to-strong"
    "modification-susceptible" "modifications" "modiﬁcations"
    "molecularly-defined" "molecularly-driven" "molecularly-targeted"
    "molecules" "mono-ADP-ribose" "mono-ADP-riboses"
    "mono-ADP-ribosylhydrolase" "mono-specific" "mono-ubiquitin"
    "monocyte-derived" "monolayer" "monotherapy" "morbidities" "morphants"
    "morpho" "morpho-immunohistochemical" "morpho-immunohistologic"
    "morpholino" "morpholinos" "motif-containing" "motile" "mouse-ICOS-L" "mt"
    "mucosa" "mucosae" "multi-basic" "multi-component" "multi-cycle"
    "multi-drug" "multi-ethnic" "multi-ethnicity" "multi-functional"
    "multi-gene" "multi-institutional" "multi-layer" "multi-level"
    "multi-membrane" "multi-mono-ubiquitination-dependent" "multi-mutational"
    "multi-organ" "multi-photon" "multi-protein" "multi-step" "multi-system"
    "multi-unit" "multicenter" "multicentre" "multichains" "multicycle"
    "multilineage" "multimarker" "multinucleate" "multiorgan" "multiple-factor"
    "multiple-independent" "multiple-mono-ubiquitination" "multiple-test"
    "multiprotein" "multisite" "multistage" "multisystem" "multitarget"
    "multityrosine" "muscle-invasive" "muscle-specific" "muscularis"
    "mutant=15" "mutants" "mutations" "mutp53" "myc-CHIP" "myocardium"
    "myocytes" "myofi" "myofi-broblast" "myofibro" "myofibro-blasts"
    "myofibroblastic-type" "myosinIIb" "myristate" "myristoyl" "mytomicin"
    "myxoid" "myxovirus" "n-3PUFA" "n=10" "n=12" "n=13" "n=15" "n=17" "n=18"
    "n=19" "n=2" "n=21" "n=3" "n=4" "n=48" "n=5" "n=6" "n=7" "n=8" "n=9"
    "nCounter" "nPKCs" "nanoliter-sized" "nantais" "naphthyl" "naphthylmethyl"
    "native-PAGE" "naturalis" "naïveIcos" "ncomms7263" "ncomms7285"
    "ncomms7377" "ncomms7496" "near-complete" "nearby-localized" "nearest"
    "necrostain" "neg" "negative-feedback" "negatively-charged" "neo-adjuvant"
    "neoadjuvant" "neocortex" "neointima" "neoplastic-specific" "neovas"
    "neovas-cularization" "nephrectomy" "nephron" "nephropathy" "nepthropathy"
    "network-based" "neurite" "neuro" "neuro-inflammatory" "neurode"
    "neuroendocrine" "neuropathology" "neurosphere" "neurospheres"
    "neurosurgeons" "neurotrophic-like" "neutropenia" "never-smoker"
    "never-smokers" "new-diagnosed" "newer" "newly-introduced"
    "newly-published" "next-generation" "nicotine-alone–treated" "nigricans"
    "nitrosocompounds" "nitrosoproteome" "nocodazol" "noncancer" "noncarriers"
    "nondamage" "nonhistone" "nonhomology" "nonliver" "nonmalignant"
    "nonrepair" "nonrepressed-2" "nonresponders" "nonresponse"
    "nonresponsiveness" "nonsignificant" "nonsteroid" "nonuniform"
    "normal-growing" "normal-like" "normal-tumor" "not-yet-identified"
    "notHRasV12" "notochord" "notochords" "nt" "nterferon" "nuclear-negative"
    "nuclear-positive" "nuclear-to-cytoplasm" "nucleases" "nucleate" "nucleo"
    "nucleoproteins" "null-associated" "null-mutation" "nullatg1" "nuocytes"
    "occlusion-induced" "oedema" "oestrogen" "of-2.74" "of-4.19" "of-4.8"
    "of-4.87" "of-6.58" "ofBraf" "ofCC10" "ofEGFR" "ofHrasV12" "ofIcos"
    "ofMig6" "ofNf1" "ofPrkaa2" "ofdhtt" "off-target" "ofp53" "olddhtt"
    "olderMig6" "oleic" "oligo" "oligomycin" "oligopyrimidine" "oligos" "ology"
    "olymorphisms" "omega-3" "omentum" "on-going" "on-line" "on-target"
    "oncogenic-Ras-expressing" "oncology" "oncosphere" "oncotarget" "oncovin"
    "one-component" "one-factor" "one-shot" "one-sided" "one-sixth" "one-step"
    "one-third" "one-year" "onlyFAT3" "ontogeny" "oocytes" "oophorectomy"
    "open-circuit" "open-label" "opy" "or-3" "orEGFR" "orIcos" "orKras"
    "orMig6" "order-disorder" "ordinate" "ordinates" "organelle" "organelles"
    "organoid" "organs" "orgine" "ornithine" "oropharnyx" "oropharynx"
    "orosphere" "orp53" "ortholog" "orthologue" "orthologues"
    "orthomyxoviruses" "orthotopic-implanted" "osteoblasts"
    "osteochondrodysplasia" "osteopenia" "ought" "out-migration" "out-of-focus"
    "out-of-frame" "outcomes1" "outcompete" "outs" "over-activation"
    "over-activity" "over-fitting" "over-matching" "over-phosphorylation"
    "over-production" "over-representation" "overall-survival" "overdose"
    "oxPAPC" "oxi" "oxi-dative" "oxidative-stress" "oxygenase-1" "p21Waf1"
    "p21p23" "p27CK-DD" "p27CK-expressing" "p27T157DT198D" "p27pT157"
    "p27pT157pT198" "p27pT198" "p300-Ab1" "p300-Ab2" "p300-TAp73"
    "p300-mediated" "p300-recruiting" "p300-regulatory" "p38MAPK" "p38β"
    "p3X-FLAG-114HA" "p3X-FLAG-CMV9" "p50α" "p53-CGI" "p53-defective"
    "p53-defficient" "p53-hubs" "p53-independence" "p53-mutant" "p53-null"
    "p53-proficient" "p53-regulated" "p53-repressive" "p53DBS" "p53RE" "p53REs"
    "p53β" "p53–CHIP–BACE1" "p53–DNA" "p55α" "p61B-RAF" "p70S6K1-mediated"
    "p70S6kinase" "p70pT389" "p73-A2B" "p73-mediated" "p73β" "p85-sXBP1"
    "p85α-sXBP1" "p90S6" "p90pT359" "p=0.0002" "p=0.0004" "p=0.0005" "p=0.001"
    "p=0.002" "p=0.003" "p=0.004" "p=0.013" "p=0.017" "p=0.022" "p=0.034"
    "p=0.04" "p=0.06" "p=0.07" "p=0.08" "p=0.09" "p=0.133" "p=0.25" "p=0.261"
    "p=0.27" "p=0.28" "p=0.31" "p=0.356" "p=0.41" "p=0.51" "p=0.56" "p=0.86"
    "p=0.89" "p=5.5×10" "p=5.78×10" "p=9.59×10" "pABCE" "pABCE1" "pABCE1-V5"
    "pAMPK" "pApo" "pBabe" "pBin" "pBin61-ABCE1" "pBin61-AtRLI2" "pBin61-GFFG"
    "pBin61-GFP" "pCDNA-SPRY4-IT1" "pCDNA-ZNF703" "pCDNA3" "pCHK1" "pCMV"
    "pCMV-ISceI-3NLS" "pCMV6-XL5" "pCR" "pCRMP2" "pDCX" "pDSRed-I-SceI-GR"
    "pDSRed-ISceI-GR" "pEGFP-C1" "pEGFP-C1-TNKS1BP1" "pEGFP-RUFY3" "pEGFR"
    "pEGFR-1068" "pEZX" "pEZX-PG04" "pFAK" "pFLuc" "pGC" "pGL3-Basic"
    "pGL3-basic" "pGab1" "pH" "pHER2" "pJAK2" "pJNK" "pMKP1-Ser334-dependent"
    "pMSCV-PGK-EGFP" "pMSCV-miR-199a5p-PGK-EGFP" "pMtor" "pN" "pP" "pP19-V5"
    "pPELP1" "pS" "pS70SK" "pS77" "pS807" "pSAHB" "pSAHBs" "pSPTF" "pSTAT3"
    "pSTAT3pY705" "pSXXF" "pSecTag2C" "pSer2056" "pStAR" "pT" "pT2" "pT2–4"
    "pT3" "pT308" "pT4" "pT473" "pTNM" "pTyr-H3" "pULK3FLAG" "pUb-reactive"
    "pUb-substrates" "pY-PPI" "pY-PPIs" "pY-Y2H" "pY-interaction" "pY-reader"
    "pY-reader–pY-reader" "pY68" "pYAP" "pYxNx" "pack-year" "pair-specific"
    "paired-end" "palmitoyl" "pan-cancer" "pan-genotypic" "pan-inhibitors"
    "pan-sirtuin" "pancreatitis" "panniculectomy" "papaverine" "para-crine"
    "parachrine" "paracrine" "parainfluenzavirus" "paralog" "paralogues"
    "paraoxonase-1" "parenchyma" "partners" "patho" "patho-histologically"
    "pathobiology" "pathogen-associated" "pathogen-induced" "pathomechanism"
    "pathophysi" "pathophysi-ology" "pathophysiology" "pathways" "patients"
    "patients-lung" "patients-tumors" "pattern-recognition" "pb" "pcDNA3-Akt"
    "pcDNA3-STAT3" "pcDNA3-empty" "pcDNA3.1-CK1δ" "pcDNA3.1-PCNA" "pcDNA3.1A"
    "pdgfra" "pectus" "pedicle" "pedicles" "pegfilgrastim" "peginterferon"
    "penetrance" "penetrant" "pentanucleotide" "pentose-phosphate" "peptidases"
    "peptide-substrate" "peptide–DNA" "perhaps" "peri-lesional"
    "peri-operative" "peritoneum" "peroxylipid" "pertuzumab-trastuzumab"
    "phagophore" "pharmacophore" "pharmacotherapy" "phase-I" "phase-contrast"
    "phase-specific" "phenethyl" "phenobarbitol" "phenyl" "phenylmethysulfonyl"
    "phenylpyridinium" "phenytetrazoliumromide" "phloem" "phosphate-mimicking"
    "phosphatidylinositol-3-phosphate" "phosphatidylinositol-4,5-biphosphate"
    "phosphatidylinositol-4,5bisphosphate" "phospho-S308" "phosphoAKT"
    "phosphoERK1" "phosphoH3" "phosphoS6" "phosphoSTAT5" "phosphoamino"
    "phosphodiester" "phosphohistone" "phosphoinositides" "phosphoinositol"
    "phosphoinositol-3-kinase" "phosphopantetheinyl" "phosphopeptide"
    "phosphopeptides" "phosphor-specific" "phosphorylated-S6"
    "phosphorylated-tyrosine" "phosphorylation-deﬁcient" "phosphosulfate"
    "photomicrographs" "photons" "photoproduct" "phyla" "physicians" "phytogen"
    "phytohemaggluttinin" "pi-pi" "pifithrin-α" "pigmentosa" "pinciple"
    "piperidin" "piperidin-1-ylmethyl" "pituitary-adrenal-endocrine" "pixel"
    "placebo-controlled" "placebo-treated" "plasmacytoid" "plasmid–CPP"
    "plasmid–CPPs" "platin" "platin–pemetrexed" "pleomorphism" "plexiform"
    "pneumonic-type" "podosome-like" "poietin" "polethylglycol"
    "polethylglycol–hydrogel" "polo-box" "poly-ADP-ribose" "poly-Glutamine"
    "poly-ribosylation" "polyQ" "polyhedron" "polyhydramnios" "polymerase-1"
    "polymorphism-308G" "polypeptide-like" "polyphenols" "polyploid"
    "polysome-bound" "polysomy" "polyubiquitination-proteosome"
    "poor-prognosis" "poor-responders" "poorer" "poorest" "poorly-defined"
    "pore-forming" "pos" "positive-to-total" "positron-emission-tomography"
    "post-5" "post-BM" "post-IAV" "post-STZ" "post-attachment"
    "post-castration" "post-diagnosis" "post-end" "post-endocytic" "post-entry"
    "post-infection" "post-injury" "post-irradiation" "post-ligation"
    "post-menopausal" "post-metastasectomy" "post-mitotic" "post-natal"
    "post-operative" "post-pregnancy" "post-prostatectomy" "post-pubescent"
    "post-radical" "post-receptor" "post-replicative" "post-surgical"
    "post-transcriptional" "post-transcriptionally" "post-transduction"
    "post-transfection" "post-translation" "post-translational"
    "post-translationally" "post-transplantation" "post-treatment"
    "postdischarge" "posttest" "predrug" "pregnane" "premiR" "premiR-30a"
    "preprotrypsin" "preterm" "pretest" "pretreatment-mediated"
    "prevalence-incidence" "preventes" "pri" "pri-miR-30a" "pri-to"
    "primer-probesets" "primer-template" "principalcells" "prion-like" "priori"
    "pro-EMT" "pro-angiogenic" "pro-apopotic" "pro-autophagic" "pro-autophagy"
    "pro-cancer" "pro-caspase-3" "pro-caspase-9" "pro-fibrotic"
    "pro-inflammatory" "pro-invasion" "pro-invasive" "pro-malignant"
    "pro-metastatic" "pro-migratory" "pro-proliferative" "pro-recombinogenic"
    "pro-survival" "pro-tumor" "pro-tumorigenic" "proband" "probands"
    "probe-set" "probesets" "procaspase-3" "procaspase-3 " "processing-body"
    "product-moment" "progenies" "progeny" "prognosis-gene" "progressors"
    "progrowth" "proliferator-activated" "proliferator-activator"
    "promoter-activity" "promoterless" "proof-of-concept" "proof-of-principal"
    "proof-of-principle" "proportional-hazards" "propria" "proprolif"
    "proprolif-erative" "prorenin" "prosperities" "prostaglandins"
    "prostatectomy" "protein-10" "protein-DNA" "protein-coding" "protein-drug"
    "protein-interaction" "protein-ligand" "protein-peptide" "protein-sequence"
    "protein-α" "proteinopathy" "proteins" "protein–DNA" "protein–substrate"
    "proteome" "proteome-scale" "proteome-wide" "proteosome" "protomer"
    "protoncogene" "protooncogene" "proven" "pscore" "pscores"
    "pseudo-acetylated" "pseudo-contiguous" "pseudo-control" "pseudo-substrate"
    "pseudo-tumor" "pseudosubstrate" "pseudotype" "pull-down" "pulldown"
    "pulled-down" "pulposus" "pulsatile" "pulse-chase" "pulsed-field" "punctae"
    "pyrazinamide" "pyrene-trans-7,8-dihydrodiol-9,10-epoxide"
    "pyridazin-3-ylamine" "pyridin" "pyridin-3-yl" "pyridin-4-ylmethylene"
    "pyridine" "q-value" "qua" "quantitated±PMA" "quarter-century" "quasi"
    "quasi-two-dimensional" "quasispecies" "quiesce" "rFSH" "rLH" "rPAI"
    "rPAI-1" "race-specific" "radiation-associated" "radiation-induced"
    "radiculopathy" "radio-labelled" "radio-resistance" "radio-sensitization"
    "radiobiology" "radioresistance" "radioresistant" "raft–associated"
    "random-effect" "random-effects" "random-model" "rank-sum" "rapalog"
    "rapalogs" "rapamcyin" "rarer" "rasopathies" "re-analyse" "re-analyzed"
    "re-assembled" "re-assessed" "re-chromatinization" "re-classification"
    "re-classifying" "re-confirmed" "re-considered" "re-differentiated"
    "re-distributed" "re-distribution" "re-engagement" "re-enter" "re-entered"
    "re-entry" "re-establish" "re-established" "re-establishment" "re-evaluate"
    "re-evaluation" "re-examination" "re-examined" "re-express" "re-expression"
    "re-extracted" "re-immunoprecipitation" "re-ligation" "re-loading"
    "re-localized" "re-organization" "re-overexpression" "re-plating"
    "re-replication" "re-routing" "re-run" "re-sensitize" "re-sensitized"
    "re-sensitizes" "re-started" "re-tested" "re-uptake" "re1epithelialization"
    "re1epithelization" "reaction-restriction" "read-out" "read-outs" "readout"
    "readouts" "real-world" "recepteur" "receptor-coactivator"
    "receptor-ligand" "receptor-mediated" "receptor-receptor" "receptor-γ"
    "recombination-mediated" "recoveredp53" "recta" "recuurences" "red-colored"
    "red-to-green" "reengage" "reestablishes" "refold" "refractoriness"
    "refs13–17" "regions" "regions1" "regrowth" "regulaton" "regulators"
    "regulome" "relatedness" "remodelers" "repair-independent"
    "repeat-containing" "repeat-driven" "replication-associated"
    "replication-based" "replication-competent" "replicon" "reporter-gene"
    "repressors" "reproductive-aged" "residuals" "resistance-genes" "resp"
    "responder" "retentate" "reticularis" "retro" "retrotranslocate"
    "retrovirus" "reuptake" "reverse-phase" "reverse-transcription"
    "reversion-inducing" "revertant" "rhabdoid" "rho-value" "rho=0.28" "ribose"
    "ribosylases" "right-sided" "rightmost" "rigid-body" "ring-atom" "risen"
    "risk-reductions" "risk-stratify" "rituxan" "rosette-like" "rosveritrol"
    "rotarod" "roziglitazone" "rpm" "rs10318" "rs10411210" "rs10411210C"
    "rs1042522" "rs1053004" "rs1053005" "rs1053023"
    "rs1053023-rs1053005-rs1053004" "rs10749971" "rs10787498"
    "rs10787498-rs4353229" "rs10787498G" "rs10787498GT"
    "rs10787498TT-rs12247479GG" "rs10795668" "rs10849605" "rs1127687"
    "rs1127687-rs10787498" "rs1127687AG" "rs1127687GG-rs10787498TT"
    "rs1127687GG-rs12247479GG" "rs11571833" "rs12247479" "rs12247479A"
    "rs12247479AG" "rs12247479GG" "rs1321311" "rs1321311G" "rs139701269"
    "rs143880510" "rs1524107" "rs1800469" "rs1800629" "rs1800795" "rs1800796"
    "rs1801321" "rs1805388" "rs20417" "rs2066992" "rs2069837" "rs2227631"
    "rs2227956" "rs2273773" "rs2279744" "rs2293152" "rs2735940" "rs2736098"
    "rs2736100" "rs2853669" "rs2868371" "rs2910164" "rs3024505" "rs3218536"
    "rs355527" "rs3740051" "rs3818292" "rs4353229" "rs4353229TT" "rs4648551"
    "rs4746720" "rs4779584" "rs4939827" "rs4986790" "rs5275" "rs5788" "rs6092"
    "rs630923" "rs689466" "rs7045" "rs7069102"
    "rs7069102G-rs3818292A-rs4746720T" "rs718282" "rs744166" "rs7574865"
    "rs7895833" "rs8074524" "rs9282860" "rs957970" "rs961253" "rsNGT"
    "rsNGT-RYGB" "rsT2DM" "run-on" "s00428-015-1719-6" "s10549-015-3281-y"
    "s10555-015-9552-6" "s12943-015-0309-1" "s12943-015-0314-4"
    "s12943-015-0316-2" "s12943-015-0318-0" "s12943-015-0323-3" "sDAF"
    "sarcomatoid" "scatterplots" "sclero" "sclero-derma" "screenings" "sd"
    "sec-2" "second-degree" "second-generation" "second-line" "second-most"
    "secretome" "secretomes" "seed-soil" "self-acetylation" "self-cleavage"
    "self-comorbidities" "self-polymerization" "self-propagating"
    "self-reactive" "self-regulatory" "self-renew" "self-renewal"
    "self-ubiquitination" "selfrenew" "sella" "selumetanib" "semi"
    "semi-permeable" "semi-quantitative" "semi-quantitatively" "senesce"
    "senescence-inducing" "senescence-like" "sensitizer" "sensitizers" "sensu"
    "sequelae" "sequence-selectivity" "sequence-specific"
    "sequence-specifically" "sequestosome" "sequestosomes"
    "ser-10-phosphorylated" "serine-2" "serine-3" "serine-phosphatases"
    "serine-proteases" "serine-threonine-kinase" "seroconvert" "seroconverters"
    "serologically-confirmed" "seronegatives" "serpine"
    "serum-glucocorticoid-induced" "serum-proficient" "serumfree" "seven-day"
    "sex-based" "sex-specific" "shAKT" "shCONTROL" "shCTNNB1" "shFBXW7"
    "shFBXW7-10" "shFBXW7-8" "shGFP" "shHDAC9" "shMS4A4" "shMS4A4v4" "shNRF2"
    "shNSC" "shPML" "shPdk1" "shR" "shR-554" "shR-749" "shR-MOCK" "shRNA-mir"
    "shRNAp53" "shSgk3" "shake-off" "sheet-like" "sheet-αC" "shock-induced"
    "short-chain" "short-circuit" "short-extremity" "short-hairpin"
    "short-limb" "short-segment" "short-term" "short-time" "showen" "shp62"
    "shrunken" "shut-down" "si-AP2" "si-G9-1" "si-NS"
    "si-SPRY4-IT1-transfected" "si-SPRY4-IT1-treated" "si-eIF4E" "si-eIF4G"
    "si-eIF4GI" "siAP-1" "siCTRL" "siControl" "siDicer" "siERK" "siERK1"
    "siERK1+2" "siERK2" "siGALNT1" "siGLI2" "siNDRG1" "siNDRG1-trans-fected"
    "siNT" "siPKC" "siPKC-α" "siPML" "siRAD51" "siRAD54B" "siRAD54L"
    "siRAD54L+B" "siRAD54L+B-2" "siRAD54L+RAD54B" "siRAD54L+RAD54B-2" "siRNA"
    "siRNA-374" "siRNA-ERK#1" "siRNA-ERK#2" "siRNA-PTK6#1" "siRNA-PTK6#4"
    "siRNA1" "siRNA3" "siScramble" "siScramble-MGC-803" "siYAP1"
    "siYAP1-MGC-803" "siYB-1" "side-by-side" "side-chain" "side-effect"
    "side-effects" "sidechains" "sigmoid" "signal-strength" "signal-to-noise"
    "silico" "simpler" "simplest" "simplex" "simulatio" "single-cell"
    "single-chain" "single-copy" "single-gene" "single-institution"
    "single-lab" "single-lumen" "single-molecule" "single-nucleotide"
    "single-site" "single-step" "single-strand" "single-unit" "sinusoid"
    "sirtuin-acetyl-lysine-peptide" "sirtuins-a" "site-specifc" "site-specific"
    "situ" "six-year" "sixty-eight" "skinfold" "slightly-pivoted" "smMIP"
    "smMIPs" "small-cell" "small-interfering" "small-molecular"
    "small-molecule" "small-sampled" "small-sized" "smokers" "snoRNA55"
    "sodium-chloride" "soleus" "solution-phase" "solvent-accessible" "somite"
    "somites" "spacer" "spacers" "specifc" "specificity-determining" "speciﬁc"
    "spectrometer" "sphenoid" "sphere-cultured" "sphere-cultures"
    "sphere-forming" "spindle-like" "spindle-microtubule" "spinning-disk"
    "splice-blocking" "spot1" "spot2" "spot3" "squamous-cell" "squamous-type"
    "ss" "ss-DNA" "stabiliser" "stably-knocked-down" "standard-of-care"
    "state-of-the-art" "stateIcos" "statu" "steady-state" "stellate"
    "stem-like" "stem-loop" "stemness" "stem–loop–stem" "stent" "step-by"
    "step-by-step" "step-wise" "stepwise" "stereochemistry" "steroid-mediated"
    "stimulationIcos" "stimulators" "streptonigrin" "stress-activated"
    "stress-dependent" "stress-induced" "stress-inducible" "stress-response"
    "stress-responsive" "stressful" "stressors" "strictu"
    "structurally-diverse" "structurally-related" "structurally-similar"
    "structure-activity" "structure-affinity" "structure-based"
    "structure-derived" "structure-function" "structure-specific"
    "structure–activity" "studies" "study-wide" "sub-G" "sub-G1"
    "sub-Mendelian" "sub-cellular" "sub-class" "sub-cohort" "sub-collectives"
    "sub-continental" "sub-epithelial" "sub-family" "sub-fraction" "sub-group"
    "sub-groups" "sub-hub" "sub-lethally" "sub-maximal" "sub-nanometer"
    "sub-network" "sub-population" "sub-populations" "sub-segments"
    "sub-therapeutic" "sub-type" "sub-types" "subarachnoid" "subcapsule"
    "subclass" "subcutaneousHrasV12" "subdiploid" "subendothelium"
    "subfamilies" "subj" "sublines" "submucosa" "subset" "subsets" "subsite"
    "subsites" "substrate-peptide" "substrate-sirtuin" "subtilisin-like"
    "subtractingrather" "subtype" "succinate" "succinyl"
    "succinyl-lysine-binding" "sulfate-polyacrylamide" "sulfhydryl"
    "sulfophenyl" "sulphonate" "sumoylation-consensus" "sumoylation-irrelevant"
    "sunitinb" "super-antagonistic" "super-family" "super-multiplicative"
    "super-physiological" "super-series" "super-shifted" "supernatant"
    "supernatants" "suppresser" "sural" "surfs" "survivorship"
    "symmetry-detection" "synapse" "synapses" "sync"
    "synergistically-regulated" "tCRMP2" "tTA" "tagSNP" "tagSNPs"
    "tandem-domains-bound" "target-gene" "tartrate" "td-Tomato" "te"
    "telomerase-deficient" "telomerase-independent" "temperature-sensitive"
    "terbium" "terminal-case" "tert" "tertile" "tertiles" "tet-on"
    "tetO-Shp2CSDA" "tetrachloride" "tetrahydropyrido" "tetramethylammonium"
    "tetraploid" "tetrazole" "tetrazolium" "tfLC" "tfLC3-S94Ar" "tfLC3-WTr"
    "tfLC3-shYAP" "tg" "thaliana" "thanCC10" "thanHRasV12" "thatDbc1"
    "thatFbxw7" "thatHrasV12" "theBraf" "theEGFR" "theO" "theheterodimer"
    "thek" "therapy11" "thesystem" "thiazole" "thiazole-pyridine"
    "thiazole-to-pyridine" "thiazoline" "thiazoline-pyridine"
    "thiazoline-thiazole" "thiazolyl" "thiolate-zinc" "thiomyristoyl"
    "thiosemicarbazone" "third-generation" "third-line" "thirty-one"
    "thisstudy" "three-dimensional" "three-quarters" "three-stranded"
    "threonine-specific" "thrombocythemia" "thrombus" "thymocytes" "thymopathy"
    "tibialis" "tilt-pair" "time-course" "time-dependant" "time-dependently"
    "time-lapse" "time-of-drug" "time-point" "time-points" "timeframe"
    "timepoint" "timepoints" "tinctoria" "tissuemiR" "tissuemiR-21" "to-1"
    "to-date" "toFbxw7" "toHrasV12" "toMig6" "toRag2" "todhtt" "tombusvirus"
    "toolkit" "top53" "topoisomerases" "topology" "tracheostomy" "trade-off"
    "tranlocase-mediated" "trans-activators" "trans-adhesion"
    "trans-endothelial" "trans-regulatory" "trans-well" "transactivators"
    "transaminases" "transcription-PCR" "transcriptional-level"
    "transcriptionally-dead" "transcriptome" "transcriptomes"
    "transdifferentiate" "transducer" "transepithelail" "transferase–mediated"
    "transformants" "transgenicEGFR" "translation-competent"
    "translational-dependent" "translocase-depleted" "translocase-mediated"
    "transmembrane-associated" "transmembrane-helix" "transposon" "treatedBraf"
    "treatment-naïve" "treatment=0.54" "treatments" "tri-lateral" "triage"
    "trichilemmonas" "trichostan" "triglydcerides" "trim-and-fill" "trimester"
    "tripartite-UPR" "triphosphate" "triplaxtinin" "triple-SILAC" "trisomy"
    "trisphosphate" "trophoectoderm" "tryglyceride" "trypsin-like" "ts"
    "tube-like" "tuberin-null" "tubule" "tubules" "tubulo"
    "tubulo-interstitial" "tubulo-protective" "tumor-adjacent" "tumor-driver"
    "tumor-like" "tumor-node-metastases" "tumor-related" "tumor-stromal"
    "tumor-suppressive" "tumorigenes" "tumour-promoting" "tumour-responsive"
    "tumour-suppressive" "tumour-suppressor" "tumour-targeted"
    "tumour-targeting" "tumours" "turn-over" "twenty-eight" "twenty-six"
    "twenty-three" "two-dimensioned" "two-domain" "two-drug" "two-hybrid"
    "two-locus" "two-month-old" "two-photon" "two-pronged" "two-sided"
    "two-stage" "two-step" "two-tailed" "two-thirds" "two-way" "type-1"
    "type-I" "tyramide" "tyroid" "tyrosine-kinase" "tyrosine-recognition"
    "uAUGs" "uL" "uORF" "uORFs" "ub" "ubiquitiation-dependent"
    "ubiquitin-reactive" "ubiquitination-and" "ubiquitinproteasome"
    "ucleoprotein" "ucleotide" "ultralow" "ultralow-attachment" "un"
    "un-informative" "unc" "unc-54" "uncoupler" "under-explored"
    "under-expressed" "under-replication" "under-representation" "undergoes"
    "undergone" "underpinnings" "undertaken" "unfavoravle" "units" "univariate"
    "unmet" "unpubl" "unresponsiveness" "untreatedp53" "up-stream" "up-taken"
    "uracils" "urea" "urothelium" "uteri" "uveal" "vIII" "vMIA" "vRNA"
    "vacuole" "vacuoles" "value=0.001" "values" "van-der-Waals" "vasospasm"
    "vdW" "vec" "vector–CPP" "vehicle-treated" "vehicle-treatment" "vemurfenib"
    "vena" "venous-lymphatic" "vera" "vesicle-bound" "vessel-bound" "vessels"
    "villous-tubular" "villus" "viral-hepatitis" "viral-mediated" "viremia"
    "viscera" "vitaminD" "vitor" "vitreo" "vitro" "vivo" "viz"
    "voltage-activated" "voltohmeter" "vulgaris" "waist-to" "was-13.4"
    "was-8.1" "was-8.9" "wasNRAS" "washings" "waste-basket" "wave-front"
    "wave-fronts" "wave-like" "weakest" "websites" "well-being" "well-blended"
    "well-characterised" "well-defined" "well-designed" "well-differentiated"
    "well-documented" "well-ordered" "well-recognized" "well-responsive"
    "well-studied" "well-tolerated" "wellness" "wenty" "were-2.8"
    "whereasHrasV12" "whereasp53" "whereras" "whileIcos" "whole-animal"
    "whole-body" "whole-cell" "whole-exome" "whole-eye" "whole-genome"
    "whole-transcript" "wide-field" "wide-ranging" "wide-spread" "widely-used"
    "wild-type-PMP22" "wild-types" "wild1type" "wildtype" "winged-helix"
    "withBRAF" "withIcos" "withMig6" "wk" "work-place" "workers" "wpi"
    "written" "wtCav-1" "wtp53" "x-axis" "x-ray" "xHis" "xenoreactions" "xl"
    "y-axis" "yH2AX" "year-old" "years" "yin" "ying-yang" "yl" "ylmethyl"
    "zinc-dependent" "zipper-interacting" "zn1" "zona" "zymogen" "×10" "×260"
    "×320" "×GTP" "×met-RNA" "× 10" "× 10" "˚C" "ΑRΝΤ" "Δ-1" "Δ-13"
    "Δ-246–-218" "Δ1" "Δ105–112" "Δ133" "Δ133-isoform-silenced" "Δ133p53"
    "Δ133p53-dependent" "Δ133p53α" "Δ133p53β" "Δ133p53β-expressing" "Δ133p53γ"
    "Δ133α" "Δ141–171" "Δ160" "Δ160p53" "Δ160p53α" "Δ160α" "Δ1–230" "Δ2"
    "Δ254-264" "Δ290–320" "Δ3" "Δ32" "Δ3d" "Δ4" "Δ40" "Δ40p53" "Δ40p53α"
    "Δ421–475" "Δ464-471" "Δ48–171" "Δ8" "Δ99–171" "ΔAMPK" "ΔAP1-ETSα"
    "ΔAP1-ETSα-NFAT" "ΔBMI" "ΔC" "ΔCID" "ΔCq" "ΔG" "ΔLBD" "ΔLZ" "ΔLep" "ΔN220"
    "ΔN390" "ΔNLS" "ΔNp73" "ΔOTC" "ΔR" "ΔT" "ΔTRAF" "ΔUbox" "ΔZn" "Δad" "Δp85"
    "ΔΔG" "ΔΝ" "ΨKxE" "α-1-antitrypsin" "α-1-antitrypsin•substrate" "α-ENaC"
    "α-Endosulfine" "α-GalNAc" "α-HPV" "α-HPVs" "α-Helical" "α-PAI-1"
    "α-domain" "α-helical" "α-helices" "α-helix" "α-methylene-γ-lactone"
    "α-subunit" "α1–α2" "α2-integrin" "α2–α3" "α3" "α3–α4" "α4" "α5" "α5–α6"
    "α5–α9" "α6" "α6β1" "α7" "α8" "α9" "α9β1" "αB-Cryst" "αB-Crystallin"
    "αB-crystallin" "αC" "αL" "β-HPV" "β-HPVs" "β-ICs" "β-N-Acetyleglucosamine"
    "β-agonists" "β-cantenin" "β-cleavage" "β-galactoside–containing" "β-human"
    "β-intercalated" "β-oxidation" "β-secretase" "β-sheet" "β-site" "β-staple"
    "β-strand" "β-subunit" "β-subunit-like" "β-transducin" "β-turn" "β1-β2"
    "β2–3" "β3" "β3-αC" "β3-β4" "β4" "β7" "γ-ATP" "γ-ENaC" "γ-GCS"
    "γ-glutamate" "γ-glutamylcysteine" "γ-herpesvirus" "γ-irradiated"
    "γ-irradiation" "γ-rays" "γ-secretases" "γ1" "γ2" "γ3" "γGCS" "γH2A"
    "ε-N-acetylated" "ε-amino" "εV1-2" "κ-deficient" "κ-light-chain" "κB"
    "λ-PPase" "μAm" "μCT" "μCi" "μL" "μM" "μg" "μg " "μg " "μl" "μmol"
    "π–π-stacking" "χ²" "ψεRACK" "∆sg" "−versus" "∽17,000" "∽20%" "∽5.6%"
    "∽50%" "∽73%" "∽75%" "、XIAP" "，33"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-14401-14700*
  '("Yamada" "Moritz" "Bordoli" "Murayama" "Franco" "Klosek" "Rahuel" "pYxNx"
    "co-IPs" "non-RTKs" "widespread Y-phosphorylation" "∽17,000" "GeneID"
    "Worseck" "Krogan" "Ideker" "Rolland" "Michnick" "Sanchez" "Castro"
    "Otsubo" "Sadej" "Lazo" "TSPANs" "Wong" "Hemler" "Bisson" "Mayer" "Yaoi"
    "Hegele" "∽5.6%" "∽73%" "pY-reader–pY-reader" "Higo" "Waksman" "Bradshaw"
    "C10orf81/PLEKHS1" "C10orf81" "SH2/PTB"
    "the cullin-associated WD domain-containing protein DCAF12L1" "DCAF12L1"
    "Sos" "ConsensusPathDB" "Kamburov" "Ack" "Blume" "Fes" "IPR002404"
    "IPR006020" "IPR000980" "GeneIDs" "Entrez" "identifiers" "InterPro"
    "UniProt" "Pawson" "Weimann" "Mothe" "Myers" "Venkatesan" "Braun" "Y2H"
    "Zheng" "Hornbeck" "Olsen" "Tinti" "Koytiger" "Huang" "Cantley" "Songyang"
    "Lemmon" "Schlessinger" "Seet" "Vinayagam" "Perrimon" "Friedman" "Stelzl"
    "Woodsmith" "Vidal" "Beltrao" "Ochoa" "phenotypic readouts" "PPIs" "36 h"
    "Non-receptor tyrosine kinases" "co-localizing" "∽75%" "∽50%" "∽20%" "S5A"
    "= 6" "= 4" "element-1" "viral genomes" "IFU" "revertant" "CR208" "Towne"
    "Δ290–320/" "Δ290–320" "INFβ-induced" "Δ421–475" "siPML" "shPML" "IE1core"
    "IE" "type-1" "B-boxes" "ISRE" "incoming viral genomes" "200X" "1 x 10"
    "RE-1" "STE20-like" "tfLC3-S94Ar" "WTr" "tfLC" "TEAD1/3/4" "TEADs"
    "significantly more co-localization" "tfLC3" "mRFP" "ND + CQ" "ND+CQ" "CQ"
    "Liang" "shYAP" "Maejima" "11q22" "Hippo/MST" "6P" "autophagosome/lysosome"
    "Nonsignificant" "phenytetrazoliumromide" "-dimethylthiahiazo"
    "dimethylthiahiazo" "mean±S" "Non-migrated" "~24 h" "2–4 h" "Tseng"
    "nonhomology" "concurrent chemoradiotherapy" "GTV" "SCRT" "CCRT" "III~IV"
    "13q33" "radiobiology" "rs2868371" "rs1805388" "RILI" "≥3 " "≥2 "
    "Approximately three-quarters" "DAKO" "particularly aggressive subset"
    "histomorphology" "3 +" "≥ 2" "pT3" "n  = 17" "n  = 4" "HER2/neu"
    "group A2" "BRDT" "BRD" "re-sensitizes" "JQ1" "~40%" "~7-fold"
    "functional excitatory synapses" "Homozygote" "filopidia" "dendrite"
    "Allen" "mammalian neural circuitry" "active synapses" "DIV14"
    "excitatory synapses" "synapses" "neuronal circuitry" "A482T" "morphants"
    "notochords" "somites" "morpholino (MO)" "somite" "morpholino" "ctnnd2b"
    "NDDs" "DGV" "AGRE" "Emory" "FEMF" "SSC" "Simplex" "Luhyan" "EVS" "VOI"
    "Proband" "rarer" "Rett" "FEMFs" "n=17" "20x" "P=0.04" "1000 Genomes"
    "microseconds" "such genotoxic stressors" "BrPA" "PI3K/Akt/mTOR" "AD8"
    "prevention/therapeutic strategies" "LR" "QV" "P72A/P75A" "Watkins" "Δ-1"
    "Δ-13" "thymopathy" "non-progressor" "S52D/S56D" "NLADA" "TCID" "Dave"
    "Damme" "naive and memory CD4 + T cells" "quasispecies" "4A5A" "APOBEC3D"
    "YRHHY" "DRMR" "wpi" "LAI" "systemic viremia" "human thymic organoid"
    "the spleen, liver, lung, or human thymic organoid" "FS" "vi" "Krisko"
    "viremia" "hHSC" "JRCSF" "Izumi" "B/C" "APOBEC3" "uracils"
    "transplanted human thymic organoid" "T cells/thymocytes" "6–12"
    "xenoreactions" "histoculture" "phytohemaggluttinin" "anti-HIV-1" "A/P"
    "~3-fold" "ubiquitin/proteasome" "state-of-the-art" "CD4 + T cells" "Eid"
    "Volm" "Iwakawa" "non-SCC" "3q26" "PISCC" "EHSCC" "squamous histology"
    "UCCC" "GCNs" "GCN" "mean ± SD" "= 38" "= 58" "≥4"
    "the active caspase-1and 3" "CD4+T cells" "progressors" "nterferon"
    "SIV-infected sooty mangabeys" "mangabeys" "cells/μl" "CD3+" "or -3"
    "hexapeptide" "re-establish" "tubular epithelium"
    "the human proximal tubule" "The proximal tubules chosen"
    "the human kidney proximal tubule" "the fetal proximal tubule"
    "the mature proximal tubules" "the proximal tubules" "transepithelail"
    "caherin" "re-establishment" "20/12FCS" "20/12EGF" "DME" "Detrisac" "Ryan"
    "Distal tubules" "distal tubules" "proximal tubules"
    "Human Kidney Proximal Tubules" "Tubules" "the renal proximal tubule" "BPE"
    "ATCC" "KSFM" "endoMT" "coworkers" "Prunotto"
    "the human renal proximal tubule" "evaluators" "Pinera" "Perez"
    "underwent modified radical mastectomy" "polysomy" "trisomy"
    "underwent mastectomy" "palliative mastectomy"
    "Most stage III patients (n = 22, 91.7%) underwent modified radical mastectomy"
    "considerable CNGs" "CNGs" "non-IBC" "numerous dermal tumor emboli"
    "emboli" "curative mastectomy" "Non-rearranged" "2p23" "5/8" "HFK"
    "formation/resolution" "BRCA1/2" "Δ8" "HFKs" "NMSCs" "oropharnyx"
    "the mucosal and cutaneous epithelia" "Non-homologous" "Rad3" "tissuemiR"
    "miR-21 expression" "miR-21expression" "non-receptor type" "MiR-21is"
    "homolog ( PTEN )" "-UTRs" "BALB/C" "G1/G0" "risen" "Bethyl" "senesce"
    "quiesce" "homologuos" "ofMDM2 C464A" "V75A" "Responder" "12q13-15"
    "responder" "non-responder" "LS7785-10" "LS8313" "LS7785-1" "LS8107"
    "non-responders" "LS0082" "LS141" "LS8817" "non-proliferative" "es"
    "viral progeny titer" "non-discriminative" "VP3/4" "siERK" "siERK1+2"
    "progeny viral titers" "siERK2" "siERK1" "non-enveloped" "0 h" "36 h" "2C"
    "GeneCards" "classifiers" "DEFA" "CASP8AP" "ΔCq" "hyperdiploidy/"
    "rearrangements/t" "DEFA1" "relapse/death" "Cq" "= 0.41" "= 1.01" "1-3"
    "= 0.039" "≤ 0.001" "re-confirmed"
    "the acetylation-deﬁcient mimic EZH2-8KR" "speciﬁc" "EZH2-8KR" "EZH"
    "anti-acetylated-lysine" "Post-translational modiﬁcations" "modiﬁcations"
    "S4E" "∼90%" "S1G" "S1D" "Non-migratory" "700 bp" "Non-histone" "T394K"
    "10-12" "chorionic villus" "villus" "trimester"
    "Our case underwent tracheostomy" "underwent tracheostomy" "MacDonald"
    "Tracheostomy" "tracheostomy" "a patent ductus arteriosus" "hypotonia" "˚C"
    "polyhydramnios" "osteochondrodysplasia" "dwarfisms"
    "Patent ductus arteriosus" "arteriosus" "ductus" "brainstem" "Ammon"
    "fontanel" "almost all type 2 TD" "lambdoid" "metaphyses" "Lamy"
    "Maroteaux" "the skeletal system and short-limb dwarfism"
    "a congenital skeletal dysplasia" "skeletal dysplasia"
    "Thanatophoric dysplasia (TD)" "TD" "4-year" "subcapsule" "timeframe"
    "sequential immunohistochemistry (IHC)" "RNAfold" "VARNAGUI" "promoterless"
    "cellulo" "-UTR-" "anti–YB-1" "siYB-1" "NRS" "TIA-1–" "TIA"
    "-azidohomoalanine" "azidohomoalanine" "siControl" "phytogen" "FTLD"
    "lobar" "kd" "triage" "PBs" "= 79" "3BP" "n = 8" "mJ/cm 2" "3 B" "2 C"
    "tumorigenes" "-BACMEFs" "BACMEFs" "ferroptos" "E5.5" "intercrosses"
    "ofp53" "progenies" "methylademine" "ferr-1" "shrunken" "andp53"
    "thesystem" "3KR/3KR" "4q28-31" "NU/NU" "Ferrostatin-1" "p53 RE" "3/5"
    "8/10" "ferrostatin-1" "non–canonical" "cystine/glutamate" "non–apoptotic"
    "anti-CNTFRα" "AAV" "1-methyl-4-phenylpyridinium" "phenylpyridinium"
    "preventes" "CNTF/CNTFRα" "S16H" "hRheb" "adeno" "CNTFRα" "α 4"
    "anti-tyrosine" "adhesion/de-adhesion" "discoideum" "LISA" "podosome-like"
    "MDA-MB-231/ARF6T157N" "rosette/hr" "siNT" "kymograph" "F-actin/cortactin"
    "TIRFM" "TIRF" "ARF6T27N" "dot-like" "ARF6T157N" "CDRs" "SCAR/WAVE"
    "sheet-like" "Ventral rosette-like" "rosette-like" "100 ng/mL"
    "self-reactive thymocytes" "aureus" "an accessible cell subset"
    "356069±194855" "= 0.15" "= 0.62" "anti-lypolytic" "OGTT" "AchRα7" "AchR"
    "nicotine-induced nuclear-localized AMPKα2" "ofPrkaa2" "andPrkaa2" "Mtor"
    "pMtor" "fromPrkaa2" "adipose AMPKα2" "inPrkaa2" "andPrkaa1" "Δad" "pAMPK"
    "Adipose AMPKα2" "IPGTTs" "IPGTT" "slightly higher VO 2"
    "markedly higher liver triglydcerides (TG)" "triglydcerides (TG)"
    "triglydcerides" "ISO" "BAT" "eWAT" "soleus" "tibialis" "HGP" "GIR"
    "osmotic minipumps" "C57BL/6J" "These results newly place AMPKα2" "AMPKα2"
    "4h" "co-administration" "VCO 2" "VO 2" "± 5" "10-week-old" "Phipps"
    "= 1.05–4.05" "= 1.00–4.20" "= 1.05–3.57" "= 1.00–3.60"
    "Cyclin-dependent kinase inhibitor 1A" "rs10411210C" "rs1321311G"
    "doxifluridine" "rs10411210" "rs1321311" "Sequenom" "= 1.05"
    "nonresponders" "STAT1 activation" "anti-HCV" "transaminases" "pegIFN"
    "miravirsen" "ISREs" "LV-shDUSP1-infected" "SVR" "myxovirus"
    "replicon (FK)" "PegIFN" "peginterferon" "hetpatitis" "C-statistic"
    "Spearman's" "ECE" "underwent radical prostatectomy" "Angeles"
    "publicly available datasets" "Grasso" "Barbieri" "associated-1" "P = 0.06"
    "non-cell" "accorandance" "dioxygenases" "R-enantiomer" "ketoglutarate"
    "hydroxylglutarate" "enantiomer" "KG" "gliobastoms"
    "oligodendroglial histologies" "recuurences" "CDKN2A /B" "codeletions"
    "132/165" "14/28" "19/47" "co-deletions" "1p" "CDKN2A/B" "_125CC"
    "Freiburg" "Neurosurgery" "1p/19q" "the oligodendroglial subtype" "P = 0.3"
    "III + IV" "P = 0.0004" "19q" "MB-435" "686LN" "mTORCs" "short-time"
    "GSK3βCA" "EKVX" "/WT" "a 3-day" "GSK3 is" "RAS-mutant"
    "particularly MEK inhibitor monotherapy" "forBRAF" "non-uveal" "95 % CI"
    "formation/dissociation" "only proteins containing PIP degrons" "Chk1S345A"
    "Chk1S317A" "B-lymphoma" "re-loading" "mytomicin" "CHOC"
    "UV irradiation or Benzo(a)pyrene diolepoxide (BPDE)" "diolepoxide (BPDE)"
    "diolepoxide" "Benzo" "Mcm2-7" "14-3-3γ" "PbR" "Rad17/9-1-1 complex"
    "9-1-1" "heterotrimer" "nucleate" "stranded/double" "Okazaki" "U20S"
    "Pol η-mediated" "rLH" "rFSH" "collegues" "Feng" "1.02–1.83" "1.23–3.31"
    "Marca" "Nardo" "rs4648551" "IVF" "oocytes" "blastocyst" "antral follicles"
    "≤9" "ORPI" "AFC" "ICSI" "Andrulis" "VGPR" "ISS" "Lorh" "Exomes" "Lohr"
    "3 bp" "n =10" "non-classic"
    "the National Heart, Lung, and Blood Institute Grand Opportunity Exome"
    "E396del" "inframe" "classic CALR indel and JAK2 V617F co-mutations"
    "co-mutations" "*59" "K385fs*47" "rs143880510" "*50" "K385fs" "*48"
    "L367fs" "*47" "*46" "fs" "York" "IBM" "Mackay"
    "Essential thrombocythemia (ET)" "vera" "thrombocythemia" "co-occur"
    "=0.023" "=0.025" "JAK2 V617F" "-ribose" "specifc" "mechanosensors"
    "Washington" "Bothell" "Oncogenex" "CA19–9" "HCG"
    "Pulmonary metastasectomy" "Sato" "Tsujino" "goes" "Henry" "mean±SD" "LMFS"
    "significantly more microvessels" "median/cut" "low/negative" "and 3+"
    "Dvorak" "pulmonary metastasectomy" "P-values" "rs11571833" "3MBp"
    "GISTIC2" "= 3x10" "RAD52/12p13.33" "/12p13.33" "oropharynx" "= 9x10"
    "HNSC" "non-drinkers" "1.04–1.15" "LUAD" "12p13.33" "= 6x10" "inUADT"
    "rs10849605" "UADT" "LUSC" "= 0.75" "= 8" "isozyme" "isopropyl" "Cγ"
    "Å–2.4" "tetrazole" "HDAC8– 3" "S–C–C–C" "°–129" "polyhedron" "HDAC8– 2"
    "°–119" "thiazoline" "HDAC8– 1" "C–C–S–Zn 2+" "Vannini" "isozymes"
    "pyridine" "Williams" "trans- acetyl-L-lysine" "- acetyl-L-lysine" "Fe"
    "thiazole" "The macrocyclic depsipeptide Largazole" "Largazole" "= 6" "= 7"
    "–4-" "2+" "40%reduction" "Mitotracker" "ΔOTC" "mt" "mitomycin" "HSCORE"
    "HSCOREs" "P = 0.013" "multiple ‘weak’ p53REs" "biological replicates"
    "this external dataset" "Botcheva"
    "a publicly available breast cancer dataset" "E1A/RAS" "SREBFs"
    "at least two different datasets" "four publicly available cancer datasets"
    "numerous external high-throughput datasets" "regulome" "transposon"
    "PiggyBac" "metabolism/processing" "Rcade" "the distal p53RE"
    "The distal p53RE" "p53RE" "p53REs" "non-CGI" "CGIs" "non-CGI-promoters"
    "browser" "at least three replicates" "pApo" "acDDR" "anti-lipogenic"
    "external clinical datasets" "CGI" "Brady" "Christophorou"
    "public clinical datasets" "external high-throughput datasets"
    "co-regulated" "UVB-" "Dimitorvaet" "Huarte" "Dimitrova" "INXS"
    "UVB-treated K5Cre +/tg" "LSLp53" "+/tg" "K5Cre" "NMSC" "+/R172H"
    "non-melanoma" "4 h" "~85%" "surfs" "incognita" "thiosemicarbazone"
    "Paolo Pinton's" "Pinton" "Paolo" "MCU" "skinfold" "SERCA" "Giorgi"
    "co-workers" "QSAR" "simulatio" "larger dataset" "hetrodimers" "RTPKs"
    "1q21" "Cys 773 likely forms another H-bond" "0δ2" "Sγ" "2GS2"
    "bound structure is-4.21 kcal/mol" "Waals" "non-polar" "1MR8" "Hbond" "vdW"
    "stereochemistry" "PDBID" "biofunctions" "CEGMR" "GSE7023" "≥ 2" "Cβ"
    "CD135" "benzoylstaurosporine" "endproducts (RAGE)" "endproducts" "NCBI’s"
    "≥2" "HuGene" "Saudi" "co-crystal" "fibrosis /" "±5" "Masubuchi"
    "ischaemia" "hepatocellular DILI" "IU/L" "overdose" "rs2066992" "rs1524107"
    "rs2069837" "Haplotype" "ULN" "rs2227956" "polymorphisms/haplotypes" "DILI"
    "the most serious ADRs" "incompliance" "Anti-tuberculosis" "ADRs" "SM"
    "ethambutol" "PZA" "pyrazinamide" "rs1053004" "rs1053005" "rs1053023"
    "89 incident ATDH" "anti-tuberculosis" "ATDH" "with/without" "Gensini"
    "Haselbauer" "Abboud" "Mestizo" "Western Mexicans" "Sahara" "Mexicans"
    "RENASICA" "overweight/obesity" "Saharan" "antiplatelet" "serpine" "NSTEMI"
    "STEMI" "Western Mexico" "ACS" "EMAP" "papaverine" "guanylate" "+ PKCεI"
    "PKCεI" "+ PKCεA" "PKCεA" "εV1-2" "ψεRACK" "NC + PKCε" "NC+PKCε" "+ PKCε"
    "+PKCε" "multichains" "Cε" "GECs" "MicroRNA-34a" "2 ×10" "remodelers"
    "global H4K12ac" "heatmaps" "Heatmaps" "H2Bub1" "heptapeptide"
    "Cyclin-Dependent Kinase-9" "TEFb" "protein A-1" "H4K12ac" "5 μg/mL"
    "H3K27" "ER +" "Kwon" "Shimada" "malignance" "gene-1" "Goldberg"
    "P = 0.005" "P = 0.007" "Keane" "MCF-7/Adr" "invaginations"
    "adriamycin resistant gastric cancer SGC7901/Adr" "SGC7901/Adr" "APC/CCdh1"
    "arrest/quiescence" "dimmers" "phospho-p90RSK" "S255/T256" "Ser1981"
    "phospho-p70S6kinase" "MWAs" "MWA" "gavage" "sublines" "neutropenia" "SEER"
    "T421/S424" "Anti-rabbit" "Thr421/Ser424" "S1981" "Thr180/Tyr182"
    "S807/811" "H3K9Ac" "co-recruited" "GFP-p53MT" "normal breast-like" "MTp53"
    "the most aggressive breast cancer subtype" "ER+ve" "4 h" "WTp53" "Sandhu"
    "Wilson" "Horton" "Kedar" "Brenner" "Rajamohan" "Kraus" "Jirawatnotai"
    "reengage" "foci/cell" "Cyclin D1b" "distribution/stability" "Icells" "Vec"
    "Weyemi" "Landis" "Casimiro" "Bourgo" "Napoles" "histoarchitecture"
    "hindlimb" "Ccnd" "Sicinski" "+/KI" "the respective genotypes"
    "developing mouse blastocysts" "blastocysts" "5/3" "4/intron" "Carrere"
    "Solomon" "Augello" "Bueno" "Moreno" "Rudas" "Lundgren" "Bertoni" "Benzeno"
    "PEST" "Bigoni" "Bosch" "Gautschi" "Garcea" "Papanikolaou" "Arnold"
    "Schiewer" "Knudsen" "Zwijsen" "Burd" "Draviam" "Petre" "Fu" "McMahon"
    "Comstock" "Bienvenu" "Barbacid" "Malumbres" "Musgrove" "et " "5 μg/ml"
    "D-Type" "rs630923" "Amplicon" "amplicons" "NFκB3" "+45" "−5" "−125" "−247"
    "−345" "the cxcr5 intronic enhancer"
    "available epigenetic information and UCSC Genome" "UCSC" "MCF-7-2si"
    "ThinCert" "MCF-7-2Si" "700 bp" "NFκB1" "non-hematopoietic" "C6–7"
    "interspace" "L1-L2" "Sartoris" "Col2α1Cre" "100 percent penetrant"
    "pulposus (NP)" "Col2α1-Cre" "pulposus" "notochord" "forelimbs"
    "Nf1 nullizygous osteoblasts" "Nf1 nullizygous MSCs/osteoblasts"
    "MSCs/osteoblasts" "mature osteoblasts" "non-dystrophic" "macules"
    "carinatum" "pectus" "anisotropy (DA)" "anisotropy" "μCT" "∼8.7%" "∼36.6%"
    "15/41" "MS/BS" "photomicrographs" "BV" "trabecular microarchitecture"
    "3/43" "∼7%" "3Cre" "Col2" "induced tibial fracture non-union" "non-union"
    "conditional Nf1 nullizygous osteoblasts" "PeriCre" "models: Nf1"
    "plexiform" "pedicle" "Non-dystrophic" "boney" "Col2.3Cremice" "ofNf1"
    "microarchitecture" "histomorphometry" "PeriCreandNf1" "∼20%" "∼55%"
    "1 / 2" "200x" "12-months" "genoype" "Figarska" "co-overexpression"
    "expression/activity" "polymerase-1 (PARP)" "homozygote" "status (TOS)"
    "status (TAS)" "paraoxonase-1" "rs2273773"
    "a significantly shorter lifespan" "10q21.3" "rs7895833" "OSI" "TAS"
    "p = 0.017" "CDK2AP1knockdown" "co-transduced" "NuRD" "necrotic/apoptotic"
    "shRNA2" "HDFs" "hemocytometer" "shRNA1" "CDK2AP1 in" "2 +" "= 0.0004"
    "20X" "anti-tumorigenic" "activation/infiltration" "senescence/cell"
    "the global transcriptome" "p19ARF−/−versus" "p19ARF−/−" "p53−/−"
    "palpable lymphadenopathy" "CD4+/CD8+" "tTA" "Eμ" "SR"
    "functions/abilities" "OptiView" "_1800TG" "_1799GT" "Optiview" "Cobas"
    "Ventana" "VE1" "Percipalle" "Obrdlik" "outcome/prognosis" "Sotiropoulos"
    "C3H-2K" "Nishida" "chemotherapy/radiotherapy" "ONM" "Kligys" "qua" "NCSLC"
    "wellness" "non-histone" "/ATP" "unfavoravle" "Ueno" "kinase-2" "Jonasch"
    "cT" "staging/restaging" "non-clear" "non-ccRCC" "Karnofsky" "glomerulus"
    "SUVmax " "SUVmax" "nephrectomy" "n=12" "n=13" "= 0.01" "= 0.04" "= 0.41"
    "= 0.0001" "= 0.63" "=19" "= 6" "mean ± S" "4 h" "3/4" "confounder"
    "unresponsiveness" "10q25" "rs1127687AG/AA" "rs12247479GG" "GLM"
    "rs1127687AG" "rs4353229TT" "rs10787498" "rs10787498GT/GG" "rs12247479"
    "rs1127687" "rs10787498 GT" "= 1.00–1.41" "rs10787498GT" "rs4353229" "=
0"
    "= 1.08" "95%
CI"
    "= 1.00" "non-TSC" "=39" "EXIST-2" "EXIST-1" "Monro" "foramen" "≥50%"
    "KLFs" "protoncogene" "Helsen" "conformers" "thiazolyl" "C@R568" "G@V564"
    "were-2.8" "energy-2.7" "contributed-3.2" "A@R568" "G@K563" "GGCA"
    "Kimberley" "P-boxes" "bps" "anti-parallel" "ASRND" "GSCKV"
    "increase/decrease" "ENDOG" "catalyses" "protooncogene" "AATK"
    "mineralcorticoid" "3bp" "p = 0.003" "p = 0.0005" "p = 0.002" "p = 0.004"
    "AR+" "~2μM" "Nakatani" "Kurtoglu" "Warburg’s" "succinate" "1h-3h" "or 2DG"
    "and 2DG" "elF2a" "2mM 2DG" "110mg/dL" "~7μM" "positron" "to 2DG"
    "Positron" "N-linked" "-O-Methyl-RNA" "Garimella" "Dangi" "Schultz" "n"
    "miRNA-23b" "VPl" "CVA16" "Coxsackie" "h" "EV71" "N+" "non-infected"
    "simplest" "R3A" "delSARAH" "NORE" "SARAH" "H-Ras12v" "HBEC-3KT"
    "effector/tumor" "rasopathies" "anti-acetyl" "anti–acetyl"
    "Co-transfection" "hyperphagia" "autoinhibit" "Quantitative Real-Time PCR"
    "2–3 " "≥30 " "kg/m 2" "glycogen synthase
kinase-3β"
    "n = 15" "= 36" "tryglyceride" "de-emphasized" "Ferrante" "re-uptake"
    "ApoE−/−ITCH−/−" "RER" "calorimetry" "MOMA-2" "glycaemia" "reuptake"
    "T-regulatory" "12 hrs" "T- regulatory" "SGH" "siNDRG1" "~57–65%"
    "G 0 /G 1" "G 0 /G 1 phase" "n=7" "2×10" "adenylate" "Carney" "OMIM"
    "corticosteroid" "Hsd3b6" "metanephrines" "*16"
    "the heterozygous NF1 mutation NM_000267:c" "_000267:c" "corticoserone"
    "pStAR" "SID343" "Mutant/Control" "X-zone" "peroxylipid"
    "hypercorticosteronaemia" "two-month-old" "Azan" "glomerulosa"
    "reticularis" "fasciculata" "zona" "hypercorticosteronemia" "mT/mG" "Rosa"
    "adrenal medulla" "NF1Prx1" "NF1 patient" "chromaffin" "BLBPcre"
    "the NF1 tibial dysplasia" "hypertensive NF1 patients" "NF1 patients"
    "learning disabilitiesand" "disabilitiesand" "focal skeletal dysplasias"
    "sphenoid" "osteopenia" "CALS" "lait" "café" "hyperpigmentations" "Nf1Prx1"
    "NF1patient" "3B" "= 0.63" "pg/mL" "≥ 20" "NCRN" "BioBank" "Oxford" "NRES"
    "ClinicalTrials" "NCRI" "non-toxic" "R-hyper-CVXD-MA" "OFAR1" "OFAR2"
    "pegfilgrastim" "FACPGM" "CVXD" "dose-limiting co-morbidities" "oncovin"
    "Hodgkin’s" "Richter’s" "asymmetrical lymphadenopathy" "hypercalcaemia"
    "fluorodeoxyglucose" "rapidly fatal generalized lymphadenopathy" "Maurice"
    "chemo-resistant high-grade non-Hodgkin’s" "CDCC" "Richter" "≥ 10%" "20 as"
    "heathy" "Bastiaens" "Arg/Pro" "cytoplasma" "or-3" "*** P" "begun" "** P"
    "invariant" "procaspase-3" "-3 A" "siRNA-1" "co-localises"
    "differential co-location" "wtCav-1" "-ENaC" "S12V" "PI3KΔp85" "Δp85"
    "S17N" "kΩ" "μAm/cm 2" "basal transepithelial potential difference of-2.74"
    "of-2.74" "exogenous ENaC" "phosphoinositol" "Liddle’s" "Liddle"
    "the distal collecting tubules" "p38 MAPK" "n = 9" "co-transporter" "Ratka"
    "Shang" "factor-1" "interferon regulatory factor-1" "Narayan" "Fischer"
    "PFT-α" "PAb240" "Jana" "Dikshit" "Buizza" "Chun" "DBS" "+127 " "p53DBS"
    "Cartharius" "+150" "+127" "Hsp70/90" "anti-flag" "ΔTPR" "ΔUbox" "CTFβ"
    "APP695" "Oddo" "Esser" "Petrucelli" "Meacham" "Tripathi" "Kimura"
    "Almeida" "Piccini" "Luo" "Evin" "Lanni" "Gambino" "Uberti" "Cenini"
    "carbonyls" "NF-kβ" "Riederer" "Hegde" "Upadhya" "Christensen" "Nowak"
    "Sastre" "Tamagno" "Gatz" "LeVine" "Aβ" "2–3 " "2 × 10" "re-routing"
    "redirects" "CVP" "evalute" "pYAP" "GRCFP" "Tg" "organoid" "Massagué"
    "electric cell impedance" "trophoectoderm" "8W10E" "MiR29" "~60%"
    "nonsteroid" "each vaginal lavage" "vaginal lavage" "ERE2/3" "ERE1"
    "a 2-kb" "Pennsylvania" "menses" "commensalism" "hydroxytryptophan"
    "oral and genital mucosae" "CMCD" "the commensal fungus Candida albicans"
    "albicans" "the vaginal lavage" "HDAC1/2" "E2/ERα" "n = 6" "P- value"
    "3-day" "Non-targeting" "5 μg/ml" "toRag2" "Fc" "byIcos" "nuocytes"
    "whileIcos" "Burmeister" "anti-human-ICOS-L"
    "rh-IL-7 (20 ng/ml) adoptively transferred ILC2s" "A4" ".8A4"
    "human peripheral ILC2s" "Human peripheral ILC2s" "PhosphoSTAT5"
    "100 ng/ml" "orIcos" "withIcos" "/mouse" "μg/mouse" "IL-33R" "naïveIcos"
    "nCounter" "IL-2Rα" "phosphoSTAT5" "fromIcos" "ofIcos" "betweenIcos"
    "stimulationIcos" "β7" "stateIcos"
    "early apoptotic and late apoptotic ILC2s" "andIcos" "treatedIcos" "inIcos"
    "ILC2" "IL2Rα" "Alternaria" "alymphoid" "ICOS:ICOS-Ligand" "ILC2s"
    "eosinophilia" "N=4" "Fixation/Permeabilization" "non-antigen" "5q31"
    "microdeletions" "1-year" "intermediate-2" "RAEB" "non-blastic" "blasts-1"
    "CMML" "IGHV" "the most well-studied nonsynonymous SNPs" "leukemogens"
    "5q34" "non-del" "C-allele" "P =0.09" "P =0.51" "=0.39" "=0.64" "P =0.07"
    "=0.12" "non-Caucasian" "rs1042522" "P =0.08" "ie" "CC/GC"
    "gain-of-the-function" "DLCO" "FVC" "function/disease" "rs2910164"
    "non-protein" "knockin" "Puc" "Catalouge" "P94A" "endometrioid" "ΔMATH"
    "ΔBTB" "exon6/7" "immunoprecipiate" "Non-specific" "MW299" "imidazol-5-yl"
    "2-chloro-" "-benzo" "benzo" "2–3 " "–12 " "–9 " "co-immunostaining"
    "-TC-6" "subfamilies" "tyroid" "co-chaperones" "g/ml" "non-enzymatic"
    "1- μ M" "RUFY" "the Spearman's" "SGC" "myosinIIb" "RIPX" "axon-related1"
    "RUFY3 (RUN and FYVE domain containing 3)/SINGAR1 (single axon-related1)/RIPX"
    "≥3" "non-saturating" "P =0.002" "P =0.003" "1 and 2" "α 3" "streptonigrin"
    "stalled/collapsed" "S7a" "Multinucleate" "multinucleate" "CldU/IdU" "CldU"
    "nonspecific DNA co-aggregates" "co-aggregates" "f" "siRAD54L+RAD54B-2"
    "siRAD54L+RAD54B" "RAD54L+B" "irradiation-induced RAD51 foci co-localized"
    "siRAD54B" "siRAD54L" "foci/nucleus" "RAD54L+B-2" "S3d" "S1c"
    "RAD54L+RAD54B" "S2b" "S2c" "S2a" "complexes/nucleus" "nondamage" "ssDNAs"
    "homologous dsDNA" "nonrepair" "heteroduplex" "dsDNA" "= 43" "47 ± 9%" "3b"
    "co-stained" "100X" "Castiglioni" "Broeks" "simplex" "8p 11.2" "11q" "9p"
    "3p" "6p" "16p" "ER+" "arrayCGH" "17q21–24" "8p11.2" "8q24" "17q" "17q12"
    "situ" "Curtis" "Hodgkin" "CCSS" "non-irradiated" "–12" "N = 6" "N = 4"
    "n = 5" "n = 7" "N = 18" "N = 21" "non-Hodgkin" "n = 12" "= 19"
    "phosphorylation/activation" "pigmentosa" "MV4" "YO" "lowAR" "UNC1653"
    "Carna" "MCE" "UNC1062" "UNC1666" "cells/mL" "non-active" "G2M" "~15%"
    "important anti-tumor" "tube-like" "SubG" "terbium" "DW22" "= 16"
    "n-3 PUFAs" "roziglitazone" "eIF2α-S51A" "di -substituted" "×met-RNA"
    "-diarlyureas" "diarlyureas" "C#2" "eIF2·GTP·Met-tRNA" "·Met-tRNA" "++"
    "Menhaden" "manhedan" "BRCA1b" "UTRb" "uAUGs" "uORF" "a minimal 90 bp"
    "renilla" "GFP-eIF2αS51A" "1and 2" "heavier" "di-substituted" "CLT" "ureas"
    "GCN4" "·GTP" "·GDP" "AUG" "translational repressed BRCA1 mRNAb" "mRNAb"
    "uORFs" "mRNAa" "non-phosphorylatable" "2B" "LFL" "Δ133p53α"
    "RP11–199F11.2" "non-spliced" "non-replicative" "FoSTeS" "CytoScan"
    "Semi quantitative genomic PCR" "Semi" "OncoScan" "Δ133α" "co-segregating"
    "only 45 bp" "KRD" "YZH" "AJF" "intergenic or intronic breakpoints"
    "breakpoints" "– 9" "= 33" "= 23" "= 62" "= 11" "= 14" "= 54" "Δ160p53"
    "n = 17" "tumor-like" "miR-145" "-145" "indicatedthe" "cyclesuch" "NRE"
    "mediater" "VDREs" "mediatesthe" "cellgrowth" "Pearson's" "websites"
    "oligos" "μmol" "VDRE" "vitaminD"
    "The most active vitamin D3 metabolite 1alpha" "1alpha" "dihydroxyvitamin"
    "miR-27a" "S2035T/D2357E" "KTC-26" "polarization/protrusion" "p-S6K1"
    "mTORC1/2" "~90%" "IGF-1-stimulated" "KTC" "eIF4G protein"
    "cell growth/proliferation" "cells/ml" "2 × 10" "Ser235/236" "de-adhesion"
    "S235/236" "HAMA" "rituxan" "TGN1412" "E:T" "imidazole" "xHis" "-VH" "-VL"
    "VL" "VH" "HER2/CD3" "1 μ g/ml" "HER 2/" "μ g/ml" "anti-tumoral" "PDGFβ"
    "shHDAC9" "quantitative real-time PCR" "French's" "mmol/L" "μg /ml"
    "this histologic subtype" "BIBW2922" "LungCarta" "n = 2" "race/ethnicity"
    "pharmacophore" "minipumps" "synapse" "DRP" "tCRMP2" "pCRMP2" "pDCX"
    "nucleo" "neuropathology" "CRAM" "SIVE" "re-distribution" "non-tg"
    "immunoreactivty" "HIV+" "tg" "Addgene" "Nucleo" "calpain-1" "neurite"
    "nantais" "orgine" "recepteur" "neocortex" "neurode" "co-infection"
    "the pre-HAART era severe HIVE" "macrophages/microglial cells" "MNGC"
    "HIVE" "Clinico" "re-entry" "neuro" "24 hrs" "co-morbidities" "Noonan"
    "non-mutated" "Non-stable" "PP6R" "PP6Rs" "PP6R2" "IGBP1/α4" "histidinol"
    "MEFS" "TSC2−/−" "LC3I→LC3II" "ULK" "ULK1/2" "-51–like" "rapamcyin"
    "minimal LC3I" "S51A/S51A" "SIT4" "eukaryotic initiation factor 2α"
    "the eukaryotic initiation factor 2α" "factor 2α" "nonrepressed-2"
    "Anti-Flag" "51–like" "insulin/IGF1" "1IR3"
    "the kinase dimer-disrupting F979A/R" "Cy3-" "Cy" "phosphopantetheinyl"
    "Sfp" "DOGS-NTA-Ni" "quasi" "frugiperda" "Spodoptera" "hexahistidine" "-αC"
    "αC" "AMPPCP" "JMTK" "the dimeric IR ectodomain" "ectodomains" "protomer"
    "~55%" "10.1038/ncomms7377" "Niederst" "# 7" "cells/tumours" "#7"
    "a previous liver biopsy" "CCLE" "the mesenchymal subtype" "Berns"
    "MGH131-2" "MGH131-1" "relatedness"
    "resistant tumours underwent phenotypic/histological" "low/absent"
    "-mutant" "=57" "#6" "Hedgehog/GLI1" "non-signaling" "shCTNNB1" "shCtrl"
    "shAKT" "A-704-mut2" "selfrenew" "vec" "A-704-mut1" "786-mut1" "oncosphere"
    "CRISPR/Cas9" "outcomes1" "UMPP" "P = 0.07" "CXCR4 +" "= 0.0014" "n = 18"
    "n = 21" "n = 13" "CRISPR/Cas" "Erridge" "ketocholesterol"
    "1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine" "Walton"
    "oxPAPC" "Pasini" "Fratta" "Doyle" "Choi" "Netea" "Boekholdt" "Ameziane"
    "Hernesniemi" "Kiechl" "intima" "carotid" "Paolillo" "Gebbia" "Funaba"
    "Ikeda" "Plex" "Esterbauer" "Sottero" "Zhong" "Moreau" "Gargiulo"
    "Leonarduzzi" "Sánchez" "Chávez" "mmLDLs" "Hollestelle" "Geng" "Methe"
    "Higashimori" "Michelsen" "Björkbacka" "Dekker" "Pasterkamp" "Cole"
    "Tobias" "Curtiss" "Schoneveld" "Vink" "Edfeldt" "Bijani" "Jeong"
    "Seneviratne" "Steinberg" "Hansson" "hydroxycholesterol" "μg " "Diao"
    "HCVpp" "lipoproteins" "DENV" "JS81" "JFH1" "mitotracker" "Rep2a" "or 2a"
    "RLU" "pseudotype" "replicon" "HCVcc" "ffu" "FAM14" "WNV"
    "HCV viral titers" "1 μg/ml" "48 h" "rightmost" "Koike" "PNAS" "Hirota"
    "Oklejewicz" "Rossant" "Janet" "non-redundant" "S18A" "paralog"
    "their ancestral homologs" "photoproduct" "Cry1/2" "CRYs" "cryptochromes"
    "Huber" "Cryptochrome" "eLife" "DOI" "cryptochrome" "+ 1" "pcDNA 3" "1  +"
    "non-dividing" "endolyn" "Galectins" "Jung" "Khader" "MOIs" "0.1–1" "PL046"
    "DV2" "thisstudy" "Jayaraman" "si-G9-1" "0.1-1" "galectin" "Matsuura"
    "plasmacytoid" "immunoglobulin-3" "β-galactoside–containing glycans"
    "glycans" "non-significantly" "2 hrs" "/K" "non-immune"
    "pluripotency/reprogramming" "C3LND" "D3H2LN" "Sh6" "Sh5" "OCT 3/4"
    "Δ40p53" "TAp53" "Δ160" "Δ133" "TAp53α" "Δ40" "Δ133p53" "Roux" "OCT3/4"
    "Δ133p53β" "S4C" "and 3E" "and 3C" "Gibbs" "enthalpy" "Boltzmann" "Poisson"
    "···HN14" "···HN15" "weakest" "···N6" "The next most important H-bond"
    "··HN14" "a moderately strong H-bond" "H-bond" "··NH14" "··N6" "··HN15"
    "RMSDs" "RMSD" "·NH14" "·HN14" "·N6" "·HN15" "HN" "HN14" "ASP133" "GUA81"
    "2,3-triazole-4-carbohydrazide" "pyridin-4-ylmethylene"
    "piperidin-1-ylmethyl" "4-amino-1,2" "tinctoria" "Indigofera" "indirubin-3"
    "machanisms" "-bisindole" "bisindole" "naturalis" "ChEMBL474807"
    "glycogen synthase kinase-3β" "cyclin-dependent kinase-2" "carbohydrazide"
    "ylmethyl" "piperidin" "Δ G" "∼15 %" "non-negligible" "10.1038/ncomms7496"
    "Madhusudhan" "tubulo" "ERSE2" "LoxP" "nephromine" "GENCs" "Ju"
    "Nephromine" "db/db" "Diabetic nephropathy (DN)" "p85α" "sXBP1"
    "diabetic nephropathy (DN)" "μg " "8-week-old" "/LoxP" "non-diabetic"
    "deacetylators" "acetylators" "yang" "nepthropathy" "Ac"
    "early diabetic microangiopathy" "mmol/l" "Iα" "n  = 10" "EBM-2" "Kirshner"
    "residual RAD51 foci co-localized" "SCEs" "acetonide (TA)" "acetonide"
    "euchromatic DSBs" "heterochromatic DSBs" "secondary DSBs" "ATMi" "CenpF"
    "the previously described ATM-deficient SKX-cells ( xref )"
    "the previously described ATM-deficient SKX-cells"
    "described ATM-deficient SKX-cells" "ATM-deficient SKX-cells" "SKX-cells"
    "SKX" "D-loop" "pGC" "-ssDNA" "P = 0.09" "P = 0.56" "100x" "40x" "10 ng/ml"
    "A/CDK2" "cylin" "Minella" "SW1990/FBW7"
    "MAPK kinase signaling indeed controls FBW7 phosphorylation status"
    "= 0.029" "= 86" "P = 0.017" "MAPK/ERK" "A / p" "a unique transcriptome"
    "ERα/mitogenic" "NF-κB/proinflammatory" "This unique transcriptome"
    "Transcriptomes" "Veh" "E2+ TNFα" "latent/gained" "gained/latent"
    "Enhancers" "the classical estrogen-induced ERα cistrome"
    "the lost ER enhancers" "DNase1"
    "The Classical Estrogen-induced ERα Cistrome" "Cistrome"
    "a unique inducible ERα cistrome" "nearest" "eRNA" "eRNAs" "Enhancer"
    "the unique E2 + TNFα-regulated transcriptome" "GOBO"
    "this unique transcriptome" "E2 + TNFα" "an active enhancer" "E2+TNFα"
    "co-occupancy" "interwoven" "siDicer" "Calphstin" "siPKC" "LGPUC" "HGPUC"
    "scatterplots" "urothelium" "aPKCs" "nPKCs" "cPKCs" "US" "Calphostin"
    "24 hrs" "sd" "TEAD1ΔC-YAP(AD)" "TEAD1ΔC-YAP" "TEAD1ΔC–YAP" "PhosphoSite"
    "YAP-5SA" "Ctgf" "lambda" "density/cell" "MST1/2" "*  P" "ANTI-FLAG"
    "YAP/TAZ" "chromatids" "Topo2α" "penetrant" "RERT" "49%±2.03%"
    "centromeres" "Topo2" "co-depletion" "D-box" "7%±0.01%" "9%±0.04%"
    "13%±0.02%" "6%±0.03%" "approximately 6%±0.03%" "roughly 28%±0.04%"
    "82%±0.03%" "PP2A-Cα" "siCTRL" "chromatid" "Ensa" "protein phosphatase 2A"
    "the mitotic APC/C" "RXXL" "SIE4" "SIE3" "SIEs" "IL-6/STAT3/Fra-1" "STAT3/"
    "TNSK1BP1" "Verghese" "TNKS1BP1/TAB182" "TNKS1BP1 did" "DNA-PKcs/S2056"
    "HeLa-mycTNKS1BP1" "TNKS1BP1did" "immunoprecitates" "DNA-PKcs/Ser 2056"
    "DNA-PKcs/Ser2056" "4 Gy" "HepG2-shTNKS1BP1" "HeLa-shTNKS1BP1" "HepG"
    "/ser2056" "Werner" "PQR" "ABCDE" "re-ligation" "re-sensitized"
    "miR-491- 3p" "miR-491-3p/mTORC2" "MiR-491-3p/mTORC2" "suppresser"
    "expressionand" "MiR-491-3p" "Tca8113/PYM" "re-overexpression" "miR-200b"
    "TSCC" "Adam" "miR-491-3p" "protein/DNA" "PGH" "OLINK" "biolipid" "ICCM"
    "Bcl" "Xl" "Oliver" "Verhaak" "μ l" "4/5" "F/B" "S/B" "Bp" "chemoresponse"
    "FIGO" "cDNA/FBN1" "OVCA429/FBN1" "cantenin" "siRNA1" "OVCA429/BRCA2"
    "OVCA420/BRCA2" "OVCA420/Aur" "OVCA429/Aur" "FBNI" "Marchesani" "Weill"
    "Aur" "= 25" "= 0.003" "MAPK/ERKs" "especially TNBC subtypes" "Y1135/Y1136"
    "PF878" "defactinib" "Quantitative real-time PCR" "EV" "co-targeting"
    "synergistic anti-tumor" "mesenchymal TNBCs" "cobblestone-like" "5-years"
    "92a-1" "20a" "miR-17–92" "miR-17-92" "miR-17-" "pTNM" "timepoints"
    "siRNA-PTK6#4" "siRNA-ERK#2" "siRNA-ERK#1" "#4" "p-ERK1/2" "miR-18a"
    "Schulze" "strictu" "sensu" "keratincoytes" "p38MAPK" "AK23/PFIgG"
    "foliaceus" "-12" "AK23-" "microlesions" "outs" "deoxynucleotidyl"
    "non-lesional" "AK23-treated biopsies" "granulosum" "Biopsies"
    "microblisters" "the Dsg3-specific pathogenic antibody AK23"
    "previously used biopsies" "vulgaris (PV)" "PVIgG" "AK23"
    "desmosomal cadherins desmoglein" "desmoglein" "vulgaris" "caspase-3/7"
    "Caspase-3/7" "C57Bl/6" "n=6" "Rydén" "human mature adipocytes co-cultured"
    "infiltrant" "pg/ml" "Coculture" "IL-6sR"
    "insulin-like growth factor binding protein-2" "A-CM" "CAA-CM-"
    "co-cultivated" "C-CM" "CAA-CM" "co-cultures" "VI" "co-culture"
    "fibroblast-like" "≥ 1" "Δ32" "the top 20 ranking HESN"
    "the top 40 ranking HESN" "pscores" "the top 40 ranked HESN" "copies/ng"
    "the 20 HESN" "the top 20 ranked HESN" "very high risk HESN"
    "the top 40 HESN" "seroconvert" "pscore" "seronegatives (HESN)"
    "seroconverters (LESC)" "LESC" "seroconverters" "HESN" "seronegatives"
    "= 0.01" "non-significant" "P = 0.86" "= 0.13" "= 53" "= 0.12" "= 1"
    "= 111" "subsequent pulmonary oedema" "stabiliser" "pulmonary oedema"
    "oedema" "HPMECs" "Pearson’s" "Oncomine" "PCGEM1 ’s" "viz" "Prensner"
    "LTL-331" "FPKM" "Srikantan" "PCAT18" "GENCODE" "PES" "PRNCR1" "PCGEM1"
    "= 5" "easyFRAP" "ΔΝ" "pEGFP" "flavonoid" "viii" "casein kinase 1δ"
    "hydroxylases" "HIFβ" "CK1δ" "* P  " "molecules/pathways" "Giampieri"
    "significantly 2-fold greater" "non-migratory" "non-migrated" "Fluc"
    "co-infected" "non-Smad3" "non-wound" "td" "CAGA-Td-Tom" "Td"
    "non-metastatic" "SJACT069" "Aneuploidy" "Assié" "aneuploid"
    "non-recurrent" "kataegis" "LINC00290" "4q34" "SJACT017" "SJACT004"
    "the maternal chromosome 11p" "Microsatellite" "uniparental disomy (UPD)"
    "disomy" "=6" "=13" "insT" "BMR" "insertions/deletions" "PCGP" "mitotane"
    "WGS" "southern Brazil" "11p15" "BWS" "Fraumeni" "17p" "= 2.4" "n=15" "n=3"
    "= 0.023" "n=4" "n=5" "=18" "=12" "n=10" "11p" "stellate" "miR-15a/16-1"
    "siScramble" "knowdown" "anti-miR-15a" "Renilla" "miR-15a/miR-16-1"
    "mucosae" "MREs" "normal gastric epithelium" "miR-16-1" "Ser807/811" "S1F"
    "miR-15a/16" "13q14.2" "= 0.048" "P  = 0.013" "= 0.006" "= 0.035" "S1C"
    "-G/G" "-T/T" "cardia" "135G/C" "Korean"
    "the homologous recombination repair RAD51 and XRCC2 SNPs"
    "Scarf-Bloom-Richardson" "homozygotes" "heterozygotes" "-41657C/T"
    "-172G/T" "41657C/T" "172G/T" "15q14-15" "P -values " "= 70" "= 2"
    "p  = 0.001" "C/T" "2/17" "FAT2" "999del5" "RefSeq" "Kandoth" "T:A" "C:G"
    "Jiao" "dbSNPs" "human nonsynonymous SNVs" "CONDEL" "SIFT" "TpG"
    "frameshift" "SNVs" "Gb" "mutations/Mb" "Exome" "enhancs" "ZNF703plays"
    "ZNF703 is" "amplicon" "inhibites" "SPRY40" "Reynisdottir" "pCDNA"
    "/Hoechst" "MD-MB-435S" "8p12" "Zou" "GenBank" "comparedwith" "S2D" "G0/G1"
    "HER2/NEU" "doi:10.1186" "Written" "cryosections" "Whitehall" "Leggett"
    "coherences" "Berlin" "Universitätsmedizin" "Charité" "IRB" "patho"
    "microsatellite" "SPSS" "UICC" "= 0.039" "P = 0.001" "P = 0.022"
    "P = 0.003" "immunophenotypes" "DMFS" "an immunohistochemical algorithm"
    "immunophenotype" "adjuvant/neoadjuvant" "checkerboard" "HDPP" "Staaf"
    "classifier" "Geile" "Pogue" "/neoadjuvant" "≥ 10%" "basal 2/HER2+" "≥10%"
    "basal-HER+" "re-classification" "Laakso" "non-amplified" "subclass"
    "Harris" "CK5/6" "morpho" "EMT-like" "CSC-like" "= 0.037" "HER2 +"
    "P = 0.022" "= 0.035" "non-responding" "the Begg’s" "Malats" "CUETO"
    "EORTC" "EAU" "Urology" "1.08–1.77" "0.90–2.09" "1.08–2.27" "0.91–2.16"
    "Netherlands" "France" "Korea" "Lacombe" "Beltran" "Lopez" "Oderda" "TURB"
    "NMIBCs" "Galbraith" "Wanfang" "Guérin" "Calmette" "mTOR-" "mTOR"
    "hypothermia" "anti-tumour" "Anti-tumour" "pS6K/S6" "Sk" "Talalay" "Chou"
    "mTOR/S6K1 and" "BTCs" "Hhpathways" "=1" "8-week" "48 h" "PI3K/mTOR" "hoc"
    "FIRE-3" "bidirectional sanger" "sanger" "OPUS" "Hurwitz" "0.71–1.17" "=89"
    "CBM" "nonresponse" "P =0.04" "P =0.03" "n =5" "n =8" "=86" "P- values"
    "BRCAness" "shorter MFS" "miR-26b" "miR-26a"
    "No prognostic marker more discriminant" "discriminant" "HR+/ERBB2+"
    "real-time quantitative reverse-transcription PCR" "MFS" "P =0.022"
    "Alexa647" "n =4" "severe hyperinsulinemia" "mild hyperinsulinaemia"
    "Moller" "Tukey" "rsT2DM" "rsNGT" "significantly higher HbA1c" "HbA1c"
    "Phosphenolpyruvate" "Roux-en-Y" "hyperinsulinaemia" "INSRA/INSRB"
    "Belfiore" "INSRB:A" "RYGB" "T2DM" "INSRB" "INSRA" "p = 0.06" "p = 0.01"
    "p = 0.04" "μg/ml" "PCMV6" "= 27" "JAKand" "Ogata"
    "our current pharmacologic armamentarium" "armamentarium" "TGF-β1 and"
    "normal non-Crohn's" "e" "pEZX" "non-CD" "B2 Crohn's" "540±110%"
    "inflammatory B1 phenotype Crohn's" "penetrating B3 Crohn's" "mucosa"
    "ileum" "pg/μg" "B1, B2 and B3 phenotype Crohn's" "fibrostenotic Crohn's"
    "fibrostenotic Crohn" "Transducers" "propria" "muscularis"
    "fibrostenotic Montreal B2 Crohn's" "fibrostenotic Montreal B2 Crohn"
    "Crohn's" "Montreal B2 Crohn's" "Montreal B2 Crohn" "dnSTAT3"
    "other Crohn's" "non-Crohn's" "Montreal B2 fibrostenotic Crohn's"
    "Montreal B2 fibrostenotic Crohn" "Crohn" "co-association" "Δ4" "Δ2" "Δ3"
    "Δ1" "ZR" "ILF" "EREs" "G0/G1 phase" "non-transfected" "co-precipitation"
    "G/T" "regrowth" "the accurate biochemical readouts" "UW425" "subarachnoid"
    "gm" "at least 48 hr" "phosphohistone" "Ark5/Nuak1"
    "unique anti-proliferative" "polyploid" "UW426" "fetal cerebellum" "G3MB"
    "normal fetal cerebellum" "cerebellum" "AURKC" "=103" "HQPA" "AZD" "200 x"
    "40X" "4,5-dimethylthiazol-2-yl" "5/5" "P= 0.003" "=4" "= 2.9"
    "25 mg/kg/day" "N=3" "N=8" "P=0.002" "= 0.0001" "P=0.001" "JNJ-26854165"
    "JNJ" "JapA's" "ETSα" "mg/kg/d" "JapA-" "HMLE" "InuA" "Schrodiger"
    "undertaken" "anti-breast" "guaianolide" "disesquiterpenoid" "SMIs"
    "genetic/genomic" "JapA" "Gmh1p" "nicotinic AChR" "shR" "GeneBank" "AChRs"
    "levamisole-sensitive nicotinic AChR" "levi" "AChR" "UNC" "tetrazolium"
    "ionization–time" "≥1" "gloimas" "vitor" "amd" "leukoencephalopathy"
    "684GA" "684AA" "684GG" "KPS" "Genotypes" "NOTHC3" "karnofsky"
    "non-functional" "95%CIs" "= 3" "= 5" "III + IV" "Germinin" "APC/C"
    "Cyclin E2" "effecter" "and 3q25.3" "MiR-15a" "anti-miR-10b" "Argonaut"
    "miR-15a" "tetraploid" "-O-methoxyethyl" "LGG" "bioterms" "miRNA-10b"
    "MicroRNA-10b" "13q" "de-repressed" "ΔT" "ΔTRAF" "sensitizer" "ΔZn" "ΔR"
    "expressers" "BCT" "NBT" "PI3K/AKT/mTOR" "p70s6k/S6" "μl" "= 12"
    "cytoplasmic/nuclear" "MCF7 and" "p = 0.02" "BVD" "3-cyclopropyl-5-"
    "acetamide" "phenyl" "-yl" "tetrahydropyrido" "hippo/YAP" "CA10561"
    "the small-molecular ERK2 inhibitor CAY10561" "GTIIC" "non-targeting"
    "semi-quantitative real-time PCR" "CAY10561" "-4-" "yl" "pyridin"
    "chlorophenyl" "Yes" "Hippo/YAP" "-5-" "MAPK/"
    "Salmonella enterica serovar Typhimurium" "Humphreys" "Typhimurium"
    "enterica" "ARNO 3G" "phosphoinositides" "trisphosphate" "ELMO"
    "demyristoylates" "AFA" "adaptin" "K/D" "motile" "IpgB1" "DOCK180/ELMO"
    "T3SS" "cytohesin" "flexneri" "= 0.0006" "P = 0.003" "P = 0.03" "and 2 h"
    "Joseph" "≥5%" "non-statistically" "non- NRAS" "p=0.01" "ORR" "p=0.07"
    "non-NRAS" "withBRAF" "wasNRAS" "secondary endpoints" "≥ 24"
    "Memorial Sloan" "MGH" "VICC" "Vanderbilt" "asNRAS" "Newer"
    "clinically relevant subsets" "=48" "p=0.86" "NASH-like" "mNampt" "mSirt1"
    "hepatome" "/NADH" "non-C" "non-B" "sinusoid" "NBNC" "P  = 0.02"
    "P  = 0.04" "P  = 0.03" "P  = 0.005" "Non-parametric" "14-day"
    "co-resistance" "Chemoresistance" "/44" "= 0.018" "P  = 0.001" "P  = 0.013"
    "= 0.048" "= 0.035" "non-homologous" "P -values " "n  = 21" "1 μg/mL"
    "strong co-localization" "Walsh" "pEGFR/EGFR" "isogenic HBECs" "Y394/395F"
    "E83Stop" "Y394/Y395" "Phosphosite" "HBECs" "L858R+T790M" "theEGFR"
    "orEGFR" "orMig6" "anti-pEGFR" "fromEGFR" "toMig6"
    "quantitative genomic PCR" "andEGFR" "ofEGFR" "fromMig6" "transgenicEGFR"
    "inEGFR" "theMig6" "ofMig6" "andMig6" "dysplasias" "inMig6" "TheMig6"
    "transgenes" "thanCC10" "andCCSP" "SILAC" "Y394/395" "incidental DSBs"
    "programmed DSBs" "the subsequent damage-induced poly(ADP-ribosyl)ation"
    "ation" "mono-ADP-ribosylhydrolase" "GVD" "GVF" "mono-ADP-riboses"
    "considerable co-localization" "aminobenzamide" "mono-ADP-ribose" "MRN"
    "S2F" "S2C" "regions 1" "10-cm" "Co-IP" "mass-forming pancreatitis" "FNA"
    "EUS" "codon 72" "Nacaeeati" "Sonoyama" "T/G" "G/G" "df" "Arg/Arg"
    "pancreatitis (CP)" "pancreatitis" "p = 0.001" "= 4" "= 0.016"
    "10.1038/ncomms7285" "Grabner" "Network:were" "co-authors" "re-evaluation"
    "multistage" "inhibiton" "co-stimulation" "G12D/+ animals" "MDSCs"
    "bronchoalveolar lavage (BAL)" "Pdgfa"
    "Stat3 -proficient control littermates" "G12D/+ mice" "G12D /+animals"
    "G12D /+mice" "littermate" "ΔLep/ΔLep" "ΔLep" "ΔLep/" "AdCre" "fl/fl"
    "G12D/+" "kirsten" "* P" "P =0.017" "cerevisiae" "much longer ssDNA"
    "iPOND" "S4/S8" "-deoxyuridine" "deoxyuridine"
    "reversed forks averaged around 300 bp" "occasional ssDNA" "larger ssDNA"
    "PFGE" "Tus" "a reliable readout" "laevis" "methanesulfonate (MMS)"
    "methanesulfonate" "DOX" "topoisomerases" "–5-" "pChk1" "anti–rabbit"
    "anti–mouse" "2 B" "Ing1b" "Δ1–230" "ΔLZ" "interactes" "ub" "8p21" "pGab1"
    "anti-phosphotyrosine" "Dox-fed" "C/Sdn/CL858R"
    "the small bronchiolar epithelia" "Aperio" "C/Sdn/EL858R" "C/EL858R"
    "Histology" "bi-" "C/Sdn" "rtTA" "Gab1FF" "LREA" "BTAM" "bisphosphoryl"
    "Shp2CSDA" "= 2" "T202/Y204" "non-mucinous" "pStat3" "non-silencing"
    "H1975" "chemotypes" "anilinoquinazoline" "benifits" "responders"
    "Changzheng" "/sr" "Imager" "IVIS" "HCC-827GR" "EFGR" "bio" "amaranth"
    "Paez" "WB-308" "WB" "oncotarget" "16 hrs" "1/10" "Phospho-ERK1/2" "n = 10"
    "PC3AR-LBD" "cellular de-adhesion" "CDCP1/gp140" "72kDa" "ARΔLBD" "ARΔNLS"
    "ΔLBD" "ΔNLS" "α6β1" "non-nuclear" "non-genomic" "non-genomically"
    "non-stimulated" "O-glycosite" "O-glycosites" "glycosites" "glycosite"
    "late endosome/lysosome" "VVA" "p-Y1068" "chemoattractants"
    "hemorrhagic coagulants" "coagulants" "GALNT1/pcDNA3.1A" "NTUH" "NextBio"
    "EOC" "Tn" "N-acetylgalactosamine" "GALNT" "acetylgalactosamine" "Taiwan"
    "GalNAc" "O-glycosylation" "Non-uniform" "five-year"
    "other racial population ought" "ought" "COX-2-765G/C" "COX-2+8473T/C"
    "COX-2 +8473T/C" "COX2-765G/C" "COX2-765G" "1.069–1.555" "1.180–1.838"
    "homozygous model:P" "PBu" "1.055–2.303" "All the Egger’s" "The Begg’s"
    "Egger’s" "Egger" "Turkish" "GC+CC" "COX-2-765G" "GG+GA" "GG:OR" "GA+AA"
    "GG: OR" "- 765G" "95%CL" "COX-2-1195G/A" "COX-2-1195G" "nucleoproteins"
    "+8473T/C" "-765G" "-1195G" "WanFang" "Google" "HCL-v-" "IGHV-34-positive"
    "Tiacci" "PCR" "BioSewoom" "HCL-v" "non-equivalently" "is 2:1" "A/B" "ΔCID"
    "CID" "SRCID" "SRC-3a" "SRC-3b" "Segger" "Ab2" "EMAN" "EMAN2" "×320"
    "DNA-bound ERαs" "Coomassie"
    "multiple publicly available ChIP-seq datasets" "cistromes" "cryo" "ERE"
    "the ligand-bound ERα LBD" "LXXLL" "LBD" "SRC-3s" "= 70" "=2" "2 hrs" "+ 2"
    "MAPKAPK-2/3" "WASP" "calphostin" "HSPB1 phosphorylation"
    "HSPB1phosphorylation" "ferrostain-1" "necrostain" "ClpB" "HSP100"
    "non-apoptotic" "Brent" "/ i" "NOD/SCID" "#S" "unpubl" "Luca" "Mologni"
    "Waal" "der" "entropy" "Heuckmann" "NPM-ALK-positive" "the absolute IC 50"
    "ASP3026" "Philadelphia" "NPM-ALK-" "AP26113" "= 2" "IC 50  " "= 3" "μ Ci"
    "μ mol/L" "pcDNA3" "I/II" "Shor" "nonuniform"
    "Typical immunohistochemistry" "fusiform" "Hubei" "Wuhan" "Zhongnan" "+ 2T"
    "+ 1G" "G/p" "at least two different algorithms" "deletions/insertions"
    "C/p" "A/p" "T/p" "+ 2" "+ 1" "B23/NPM" "Rodway" "ARFT8D"
    "inactivation/deregulation" "ARFT8A" "T8A" "T8D" "Vivo"
    "Bisindolylmalemide" "us" "2-14/82-101" "p21Waf1/Cip1" "non-nucleolar"
    "acetylcholine" "mucosal epithelium" "minichromosome" "up/down-regulated"
    "iReport" "UASMC" "~12-fold" "CASMC" "vasospasm"
    "normotensive Wistar Kyoto" "Kyoto" "DAPKs" "peptidases" "n = 3" "~35%"
    "~30%" "~80%" "2P" "#s" "~ 50%" "~ 80%" "6/20" "cribriform" "D5F3" "inv2"
    "CARS" "TPM3/4" "eosinophils" "=7" "5/7"
    "focal marked nuclear pleomorphism" "pleomorphism" "mediastinum" "rhabdoid"
    "myxoid" "MF/10" "lacked significant cytologic atypia" "atypia" "omentum"
    "loose fascicles" "fascicles" "immunoprofile" "fibromyxoid" "viscera"
    "42/62" "FusionSeq" "recurrent/advanced" "4/35" "18/20" "=3" "=15"
    "the more tumorigenic T24T cells" "CNUH" "hungbuk" "the mild lysis" "mmuno"
    "ite" "opy" "olymorphisms" "ucleotide" "ingle" "UC23" "wenty-" "wenty"
    "ase" "ucleoprotein" "ibo" "u rothelial c ancer (UC)" "ancer (UC)" "UC"
    "ancer" "u" "everse" "te" "non-invasive" "~4-fold" "= 87" "PARPi"
    "interactomes" "co-purify" "SUMO-2/3" "ΔSIM" "DVVEV" "VIDVE" "EVILLLDSDE"
    "mSLX4" "re-entered" "sulphonate (MMS)" "sulphonate" "SIM-" "SIM"
    "nucleases" "non-covalent" "SIMs" "interstrand" "homozygous genotypes"
    "Gebhardt" "CASSR1" "0–1" "Kuwait" "Kharrat" "Ocvirk" "Acneiform" "CTCAE"
    "NCI" "Intron 1" "corticosteroids" "intron 1" "IMC" "Spearman’s"
    "acneiform" "–9" "=  0" "=  0" "= 0.040" "p  = 0.356" "isocyanates" "2b"
    "submucosa" "COUPTFs" "COUP" "bronchial biopsies" "UniGene" "COUPTF" "eQTL"
    "DNaseI" "RegulomeDB" "Spain" "rs1800629" "rs1800469" "rs5788" "rs20417"
    "HWE" "diisocyanates" "OA" "NAG-1/GDF15" "NAG-1/" "diisocyanate (MDI)"
    "-diphenylmethane" "diphenylmethane" "237 Caucasian French Canadians" "AW"
    "Canadians" "French" "diisocyanate" "Diisocyanates" "= 0.053" "= 0.057"
    "= 1.06" "the cancer-supportive transcriptome" "activation/attenuation"
    "deficiency/mutation" "FBXW7-" "FBXW" "toFbxw7"
    "both proteotoxic stressors" "degrons" "phosphoamino" "SPPQS" "degron"
    "ubiquitinproteasome" "FBXW7α" "co-opted" "1 μg/mL" "invasion/metastasis"
    "P =0.01" "icariside" "NF-kB1" "bromelain" "/G 1 -phase" "lithospermum"
    "SN50" "Z–Asp–CH2–DCB" "procaspase-3 " "epidermoid" "erythrorhizon"
    "Lithospermum" "approximately 12000 Americans" "Z-Asp-CH2-DCB"
    "the Chinese herbal Zicao" "Zicao" "G 1 /S" "and -9" "Tris/HCl"
    "basal-like aggressive MIBC" "clearer" "the soluble ectodomain" "HB-CLS-2"
    "pT2+" "mean+2 s" "secretome" "quantitated±PMA" "secretomes" "haematuria"
    "multimarker" "an attractive biospecimen" "biospecimen"
    "sophisticated clinicopathological algorithms" "the most aggressive UBCs"
    "UBCs" "algorithms" "cystectomy" "chemoradiotherapy" "MIBC" "NMIBC"
    "commonest" "shed soluble EGFR ectodomain" "noncancer" "P =0.001" "+2 s"
    "=87" "μ g " "Ms4a4b" "HuMC" "phosphatidylinositol-4,5-biphosphate"
    "chemoattractant" "568/570" "LEs" "LE" "EEs" "shMS4A4v4" "shMS4A4" "wk"
    "HuMCs" "HLMCs" "γ1" "late-onset Alzheimer's" "11q12-q13" "topology"
    "microdomains" "Alexa 647" "800CW" "PI3K/AKT" "S4A" "growth/survival"
    "hESCs" "Jang" "Vlashi" "Achuthan" "ABSCs" "GCS" "chemoresistant"
    "survival/growth" "nonadherent MCF7 mammospheres" "Hoechst"
    "a fluorogenic dye carboxy-2" "carboxy-2" "-dichlorofluorescein"
    "dichlorofluorescein" "Mammosphere" "shNRF2" "1c1" "ultralow"
    "detoxifying/antioxidant" "neurospheres" "neurosphere" "Reynold"
    "non-stem cells" "apoptosis/necrosis" "trypsin-like" "Transcriptome" "BVZ"
    "4EGI" "ARK" "Timlip" "sync" "LC3I" "pJNK" "Toppgene" "ToppGene"
    "Webgestalt" "Wilcoxon" "Smirnov" "Kolmogorov" "Aviv" "un" "Cenci"
    "eIF4E/eIF4GI" "3MA" "Thr183/Tyr185" "Africans" "1.02–1.13" "=1.08"
    "0.82–1.24" "1.00–1.10" "=1.01" "=1.05" "1.02–1.11" "=1.06" "Zhang"
    "TTAGGG" "rs2735940" "=0.87" "P =0.004" "P =0.005" "95% CIs"
    "Material/Methods" "a bilateral mastectomy" "mastectomy" "pCR"
    "oophorectomy" "survivorship" "Western Europeans" "Europeans" "European"
    "185delAG" "Chilean" "Jewish" "Spanish" "non-carriers" "$20" "USD"
    "HISPANEL" "Venezuela" "Uruguay" "Rica" "Costa" "Colombia" "Brazil"
    "ex9-12del" "Mexican"
    "endobronchial ultrasound-guided biopsy and mediastinoscopy lymph node biopsy"
    "mediastinoscopy" "Yanagawa" "the histologic subtype" "non-P-LC"
    "Guangzhou" "= 0.006" "P  = 0.009" "95% CI " "P  = 0.002" "= 0.089"
    "P  = 0.004" "= 0" "P  = 0.001" "antiautophagy" "discrepant" "GFP-LC3B"
    "ABT-737-induced" "DKO" "multisite" "1:5,000" "173/2010" "POSCCE" "Latin"
    "1/17" "Maria" "_value = 0.000" "=II" "_TNM" "_value = 0.015" "=I"
    "Mutationin" "GAC" "Codon" "pb" "Bevazucimab" "PCT" "codons" "diphosphate"
    "NIRDPBS" "= 0.025" "12 /13" "preoperative BRAF mutation status" "cytology"
    "eightfold" "Gouveia" "Francisco" "1.1–2.7" "1.1–2.9" "1.1–2.6"
    "heterozygote" "TspRI" "classic papillary histology" "P  =   0.009"
    "P  = 0.004" "P  = 0.002" "P  =   0.004" "P  =   0.001" "P  =   0.003"
    "=   0" "48 h" "PDK1 is" "BRAFi" "MEKi" "YUMM1.9" "PDKi" "UACC903" "PDK1i"
    "SGKi" "ofBRAF" "YUMM1.5" "Sgk3-" "Sgk" "Ptenmice" "andBraf" "fromBraf"
    "theBraf" "7/12" "treatedBraf" "ofBraf" "inBraf" "::Cdkn2a" "PDK" "PTENWT"
    "humanBRAF" "SGKs" "PI3K/PDK1" "WTPTEN" "~70%" "AGC" "and 3D" "1 +"
    "Ser 235/236" "non-epithelial" "Oncology/College" "mammography" "ASCO"
    "ISH-" "IHC+" "non-existent" "protein 3+" "ISH" "BO18255" "multicenter"
    "gallbladder" "Caris" "CLIA" "amplification/overexpression" "andv"
    "marginals" "Bayes" "MCMC" "co-binding" "MATLAB" "48 h" "co-occurrence"
    "E2F/pocket" "S2A" "48h" "E2F1–3A" "de-repression" "transcription factor-1"
    "–3A" "Accelrys" "licochalcone" "phenylmethysulfonyl" "Beckman" "μCi/μL"
    "μCi" "Avanti" "Finland" "Helsinki" "Luminoskan" "luminometer"
    "immunoassay" "rpm" "Israel" "Labsystems" "microplate" "Multiskan"
    "sulfophenyl" "carboxymethoxyphenyl" "Rockville" "American" "WI" "Promega"
    "Hercules" "Bio" "Ann" "Piscataway" "CNBr" "Billerica" "Merck" "Carlsbad"
    "Gibco" "MEM" "Glycyrrhizin" "Licochalcone" "Akt/mTOR" "PD318088" "methoxy"
    "hydroxyl" "multitarget" "anti-parasitic" "approximately 300 polyphenols"
    "TPA" "dimethylbenz" "aglycone" "GA" "Akt/" "anti-carcinogenic" "PI3K/Akt"
    "botanicals" "LicoA" "Gc" "Thr202/Tyr204" "non-competitive"
    "non-receptor-mediated" "AGE-BSA-treated" "AGE-BSA-"
    "the AGEs-induced EndMT" "type I interstitial collagens"
    "transdifferentiate" "diabetic microangiopathy" "microangiopathy"
    "Maillard" "hyperinsulinemia" "mellitus (DM)" "RSV" "TGFR" "BSAs" "EndMT"
    "the mutation homozygous genotype (AA)" "Henan" "Jiangsu" "Hebei"
    "the mutation homozygous genotype (TT)" "Casson" "nitrosocompounds" "GG"
    "only haplotype CGC" "CGC" "SNPHAP" "heterozygous and homozygous genotypes"
    "Taiwanese" "Lunn" "19q13.2-13.3" "introns" "hydroxyuracil"
    "hydroxyguanine" "RFLP" "= 0.54" "MADISH" "Slpi" "infundibula" "carbinol"
    "indol" "diindolylometan" "Polyphenols" "brassica" "betle" "polyphenols"
    "maleate" "diethyl" "Mrp" "trichostan" "miofibrocytes" "afamelanotide"
    "HHD" "Hailey" "IRES" "melanotropine" "level/activity" "NHK" "pCMV" "XL"
    "diphenolaze" "Melanin" "azoles" "UVA" "D3T" "carbonitriles"
    "-guglesterone" "guglesterone" "erythema" "brussels" "flavonoids" "UVB"
    "eugenol" "Merkel" "Langerhans" "glutamylcysteine" "pharmacotherapy"
    "melanin" "Nrf2/ARE" "Fn" "explants" "Isotype"
    "healthy control skin biopsy" "dorsal forearm skin biopsy" "MRSS"
    "diffuse-proliferative intrinsic subsets"
    "the diffuse-proliferative intrinsic subset"
    "5 previously defined intrinsic subsets"
    "healthy control (n = 6) skin biopsy" "fibroSblasts" "nonhistone" "SIRTs"
    "SSc" "= 0.008" "P = 0.002" "P = 0.004" "normal-like" "24-hour" "vitro"
    "selumetanib" "BCL-xl" "xl" "BCL" "vemurfenib" "p-ERK 1/2" "Flaherty"
    "non-V600E" "IPASS" "non-V600" "Homolog" "Yasuhiko" "Belgian Caucasians"
    "rs3740051" "1.09–1.84" "haplotypes" "1.14–2.35" "CG/GG" "1.15–2.16"
    "HapMap" "neointima" "tagSNP" "rs7069102G-rs3818292A-rs4746720T"
    "haplotype" "rs4746720" "rs3818292" "rs7069102" "tagSNPs" "non-coding"
    "≥ 90" "Th17" "T-helper" "Xinjiang" "45/46" "non-cervical" "America"
    "Cunningham" "microbiota" "1+" "M±SD" "2+/3+" "1+/2+/3+" "3+" "I+II"
    "III+IV" "15/50" "46/95" "GLOBOCAN" "colorectum" "= 0.38" "P = 0.001"
    "P = 0.034" "non-cancerous" "Yang’s" "Paik’s" "Paik" "Takamochi’s"
    "Takamochi" "non-smoking" "non-Asian" "non-adenocarcinoma"
    "a robust and effective diagnostic algorithm" "2p" "ontogeny" "P = 0.08"
    "= 17" "= 3" "rs3024505" "Danes" "covaries" "ins/del" "A-allele"
    "/rs4986790" "rs4986790" "meat/day" "non-smokers" "tertiles" "int"
    "tertile" "1.03–1.34" "1.01–1.51" "1.05–1.60" "Weinberg" "G-allele"
    "/rs5030728" "Swedish" "/rs28362491"
    "gram-negative bacterial lipopolysaccharide (LPS)" "Danish" "= 0.0003"
    "= 0.006" "= 0.040" "= 0.04" "= 0.03" "P-value" "non-steroidal" "P = 0.04"
    "P = 0.02" "deoxycitidine" "HAART" "genes/miRNAs" "anti-Tat"
    "cellular proteins/RNAs" "the viral genome" "antagomirs" "hsa-miR148"
    "mimics/inhibitors" "mimic/antagonists" "miR29" "DNMT3a/b" "B-lymphomas"
    "lymphopenia" "BKV" "miR148-152" "pCDNA3" "miR-148b" "types/conditions"
    "LC3 II" "LC3II" "MTS" "forkhead box O3A" "misbalance" "/cell" "Dalmases"
    "VK" "ΨKxE" "Brandl" "phenethyl" "isopeptide" "acetylation/deacetylation"
    "non-canonical/alternative" "IKKs" "mSIN3A" "X 100" "arisen" "shGFP"
    "Dmp53" "Sogame" "simpler" "orthologues" "particularly binding site #1"
    "25,26/25,26" "minimal spacers" "RRRCWWGYYY" "latentKras" "orKras" "inKras"
    "hydroxymethylglutaryl"
    "peroxisome proliferator-activated receptor (PPAR) α and PPARγ coactivator-1α"
    "coactivator-1α" "FADH" "PANTHER" "orthologue" "inHrasV12" "thanHRasV12"
    "betweenHrasV12" "andHRasV12" "oligomycin" "Nicholls" "uncoupler" "XF"
    "toHrasV12" "decreased survival compared toHrasV12" "andHrasV12"
    "ofHrasV12" "HrasV12" "3KR" "bisphosphate" "Attardi" "Broz" "Kenzelmann"
    "OXPHOS" "HT1080" "defatty" "glutaryl" "decanoyl" "hexanoyl" "decreasedK"
    "the long-chain fatty acyl" "lowerK" "Nε" "OH" "NH" "fulgidus"
    "Archaeoglobus" "TMy" "/ K" "H3K9" "thek" "H2BK12" "H4K16" "demyristoylate"
    "SIRT1-3" "thiomyristoyl" "myristoyl" "long-chain fatty acyl" "palmitoyl"
    "furthers" "outcompete" "EE" "PD033299" "SecondDiv" "SecondDiv  "
    "FirstDiv" "Subsets" "the mitotic marker phosphoH3" "phosphoH3" "and 2B"
    "immune/inflammatory response" "Temporal Regulation algorithm"
    "xenotransplant" "multilineage" "Alexa 488" "and 2H" "S807/S811" "S1E"
    "CD90" "S-adenosyl-L-methionine" "GYS1B" "GPi" "HA-tagged active ΔAMPK"
    "ΔAMPK" "5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR)"
    "GSKβ" "8/11" "p=0.04" "oligo-" "oligo" "ITD" "=0.27" "p=0.002" "=0.004"
    "1μg/mL" "PI3KCA" "Filho" "Reis" "Gilbert" "EGFR/PI3K/AKT1" "/PI3K/AKT"
    "co-heightened" "karyotypes" "RP11-203M5" "HDF" "centromere" "7p12"
    "Co-heightened" "P -value  " "P  = 0.001" "= 0.0001" "P  = 0.0002" "PI3K/"
    "let-7/cyclin D1" "N3-treated MCF-7 mammospheres" "mammospheres"
    "mammosphere" "let-7b" "RNAas" "UTRs" "16 hrs" "cells/well" "1T2V" "DpSPVF"
    "Phosphopeptides" "the idealised polyproline II (PPII) helix" "phi/psi"
    "Ramachandran" "sidechains" "shallower" "+2" "Missense" "BRCT7" "pSPTF"
    "EPTF" "S1655/G1656" "+3" "1T29" "αL" "mainchain" "H-bonds"
    "All bound phosphopeptides" "CREDO" "pSXXF" "HBOC" "PIKKs"
    "phosphopeptides" "Massachusetts" "Oncology" "-delL747_P753insQS" "mg/day"
    "- delL747_P753insS" "stent" "bronchoscopy" "Genotype" "-delL747_P753insS"
    "Transbronchial biopsy" "lymphadenopathy" "hilar" "insQS" "insS"
    "pack-year" "_P753insQS" "_P753insS" "non-small" "year-old" "Csibi"
    "Bourke" "Atkinson" "2DG" "stressful" "the organelle's" "fluorimeter"
    "bafilomycinA" "S8B" "S8A" "S6A" "succinyl" "hexachlorophene" "Urea"
    "BPTES" "ribosylases" "SIRT" "Sirtuins" "MAP1LC3B‒PE" "phagophore" "MC3482"
    "nonliver" "urea" "+1" "ology" "pathophysi" "endpoints" "APA5" "ImClone"
    "mesentericartery" "subj" "neovas" "PPVL" "Thailand" "DEN/PB" "vitreo"
    "oxi" "IPF" "adenomatous polyposis coli (APC)" "coli (APC)" "DEN/"
    "phenobarbitol" "multityrosine" "146a" "Zhu" "cotarget"
    "chemo/radiotherapy" "46/63" "cyte" "hepato" "Perhaps"
    "chronic hepatitis/cirrhosis" "giocytes" "cholan" "sequelae" "serumfree"
    "LSEC" "TAA" "myofi" "undergone" "TβRs" "SMAD2/3" "IMC-3G3" "derma"
    "sclero" "myofibro" "PDGFRαα" "activation/ proliferation" "PDGFRαβ" "Hayes"
    "genic" "activation/proliferation" "Knodell" "tetrachloride" "Disse"
    "littermates" "pdgfra" "hepatectomy" "proprolif" "mesenchyme" "poietin"
    "erythro" "coculture" "around 5.5 million Americans" "Americans" "ExAC"
    "contemporary exome" "performing even larger exome" "LGALSL" "Alsin" "ALS2"
    "penetrance" "dense cytoplasmic protein/RNA" "protein/RNA"
    "a cargo-specific subtype" "ATXN2" "HGMD" "SALS" "LoF" "=3.63×10"
    "p=5.78×10" "=1.13×10" "SIRPA" "exomes" "proteinopathy" "= 0.0002" "=9"
    "−9" "=5" "resident stem/progenitor" "Tata" "Morimoto" "NICD3" "NICD4"
    "NICD2" "Lenti" "NICD1-4" "NICD1" "DNAI1" "probesets" "DBZ" "24 hr" "100 x"
    "40 x" "Anti-Rabbit" "Anti-Mouse" "stem/progenitor" "non-stress" "Drohsa"
    "damage/p53" "Co-expression" "premiR" "pri" "pre-miR-30a" "pri-miR-30a"
    "autoradiograph" "RNA/miRNA" "PureLink" "stress-induced regulaton"
    "regulaton" "ΔN390" "cytochemistry" "aa340-360" "201-390aa" "ΔN220"
    "T180/Y182" "210-390aa" "progrowth" "George" "DiGeorge" "to/interact"
    "histopathology" "TAR" "non-random" "indel" "TTS " "indels" "SBMs"
    "DRIP+RH" "seq" "transcriptomes" "TTS" "DSBs" "Akirin1" "CoTC"
    "prevention/repair" "R-Loop" "co-recruitment" "F6C"
    "Weak or undetectable co-IP" "insertion/deletion" "co-transcriptional"
    "RNAPII" "Setx" "TAP-MS-based" "DSB" "R-loop" "relevant R-loop" "ssDNA"
    "R-loops" "Co-Immunoprecipitation" "= 0.021" "S4B" "anti-sense"
    "non-template" "S2B" "G-rich" "uteri" "Eker" "nonmalignant"
    "vessels/fields" "meth" "chylothorax" "smooth muscle-like" "axial"
    "LAM/TSC" "multisystem" "ErbB" "migration/invasion" "μ g/mL" "= 15" "50/50"
    "re-assembled" "S3D" "S3C" "INKc" "Status" "BJ-TERT-tsLT" "BJ"
    "senescence-like" "non-permissive" "ts" "D-type" "re-established" "S3E"
    "co-precipitates" "anti-oncogene" "HCI" "co-transfection" "5-aza-2"
    "Hypoxia inducible factor-1α" "non-receptor tyrosine kinases" "1:1,000"
    "hotspots" "AVM" "Costello" "VASC105" "VASC103" "VASC104" "VASC102"
    "VASC101" "VASC100" "pulsatile" "Yale" "lobules" "Kamada" "、XIAP"
    "eosinophil" "BMS" "to-1"
    "one potential NF-κB binding site (GGGAATCCCC) from-1" "from-1"
    "GGGAATCCCC" "and-9" "PRAP" "IκBɑ" "κB" "FRA" "Caucasoid" "noncarriers"
    "immunotherapy" "Hu" "the nonbasal TNBC" "Sutton" "non-TNBCs" "SSCP"
    "TNBCs" "BL1" "mesenchymal-like" "Lehmann" "unique molecular subtypes"
    "basal-like" "at least 5 subtypes" "non-TNBC" "TNBC" "~50%" "Q -test" "= 9"
    "= 5" "Merzbacher" "Pelizaeus" "Dawson" "MSF2" "EDSS" "Luxol" "TCCP"
    "discordances" "ORs" "DRB1*1501" "slightly younger" "PPMS" "MSF4" "MSSS"
    "axons" "thymocytes" "Jegher" "GWASs" "African" "Japanese" "HLA-DRB1*1501"
    "GWAS" "*1501" "rs9282860" "TaqMan" "Jeghers" "Peutz" "P = 0.009" "= 0"
    "95% CI " "XTrJ" "∼10%" "rotarod" "CMA" "KFERQ" "athanogene" "S-pulse"
    "autophago" "immunoglobulin" "HA-like" "VVL" "HA3" "∼6%" "PNGaseF" "EndoH"
    "Representative confocal micrographs" "PMP22-" "PMP"
    "The representative micrographs" "micrographs" "LLVY" "mono-ubiquitin"
    "∼16%" "Wt" "αB-Crystallin" "nonneuropathic Ct" "HSP70.1/3" "HSP104/110"
    "cochaperone" "retro" "endothelia" "TrJ" "Trembler" "PNS"
    "Trembler-J-PMP22" "∼50%" "× 10" "24 hr" "∼80%" "Darby" "Madin" "ionic"
    "pseudosubstrate" "anti-biotin" "Langerak" "hypermutations"
    "Polη-proficient" "Polζ" "WI38VA13/PCNA" "Polη-deficient" "#3" "J/m 2"
    "co-precipitate" "Ni-pull-down" "Ni" "UVC" "RAD6" "Polη-mediated"
    "Y-family" "Polη" "co-precipitated" "DDAH/" "GCTGAGnnn" "TGACnnnGC" "58±4%"
    "47±9%" "24hr" "∙l −1" "CKD" "advanced diabetic nephropathy"
    "diabetic nephropathy" "nephropathy" "bardoxolene" "microvessels"
    "redirect" "glomeruli" "glutathione S-transferase-1" "oxygenase-1"
    "notably mafmusculoaponeurotic fibrosarcoma oncogene homolog" "dimerises"
    "-butylhydroxyquinone" "butylhydroxyquinone" "tert" "rosveritrol"
    "Kelch-like" "Keap" "HRGECs" "HBX" "non-canonical" "Ser-9"
    "mitogen-activated protein kinase kinase 1/2" "S33F" "TOPFlash/FOPFlash"
    "FOPFlash" "TOPFlash" "casein kinase 1α" "adenomatous polyposis coli"
    "microautophagy" "unnecessary organelles" "Co-immunoprecipitation"
    "phospho-P70S6K" "p=0.08" "Mier" "Poeta" "BUM" "LOF" "cisplatn" "mutp53"
    "pBabe" "apoptotioc" "A161S" "status" "statu" "wtp53" "Osman" "Neskey"
    "neoadjuvant" "EAp53" "=0.029" "phosphopeptide" "pregnane" "re-enter"
    "fixation/permeabilization" "Kumar" "Martinez" "non-phosphorylated" "AR21"
    "2hrs" "±0.21" "S-late+G2" "G1+S-early" "S-late" "S-early" "ImageStream"
    "LHS" "approximately 0.7-1" "anti-total" "CRPC" "2-hour" "Co-localization"
    "Bax1" "proteosome" "cyclohexamide" "LCLs" "EBNA" "lymphoblastoid"
    "lost greater" "Wakahara" "ETS-1 expression" "−337" "−74" "co-exist"
    "aneuploidy" "Burkitt's" "Burkitt" "ectodomain" "Breflate" "BFA"
    "Abagovomab" "non-expressing" "Carboxyl" "recurrent OC" "peritoneum"
    "photons/sec" "heterochromatin protein 1α" "H3Y41"
    "non-receptor tyrosine kinase" "*P" "C-ter" "non-permeabilized" "CMV10"
    "CMV9" "preprotrypsin" "p3X-FLAG-CMV9" "Uniprot" "Seelenmeyer"
    "NFSPLARRVDR" "OC" "F114HA" "Cter" "=0.03" "stem cell-like" "mutation/drug"
    "AACR" "JNJ-ROS1i-A" "Mevellec" "WCLC" "Ou" "SI" "intra" "initio"
    "somatic mutations/rearrangements" "ROS1+" "2-4 h" "μg/mL" "units/mL"
    "γH2A" "2RA" "phosphorylating H3.3S31" "the extensive H3.3S31ph"
    "intense H3.3S31ph" "the aberrant H3.3S31ph" "re-distributed"
    "aberrant H3.3S31ph" "the antibody specifically targets H3.3S31ph"
    "intense and aberrant H3.3S31ph" "H3.3S31" "further aberrant H3.3"
    "neuroendocrine" "re-express" "H3.3S31ph" "H3.3S" "the global genome"
    "H3.3" "1 μg/ml" "TUNEL" "−82" "−87" "−3410" "−3415" "CACGCG" "CACGTG"
    "CATGTG" "COLO-320" "COLO" "pcDNA" "/+" "P  = 0.0004" "= 0.002" "Nu/Nu"
    "8P" "Δ C" "stimulators" "co-regulation" "Co-treatment" "Phiphilux"
    "secondary apoptotic/necrotic cell death" "Co-treatments"
    "secondary apoptosis/necrosis" "Fluos" "or/and" "S-like" "co-treated"
    "BafA1" "acidic vesicular organelles" "hrs" "antitumour" "DG" "WP631" "bis"
    "= 0" "co-treatments" "Schweiger"
    "significantly more thoracic and colorectal LNI" "codon" "thoracic LNI"
    "LRRFS" "FOLFOX" "nonsignificant" "pT" "pN+" "Cramer"
    "significantly more LNI" "peritoneal LNI" "their thoracic metastasectomy"
    "thoracic metastasectomy"
    "V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "Kirsten" "antigen (CEA)" "LNI" "parenchyma"
    "Thoracic metastasectomy" "pN−" "pN" "metastasectomy" "mBRAF" "mKRAS"
    "=0.003" "=0.54" "P =0.06" "pT4" "pT2" "=0.04" "=0.008" "butyrateand"
    "whereras" "disatinib" "Spred2" "erythorid" "GEMM" "NBM" "domainprotein 2"
    "EVH1" "domainprotein2" "phospho-ERK1/2" "dwarfism" "apriori" "ECTM"
    "nigricans" "Crouzon" "A391E" "-FP" "EC-TM-JM" "-JM-YFP" "the dimeric
helices"
    "decouple" "at least −1.5 kcal/mol" "kcal/mol" "ΔΔG" "kcal/mole" "ΔG" "Ẽ"
    "QI" "EC-TM-JM-YFP" "EC-TM-" "phosphorylate/activate" "emphasise" "Crm"
    "interactio" "received chemotherapy longer BCSS" "shorter BCSS"
    "longer BCSS" "BCSS" "Ki67LI" "oestrogen" "NPI" "the key distal transducer"
    "multiprotein" "transducers" "florouracil" "pCHK1" "=10" "=0.018"
    "abraxane" "30-40h" "extracellular signal-regulated kinase 1/2" "pEGFR"
    "pHER2" "mg/kg/day" "HPNE" "hTERT" "CD18/HPAF" "gifatinib" "Mendelsohn"
    "Celgene" "Abraxane" "farnesyl" "pFAK" "anti-Mouse" "anti-Rabbit" "1/2"
    "24h" "polyQ" "aggregophagy" "GST-4E-BP1" "sequestosomes" "dHtt" "vacuole"
    "autophagic vacuoles" "the observed autophagic vacuoles" "methyladenine"
    "oleic" "vacuoles" "organelles" "todhtt" "ofdhtt" "hHtt" "anddhtt" "Tau-ΔC"
    "ko−/−" "wildtype" "red fluorescent punctae" "olddhtt" "punctae"
    "adultdhtt" "heterozygous nullatg1 Δ3d" "Δ3d" "d4−/−" "/+flies" "ATau"
    "heterozygousdhtt" "indhtt" "dhtt" "Huntington’s" "organelle" "lipotoxicy"
    "the Huntington’s" "Huntington" "FN1EDA" "Fluoromount" "Alexa" "Rockland"
    "IST-9" "Lincoln" "LiCor" "washings" "800cw" "Licor" "Cambridge" "SDS/PAGE"
    "Indianapolis" "RIPA" "lysis" "Alameda" "Qiagen" "RNeasy" "betadine"
    "Jefferson" "Thomas" "panniculectomy" "Varga" "Muro" "cFN" "collagens"
    "FNs" "-9" "= 0" "lumbar radiculopathy" "radiculopathy" "C57bl/6" "CRPS"
    "callosum" "explant" "Marinelli" "both the mechanical allodynia" "Dawley"
    "Sprague" "Cui" "reduced mechanical allodynia" "sural"
    "secondary hyperalgesia" "thermal hyperalgesia" "mechanical allodynia"
    "A-fiber" "A-fibers" "mechanical hyperalgesia"
    "either centrally or locally significantly reduced mechanical hyperalgesia"
    "axon" "the complete Freund's" "WDR neuronal postdischarge" "postdischarge"
    "predrug" "nociceptive C-fiber afferents" "lumbar vertebral segments L1–L3"
    "L1–L3" "WDR" "sensory afferents" "Díaz" "Jiménez" "subsets" "SNI" "Asante"
    "complete Freund's" "Freund" "spinal glia" "tyramide" "Géranton" "glia"
    "PIKK" "rapalog" "40-O-" "hydroxyethyl" "RAD-001" "Rapalogs" "rapalogs"
    "Sabatini's" "FRB" "allograft" "Nui" "Easter" "hygroscopicus" "Schwann"
    "eIF-" "eIF" "aminoacids" "Sabatini" "Laplante" "TSC1/2" "theheterodimer"
    "amygdala" "lamina" "resp" "hyperalgesia" "allodynia" "afferents" "μ L"
    "sensitizers" "retrotranslocate" "vMIA" "65-amino-acid-long" "PRE" "α8"
    "HSQC" "Y28C" "MTSL" "methanesulfonothioate" "α4" "α9" "BAXΔC" "ΔC" "α6"
    "pSAHB" "biotinylated BCL-2 BH4 photoreactive SAHBs" "pSAHBs"
    "the BAX-activating BIM BH3 helix" "circular dichroism" "FP" "dichroism"
    "HXMS" "an amphipathic BH4 helix" "SAHB" "alpha-helices" "SAHBs" "refold"
    "TAT" "/I" "16C" "α3" "non-tumorigenic" "S6pS240" "S6pS235" "p90pT359"
    "p70pT389" "=0" "Proteome" "4175shp27" "p27CK-DD-" "pSTAT3" "multiorgan"
    "p27pT198" "p27pT157" "FERM" "p27pT157pT198" "STAT3DN" "C-terminally"
    "p27CK-DD" "Cell cycle-defective phosphomimetic p27T157DT198D"
    "feedforward" "G-agarose" "× 10" "=0.0003" "=0.006" "non-malignant"
    "re-expression" "E-box" "HME3" "hypoxia-inducible factor-1α"
    "TGF-β1/H 2 O 2" "/HOCl" "nu/nu" "× 10" "underpinnings"
    "response/progression" "naïve" "Colorado" "NA" "0.44–1.39" "=0.41" "newer"
    "Non-small-cell" "95% CI" "non-small-cell" "autocrine/paracrine"
    "cerebral edema" "the VEGFR-2-associated chemoresistance" "theO" "chemo-"
    "constitutively active variant vIII" "vIII" "Lu" "non-endothelial cells"
    "NEG" "POS" "bodyweight" "supernatants" "hypointense" "ARHGEF" "CXCL"
    "the organotypic brain slice culture system ex vivo"
    "kappa-light-chain-enhancer"
    "the three-dimensional brain tissue cytoarchitecture" "cytoarchitecture"
    "U138MG" "heterodeletions" "Immunohistochemistry" "GIC" "co-staining"
    "heterocomplex" "Phillips" "unmet" "AVAglio" "BEV" "= 0.002" "1–3"
    "= 0.018" "AngII-" "Gs" "ICMD" "Gonzalez’s" "IMCD" "pinciple"
    "principalcells" "ENaC" "parachrine" "metabsoslsim" "recta" "Prorenin"
    "Gonzalez" "exmaine" "densa" "macula" "Kaneshiro" "angiontensinogen"
    "the proximal tubule" "paracrine" "tubule" "tubules" "CDs"
    "renal interstitial and tubular fluid AngII" "medulla" "Goldblatt" "CD"
    "subendothelium" "prorenin" "blockers" "ACEi" "angiontensin"
    "the distal nephron" "nephron" "AngII" "malformative/overgrowth"
    "Bockenheimer" "SOLAMEN" "Wiedemann" "Beckwith" "genotype" "400x" "smMIP"
    "23/31" "Droplet" "4/8" "16/17" "19/21" "generally no positive droplets"
    "amplimer" "Droplets" "14,000 nanoliter-sized PCR droplets" "droplets"
    "fibroadipose" "n=21" "hotspot"
    "likely disease-causing PIK3CA mutations in 1/8 LM and 2/7" "and 2/7" "n=8"
    "=21" "=17" "non-overlapping" "hemimegalencaphy" "Seattle" "CLOVES" "FAVA"
    "fibro" "Boston" "smMIPs" "ddPCR" "droplet" "KTS" "Trenaunay" "Klippel"
    "covariates" "monotherapy" "Reungwetwattana" "Li Xiao’s" "Xiao"
    "significantly shorter DFS" "Begg’s" "Begg" "95%CI" "HRs" "CNKI" "Medline"
    "filoviruses" "coronaviruses" "orthomyxoviruses" "retroviruses"
    "the first extracellular directly antiviral ISG"
    "a somewhat unconventional ISG" "camostat" "actinomyces" "morpholinos"
    "H5N1" "MSPL" "T/T" "multicycle" "A/A" "T/A" "A43T" "rs6092"
    "polymorphisms" "vRNA" "genotypes" "alveoli" "mPAI-1" "IAVs" "S2I" "clades"
    "Vietnam" "Rico" "Puerto" "HA0" "Progeny" "ubiquitous endoproteases"
    "endoproteases" "Sendai" "triplaxtinin" "parainfluenzavirus" "rPAI"
    "rPAI-1" "supernatant" "nonresponsiveness"
    "differentiated human ciliated airway epithelium" "HAEC" "∼10-fold" "H1N1"
    "HTM" "NHBE" "WSN/33" "hr" "MOI" "Achilles" "progeny" "IAV" "ISG" "ISGs"
    "1μg/ml" "1 μg/ml" "Tibco" "Spotfire" "Redmond" "Microsoft" "Refseq"
    "two neighboring regions/segments" "breakpoint"
    "minimum genomic markers/probes" "diploid" "algorithm" "Hapmap" "Partek"
    "Ibeawuchi" "Gleason" "Rotterdam" "Erasmus" "Muenster"
    "spondyloepimetaphyseal dysplasia (SEMD)" "SEMD" "dysplasia" "Pakistani"
    "-phosphosulfate" "phosphosulfate" "PAPS" "non-specificity" "Haffner" "16q"
    "8p" "ANKRD22" "ATAD1" "LIPA" "8p21.2" "8p21.3" "21/43" "13/43" "22q11.1"
    "16p12.1" "15q22.31" "9q21.11" "8q21.11" "8q22.3" "7/43" "CNVs" "Clara"
    "antigen (PSA)" "prostatectomy" "10q" "10q23.31" "frozen" "Affymetrix"
    "clinico" "= 30" "= 10" "multicentre" "MLVD" "Bachet"
    "angiogenesis/lymphangiogenesis" "desmoplasia" "Handra" "Funel" "≥60"
    "CXCR4−" "CXCR" "EGFR+" "CXCR4+" "χ²" "，33" "erbB" "poorest" "DFS"
    "P -value" "= 0.004" "= 0.048" "coid" "glucocorti" "methasone" "dexa"
    "87.1%±3.1%" "67.5%±5.6%" "65.2%±4.1%" "57.4%±5.5%" "80.1%±4%" "×10"
    "47.2%±6.7%" "53.8%±9.2%" "LABA" "=8" "Corticosteroids" "Anti-inflammatory"
    "dormancy" "α5" "pixel" "vena" "Reincke" "ATCH" "neurosurgeons"
    "immunochemistry" "deubiquinates" "sella" "Whitney" "Pearson" "14-3-3ε"
    "missense" "RSXSXP" "C2159G/p" "dbSNP" "Genomes" "S718del" "CNV"
    "non-synonymous" "blastomas" "Albright" "McCune" "adenomectomy" "exome"
    "= 0.001" "P = 0.01" "= 150" "isomers" "Spearman" "pS807/811" "biopsy"
    "radioresistant" "Gy" "HU" "Luc" "RbSP" "RbLP" "anti-mouse" "Ribes" "Soeda"
    "PRKX" "Ullrich" "Bender" "sunitinb" "=0.013" "caspase 3/7" "orosphere"
    "Krishnamurthy" "co-treatment" "Jin" "Beeser" "HKC" "prosperities"
    "covariate" "ECOG" "Univariate" "Fuhrman" "thrombus" "Sullivan" "=0.001"
    "=0.002" "5-year" "Stem-like" "NHEMs" "GSE3189" "re-localized" "CD95/F"
    "DTIC" "undergoes" "anti-rabbit" "μ g" "Doulias" "3TBL"
    "atomic co-ordinates" "silico" "myocardium" "glyco" "bisphosphoglycerate"
    "adducts" "Tsang" "Singh" "lipopolysaccharide" "Yao" "C81/162A" "HPDP"
    "BST/Western" "immuno" "antigens" "MMTS" "SNOC" "BST" "micrOTOF" "PDQuest"
    "S-nitrosoproteomes" "S-Nitrosoproteome" "nitrosoproteome" "denitrosylates"
    "sulfhydryl" "ONOO" "Sulzer" "compacta" "CyDye" "ischemia/reperfusion"
    "mg/ml" "Lassa" "Hantaan" "Marburg" "HPCS" "proteome" "#31" "#150" "#193"
    "TAFIa" "CPN" "zymogen" "TAFI" "RGD" "aPPT" "about potential co-morbidity"
    "mg/dL" "INR" "aPTT" "/mL" "severe HCPS" "WBC" "C3c" "•substrate" "C3C"
    "α-1-antitrypsin" "#53" "readouts" "fatal HCPS" "UNMH" "broader"
    "mild and severe HCPS" "HCYTMAG-60K-PX41" "RhoGTPases" "erythrocytes"
    "sDAF" "the ratiometric calculation Arg/" "Arg/" "eluates" "Retentates"
    "retentate" "NMWCO" "Danvers" "microcon" "fractionate" "Novi" "atand"
    "SwissProt" "spectrometer" "μg" "Biochemicals" "Roche" "μL" "Columbia" "/i"
    "Hochberg" "Benjamini" "iswhere" "∆sg" "subtractingrather" "=ln" "isg"
    "Durham" "Irvine" "Griot" "Melles" "PDSI" "densitometer" "mA/gel" "IEF"
    "Germany" "Heidelberg" "Serva" "Servalytes" "Isodalt" "Kendrick" "BCA"
    "Amicon" "CalbioChem" "Proteoextract" "Alexa488" "Invitrogen" "Abcam"
    "X100" "Tek" "Nunc" "Zeiss" "monolayers" "Diego" "GraphPad" "posttest"
    "Bonferroni" "live SNV strain SN77734 inocula" "moi" "inocula" "BSL3"
    "Endohm" "voltohmeter" "monolayer" "transmonolayer" "Tewksbury"
    "Transmonolayer" "impedance" "at least 24 h" "ECIS cultureware"
    "cells/cm 2" "cultureware" "microelectrodes" "biosafety" "Walkersville"
    "Lonza" "SingleQuot" "HLMVEC" "Dulbecco’s" "GIBCO" "DMEM" "Dulbecco" "CaCl"
    "NaH" "HBSS" "HHB" "pH" "Inc" "Mediatech" "°C" "≥30" "acute HCPS" "UNM"
    "ECMO" "noncardiogenic pulmonary edema" "dyspnea" "Argentina" "Chile"
    "Andes" "Canada" "annum" "HPS" "acute ≥30" "serologically-confirmed HCPS"
    "Electric Cell-substrate Impedance" "Mexico" "drawn" "ECIS" "Impedance"
    "non-cardiogenic pulmonary edema" "edema" "HCPS" "Bunyaviridae" "SNV"
    "Nombre" "refractoriness" "exons"
    "lymphocytic infiltration around thyroid follicles" "TDS" "BRS" "N-stage"
    "showed lymphocytic infiltration around thyroid follicles" "follicles"
    "T-stage" "NCBI" "Datasets" "= 0.023" "Toll-like" "= 0.048" "= 0.025"
    "= 0.0003" "10.1038/ncomms7263" "doi" "Rumpf" "CHIC-35" "CHIC"
    "the macrocyclic peptide S2iL5" "S2iL5" "SirReal6" "KDAC6"
    "possible docking poses" "poses" "Sirt5/6" "dimethylmercaptophenyl" "-KAc"
    "KAc" "the above-mentioned ternary sirtuin" "-Ac-Lys-ACS-peptide"
    "PDB-ID 2H4F" "sirtuin-acetyl-lysine-peptide"
    "Sir2Tm-Ac-Lys-p53-peptide-NAD +" "ternary sirtuin" "Carba"
    "naphthylmethyl" "benzyl" "ornithine" "SirReal1" "carbonyl" "DMP"
    "dimethylmercaptopyrimidine" "naphthyl" "C-site" "C-pocket"
    "bacterial sirtuin" "Sirt" "3ZGO" "PDB-ID 1J8F" "Rossmann" "cosubstrate"
    "ribose (ADPR)" "ADPR" "ribose" "SirReals" "Sirt1–3" "fluorophore"
    "catalyse" "sirtuins" "drug-like" "sirtuin" "SirReal2" "Sirtuin" "isotype"
    "non-linear" "C α" "TMAF" "tetramethylammonium" "hydrogel" "polethylglycol"
    "Ct" "SMMC-7721 cells" "SMMC-7721cells" "autoradiography" "Jiang"
    "expressed/overexpressed" "associated cargos" "cargos" "non-viral"
    "a shorter G 2 /S-phase" "/S-phase" "24 h" "polymorphism (SNP)" "SNP"
    "polymorphism" "RhoA" "GST-FAD104N" "PXXY" "PPXP" "PXXP" "#2" "#1" "mmps"
    "transwell" "A375C6" "fndc" "the N-terminal autoinhibitory helices"
    "perhaps" "spacers" "spacer" "presence/absence" "Cα" "phosphodiester" "β1"
    "β4" "β3" "antiparallel" "a pseudo-contiguous double helix" "duplexes"
    "-CACTTCCGGT" "CACTTCCGGT" "-ACCGGAAGTG" "ACCGGAAGTG" "paralogues"
    "re-examination" "2NNY" "and 3MFK" "IDs" "HI-2" "HI-1" "helices" "Etv-4"
    "Etv" "A/T" "helix" "phyla" "2–3" "CK1ɛ" "Mst"
    "-carbobenzyloxy-L-leucyl-L-leucyl-L-leucinal" "TAZS89A" "mSki" "anti-Flag"
    "NDR/LATS" "TAZ/YAP" "the constitutively active TAZS89A" "to 14-3-3"
    "Lats1/2" "Mst1/2" "co-repressor" "1p36" "Sloan" "co-repressors" "TEA"
    "hetero-" "4-hours" "tartrate" "triple co-cultured" "co-cultured"
    "osteoblasts" "BoM" "EMC" "14-3-3σ" "PyVmT" "Smad2/3" "Smads" "14-3-3ζ"
    "H&E" "=0.034" "/D2" "33b" "DBQ" "co-localized"
    "polyadenylate-binding protein-1"
    "heterogeneous nuclear ribonucleoprotein M3-M4" "TATA" "hnRNPQ" "hnRNPM"
    "further matrix-assisted laser desorption ionization-time"
    "ionization-time" "biotin-X-SSE" "dibenzoquinolines" "Moraceae"
    "Asclepiadaceae" "carboxyl" "antigen" "anti-cancer" "dibenzoquinoline"
    "anti-oncogenic" "D1/D2" "Warburg" "mg/mL" "24 h" "anti-tumor" "~5%"
    "co-localize" "co-localizes" "pulldown" "−891" "co-activator" "+9" "biotin"
    "non-specific" "Dotap" "siAP-1" "P=0.01" "non-cancer" "enhancers" "hetero"
    "DNA-bound transactivators" "C/EBP" "myristate" "transactivators"
    "enhancer" "auto-crine" "crine" "prostaglandins"
    "Activating enhancer-binding protein-2α" "=0.01" "Akhoondi" "endometrium"
    "leukemic stemness" "available datasets" "Toyoshima's" "pairwise" "HFF"
    "Toyoshima" "timepoint" "S/G2" "Chromatin-bound MYCER" "active MYCER"
    "shFBXW7" "shCONTROL" "=-1.1469" "Liu's" "Kessler's" "Kessler" "SAE1/2"
    "DAVID" "KEGG" "Log2FC" "the unique 60-nucleotide barcodes" "barcodes"
    "Barrueco" "Rodriguez" "2-3" "USA" "Waltham" "Biosystems" "Thermo" "mir"
    "GIPZ" "chromatin-bound MYCER" "active chromatin-bound MYCER" "MYCER"
    "AuroraA/B" "SCF-like" "=0.28" "G1/S" "non-transformed" "trichilemmonas"
    "the predominant histological subtype" "=0.039" "epigenotype" "greatest"
    "proband" "Kendall" "probands" "Pairwise" "acral" "multivariate" "Stepwise"
    "Multivariate" "follicular histology" "histologies" "Wallis" "VUS" "COBRA"
    "pretest" "CC" "mutation/VUS" "EpiTYPER" "MassARRAY" "germline"
    "mutation/variant" "Cowden" "Germline" "P -values" "coli" "clinicians"
    "co-existed" "FACS" "HL7702" "non-tumor" "9p21" "P16/INK2A" "a 3-year"
    "emphasises" "=0.63" "=0.62" "=0.057" "=0.0049" "=0.0072" "=0.51" "=0.75"
    "=0.0002" "The
histological subtype"
    "=0.037" "Histological subtype" "subtypes" "=0.066" "=0.048" "=0.13"
    "=0.38" "=0.0001" "=0.0014" "=0.48" "=0.15" "FFPE" "=0.016" "Fifty-one"
    "=0.021" "The histological subtype" "the histological subtype"
    "sarcomatoid" "epithelioid" "the
histological MPM subtype"
    "collectives" "epitheloid" "pathomechanism" "folic" "histological subtype"
    "platin" "Meier" "Kaplan" "⩽0.002" "logrank" "PFS" "non-genotoxic" "IC 50"
    "=0.0004" "24 h" "TAp73β's" "normal cervical epithelium" "p73β" "bp"
    "gatekeeper" "= 47" "24 h" "co-activators" "Wu" "colocalizes" "and 3A"
    "ATXN" "S12AS77AT82A" "si" "Plk1 and" "~20%" "pS77" "pS" "BI2356 (BI)"
    "IVK" "B-dependent" "nocodazol" "midzone" "intron" "pentanucleotide" "S12A"
    "ATTCT" "anti-FLAG" "Cleveland" "exocrine" "acyl" "miR-199-5p"
    "alveolar MΦs" "conductance" "Cl" "secretory epithelia" "epithelia" "GI"
    "Hyper" "AKT/miR-199a-5p/CAV1" "Pre" "eosin" "MAC" "TOT" "lavage"
    "miR-199a/CAV1" "celecoxib pre-treated CF MΦs" "phosphoAKT" "miR-199-3p"
    "SC79" "miR199-5p/CAV1" "and 2h" "LY94002" "cardiac myocytes" "stressors"
    "miR-199a-5p/CAV1" "MΦ" "miR199a-3p" "neg" "pos"
    "pMSCV-miR-199a5p-PGK-EGFP" "retrovirus" "miR-199a-2" "miR-199a" "MiR-199a"
    "UPR-associated transcriptome" "transducer" "myocytes" "pathobiology"
    "Celebrex" "199a-5p" "mechanism/s" "mucosal MΦs" "lipopolysaccharides" "KO"
    "F508del" "MΦs" "the only drug proven" "Cftr" "reestablishes"
    "microRNA-199a-5p" "hyper" "C57BL/6" "mg/Kg" "sigmoid" "flexure" "cecum"
    "priori" "pedicles" "MSKCC" "Eveno" "Søreide" "AJCC" "residuals"
    "univariate" "confounders" "younger" "colectomy" "subsite"
    "anatomical subsites" "incisional biopsies" "biopsies" "written" "Dutch"
    "German" "English" "Rodolico" "Pathare" "Q-test" "Zhao" "Caucasians"
    "Asians" "Hanken" "immunohistochemistry (IHC)" "1.43–3.16" "NPV"
    "Prapinjumrune" "IHC" "Australia" "Europe" "proven" "subsites" "QUADAS-2"
    "Takahashi" "Yoshioka" "flowchart" "Michikawa" "Miyamoto" "Asian" "HNSCC"
    "LNM" "Cochrane" "11q13" "oncology" "doi:10.1007" "transcriptome"
    "bivariate" "immunohistochemistry" "endpoint" "MCF7EV16" "MCF7SC29"
    "MCF7EV" "MCF7SC" "Clontech" "Cip/Kip" "currently no co-regulators"
    "co-regulators" "co-regulator" "y" "co-suppressor" "SCRIPT"
    "anti-proliferative" "Mueller" "Sakata"
    "pyrene-trans-7,8-dihydrodiol-9,10-epoxide" "anti-benzo" "Shen"
    "antioncogene" "Liu" "Kwak" "Qiang" "Yu" "Tu" "Croce" "Collins"
    "Reifenberger" "Wynsberghe" "p  " "Transwell" "U251" "miR-494-3P"
    "stem-like" "Yanyang" "Li" "Mendell" "Hwang" "Xu" "Estrella" "Davies" "Kim"
    "Dimpy" "Kesari" "miR-494-3p" "cistrome" "a unique subset" "subset" "&E"
    "titers" "wt/loxP" "wt" "chemokine-like" "lobule" "histology" "BW" "LW"
    "titer" "/loxP" "ex3" "GS" "loxP" "carcinogen/initiator"
    "dichloropyridyloxy" "Bis" "anti-inflammatory" "XU" "chun" "Ye" "SONG"
    "ZHONG" "YE" "FENG" "yin" "neurotrophic-like" "anti-ischemic"
    "co-localization" "chosen" "dockings" "μmol/L" "nmol/L"
    "cyclopentyladenosine (CPA)" "cyclopentyladenosine" "R-mediated" "subtype"
    "8-cyclopentyl-1" "dipropylxanthine" "MCAO" "DPCPX" "HEK293/A" "OGD/R"
    "Radix" "Paeoniae" "co-IP" "A 2A" "dyslipidemia" "triphosphate" "=0.0493"
    "Ortega" "pre-pregnant BMI" "hFINS" "higher pre-pregnant BMI" "=121.882"
    "=0.867" "=0.931" "+0.07x" "x" "hPG" "ΔBMI" "gestational diabetes mellitus"
    "Gestational diabetes mellitus (GDM)" "macrosomia" "preterm" "stepwise"
    "BMI" "=30" "gestational diabetes mellitus (GDM)" "mellitus (GDM)" "GDM"
    "mellitus" "Sanger" "Wellcome" "anti-apoptotic" "Dox" "subdiploid" "dox"
    "-TAp73γ" "-TAp73β" "TetOn" "iv" "iii" "ii" "ΔNp73" "TAp73β" "TAp73α"
    "TAp73γ" "TAp73" "A2B" "clonogenicty" "HER2/ neu" "bi" "greater" "semi"
    "Boyden" "HA" "shNSC" "TCGA" "HER2+" "Genome" "soft agar" "agar"
    "transformants" "MMECs" "genome" "VBIM" "pre" "epithelium" "HER2/" "mg/kg"
    "Targetscan" "Yang" "extravasate" "et" "Zhou" "miroRNAs" "miR-200s" "multi"
    "231BoM" "intracardiac" "pre-miR-509" "poorer" "TEER" "MDA231 cells"
    "MDA231cells" "TNF±" "immunocytochemistry" "RayBio" "mBrEC" "GSE14020"
    "GSE5327" "GSE2603" "GSE2034" "GSE12276" "-UTR" "pre- miR-509" "CN34BrM"
    "miRWalk" "miRDB" "miRanda" "TragetScan" "231BrM" "MDA-MB-231BrM2a"
    "TargetScan" "Taqman" "p" "GeneChip" "Affymatrix" "Rosenfeld" "b" "IDC"
    "Volinia" "miR-30c" "chemoresistance" "c" "stemness" "UTR" "chemo" "BBB"
    "co-transfected" "ss" "PTGS" "tombusvirus" "TGS" "phloem" "C3PO" "homologs"
    "LC-MS/MS" "pcDNA3.1" "anti-V5" "orthologs" "gfp" "unc" "pFLuc" "pP"
    "pABCE1" "pULK3FLAG" "ImageJ" "pABCE" "GFFG" "pBin" "16c" "nt" "UV"
    "pBin61" "co-infiltrated" "homolog" "2–5A" "ABCE" "melanogaster" "ortholog"
    "AtRLI2" "Dictyostelium" "genomes" "benthamiana" "Nicotiana" "thaliana"
    "mTOR/p70S6K/4E-BP1" "oligopyrimidine" "showen" "suppreses" "inhibite"
    "methoxyestradiol" "mTOR/p70S6K" "phospho-p70S6K" "microvessel" "mg/g"
    "ELISA" "4E-BP1 signaling pathway" "CHX" "WCE" "miltiorrhiza" "Danshen"
    "IIA" "deeper" "the comprehensive kinome" "kinome" "vivo" "ex" "circuitry"
    "S/T" "isotypes" "pathophysiology" "Rb" "β-TrCP1/2" "interdomain" "mV"
    "AIS" "XIII" "multidimensional datasets" "dataset" "PCA" "datasets"
    "inflammosome" "heatmap" "interactome" "screenings" "IC50" "agonism"
    "NH125" "6 biological replicates" "replicates" "CD4-Nav1.6-Nluc" "BAY" "Gö"
    "Aldrich" "Biotech" "Cruz" "Tocris" "Selleckchem" "Millipore" "readout"
    "FGF14:Nav1.6" "SNPs" "Nav" "CNS" "Parkinson’s" "Alzheimer’s" "Alzheimer"
    "Parkinson" "lifespan" "toolkit" "PPI"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-14401-14700*
  '(("TSPAN2–PIK3R3" . SPARSER::COLLECTION)
    ("TSPAN2–GRB2" . SPARSER::COLLECTION)
    ("proteins, GRB2 or PIK3R3" . SPARSER::COLLECTION)
    ("CD151 or CD9" . SPARSER::COLLECTION)
    ("p130Cas, FAK, paxillin and Src" . SPARSER::COLLECTION)
    ("TSPAN" . SPARSER::PROTEIN)
    ("MET (Klosek et al , xref ; Franco et al , xref ) or EGFR (Murayama et al , xref , xref )"
     . SPARSER::COLLECTION)
    ("DDR1 (Castro-Sanchez et al , xref ), MET (Klosek et al , xref ; Franco et al , xref ) or EGFR (Murayama et al , xref , xref )"
     . SPARSER::COLLECTION)
    ("CD9 and CDC151" . SPARSER::COLLECTION)
    ("metalloproteases and receptor" . SPARSER::COLLECTION)
    ("IPs" . SPARSER::PROTEIN) ("recorded pY" . SPARSER::PROTEIN)
    ("relatively few interacting proteins" . SPARSER::PROTEIN)
    ("Substrate" . SPARSER::SUBSTRATE)
    ("prey and protein" . SPARSER::COLLECTION)
    ("kinase or phosphatase" . SPARSER::COLLECTION)
    ("PIK3R3-TSPAN2" . SPARSER::COLLECTION)
    ("GRB2/PIK3R3" . SPARSER::COLLECTION) ("TSPAN2-GRB2" . SPARSER::COLLECTION)
    ("GRB2-TSPAN2" . SPARSER::COLLECTION)
    ("GRB2 or PIK3R3 and TSPAN2" . SPARSER::COLLECTION)
    ("PIK3R3 and TSPAN2" . SPARSER::COLLECTION)
    ("CD9 or CD151" . SPARSER::COLLECTION) ("YFP-TSPAN2" . SPARSER::COLLECTION)
    ("CD9 (the closest TSPAN2 relative) or CD151" . SPARSER::COLLECTION)
    ("GRB2 and PIK3R3" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs) and intracellular signaling molecules"
     . SPARSER::COLLECTION)
    ("proteins, GRB2 and PIK3R3" . SPARSER::COLLECTION)
    ("SH2-domain-containing proteins" . SPARSER::PROTEIN)
    ("PIK3R3 and GRB2" . SPARSER::COLLECTION)
    ("PIK3R3-C10orf81/PLEKHS1" . SPARSER::PROTEIN-PAIR)
    ("SH2D1B-OLIG1" . SPARSER::COLLECTION)
    ("PIK3R3-SH2D2A" . SPARSER::COLLECTION)
    ("a previously uncharacterized protein" . SPARSER::PROTEIN)
    ("PIK3R3 (p55γ regulatory subunit of PI3 kinase) and C10orf81"
     . SPARSER::COLLECTION)
    ("orf" . SPARSER::PROTEIN) ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("ERBB2, KIT or INSR" . SPARSER::COLLECTION)
    ("19 PTB domain-containing proteins (Fig xref ) and 157 putative tyrosine-phosphorylated proteins"
     . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN) ("MATa" . SPARSER::PROTEIN)
    ("BMX (Tec family) and JAK2 (Jak family)" . SPARSER::COLLECTION)
    ("Tec" . SPARSER::PROTEIN) ("BMX" . SPARSER::PROTEIN)
    ("SYK" . SPARSER::PROTEIN) ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FES" . SPARSER::PROTEIN) ("Frk" . SPARSER::PROTEIN)
    ("FRK" . SPARSER::PROTEIN) ("PID" . SPARSER::PROTEIN)
    ("our matrix and the pY-reader protein" . SPARSER::COLLECTION)
    ("Y2H" . SPARSER::PROTEIN) ("pY-Y2H" . SPARSER::COLLECTION)
    ("PIK3R3 and IRS1" . SPARSER::COLLECTION) ("FYN" . SPARSER::PROTEIN)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PPI" . SPARSER::PROTEIN)
    ("kinases and pY-binding proteins" . SPARSER::COLLECTION)
    ("mass spectrometry-based proteome-wide mapping" . SPARSER::PROTEIN)
    ("PTB" . SPARSER::PROTEIN) ("Systematic mapping" . SPARSER::PROTEIN)
    ("TSPAN2 (tetraspanin 2) and GRB2 or PIK3R3 (p55γ)" . SPARSER::COLLECTION)
    ("GRB2 or PIK3R3" . SPARSER::COLLECTION) ("PPIs" . SPARSER::PROTEIN)
    ("pY-PPIs" . SPARSER::COLLECTION) ("v19" . SPARSER::PROTEIN)
    ("CYC1" . SPARSER::PROTEIN) ("ADE2" . SPARSER::PROTEIN)
    ("GAL1" . SPARSER::PROTEIN) ("ura3" . SPARSER::PROTEIN)
    ("cyh2" . SPARSER::PROTEIN) ("leu2" . SPARSER::PROTEIN)
    ("trp1" . SPARSER::PROTEIN) ("L40" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("TSPAN8" . SPARSER::PROTEIN)
    ("DDR1" . SPARSER::PROTEIN) ("CD9" . SPARSER::PROTEIN)
    ("Phospho-tyrosine" . SPARSER::MOLECULE) ("OLIG1" . SPARSER::PROTEIN)
    ("SH2D1B" . SPARSER::PROTEIN) ("PLEKHS1" . SPARSER::PROTEIN)
    ("p97" . SPARSER::PROTEIN) ("SH2D2A" . SPARSER::PROTEIN)
    ("Tie2" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("PTK2" . SPARSER::PROTEIN) ("TNK1" . SPARSER::PROTEIN)
    ("ABL2" . SPARSER::PROTEIN) ("tetraspanin 2" . SPARSER::PROTEIN)
    ("TSPAN2" . SPARSER::PROTEIN) ("RNA or virus" . SPARSER::COLLECTION)
    ("PML-VI" . SPARSER::PROTEIN-PAIR)
    ("HDAC1, HDAC2, HDAC3, and HDAC6" . SPARSER::COLLECTION)
    ("IE1 and HDACs" . SPARSER::COLLECTION)
    ("PML and HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("PML and STAT1" . SPARSER::COLLECTION)
    ("CoREST/REST" . SPARSER::COLLECTION)
    ("transcription factor (REST)" . SPARSER::PROTEIN)
    ("CoREST, HDACs, and histone" . SPARSER::COLLECTION)
    ("CoREST" . SPARSER::PROTEIN) ("REST" . SPARSER::PROTEIN)
    ("STAT1 or STAT2" . SPARSER::COLLECTION)
    ("PML, STAT2, and HDAC1" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC6" . SPARSER::COLLECTION)
    ("HDAC2 and HDAC1" . SPARSER::COLLECTION)
    ("IE1(Δ290–320) and IE1(Δ421–475)" . SPARSER::COLLECTION)
    ("IE1 and IE1" . SPARSER::COLLECTION)
    ("STAT2 or HDACs" . SPARSER::COLLECTION)
    ("STAT2 and HDACs" . SPARSER::COLLECTION)
    ("IE1, PML, STAT2, HDAC2, and HDAC1" . SPARSER::COLLECTION)
    ("IRF9 and p52" . SPARSER::COLLECTION)
    ("STAT1, STAT2, HDAC1, HDAC2, and PML" . SPARSER::COLLECTION)
    ("input viral DNAs" . SPARSER::DNA) ("IFA" . SPARSER::PROTEIN)
    ("IE1-PML" . SPARSER::COLLECTION) ("viral IE proteins" . SPARSER::PROTEIN)
    ("virus titers" . SPARSER::PROTEIN) ("HF-IE1" . SPARSER::COLLECTION)
    ("IE1, and IE1" . SPARSER::COLLECTION)
    ("ISG54 mRNA in HF cells stably expressing wild-type or mutant IE1 proteins"
     . SPARSER::COLLECTION)
    ("ISRE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ISGF3 and HDACs" . SPARSER::COLLECTION)
    ("ISG54 and CXCL10" . SPARSER::COLLECTION)
    ("STAT2, HDAC1, and HDAC2" . SPARSER::COLLECTION)
    ("IRF9 and ribonucleotide" . SPARSER::COLLECTION)
    ("STAT1, STAT2, HDAC1, and HDAC2" . SPARSER::COLLECTION)
    ("IgG or anti-IFNα/β" . SPARSER::COLLECTION) ("IFNAR" . SPARSER::PROTEIN)
    ("p-STAT2" . SPARSER::COLLECTION)
    ("STAT1 and its activated form (p-STAT1)" . SPARSER::COLLECTION)
    ("Neo" . SPARSER::PROTEIN)
    ("IFNβ or UV-HCMV-mediated" . SPARSER::COLLECTION)
    ("control siRNA (siC) or PML-specific siRNA (siPML)" . SPARSER::COLLECTION)
    ("dsRNA" . SPARSER::RNA)
    ("a cellular immediate-early response gene" . SPARSER::GENE)
    ("ChREBP" . SPARSER::PROTEIN) ("shC and shPML" . SPARSER::COLLECTION)
    ("shC" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("CIITA" . SPARSER::PROTEIN) ("INF" . SPARSER::PROTEIN)
    ("IE1-STAT2" . SPARSER::COLLECTION)
    ("several viral and cellular promoters" . SPARSER::PROMOTER)
    ("immediate-early (IE) 1 protein" . SPARSER::PROTEIN)
    ("PML and other major components" . SPARSER::COLLECTION)
    ("Sp100, Daxx, and ATRX" . SPARSER::COLLECTION) ("Daxx" . SPARSER::PROTEIN)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Promyelocytic leukemia protein (PML)" . SPARSER::PROTEIN)
    ("the tripartite motif family (TRIM)" . SPARSER::PROTEIN-FAMILY)
    ("family (TRIM)" . SPARSER::PROTEIN-FAMILY) ("RBCC" . SPARSER::PROTEIN)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("newly synthesized IFNα and/or IFNβ" . SPARSER::COLLECTION)
    ("IFNα and/or IFNβ" . SPARSER::COLLECTION)
    ("multifunctional cytokines" . SPARSER::PROTEIN)
    ("PML and STAT2" . SPARSER::COLLECTION)
    ("viral IE1 protein" . SPARSER::PROTEIN)
    ("PML, STAT1, STAT2, and HDACs" . SPARSER::COLLECTION)
    ("interferon-β or infection" . SPARSER::COLLECTION)
    ("E-23" . SPARSER::PROTEIN) ("PG-M" . SPARSER::PROTEIN)
    ("pp71" . SPARSER::PROTEIN) ("UL44" . SPARSER::PROTEIN)
    ("IE2" . SPARSER::PROTEIN) ("ISG54" . SPARSER::PROTEIN)
    ("ICP0" . SPARSER::PROTEIN) ("TRIM19" . SPARSER::PROTEIN)
    ("IRF9" . SPARSER::PROTEIN) ("Janus kinase 1" . SPARSER::PROTEIN)
    ("interferon regulatory factor 3" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ISGF3" . SPARSER::PROTEIN) ("IE1" . SPARSER::PROTEIN)
    ("Promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("enzymes or proteins" . SPARSER::COLLECTION) ("WTr" . SPARSER::PROTEIN)
    ("tfLC3-WTr" . SPARSER::COLLECTION) ("tfLC3" . SPARSER::PROTEIN)
    ("tfLC3-shYAP" . SPARSER::COLLECTION)
    ("Ar" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CQ or NH 4 Cl" . SPARSER::COLLECTION)
    ("GFP and mRFP" . SPARSER::COLLECTION)
    ("Tandem fluorescent mRFP-GFP-tagged LC3" . SPARSER::PROTEIN)
    ("phosphatase (ACP)" . SPARSER::PHOSPHATASE) ("ACP" . SPARSER::PROTEIN)
    ("LysoTracker" . SPARSER::DRUG) ("Lysosomal" . SPARSER::PROTEIN)
    ("shCtrl and shYAP" . SPARSER::COLLECTION)
    ("CQ or Bafilomycin A1" . SPARSER::COLLECTION)
    ("shCtrl" . SPARSER::PROTEIN) ("LC3-II and p62" . SPARSER::COLLECTION)
    ("MCF7-shCtrl and shYAP" . SPARSER::COLLECTION)
    ("MCF7-shCtrl" . SPARSER::COLLECTION)
    ("shYAP and shCtrl" . SPARSER::COLLECTION)
    ("18 h or 36 h" . SPARSER::COLLECTION)
    ("CQ and NH 4 Cl" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("Chloroquine (CQ) and NH 4 Cl" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN) ("shYAP" . SPARSER::PROTEIN)
    ("MCF7-shYAP" . SPARSER::PROTEIN-PAIR)
    ("the mammalian transcriptional coactivator Yes-associated protein (YAP)"
     . SPARSER::PROTEIN)
    ("The Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("MC7" . SPARSER::PROTEIN) ("MST-1" . SPARSER::PROTEIN)
    ("STE20" . SPARSER::PROTEIN) ("complex, and tumor" . SPARSER::COLLECTION)
    ("CC-3 and Bax" . SPARSER::COLLECTION)
    ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("3-(4, 5)-dimethylthiahiazo(-z-y1)-3" . SPARSER::PROTEIN)
    ("Nifuroxazide" . SPARSER::DRUG) ("MMP7 and MMP-9" . SPARSER::COLLECTION)
    ("estrogen receptor or progesterone receptor" . SPARSER::COLLECTION)
    ("caspases-3 and Bax" . SPARSER::COLLECTION)
    ("nifuroxazide" . SPARSER::DRUG) ("a 20 " . SPARSER::PROTEIN)
    ("the different pathological types" . TYPE)
    ("severe RP" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase (DNA-PK) and the XRCC4/Lig4 complex [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("XRCC4/Lig4" . SPARSER::COLLECTION)
    ("the ionizing radiation-induced DNA" . SPARSER::DNA)
    ("the glutathione and the pathways of DNA repair" . SPARSER::COLLECTION)
    ("LIG4 (rs1805388) and HSPB1 (rs2868371)" . SPARSER::COLLECTION)
    ("CC and rs2868371" . SPARSER::COLLECTION) ("GC/CC" . SPARSER::COLLECTION)
    ("LIG4 (rs1805388) and HSPB1 (rs2868371) genotypes" . SPARSER::COLLECTION)
    ("developed grade ≥2 RP" . SPARSER::PROTEIN) ("DNA-strand" . SPARSER::DNA)
    ("RP and RILI" . SPARSER::COLLECTION)
    ("LIG4 and HSPB1" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("Lig4" . SPARSER::PROTEIN)
    ("heat shock protein beta 1" . SPARSER::PROTEIN)
    ("DNA Ligase IV" . SPARSER::PROTEIN) ("Ligase IV" . SPARSER::PROTEIN)
    ("LIG4" . SPARSER::PROTEIN) ("the aggressive HER2" . SPARSER::PROTEIN)
    ("Asparagine and tyrosine" . SPARSER::COLLECTION)
    ("Asparagine" . SPARSER::AMINO-ACID)
    ("histidine or tyrosine" . SPARSER::COLLECTION)
    ("HER2, EGFR, and PLCγ" . SPARSER::COLLECTION)
    ("tested 15 micropapillary UBC" . SPARSER::PROTEIN)
    ("the other histological components" . SPARSER::COMPONENT)
    ("micropapillary UBC" . SPARSER::PROTEIN)
    ("minor micropapillary fractions" . SPARSER::COMPONENT)
    ("purely or predominantly micropapillary UBC" . SPARSER::PROTEIN)
    ("first identified HER2 amplified UBC" . SPARSER::PROTEIN)
    ("the micropapillary variant" . SPARSER::VARIANT)
    ("the particularly aggressive micropapillary variant" . SPARSER::VARIANT)
    ("superficial and deep parts" . SPARSER::COMPONENT)
    ("micropapillary components" . SPARSER::COMPONENT)
    ("advanced metastasizing UBC" . SPARSER::PROTEIN)
    ("erbB4" . SPARSER::PROTEIN)
    ("frequently featured micropapillary tumor components"
     . SPARSER::COMPONENT)
    ("histological variants" . SPARSER::VARIANT)
    ("150 metastasizing primary UBC" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("erbB1" . SPARSER::PROTEIN)
    ("laminin and collagen" . SPARSER::COLLECTION)
    ("ZEB1 and EMT" . SPARSER::COLLECTION)
    ("Snail or ZEB1" . SPARSER::COLLECTION)
    ("GLI2 and BRD4" . SPARSER::COLLECTION) ("cFLIP" . SPARSER::PROTEIN)
    ("GLI" . SPARSER::PROTEIN) ("BRD4 and GLI2" . SPARSER::COLLECTION)
    ("JQ1 and GLI2" . SPARSER::COLLECTION)
    ("SMAD and lymphoid" . SPARSER::COLLECTION)
    ("Smad and β-catenin" . SPARSER::COLLECTION)
    ("GLI1 or Patched2" . SPARSER::COLLECTION)
    ("Patched1 and GLI2" . SPARSER::COLLECTION)
    ("Patched1, Patched2, GLI1 and GLI2" . SPARSER::COLLECTION)
    ("FOSL1 or HMGA2" . SPARSER::COLLECTION)
    ("c-MYC, FOSL1 or HMGA2" . SPARSER::COLLECTION)
    ("miR-200a and miR-200c" . SPARSER::COLLECTION)
    ("c-MYC, FOSL1 and HMGA2" . SPARSER::COLLECTION)
    ("the structurally-related BET inhibitor I-BET151" . SPARSER::MOLECULE)
    ("JQ1" . SPARSER::PROTEIN) ("CD18-JQ1" . SPARSER::COLLECTION)
    ("an architectural protein" . SPARSER::PROTEIN)
    ("c-MYC and FOSL1" . SPARSER::COLLECTION)
    ("the bromodomain (BRD) and extra terminal domain (BET) family"
     . SPARSER::COLLECTION)
    ("bromodomain (BRD)" . SPARSER::PROTEIN)
    ("FOSL1 and HMGA2" . SPARSER::COLLECTION) ("Patched2" . SPARSER::PROTEIN)
    ("Patched1" . SPARSER::PROTEIN) ("miR-200c" . SPARSER::MOLECULE)
    ("miR-200a" . SPARSER::MOLECULE) ("group A" . SPARSER::PROTEIN)
    ("BRD2" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("FOSL1" . SPARSER::PROTEIN) ("I-BET151" . SPARSER::MOLECULE)
    ("N-Cadherins and PSD95" . SPARSER::COLLECTION)
    ("cadherin, and N-cadherin" . SPARSER::COLLECTION)
    ("ZBTB33 (Kaiso) and the NCoR co-repressor complex" . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN) ("Kaiso" . SPARSER::PROTEIN)
    ("erbin" . SPARSER::PROTEIN) ("Discs" . SPARSER::BIO-COMPLEX)
    ("src" . SPARSER::PROTEIN) ("presenilins" . SPARSER::PROTEIN-FAMILY)
    ("PKP4, CTNND1, and ARVCF" . SPARSER::COLLECTION)
    ("ARVCF" . SPARSER::PROTEIN)
    ("an important neurodevelopmental protein" . SPARSER::PROTEIN)
    ("CTNND2 and autism genes" . SPARSER::COLLECTION)
    ("CTNND2 and all other genes (absolute correlation >0.3, P=2.84x10 −6 given multiple comparisons)"
     . SPARSER::COLLECTION)
    ("AMPA" . SPARSER::MOLECULE) ("GluA" . SPARSER::PROTEIN)
    ("postsynaptic marker PSD95 and presynaptic marker vGluT1"
     . SPARSER::COLLECTION)
    ("presynaptic marker vGluT1" . SPARSER::PROTEIN)
    ("postsynaptic marker PSD95" . SPARSER::PROTEIN)
    ("vGluT1" . SPARSER::PROTEIN)
    ("those expressing GFP or wild type CTNND2" . SPARSER::COLLECTION)
    ("GFP or GFP" . SPARSER::COLLECTION)
    ("GFP-tagged CTNND2 and Flag-tagged CTNNB1" . SPARSER::COLLECTION)
    ("CTNNB1-CTNND2" . SPARSER::COLLECTION) ("chordin" . SPARSER::PROTEIN)
    ("Variants (DGV)" . SPARSER::VARIANT) ("Medicine" . SPARSER::DRUG)
    ("an autistic male" . SPARSER::MOLECULE)
    ("pathogenic alleles" . SPARSER::ALLELE)
    ("chromatin and histone" . SPARSER::COLLECTION)
    ("CYFIP1, DLG1, PLXNA3, and CTNND2" . SPARSER::COLLECTION)
    ("enteric" . SPARSER::PROTEIN) ("NDD" . SPARSER::PROTEIN)
    ("likely severe coding variants" . SPARSER::VARIANT)
    ("epidemiologically rarer classes" . CLASS)
    ("families or FEMFs" . SPARSER::COLLECTION)
    ("the adhesive junction-associated delta catenin protein"
     . SPARSER::PROTEIN)
    ("Ctnnd2" . SPARSER::PROTEIN) ("get 3" . SPARSER::PROTEIN)
    ("For 3" . SPARSER::PROTEIN) ("SEMA5A" . SPARSER::PROTEIN)
    ("post-synaptic density protein" . SPARSER::PROTEIN)
    ("N-Cadherins" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("p120ctn" . SPARSER::PROTEIN) ("CTNND1" . SPARSER::PROTEIN)
    ("PKP4" . SPARSER::PROTEIN) ("NSD1" . SPARSER::PROTEIN)
    ("ARID1B" . SPARSER::PROTEIN) ("HCFC1" . SPARSER::PROTEIN)
    ("ATXN7" . SPARSER::PROTEIN) ("EP400" . SPARSER::PROTEIN)
    ("YEATS2" . SPARSER::PROTEIN) ("HUWE1" . SPARSER::PROTEIN)
    ("DLG4" . SPARSER::PROTEIN) ("SHANK1" . SPARSER::PROTEIN)
    ("PDLIM5" . SPARSER::PROTEIN) ("Pax6" . SPARSER::PROTEIN)
    ("PAX6" . SPARSER::PROTEIN) ("ZBTB33" . SPARSER::PROTEIN)
    ("axin2" . SPARSER::PROTEIN) ("ADI-R" . SPARSER::PROTEIN)
    ("MECP2" . SPARSER::PROTEIN) ("beta catenin" . SPARSER::PROTEIN)
    ("delta 2" . SPARSER::PROTEIN) ("PLXNA3" . SPARSER::PROTEIN)
    ("DLG1" . SPARSER::PROTEIN) ("CYFIP1" . SPARSER::PROTEIN)
    ("CTNND2" . SPARSER::PROTEIN) ("delta catenin" . SPARSER::PROTEIN)
    ("rapamycin and/or radiation ( xref )" . SPARSER::COLLECTION)
    ("HK II and MnSOD" . SPARSER::COLLECTION) ("MnSOD" . SPARSER::PROTEIN)
    ("mTOR/HK II" . SPARSER::COLLECTION)
    ("mTORC1 and HK II" . SPARSER::COLLECTION)
    ("mTOR/Hexokinase II complex" . SPARSER::BIO-COMPLEX)
    ("mTOR/Hexokinase" . SPARSER::COLLECTION)
    ("outer membrane protein, and mTOR" . SPARSER::COLLECTION)
    ("Radiation-induced DNA" . SPARSER::DNA)
    ("mSIN1, protor, and mLST8" . SPARSER::COLLECTION)
    ("p70 ribosomal S6 kinase 1 (referred to S6K1) and 4E-BP1"
     . SPARSER::COLLECTION)
    ("p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("two well-defined substrates" . SPARSER::SUBSTRATE)
    ("mLST8/GbL" . SPARSER::COLLECTION) ("GbL" . SPARSER::PROTEIN)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("Serine/Threonine" . SPARSER::COLLECTION)
    ("approximately 34 molecules" . SPARSER::MOLECULE)
    ("Hexokinase" . SPARSER::PROTEIN) ("CDK 1" . SPARSER::PROTEIN)
    ("outer membrane protein" . SPARSER::PROTEIN) ("TOM40" . SPARSER::PROTEIN)
    ("FKBP38" . SPARSER::PROTEIN) ("Hexokinase activity" . SPARSER::PROTEIN)
    ("TOM 40" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HK II" . SPARSER::PROTEIN)
    ("especially accessory proteins" . SPARSER::PROTEIN)
    ("PAK2 and HCK" . SPARSER::COLLECTION)
    ("p21 protein (Cdc42/Rac)-activated kinase 2 (PAK2) and a tyrosine kinase"
     . SPARSER::COLLECTION)
    ("hematopoietic cell kinase (HCK)" . SPARSER::PROTEIN)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("HCK" . SPARSER::PROTEIN)
    ("CCR5/CXCR4" . SPARSER::COLLECTION) ("coreceptors" . SPARSER::PROTEIN)
    ("a pluripotent protein" . SPARSER::PROTEIN)
    ("BST2 and CD4" . SPARSER::COLLECTION) ("BTRC" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("NL4-3" . SPARSER::COLLECTION)
    ("Vif (described above) and Vpu (described below)" . SPARSER::COLLECTION)
    ("protein (VPRBP)" . SPARSER::PROTEIN) ("UNG" . SPARSER::PROTEIN)
    ("VPRBP" . SPARSER::PROTEIN)
    ("the cellular structure-specific endonuclease regulator SLX4 complex"
     . SPARSER::BIO-COMPLEX)
    ("CCR5 and CXCR4" . SPARSER::COLLECTION)
    ("APOBEC3F and APOBEC3G" . SPARSER::COLLECTION)
    ("proviral DNA" . SPARSER::DNA) ("vif-" . SPARSER::PROTEIN)
    ("proteins and Vif" . SPARSER::COLLECTION) ("CBF" . SPARSER::PROTEIN)
    ("elongin" . SPARSER::PROTEIN) ("the nascent viral DNA" . SPARSER::DNA)
    ("guanines" . SPARSER::NUCLEOBASE) ("cytosines" . SPARSER::NUCLEOBASE)
    ("cytidine" . SPARSER::MOLECULE) ("abortive fetuses" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN) ("NOG and NSG" . SPARSER::COLLECTION)
    ("NOG" . SPARSER::PROTEIN) ("BLT" . SPARSER::PROTEIN)
    ("anti-CD3/CD28" . SPARSER::COLLECTION)
    ("these viral accessory proteins" . SPARSER::PROTEIN)
    ("rev" . SPARSER::PROTEIN-FAMILY) ("env" . SPARSER::PROTEIN)
    ("HIV-1 accessory proteins" . SPARSER::PROTEIN)
    ("these HIV-1 accessory proteins" . SPARSER::PROTEIN)
    ("Vpu" . SPARSER::PROTEIN) ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vif" . SPARSER::PROTEIN) ("four accessory genes" . SPARSER::GENE)
    ("vpu" . SPARSER::PROTEIN) ("hematopoietic cell kinase" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("HM1" . SPARSER::PROTEIN)
    ("CD317" . SPARSER::PROTEIN)
    ("bone marrow stromal cell antigen 2" . SPARSER::PROTEIN)
    ("CD1d molecule" . SPARSER::PROTEIN) ("NTB-A" . SPARSER::PROTEIN)
    ("SLAMF6" . SPARSER::PROTEIN) ("member 6" . SPARSER::PROTEIN)
    ("CD4 molecule" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("SMUG1" . SPARSER::PROTEIN)
    ("single-strand-selective monofunctional uracil-DNA glycosylase 1"
     . SPARSER::PROTEIN)
    ("UNG2" . SPARSER::PROTEIN) ("Uracil-DNA glycosylase" . SPARSER::PROTEIN)
    ("damage-specific DNA binding protein 1" . SPARSER::PROTEIN)
    ("cullin 4" . SPARSER::PROTEIN) ("NKG2D" . SPARSER::PROTEIN)
    ("ULBP2" . SPARSER::PROTEIN) ("UL16 binding protein 2" . SPARSER::PROTEIN)
    ("core binding factor beta" . SPARSER::PROTEIN) ("CUL5" . SPARSER::PROTEIN)
    ("cullin 5" . SPARSER::PROTEIN) ("APOBEC3F" . SPARSER::PROTEIN)
    ("Apolipoprotein B mRNA editing enzyme" . SPARSER::PROTEIN)
    ("TERC and MYC" . SPARSER::COLLECTION)
    ("RNA, and ribozymes" . SPARSER::COLLECTION) ("ribozymes" . SPARSER::RNA)
    ("MYC and EIF3H" . SPARSER::COLLECTION)
    ("a possible specific target" . SPARSER::TARGET-PROTEIN)
    ("MYC and eukaryotic translation initiation factor 3 subunit H"
     . SPARSER::COLLECTION)
    ("small-sized ADCs" . SPARSER::PROTEIN)
    ("ADCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("histologic types" . TYPE)
    ("Yan" . SPARSER::PROTEIN) ("Fan" . SPARSER::PROTEIN)
    ("MYC , MYCN , and MYCL1" . SPARSER::COLLECTION)
    ("high MYC (mean ≥2.83 copies/cell) and TERC (mean ≥2.65 copies/cell) GCNs"
     . SPARSER::COLLECTION)
    ("MYC and TERC" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("EIF3H" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 3 subunit H" . SPARSER::PROTEIN)
    ("MYCL1" . SPARSER::PROTEIN)
    ("the inflammatory cytokines interleukin-1β (IL-1β) and IL-18"
     . SPARSER::COLLECTION)
    ("a compromised gastrointestinal barrier" . SPARSER::PROTEIN)
    ("mainly type I interferon and interferon-induced protein"
     . SPARSER::PROTEIN)
    ("interferon and interferon-induced" . SPARSER::COLLECTION)
    ("caspase-1 and Caspase-3" . SPARSER::COLLECTION)
    ("commercially available monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Caspase-1 and Caspase-3" . SPARSER::COLLECTION)
    ("interleukin-1β" . SPARSER::PROTEIN) ("plasma)" . SPARSER::PROTEIN)
    ("Mch5" . SPARSER::PROTEIN) ("p20" . SPARSER::PROTEIN)
    ("p10" . SPARSER::PROTEIN) ("Caspase-1" . SPARSER::PROTEIN)
    ("EMT and MET" . SPARSER::COLLECTION)
    ("renal EMT or MET" . SPARSER::COLLECTION)
    ("EMT or MET" . SPARSER::COLLECTION)
    ("undergone appreciable EMT" . SPARSER::PROTEIN)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("ions and water" . SPARSER::COLLECTION)
    ("triiodothyronine (4 pg/ml) and epidermal growth factor (10 ng/ml)"
     . SPARSER::COLLECTION)
    ("triiodothyronine" . SPARSER::DRUG) ("selenium" . SPARSER::MOLECULE)
    ("calbindin and aquaporin" . SPARSER::COLLECTION)
    ("aquaporin" . SPARSER::PROTEIN) ("calbindin" . SPARSER::PROTEIN)
    ("metallothionein" . SPARSER::PROTEIN)
    ("HPT and HK-2" . SPARSER::COLLECTION)
    ("EMT, E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("antidiuretic hormone" . SPARSER::MOLECULE)
    ("phlorizin" . SPARSER::MOLECULE)
    ("integrin and fibronectin" . SPARSER::COLLECTION)
    ("E6/E7" . SPARSER::COLLECTION) ("HK-2 and HPT" . SPARSER::COLLECTION)
    ("HPT" . SPARSER::PROTEIN-FAMILY)
    ("gap junction protein" . SPARSER::PROTEIN)
    ("cadherin-6" . SPARSER::PROTEIN) ("cadherin 6" . SPARSER::PROTEIN)
    ("MT-1E" . SPARSER::PROTEIN) ("connexin 32" . SPARSER::PROTEIN)
    ("Connexin 32" . SPARSER::PROTEIN) ("STX2" . SPARSER::PROTEIN)
    ("Aquaporin-1" . SPARSER::PROTEIN) ("aquaporin-1" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("K-cadherin" . SPARSER::PROTEIN)
    ("parathyroid hormone" . SPARSER::PROTEIN) ("MT-3" . SPARSER::PROTEIN)
    ("ALK CNG (+) and ALK CNG (-)" . SPARSER::COLLECTION)
    ("CNG and protein" . SPARSER::COLLECTION)
    ("CNG and ALK" . SPARSER::COLLECTION)
    ("FISH and ALK" . SPARSER::COLLECTION)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("significantly worse RFS" . SPARSER::PROTEIN) ("ANK" . SPARSER::PROTEIN)
    ("ER/PR/HER2" . SPARSER::COLLECTION)
    ("a valuable molecular target" . SPARSER::TARGET-PROTEIN)
    ("cMet and ALK" . SPARSER::COLLECTION) ("cMet" . SPARSER::PROTEIN)
    ("GTPase, p53, and WISP3" . SPARSER::COLLECTION)
    ("significantly poorer RFS" . SPARSER::PROTEIN)
    ("HER2 and ER" . SPARSER::COLLECTION) ("CNG" . SPARSER::PROTEIN)
    ("the most aggressive form" . SPARSER::FORM) ("WISP3" . SPARSER::PROTEIN)
    ("RHO-C" . SPARSER::PROTEIN) ("UV light" . SPARSER::PROTEIN)
    ("this viral protein" . SPARSER::PROTEIN)
    ("robust BRCA1" . SPARSER::PROTEIN)
    ("BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("RPA or RAD51" . SPARSER::COLLECTION)
    ("HR α-HPV E6’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("foci and DSB" . SPARSER::COLLECTION)
    ("RAD51/RPA70" . SPARSER::COLLECTION)
    ("DSBs, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("more deleterious DSBs" . SPARSER::PROTEIN)
    ("a previously described and inactive mutant p300" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2 protein" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("BRCA1/BRCA" . SPARSER::COLLECTION)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("keratinocytes, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("a fully functional GFP" . SPARSER::PROTEIN)
    ("these viral proteins" . SPARSER::PROTEIN)
    ("BRCA1, BRCA2, RPA70 and RAD51" . SPARSER::COLLECTION)
    ("the viral protein’s" . SPARSER::PROTEIN)
    ("the viral protein" . SPARSER::PROTEIN)
    ("Significantly fewer β-HPV 5 and 8 E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2, RAD51 and RPA70" . SPARSER::COLLECTION)
    ("significantly less p300" . SPARSER::PROTEIN)
    ("wt and p300" . SPARSER::COLLECTION)
    ("p300 and DSB" . SPARSER::COLLECTION)
    ("a previously characterized mutant" . SPARSER::MUTANT)
    ("53bp1" . SPARSER::PROTEIN) ("Foci" . SPARSER::PROTEIN)
    ("RAD51:RPA" . SPARSER::BIO-COMPLEX)
    ("PALB2 and BRCA2" . SPARSER::COLLECTION)
    ("RPA:RAD51" . SPARSER::BIO-COMPLEX) ("Homology" . SPARSER::PROTEIN)
    ("replication forks more often encounter DNA" . SPARSER::DNA)
    ("UV-damaged DNA" . SPARSER::DNA) ("Ataxia" . SPARSER::PROTEIN)
    ("p53 as well as pRB" . SPARSER::COLLECTION)
    ("the UV-damaged DNA" . SPARSER::DNA)
    ("p300 and ATR" . SPARSER::COLLECTION) ("thymine" . SPARSER::MOLECULE)
    ("specifically β-HPV 5 and 8 E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitomycin C" . SPARSER::DRUG) ("AZD 2281" . SPARSER::DRUG)
    ("ABT 888" . SPARSER::DRUG) ("protein-G" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("RPA 70" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("a solitary biomarker" . SPARSER::MOLECULE)
    ("PTPN14, and PTEN" . SPARSER::COLLECTION)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("AKT and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("a ubiquitous tumor suppressor gene" . SPARSER::PROTEIN)
    ("These latter proteins" . SPARSER::PROTEIN)
    ("/PTPN14" . SPARSER::COLLECTION)
    ("silencing PTPN14 and/or PTEN" . SPARSER::COLLECTION)
    ("PTPN14 or PTEN" . SPARSER::COLLECTION) ("REB" . SPARSER::PROTEIN)
    ("Yes-associated protein 1 (YAP)" . SPARSER::PROTEIN)
    ("PTPN14 [ xref , xref ] and Akt" . SPARSER::COLLECTION)
    ("theoretical target genes" . SPARSER::GENE)
    ("PTEN and PTPN14" . SPARSER::COLLECTION) ("Pic" . SPARSER::BIO-COMPLEX)
    ("a noninvasive biomarker" . SPARSER::MOLECULE)
    ("a diagnostic and prognostic biomarker" . SPARSER::MOLECULE)
    ("a secretory miRNA" . SPARSER::PROTEIN)
    ("miR-21 and its direct targets PTPN14 and PTEN" . SPARSER::COLLECTION)
    ("miR-21, PTPN14 and PTEN" . SPARSER::COLLECTION)
    ("miR-21, PTPN14 , and PTEN" . SPARSER::COLLECTION)
    ("miR-21 and its targets" . SPARSER::COLLECTION)
    ("phosphatase and tension homolog ( PTEN )" . SPARSER::COLLECTION)
    ("RECK" . SPARSER::PROTEIN) ("genes or oncogenes" . SPARSER::COLLECTION)
    ("Several aberrantly-expressed serum and tissue miRNAs" . SPARSER::PROTEIN)
    ("miR-21 and tumor suppressor genes" . SPARSER::COLLECTION)
    ("PTPN14 and PTEN" . SPARSER::COLLECTION)
    ("small nuclear RNA" . SPARSER::RNA)
    ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("programmed cell death 4" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("PTPN14" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase or nutrient" . SPARSER::COLLECTION)
    ("PI3-kinase and mTOR" . SPARSER::COLLECTION)
    ("antagonists and AKT" . SPARSER::COLLECTION)
    ("MDM4, UBC, RB, YY1, HDAC1, DAXX, and PML and Sp100"
     . SPARSER::COLLECTION)
    ("PML and Sp100" . SPARSER::COLLECTION) ("SAP" . SPARSER::PROTEIN)
    ("macroH2A" . SPARSER::PROTEIN) ("nucleosome" . SPARSER::PROTEIN)
    ("ENIGMA/PDLIM7" . SPARSER::COLLECTION) ("palbociclib" . SPARSER::DRUG)
    ("p21 or E2F7" . SPARSER::COLLECTION) ("skp2" . SPARSER::PROTEIN)
    ("skp" . SPARSER::PROTEIN) ("a cell-autonomous barrier" . SPARSER::PROTEIN)
    ("four modified peptides and two unmodified control peptides"
     . SPARSER::COLLECTION)
    ("the last 50 amino acids of ATRX" . SPARSER::PROTEIN)
    ("the last 50 amino acids" . SPARSER::AMINO-ACID)
    ("two independent lentiviral hairpins" . SPARSER::PROTEIN-FAMILY)
    ("SA-β-gal or SAHF" . SPARSER::COLLECTION)
    ("HAUSP/USP7" . SPARSER::COLLECTION)
    ("ubiquitinase" . SPARSER::UBIQUITINASE) ("that MDM2's" . SPARSER::PROTEIN)
    ("phospho-Rb and cyclin" . SPARSER::COLLECTION)
    ("CDK4 and MDM2" . SPARSER::COLLECTION)
    ("CDK4i or CDK4" . SPARSER::COLLECTION)
    ("Arf and p16" . SPARSER::COLLECTION)
    ("a senescent or quiescent state" . SPARSER::BIO-STATE)
    ("lentiviral transduced shRNAs" . SPARSER::RNA)
    ("LEE011 and LY2835219" . SPARSER::COLLECTION)
    ("SA-β-gal and SAHF" . SPARSER::COLLECTION)
    ("responders and non-responders" . SPARSER::COLLECTION)
    ("β-galactosidase (SA-β-gal, Figure xref ) and focal HP1γ"
     . SPARSER::COLLECTION)
    ("heterochromatic foci" . SPARSER::PROTEIN)
    ("focal HP1γ" . SPARSER::PROTEIN) ("Bromodeoxyuridine" . SPARSER::DRUG)
    ("MDM2 and CDK4" . SPARSER::COLLECTION)
    ("ATRX and MDM2" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("p53 and INK4" . SPARSER::COLLECTION)
    ("p16 and/or Arf" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and Ink4" . SPARSER::COLLECTION)
    ("target essential regulators" . SPARSER::REGULATOR)
    ("Palbociclib" . SPARSER::DRUG) ("MDM2 and ATRX" . SPARSER::COLLECTION)
    ("CDK4i" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sp100" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("alpha-globin" . SPARSER::PROTEIN) ("PDLIM7" . SPARSER::PROTEIN)
    ("WIP1" . SPARSER::PROTEIN) ("V75" . SPARSER::PROTEIN)
    ("LY2835219" . SPARSER::DRUG) ("LEE011" . SPARSER::DRUG)
    ("HP1γ" . SPARSER::PROTEIN)
    ("the viral genomic RNAs and proteins" . SPARSER::COLLECTION)
    ("viral RNAs and proteins" . SPARSER::COLLECTION)
    ("RNAs and proteins" . SPARSER::COLLECTION) ("viral RNA" . SPARSER::RNA)
    ("central neural system etc." . SPARSER::PROTEIN)
    ("varieties" . SPARSER::VARIETY)
    ("intracellular viral RNAs" . SPARSER::RNA)
    ("ERK1, or ERK2, or ERK1/2" . SPARSER::COLLECTION)
    ("ERK2, or ERK1/2" . SPARSER::COLLECTION)
    ("ERK2, or siERK1+2" . SPARSER::COLLECTION)
    ("ERK1, ERK2, or ERK1/2" . SPARSER::COLLECTION)
    ("viral genomic RNA" . SPARSER::RNA) ("Viral VP1 gene" . SPARSER::GENE)
    ("total viral RNAs" . SPARSER::RNA) ("CPE" . SPARSER::PROTEIN)
    ("MEKs, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("phosph-ERK2" . SPARSER::COLLECTION) ("phosph-ERK1" . SPARSER::COLLECTION)
    ("MEK1/2 and in turn activating variety" . SPARSER::COLLECTION)
    ("ERKs, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("Raf, MEK and ERK" . SPARSER::COLLECTION)
    ("seven nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) and four structural proteins (VP1, VP2, VP3, and VP4)"
     . SPARSER::COLLECTION)
    ("seven nonstructural proteins" . SPARSER::PROTEIN)
    ("MEK1-ERK1/2" . SPARSER::COLLECTION)
    ("specific ERK siRNAs and selective inhibitor U0126" . SPARSER::COLLECTION)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf-MEK-ERK1/2" . SPARSER::COLLECTION) ("anti-viral" . SPARSER::DRUG)
    ("MEK2" . SPARSER::PROTEIN) ("CASP8AP2 and WNT5A" . SPARSER::COLLECTION)
    ("IL10, OPAL1, and CCND2" . SPARSER::COLLECTION)
    ("IL10, WNT5A, OPAL1, CCND2, and CASP8AP2" . SPARSER::COLLECTION)
    ("IL2RA, SORT1, FLT3, and DEFA1" . SPARSER::COLLECTION)
    ("EFS/RFS" . SPARSER::COLLECTION)
    ("IL2RA, SORT1, and FLT3" . SPARSER::COLLECTION)
    ("genes and times" . SPARSER::COLLECTION)
    ("IL10, WNT5A, OPAL1, CCND2, and CASP8AP" . SPARSER::COLLECTION)
    ("IL10, WNT5A, FZD3, JNK, SOS1, JUN, OPAL1, MYC, CCND2, PDE4D, CREB1, FOS, CYLD, RAPGEF2, SORT1, DOCK10, PAPD5, HOXA9, and CASP8AP2"
     . SPARSER::COLLECTION)
    ("CYLD" . SPARSER::PROTEIN) ("MIC" . SPARSER::PROTEIN-FAMILY)
    ("a comprehensive gene expression profile of 45 candidate genes"
     . SPARSER::GENE)
    ("MYC-IGH" . SPARSER::PROTEIN-PAIR) ("TCF3-PBX1" . SPARSER::COLLECTION)
    ("/t" . SPARSER::COLLECTION) ("ETV6-RUNX1" . SPARSER::COLLECTION)
    ("TEL-AML1" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("Acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("FLT3 and DEFA1" . SPARSER::COLLECTION)
    ("IL2RA, SORT1, DEFA1, and FLT3" . SPARSER::COLLECTION)
    ("Acute lymphoblastic leukemia type B" . SPARSER::PROTEIN)
    ("T-Cell" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("WNT5A" . SPARSER::PROTEIN) ("Pre-B" . SPARSER::PROTEIN)
    ("CASP8AP2" . SPARSER::PROTEIN) ("OPAL1" . SPARSER::PROTEIN)
    ("TNFRSF7" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("NKG2" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("PAPD5" . SPARSER::PROTEIN) ("MYH9" . SPARSER::PROTEIN)
    ("DOCK10" . SPARSER::PROTEIN) ("RAPGEF2" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("PDE4D" . SPARSER::PROTEIN)
    ("BCL2A1" . SPARSER::PROTEIN) ("BCL11A" . SPARSER::PROTEIN)
    ("SOS1" . SPARSER::PROTEIN) ("FZD3" . SPARSER::PROTEIN)
    ("PBX1" . SPARSER::PROTEIN) ("ETV6" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("SORT1" . SPARSER::PROTEIN)
    ("IL2RA" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("p53, FOXO1 and STAT1" . SPARSER::COLLECTION)
    ("PCAF or SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and PRC2" . SPARSER::COLLECTION)
    ("PCAF and SIRT1" . SPARSER::COLLECTION)
    ("SUZ12 and EED" . SPARSER::COLLECTION)
    ("348-EZH2 antibody and normal IgG" . SPARSER::COLLECTION)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HOXA10 and DAB2IP" . SPARSER::COLLECTION)
    ("FLAG-EZH2-wt" . SPARSER::COLLECTION)
    ("K348 acetylated EZH2 and T487 phosphorylated EZH2" . SPARSER::COLLECTION)
    ("T487A phosphorylation-deﬁcient mutants" . SPARSER::MUTANT)
    ("FLAG-SIRT2" . SPARSER::COLLECTION) ("FLAG-SIRT1" . SPARSER::COLLECTION)
    ("Myc-EZH2" . SPARSER::COLLECTION) ("p53 and FOXO3a" . SPARSER::COLLECTION)
    ("8KR" . SPARSER::PROTEIN) ("EZH2-wt" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID)
    ("Eight lysines (K10, K245, K309, K318, K344, K348, K472 and K735) of EZH2"
     . SPARSER::PROTEIN)
    ("HAT and ADA" . SPARSER::COLLECTION) ("BROMO" . SPARSER::MOLECULE)
    ("ADA" . SPARSER::PROTEIN) ("SET" . SPARSER::PROTEIN)
    ("GFP-EZH2" . SPARSER::COLLECTION) ("EZH2 and PCAF" . SPARSER::COLLECTION)
    ("EZH2 and His-PCAF" . SPARSER::COLLECTION)
    ("FLAG-PCAF" . SPARSER::COLLECTION)
    ("CBP, P300 and hMOF" . SPARSER::COLLECTION) ("hMOF" . SPARSER::PROTEIN)
    ("FLAG-EZH2" . SPARSER::COLLECTION) ("EZH2-S21" . SPARSER::COLLECTION)
    ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("EZH2, EED, SUZ12 and RbAp46/48" . SPARSER::COLLECTION)
    ("polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("P300/CBP-associated factor (PCAF)" . SPARSER::PROTEIN)
    ("PCR2" . SPARSER::PROTEIN) ("HOXA10" . SPARSER::PROTEIN)
    ("K10" . SPARSER::PROTEIN)
    ("Methyltransferase Activity" . SPARSER::PROTEIN)
    ("HA-CBP" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN) ("ADRB2" . SPARSER::PROTEIN)
    ("RbAp46" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("P300/CBP-associated factor" . SPARSER::PROTEIN)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("Seizures" . SPARSER::PROTEIN) ("anticonvulsant" . SPARSER::DRUG)
    ("hypertensive state" . SPARSER::BIO-STATE) ("methyldopa" . SPARSER::DRUG)
    ("the dentate gyrus and Ammon’s" . SPARSER::COLLECTION)
    ("gyrus and Ammon" . SPARSER::COLLECTION) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("The temporal lobes" . SPARSER::PROTEIN)
    ("ribs" . SPARSER::DRUG) ("the temporal lobe" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("those encoding chaperones and repair enzymes" . SPARSER::COLLECTION)
    ("YB-1 and SG proteins" . SPARSER::COLLECTION)
    ("G3BP1 and TIA-1" . SPARSER::COLLECTION)
    ("both YB-1 and its translational target G3BP1" . SPARSER::COLLECTION)
    ("its translational target G3BP1" . SPARSER::PROTEIN)
    ("viral 3C proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G3BP1 and TIA-1, and G3BP1" . SPARSER::COLLECTION)
    ("TIA-1, and G3BP1" . SPARSER::COLLECTION)
    ("cellular mRNAs" . SPARSER::PROTEIN)
    ("YB-1 and G3BP1, FMRP, and eIF3η" . SPARSER::COLLECTION)
    ("G3BP1, FMRP, and eIF3η" . SPARSER::COLLECTION)
    ("SG associated proteins" . SPARSER::PROTEIN) ("Bip" . SPARSER::PROTEIN)
    ("pimonidazole" . SPARSER::DRUG)
    ("full-length or G3BP1" . SPARSER::COLLECTION)
    ("full-length and M4 mutant" . SPARSER::COLLECTION)
    ("Mutants" . SPARSER::MUTANT) ("Rluc" . SPARSER::PROTEIN)
    ("/YB-1" . SPARSER::COLLECTION) ("β-Globin-Luc" . SPARSER::COLLECTION)
    ("G3BP1-Luc" . SPARSER::COLLECTION)
    ("a known polysome-associated control protein" . SPARSER::PROTEIN)
    ("polysomal fractionated (ribosome-bound) mRNAs" . SPARSER::PROTEIN)
    ("YB-1–bound G3BP1 or control XIAP mRNAs" . SPARSER::COLLECTION)
    ("YB-1–associated mRNAs" . SPARSER::PROTEIN)
    ("a known translational regulator" . SPARSER::REGULATOR)
    ("YB-1–, TIA-1–, FMRP-, and eIF3η-associated" . SPARSER::COLLECTION)
    ("FMRP-" . SPARSER::PROTEIN) ("YB-1–" . SPARSER::PROTEIN)
    ("FMRP" . SPARSER::PROTEIN) ("Streptavidin" . SPARSER::PROTEIN)
    ("TIA-1 and GRB2" . SPARSER::COLLECTION)
    ("translational components" . SPARSER::COMPONENT)
    ("RPS6, PABP1, and FXR1" . SPARSER::COLLECTION)
    ("eEF2 and eIF2" . SPARSER::COLLECTION) ("FXR" . SPARSER::PROTEIN)
    ("TIAR" . SPARSER::PROTEIN)
    ("known SG-associated proteins" . SPARSER::PROTEIN)
    ("G3BP1, eIF3η, and TIA-1" . SPARSER::COLLECTION)
    ("Myc-YB-1" . SPARSER::COLLECTION) ("eIF3η" . SPARSER::PROTEIN)
    ("PARP or caspase-3" . SPARSER::COLLECTION)
    ("Annexin V-FITC–based flow cytometry" . SPARSER::PROTEIN)
    ("arsenite or H 2 O 2" . SPARSER::COLLECTION)
    ("H 2 O 2 and the plant phytogen piperlongumine (unpublished data)"
     . SPARSER::COLLECTION)
    ("piperlongumine" . SPARSER::DRUG)
    ("SG-associated poly(A) + mRNAs" . SPARSER::PROTEIN)
    ("arsenite and H 2 O 2" . SPARSER::COLLECTION)
    ("a downstream translational effector" . SPARSER::EFFECTOR)
    ("a global translational repressor" . SPARSER::REPRESSOR)
    ("translationally inactive mRNPs" . SPARSER::BIO-COMPLEX)
    ("CSD" . SPARSER::PROTEIN) ("IMD" . SPARSER::PROTEIN-FAMILY)
    ("chaperones and repair enzymes" . SPARSER::COLLECTION)
    ("vital proteins" . SPARSER::PROTEIN)
    ("TIA1 or G3BP1" . SPARSER::COLLECTION) ("arsenite" . SPARSER::DRUG)
    ("Gln or Asn" . SPARSER::COLLECTION)
    ("TIA-1 and G3BP1" . SPARSER::COLLECTION)
    ("eIF4G, and PABP" . SPARSER::COLLECTION) ("PABP" . SPARSER::PROTEIN)
    ("stalled mRNA preinitiation complexes form mRNA–protein"
     . SPARSER::COLLECTION)
    ("mRNA–protein" . SPARSER::COLLECTION) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("hypoxia, or nutrient" . SPARSER::COLLECTION)
    ("YB-1 and G3BP1" . SPARSER::COLLECTION)
    ("translationally silent mRNAs" . SPARSER::PROTEIN)
    ("FMR1" . SPARSER::PROTEIN) ("F–J" . SPARSER::PROTEIN)
    ("SRp55" . SPARSER::PROTEIN) ("β-Globin" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("GRB2" . SPARSER::PROTEIN)
    ("PABP1" . SPARSER::PROTEIN) ("RH-30" . SPARSER::PROTEIN)
    ("DDX6" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("TIA1" . SPARSER::PROTEIN) ("TIA-1" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("severe DNA" . SPARSER::DNA)
    ("TIGAR (also known as C12 or f5) and GLS2" . SPARSER::COLLECTION)
    ("the primary cellular antioxidant" . SPARSER::PROTEIN)
    ("glutathione (GSH)" . SPARSER::DRUG)
    ("TIGAR, GLS2 and SCO2" . SPARSER::COLLECTION)
    ("ROS or erastin" . SPARSER::COLLECTION)
    ("etoposide and doxorubicin" . SPARSER::COLLECTION)
    ("nutlin and ROS" . SPARSER::COLLECTION) ("nutlin" . SPARSER::DRUG)
    ("p21 or PUMA" . SPARSER::COLLECTION)
    ("Ki67 and BrdU" . SPARSER::COLLECTION)
    ("day E7.5" . SPARSER::PROTEIN-FAMILY) ("ferr-1" . SPARSER::COLLECTION)
    ("3KR/3KR" . SPARSER::COLLECTION) ("3KR" . SPARSER::PROTEIN)
    ("-cystine" . SPARSER::MOLECULE)
    ("extracellular cystine" . SPARSER::MOLECULE)
    ("the acetylation-defective mutant p53 3KR" . SPARSER::PROTEIN)
    ("p53 3KR" . SPARSER::PROTEIN) ("Slc7a11" . SPARSER::PROTEIN)
    ("inp53" . SPARSER::PROTEIN)
    ("p21 (also known as CDKN1A) or PUMA (also known as BBC3)"
     . SPARSER::COLLECTION)
    ("TIGAR and MDM2" . SPARSER::COLLECTION)
    ("polypeptides" . SPARSER::PROTEIN)
    ("a radio-labelled oligonucleotide" . SPARSER::MOLECULE)
    ("acetylation-defective p53 mutants" . SPARSER::MUTANT)
    ("an acetylation–defective mutant" . SPARSER::MUTANT)
    ("antiporter" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("K 3" . SPARSER::PROTEIN) ("Mki67" . SPARSER::PROTEIN)
    ("tert-butyl hydroperoxide" . SPARSER::MOLECULE)
    ("nutlin-3a" . SPARSER::DRUG) ("E-2" . SPARSER::PROTEIN)
    ("LB3" . SPARSER::PROTEIN) ("ATP1A1" . SPARSER::PROTEIN)
    ("necrostatin-1" . SPARSER::MOLECULE) ("a11" . SPARSER::PROTEIN)
    ("nutlin-3" . SPARSER::DRUG) ("SLC7A11" . SPARSER::PROTEIN)
    ("GDNF and BDNF" . SPARSER::COLLECTION)
    ("focal cerebral ischemia" . SPARSER::PROTEIN) ("dopamine" . SPARSER::DRUG)
    ("STR" . SPARSER::PROTEIN) ("antibodies or MPP +" . SPARSER::COLLECTION)
    ("hRheb" . SPARSER::PROTEIN)
    ("anti-CNTF or anti-CNTFRα" . SPARSER::COLLECTION)
    ("AAV-hRheb" . SPARSER::COLLECTION) ("AAV" . SPARSER::PROTEIN)
    ("AAV-GFP and AAV-hRheb" . SPARSER::COLLECTION)
    ("AAV-GFP" . SPARSER::COLLECTION) ("BDNF and GDNF" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID)
    ("CNTF, GDNF, and BDNF" . SPARSER::COLLECTION)
    ("glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF)"
     . SPARSER::COLLECTION)
    ("GDNF" . SPARSER::PROTEIN) ("tripartite receptor" . SPARSER::RECEPTOR)
    ("a neurotrophic cytokine" . SPARSER::PROTEIN)
    ("CNTF and CNTFRα" . SPARSER::COLLECTION) ("CNTFR" . SPARSER::PROTEIN)
    ("CNTF" . SPARSER::PROTEIN) ("MPP +" . SPARSER::MOLECULE)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("S16" . SPARSER::PROTEIN)
    ("Ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("ventral ARF6/actin" . SPARSER::COLLECTION)
    ("ARF6/actin" . SPARSER::COLLECTION)
    ("PKC and c-Src" . SPARSER::COLLECTION)
    ("ventral F-actin" . SPARSER::BIO-COMPLEX)
    ("ARF1 or ARF6" . SPARSER::COLLECTION)
    ("vinculin and other adhesive proteins" . SPARSER::COLLECTION)
    ("talin and zyxin" . SPARSER::COLLECTION) ("zyxin" . SPARSER::PROTEIN)
    ("talin" . SPARSER::PROTEIN) ("Rac1 and its GEF" . SPARSER::COLLECTION)
    ("GTP:Rac1" . SPARSER::BIO-COMPLEX) ("ARF6 and Rac1" . SPARSER::COLLECTION)
    ("F-actin-" . SPARSER::BIO-COMPLEX)
    ("Rac1 and F-actin" . SPARSER::COLLECTION)
    ("ARF6T157N or EGF" . SPARSER::COLLECTION)
    ("complex or SCAR/WAVE and N-WASP" . SPARSER::COLLECTION)
    ("Pentameric SCAR/WAVE complex" . SPARSER::BIO-COMPLEX)
    ("NPFs" . SPARSER::PROTEIN)
    ("c-Src and phosphorylated-tyrosine" . SPARSER::COLLECTION)
    ("ARF6T157N" . SPARSER::PROTEIN) ("ARF6T157N-GFP" . SPARSER::PROTEIN-PAIR)
    ("cortactin-DsRed" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("fibrillar type I collagen" . SPARSER::PROTEIN)
    ("Tyrosine-kinase and phosphorylated-tyrosine" . SPARSER::COLLECTION)
    ("paxillin, vinculin and β1-integrin" . SPARSER::COLLECTION)
    ("the SCAR/WAVE complex and its most prominent regulator Rac1"
     . SPARSER::COLLECTION)
    ("Rac1-GEFs" . SPARSER::COLLECTION) ("cofilin" . SPARSER::PROTEIN)
    ("invadopodial components cortactin and paxillin" . SPARSER::COLLECTION)
    ("cortactin and paxillin" . SPARSER::COLLECTION)
    ("lipids and proteins" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs) and other membrane receptors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("MT1-MMPs" . SPARSER::COLLECTION)
    ("cortactin, Arp2/3 and SCAR/WAVE" . SPARSER::COLLECTION)
    ("surface receptors and membrane components" . SPARSER::COLLECTION)
    ("TIAM1" . SPARSER::PROTEIN) ("Nap1" . SPARSER::PROTEIN)
    ("p34-Arc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("F-actin-binding protein" . SPARSER::PROTEIN)
    ("β1-integrin" . SPARSER::PROTEIN) ("JIP3" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("AMAP1" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("EGF-R" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("MT1" . SPARSER::PROTEIN)
    ("collagen, aggrecan, and glycosaminoglycan" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE) ("aggrecan" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN) ("IL-23/IL-17" . SPARSER::COLLECTION)
    ("monocytes or macrophages" . SPARSER::COLLECTION)
    ("TNF, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("two closely related proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-23 and IL-6" . SPARSER::COLLECTION)
    ("TNF, IL-6 and RANTES" . SPARSER::COLLECTION)
    ("TNF, IL-1beta and IL-6" . SPARSER::COLLECTION)
    ("IL-6 and TNF" . SPARSER::COLLECTION) ("p70/IL-23" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("cathepsin" . SPARSER::PROTEIN)
    ("ligand (RANKL)" . SPARSER::MOLECULE)
    ("other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("NF-kappa B-dependent genes even more complex" . SPARSER::BIO-COMPLEX)
    ("both Sirt1 and RelA/p65 proteins" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("ACPA" . SPARSER::PROTEIN)
    ("severe RA" . SPARSER::PROTEIN) ("RA and HC" . SPARSER::COLLECTION)
    ("TNF and IL-8" . SPARSER::COLLECTION)
    ("IL-6 (p = 0.17) and TNF (p = 0.11)" . SPARSER::COLLECTION)
    ("ESR" . SPARSER::PROTEIN) ("DAS" . SPARSER::DRUG)
    ("PGC" . SPARSER::PROTEIN)
    ("Active pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-23 and Sirt1" . SPARSER::COLLECTION)
    ("serum IL-23 and serum IL-6" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("IL-23p19" . SPARSER::PROTEIN) ("IL-1beta" . SPARSER::PROTEIN)
    ("ITF2357" . SPARSER::DRUG) ("interleukin-12" . SPARSER::PROTEIN)
    ("cathepsin K" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("A ‘" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor-gamma" . SPARSER::PROTEIN)
    ("NF-kappaB" . SPARSER::PROTEIN) ("HDAC 11" . SPARSER::PROTEIN)
    ("HDAC 4" . SPARSER::PROTEIN) ("HDAC 1" . SPARSER::PROTEIN)
    ("Interleukin-23" . SPARSER::PROTEIN)
    ("Sirt1 and PGC-1α" . SPARSER::COLLECTION) ("high-fat" . SPARSER::PROTEIN)
    ("IRS-Akt" . SPARSER::COLLECTION)
    ("delayed insulin-induced pAkt" . SPARSER::PROTEIN-FAMILY)
    ("triglycerides (TG)" . SPARSER::MOLECULE)
    ("MKP1 and IRS1" . SPARSER::COLLECTION)
    ("AMPK-MKP1-IRS1" . SPARSER::COLLECTION)
    ("Nicotinic acetylcholine receptor α7 subunit" . SPARSER::FRAGMENT)
    ("MKP1 or GFP" . SPARSER::COLLECTION) ("SAMS" . SPARSER::PROTEIN)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-p38 and pJNK" . SPARSER::COLLECTION)
    ("p38 or JNK" . SPARSER::COLLECTION)
    ("SIK2 and AMPK" . SPARSER::COLLECTION)
    ("pS6K (Thr389) or pMtor (Ser2448)" . SPARSER::COLLECTION)
    ("pS6K and pMtor" . SPARSER::COLLECTION) ("JNK-p38" . SPARSER::COLLECTION)
    ("adipose AMPKα isoforms" . SPARSER::ISOFORM)
    ("Adipoq-Cre" . SPARSER::COLLECTION) ("Adipoq" . SPARSER::PROTEIN)
    ("pACC" . SPARSER::PROTEIN) ("Prkaa2" . SPARSER::PROTEIN)
    ("Prkaa1" . SPARSER::PROTEIN) ("Irs1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Irs" . SPARSER::PROTEIN) ("nicotine and acipimox" . SPARSER::COLLECTION)
    ("acipimox" . SPARSER::DRUG) ("FFA" . SPARSER::PROTEIN)
    ("Acipimox" . SPARSER::DRUG) ("RQ" . SPARSER::MOLECULE)
    ("isoproterenol" . SPARSER::PROTEIN) ("PDE" . SPARSER::PROTEIN)
    ("PDEs" . SPARSER::PROTEIN) ("phosphodiesterases" . SPARSER::PROTEIN)
    ("smaller adipocytes" . SPARSER::PROTEIN)
    ("vehicle-treated mice nicotine" . SPARSER::DRUG)
    ("hyperinsulinemic-euglycemic clamp" . SPARSER::PROTEIN-FAMILY)
    ("hypothalamic AMPK" . SPARSER::PROTEIN)
    ("threonine/serine" . SPARSER::COLLECTION)
    ("nicotine or smoking" . SPARSER::COLLECTION)
    ("p38-JNK" . SPARSER::COLLECTION)
    ("smoke, and nicotine" . SPARSER::COLLECTION)
    ("The Jun N-terminal kinase (JNK) and the p38 protein kinases (p38)"
     . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("smoke or nicotine" . SPARSER::COLLECTION) ("Nicotine" . SPARSER::DRUG)
    ("mitogen-activated protein kinase and c-Jun" . SPARSER::COLLECTION)
    ("this latter protein" . SPARSER::PROTEIN) ("nicotine" . SPARSER::DRUG)
    ("P 32" . SPARSER::PROTEIN) ("pIRS1" . SPARSER::PROTEIN)
    ("pp38" . SPARSER::PROTEIN) ("AMPK-α1" . SPARSER::PROTEIN)
    ("Mkp1" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN) ("SIK2" . SPARSER::PROTEIN)
    ("pIrs1" . SPARSER::PROTEIN) ("acetyl-coA" . SPARSER::MOLECULE)
    ("H-E" . SPARSER::PROTEIN)
    ("stress-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MKP1" . SPARSER::PROTEIN) ("phosphatase-1" . SPARSER::PROTEIN)
    ("CDKN1A and RHPN2" . SPARSER::COLLECTION)
    ("a possible biomarker" . SPARSER::MOLECULE) ("leucovorin" . SPARSER::DRUG)
    ("the CDKN1A (rs1321311) and RHPN2 (rs10411210) genes"
     . SPARSER::COLLECTION)
    ("the rs1321311 TT genotype (vs. GG + GT) and rs10411210 TT genotype (vs. CC + CT)"
     . SPARSER::COLLECTION)
    ("CDKN1A and rs10411210C" . SPARSER::COLLECTION)
    ("SMAD 7" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("RHPN2" . SPARSER::PROTEIN) ("ISG15 and USP18" . SPARSER::COLLECTION)
    ("MxA, OAS1, ISG15, CXCL10, and USP18" . SPARSER::COLLECTION)
    ("STAT1 and STAT2" . SPARSER::COLLECTION)
    ("whose polymorphisms" . SPARSER::PROTEIN) ("HTA" . SPARSER::PROTEIN)
    ("antivirals" . SPARSER::DRUG) ("HTAs" . SPARSER::PROTEIN)
    ("pcDNA3.1-DUSP1" . SPARSER::COLLECTION)
    ("DUSP1-siRNA" . SPARSER::COLLECTION) ("DUSP1-shRNA" . SPARSER::COLLECTION)
    ("NS5A and NS5B" . SPARSER::COLLECTION) ("cont" . SPARSER::PROTEIN)
    ("phosphatase (MKP)" . SPARSER::PHOSPHATASE)
    ("dual specificity phosphatase 1 (DUSP1) and ubiquitin-specific protease"
     . SPARSER::COLLECTION)
    ("host-specific genes" . SPARSER::GENE) ("ribavirin" . SPARSER::DRUG)
    ("MxA" . SPARSER::PROTEIN) ("phosho-STAT1" . SPARSER::COLLECTION)
    ("LV" . SPARSER::MOLECULE) ("FK" . SPARSER::MOLECULE)
    ("STAT2" . SPARSER::PROTEIN) ("NIM811" . SPARSER::DRUG)
    ("NS5B" . SPARSER::PROTEIN) ("NS5A" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL28B" . SPARSER::PROTEIN) ("USP18" . SPARSER::PROTEIN)
    ("ISG15 ubiquitin-like modifier" . SPARSER::PROTEIN)
    ("OAS1" . SPARSER::PROTEIN)
    ("2'-5'-oligoadenylate synthetase 1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("DUSP1" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("ATP-site" . SPARSER::ATP) ("MTA1 or YB-1" . SPARSER::COLLECTION)
    ("a particular tissue type" . SPARSER::PROTEIN)
    ("YB-1 and MTA1-specific antibodies" . SPARSER::COLLECTION)
    ("PIN, and prostatic" . SPARSER::COLLECTION) ("Los" . SPARSER::MOLECULE)
    ("YB-1 or MTA1" . SPARSER::COLLECTION)
    ("others previously identified Y-box binding protein 1 (YB-1) and metastasis associated-1 (MTA1)"
     . SPARSER::COLLECTION)
    ("others previously identified Y-box binding protein 1" . SPARSER::PROTEIN)
    ("DNA or RNA" . SPARSER::COLLECTION)
    ("the Y-box binding protein-1 (YB-1) and the chromatin"
     . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("YB-1 and MTA1" . SPARSER::COLLECTION) ("YBX1" . SPARSER::PROTEIN)
    ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("histone and DNA" . SPARSER::COLLECTION)
    ("Elk1 and Elk4" . SPARSER::COLLECTION) ("Elk1" . SPARSER::PROTEIN)
    ("temozolomide or dacarbazine" . SPARSER::COLLECTION)
    ("IDH and the TERT promoter" . SPARSER::COLLECTION)
    ("received temozolomide and radiotherapy" . SPARSER::COLLECTION)
    ("procarbazine or temozolomide" . SPARSER::COLLECTION)
    ("procarbazine" . SPARSER::DRUG)
    ("both TERT promoter and IDH mutations (median survival 246.5 months)"
     . SPARSER::COLLECTION)
    ("IDH1 or IDH2" . SPARSER::COLLECTION)
    ("IDH2 and chromosome arms 1p and 19q" . SPARSER::COLLECTION)
    ("Ets/TCF" . SPARSER::COLLECTION)
    ("a new biomarker and eventual therapeutic target [ xref ]"
     . SPARSER::COLLECTION)
    ("IDH 1 and IDH 2" . SPARSER::COLLECTION) ("Isocitrate" . SPARSER::DRUG)
    ("IDH and TERT" . SPARSER::COLLECTION)
    ("TERT promoter and IDH mutations in oligodendroglial tumors (OR = 26.3; 95% CI 2.5–250.2) and inverse association in primary glioblastomas (OR = 0.13; 95% CI 0.03–0.58)"
     . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("chi 2" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1a" . SPARSER::PROTEIN)
    ("R-2" . SPARSER::PROTEIN) ("Elk4" . SPARSER::PROTEIN)
    ("Chr5" . SPARSER::PROTEIN) ("INK4C" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("IDH 2" . SPARSER::PROTEIN) ("IDH 1" . SPARSER::PROTEIN)
    ("both mTOR kinase inhibitors and rapalogs" . SPARSER::COLLECTION)
    ("ligases, FBX4 and FBXW7" . SPARSER::COLLECTION)
    ("a possible predictive biomarker" . SPARSER::MOLECULE)
    ("p-GSK3 is" . SPARSER::PROTEIN-PAIR)
    ("RAS/ERK/RSK2" . SPARSER::COLLECTION)
    ("PC-3 and MB-435" . SPARSER::COLLECTION)
    ("PKCα and SGK1" . SPARSER::COLLECTION)
    ("Akt, PKCα and SGK1" . SPARSER::COLLECTION)
    ("DU145 and PC-3" . SPARSER::COLLECTION)
    ("FBXW7-KO" . SPARSER::PROTEIN-PAIR)
    ("cyclin D1 [ xref ] and FBXW7" . SPARSER::COLLECTION)
    ("CHIR99021, and GSK3" . SPARSER::COLLECTION)
    ("proteins, c-Myc and Mcl-1" . SPARSER::COLLECTION)
    ("either p-S6 or p-4EBP1 (Fig. xref )" . SPARSER::COLLECTION)
    ("p-4EBP1" . SPARSER::COLLECTION)
    ("cyclin D1, c-Myc and Mcl-1" . SPARSER::COLLECTION)
    ("rapamycin ( r = 0.7895, P = 0.0013) or RAD001 ( r = 0.7870, P = 0.0014)"
     . SPARSER::COLLECTION)
    ("rapamycin or RAD001" . SPARSER::COLLECTION)
    ("p-GSK3" . SPARSER::COLLECTION)
    ("rapamycin and RAD001" . SPARSER::COLLECTION)
    ("GSK3β-KO" . SPARSER::COLLECTION) ("GSK3α-KO" . SPARSER::COLLECTION)
    ("INK128 and SB216763" . SPARSER::COLLECTION)
    ("SB216763 and rapamycin" . SPARSER::COLLECTION)
    ("SB216763 or CHIR99021" . SPARSER::COLLECTION)
    ("c-Myc and Mcl-1" . SPARSER::COLLECTION)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("a ubiquitous serine/threonine kinase" . SPARSER::KINASE)
    ("rapamycin and its analogues (rapalogs)" . SPARSER::COLLECTION)
    ("an attractive cancer therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("cyclin D1, c-Myc, Mcl-1, HIF1α and VEGF" . SPARSER::COLLECTION)
    ("cyclin D1, Mcl-1 and c-Myc" . SPARSER::COLLECTION)
    ("GSK-3α" . SPARSER::PROTEIN) ("RSK2" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("FBX4" . SPARSER::PROTEIN)
    ("INK128" . SPARSER::DRUG) ("SB216763" . SPARSER::DRUG)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("RAF inhibitors (alone and in combination), ERK inhibitors, and other more experimental strategies"
     . SPARSER::COLLECTION)
    ("CDK4/Rb" . SPARSER::COLLECTION) ("Binimetinib" . SPARSER::DRUG)
    ("dabrafenib and trametinib" . SPARSER::COLLECTION)
    ("CRAF and BRAF" . SPARSER::COLLECTION) ("Tipifarnib" . SPARSER::DRUG)
    ("FTI" . SPARSER::DRUG)
    ("vemurafenib, dabrafenib, and trametinib" . SPARSER::COLLECTION)
    ("distinct biologic" . SPARSER::DRUG) ("binimetinib" . SPARSER::DRUG)
    ("MEK162" . SPARSER::DRUG)
    ("a substrate of ATR ( xref ) and Pol κ" . SPARSER::COLLECTION)
    ("soluble Chk1" . SPARSER::PROTEIN) ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PCNA and TLS polymerases ( xref )" . SPARSER::COLLECTION)
    ("just PIP" . SPARSER::PROTEIN) ("Pol η and Chk1" . SPARSER::COLLECTION)
    ("Cul4A/DDB1" . SPARSER::COLLECTION)
    ("the phosphomimetic mutant Chk1S345E" . SPARSER::PROTEIN)
    ("Chk1S345E" . SPARSER::PROTEIN)
    ("The F box protein FBX6 and the DDB1- and CUL4-associated factor (DCAF) CDT2"
     . SPARSER::COLLECTION)
    ("the DDB1- and CUL4-associated factor (DCAF) CDT2" . SPARSER::COLLECTION)
    ("CUL4-associated factor (DCAF) CDT2" . SPARSER::PROTEIN)
    ("CRL1 and CRL4" . SPARSER::COLLECTION) ("DDB1-" . SPARSER::PROTEIN)
    ("DCAF" . SPARSER::PROTEIN) ("Cul1 and Cul4A" . SPARSER::COLLECTION)
    ("CRLs" . SPARSER::PROTEIN) ("SLX4 and GEN1" . SPARSER::COLLECTION)
    ("Chk1 and Mus81" . SPARSER::COLLECTION)
    ("the Mus81 endonuclease ( xref ; xref ) and the MRE11 nuclease ( xref )"
     . SPARSER::COLLECTION)
    ("Nuclease" . SPARSER::PROTEIN)
    ("the recombinase Rad51 and its loading factor BRCA2"
     . SPARSER::COLLECTION)
    ("UV-activated Chk1" . SPARSER::PROTEIN)
    ("PrimPol and Rev1" . SPARSER::COLLECTION) ("PrimPol" . SPARSER::PROTEIN)
    ("Pol η-mediated post-replicative gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("elongation and Pol η" . SPARSER::COLLECTION)
    ("Rad18 and Pol η" . SPARSER::COLLECTION) ("ATR-" . SPARSER::PROTEIN)
    ("Rad6/Rad18" . SPARSER::COLLECTION) ("variant (XPV)" . SPARSER::VARIANT)
    ("XPV" . SPARSER::PROTEIN)
    ("UV-induced cyclobutane pyrimidine dimers" . SPARSER::DIMER)
    ("CPDs" . SPARSER::PROTEIN) ("cyclobutane" . SPARSER::MOLECULE)
    ("polymerases and the helicase" . SPARSER::COLLECTION)
    ("the Chk1 inhibitor UCN-01 and Chk1−/− avian B-lymphoma cells"
     . SPARSER::COLLECTION)
    ("replication-associated DSBs" . SPARSER::PROTEIN)
    ("Cdk-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Treslin-TopBP1" . SPARSER::COLLECTION)
    ("Chk1-Treslin" . SPARSER::COLLECTION)
    ("the CMG replicative helicase" . SPARSER::PROTEIN)
    ("TopBP1/Treslin" . SPARSER::COLLECTION) ("Treslin" . SPARSER::PROTEIN)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("Chk1-Dbf4" . SPARSER::COLLECTION)
    ("Chk1 and HU-" . SPARSER::COLLECTION) ("Dbf4-Cdc7" . SPARSER::COLLECTION)
    ("HU-" . SPARSER::DRUG)
    ("the DNA topoisomerase II inhibitor etoposide" . SPARSER::DRUG)
    ("Stress-activated Chk1" . SPARSER::PROTEIN)
    ("genotoxins" . SPARSER::MOLECULE) ("APH or BPDE" . SPARSER::COLLECTION)
    ("BPDE" . SPARSER::DRUG)
    ("Cdc45 and the GINS (go-ichi-ni-san) complex" . SPARSER::COLLECTION)
    ("Cyclin E-Cdk2" . SPARSER::COLLECTION) ("CMG" . SPARSER::MOLECULE)
    ("san" . SPARSER::PROTEIN) ("GINS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ddk" . SPARSER::BIO-COMPLEX) ("Mcm" . SPARSER::PROTEIN)
    ("caffeine" . SPARSER::DRUG) ("Genotoxins" . SPARSER::MOLECULE)
    ("the homologous recombination (HR) factors Rad51 and BRCA2"
     . SPARSER::COLLECTION)
    ("stress-activated Chk1" . SPARSER::PROTEIN)
    ("Rad51 and BRCA2" . SPARSER::COLLECTION)
    ("HU or cisplatin" . SPARSER::COLLECTION)
    ("A recently identified chromatin-bound stress-dependent Chk1 target"
     . SPARSER::TARGET-PROTEIN)
    ("cdk1 and cyclin B1" . SPARSER::COLLECTION)
    ("nucleoplasmic Chk1" . SPARSER::PROTEIN)
    ("the total cellular Chk1" . SPARSER::PROTEIN)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinase-activated p90 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Claspin-" . SPARSER::PROTEIN) ("Chk1-Claspin" . SPARSER::COLLECTION)
    ("Claspin and Poly(ADP-ribose) polymerase" . SPARSER::COLLECTION)
    ("ATRIP and the 9-1-1 clamp" . SPARSER::COLLECTION)
    ("TopBP1-ATR" . SPARSER::COLLECTION) ("Rad17/RFC" . SPARSER::COLLECTION)
    ("Rad9-Hus1-Rad1" . SPARSER::COLLECTION)
    ("the BRCT-containing protein DNA topoisomerase II binding protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SSBs" . SPARSER::PROTEIN) ("ATRIP-RPA" . SPARSER::COLLECTION)
    ("ATR-ATRIP" . SPARSER::COLLECTION)
    ("ATR-interacting protein (ATRIP)" . SPARSER::PROTEIN)
    ("a stable heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("ATRIP" . SPARSER::PROTEIN) ("RPA-ssDNA" . SPARSER::COLLECTION)
    ("protein A (RPA)" . SPARSER::PROTEIN)
    ("excessive ssDNA" . SPARSER::PROTEIN)
    ("helicase-polymerase" . SPARSER::COLLECTION)
    ("the parental DNA" . SPARSER::DNA) ("RFC" . SPARSER::PROTEIN)
    ("Chk1 and DNA-lesion" . SPARSER::COLLECTION) ("DNA-lesion" . SPARSER::DNA)
    ("PPM1D" . SPARSER::PROTEIN) ("Wip1" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN) ("PP2C" . SPARSER::PROTEIN)
    ("CDT2" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("FBX6" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("AZD7762" . SPARSER::DRUG)
    ("GEN1" . SPARSER::PROTEIN) ("Mus81" . SPARSER::PROTEIN)
    ("MAP kinase-activated protein kinase 2" . SPARSER::PROTEIN)
    ("Rad18" . SPARSER::PROTEIN) ("Rad6" . SPARSER::PROTEIN)
    ("Pol η" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("Dbf4" . SPARSER::PROTEIN) ("pre-RC" . SPARSER::BIO-COMPLEX)
    ("APC1" . SPARSER::PROTEIN) ("cdk1" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("Rad1" . SPARSER::PROTEIN) ("Hus1" . SPARSER::PROTEIN)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rad17" . SPARSER::PROTEIN)
    ("SSB1" . SPARSER::PROTEIN) ("ATR-interacting protein" . SPARSER::PROTEIN)
    ("Checkpoint kinase 1" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("this gene and follicular numbers" . SPARSER::COLLECTION)
    ("AMH and AFC" . SPARSER::COLLECTION)
    ("AMH, AFC and ORPI" . SPARSER::COLLECTION)
    ("polymorphism–SNP" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION)
    ("p63, p73 and p53" . SPARSER::COLLECTION) ("AMH" . SPARSER::PROTEIN)
    ("Tp73" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE) ("anti-Mullerian hormone" . SPARSER::PROTEIN)
    ("very aggressive BRAF V600E" . SPARSER::PROTEIN)
    ("BRAF, KRAS and NRAS" . SPARSER::COLLECTION)
    ("bortezomib, lenalidomide and carfilzomib" . SPARSER::COLLECTION)
    ("NRAS or KRAS" . SPARSER::COLLECTION) ("Creatinine" . SPARSER::PROTEIN)
    ("patients 8 and 11 shared one gene (HCFC2) and patients 1 and 8 shared three genes (IQSEQ3, PCMTD1, PNRC2)"
     . SPARSER::COLLECTION)
    ("Patients 1 and 11 shared one gene (ATXN1), patients 8 and 11 shared one gene (HCFC2) and patients 1 and 8 shared three genes (IQSEQ3, PCMTD1, PNRC2)"
     . SPARSER::COLLECTION)
    ("BRAF/KRAS" . SPARSER::COLLECTION) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("BRAF, NRAS and KRAS" . SPARSER::COLLECTION)
    ("the small-molecular BRAF V600E inhibitor vemurafenib" . SPARSER::DRUG)
    ("a large mutated cell fraction" . SPARSER::COMPONENT)
    ("alkylators" . SPARSER::MOLECULE) ("PNRC2" . SPARSER::PROTEIN)
    ("PCMTD1" . SPARSER::PROTEIN) ("HCFC2" . SPARSER::PROTEIN)
    ("ATXN1" . SPARSER::PROTEIN) ("A 20 " . SPARSER::PROTEIN)
    ("CD138" . SPARSER::PROTEIN) ("M-protein" . SPARSER::PROTEIN)
    ("MPL, CSF3R , ASXL1 and ZRSR2" . SPARSER::COLLECTION)
    ("Sanger" . SPARSER::PROTEIN)
    ("PMF (E379D) and chronic neutrophilic leukemia (E398D)"
     . SPARSER::COLLECTION)
    ("chronic neutrophilic leukemia" . SPARSER::PROTEIN)
    ("not detected using Sanger" . SPARSER::PROTEIN)
    ("CALR and JAK2 V617F" . SPARSER::COLLECTION)
    ("JAK2 and MPL" . SPARSER::COLLECTION) ("The latter p" . SPARSER::PROTEIN)
    ("a single amino acid of glutamic acid" . SPARSER::AMINO-ACID)
    ("distinct melting" . SPARSER::DRUG)
    ("JAK2 , CALR and MPL" . SPARSER::COLLECTION) ("pGEM" . SPARSER::MOLECULE)
    ("DNAs" . SPARSER::DNA) ("HRMA and Sanger" . SPARSER::COLLECTION)
    ("HRMA" . SPARSER::PROTEIN) ("BCL-ABL1" . SPARSER::PROTEIN-PAIR)
    ("MPL" . SPARSER::PROTEIN) ("CALR" . SPARSER::PROTEIN)
    ("calreticulin" . SPARSER::PROTEIN) ("PMF" . SPARSER::PROTEIN)
    ("ZRSR2" . SPARSER::PROTEIN) ("ASXL1" . SPARSER::PROTEIN)
    ("CSF3R" . SPARSER::PROTEIN) ("PARP-1/HMGB1" . SPARSER::COLLECTION)
    ("PARP-1 and ICAM-1" . SPARSER::COLLECTION)
    ("nitric oxide synthase, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1"
     . SPARSER::COLLECTION)
    ("JNK and NF-κB" . SPARSER::COLLECTION)
    ("nicotinamide and ADP-ribose" . SPARSER::COLLECTION)
    ("polymers" . SPARSER::MOLECULE) ("HSS" . SPARSER::PROTEIN)
    ("PECAM-1/PARP-1/HMGB1" . SPARSER::COLLECTION)
    ("PECAM-1 and PARP-1" . SPARSER::COLLECTION)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION) ("LSS" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("High mobility group box 1" . SPARSER::PROTEIN)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("CEA and CA19–9" . SPARSER::COLLECTION)
    ("CEA, CA19–9 and beta-HCG" . SPARSER::COLLECTION)
    ("Adjuvant" . SPARSER::DRUG) ("a pivotal kinase" . SPARSER::KINASE)
    ("adequate cohort" . SPARSER::MOLECULE)
    ("CRP or fibrinogen" . SPARSER::COLLECTION)
    ("a polymerized form" . SPARSER::FORM)
    ("soluble total Hsp27 and phospho-Hsp27" . SPARSER::COLLECTION)
    ("a relevant inducer" . SPARSER::PROTEIN)
    ("stage II and III primary CRC" . SPARSER::PROTEIN)
    ("the low, intermediate and high stromal Hsp27 or α-SMA"
     . SPARSER::COLLECTION)
    ("Hsp27 or α-SMA" . SPARSER::COLLECTION)
    ("primary colon cancer" . SPARSER::PROTEIN) ("FAP" . SPARSER::PROTEIN)
    ("a well-defined study cohort" . SPARSER::MOLECULE)
    ("their stromal Hsp27" . SPARSER::PROTEIN)
    ("CRP and fibrinogen" . SPARSER::COLLECTION)
    ("stromal Hsp27" . SPARSER::PROTEIN)
    ("a proangiogenic cytokine" . SPARSER::PROTEIN)
    ("Hsp27 and phospho-Hsp27" . SPARSER::COLLECTION)
    ("soluble Hsp27" . SPARSER::PROTEIN) ("Soluble Hsp27" . SPARSER::PROTEIN)
    ("stromal Hsp27 and α-SMA" . SPARSER::COLLECTION)
    ("extensive stromal Hsp27 stromal Hsp27 and α-SMA" . SPARSER::COLLECTION)
    ("neither α-SMA nor Hsp27" . SPARSER::COLLECTION)
    ("Stromal Hsp27" . SPARSER::PROTEIN)
    ("strong Hsp27 and α-SMA" . SPARSER::COLLECTION)
    ("Hsp27 and α-SMA" . SPARSER::COLLECTION)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("α-SMA and vimentin" . SPARSER::COLLECTION)
    ("the stromal Hsp27" . SPARSER::PROTEIN)
    ("Hsp27 and vimentin" . SPARSER::COLLECTION)
    ("cellular and secreted Hsp27" . SPARSER::PROTEIN)
    ("extracellular Hsp27" . SPARSER::PROTEIN)
    ("VEGF and interleukin-8" . SPARSER::COLLECTION)
    ("p38-MAPK" . SPARSER::COLLECTION) ("palladin" . SPARSER::PROTEIN)
    ("α-SMA and Hsp27" . SPARSER::COLLECTION)
    ("Hsp27 and αSMA" . SPARSER::COLLECTION)
    ("Strong stromal Hsp27" . SPARSER::PROTEIN)
    ("alpha-SMA ( P <0.001) and vimentin ( P <0.001)" . SPARSER::COLLECTION)
    ("PM" . SPARSER::PROTEIN)
    ("phospho-Hsp27 and total Hsp27" . SPARSER::COLLECTION)
    ("alpha-SMA, CD31, Hsp27 and vimentin" . SPARSER::COLLECTION)
    ("PMs" . SPARSER::PROTEIN) ("OGX-427" . SPARSER::DRUG)
    ("ETS1" . SPARSER::PROTEIN) ("angiopoietin-2" . SPARSER::PROTEIN)
    ("heat-shock protein" . SPARSER::PROTEIN)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("NfκB" . SPARSER::PROTEIN) ("heat-shock protein 27" . SPARSER::PROTEIN)
    ("αSMA" . SPARSER::PROTEIN) ("alpha-SMA" . SPARSER::PROTEIN)
    ("Heat-shock protein 27" . SPARSER::PROTEIN)
    ("BRCA1-PALB2-BRCA2" . SPARSER::COLLECTION)
    ("smoke and alcohol" . SPARSER::COLLECTION)
    ("the most probable candidate driver gene" . SPARSER::GENE)
    ("an alternate susceptibility gene" . SPARSER::GENE)
    ("a plausible candidate gene" . SPARSER::GENE)
    ("the rs10849605 variant and the RAD52 /12p13.33 locus"
     . SPARSER::COLLECTION)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a helical nucleoprotein filament" . SPARSER::PROTEIN-FAMILY)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("-eQTL" . SPARSER::COLLECTION) ("eQTL" . SPARSER::PROTEIN)
    ("a common intronic variant" . SPARSER::VARIANT) ("p13" . SPARSER::PROTEIN)
    ("isosteric ligands" . SPARSER::LIGAND)
    ("the macrocyclic depsipeptide inhibitor Largazole and its amide"
     . SPARSER::COLLECTION)
    ("the macrocyclic depsipeptide inhibitor Largazole" . SPARSER::PROTEIN)
    ("hydroxamate" . SPARSER::MOLECULE)
    ("Largazole and related depsipeptide inhibitors" . SPARSER::COLLECTION)
    ("- 1" . SPARSER::PROTEIN)
    ("substrates and inhibitors" . SPARSER::COLLECTION)
    ("substrates or inhibitors" . SPARSER::COLLECTION)
    ("ligands, and residues" . SPARSER::COLLECTION)
    ("structurally-similar ligands" . SPARSER::LIGAND)
    ("the anticlinal thiol side chain conformation"
     . SPARSER::BIO-CONFORMATION)
    ("macrocyclic thiols" . SPARSER::MOLECULE)
    ("antiperiplanar conformations" . SPARSER::BIO-CONFORMATION)
    ("Largazole and its derivatives" . SPARSER::COLLECTION)
    ("macrocycles" . SPARSER::MOLECULE)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("the macrocyclic depsipeptide" . SPARSER::DRUG)
    ("Monomer" . SPARSER::MONOMER)
    ("the newly-introduced pyridine ring" . SPARSER::MOLECULE)
    ("the macrocyclic peptide" . SPARSER::PEPTIDE)
    ("Solvent" . SPARSER::MOLECULE)
    ("the macrocycle conformations of Largazole and 1" . SPARSER::COLLECTION)
    ("a planar conformation" . SPARSER::BIO-CONFORMATION)
    ("The higher energetic barrier" . SPARSER::PROTEIN)
    ("the ester and 180" . SPARSER::COLLECTION) ("–ligand" . SPARSER::LIGAND)
    ("– 1" . SPARSER::PROTEIN) ("HDAC8-Largazole" . SPARSER::COLLECTION)
    ("-oxazole" . SPARSER::MOLECULE) ("oxazole" . SPARSER::MOLECULE)
    ("Largazole and Romidepsin" . SPARSER::COLLECTION)
    ("thiolate" . SPARSER::MOLECULE)
    ("either Zn 2+ and/or Fe 2+  in vivo" . SPARSER::COLLECTION)
    ("Istodax" . SPARSER::DRUG) ("Zolinza" . SPARSER::DRUG)
    ("macrocyclic inhibitors" . SPARSER::INHIBITOR)
    ("a 6-membered pyridine ring" . SPARSER::MOLECULE)
    ("macrocycle" . SPARSER::MOLECULE) ("Largazole" . SPARSER::PROTEIN)
    ("HDAC8–Largazole" . SPARSER::COLLECTION)
    ("a macrocyclic depsipeptide" . SPARSER::DRUG)
    ("Romidepsin" . SPARSER::DRUG) ("depsipeptide" . SPARSER::DRUG)
    ("HDAC– 1" . SPARSER::PROTEIN) ("L31" . SPARSER::PROTEIN)
    ("thiolate anion" . SPARSER::MOLECULE) ("K33" . SPARSER::PROTEIN)
    ("L14" . SPARSER::PROTEIN) ("P91" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("PEG 3" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("pyridine ring" . SPARSER::MOLECULE) ("Zn 2+" . SPARSER::MOLECULE)
    ("very few mitochondria" . SPARSER::PROTEIN) ("Myeloid" . SPARSER::PROTEIN)
    ("lymphoid and myeloid" . SPARSER::COLLECTION) ("MTG" . SPARSER::PROTEIN)
    ("SIRT7 and canonical UPR mt genes" . SPARSER::COLLECTION)
    ("mitochondrial chaperones" . SPARSER::PROTEIN)
    ("Nutrient" . SPARSER::MOLECULE)
    ("mitochondrial ribosomal proteins" . SPARSER::PROTEIN)
    ("the proximal promoters" . SPARSER::PROMOTER) ("mTFs" . SPARSER::PROTEIN)
    ("Flag-SIRT7" . SPARSER::COLLECTION)
    ("SIRT7 and NRF1" . SPARSER::COLLECTION)
    ("ornithine transcarbamylase" . SPARSER::PROTEIN)
    ("citrate synthase" . SPARSER::PROTEIN) ("RPS20" . SPARSER::PROTEIN)
    ("nuclear respiratory factor 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase/AKT" . SPARSER::COLLECTION)
    ("platinum and 5-FU" . SPARSER::COLLECTION) ("MVP" . SPARSER::PROTEIN)
    ("the multidrug resistance gene MDR1 and the multidrug resistance-associated protein [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("tamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("a rectal cancer-associated oncogene" . SPARSER::ONCOGENE)
    ("only weak YB-1" . SPARSER::PROTEIN)
    ("p53 and repressor" . SPARSER::COLLECTION)
    ("the most evolutionarily conserved nucleic acid-binding protein"
     . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein" . SPARSER::PROTEIN)
    ("vasohibin-1" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("Y-box binding protein-1" . SPARSER::PROTEIN)
    ("p53 and SREBF1" . SPARSER::COLLECTION)
    ("lipogenic genes" . SPARSER::GENE) ("SCD and FASN" . SPARSER::COLLECTION)
    ("another key lipogenic enzyme" . SPARSER::ENZYME)
    ("FASN and SREBF1" . SPARSER::COLLECTION) ("CGIs" . SPARSER::PROTEIN)
    ("CGI" . SPARSER::PROTEIN) ("p53-CGI" . SPARSER::PROTEIN-PAIR)
    ("p53-cofactors" . SPARSER::COLLECTION)
    ("global chromatin" . SPARSER::PROTEIN)
    ("the RIS (6148 CGI-peaks) and pApo (6566 CGI-peaks)"
     . SPARSER::COLLECTION)
    ("genome-wide mapping" . SPARSER::PROTEIN)
    ("p53 and Scd1" . SPARSER::COLLECTION) ("P48-cre" . SPARSER::COLLECTION)
    ("Pdx1-cre" . SPARSER::COLLECTION) ("KP" . SPARSER::PROTEIN)
    ("lox" . SPARSER::PROTEIN) ("mPDA" . SPARSER::PROTEIN)
    ("hyperactive RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oleate and palmitoleate" . SPARSER::COLLECTION)
    ("palmitoleate" . SPARSER::MOLECULE) ("oleate" . SPARSER::MOLECULE)
    ("PPARs" . SPARSER::PROTEIN)
    ("clinically relevant p53 putative targets" . SPARSER::TARGET-PROTEIN)
    ("the lipogenic enzyme SCD" . SPARSER::PROTEIN)
    ("RIS, pApo, and cancer" . SPARSER::COLLECTION)
    ("acute DNA" . SPARSER::DNA)
    ("distinct p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biochemical complexes" . SPARSER::BIO-COMPLEX)
    ("acute lymphocytic leukemia (ALL)" . SPARSER::PROTEIN)
    ("ANKRA2 and HSPA4L" . SPARSER::COLLECTION)
    ("Chronic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and CGI" . SPARSER::COLLECTION)
    ("introns, exons or up-stream" . SPARSER::COLLECTION)
    ("RIS and pApo" . SPARSER::COLLECTION)
    ("RIS or pApo" . SPARSER::COLLECTION)
    ("the ‘immortalizing’ adenoviral oncoprotein" . SPARSER::PROTEIN)
    ("RIS" . SPARSER::PROTEIN) ("p21 and MDM2" . SPARSER::COLLECTION)
    ("proteins and p16" . SPARSER::COLLECTION)
    ("acute p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the classical DDR" . SPARSER::PROTEIN)
    ("genome-wide p53 mapping" . SPARSER::PROTEIN)
    ("new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a stress-responsive transcription factor (TF)" . SPARSER::PROTEIN)
    ("pro-apoptotic states" . SPARSER::BIO-STATE)
    ("genome-wide p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a frequently mutated tumour suppressor" . SPARSER::SUPPRESSOR)
    ("chronic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cancer-associated lipogenic enzyme" . SPARSER::ENZYME)
    ("SCD" . SPARSER::PROTEIN) ("p53 and many p53" . SPARSER::COLLECTION)
    ("‘chronic’ p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SESN1" . SPARSER::PROTEIN) ("HS4" . SPARSER::PROTEIN)
    ("RASV12" . SPARSER::DRUG) ("SREBF1" . SPARSER::PROTEIN)
    ("malic enzyme 2" . SPARSER::PROTEIN) ("P48" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("Scd1" . SPARSER::PROTEIN)
    ("putative)" . SPARSER::PROTEIN) ("HSPA4L" . SPARSER::PROTEIN)
    ("ANKRA2" . SPARSER::PROTEIN) ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("the global trans regulator" . SPARSER::REGULATOR)
    ("pro-apoptotic genes Noxa and Bax" . SPARSER::COLLECTION)
    ("Mcl1, Stat3 and Atf2" . SPARSER::COLLECTION) ("Atf2" . SPARSER::PROTEIN)
    ("Gas5" . SPARSER::PROTEIN) ("UVB radiation-induced DNA" . SPARSER::DNA)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("flox and K5Cre" . SPARSER::COLLECTION)
    ("the pro-apopotic factors Noxa and Bax" . SPARSER::COLLECTION)
    ("Noxa and Bax" . SPARSER::COLLECTION)
    ("lincRNA-p21-depleted keratinocytes" . SPARSER::PROTEIN)
    ("doxorubicin-treated MEFs" . SPARSER::PROTEIN) ("MED" . SPARSER::PROTEIN)
    ("p53 protein and its target gene" . SPARSER::COLLECTION)
    ("Balb/MK2" . SPARSER::COLLECTION)
    ("a long intergenic non-coding RNA" . SPARSER::RNA)
    ("possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("LncRNAs" . SPARSER::RNA) ("lincRNA" . SPARSER::RNA)
    ("p53 and HIF-1α" . SPARSER::COLLECTION) ("LincRNA" . SPARSER::RNA)
    ("ATF2" . SPARSER::PROTEIN) ("MEG3" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("keratin 5" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and SERCA" . SPARSER::COLLECTION)
    ("mitochondrial calcium uniporter (MCU)" . SPARSER::PROTEIN)
    ("BAPTA" . SPARSER::MOLECULE)
    ("the ratiometric Ca 2+" . SPARSER::CALCIUM-ION)
    ("Fura-2" . SPARSER::COLLECTION) ("photosensitizer" . SPARSER::DRUG)
    ("p53-overexpressing human cervical carcinoma HeLa cells and Trp53  −/− MEFs"
     . SPARSER::PROTEIN)
    ("ER and mitochondria" . SPARSER::COLLECTION)
    ("doxorubicin or hydrogen peroxide" . SPARSER::COLLECTION)
    ("BAX, BCL-2 and BCL-X" . SPARSER::COLLECTION)
    ("mitochondrial calcium uniporter" . SPARSER::PROTEIN)
    ("α -amanitin" . SPARSER::MOLECULE)
    ("purinergic receptor" . SPARSER::PROTEIN) ("ATP2A" . SPARSER::PROTEIN)
    ("fast twitch 1" . SPARSER::PROTEIN) ("cardiac muscle" . SPARSER::PROTEIN)
    ("Ca++ transporting" . SPARSER::PROTEIN)
    ("MDM2 proto-oncogene" . SPARSER::PROTEIN)
    ("an attractive anticancer target and midostaurin" . SPARSER::COLLECTION)
    ("target and midostaurin" . SPARSER::COLLECTION)
    ("quinazoline" . SPARSER::MOLECULE)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("midostaurin and gefitinib" . SPARSER::COLLECTION)
    ("a previously known inhibitor of EGFR and its co-crystal structure"
     . SPARSER::COLLECTION)
    ("a previously known inhibitor" . SPARSER::INHIBITOR)
    ("cation" . SPARSER::MOLECULE)
    ("midostaurin, enzastaurin and gefitinib" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN) ("LXR/RXR" . SPARSER::COLLECTION)
    ("LXR" . SPARSER::PROTEIN) ("KC-associated genes" . SPARSER::GENE)
    ("Identified differentially expressed genes" . SPARSER::GENE)
    ("an optimized conformation and relative orientation"
     . SPARSER::COLLECTION)
    ("protein and ligand" . SPARSER::COLLECTION)
    ("GSK3β and AKT" . SPARSER::COLLECTION)
    ("PKCβ and AKT" . SPARSER::COLLECTION)
    ("bisindolylmaleimide" . SPARSER::DRUG) ("Enzastaurin" . SPARSER::DRUG)
    ("bacterial staurosporine" . SPARSER::DRUG)
    ("alkaloid" . SPARSER::MOLECULE) ("Midostaurin" . SPARSER::DRUG)
    ("PKIs" . SPARSER::PROTEIN-FAMILY) ("EGFR and S100A" . SPARSER::COLLECTION)
    ("therapeutic biomarker" . SPARSER::MOLECULE)
    ("heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("midostaurin, enzastaurin, and gefitinib" . SPARSER::COLLECTION)
    ("enzastaurin" . SPARSER::DRUG) ("rational drug" . SPARSER::DRUG)
    ("Molecules" . SPARSER::MOLECULE)
    ("attractive anticancer targets and midostaurin" . SPARSER::COLLECTION)
    ("targets and midostaurin" . SPARSER::COLLECTION)
    ("midostaurin" . SPARSER::DRUG)
    ("potential therapeutic biomarkers" . SPARSER::MOLECULE)
    ("S100A8 and EGFR" . SPARSER::COLLECTION)
    ("proinflammatory S100A8" . SPARSER::PROTEIN)
    ("S100A8 and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("non-selective" . SPARSER::PROTEIN) ("EF-hand" . SPARSER::PROTEIN-FAMILY)
    ("GS2" . SPARSER::PROTEIN) ("anti—VEGF" . SPARSER::DRUG)
    ("PKCβ" . SPARSER::PROTEIN) ("PKC412" . SPARSER::DRUG)
    ("S100A" . SPARSER::PROTEIN) ("S100A8/A9" . SPARSER::PROTEIN)
    ("S100A9" . SPARSER::PROTEIN) ("S100A8" . SPARSER::PROTEIN)
    ("HBsAg" . SPARSER::DRUG)
    ("a well-designed prospective cohort" . SPARSER::MOLECULE)
    ("Flucloxacillin" . SPARSER::MOLECULE) ("APAP" . SPARSER::DRUG)
    ("IL-6 and HSP70" . SPARSER::COLLECTION)
    ("proteins (HSP)" . SPARSER::PROTEIN)
    ("ECG and hepatitis viral proteins [ xref ]" . SPARSER::COLLECTION)
    ("hepatitis viral proteins" . SPARSER::PROTEIN) ("ECG" . SPARSER::DRUG)
    ("European descent found STAT4 (rs7574865) polymorphism"
     . SPARSER::PROTEIN)
    ("at least part" . SPARSER::COMPONENT)
    ("HSP70, Bcl-2, Bcl-xL, Mcl-1, FLIP, Ref-1, cyclin D1 and c-myc"
     . SPARSER::COLLECTION)
    ("FLIP" . SPARSER::PROTEIN) ("Dimerized STAT3" . SPARSER::PROTEIN)
    ("its soluble receptor" . SPARSER::RECEPTOR)
    ("-STAT3" . SPARSER::COLLECTION) ("sIL" . SPARSER::PROTEIN)
    ("IL-4, IL-6, IL-10 and TNF-" . SPARSER::COLLECTION)
    ("a vital transcription factor" . SPARSER::PROTEIN)
    ("aminotransferase" . SPARSER::PROTEIN) ("acetaminophen" . SPARSER::DRUG)
    ("transaminase" . SPARSER::PROTEIN)
    ("IL-6 and HSPA1L" . SPARSER::COLLECTION) ("AAT" . SPARSER::PROTEIN)
    ("IL-6 and three SNPs" . SPARSER::COLLECTION)
    ("IL-6 and STAT3" . SPARSER::COLLECTION) ("bilirubin" . SPARSER::MOLECULE)
    ("flucloxacillin" . SPARSER::MOLECULE) ("tacrine" . SPARSER::DRUG)
    ("IL-10–592 AA and IL-10–819 TT genotypes" . SPARSER::COLLECTION)
    ("TNF-" . SPARSER::PROTEIN) ("IL-10 and IL-4" . SPARSER::COLLECTION)
    ("diclofenac" . SPARSER::DRUG) ("isoniazid (INH)" . SPARSER::DRUG)
    ("EMB" . SPARSER::PROTEIN) ("RIF" . SPARSER::PROTEIN)
    ("rifampicin" . SPARSER::MOLECULE) ("isoniazid" . SPARSER::DRUG)
    ("GAT and AGC" . SPARSER::COLLECTION)
    ("STAT3 (rs1053004, rs1053023, rs1053005) and HSPA1L (rs2227956)"
     . SPARSER::COLLECTION)
    ("IL-6, STAT3 and HSPA1L" . SPARSER::COLLECTION)
    ("STAT4" . SPARSER::PROTEIN) ("Ref-1" . SPARSER::PROTEIN)
    ("Concanavalin A" . SPARSER::DRUG) ("70kD" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN) ("HSPA1L" . SPARSER::PROTEIN)
    ("SCA" . SPARSER::PROTEIN) ("PAI" . SPARSER::PROTEIN)
    ("AG and GG genotypes" . SPARSER::COLLECTION)
    ("PAI-1 or the mRNA" . SPARSER::COLLECTION)
    ("A allele and AA genotype" . SPARSER::COLLECTION)
    ("protein [ xref , xref , xref , xref ] and mRNA [ xref ]"
     . SPARSER::COLLECTION)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("American" . SPARSER::PROTEIN) ("Cardiac biomarkers" . SPARSER::MOLECULE)
    ("hyperglycemic states" . SPARSER::BIO-STATE)
    ("tPA and uPA" . SPARSER::COLLECTION) ("HBP" . SPARSER::PROTEIN)
    ("Allele and genotype frequencies" . SPARSER::COLLECTION)
    ("Afro-American" . SPARSER::PROTEIN-PAIR) ("Afro" . SPARSER::PROTEIN)
    ("atorvastatin" . SPARSER::DRUG) ("statins" . SPARSER::DRUG)
    ("clopidogrel" . SPARSER::DRUG) ("plasmatic glucose" . SPARSER::PROTEIN)
    ("creatine" . SPARSER::PROTEIN) ("troponin" . SPARSER::PROTEIN)
    ("the principal inhibitor" . SPARSER::INHIBITOR)
    ("a fibrinolytic inhibitor" . SPARSER::INHIBITOR)
    ("acute myocardial ischemia" . SPARSER::PROTEIN)
    ("A allele and AA genotype of -844 polymorphism" . SPARSER::COLLECTION)
    ("A allele (OR = 1.27, P = 0.04) and AA genotype (OR = 1.86, P = 0.02)"
     . SPARSER::COLLECTION)
    ("Prothrombotic and proinflammatory states" . SPARSER::BIO-STATE)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("Dominant and recessive" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("Interleukin" . SPARSER::PROTEIN)
    ("ZO-1, occludin, or claudin-5" . SPARSER::COLLECTION)
    ("PKCε and p-PKCε" . SPARSER::COLLECTION)
    ("claudin-5, occludin, and ZO-1" . SPARSER::COLLECTION)
    ("bradykinin" . SPARSER::BRADYKININ)
    ("occludin, claudin-5, and F-actin" . SPARSER::COLLECTION)
    ("occludin and claudin-5" . SPARSER::COLLECTION)
    ("ZO-1, and occludin" . SPARSER::COLLECTION)
    ("p-PKCε/PKCε" . SPARSER::COLLECTION)
    ("the miR-34a (+) NC + PKCε (+) NC and miR-34a (–) NC + PKCε (–) NC"
     . SPARSER::PROTEIN)
    ("wt and miR-34a" . SPARSER::COLLECTION)
    ("NC and PKCε" . SPARSER::COLLECTION)
    ("mut and miR-34a" . SPARSER::COLLECTION)
    ("PKCε (PKCε wt) and a mutant-type 3" . SPARSER::COLLECTION)
    ("PKCε in ECs and GECs" . SPARSER::COLLECTION)
    ("NC, and miR-34a" . SPARSER::COLLECTION)
    ("ZO-1 and occludin" . SPARSER::COLLECTION)
    ("ZO-1, occludin, and claudin-5" . SPARSER::COLLECTION)
    ("the miR-34a (+) NC and miR-34a (–) NC" . SPARSER::PROTEIN)
    ("NC and miR-34a" . SPARSER::COLLECTION)
    ("c-Met, Notch-1, Notch-2, and CDK6" . SPARSER::COLLECTION)
    ("miR-34a, b, and c" . SPARSER::COLLECTION)
    ("miR-34a and PKCε" . SPARSER::COLLECTION) ("p-PKCε" . SPARSER::COLLECTION)
    ("kinase–like" . SPARSER::PROTEIN-FAMILY) ("claudin-5" . SPARSER::PROTEIN)
    ("Notch-2" . SPARSER::PROTEIN) ("MiR-34a" . SPARSER::MOLECULE)
    ("1-2" . SPARSER::PROTEIN) ("PKCε" . SPARSER::PROTEIN)
    ("deacetylases or histone" . SPARSER::COLLECTION)
    ("antiestrogens" . SPARSER::DRUG) ("Fulvestrant" . SPARSER::DRUG)
    ("RNAPII and H2Bub1" . SPARSER::COLLECTION)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("histones and chromatin" . SPARSER::COLLECTION)
    ("transcription factor and co-factor" . SPARSER::COLLECTION)
    ("BRD4-regulated genes [ xref ] as well as genes" . SPARSER::COLLECTION)
    ("enhancers and transcriptional elongation" . SPARSER::COLLECTION)
    ("RNAPII and co-transcriptional" . SPARSER::COLLECTION)
    ("our previously published RNA" . SPARSER::RNA)
    ("ERα, FOXA1, BRD4 and H3K27ac" . SPARSER::COLLECTION)
    ("BRD4 and RNAPII" . SPARSER::COLLECTION)
    ("H4K12ac around EREs" . SPARSER::PROTEIN)
    ("H3K27ac, BRD4 and ERα" . SPARSER::COLLECTION)
    ("FOXA1 and BRD4" . SPARSER::COLLECTION)
    ("BRD4 and H3K27ac" . SPARSER::COLLECTION)
    ("distal ERα-bound enhancers" . SPARSER::PROTEIN)
    ("ERα, FOXA1 and H3K27ac" . SPARSER::COLLECTION)
    ("distal EREs" . SPARSER::PROTEIN)
    ("ERα- and FOXA1-bound enhancers" . SPARSER::COLLECTION)
    ("CDK9 and BRD4" . SPARSER::COLLECTION) ("PSer" . SPARSER::PROTEIN)
    ("RNA polymerase (RNAPII) as well as subunits" . SPARSER::COLLECTION)
    ("Elongation Factor (NELF)" . SPARSER::PROTEIN)
    ("polymerase (RNAPII)" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("DSIF" . SPARSER::PROTEIN) ("NELF" . SPARSER::PROTEIN)
    ("Elongation Factor-b" . SPARSER::COLLECTION)
    ("extraterminal (BET) domain protein family" . SPARSER::PROTEIN-FAMILY)
    ("bromo-" . SPARSER::MOLECULE) ("BET" . SPARSER::PROTEIN)
    ("bromo" . SPARSER::MOLECULE)
    ("p300/CBP-associated factor (PCAF)" . SPARSER::PROTEIN)
    ("SRC1/NCOA1" . SPARSER::COLLECTION) ("17 β-estradiol" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("RNF20" . SPARSER::PROTEIN)
    ("Elongation Factor" . SPARSER::PROTEIN)
    ("Cyclin-Dependent Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K5" . SPARSER::PROTEIN) ("protein-4" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("NCOA1" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("BRD4" . SPARSER::PROTEIN)
    ("bromodomain-containing protein" . SPARSER::PROTEIN)
    ("Bim and PKM2" . SPARSER::COLLECTION)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION) ("Gao" . SPARSER::PROTEIN)
    ("Bim/PKM2" . SPARSER::COLLECTION)
    ("Bak, Mcl-1, Bad and Bid" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("Caspase 9 and Caspase 3" . SPARSER::COLLECTION)
    ("58 (93.1%) primary HCC" . SPARSER::PROTEIN) ("MOMP" . SPARSER::PROTEIN)
    ("pyruvate and ATP" . SPARSER::COLLECTION) ("PEP" . SPARSER::DRUG)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("PKM2 and Bim" . SPARSER::COLLECTION) ("Pyruvate" . SPARSER::PROTEIN)
    ("pcDNA 3.1" . SPARSER::PROTEIN) ("TGIF2" . SPARSER::PROTEIN)
    ("Cos-7" . SPARSER::PROTEIN) ("AKT-induced" . SPARSER::PROTEIN)
    ("Spry2" . SPARSER::PROTEIN) ("MEK5" . SPARSER::PROTEIN)
    ("stat3" . SPARSER::PROTEIN) ("α-Fetoprotein" . SPARSER::PROTEIN)
    ("Drg1" . SPARSER::PROTEIN) ("Bub3" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("Cbl-b and P-gp" . SPARSER::COLLECTION)
    ("c-Src/Cav-1" . SPARSER::COLLECTION)
    ("c-Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("VEGFR2 or EGFR" . SPARSER::COLLECTION)
    ("VEGFR2 and EGFR" . SPARSER::COLLECTION)
    ("anti-Cbl-b and anti-P-gp" . SPARSER::COLLECTION)
    ("approximately 100 mm 3" . SPARSER::PROTEIN)
    ("PBS or Dox" . SPARSER::COLLECTION)
    ("Cbl-b/pcDNA3.1" . SPARSER::COLLECTION)
    ("c-Src and Cbl-b" . SPARSER::COLLECTION)
    ("Polyubiquitinated" . SPARSER::PROTEIN)
    ("P-gp/Cav-1" . SPARSER::COLLECTION)
    ("P-gp and Cav-1" . SPARSER::COLLECTION) ("MCF7/Adr" . SPARSER::COLLECTION)
    ("Dox" . SPARSER::PROTEIN)
    ("EGFR and its related signaling molecules" . SPARSER::COLLECTION)
    ("Pgp and MRP1" . SPARSER::COLLECTION) ("Trc8" . SPARSER::PROTEIN)
    ("Pgp" . SPARSER::PROTEIN) ("Cbl" . SPARSER::PROTEIN)
    ("caveolin" . SPARSER::PROTEIN)
    ("anthracyclines, alkaloids and taxanes" . SPARSER::COLLECTION)
    ("Adr" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("c-Src-" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("PS34" . SPARSER::PROTEIN) ("FBXO15" . SPARSER::PROTEIN)
    ("CD109" . SPARSER::PROTEIN) ("Cbl-b" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("conventional Western blot" . SPARSER::PROTEIN)
    ("Skp2 or siRNA" . SPARSER::COLLECTION)
    ("Skp2 and induction p53, p21 Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("p53, p21 Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("Rb, cyclin D1, and Cdk4" . SPARSER::COLLECTION)
    ("Cdk4, cyclin D1, and Rb" . SPARSER::COLLECTION)
    ("total and phosphorylated Rb" . SPARSER::PROTEIN)
    ("Honokiol" . SPARSER::DRUG) ("p21 Cip1 and p53" . SPARSER::COLLECTION)
    ("PC-3 and LNCaP" . SPARSER::COLLECTION) ("honokiol" . SPARSER::DRUG)
    ("E2F1 and phospho-Rb" . SPARSER::COLLECTION)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("cyclin D/Cdk4/Cdk6" . SPARSER::COLLECTION)
    ("NF-κB [ xref ] and Akt1 (Figure xref )" . SPARSER::COLLECTION)
    ("NF-κB and Akt1" . SPARSER::COLLECTION)
    ("ATP and amino acid" . SPARSER::COLLECTION)
    ("phosphor-mTOR" . SPARSER::PROTEIN)
    ("PI3 kinase/Akt" . SPARSER::COLLECTION) ("-Akt" . SPARSER::COLLECTION)
    ("Akt and PDK1" . SPARSER::COLLECTION)
    ("mTOR kinase, its associated protein rector, and SIN1/MIP1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("SIN1/MIP1" . SPARSER::COLLECTION)
    ("Akt1, Akt2, and Akt3" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin H, E2F1, and c-Myc" . SPARSER::COLLECTION)
    ("Cyclin D and Cdk4 or Cdk6" . SPARSER::COLLECTION)
    ("Cdk4 or Cdk6" . SPARSER::COLLECTION)
    ("Cdk4, Rb, and phosphor-Rb" . SPARSER::COLLECTION)
    ("Cdk2 and Akt" . SPARSER::COLLECTION)
    ("Cdk7 and cyclin H" . SPARSER::COLLECTION)
    ("Cdk2 and cyclin" . SPARSER::COLLECTION)
    ("Cdk2-cyclin E" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , p53, and ATF4" . SPARSER::COLLECTION)
    ("p21 Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , and ATF4" . SPARSER::COLLECTION)
    ("Both luminal and basal epithelial cells in normal prostate"
     . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , p57, p130, Tob1, and FoxO1" . SPARSER::COLLECTION)
    ("p53, ATM, and ATR" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , Chk1, and Chk2" . SPARSER::COLLECTION)
    ("Cdk2-Cyclin" . SPARSER::COLLECTION)
    ("active ATM monomers" . SPARSER::MONOMER)
    ("protein (ARF)" . SPARSER::PROTEIN)
    ("LY294002 or ABT737" . SPARSER::COLLECTION)
    ("p27 Kip1 , p21 Cip1 , and p53" . SPARSER::COLLECTION)
    ("p27 Kip1 , p21 Cip1 , or p53" . SPARSER::COLLECTION)
    ("Skp2, Cdk2, and phospho-Cdk2" . SPARSER::COLLECTION)
    ("p27 Kip1 and p21 Cip1" . SPARSER::COLLECTION)
    ("Cdk2 and phospho-Cdk2" . SPARSER::COLLECTION)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("Skp2, c-Myc, or Akt" . SPARSER::COLLECTION)
    ("Skp2, c-Myc, and Akt1" . SPARSER::COLLECTION)
    ("Skp2, p21 Cip1 , p27 Kip1 , and p53" . SPARSER::COLLECTION)
    ("Chk1, Chk2, ATM, and ATR" . SPARSER::COLLECTION)
    ("Bax, CKIIα, and TRIB3" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("Akt, Akt1, Akt2, and phospho-Akt" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin H, and E2F1" . SPARSER::COLLECTION)
    ("fatty acid synthase (FAS)" . SPARSER::PROTEIN)
    ("p53 and p27 Kip1" . SPARSER::COLLECTION)
    ("LC3-II and Beclin" . SPARSER::COLLECTION) ("Beclin" . SPARSER::PROTEIN)
    ("p21 Cip1 , p27 Kip1 , and p53" . SPARSER::COLLECTION)
    ("LNCaP and PC-3" . SPARSER::COLLECTION)
    ("NF-κB and DNA" . SPARSER::COLLECTION)
    ("Caffeic acid phenethyl ester (CAPE)" . SPARSER::MOLECULE)
    ("An androgen-dependent clonal subline" . SPARSER::PROTEIN)
    ("subline" . SPARSER::PROTEIN)
    ("AR and prostate specific antigen (PSA)" . SPARSER::COLLECTION)
    ("Androgen receptor (AR)" . SPARSER::PROTEIN)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("Skp2, p53, p21 Cip1 , and p27 Kip1" . SPARSER::COLLECTION)
    ("LY294002 or Bcl-2" . SPARSER::COLLECTION)
    ("Skp2, or siRNA" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , or p53" . SPARSER::COLLECTION)
    ("Skp2 and Akt1" . SPARSER::COLLECTION) ("phospho-mTOR" . SPARSER::PROTEIN)
    ("caffeic acid phenethyl ester (CAPE)" . SPARSER::MOLECULE)
    ("BCl-2" . SPARSER::PROTEIN) ("NP2" . SPARSER::PROTEIN)
    ("p45" . SPARSER::PROTEIN) ("Cyclin H" . SPARSER::PROTEIN)
    ("F-1" . SPARSER::PROTEIN) ("p90 RSK1" . SPARSER::PROTEIN)
    ("waf1" . SPARSER::PROTEIN) ("triton x-100" . SPARSER::MOLECULE)
    ("MIP1" . SPARSER::PROTEIN) ("SIN1" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("T160" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("Tob1" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("CK2α" . SPARSER::PROTEIN) ("ABT737" . SPARSER::DRUG)
    ("TRIB3" . SPARSER::PROTEIN) ("S6kinase" . SPARSER::PROTEIN-FAMILY)
    ("cyclin H" . SPARSER::PROTEIN) ("Cdk7" . SPARSER::PROTEIN)
    ("PELP1 axis-targeted drugs" . SPARSER::DRUG)
    ("hyperactive ATM" . SPARSER::PROTEIN) ("demethylase" . SPARSER::PROTEIN)
    ("MTp53 and PELP1" . SPARSER::COLLECTION)
    ("MTp53-NF-Y" . SPARSER::COLLECTION)
    ("PELP1, and PELP1" . SPARSER::COLLECTION)
    ("DDR-PELP1-MTp53" . SPARSER::COLLECTION) ("p-PELP1" . SPARSER::COLLECTION)
    ("cdc25c" . SPARSER::PROTEIN) ("mutant (MT)" . SPARSER::MUTANT)
    ("camptothecin and PELP1" . SPARSER::COLLECTION)
    ("DMSO or NCL-1" . SPARSER::COLLECTION)
    ("DMSO or camptothecin" . SPARSER::COLLECTION)
    ("commercial antibodies" . SPARSER::ANTIBODY) ("lys" . SPARSER::PROTEIN)
    ("p73 , Bim , and Noxa" . SPARSER::COLLECTION)
    ("p73 and Bim" . SPARSER::COLLECTION) ("PELP1-siRNA" . SPARSER::COLLECTION)
    ("camptothecin ( xref ) or carboplatin ( xref ) or cisplatin ( xref )"
     . SPARSER::COLLECTION)
    ("carboplatin ( xref ) or cisplatin ( xref )" . SPARSER::COLLECTION)
    ("Cyclin A2 and Cdc25c" . SPARSER::COLLECTION)
    ("Acetyl" . SPARSER::MOLECULE) ("IgG or PELP1" . SPARSER::COLLECTION)
    ("Cdc25c and Cyclin A2" . SPARSER::COLLECTION)
    ("promoters and epigenetic changes" . SPARSER::COLLECTION)
    ("Cyclin A2 , and Cdc25c" . SPARSER::COLLECTION)
    ("Cdc25c" . SPARSER::PROTEIN) ("PELP1-shRNA" . SPARSER::COLLECTION)
    ("Hot" . SPARSER::PROTEIN) ("GFP-MTp53" . SPARSER::COLLECTION)
    ("MTp53" . SPARSER::PROTEIN) ("GFP-TRAP" . SPARSER::COLLECTION)
    ("GST-PELP1" . SPARSER::COLLECTION) ("PELP1–MTp53" . SPARSER::PROTEIN-PAIR)
    ("PELP1 and MTp53" . SPARSER::COLLECTION)
    ("IgG, PELP1, or p53" . SPARSER::COLLECTION)
    ("E2F1, and differentially" . SPARSER::COLLECTION)
    ("kinases (DDR)" . SPARSER::PROTEIN)
    ("E2F1 ( xref ) and p53 ( xref )" . SPARSER::COLLECTION)
    ("ER target genes and therapy resistance ( xref )" . SPARSER::COLLECTION)
    ("Glutamic acid-" . SPARSER::AMINO-ACID) ("Proline-" . SPARSER::AMINO-ACID)
    ("p73, Bim, PUMA, and NOXA" . SPARSER::COLLECTION)
    ("claudin" . SPARSER::PROTEIN) ("anti-estrogen-" . SPARSER::DRUG)
    ("Her2+" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("NCL-1" . SPARSER::PROTEIN) ("LSD1" . SPARSER::PROTEIN)
    ("Set9" . SPARSER::PROTEIN) ("CyclinA2" . SPARSER::PROTEIN)
    ("Glutamic acid" . SPARSER::AMINO-ACID) ("NF-Y" . SPARSER::PROTEIN)
    ("KDM1A" . SPARSER::PROTEIN) ("PELP1" . SPARSER::PROTEIN)
    ("type and stage" . SPARSER::COLLECTION) ("Fong" . SPARSER::PROTEIN)
    ("Koh" . SPARSER::MOLECULE) ("cyclin D1b and DNA" . SPARSER::COLLECTION)
    ("only cells expressing cyclin D1b" . SPARSER::PROTEIN)
    ("KE" . SPARSER::MOLECULE)
    ("Re-plating both the Ccnd1  +/+ and Ccnd1  KI/KI cells (which were co-treated)"
     . SPARSER::COLLECTION)
    ("Re-plating both the Ccnd1  +/+" . SPARSER::PROTEIN)
    ("IR and ABT-888" . SPARSER::COLLECTION)
    ("both Ccnd1  +/+ and Ccnd1  KI/KI cells showed similar proliferative kinetics"
     . SPARSER::COLLECTION)
    ("p-H2AX" . SPARSER::COLLECTION)
    ("p-RB(S780) and cyclin" . SPARSER::COLLECTION)
    ("the proliferative markers p-RB(S780) and cyclin" . SPARSER::COLLECTION)
    ("exclusively expressing cyclin D1a ( Ccnd1  +/+ ) or cyclin D1b ( Ccnd1  KI/KI )"
     . SPARSER::COLLECTION)
    ("CDK and cyclin" . SPARSER::COLLECTION)
    ("cyclin A2 and cyclin B1" . SPARSER::COLLECTION)
    ("a constitutively active promoter" . SPARSER::PROMOTER)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("either cyclin D1a (in Ccnd1  +/+ MAFs +/+-D1a) or cyclin D1b (in Ccnd1  KI/KI MAFs- KI/KI-D1b)"
     . SPARSER::COLLECTION)
    ("the subcutaneous fat" . SPARSER::PROTEIN)
    ("respective cyclin D1 isoforms" . SPARSER::ISOFORM)
    ("cyclin D1a and cyclin D1b" . SPARSER::COLLECTION)
    ("hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("both cyclin D1a (lanes 1, 2) and cyclin D1b (lanes 2, 3)"
     . SPARSER::COLLECTION)
    ("cyclin D1/1b" . SPARSER::COLLECTION)
    ("cyclin D1b and cyclin D1a" . SPARSER::COLLECTION)
    ("wherein all C-terminal-encoding components" . SPARSER::COMPONENT)
    ("a putatively neoplastic-specific isoform" . SPARSER::ISOFORM)
    ("the shorter isoform cyclin D1b" . SPARSER::PROTEIN)
    ("MCL" . SPARSER::PROTEIN) ("IGH" . SPARSER::PROTEIN)
    ("IP 1" . SPARSER::PROTEIN) ("mKi67" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("C-22" . SPARSER::PROTEIN)
    ("Erbb2" . SPARSER::PROTEIN) ("cyclin D1a" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("p-RB" . SPARSER::PROTEIN)
    ("h-Ras" . SPARSER::PROTEIN) ("h-RAS" . SPARSER::PROTEIN)
    ("cyclin D1a " . SPARSER::PROTEIN) ("cyclin D1a" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("cyclin D1b" . SPARSER::PROTEIN)
    ("NFκB as well as several other families" . SPARSER::COLLECTION)
    ("AP-1 and Ets-1" . SPARSER::COLLECTION)
    ("c-jun and ATF-1" . SPARSER::COLLECTION)
    ("AP-1, Sp-1 and Ets-1" . SPARSER::COLLECTION) ("cxcr4" . SPARSER::PROTEIN)
    ("Ptgs2" . SPARSER::PROTEIN) ("CXCL13 and CXCR5" . SPARSER::COLLECTION)
    ("minimal CMV promoter" . SPARSER::PROMOTER)
    ("active and demonstrated" . SPARSER::COLLECTION)
    ("Promoter" . SPARSER::PROMOTER) ("NFκB2 and NFκB3" . SPARSER::COLLECTION)
    ("the main functional antagonists" . SPARSER::MOLECULE)
    ("p53, and p53" . SPARSER::COLLECTION)
    ("the most distal del1" . SPARSER::PROTEIN)
    ("CXCR5-CXCL13" . SPARSER::COLLECTION) ("Si" . SPARSER::PROTEIN)
    ("NFκB and p53" . SPARSER::COLLECTION)
    ("CCR2 and CCR5" . SPARSER::COLLECTION)
    ("CXCL12-CXCR4" . SPARSER::COLLECTION)
    ("CXCL13-CXCR5" . SPARSER::COLLECTION)
    ("CXCR5 and CCR7" . SPARSER::COLLECTION)
    ("lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("cxcr5" . SPARSER::PROTEIN) ("NFATc3" . SPARSER::PROTEIN)
    ("p53-2" . SPARSER::PROTEIN) ("c-jun" . SPARSER::PROTEIN)
    ("Sp-1" . SPARSER::PROTEIN) ("IL11" . SPARSER::PROTEIN)
    ("NFκB2" . SPARSER::PROTEIN) ("del3" . SPARSER::PROTEIN)
    ("del2" . SPARSER::PROTEIN) ("del1" . SPARSER::PROTEIN)
    ("DNase-I" . SPARSER::PROTEIN)
    ("ADP-ribosylation factor 1" . SPARSER::PROTEIN)
    ("AKT-1 kinase" . SPARSER::PROTEIN)
    ("RAC-alpha serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("seven-transmembrane" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("CXCL13" . SPARSER::PROTEIN)
    ("CXCR5" . SPARSER::PROTEIN) ("MSCs and osteoblasts" . SPARSER::COLLECTION)
    ("even Nf1  flox/flox" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("the Periostin promoter and the 2.3kb segment" . SPARSER::COLLECTION)
    ("-Collagen" . SPARSER::COLLECTION) ("Periostin" . SPARSER::PROTEIN)
    ("characteristic NF1" . SPARSER::PROTEIN)
    ("dystrophic and non-dystrophic" . SPARSER::COLLECTION)
    ("NF1 and dystrophic" . SPARSER::COLLECTION)
    ("an absent disc" . SPARSER::BIO-COMPLEX)
    ("segmental NF1" . SPARSER::PROTEIN) ("AF and NP" . SPARSER::COLLECTION)
    ("BFR" . SPARSER::PROTEIN) ("BS" . SPARSER::PROTEIN)
    ("calcein and alizarin" . SPARSER::COLLECTION)
    ("calcein (20 mg/kg) and alizarin" . SPARSER::COLLECTION)
    ("alizarin" . SPARSER::DRUG) ("calcein" . SPARSER::MOLECULE)
    ("fluorochromes" . SPARSER::MOLECULE) ("hunchback" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("Cobb" . SPARSER::PROTEIN)
    ("Dystrophic" . SPARSER::PROTEIN) ("rib" . SPARSER::DRUG)
    ("triphosphatase-activating protein" . SPARSER::COLLECTION)
    ("triphosphatase" . SPARSER::PROTEIN)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("the intervertebral disc (IVD)" . SPARSER::BIO-COMPLEX)
    ("IVD" . SPARSER::PROTEIN) ("disc" . SPARSER::BIO-COMPLEX)
    ("dystrophic" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("Col2a1" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("genoype (GG)" . SPARSER::PROTEIN)
    ("high-density lipoprotein (HDL)" . SPARSER::PROTEIN)
    ("genotype (GG)" . SPARSER::PROTEIN)
    ("this SNP and all genotypes" . SPARSER::COLLECTION)
    ("SIRT1/eNOS" . SPARSER::COLLECTION)
    ("SIRT1 and HDL" . SPARSER::COLLECTION)
    ("either PON-1 (AUC: 0.718 [95% CI 0.653–0.777]) or SIRT1 (AUC: 0.843 [95% CI 0.788–0.889])"
     . SPARSER::COLLECTION)
    ("either PON-1 (AUC: 0.577 [95% CI 0.509–0.642]) or eNOS (AUC: 0.547 [95% CI 0.479–0.613])"
     . SPARSER::COLLECTION)
    ("either PON-1 (AUC: 0.661 [95% CI 0.596–0.721]) or SIRT1 (AUC: 0.558 [95% CI 0.492–0.623])"
     . SPARSER::COLLECTION)
    ("AA and CC" . SPARSER::COLLECTION) ("genotype (CT)" . SPARSER::PROTEIN)
    ("genotype and heterozygote" . SPARSER::COLLECTION)
    ("CT genotype and TT genotype" . SPARSER::COLLECTION)
    ("genotypes and alleles" . SPARSER::COLLECTION)
    ("SIRT1 and PON-1" . SPARSER::COLLECTION)
    ("eNOS and PON-1" . SPARSER::COLLECTION)
    ("SIRT1, eNOS and PON-1" . SPARSER::COLLECTION)
    ("SIRT1 and eNOS" . SPARSER::COLLECTION) ("paraoxonase" . SPARSER::PROTEIN)
    ("a transcription factor and a cofactor" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("introns" . SPARSER::PROTEIN) ("SNP and lifespan" . SPARSER::COLLECTION)
    ("TOS" . SPARSER::PROTEIN) ("famous molecules" . SPARSER::MOLECULE)
    ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("free-radical" . SPARSER::MOLECULE)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("FoxO1a" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("PON-1" . SPARSER::PROTEIN)
    ("p21 , BAX or PUMA" . SPARSER::COLLECTION)
    ("the epigenetically repressive complex" . SPARSER::BIO-COMPLEX)
    ("p21, p27, p14 ARF or p53" . SPARSER::COLLECTION)
    ("p21 and the candidate p53-responsive apoptotic genes BAX and PUMA"
     . SPARSER::COLLECTION)
    ("p14 ARF or ATM" . SPARSER::COLLECTION)
    ("DUSP4 and DUSP7" . SPARSER::COLLECTION) ("Cdk2ap1" . SPARSER::PROTEIN)
    ("CDK2AP1 and p53" . SPARSER::COLLECTION)
    ("CDK2AP1 shRNA2 and exogenous CDK2AP1 (CDK2AP1-shRNA2 + CDK2AP1 ) or HDFs"
     . SPARSER::COLLECTION)
    ("exogenous CDK2AP1 (CDK2AP1-shRNA2 + CDK2AP1 ) or HDFs"
     . SPARSER::COLLECTION)
    ("exogenous CDK2AP1" . SPARSER::PROTEIN)
    ("p53 and CDK2AP1 in" . SPARSER::COLLECTION)
    ("shRNA1 or HDFs" . SPARSER::COLLECTION)
    ("shRNA2 and p53" . SPARSER::COLLECTION)
    ("p53 , p21 , BAX and PUMA" . SPARSER::COLLECTION)
    ("CDK2AP1 , p53 , p21 , BAX and PUMA" . SPARSER::COLLECTION)
    ("Nucleosome" . SPARSER::BIO-COMPLEX)
    ("candidate p53-responsive apoptotic genes" . SPARSER::GENE)
    ("BAX and PUMA" . SPARSER::COLLECTION)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("shRNA2" . SPARSER::PROTEIN) ("shRNA1" . SPARSER::PROTEIN)
    ("CDK2AP1-shRNA2" . SPARSER::COLLECTION)
    ("CDK2AP1-shRNA1" . SPARSER::COLLECTION)
    ("CDK2AP1 shRNA2" . SPARSER::PROTEIN)
    ("SMADs and CDK2AP1" . SPARSER::COLLECTION)
    ("CDK2AP1 and p21" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("DNA polymerase-alpha-primase" . SPARSER::COLLECTION)
    ("DNA polymerase/alpha-primase" . SPARSER::COLLECTION)
    ("primase" . SPARSER::PROTEIN) ("monomeric CDK2" . SPARSER::PROTEIN)
    ("p53 and CDK2AP1" . SPARSER::COLLECTION)
    ("p21 , BAX and PUMA" . SPARSER::COLLECTION)
    ("p53 , p21 , BAX and PUMA and p53" . SPARSER::COLLECTION)
    ("PUMA and p53" . SPARSER::COLLECTION)
    ("sequestering monomeric CDK2" . SPARSER::PROTEIN)
    ("DUSP7" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("P14 ARF" . SPARSER::PROTEIN) ("p14 ARF" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN) ("CDK2AP1" . SPARSER::PROTEIN)
    ("Protein-1" . SPARSER::PROTEIN)
    ("Cyclin Dependent Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F1, NFκB, HIF1α, and AR" . SPARSER::COLLECTION)
    ("NPM1, NCL, and DDX5" . SPARSER::COLLECTION) ("NCL" . SPARSER::PROTEIN)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("specifically some senescence pathway genes" . SPARSER::GENE)
    ("EFS" . SPARSER::PROTEIN) ("Macrophage" . SPARSER::PROTEIN)
    ("genes (SEG)" . SPARSER::GENE) ("MYC or p19ARF" . SPARSER::COLLECTION)
    ("NPM, NCL1, and BAX" . SPARSER::COLLECTION)
    ("ODC1 and CCNA" . SPARSER::COLLECTION) ("CCNA" . SPARSER::PROTEIN)
    ("MYC or MYC" . SPARSER::COLLECTION) ("p19ARF/p53" . SPARSER::COLLECTION)
    ("shRNA and p19ARF" . SPARSER::COLLECTION)
    ("MYC and MYC" . SPARSER::COLLECTION) ("FACS" . SPARSER::PROTEIN)
    ("IgM-" . SPARSER::PROTEIN) ("CD8-" . SPARSER::PROTEIN)
    ("CD4-" . SPARSER::PROTEIN) ("IgM" . SPARSER::PROTEIN)
    ("Eμ-MYC" . SPARSER::PROTEIN-PAIR) ("p19ARF and p53" . SPARSER::COLLECTION)
    ("TRE-MYC" . SPARSER::COLLECTION) ("ARF or p53" . SPARSER::COLLECTION)
    ("MIZ1" . SPARSER::PROTEIN) ("p16INK4A and p14ARF" . SPARSER::COLLECTION)
    ("Acute T-cell lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("p53 or p19ARF" . SPARSER::COLLECTION)
    ("p19ARF or p53" . SPARSER::COLLECTION) ("p15INK4B" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("B-ALL" . SPARSER::PROTEIN) ("NCL1" . SPARSER::PROTEIN)
    ("beta-galactosidase activity" . SPARSER::PROTEIN)
    ("DDX5" . SPARSER::PROTEIN) ("INK4A" . SPARSER::PROTEIN)
    ("TRP53" . SPARSER::PROTEIN) ("p16INK4A" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN)
    ("Only 2 PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Ventana BRAF V600E (VE1) mouse monoclonal primary antibody"
     . SPARSER::ANTIBODY)
    ("DAB" . SPARSER::MOLECULE)
    ("BRAF V600E (VE1) mouse monoclonal primary antibody" . SPARSER::ANTIBODY)
    ("V600E mutated BRAF" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("mouse monoclonal anti-BRAF V600E (VE1) primary antibody"
     . SPARSER::ANTIBODY)
    ("Mitogen Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SRF" . SPARSER::PROTEIN) ("monomeric actin" . SPARSER::PROTEIN)
    ("TKI and antibodies" . SPARSER::COLLECTION)
    ("EGFR and DNA-PK" . SPARSER::COLLECTION)
    ("complex (NPC)" . SPARSER::BIO-COMPLEX)
    ("EGFR and importin" . SPARSER::COLLECTION) ("INM" . SPARSER::PROTEIN)
    ("nucleoporins" . SPARSER::PROTEIN)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tyr" . SPARSER::AMINO-ACID)
    ("LIMK" . SPARSER::PROTEIN)
    ("p21-activated kinase 1 (PAK1) and Rho-dependent protein kinase"
     . SPARSER::COLLECTION)
    ("Rac and CDC42" . SPARSER::COLLECTION) ("EGFR-PI3K" . SPARSER::COLLECTION)
    ("EGFR and cofilin-1" . SPARSER::COLLECTION)
    ("Cofilin-1 and EGFR" . SPARSER::COLLECTION)
    ("an important chemotactic molecule" . SPARSER::MOLECULE)
    ("PLC-gamma/PKC" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK" . SPARSER::COLLECTION)
    ("EGFR, or HER1" . SPARSER::COLLECTION)
    ("ErbB3/HER-3" . SPARSER::COLLECTION) ("ErbB2/HER-2" . SPARSER::COLLECTION)
    ("HMG1 and HMG2" . SPARSER::COLLECTION) ("NER" . SPARSER::PROTEIN)
    ("GpG" . SPARSER::PROTEIN) ("purines" . SPARSER::DRUG)
    ("Cisplatin" . SPARSER::DRUG) ("metallothioneins" . SPARSER::PROTEIN)
    ("MRP" . SPARSER::PROTEIN) ("ATPases" . SPARSER::PROTEIN)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("a retrospective NSCLC cohort" . SPARSER::MOLECULE)
    ("a general mechanism whereby membrane lipids" . SPARSER::PROTEIN)
    ("LIMK1 and LIMK2" . SPARSER::COLLECTION) ("TES" . SPARSER::PROTEIN)
    ("chronophin" . SPARSER::PROTEIN) ("SSH" . SPARSER::MOLECULE)
    ("Slingshot" . SPARSER::PROTEIN) ("cysteins" . SPARSER::MOLECULE)
    ("PtdIns" . SPARSER::PROTEIN) ("oxidants" . SPARSER::MOLECULE)
    ("cofilin-1 and EGFR" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("added EGFR (Epidermal Growth Factor Receptor) and ALK (Anaplastic Lymphoma Kinase)"
     . SPARSER::COLLECTION)
    ("cofilin-1/EGFR" . SPARSER::COLLECTION)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serum response factor" . SPARSER::PROTEIN) ("H-2K" . SPARSER::PROTEIN)
    ("γH 2 AX" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("NHE1" . SPARSER::PROTEIN) ("SSH1" . SPARSER::PROTEIN)
    ("PLC-gamma" . SPARSER::PROTEIN-FAMILY) ("HER-4" . SPARSER::PROTEIN)
    ("HER-3" . SPARSER::PROTEIN) ("HMG2" . SPARSER::PROTEIN)
    ("HMG1" . SPARSER::PROTEIN) ("ATP7A" . SPARSER::PROTEIN)
    ("CTR1" . SPARSER::PROTEIN) ("TESK2" . SPARSER::PROTEIN)
    ("TESK1" . SPARSER::PROTEIN) ("CFL1" . SPARSER::PROTEIN)
    ("Cofilin-1" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("SUVmax, pAkt (Ser-473), pAkt (Thr-308) and pS6" . SPARSER::COLLECTION)
    ("immuno-cytokine" . SPARSER::PROTEIN-PAIR)
    ("pAkt (Thr-308) and pS6" . SPARSER::COLLECTION)
    ("pAkt (Ser-473), pAkt (Thr-308) and pS6" . SPARSER::COLLECTION)
    ("both pAkt (Ser-473) and pAkt (Thr-308)" . SPARSER::COLLECTION)
    ("axitinib" . SPARSER::DRUG)
    ("sorafenib and interferon alpha" . SPARSER::COLLECTION)
    ("interferon alpha and sorafenib" . SPARSER::COLLECTION)
    ("HIF2α and mTORC2" . SPARSER::COLLECTION)
    ("S6K1 and 4EBP1" . SPARSER::COLLECTION)
    ("the regulatory associated protein of mTOR (Raptor) and the rapamycin-insensitive companion of mTOR (Rictor)"
     . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("pAkt (Ser-473) and pAkt (Thr-308)" . SPARSER::COLLECTION)
    ("pAkt (Ser-473) and pS6 (r 2  = 0.52, P  = 0.000072, Figure  xref B)"
     . SPARSER::COLLECTION)
    ("pAkt (Thr-308) and pS6 (r 2  = 0.45, P  = 0.000087, Figure  xref C)"
     . SPARSER::COLLECTION)
    ("SUVmax" . SPARSER::PROTEIN) ("p-SUVmax" . SPARSER::COLLECTION)
    ("pAkt (Ser-473) pAkt (Thr-308) and pS6 protein" . SPARSER::COLLECTION)
    ("pAkt (Ser-473) pAkt" . SPARSER::PROTEIN-FAMILY)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("fluorodeoxy-glucose" . SPARSER::COLLECTION)
    ("pAkt and pS6" . SPARSER::COLLECTION)
    ("pAkt(Ser-473), pAkt (Thr-308), and pS6 protein in the primary tumor"
     . SPARSER::COLLECTION)
    ("the SUV and these proteins" . SPARSER::COLLECTION)
    ("Akt, and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("SUV" . SPARSER::PROTEIN) ("serine residue" . SPARSER::MOLECULE)
    ("kinase-1" . SPARSER::PROTEIN) ("interferon alpha" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN) ("PDK2" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("IFN-alpha" . SPARSER::PROTEIN)
    ("genotypes and mRNA" . SPARSER::COLLECTION) ("CART" . SPARSER::PROTEIN)
    ("FPRP" . SPARSER::PROTEIN) ("AG" . SPARSER::PROTEIN)
    ("an evolutionary
conserved family"
     . SPARSER::PROTEIN-FAMILY)
    ("cysteine-aspartic acid" . SPARSER::COLLECTION)
    ("the causal variants and/or mechanisms
underlying"
     . SPARSER::COLLECTION)
    ("four potentially functional polymorphisms" . SPARSER::PROTEIN)
    ("beta 8" . SPARSER::PROTEIN)
    ("cysteine
peptidase"
     . SPARSER::PROTEIN)
    ("CASP7" . SPARSER::PROTEIN) ("Caspase-7" . SPARSER::PROTEIN)
    ("either TSC1 (in the limited number of cases available from each study; xref and xref ) or TSC2 ( xref , and xref and xref )"
     . SPARSER::COLLECTION)
    ("both TSC2 and the adjacent PKD1 gene" . SPARSER::COLLECTION)
    ("everolimus and rapamycin" . SPARSER::COLLECTION)
    ("seizures" . SPARSER::PROTEIN) ("everolimus-" . SPARSER::DRUG)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("Everolimus" . SPARSER::MOLECULE)
    ("type or location" . SPARSER::COLLECTION)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("HF 2" . SPARSER::PROTEIN)
    ("PKD1" . SPARSER::PROTEIN)
    ("paclitaxel and anthracyclines" . SPARSER::COLLECTION)
    ("paclitaxel and bicalutamide" . SPARSER::COLLECTION)
    ("SGOL2, KLF6 and CDT1" . SPARSER::COLLECTION)
    ("ABL1, KLF6, SGOL2 and CDT1" . SPARSER::COLLECTION)
    ("AR and GR" . SPARSER::COLLECTION)
    ("the accessory proteins" . SPARSER::PROTEIN)
    ("the associated complexes" . SPARSER::BIO-COMPLEX)
    ("the target ARE's" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("chemotherapeutic drug paclitaxel" . SPARSER::DRUG)
    ("a typical ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("guanine or cytosine" . SPARSER::COLLECTION)
    ("2/3 and 10/11" . SPARSER::COLLECTION)
    ("guanine and cytosine" . SPARSER::COLLECTION)
    ("protein and the DNA" . SPARSER::COLLECTION)
    ("some residual AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("drug or bicalutamide" . SPARSER::COLLECTION) ("KLF" . SPARSER::PROTEIN)
    ("the drugs cyclophosphamide and 5" . SPARSER::COLLECTION)
    ("-Fluorouracil" . SPARSER::DRUG) ("Fluorouracil" . SPARSER::DRUG)
    ("paclitaxel and DHT" . SPARSER::COLLECTION)
    ("Bicalutamide" . SPARSER::DRUG)
    ("non steroidal AR antagonist" . SPARSER::MOLECULE)
    ("decreased chemotherapeutic drug" . SPARSER::DRUG)
    ("DHT and bicalutamide" . SPARSER::COLLECTION)
    ("chemotherapeutic drug" . SPARSER::DRUG)
    ("the chemotherapeutic drug" . SPARSER::DRUG)
    ("bicalutamide (AR antagonist) or both" . SPARSER::COLLECTION)
    ("the chemotherapeutic drugs paclitaxel, 5-fluorouracil and cyclophosphamide"
     . SPARSER::COLLECTION)
    ("paclitaxel, 5-fluorouracil and cyclophosphamide" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("Paclitaxel" . SPARSER::DRUG)
    ("Cyclophosphamide and 5-fluorouracil" . SPARSER::COLLECTION)
    ("cyclophosphamide, methotrexate and 5-fluorouracil" . SPARSER::COLLECTION)
    ("Cyclophosphamide" . SPARSER::DRUG)
    ("paclitaxel, cyclophosphamide and 5-fluorouracil" . SPARSER::COLLECTION)
    ("KLF6 and SGOL2" . SPARSER::COLLECTION)
    ("AR and LIPH" . SPARSER::COLLECTION) ("AR and KLF6" . SPARSER::COLLECTION)
    ("the AR and the SGOL2 ARE was-13.4 kcal/mol" . SPARSER::COLLECTION)
    ("AR and AATK" . SPARSER::COLLECTION) ("PWM" . SPARSER::DRUG)
    ("highly conserved amino acids of AR (Lys-563, Val-564 and Arg-568)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nucleosomes and linker" . SPARSER::COLLECTION)
    ("KLF6 (p = 0.004) and SGOL2 (p = 0.009)" . SPARSER::COLLECTION)
    ("the only apoptosis inducing gene" . SPARSER::GENE)
    ("BIK (p = 0.004) and ENDOG (p = 0.0012)" . SPARSER::COLLECTION)
    ("BOK (p = 0.03), BIK (p = 0.004) and ENDOG (p = 0.0012)"
     . SPARSER::COLLECTION)
    ("BIK" . SPARSER::PROTEIN) ("BOK" . SPARSER::PROTEIN)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA) ("LPA" . SPARSER::LPA)
    ("lipase" . SPARSER::PROTEIN) ("LIPH" . SPARSER::PROTEIN)
    ("wt-MAD1L1" . SPARSER::COLLECTION)
    ("the only cell cycle related gene" . SPARSER::GENE)
    ("KLF6 and its transcript variants" . SPARSER::COLLECTION)
    ("Abl" . SPARSER::PROTEIN)
    ("KLF6 (p = 0.005) and SGOL2 (p = 0.0011)" . SPARSER::COLLECTION)
    ("ABL1 (p = 0.0001), CDT1 (p = 0.006), KLF6 (p = 0.005) and SGOL2 (p = 0.0011)"
     . SPARSER::COLLECTION)
    ("only 78 amino acids" . SPARSER::AMINO-ACID)
    ("distant AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Finally 10 genes" . SPARSER::GENE) ("AR and HER2" . SPARSER::COLLECTION)
    ("ER–" . SPARSER::PROTEIN)
    ("estrogen receptor (ER) and progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("response element (HRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("progesterone receptor and mineralcorticoid" . SPARSER::COLLECTION)
    ("A typical ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN) ("taxanes" . SPARSER::DRUG)
    ("ARE and DNA binding domain (DBD)" . SPARSER::COLLECTION)
    ("ARE and DNA binding domain" . SPARSER::COLLECTION)
    ("an essential transcription factor" . SPARSER::PROTEIN)
    ("Glucocorticoid receptor" . SPARSER::PROTEIN) ("and-1" . SPARSER::PROTEIN)
    ("DR3" . SPARSER::PROTEIN) ("KLF 6" . SPARSER::PROTEIN)
    ("SGOL2" . SPARSER::PROTEIN) ("KLF6" . SPARSER::PROTEIN)
    ("CDT1" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("MAD1L1" . SPARSER::PROTEIN)
    ("typical 2DG" . SPARSER::PROTEIN)
    ("KIT and other glycoproteins" . SPARSER::COLLECTION)
    ("glucose/2DG" . SPARSER::COLLECTION) ("GLUTs" . SPARSER::PROTEIN)
    ("normoxic conditions 2DG" . SPARSER::PROTEIN)
    ("indirectly target KIT" . SPARSER::PROTEIN)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN) ("SDH" . SPARSER::PROTEIN)
    ("substantially more glucose" . SPARSER::MOLECULE)
    ("18h and 24h" . SPARSER::COLLECTION)
    ("proapoptotic BIM" . SPARSER::PROTEIN)
    ("AKT, MAPK and Actin" . SPARSER::COLLECTION)
    ("imatinib or ABT-263" . SPARSER::COLLECTION)
    ("imatinib and ABT-263" . SPARSER::COLLECTION)
    ("the immature form" . SPARSER::FORM) ("Tunicamycin" . SPARSER::MOLECULE)
    ("elF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KIT-protein" . SPARSER::COLLECTION) ("2DG" . SPARSER::PROTEIN)
    ("glucose:2DG" . SPARSER::BIO-COMPLEX) ("glucose (LG)" . SPARSER::MOLECULE)
    ("LG" . SPARSER::MOLECULE)
    ("MCL-1, an antiapoptotic BCL-2 protein, and the combination"
     . SPARSER::COLLECTION)
    ("available glucose" . SPARSER::PROTEIN)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("hexokinase" . SPARSER::PROTEIN)
    ("sunitinib and regorafenib" . SPARSER::COLLECTION)
    ("regorafenib" . SPARSER::DRUG) ("imatinib (IM)" . SPARSER::DRUG)
    ("KIT or PDGFRA" . SPARSER::COLLECTION) ("Mannose" . SPARSER::MOLECULE)
    ("dl" . SPARSER::MOLECULE) ("GLUT4" . SPARSER::PROTEIN)
    ("IRE1a" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("d-glucose" . SPARSER::MOLECULE) ("lactic acid" . SPARSER::MOLECULE)
    ("host cellular miRNAs" . SPARSER::PROTEIN)
    ("viral core proteins" . SPARSER::PROTEIN)
    ("caspase-3 and active" . SPARSER::COLLECTION) ("FCM" . SPARSER::MOLECULE)
    ("Bax, caspase-3 and active" . SPARSER::COLLECTION)
    ("Bax, caspase-7 and caspase-3" . SPARSER::COLLECTION)
    ("HMGA" . SPARSER::PROTEIN-FAMILY) ("hook" . SPARSER::PROTEIN-FAMILY)
    ("sera" . SPARSER::PROTEIN)
    ("the EV71 viral capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("naturally occurring single-stranded short 21–23 nt non-coding RNAs"
     . SPARSER::RNA)
    ("Bax, caspase-7, caspase-3 and active" . SPARSER::COLLECTION)
    ("HMGA2" . SPARSER::PROTEIN) ("c-5" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras–NORE1A–HIPK2–p53" . SPARSER::COLLECTION)
    ("NORE1A and other RASSF proteins" . SPARSER::COLLECTION)
    ("NORE1A–HIPK2" . SPARSER::COLLECTION)
    ("RASSF1A and NORE1A" . SPARSER::COLLECTION) ("R3A" . SPARSER::PROTEIN)
    ("Ras and p53" . SPARSER::COLLECTION)
    ("NORE1A/HIPK2" . SPARSER::COLLECTION)
    ("the acetyltransferases PCAF and CBP/p300" . SPARSER::COLLECTION)
    ("HIPK2 and p53" . SPARSER::COLLECTION)
    ("NORE1A and p53" . SPARSER::COLLECTION)
    ("NORE1A and endogenous p53" . SPARSER::COLLECTION)
    ("The resultant NORE1A R92-94A mutant" . SPARSER::MUTANT)
    ("Alanines" . SPARSER::AMINO-ACID) ("Arginines" . SPARSER::AMINO-ACID)
    ("NORE1A and Ras" . SPARSER::COLLECTION)
    ("Ras and NORE1A" . SPARSER::COLLECTION)
    ("Ras/NORE1A" . SPARSER::COLLECTION)
    ("endogenous NORE1A and endogenous HIPK2 ( xref )" . SPARSER::COLLECTION)
    ("NORE1A and HIPK2" . SPARSER::COLLECTION)
    ("SAHF ( xref ) and Dec1 expression ( xref )" . SPARSER::COLLECTION)
    ("senescence-associated heterochromatin foci (SAHF) and Dec1 ( xref )"
     . SPARSER::COLLECTION)
    ("senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("viral oncoproteins" . SPARSER::PROTEIN) ("Ras–p53" . SPARSER::COLLECTION)
    ("two previously validated short hairpin RNAs" . SPARSER::RNA)
    ("NORE1A–HIPK2–p53" . SPARSER::COLLECTION)
    ("p53 and HIPK2" . SPARSER::COLLECTION)
    ("the acetyl transferases PCAF and CBP/p300" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN) ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("Raf–MAPK" . SPARSER::COLLECTION)
    ("NORE1A and the kinase HIPK2" . SPARSER::COLLECTION)
    ("anti–mouse" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("Ph1" . SPARSER::PROTEIN) ("1 b" . SPARSER::PROTEIN)
    ("HIPK1" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("p53 regulator" . SPARSER::PROTEIN) ("Dec1" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("S46" . SPARSER::PROTEIN)
    ("scaffolding molecule" . SPARSER::PROTEIN) ("RASSF5" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("NORE1A" . SPARSER::PROTEIN)
    ("proteins
and Mammalian Target Of Rapamycin"
     . SPARSER::COLLECTION)
    ("RhoA-associated kinase (ROCK)" . SPARSER::KINASE)
    ("neither CK2
nor GSK3β"
     . SPARSER::COLLECTION)
    ("The latter sites form" . SPARSER::FORM) ("Casein" . SPARSER::PROTEIN)
    ("COOH" . SPARSER::MOLECULE)
    ("a dual protein and lipid phosphatase" . SPARSER::PHOSPHATASE)
    ("pPTEN/PTEN" . SPARSER::COLLECTION) ("PTEN/GAPDH" . SPARSER::COLLECTION)
    ("higher superficial
subcutaneous fat"
     . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3-kinase/Akt" . SPARSER::COLLECTION)
    ("skeletal
muscle"
     . SPARSER::PROTEIN)
    ("total and
phosphorylated PTEN protein"
     . SPARSER::PROTEIN)
    ("S6K
1"
     . SPARSER::PROTEIN)
    ("Mammalian Target Of Rapamycin" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatase and tensin
homolog"
     . SPARSER::PROTEIN)
    ("P73/PML/PPARδ" . SPARSER::COLLECTION)
    ("specifically target PCSK9" . SPARSER::PROTEIN)
    ("LDLr" . SPARSER::PROTEIN) ("SREBP2 and SIRT6" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN)
    ("the classical activators" . SPARSER::ACTIVATOR)
    ("CPT1, NRF1, TFAM and ERRalpha" . SPARSER::COLLECTION)
    ("ERRalpha" . SPARSER::PROTEIN) ("TFAM" . SPARSER::PROTEIN)
    ("PPARalpha" . SPARSER::PROTEIN) ("CD36 and SCD1" . SPARSER::COLLECTION)
    ("FABP4, SREBP1 and PGC1beta" . SPARSER::COLLECTION)
    ("VO" . SPARSER::MOLECULE) ("neutral lipids" . SPARSER::LIPID)
    ("BMT" . SPARSER::PROTEIN) ("HDL" . SPARSER::PROTEIN)
    ("Kda" . SPARSER::PROTEIN) ("agouti" . SPARSER::PROTEIN-FAMILY)
    ("low density lipoprotein (LDL)" . SPARSER::PROTEIN)
    ("SIRT6 and SREBP2" . SPARSER::COLLECTION)
    ("pro-inflammatory macrophages" . SPARSER::PROTEIN)
    ("CD115" . SPARSER::PROTEIN) ("SIRT 6" . SPARSER::PROTEIN)
    ("PPARδ" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("PCSK9" . SPARSER::PROTEIN) ("LDL-receptor" . SPARSER::PROTEIN)
    ("CPT1" . SPARSER::PROTEIN) ("PGC1beta" . SPARSER::PROTEIN)
    ("SCD1" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("Ubiquitin Ligase" . SPARSER::PROTEIN) ("SREBP2" . SPARSER::PROTEIN)
    ("NDRG1, or NDRG1" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin and NDRG1" . SPARSER::COLLECTION)
    ("E-cadherin and NDRG1" . SPARSER::COLLECTION)
    ("N-cadherin and the invasive marker E-cadherin" . SPARSER::COLLECTION)
    ("the invasive marker E-cadherin" . SPARSER::PROTEIN)
    ("the RV-NDRG1-transfected U87 MG" . SPARSER::PROTEIN)
    ("N-cadherin, vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, PCNA, Ki-67, Bcl-2 and Bcl-xL"
     . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("Vimentin, N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bax, cleaved-PARP and cleaved-caspase-3" . SPARSER::COLLECTION)
    ("the following apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E, Ki-67 and PCNA" . SPARSER::COLLECTION)
    ("cell cycle arrest-associated proteins" . SPARSER::PROTEIN)
    ("siNC" . SPARSER::DRUG)
    ("p27 ( xref ) and p21 ( xref )" . SPARSER::COLLECTION)
    ("NDRG1, NDRG2, NDRG3 and NDRG4" . SPARSER::COLLECTION)
    ("N-myc and c-myc" . SPARSER::COLLECTION)
    ("NDRG1 and its downstream targets" . SPARSER::COLLECTION)
    ("NDRG1, and NDRG1" . SPARSER::COLLECTION)
    ("myc protein" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("NDRG4" . SPARSER::PROTEIN) ("NDRG3" . SPARSER::PROTEIN)
    ("NDRG2" . SPARSER::PROTEIN) ("U87 MG" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene" . SPARSER::PROTEIN)
    ("cGMP" . SPARSER::PROTEIN) ("GMP" . SPARSER::MOLECULE)
    ("the stimulatory G-protein alpha subunit" . SPARSER::PROTEIN)
    ("corticotropin" . SPARSER::PROTEIN) ("Steroidogenic" . SPARSER::PROTEIN)
    ("endocrine and non-endocrine" . SPARSER::COLLECTION)
    ("circadian clock and neurofibromin" . SPARSER::COLLECTION)
    ("clock and neurofibromin" . SPARSER::COLLECTION)
    ("HSD3B1" . SPARSER::PROTEIN) ("Prx1-cre" . SPARSER::COLLECTION)
    ("delG" . SPARSER::PROTEIN)
    ("the mitochondrial protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SID" . SPARSER::PROTEIN-FAMILY) ("steroidogenic" . SPARSER::PROTEIN)
    ("aldosterone and corticosterone" . SPARSER::COLLECTION)
    ("HSD3b1" . SPARSER::PROTEIN) ("Cyp11b2" . SPARSER::PROTEIN)
    ("HSD" . SPARSER::PROTEIN) ("Cyp11a1 and Cyp21a1" . SPARSER::COLLECTION)
    ("Cyp11a1" . SPARSER::PROTEIN) ("pregnenolone" . SPARSER::PROTEIN)
    ("Cyp11b1, Cyp21a1, and steroidogenic acute regulatory protein"
     . SPARSER::COLLECTION)
    ("Cyp11b1" . SPARSER::PROTEIN) ("Cyp" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN) ("Prx1-Cre" . SPARSER::COLLECTION)
    ("GRD" . SPARSER::PROTEIN)
    ("hypothalamic growth hormone releasing hormone (GHRH)" . SPARSER::PROTEIN)
    ("Nf1flox/flox" . SPARSER::COLLECTION) ("GHRH" . SPARSER::PROTEIN)
    ("Rac1/Pak1/LIMK1/Cofilin" . SPARSER::COLLECTION)
    ("Rho/ROCK/LIMK2/Cofilin" . SPARSER::COLLECTION)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("Cofilin" . SPARSER::PROTEIN)
    ("c-Jun/JNK" . SPARSER::COLLECTION)
    ("NF1-associated OPG" . SPARSER::PROTEIN)
    ("PP and NF1" . SPARSER::COLLECTION) ("OPG" . SPARSER::PROTEIN)
    ("PP" . SPARSER::PROTEIN) ("Lisch" . SPARSER::PROTEIN)
    ("iris" . SPARSER::PROTEIN) ("Neurofibromin" . SPARSER::PROTEIN)
    ("StAR" . SPARSER::PROTEIN) ("adrenals" . SPARSER::DRUG)
    ("corticosterone and aldosterone" . SPARSER::COLLECTION)
    ("corticosterone" . SPARSER::MOLECULE) ("Nf1" . SPARSER::PROTEIN)
    ("neurofibromin" . SPARSER::PROTEIN) ("PDE8B" . SPARSER::PROTEIN)
    ("phosphodiesterase 8B" . SPARSER::PROTEIN) ("PDE11A" . SPARSER::PROTEIN)
    ("phosphodiesterase-11A" . SPARSER::PROTEIN) ("GNAS1" . SPARSER::PROTEIN)
    ("type VI" . SPARSER::PROTEIN) ("Lonp1" . SPARSER::PROTEIN)
    ("aldosterone synthase" . SPARSER::PROTEIN) ("HSD3b6" . SPARSER::PROTEIN)
    ("Cyp21a1" . SPARSER::PROTEIN)
    ("coagulation factor VIII" . SPARSER::PROTEIN)
    ("Delta2" . SPARSER::PROTEIN)
    ("20-alpha-HSD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p42/44" . SPARSER::PROTEIN) ("Cyp21A1" . SPARSER::PROTEIN)
    ("Akr1b7" . SPARSER::PROTEIN)
    ("growth hormone releasing hormone" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("LIMK2" . SPARSER::PROTEIN) ("Ras-GAP" . SPARSER::PROTEIN)
    ("steroidogenic acute regulatory protein" . SPARSER::PROTEIN)
    ("Prx1" . SPARSER::PROTEIN) ("REC" . SPARSER::PROTEIN)
    ("fludarabine and alemtuzumab" . SPARSER::COLLECTION)
    ("alemtuzumab" . SPARSER::DRUG)
    ("a fully humanised monoclonal IgG anti-CD20 antibody" . SPARSER::ANTIBODY)
    ("hyper-CVXD and R-hyper-CVXD-MA" . SPARSER::COLLECTION)
    ("hyper-CVXD" . SPARSER::PROTEIN-PAIR)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("daunorubicin, and dexamethasone" . SPARSER::COLLECTION)
    ("methotrexate and cytarabine" . SPARSER::COLLECTION)
    ("fludarabine, cytarabine, cyclophosphamide, cisplatin and GM-CSF"
     . SPARSER::COLLECTION)
    ("fludarabine" . SPARSER::DRUG) ("cytarabine" . SPARSER::MOLECULE)
    ("daunorubicin" . SPARSER::DRUG)
    ("Alkylator, anthracycline, platinum and purine" . SPARSER::COLLECTION)
    ("purine" . SPARSER::DRUG) ("Alkylator" . SPARSER::MOLECULE)
    ("prednisolone" . SPARSER::DRUG) ("type (ABC)" . TYPE)
    ("avid" . SPARSER::DRUG) ("FDG" . SPARSER::PROTEIN)
    ("ofatumumab" . SPARSER::DRUG)
    ("a fully human anti-CD20 monoclonal IgG1κ antibody" . SPARSER::ANTIBODY)
    ("Ofatumumab" . SPARSER::DRUG) ("m2" . SPARSER::MOLECULE)
    ("genotypes or alleles" . SPARSER::COLLECTION)
    ("UV-induced DNA" . SPARSER::DNA) ("Stata" . SPARSER::PROTEIN)
    ("HDAC6-siRNA" . SPARSER::COLLECTION)
    ("Apaf-1 and procaspase-9" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("pro-apoptotic member Bax" . SPARSER::PROTEIN)
    ("proteins and cytochrome c" . SPARSER::COLLECTION)
    ("annexinV" . SPARSER::PROTEIN) ("HDAC6-siRNA-3" . SPARSER::COLLECTION)
    ("rRNA" . SPARSER::PROTEIN) ("BITC" . SPARSER::MOLECULE)
    ("siRNA-1" . SPARSER::PROTEIN)
    ("promoters or inhibitors" . SPARSER::COLLECTION)
    ("NC-siRNA" . SPARSER::COLLECTION) ("HDAC6-siRNA-1" . SPARSER::COLLECTION)
    ("AnnexinV" . SPARSER::PROTEIN) ("HDAC6-siRNAs" . SPARSER::COLLECTION)
    ("a special class IIb histone deacetylase" . SPARSER::PROTEIN)
    ("IIb" . SPARSER::DRUG) ("Mfn2" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("COX-IV" . SPARSER::PROTEIN)
    ("Mfn 2" . SPARSER::PROTEIN) ("DCFH-DA" . SPARSER::DRUG)
    ("DCF-DA" . SPARSER::DRUG) ("X-gal" . SPARSER::MOLECULE)
    ("Histone deacetylase 6" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN) ("PKD" . SPARSER::PROTEIN)
    ("dnH-Ras" . SPARSER::COLLECTION)
    ("EGFR, H-Ras and ENaC" . SPARSER::COLLECTION)
    ("receptors, ERK1/2 and ENaC" . SPARSER::COLLECTION)
    ("K-Ras or N-Ras" . SPARSER::COLLECTION)
    ("progesterone [ xref ] and a 142 amino acid vasopressin-induced protein [ xref ]"
     . SPARSER::COLLECTION)
    ("EGF [ xref ], progesterone [ xref ] and a 142 amino acid vasopressin-induced protein [ xref ]"
     . SPARSER::COLLECTION)
    ("H-Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("vasopressin" . SPARSER::PROTEIN)
    ("ENaC or Nedd4-2" . SPARSER::COLLECTION)
    ("H-Ras/ERK" . SPARSER::COLLECTION)
    ("ENaC and Nedd4-2" . SPARSER::COLLECTION)
    ("PLC, p38 MAPK, c-Jun and PKC" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("exogenous ENaC" . SPARSER::PROTEIN)
    ("the 30 kDa α-ENaC N-terminal fragment and 95 kDa" . SPARSER::COLLECTION)
    ("the 79 kDa γ-ENaC C-terminal fragment and 95 kDa" . SPARSER::COLLECTION)
    ("ENaC mutants HA α V5 βγ ENaC or αβ HA γ V5 ENaC" . SPARSER::COLLECTION)
    ("H-Ras G12V or H-Ras S17N" . SPARSER::COLLECTION)
    ("wt-H-Ras" . SPARSER::COLLECTION) ("S17N" . SPARSER::PROTEIN)
    ("PY-motifs" . SPARSER::MOLECULE) ("wt-ENaC" . SPARSER::COLLECTION)
    ("ENaC" . SPARSER::PROTEIN) ("PY" . SPARSER::MOLECULE)
    ("c-Jun NH2-terminal kinase (SP600125), phospholipase C (U73122), p38 MAPK (SB239063) and PKC (Gö6976 and BIM)"
     . SPARSER::COLLECTION)
    ("c-Raf/MEK/ERK" . SPARSER::COLLECTION) ("H-Ras S17N" . SPARSER::PROTEIN)
    ("wtH-Ras" . SPARSER::COLLECTION)
    ("K-Ras G12V or N-Ras S12V" . SPARSER::COLLECTION)
    ("total ERK1/2 and the phosphorylated form" . SPARSER::COLLECTION)
    ("c-Raf/MEK/ERK1/2" . SPARSER::COLLECTION)
    ("K-Ras G12V or H-Ras G12V" . SPARSER::COLLECTION)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION) ("FRT" . SPARSER::PROTEIN)
    ("the basolateral membrane Na + /K + -ATPase" . SPARSER::COLLECTION)
    ("ouabain" . SPARSER::DRUG) ("nystatin" . SPARSER::DRUG)
    ("-ATPase" . SPARSER::COLLECTION) ("K-Ras and H-Ras" . SPARSER::COLLECTION)
    ("IRK1 [ xref ], the sodium-chloride co-transporter [ xref ] and ENaC [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ion channels and transporters" . SPARSER::COLLECTION)
    ("K-Ras, H-Ras and N-Ras" . SPARSER::COLLECTION)
    ("20–40 kDa monomeric guanosine triphosphase-binding proteins"
     . SPARSER::PROTEIN)
    ("-3-kinase, and protein" . SPARSER::COLLECTION)
    ("receptors (EGFR)" . SPARSER::RECEPTOR)
    ("Amiloride-sensitive epithelial Na +" . SPARSER::MOLECULE)
    ("Amiloride" . SPARSER::DRUG) ("H-Ras/c-Raf" . SPARSER::COLLECTION)
    ("EGF and H-Ras" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::COLLECTION)
    ("amiloride" . SPARSER::DRUG)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("MAP-kinase" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("SB239063" . SPARSER::MOLECULE) ("Sulfo-NHS" . SPARSER::DRUG)
    ("ATPase Activity" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("αENaC" . SPARSER::PROTEIN) ("IRK1" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("N-Ras" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("a polypeptide" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("Tal1/SCL" . SPARSER::COLLECTION) ("SCL" . SPARSER::PROTEIN)
    ("substrates and plays" . SPARSER::COLLECTION)
    ("primary astrocytes" . SPARSER::PROTEIN)
    ("APP and BACE1" . SPARSER::COLLECTION) ("PAb" . SPARSER::PROTEIN)
    ("no antibodies or nonspecific antibodies" . SPARSER::COLLECTION)
    ("nonspecific antibodies" . SPARSER::ANTIBODY)
    ("pifithrin" . SPARSER::DRUG)
    ("housekeeping gene (GAPDH)" . SPARSER::PROTEIN)
    ("client proteins" . SPARSER::PROTEIN) ("ΔTPR" . SPARSER::PROTEIN)
    ("the deletion mutants CHIP ΔTPR and CHIP ΔUbox" . SPARSER::COLLECTION)
    ("CHIP ΔTPR" . SPARSER::PROTEIN) ("-NTA" . SPARSER::MOLECULE)
    ("its client proteins" . SPARSER::PROTEIN)
    ("APP (CTFβ 99) and other proteins" . SPARSER::COLLECTION)
    ("CTF" . SPARSER::PROTEIN) ("APP and Aβ" . SPARSER::COLLECTION)
    ("Flag-BACE1" . SPARSER::COLLECTION)
    ("several diseases-associated brain proteins" . SPARSER::PROTEIN)
    ("APP, and Aβ" . SPARSER::COLLECTION) ("SFC" . SPARSER::PROTEIN)
    ("p53 and its altered conformation" . SPARSER::COLLECTION)
    ("Cho" . SPARSER::PROTEIN) ("APP and presenilin" . SPARSER::COLLECTION)
    ("presenilin" . SPARSER::PROTEIN) ("Cai" . SPARSER::DRUG)
    ("amyloid precursor protein (APP)" . SPARSER::PROTEIN)
    ("TPR" . SPARSER::PROTEIN) ("HEK-APP" . SPARSER::COLLECTION)
    ("UbcH5a" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("HIPK2" . SPARSER::PROTEIN)
    ("homeodomain interacting protein kinase 2" . SPARSER::PROTEIN)
    ("RunX1" . SPARSER::PROTEIN) ("Tal1" . SPARSER::PROTEIN)
    ("IRF-1" . SPARSER::PROTEIN) ("Fbx2" . SPARSER::PROTEIN)
    ("β-APP" . SPARSER::PROTEIN-FAMILY)
    ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pGL2" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("3-NT" . SPARSER::PROTEIN) ("BACE1" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("amyloid-beta" . SPARSER::PROTEIN) ("TNC" . SPARSER::PROTEIN)
    ("Tenascin" . SPARSER::PROTEIN) ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS and p53" . SPARSER::COLLECTION)
    ("growth factors and enzymes" . SPARSER::COLLECTION)
    ("endocrine and exocrine" . SPARSER::COLLECTION)
    ("LIFR" . SPARSER::PROTEIN) ("MST and LATS" . SPARSER::COLLECTION)
    ("invasive cell growth conditions use CXCR2" . SPARSER::PROTEIN)
    ("Verteporfin" . SPARSER::DRUG)
    ("additional exogenous IL8" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("IL8 and its receptors CXCR1 and CXCR2" . SPARSER::COLLECTION)
    ("CXCR1 and CXCR2" . SPARSER::COLLECTION)
    ("endothelial GFP" . SPARSER::PROTEIN) ("media (CM)" . SPARSER::PROTEIN)
    ("exogenous CXCL1 and IL8" . SPARSER::COLLECTION)
    ("CXCL1 and IL8" . SPARSER::COLLECTION)
    ("GMCSF and GCSF" . SPARSER::COLLECTION)
    ("cancer-cell conditioned media (CM)" . SPARSER::PROTEIN)
    ("beta-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("tenascin" . SPARSER::PROTEIN) ("GCSF" . SPARSER::PROTEIN)
    ("GMCSF" . SPARSER::PROTEIN) ("VP" . SPARSER::PROTEIN)
    ("verteporfin" . SPARSER::DRUG) ("tracer" . SPARSER::MOLECULE)
    ("sacs" . SPARSER::PROTEIN) ("tracers" . SPARSER::MOLECULE)
    ("this screen human kinome-wide shRNA" . SPARSER::PROTEIN)
    ("IL6, IL8, and CXCL1" . SPARSER::COLLECTION)
    ("E-Cadherin" . SPARSER::PROTEIN) ("green fluorescent" . SPARSER::PROTEIN)
    ("MSI1" . SPARSER::PROTEIN) ("musashi homolog 1" . SPARSER::PROTEIN)
    ("CXCR1" . SPARSER::PROTEIN) ("CSF3" . SPARSER::PROTEIN)
    ("CSF2" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("large tumor suppressor" . SPARSER::PROTEIN)
    ("REA and form" . SPARSER::COLLECTION)
    ("E2 and progesterone" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, and IL-8" . SPARSER::COLLECTION)
    ("at least HDAC1" . SPARSER::PROTEIN) ("ERα and REA" . SPARSER::COLLECTION)
    ("Il17" . SPARSER::PROTEIN) ("ERα-REA" . SPARSER::COLLECTION)
    ("RORγT and REA" . SPARSER::COLLECTION)
    ("REA and RORγT" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, and HDAC3" . SPARSER::COLLECTION)
    ("MAA" . SPARSER::MOLECULE)
    ("anti-HDAC1 and anti-HDAC2" . SPARSER::COLLECTION)
    ("anti-REA and anti-ERα" . SPARSER::COLLECTION)
    ("anti-REA or anti-ERα" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("a pre-validated commercial Rea siRNA" . SPARSER::PROTEIN)
    ("only REA, HDAC1, and HDAC2 proteins" . SPARSER::PROTEIN)
    ("REA, HDAC1, and HDAC2" . SPARSER::COLLECTION)
    ("receptors (SMART)" . SPARSER::RECEPTOR)
    ("retinoid and thyroid" . SPARSER::COLLECTION)
    ("HDAC1, and HDAC2" . SPARSER::COLLECTION) ("NCOR" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN) ("ERE2 and ERE3" . SPARSER::COLLECTION)
    ("The essential ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("-GGTCAnnnTGACC-3" . SPARSER::COLLECTION)
    ("Rorγt and Rorα" . SPARSER::COLLECTION)
    ("Il17a and Il17f" . SPARSER::COLLECTION) ("Il17f" . SPARSER::PROTEIN)
    ("Il17a" . SPARSER::PROTEIN)
    ("Rorγt , Rorα , and Stat3" . SPARSER::COLLECTION)
    ("exogenous estradiol" . SPARSER::PROTEIN)
    ("candidal 5-hydroxytryptophan metabolites" . SPARSER::MOLECULE)
    ("mannan" . SPARSER::MOLECULE) ("fungi" . SPARSER::PROTEIN)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("homolog), and EP300" . SPARSER::COLLECTION)
    ("v-maf" . SPARSER::COLLECTION) ("maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATF" . SPARSER::PROTEIN) ("BATF" . SPARSER::PROTEIN)
    ("RORα and RORγT" . SPARSER::COLLECTION)
    ("IL-17A and IL-17F" . SPARSER::COLLECTION)
    ("RORC , or RORgamma" . SPARSER::COLLECTION)
    ("RORgamma" . SPARSER::PROTEIN) ("RORC" . SPARSER::PROTEIN)
    ("TGF-β and IL-6" . SPARSER::COLLECTION)
    ("TGF-β and IL-1β" . SPARSER::COLLECTION)
    ("TGF-β and IL-21" . SPARSER::COLLECTION) ("Naïve" . SPARSER::PROTEIN)
    ("estradiol-ERα-REA" . SPARSER::COLLECTION) ("Rea" . SPARSER::PROTEIN)
    ("repressor of estrogen receptor activity (REA) and form ERα/REA complex"
     . SPARSER::COLLECTION)
    ("ERα/REA" . SPARSER::COLLECTION) ("REA" . SPARSER::PROTEIN)
    ("antifungal interleukin-17 (IL-17) cytokines" . SPARSER::PROTEIN)
    ("Estradiol" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("MTA1" . SPARSER::PROTEIN)
    ("ERE2" . SPARSER::PROTEIN) ("prohibitin 2" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("CD3ε" . SPARSER::PROTEIN)
    ("anti-mouse" . SPARSER::PROTEIN) ("Rorα" . SPARSER::PROTEIN)
    ("IL-17RA" . SPARSER::PROTEIN) ("IL-17 receptor A" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma oncogene" . SPARSER::PROTEIN)
    ("c-Maf" . SPARSER::PROTEIN)
    ("interferon regulatory factor 4" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("Forkhead box P3" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("IL-17F" . SPARSER::PROTEIN) ("orphan receptor" . SPARSER::PROTEIN)
    ("IL-21" . SPARSER::PROTEIN) ("RORγT" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG)
    ("repressor of estrogen receptor activity" . SPARSER::PROTEIN)
    ("Rorγt" . SPARSER::PROTEIN) ("interleukin-17" . SPARSER::PROTEIN)
    ("dual specific antibodies" . SPARSER::ANTIBODY)
    ("IL-2 and STAT-5" . SPARSER::COLLECTION)
    ("AHR and BAL" . SPARSER::COLLECTION)
    ("IL-13 and IL-4" . SPARSER::COLLECTION)
    ("IL-33 and IL-25" . SPARSER::COLLECTION)
    ("ICOS, IL-33 or Alternaria" . SPARSER::COLLECTION)
    ("ICOS-L and that ICOS" . SPARSER::COLLECTION)
    ("received anti-ICOS-L" . SPARSER::ANTIBODY)
    ("anti-mouse-ICOS-L" . SPARSER::PROTEIN-PAIR)
    ("IL-13 and IL-5" . SPARSER::COLLECTION)
    ("rh-IL-7 (20 ng/ml) and rh-IL-33 (20 ng/ml)" . SPARSER::COLLECTION)
    ("IL-2 and IL-7" . SPARSER::COLLECTION) ("-IL-2" . SPARSER::COLLECTION)
    ("rh" . SPARSER::MOLECULE)
    ("CD45, CRTH2, CD127 and CD161" . SPARSER::COLLECTION)
    ("functional ICOS and ICOS-L" . SPARSER::COLLECTION)
    ("cis or trans" . SPARSER::COLLECTION)
    ("rm-IL-33 (100 ng/ml) and IL-7 (20 ng/ml)" . SPARSER::COLLECTION)
    ("rm-IL2 (100 ng/ml), rm-IL-33 (100 ng/ml) and IL-7 (20 ng/ml)"
     . SPARSER::COLLECTION)
    ("ICOS-L-IgG" . SPARSER::COLLECTION)
    ("anti-ICOS (10 μg/ml,) or Rat IgG2b (10 μg/ml)" . SPARSER::COLLECTION)
    ("APCs" . SPARSER::PROTEIN) ("PBS and IL-33" . SPARSER::COLLECTION)
    ("rm-IL33 (0.5 μg/mouse) or PBS" . SPARSER::COLLECTION)
    ("functional ICOS-L" . SPARSER::PROTEIN)
    ("clinically relevant allergens" . SPARSER::MOLECULE)
    ("a clinically relevant allergen" . SPARSER::MOLECULE)
    ("received anti-ICOS" . SPARSER::ANTIBODY)
    ("ICOS-ICOS-L" . SPARSER::COLLECTION) ("Il2rg" . SPARSER::PROTEIN)
    ("STAT5 and NFATc2" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("IL-33/IL-25" . SPARSER::COLLECTION) ("IL-2/IL-7" . SPARSER::COLLECTION)
    ("naïve and IL-33" . SPARSER::COLLECTION)
    ("IL-33 or PBS" . SPARSER::COLLECTION)
    ("either rm-IL-33 (0.5 μg/mouse) or PBS" . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN) ("treatedIcos" . SPARSER::PROTEIN)
    ("CD127, ST2 and CD117" . SPARSER::COLLECTION)
    ("CD25, CD127, ST2 and CD117" . SPARSER::COLLECTION)
    ("ST2" . SPARSER::PROTEIN) ("IL-4 or IL-17a" . SPARSER::COLLECTION)
    ("receptors, CCR3, CCR4, CXCR4, CCR6 and CCR7" . SPARSER::COLLECTION)
    ("PBS or IL-33" . SPARSER::COLLECTION)
    ("PBS-treatedIcos" . SPARSER::PROTEIN-PAIR) ("rm" . SPARSER::MOLECULE)
    ("Icos" . SPARSER::PROTEIN)
    ("reduced IL-33 induced AHR" . SPARSER::PROTEIN)
    ("ILCs" . SPARSER::PROTEIN) ("ICOS:ICOS-L" . SPARSER::BIO-COMPLEX)
    ("ICOS and ICOS-L" . SPARSER::COLLECTION)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("Inducible T-cell COStimulator (ICOS)" . SPARSER::PROTEIN)
    ("c-Kit (mouse) and CRTH2 and CD161 (human)" . SPARSER::COLLECTION)
    ("CD45, CD90, cytokine receptors IL2Rα, IL-7Rα, IL-33R, c-Kit (mouse) and CRTH2 and CD161 (human)"
     . SPARSER::COLLECTION)
    ("CRTH2 and CD161" . SPARSER::COLLECTION)
    ("Thymic stromal lymphopoietin (TSLP) and fungal allergens"
     . SPARSER::COLLECTION)
    ("fungal allergens" . SPARSER::MOLECULE)
    ("amphiregulin" . SPARSER::PROTEIN) ("TSLP" . SPARSER::PROTEIN)
    ("ICOS and ICOS-Ligand" . SPARSER::COLLECTION) ("ICOS" . SPARSER::PROTEIN)
    ("IL-5 and IL-13" . SPARSER::COLLECTION) ("AHR" . SPARSER::PROTEIN)
    ("ILC" . SPARSER::PROTEIN) ("allergen" . SPARSER::MOLECULE)
    ("IL-2Rg" . SPARSER::PROTEIN) ("STAT-5" . SPARSER::PROTEIN)
    ("CD123" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("Rag2" . SPARSER::PROTEIN) ("RAG2" . SPARSER::PROTEIN)
    ("Id2" . SPARSER::PROTEIN) ("IL-17RB" . SPARSER::PROTEIN)
    ("NFATc2" . SPARSER::PROTEIN) ("STAT5b" . SPARSER::PROTEIN)
    ("GATA-3" . SPARSER::PROTEIN) ("protein-3" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("IL33" . SPARSER::PROTEIN)
    ("CCR6" . SPARSER::PROTEIN) ("CCR4" . SPARSER::PROTEIN)
    ("CCR3" . SPARSER::PROTEIN) ("ICOS-L" . SPARSER::PROTEIN)
    ("Inducible T-cell COStimulator" . SPARSER::PROTEIN)
    ("CD161" . SPARSER::PROTEIN) ("CRTH2" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("IL-7Rα" . SPARSER::PROTEIN)
    ("Thymic stromal lymphopoietin" . SPARSER::PROTEIN)
    ("IL-33" . SPARSER::PROTEIN) ("IL-25" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("costimulatory molecule" . SPARSER::PROTEIN)
    ("regulators or effectors" . SPARSER::COLLECTION)
    ("the dual specificity phosphatases CDC25C and PP2Acα"
     . SPARSER::COLLECTION)
    ("CDC25C and PP2Acα" . SPARSER::COLLECTION) ("CC" . SPARSER::PROTEIN)
    ("GG homozygous genotype" . SPARSER::PROTEIN)
    ("either del(5q) MDS ( P =0.15) or non-del(5q) MDS ( P =1.0)"
     . SPARSER::COLLECTION)
    ("genotype and TP53" . SPARSER::COLLECTION)
    ("CG and GG genotypes" . SPARSER::COLLECTION)
    ("Erythroid" . SPARSER::PROTEIN)
    ("genotype and lenalidomide" . SPARSER::COLLECTION)
    ("R72P genotype ( P =0.53) or non-del(5q) MDS ( P =0.61)"
     . SPARSER::COLLECTION)
    ("non-del(5q) MDS and del(5q) MDS" . SPARSER::COLLECTION)
    ("R72P genotype and disease status" . SPARSER::COLLECTION)
    ("morphologic subtypes" . SPARSER::PROTEIN) ("RARS" . SPARSER::PROTEIN)
    ("a homozygous C allele" . SPARSER::ALLELE)
    ("The amino-acid variants" . SPARSER::VARIANT)
    ("lenalidomide" . SPARSER::DRUG) ("MDS" . SPARSER::PROTEIN)
    ("Nonsynonymous TP53 exon 4 single-nucleotide polymorphism (SNP)"
     . SPARSER::PROTEIN)
    ("PP2Ac" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("PIN1" . SPARSER::PROTEIN) ("P72" . SPARSER::PROTEIN)
    ("RPS14" . SPARSER::PROTEIN) ("mapping or haplotype" . SPARSER::COLLECTION)
    ("PGE2 and lung function status" . SPARSER::COLLECTION)
    ("COX2 as well as its catalytic product PGE2" . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT) ("COX2 and miR" . SPARSER::COLLECTION)
    ("IL-6, IL-8, TNF-α, and COX-2" . SPARSER::COLLECTION)
    ("COX2, and PGE2" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION)
    ("a virtual target gene" . SPARSER::GENE) ("DLCO" . SPARSER::MOLECULE)
    ("carbon monoxide (DLCO)" . SPARSER::MOLECULE)
    ("COX2 and PGE2" . SPARSER::COLLECTION)
    ("COX2 or PGE2" . SPARSER::COLLECTION) ("GOLD" . SPARSER::MOLECULE)
    ("carbon monoxide" . SPARSER::MOLECULE) ("IRAK1" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN) ("only ER α -M3 mutant" . SPARSER::MUTANT)
    ("prostate cancer-associated SPOP mutants" . SPARSER::MUTANT)
    ("The endometrial cancer-associated SPOP mutants" . SPARSER::MUTANT)
    ("fulvestrant" . SPARSER::DRUG) ("Tamoxifen" . SPARSER::MOLECULE)
    ("GREB1 and Cyclin D1" . SPARSER::COLLECTION)
    ("Cyclin D1 and ABCA3" . SPARSER::COLLECTION)
    ("ER α and SPOP" . SPARSER::COLLECTION)
    ("hormone 17 β -estradiol (E2) or vehicle ethanol (EtOH)"
     . SPARSER::COLLECTION)
    ("EtOH" . SPARSER::MOLECULE) ("ethanol" . SPARSER::PROTEIN)
    ("partially polyubiquitinated form" . SPARSER::FORM)
    ("endometrial cancer-associated SPOP mutants" . SPARSER::MUTANT)
    ("the endometrial cancer-associated SPOP mutants" . SPARSER::MUTANT)
    ("nine Myc-tagged endometrial cancer-associated mutants" . SPARSER::MUTANT)
    ("three major histological subtypes" . SPARSER::PROTEIN)
    ("Endometrial cancer-associated mutants" . SPARSER::MUTANT)
    ("-M2" . SPARSER::MOLECULE)
    ("SPOP and wild-type ER α" . SPARSER::COLLECTION)
    ("SPOP-ER α" . SPARSER::COLLECTION)
    ("Gli, SRC-3, and AR" . SPARSER::COLLECTION)
    ("HA-Ubiquitin" . SPARSER::COLLECTION)
    ("RBX1 or CUL3" . SPARSER::COLLECTION) ("ΔMATH" . SPARSER::PROTEIN)
    ("ΔBTB" . SPARSER::PROTEIN)
    ("SPOP-ΔBTB or SPOP-ΔMATH" . SPARSER::COLLECTION)
    ("SPOP-ΔMATH" . SPARSER::COLLECTION) ("SPOP-ΔBTB" . SPARSER::COLLECTION)
    ("MG132 or Bortezomib" . SPARSER::COLLECTION)
    ("Bortezomib" . SPARSER::DRUG) ("SPOP-" . SPARSER::PROTEIN)
    ("SPOP and ER α" . SPARSER::COLLECTION) ("Myc-SPOP" . SPARSER::COLLECTION)
    ("FH-ER α" . SPARSER::COLLECTION) ("FH-SPOP" . SPARSER::COLLECTION)
    ("Myc-ER α" . SPARSER::COLLECTION) ("-SPOP" . SPARSER::COLLECTION)
    ("FLAG-HA" . SPARSER::COLLECTION) ("FH" . SPARSER::PROTEIN)
    ("which targets ER α" . SPARSER::PROTEIN)
    ("CUL3-SPOP-RBX1" . SPARSER::COLLECTION)
    ("ER α and AR" . SPARSER::COLLECTION)
    ("the androgen receptor (AR), the estrogen receptor -β , and the progesterone receptor"
     . SPARSER::COLLECTION)
    ("Estrogen receptor-" . SPARSER::PROTEIN)
    ("CUL3-RBX1" . SPARSER::COLLECTION) ("Mapping" . SPARSER::PROTEIN)
    ("endometrial cancer-associated mutants" . SPARSER::MUTANT)
    ("a major endometrial cancer promoter" . SPARSER::PROMOTER)
    ("SPOP-CUL3-RBX1" . SPARSER::COLLECTION)
    ("estrogen receptor-" . SPARSER::PROTEIN) ("SPOP" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("ABCA3" . SPARSER::PROTEIN)
    ("P94" . SPARSER::PROTEIN) ("17 β -estradiol" . SPARSER::PROTEIN)
    ("E6-AP" . SPARSER::PROTEIN) ("CHD1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN)
    ("speckle-type POZ protein" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("RBX1" . SPARSER::PROTEIN) ("Speckle-type POZ protein" . SPARSER::PROTEIN)
    ("si-JNK" . SPARSER::COLLECTION) ("DR4 and/or DR5" . SPARSER::COLLECTION)
    ("caspase-8 and Bid" . SPARSER::COLLECTION)
    ("prosurvival Bcl-2 molecules" . SPARSER::MOLECULE)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("Bcl-XL or Bcl-2" . SPARSER::COLLECTION)
    ("Bad, Bax, Bak, Puma, Bid and Bim" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("Shc and Grb2" . SPARSER::COLLECTION)
    ("PI3K and Grb2" . SPARSER::COLLECTION)
    ("DR5, p27 and p21" . SPARSER::COLLECTION) ("p-HER2" . SPARSER::COLLECTION)
    ("PDK1, Akt, MEK and Erk1/2" . SPARSER::COLLECTION)
    ("HER2 and downstream PI3K/Akt" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("si-JNK2-2" . SPARSER::COLLECTION)
    ("si-JNK1-1" . SPARSER::COLLECTION) ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("DR5 and DR4" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("Bcl-XL and Bcl-2" . SPARSER::COLLECTION) ("p-Bad" . SPARSER::COLLECTION)
    ("caspase-7, caspase-3 and PARP" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-8" . SPARSER::COLLECTION)
    ("E2F1, CDK4, cyclin D1 and cyclin D3" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("E2F1, CDK4 and cyclin D" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("INK4 (p15 and p18) and CIP/KIP (p21 and p27) families"
     . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION)
    ("PDK1, Akt, MEK1/2 and Erk1/2" . SPARSER::COLLECTION)
    ("other gene and/or protein (such as DR5)" . SPARSER::COLLECTION)
    ("E2F1 , E2F2 and CDC20" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("MCF-10 A" . SPARSER::PROTEIN)
    ("5a not only targets EGFR and HER2" . SPARSER::COLLECTION)
    ("diphenyl" . SPARSER::DRUG) ("TRAIL, DR4 and DR5" . SPARSER::COLLECTION)
    ("DR4 and DR5" . SPARSER::COLLECTION) ("receptor (DR)" . SPARSER::RECEPTOR)
    ("DRs" . SPARSER::MOLECULE)
    ("small-molecule competitive tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("anti-EGFR or anti-HER2" . SPARSER::COLLECTION)
    ("Lapatinib" . SPARSER::DRUG)
    ("HER3 (ERBB3) and HER4 (ERBB4)" . SPARSER::COLLECTION)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, HER3 and HER4" . SPARSER::COLLECTION)
    ("ERBB and trigger" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("MEK/Erk" . SPARSER::COLLECTION)
    ("-tolyl-1" . SPARSER::COLLECTION) ("a 2-aryl" . SPARSER::COLLECTION)
    ("benzimidazole" . SPARSER::DRUG) ("aryl" . SPARSER::PROTEIN)
    ("Benzimidazole" . SPARSER::DRUG)
    ("antibodies and low-molecular-weight" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) or the closely related human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO3" . SPARSER::PROTEIN)
    ("JNK1-1" . SPARSER::PROTEIN) ("JNK2" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("TNFRSF10B" . SPARSER::PROTEIN)
    ("cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("ERBB1" . SPARSER::PROTEIN) ("death receptor 5" . SPARSER::PROTEIN)
    ("ClN 3" . SPARSER::PROTEIN) ("the mature complex" . SPARSER::BIO-COMPLEX)
    ("a physical barrier" . SPARSER::PROTEIN)
    ("BAG3 and SNAP-25" . SPARSER::COLLECTION)
    ("a monoclonal anti-tyrosine antibody" . SPARSER::ANTIBODY)
    ("the multiproteic SNARE" . SPARSER::PROTEIN)
    ("An essential part" . SPARSER::COMPONENT)
    ("syntaxin-1/SNAP-25" . SPARSER::COLLECTION)
    ("syntaxin-1 and SNAP-25" . SPARSER::COLLECTION)
    ("the contrary BAG3" . SPARSER::PROTEIN)
    ("using anti-SNAP-25 ( xref ) and anti-syntaxin-1 ( xref ) antibodies"
     . SPARSER::COLLECTION)
    ("using anti-SNAP-25" . SPARSER::ANTIBODY)
    ("Cortical F-actin" . SPARSER::BIO-COMPLEX) ("bag3" . SPARSER::PROTEIN)
    ("TRITC" . SPARSER::MOLECULE) ("localized F-actin" . SPARSER::BIO-COMPLEX)
    ("PDACs" . SPARSER::MOLECULE)
    ("the t-SNARE complex and exocytosis" . SPARSER::COLLECTION)
    ("SNAP-25/syntaxin-1" . SPARSER::COLLECTION)
    ("membrane-associated soluble N -ethylmaleimide-sensitive factor attachment protein receptors"
     . SPARSER::RECEPTOR)
    ("a standard western blot" . SPARSER::PROTEIN)
    ("a chaperone or a regulatory protein" . SPARSER::COLLECTION)
    ("bag" . SPARSER::PROTEIN-FAMILY)
    ("Bcl2-associated athanogene 3 (BAG3) protein" . SPARSER::PROTEIN)
    ("SNAP-25 and syntaxin-1" . SPARSER::COLLECTION)
    ("t-SNARE" . SPARSER::COLLECTION) ("SNARE" . SPARSER::PROTEIN)
    ("SNAREs" . SPARSER::PROTEIN) ("Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("β TC" . SPARSER::PROTEIN) ("TOS-2" . SPARSER::PROTEIN)
    ("Hsc-70" . SPARSER::PROTEIN) ("latrunculin B" . SPARSER::DRUG)
    ("β -cell" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("VAMP-2" . SPARSER::PROTEIN) ("v-SNARE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t-SNAREs" . SPARSER::PROTEIN)
    ("v-SNAREs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N -ethylmaleimide-sensitive factor attachment protein"
     . SPARSER::PROTEIN)
    ("Ca(2+)" . SPARSER::CALCIUM-ION) ("syntaxin-1" . SPARSER::PROTEIN)
    ("SNAP-25" . SPARSER::PROTEIN) ("BAG3" . SPARSER::PROTEIN)
    ("PAK1-shRNA" . SPARSER::COLLECTION)
    ("RUFY3, RUFY1, RUFY2 and RUFY4" . SPARSER::COLLECTION)
    ("Vac1 and EEA1" . SPARSER::COLLECTION)
    ("RUFY3/SINGAR1/RUFY3" . SPARSER::COLLECTION)
    ("RUFY1/Rabip4" . SPARSER::COLLECTION) ("YOTB" . SPARSER::PROTEIN)
    ("myosin and integrins" . SPARSER::COLLECTION)
    ("GES-1, RUFY3 and PAK1" . SPARSER::COLLECTION)
    ("Nowadays many small-molecule inhibitors" . SPARSER::INHIBITOR)
    ("PAK1-siRNA" . SPARSER::COLLECTION) ("Flag-RUFY3" . SPARSER::COLLECTION)
    ("myc-PAK1" . SPARSER::COLLECTION) ("GST-PAK1" . SPARSER::COLLECTION)
    ("GST-RUFY3" . SPARSER::COLLECTION) ("pEGFP-RUFY3" . SPARSER::PROTEIN-PAIR)
    ("integrin β 5 ( xref , xref ) and vinculin ( xref )"
     . SPARSER::COLLECTION)
    ("RUFY3 and integrin" . SPARSER::COLLECTION)
    ("myosin, integrins and vinculin" . SPARSER::COLLECTION)
    ("GFP-RUFY3" . SPARSER::COLLECTION)
    ("RUFY3 and its homologs" . SPARSER::COLLECTION)
    ("RUN" . SPARSER::PROTEIN-FAMILY)
    ("a 469-amino-acid protein" . SPARSER::PROTEIN)
    ("PAK1-RUFY3" . SPARSER::COLLECTION)
    ("RUFY3 and PAK1" . SPARSER::COLLECTION)
    ("PAK1 and RUFY3" . SPARSER::COLLECTION) ("/SINGAR1" . SPARSER::COLLECTION)
    ("T-2" . SPARSER::PROTEIN) ("Rab33A" . SPARSER::PROTEIN)
    ("Vac1" . SPARSER::PROTEIN) ("RUFY4" . SPARSER::PROTEIN)
    ("RUFY2" . SPARSER::PROTEIN) ("Rabip4" . SPARSER::PROTEIN)
    ("RUFY1" . SPARSER::PROTEIN) ("IPA-3" . SPARSER::MOLECULE)
    ("β 1" . SPARSER::PROTEIN) ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-like GTPase" . SPARSER::PROTEIN) ("RPIP9" . SPARSER::PROTEIN)
    ("RPIP8" . SPARSER::PROTEIN) ("Singar1" . SPARSER::PROTEIN)
    ("P21-activated kinase-1" . SPARSER::PROTEIN) ("Rap2" . SPARSER::PROTEIN)
    ("SINGAR1" . SPARSER::PROTEIN)
    ("RUN and FYVE domain containing 3" . SPARSER::PROTEIN)
    ("RUFY3" . SPARSER::PROTEIN) ("toxic DNA-bound RAD51" . SPARSER::PROTEIN)
    ("chromosome-associated RAD51" . SPARSER::PROTEIN)
    ("canonical RAD51 helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("spontaneous foci" . SPARSER::PROTEIN)
    ("RAD51-RAD54" . SPARSER::COLLECTION)
    ("helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("helical dsDNA-RAD51 nucleoprotein filaments" . SPARSER::PROTEIN-FAMILY)
    ("dsDNA-RAD51" . SPARSER::COLLECTION)
    ("the helical RAD51 nucleoprotein filaments" . SPARSER::PROTEIN-FAMILY)
    ("DNAse" . SPARSER::PROTEIN)
    ("a DNA-bound form of the protein or not" . SPARSER::COLLECTION)
    ("potentially toxic RAD51–dsDNA" . SPARSER::COLLECTION)
    ("the orthologous yeast protein" . SPARSER::PROTEIN)
    ("S33 and MCF7" . SPARSER::COLLECTION) ("adjacent IdU" . SPARSER::DRUG)
    ("IdU" . SPARSER::DRUG)
    ("a 162 bp dsDNA duplex substrate" . SPARSER::SUBSTRATE)
    ("more extensive RAD51" . SPARSER::PROTEIN)
    ("RAD51 and RAD54L+RAD54B" . SPARSER::COLLECTION)
    ("ssDNA" . SPARSER::PROTEIN) ("Rad54 and Rad51" . SPARSER::COLLECTION)
    ("RAD51-dsDNA" . SPARSER::COLLECTION)
    ("RAD51-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("RAD51–dsDNA" . SPARSER::COLLECTION)
    ("freely migrating dsDNA" . SPARSER::PROTEIN)
    ("the original dsDNA" . SPARSER::PROTEIN) ("dsDNA" . SPARSER::PROTEIN)
    ("Rad51-dsDNA" . SPARSER::COLLECTION)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("53BP1 and γH2AX" . SPARSER::COLLECTION)
    ("53BP1 (4 ± 5 versus 4 ± 6 foci/nucleus) or γH2AX foci (5 ± 3 versus 7 ± 5 foci/nucleus)"
     . SPARSER::COLLECTION)
    ("γ-H2AX and 53BP1" . SPARSER::COLLECTION)
    ("RAD51 and two key DNA" . SPARSER::COLLECTION)
    ("53BP1 and γ-H2AX" . SPARSER::COLLECTION) ("Rad54b" . SPARSER::PROTEIN)
    ("Rad54l" . SPARSER::PROTEIN)
    ("the mammary carcinoma cell line MCF7" . SPARSER::PROTEIN)
    ("aberrant RAD51" . SPARSER::PROTEIN)
    ("RAD51-filament" . SPARSER::COLLECTION)
    ("RAD51/RPA" . SPARSER::COLLECTION) ("focal RPA" . SPARSER::PROTEIN)
    ("RAD51 or RAD54L+RAD54B" . SPARSER::COLLECTION) ("S3b" . SPARSER::PROTEIN)
    ("S3a" . SPARSER::PROTEIN)
    ("nondamage-associated RAD51 foci" . SPARSER::PROTEIN)
    ("associated RPA foci" . SPARSER::PROTEIN)
    ("extensive RPA" . SPARSER::PROTEIN) ("NB" . SPARSER::PROTEIN)
    ("RPA-RAD51" . SPARSER::COLLECTION)
    ("RAD51 and the ssDNA binding protein" . SPARSER::COLLECTION)
    ("PICH" . SPARSER::PROTEIN) ("only insoluble protein" . SPARSER::PROTEIN)
    ("soluble nuclear protein" . SPARSER::PROTEIN)
    ("a doxycycline (dox)-repressible promoter" . SPARSER::PROMOTER)
    ("dox" . SPARSER::PROTEIN) ("DNA-associated RAD51" . SPARSER::PROTEIN)
    ("RAD51 and RAD54" . SPARSER::COLLECTION)
    ("nondamage-associated RAD51" . SPARSER::PROTEIN)
    ("FANCJ, FBH1, BLM or RECQ5" . SPARSER::COLLECTION)
    ("FANCJ" . SPARSER::PROTEIN)
    ("Rad51 and its meiosis-specific paralog Dmc1 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("nonrepair-associated DNA" . SPARSER::DNA) ("Dmc1" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("helical nucleoprotein filaments" . SPARSER::PROTEIN-FAMILY)
    ("RAD54L and RAD54B" . SPARSER::COLLECTION) ("hRAD54" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("S1 b" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("RS-1" . SPARSER::PROTEIN) ("RECQ5" . SPARSER::PROTEIN)
    ("FBH1" . SPARSER::PROTEIN) ("Swi2/Snf2" . SPARSER::PROTEIN)
    ("RAD54B" . SPARSER::PROTEIN) ("Rad54" . SPARSER::PROTEIN)
    ("genome-wide CNAs as well as ER expression and proliferation status"
     . SPARSER::COLLECTION)
    ("genome-wide CNAs" . SPARSER::PROTEIN)
    ("luminal or HER2+" . SPARSER::COLLECTION) ("HER2+" . SPARSER::PROTEIN)
    ("ER-HER2+" . SPARSER::PROTEIN-PAIR)
    ("ER- and HER2amp" . SPARSER::COLLECTION) ("amp" . SPARSER::AMP)
    ("genes or regions" . SPARSER::COLLECTION)
    ("a larger irradiated cohort" . SPARSER::MOLECULE)
    ("clinically achievable using orally bioavailable TKIs" . SPARSER::PROTEIN)
    ("a dual Mer/Flt3 inhibitor" . SPARSER::INHIBITOR)
    ("our dual Mer/Flt3 TKI" . SPARSER::PROTEIN)
    ("the structural homology" . SPARSER::PROTEIN)
    ("Mer and Axl" . SPARSER::COLLECTION)
    ("Mer and Flt-3" . SPARSER::COLLECTION)
    ("Flt-3 and Axl" . SPARSER::COLLECTION)
    ("iodide and propidium" . SPARSER::COLLECTION)
    ("Erk, Akt and Stat" . SPARSER::COLLECTION)
    ("Tyro-3, Axl or Trk" . SPARSER::COLLECTION)
    ("the Trk kinases as well as Tyro-3 and Axl" . SPARSER::COLLECTION)
    ("“Flt3-ITD" . SPARSER::COLLECTION) ("dim" . SPARSER::PROTEIN-FAMILY)
    ("MV" . SPARSER::PROTEIN) ("NOMO-1" . SPARSER::PROTEIN)
    ("Erk1/2, Akt and Stat5" . SPARSER::COLLECTION)
    ("Stat6" . SPARSER::PROTEIN) ("pyrazolopyrimidine" . SPARSER::MOLECULE)
    ("Tyro-3 and Axl" . SPARSER::COLLECTION) ("TAM" . SPARSER::PROTEIN)
    ("Axl" . SPARSER::PROTEIN) ("Trk" . SPARSER::PROTEIN)
    ("A comprehensive protein kinase" . SPARSER::KINASE)
    ("previously described Mer inhibitors" . SPARSER::INHIBITOR)
    ("further Mer inhibitors" . SPARSER::INHIBITOR)
    ("pyrrolopyrimidine" . SPARSER::DRUG)
    ("a novel dual specific Mer and Flt3 tyrosine kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("this ATP-binding site competitive small molecule" . SPARSER::MOLECULE)
    ("Flt-3" . SPARSER::PROTEIN) ("ponatinib" . SPARSER::DRUG)
    ("Stat5, Akt and Erk1/2" . SPARSER::COLLECTION)
    ("methylcellulose" . SPARSER::DRUG)
    ("Erk1/2, Akt and Stat6" . SPARSER::COLLECTION)
    ("Mer/Flt3" . SPARSER::COLLECTION) ("Flt3-ITD" . SPARSER::COLLECTION)
    ("Flt3 and downstream effectors Stat, Akt and Erk" . SPARSER::COLLECTION)
    ("Mer or Flt3" . SPARSER::COLLECTION)
    ("Stat, Akt and Erk" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("Mer and Flt3" . SPARSER::COLLECTION)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("Tyro3" . SPARSER::PROTEIN)
    ("Gas6" . SPARSER::PROTEIN) ("phospho-protein" . SPARSER::PROTEIN)
    ("Tyro-3" . SPARSER::PROTEIN) ("Stat5" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("Flt3" . SPARSER::PROTEIN) ("Bexarotene and SAHA" . SPARSER::COLLECTION)
    ("Ki67 and CD31" . SPARSER::COLLECTION) ("Docetaxel" . SPARSER::DRUG)
    ("RTCA and Transwell" . SPARSER::COLLECTION) ("/PI" . SPARSER::COLLECTION)
    ("AnnxinV/PI" . SPARSER::COLLECTION)
    ("SAHA or Bexarotene" . SPARSER::COLLECTION)
    ("a ligand and an agonist of RXRα" . SPARSER::COLLECTION)
    ("the well-studied RXR agonist" . SPARSER::AGONIST)
    ("dual RXR/HDAC" . SPARSER::COLLECTION) ("RXR/HDAC" . SPARSER::COLLECTION)
    ("dual targeting RXR and HDAC" . SPARSER::COLLECTION)
    ("the target gene's" . SPARSER::GENE)
    ("the RXR and the HDAC" . SPARSER::COLLECTION)
    ("SAHA (vorinostat) and FK228 (romidepsin)" . SPARSER::COLLECTION)
    ("romidepsin" . SPARSER::DRUG) ("vorinostat" . SPARSER::DRUG)
    ("SAHA" . SPARSER::DRUG)
    ("core histones and other cellular proteins" . SPARSER::COLLECTION)
    ("Bexarotene" . SPARSER::DRUG)
    ("Retinoid X receptor (RXR)" . SPARSER::PROTEIN)
    ("retinoid" . SPARSER::PROTEIN) ("HL60" . SPARSER::PROTEIN)
    ("RXRα and HDAC1" . SPARSER::COLLECTION)
    ("RXR and HDAC" . SPARSER::COLLECTION)
    ("Retinoid X receptor (RXR) and Histone deacetylase (HDAC)"
     . SPARSER::COLLECTION)
    ("WAF-1" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("endothelial cell growth factor" . SPARSER::PROTEIN)
    ("Histone 4" . SPARSER::PROTEIN) ("Histone 3" . SPARSER::PROTEIN)
    ("KLF-4" . SPARSER::PROTEIN) ("FK228" . SPARSER::DRUG)
    ("RXRα" . SPARSER::PROTEIN) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("Retinoid X receptor" . SPARSER::PROTEIN) ("PUFAs" . SPARSER::MOLECULE)
    ("EPA and perhaps" . SPARSER::COLLECTION)
    ("polyribosomes" . SPARSER::BIO-COMPLEX)
    ("CLT or EPA" . SPARSER::COLLECTION)
    ("both the BRCA1 protein and the luciferase reporter fused"
     . SPARSER::COLLECTION)
    ("ATF-4 and genes" . SPARSER::COLLECTION)
    ("the eIF2×GTP×met-RNA ternary complex" . SPARSER::BIO-COMPLEX)
    ("ternary complex" . SPARSER::BIO-COMPLEX) ("Sentinel" . SPARSER::DRUG)
    ("Western blot and BRCA1 mRNA" . SPARSER::PROTEIN)
    ("blot and BRCA1" . SPARSER::COLLECTION) ("Fish" . SPARSER::PROTEIN)
    ("mRNAb" . SPARSER::PROTEIN) ("BRCA1 mRNAb" . SPARSER::PROTEIN)
    ("AAG" . SPARSER::PROTEIN) ("the respective F-Luc mRNA" . SPARSER::PROTEIN)
    ("a bi-directional tetracycline-inducible promoter" . SPARSER::PROMOTER)
    ("heavy polysomal fractions" . SPARSER::COMPONENT)
    ("either EPA (150 μM) or DMSO" . SPARSER::COLLECTION)
    ("light polysomes or polysome-free fractions" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("polysome" . SPARSER::BIO-COMPLEX)
    ("Met/Cys" . SPARSER::COLLECTION) ("HME-Rho" . SPARSER::COLLECTION)
    ("HRI" . SPARSER::PROTEIN) ("CLT" . SPARSER::DRUG)
    ("cyclin D1, Cyclin E and Ras" . SPARSER::COLLECTION)
    ("ureas" . SPARSER::MOLECULE) ("clotrimazole" . SPARSER::DRUG)
    ("the predominant component" . SPARSER::COMPONENT)
    ("PUFA" . SPARSER::MOLECULE) ("Characteristic examples" . SPARSER::EXAMPLE)
    ("eIF2B" . SPARSER::PROTEIN)
    ("the translation-competent 80S ribosome" . SPARSER::BIO-COMPLEX)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("This ternary complex" . SPARSER::BIO-COMPLEX) ("eIF2" . SPARSER::PROTEIN)
    ("Methionine" . SPARSER::AMINO-ACID) ("the sporadic form" . SPARSER::FORM)
    ("micro RNAs" . SPARSER::RNA) ("the hereditary form" . SPARSER::FORM)
    ("such a p53 [ xref ] and PTEN" . SPARSER::COLLECTION)
    ("erbB2 and c-myc" . SPARSER::COLLECTION) ("erbB2" . SPARSER::PROTEIN)
    ("ovarian cancer susceptibility gene" . SPARSER::GENE)
    ("EPA" . SPARSER::PROTEIN) ("CAT-3" . SPARSER::PROTEIN)
    ("Deoxyribonuclease I" . SPARSER::PROTEIN)
    ("heme regulated inhibitor" . SPARSER::PROTEIN)
    ("R-Luc" . SPARSER::PROTEIN) ("n-3" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("FISH and TP53" . SPARSER::COLLECTION)
    ("LFS and Li-Fraumeni-like" . SPARSER::COLLECTION)
    ("tetramers" . SPARSER::TETRAMER)
    ("an essential protein" . SPARSER::PROTEIN) ("soma" . SPARSER::DRUG)
    ("FISH and CytoScan" . SPARSER::COLLECTION)
    ("LFS-BP2" . SPARSER::COLLECTION)
    ("a heterozygous state" . SPARSER::BIO-STATE)
    ("TP53 and the two first promoters" . SPARSER::COLLECTION)
    ("p53 (full length) and the Δ40p53 isoforms" . SPARSER::COLLECTION)
    ("A weak promoter" . SPARSER::PROMOTER) ("CNAs" . SPARSER::PROTEIN)
    ("TMA" . SPARSER::MOLECULE) ("an essential regulator" . SPARSER::REGULATOR)
    ("SUCO-TP53" . SPARSER::COLLECTION)
    ("TP53-ENPP1-TP53" . SPARSER::COLLECTION)
    ("chromatin and active" . SPARSER::COLLECTION) ("PZP" . SPARSER::PROTEIN)
    ("the entire TP53 gene as well as neighboring genes (Figure xref )"
     . SPARSER::COLLECTION)
    ("Southern blot" . SPARSER::PROTEIN)
    ("classic LFS families" . SPARSER::PROTEIN-FAMILY)
    ("the diagnostic gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P2 a" . SPARSER::PROTEIN) ("WRAP53" . SPARSER::PROTEIN)
    ("BP2" . SPARSER::PROTEIN) ("delta)" . SPARSER::PROTEIN)
    ("P13" . SPARSER::PROTEIN) ("ENPP1" . SPARSER::PROTEIN)
    ("CDK6 , c-Myc , and EGFR" . SPARSER::COLLECTION)
    ("cyclinE, cyclinA2, CDC2 , b-Myb , and E2F1" . SPARSER::COLLECTION)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY)
    ("Only few other miRNAs" . SPARSER::PROTEIN)
    ("patched1, Gli1, cyclin D1, and Bcl2" . SPARSER::COLLECTION)
    ("CDK2 and cyclin A2" . SPARSER::COLLECTION)
    ("si-E2F3" . SPARSER::COLLECTION)
    ("vital cell cycle regulators" . SPARSER::REGULATOR)
    ("CDK2 and CCNA2" . SPARSER::COLLECTION)
    ("CDK6 and E2F3" . SPARSER::COLLECTION)
    ("CDK6 , E2F3 , CCND2 , and ERBB4" . SPARSER::COLLECTION)
    ("normal GES-1" . SPARSER::PROTEIN)
    ("VDR and the miR-145-VDRE" . SPARSER::COLLECTION)
    ("VDRE" . SPARSER::DNA-RESPONSE-ELEMENT) ("sh-VDR" . SPARSER::COLLECTION)
    ("response elements (VDRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("calcitriol" . SPARSER::MOLECULE)
    ("E2F3 , CDK6 , CDK2 and CCNA2" . SPARSER::COLLECTION)
    ("E2F3 and CDK6" . SPARSER::COLLECTION) ("Rnase A" . SPARSER::PROTEIN)
    ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("b-Myb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cyclinA2" . SPARSER::PROTEIN)
    ("patched1" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("VitaminD3" . SPARSER::MOLECULE)
    ("FAK, paxillin, and p130 Cas" . SPARSER::COLLECTION)
    ("rapamycin, and mTORC1" . SPARSER::COLLECTION)
    ("shRNA or PP242" . SPARSER::COLLECTION)
    ("myr-Akt or dn-Akt" . SPARSER::COLLECTION)
    ("HA-tagged constitutively active Akt (Ad-myr-Akt) and dominant negative Akt (Ad-dn-Akt)"
     . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE)
    ("phospho-Akt and phospho-GSK3β" . SPARSER::COLLECTION)
    ("phospho-S6K1 (T389) and phospho-S6 ribosomal protein (S235/236)"
     . SPARSER::COLLECTION)
    ("S6K-IRS" . SPARSER::COLLECTION) ("S6K1-wt" . SPARSER::COLLECTION)
    ("rapamycin-resistant S6K1 mutant of S6K1 (Ad-S6K1-ca) and control virus"
     . SPARSER::COLLECTION)
    ("two essential components" . SPARSER::COMPONENT)
    ("mutant, and mTOR-TE" . SPARSER::COLLECTION)
    ("kinase active mTOR (S2035T; mTOR-T) or kinase-dead mTOR-T (S2035T/D2357E; mTOR-TE)"
     . SPARSER::COLLECTION)
    ("4E-BP1/eIF4E" . SPARSER::COLLECTION)
    ("ribosomal protein S6 and eIF4B" . SPARSER::COLLECTION)
    ("the eukaryotic initiation factor 3 (eIF3) translation initiation complex"
     . SPARSER::BIO-COMPLEX)
    ("focal adhesion proteins and small GTPases" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("rapamycin, mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("AZD8055 and PP242" . SPARSER::COLLECTION)
    ("protor" . SPARSER::PROTEIN-FAMILY)
    ("receptor and phosphatidylinositol" . SPARSER::COLLECTION)
    ("p130 Cas" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN) ("T/D" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("cap-binding protein" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("AZD8055" . SPARSER::DRUG)
    ("mSin1" . SPARSER::PROTEIN) ("GβL" . SPARSER::PROTEIN)
    ("PP242" . SPARSER::DRUG)
    ("the fully human recombinant scFv BsAb" . SPARSER::DRUG)
    ("a fully human BsAb" . SPARSER::DRUG) ("HAMA" . SPARSER::PROTEIN)
    ("antibody (HAMA)" . SPARSER::ANTIBODY) ("CD19/CD3" . SPARSER::COLLECTION)
    ("CD28 monoclonal antibody and HER2/CD3 BsAb" . SPARSER::COLLECTION)
    ("TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("BsAbs and lymphocytes" . SPARSER::COLLECTION)
    ("a fully human recombinant single chain BsAb" . SPARSER::DRUG)
    ("CD3 and HER2" . SPARSER::COLLECTION) ("RPMI" . SPARSER::PROTEIN)
    ("TNF-α, IFN-γ and IL-2" . SPARSER::COLLECTION)
    ("TNF-α, IFN-γ, IL-4 and IL-2" . SPARSER::COLLECTION)
    ("CD4 or CD8" . SPARSER::COLLECTION) ("CD4 and CD8" . SPARSER::COLLECTION)
    ("CD25 and CD69" . SPARSER::COLLECTION)
    ("HER2 and CD3" . SPARSER::COLLECTION)
    ("neither HER2 nor CD3 ( xref )" . SPARSER::COLLECTION)
    ("scFv" . SPARSER::PROTEIN) ("a fully human HER2/CD3 BsAb" . SPARSER::DRUG)
    ("a fully human recombinant single-chain HER2/CD3 BsAb" . SPARSER::DRUG)
    ("CD3 and the tumor antigens" . SPARSER::COLLECTION)
    ("BsAbs" . SPARSER::DRUG) ("granzyme" . SPARSER::PROTEIN-FAMILY)
    ("perforin" . SPARSER::PROTEIN)
    ("T-cell receptor/CD3 complex" . SPARSER::COLLECTION)
    ("epithelial cell adhesion molecule, CD19 and HER2" . SPARSER::COLLECTION)
    ("adriamycin and cyclophosphamide" . SPARSER::COLLECTION)
    ("cytotoxic chemotherapeutic drugs" . SPARSER::DRUG)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION) ("avastin" . SPARSER::DRUG)
    ("lapatinib and others" . SPARSER::COLLECTION)
    ("herceptin" . SPARSER::DRUG)
    ("antagonists and aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("Endocrine" . SPARSER::PROTEIN)
    ("cyclophosphamide, methotrexate, fluorouracil and taxane"
     . SPARSER::COLLECTION)
    ("taxane" . SPARSER::DRUG)
    ("epidermal growth factor receptor (HER)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a fully human recombinant single chain variable fragment BsAb"
     . SPARSER::DRUG)
    ("BsAb" . SPARSER::DRUG) ("CD69" . SPARSER::PROTEIN)
    ("HER 2" . SPARSER::PROTEIN) ("CD3 complex" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("c-erb-B2" . SPARSER::PROTEIN) ("in Chinese hamster" . SPARSER::PROTEIN)
    ("single chain variable fragment" . SPARSER::PROTEIN)
    ("bispecific antibody" . SPARSER::DRUG)
    ("HDAC9 and TAZ" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("HDAC9 and HDAC9" . SPARSER::COLLECTION)
    ("EGFR, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("CTGF and PDGFβ" . SPARSER::COLLECTION)
    ("molecule, and PI3K/AKT" . SPARSER::COLLECTION)
    ("CCNE-CDK2" . SPARSER::COLLECTION)
    ("cyclin D1, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("HDIs" . SPARSER::MOLECULE) ("EGFR/AKT/ERK" . SPARSER::COLLECTION)
    ("cyclin E and CDK2" . SPARSER::COLLECTION)
    ("Transcriptional coactivator with PDZ-binding motif" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("Histone deacetylase 9" . SPARSER::PROTEIN)
    ("EGFR/HER2" . SPARSER::COLLECTION)
    ("newly developed targeted drugs" . SPARSER::DRUG)
    ("EGFR (erlotinib/gefitinib) and ALK (crizotinib)" . SPARSER::COLLECTION)
    ("EGFR , KRAS , NRAS , HRAS , HER2 , BRAF , ALK , PIK3CA , TP53 , and LKB1"
     . SPARSER::COLLECTION)
    ("EGFR , KRAS , ALK , HER2 , and BRAF" . SPARSER::COLLECTION)
    ("EGFR , HER2 , ALK , KRAS , and HER2" . SPARSER::COLLECTION)
    ("KRAS and LKB1" . SPARSER::COLLECTION)
    ("EGFR and BRAF" . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("ALK , ROS1 , and RET" . SPARSER::COLLECTION)
    ("ROS1 and RET" . SPARSER::COLLECTION)
    ("KRAS , PIK3CA , TP53 , ERBB2 , and BRAF" . SPARSER::COLLECTION)
    ("gene and LungCarta" . SPARSER::COLLECTION)
    ("an invasive component" . SPARSER::COMPONENT)
    ("N1, and N2" . SPARSER::COLLECTION) ("Tobacco" . SPARSER::DRUG)
    ("other histologic subtypes" . SPARSER::PROTEIN)
    ("ALK, KRAS, PIK3CA, ERBB2, BRAF, ROS1, and RET" . SPARSER::COLLECTION)
    ("26 lung cancer-associated genes and three fusion genes"
     . SPARSER::COLLECTION)
    ("26 lung cancer-associated genes" . SPARSER::GENE)
    ("ALK, ROS1 , and RET" . SPARSER::COLLECTION)
    ("CDK5 or Tau" . SPARSER::COLLECTION) ("Tau-CRMP2" . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("CDK5 and DRP1" . SPARSER::COLLECTION)
    ("mitochondrial elongation" . SPARSER::PROTEIN)
    ("dynamin" . SPARSER::PROTEIN)
    ("proteins, Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("Tau and CRMP2" . SPARSER::COLLECTION)
    ("neurotoxins and HIV proteins" . SPARSER::COLLECTION)
    ("CDK5 and cell cycle regulators [e.g., p27]" . SPARSER::COLLECTION)
    ("neurotoxins" . SPARSER::PROTEIN)
    ("Tau, CRMP2 and DCX" . SPARSER::COLLECTION)
    ("CDK5 and p27" . SPARSER::COLLECTION)
    ("CRMP-associated molecule" . SPARSER::MOLECULE)
    ("CRMP" . SPARSER::PROTEIN)
    ("Tau [ xref , xref ] and CRMP2 [ xref , xref ]" . SPARSER::COLLECTION)
    ("GSK3β and CDK5" . SPARSER::COLLECTION)
    ("postsynaptic density protein 95 [PSD95] and MEF2 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("Tau and other substrates" . SPARSER::COLLECTION)
    ("CRMP2 [ xref ] and DCX" . SPARSER::COLLECTION)
    ("CRMP2 and DCX" . SPARSER::COLLECTION)
    ("CDK5 and pTau" . SPARSER::COLLECTION)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("vif" . SPARSER::PROTEIN)
    ("CRMP2 [ xref ] and Tau [ xref ]" . SPARSER::COLLECTION)
    ("pTau" . SPARSER::PROTEIN) ("pcDNA-GFP" . SPARSER::COLLECTION)
    ("spiked" . SPARSER::PROTEIN) ("pcDNA" . SPARSER::PROTEIN)
    ("CDK5 and cell cycle regulators" . SPARSER::COLLECTION)
    ("the post-mitotic state" . SPARSER::BIO-STATE)
    ("synaptic proteins" . SPARSER::PROTEIN)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("the predominant CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ser-Thr" . SPARSER::COLLECTION)
    ("a nuclear neuronal pro-survival transcription factor" . SPARSER::PROTEIN)
    ("the active p25/CDK5 complex" . SPARSER::BIO-COMPLEX)
    ("p25/CDK5" . SPARSER::COLLECTION)
    ("aberrantly phosphorylated neuronal substrates" . SPARSER::SUBSTRATE)
    ("types and tissues" . SPARSER::COLLECTION)
    ("Viral proteins" . SPARSER::PROTEIN)
    ("gp120 and Nef and cytokines" . SPARSER::COLLECTION)
    ("macrophages/microglia" . SPARSER::COLLECTION)
    ("doublecortin [DCX] and MEF2" . SPARSER::COLLECTION)
    ("Tau, collapsin response mediator protein-2 [CRMP2], doublecortin [DCX] and MEF2"
     . SPARSER::COLLECTION)
    ("DCX" . SPARSER::PROTEIN) ("doublecortin" . SPARSER::PROTEIN)
    ("p35 or p39" . SPARSER::COLLECTION)
    ("gp120 and Nef" . SPARSER::COLLECTION) ("p-Tau" . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("DRP1" . SPARSER::PROTEIN)
    ("Gp120" . SPARSER::DRUG)
    ("postsynaptic density protein 95" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN)
    ("microtubule-associated protein Tau" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("CRMP2" . SPARSER::PROTEIN)
    ("collapsin response mediator protein-2" . SPARSER::PROTEIN)
    ("p25" . SPARSER::PROTEIN) ("p39" . SPARSER::PROTEIN)
    ("p35" . SPARSER::PROTEIN) ("GCN2 that regulate GCN2's" . SPARSER::PROTEIN)
    ("PP6C-PP6R-GCN2" . SPARSER::COLLECTION)
    ("exogenous GCN2" . SPARSER::PROTEIN)
    ("GCN2 and PP6C" . SPARSER::COLLECTION)
    ("mTORC1 and GCN2" . SPARSER::COLLECTION) ("PP6Cs" . SPARSER::PROTEIN)
    ("Cs" . SPARSER::PROTEIN) ("PP6C and mutants" . SPARSER::COLLECTION)
    ("PP6R-GCN2" . SPARSER::COLLECTION) ("PP6R" . SPARSER::PROTEIN)
    ("PP6Rs" . SPARSER::PROTEIN) ("PP6C-PP6R" . SPARSER::COLLECTION)
    ("PP6C or PP6C" . SPARSER::COLLECTION)
    ("PP6R1, PP6R2, or PP6R3" . SPARSER::COLLECTION)
    ("both endogenous GCN2 and endogenous PP6C" . SPARSER::COLLECTION)
    ("PP6R1, PP6R2, and PP6R2" . SPARSER::COLLECTION)
    ("GCN2/PP6C" . SPARSER::COLLECTION)
    ("PP6R1, PP6R2 and PP6R3" . SPARSER::COLLECTION)
    ("PP6C, PP6Rs, and GCN2" . SPARSER::COLLECTION)
    ("4EBP1 and S6 Kinase" . SPARSER::COLLECTION)
    ("histidinyl-tRNA" . SPARSER::COLLECTION) ("synthetase" . SPARSER::PROTEIN)
    ("MEFs and TSC2" . SPARSER::COLLECTION)
    ("GCN2, and GCN2" . SPARSER::COLLECTION) ("tRNAs" . SPARSER::PROTEIN)
    ("MEFs and MEFs" . SPARSER::COLLECTION)
    ("rapamycin and chloroquine" . SPARSER::COLLECTION)
    ("the autophagy essential yeast ATG1 gene" . SPARSER::GENE)
    ("LC3-GFP" . SPARSER::COLLECTION) ("an intact eIF2α" . SPARSER::PROTEIN)
    ("PP2A or PP4" . SPARSER::COLLECTION)
    ("proteins, PP6R1, PP6R2, and PP6R3" . SPARSER::COLLECTION)
    ("SIT" . SPARSER::PROTEIN) ("Suppressor" . SPARSER::SUPPRESSOR)
    ("LC3B and ATG5" . SPARSER::COLLECTION)
    ("the highly specific bacterial product rapamycin" . SPARSER::DRUG)
    ("raptor, and mTORC2" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("the wild-type PP6C allele and increase eIF2α phosphorylation"
     . SPARSER::COLLECTION)
    ("PP6C-GCN2" . SPARSER::COLLECTION)
    ("GCN2, or eIF2α" . SPARSER::COLLECTION)
    ("Aurora Kinase A" . SPARSER::PROTEIN) ("TAP42" . SPARSER::PROTEIN-FAMILY)
    ("IGBP1" . SPARSER::PROTEIN)
    ("histidyl-tRNA synthetase" . SPARSER::PROTEIN) ("ATG1" . SPARSER::PROTEIN)
    ("gadd34" . SPARSER::PROTEIN) ("ATF-3" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("PP6R3" . SPARSER::PROTEIN)
    ("PP6" . SPARSER::PROTEIN) ("PP6R1" . SPARSER::PROTEIN)
    ("PP4" . SPARSER::PROTEIN)
    ("protein phosphatase 6 catalytic subunit" . SPARSER::PROTEIN)
    ("TORC1" . SPARSER::PROTEIN) ("ATF-4" . SPARSER::PROTEIN)
    ("ATG13" . SPARSER::PROTEIN) ("PP6C" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("receptors, TrkA-C and MuSK" . SPARSER::COLLECTION)
    ("MuSK" . SPARSER::PROTEIN)
    ("the crystallographic JMTK dimer" . SPARSER::DIMER)
    ("cis and trans" . SPARSER::COLLECTION)
    ("this symmetric dimer" . SPARSER::DIMER)
    ("a possible activated dimer" . SPARSER::DIMER)
    ("at least one acceptor Cy5-labelled protein" . SPARSER::PROTEIN)
    ("IR-JMTKs" . SPARSER::COLLECTION) ("JMTKs" . SPARSER::PROTEIN)
    ("the IR-JMTK crystallographic dimer" . SPARSER::DIMER)
    ("IR- and IGF1R-JMTK containing" . SPARSER::COLLECTION)
    ("IR ( xref ) and the equivalent valines" . SPARSER::COLLECTION)
    ("valines" . SPARSER::AMINO-ACID)
    ("the proteins and the lipids" . SPARSER::COLLECTION)
    ("NTA" . SPARSER::MOLECULE)
    ("three-dimensional solution" . SPARSER::MOLECULE)
    ("IR/IGF1R" . SPARSER::COLLECTION) ("IGF1R-JMTK" . SPARSER::COLLECTION)
    ("IR-" . SPARSER::PROTEIN) ("This symmetric dimer" . SPARSER::DIMER)
    ("molecule, and vice" . SPARSER::COLLECTION) ("AMPPNP" . SPARSER::MOLECULE)
    ("JMTK" . SPARSER::PROTEIN) ("IR-JMTK" . SPARSER::COLLECTION)
    ("a symmetric dimer" . SPARSER::DIMER) ("IRS" . SPARSER::PROTEIN)
    ("phosphoryl" . SPARSER::MOLECULE)
    ("an extracellular α subunit and a membrane-spanning β subunit"
     . SPARSER::COLLECTION)
    ("canonical RTKs" . SPARSER::PROTEIN)
    ("IR and IGF1R" . SPARSER::COLLECTION)
    ("The insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R)"
     . SPARSER::COLLECTION)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("B-factor" . SPARSER::PROTEIN) ("I1R" . SPARSER::PROTEIN)
    ("Mono-Q" . SPARSER::DRUG) ("IR-related receptor" . SPARSER::PROTEIN)
    ("1K" . SPARSER::PROTEIN) ("IR3" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mg 2 +" . SPARSER::MOLECULE)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("RB and EGFR" . SPARSER::COLLECTION)
    ("RB1 and TP53" . SPARSER::COLLECTION)
    ("the larger cohort" . SPARSER::MOLECULE)
    ("MYC , PTEN and FGFR1" . SPARSER::COLLECTION)
    ("significantly more active" . SPARSER::ACTIVE)
    ("gefitinib as well as the third-generation EGFR inhibitor"
     . SPARSER::COLLECTION)
    ("mRNA and miRNA" . SPARSER::COLLECTION) ("mm 3" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("Abt-263" . SPARSER::DRUG)
    ("RB protein" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("Wang" . SPARSER::PROTEIN)
    ("HES1, GLI1 and NANOG" . SPARSER::COLLECTION)
    ("NANOG/OCT4" . SPARSER::COLLECTION) ("WNT/CTNNB1" . SPARSER::COLLECTION)
    ("NCAD, VIM, CD44, ZEB1, and POU5F1" . SPARSER::COLLECTION)
    ("IRS-1/PI3K" . SPARSER::COLLECTION) ("monomeric p85" . SPARSER::PROTEIN)
    ("p85-p110" . SPARSER::COLLECTION)
    ("PIK3CA , AKT and PTEN" . SPARSER::COLLECTION)
    ("ERK ( P = 0.07; P = 0.45) and ERK" . SPARSER::COLLECTION)
    ("HES1 and GLI1" . SPARSER::COLLECTION)
    ("CTNNB1, HES1, GLI1, and NANOG" . SPARSER::COLLECTION)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("antibodies and anti-CXCR4" . SPARSER::COLLECTION)
    ("CD44, CD133 and CXCR4" . SPARSER::COLLECTION)
    ("PIK3R1 and ECAD" . SPARSER::COLLECTION)
    ("NCAD and VIM" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("CD44 and POU5F1" . SPARSER::COLLECTION)
    ("VIM ( P < 0.01; P < 0.05) and ZEB1 ( P < 0.05; P < 0.05)"
     . SPARSER::COLLECTION)
    ("NCAD, VIM and ZEB1" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("ECAD" . SPARSER::PROTEIN) ("WB" . SPARSER::PROTEIN)
    ("western blot (WB)" . SPARSER::PROTEIN) ("Haploid" . SPARSER::PROTEIN)
    ("NCAD" . SPARSER::PROTEIN) ("haploid" . SPARSER::PROTEIN)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("heterodimers that consist of a catalytic subunit (p110α, p110β and p110δ) and a regulatory subunit (p85α, p55α, p50α, p85β, and p55γ) xref"
     . SPARSER::COLLECTION)
    ("p110α, p110β and p110δ" . SPARSER::COLLECTION)
    ("p85α, p55α, p50α, p85β, and p55γ" . SPARSER::COLLECTION)
    ("IA" . SPARSER::MOLECULE) ("VHL" . SPARSER::PROTEIN)
    ("EMT and stem-like" . SPARSER::COLLECTION)
    ("AKT/GSK3β/CTNNB1" . SPARSER::COLLECTION)
    ("p-GSK3β" . SPARSER::COLLECTION) ("pRCC" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("P200" . SPARSER::PROTEIN)
    ("HK-2" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GLI1" . SPARSER::PROTEIN) ("POU5F1" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("P85α" . SPARSER::PROTEIN)
    ("p55γ" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("p110δ" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4, 5-bisphosphate" . SPARSER::PIP2)
    ("PBRM1" . SPARSER::PROTEIN)
    ("inflammatory cytokines and MMP-9" . SPARSER::COLLECTION)
    ("vascular SMCs" . SPARSER::PROTEIN)
    ("the increased inflammatory cytokines" . SPARSER::PROTEIN)
    ("MMPs and tissue inhibitors" . SPARSER::COLLECTION)
    ("oxLDLs and oxysterols" . SPARSER::COLLECTION)
    ("TIMPs" . SPARSER::PROTEIN) ("MP" . SPARSER::PROTEIN)
    ("IL-1β, IL-8, IL-12, IL-18, and TNF-α" . SPARSER::COLLECTION)
    ("NF-κB, and activator protein-1" . SPARSER::COLLECTION)
    ("human aortic SMCs" . SPARSER::PROTEIN)
    ("antibody or TLR4" . SPARSER::COLLECTION)
    ("TLR4 or TLR4" . SPARSER::COLLECTION)
    ("inflammatory cytokines and MMPs" . SPARSER::COLLECTION)
    ("lipids, and concentrations" . SPARSER::COLLECTION)
    ("certain pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("THP-1" . SPARSER::PROTEIN) ("TLR4 and TLR2" . SPARSER::COLLECTION)
    ("LDL" . SPARSER::PROTEIN) ("arterial SMCs" . SPARSER::PROTEIN)
    ("various inflammatory cytokines" . SPARSER::PROTEIN)
    ("TLR4 and CD36" . SPARSER::COLLECTION)
    ("IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, and IL-10" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines and MMPs" . SPARSER::COLLECTION)
    ("cytokines and MMPs" . SPARSER::COLLECTION) ("statin" . SPARSER::MOLECULE)
    ("ApoE and TLR4" . SPARSER::COLLECTION) ("/TLR4" . SPARSER::COLLECTION)
    ("ApoE  −/− and MyD88  +/+ mice" . SPARSER::COLLECTION)
    ("apolipoprotein E (ApoE) and MyD88" . SPARSER::COLLECTION)
    ("ApoE" . SPARSER::PROTEIN) ("cytokines and MMP-9" . SPARSER::COLLECTION)
    ("antibody or PTN" . SPARSER::COLLECTION)
    ("inactive and active" . SPARSER::COLLECTION)
    ("parthenolide (PTN)" . SPARSER::MOLECULE) ("PTN" . SPARSER::PROTEIN)
    ("parthenolide" . SPARSER::MOLECULE) ("TLR4/NF-κB" . SPARSER::COLLECTION)
    ("this inflammatory cytokine" . SPARSER::PROTEIN)
    ("the inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-8, TNF-α, and IL-1β" . SPARSER::COLLECTION)
    ("these inflammatory cytokines" . SPARSER::PROTEIN)
    ("the principal oxysterol" . SPARSER::PROTEIN)
    ("particular interleukin-6" . SPARSER::PROTEIN)
    ("IL-8, IL-1β, and tumor necrosis factor-α" . SPARSER::COLLECTION)
    ("Poli" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("oxidized phospholipids, cholesterol oxidation products (oxysterols), and free and esterified aldehydes"
     . SPARSER::COLLECTION)
    ("the classic endogenous ligands" . SPARSER::LIGAND)
    ("aldehydes" . SPARSER::MOLECULE) ("oxysterols" . SPARSER::MOLECULE)
    ("oxLDLs" . SPARSER::MOLECULE) ("LDLs" . SPARSER::PROTEIN)
    ("TLR2 and TLR4" . SPARSER::COLLECTION) ("TLR2" . SPARSER::PROTEIN)
    ("TLR4 and TLR3" . SPARSER::COLLECTION)
    ("exogenous and endogenous ligands" . SPARSER::LIGAND)
    ("TRIF" . SPARSER::PROTEIN) ("TIR" . SPARSER::PROTEIN-FAMILY)
    ("PAMPs" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("IL-8, IL-1β, and TNF-α" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE) ("oxysterol" . SPARSER::PROTEIN)
    ("IL-1 beta" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("amyloid-β" . SPARSER::MOLECULE) ("CD36" . SPARSER::PROTEIN)
    ("apolipoprotein E" . SPARSER::PROTEIN) ("mL -1" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("HRas/Raf-1" . SPARSER::COLLECTION)
    ("tipifarnib" . SPARSER::DRUG) ("CD81–CLDN1" . SPARSER::COLLECTION)
    ("Epithelial tight junctions form" . SPARSER::FORM)
    ("JFH1-EGFP" . SPARSER::PROTEIN-PAIR)
    ("HCV RNA and core protein release" . SPARSER::COLLECTION)
    ("Raf and HRas" . SPARSER::COLLECTION)
    ("EGF or antibody" . SPARSER::COLLECTION)
    ("EGF, CD81 or HCVcc" . SPARSER::COLLECTION)
    ("EGF, and Raf-1" . SPARSER::COLLECTION)
    ("Ras/Raf/Erk" . SPARSER::COLLECTION) ("Raf1" . SPARSER::PROTEIN)
    ("Antibody" . SPARSER::PROTEIN) ("antibody or HCVcc" . SPARSER::COLLECTION)
    ("CD81-CLDN1" . SPARSER::COLLECTION) ("HRas" . SPARSER::PROTEIN)
    ("the erythroblastic leukemia viral oncogene homolog (ERBB) family"
     . SPARSER::PROTEIN-FAMILY)
    ("CLDN1 and CD81" . SPARSER::COLLECTION)
    ("CD81 and CLDN1" . SPARSER::COLLECTION)
    ("the tetraspanin superfamily member CD81 and the tight junction protein claudin1 (CLDN1)"
     . SPARSER::COLLECTION)
    ("the tetraspanin superfamily member CD81" . SPARSER::PROTEIN)
    ("CD81 and IFI6" . SPARSER::COLLECTION)
    ("IFI6 and CD81" . SPARSER::COLLECTION)
    ("CD81 and occludin" . SPARSER::COLLECTION)
    ("IFI6 and E1 or E2" . SPARSER::COLLECTION)
    ("proteins and IFI6" . SPARSER::COLLECTION)
    ("IFI6 and HCV structural proteins (data not shown)" . SPARSER::COLLECTION)
    ("E1 or E2" . SPARSER::COLLECTION) ("IFI6-FLAG" . SPARSER::COLLECTION)
    ("/IFI6" . SPARSER::COLLECTION) ("E1 and E2" . SPARSER::COLLECTION)
    ("exogenous proteins" . SPARSER::PROTEIN)
    ("significantly fewer infected foci" . SPARSER::PROTEIN)
    ("IHH" . SPARSER::PROTEIN) ("Nile" . SPARSER::PROTEIN)
    ("IFI6 and IFI27" . SPARSER::COLLECTION)
    ("TNF-related apoptosis-inducing ligand/caspase 8" . SPARSER::COLLECTION)
    ("Ras/Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("CD81 and claudin 1" . SPARSER::COLLECTION) ("Claudin" . SPARSER::PROTEIN)
    ("associated ligands" . SPARSER::LIGAND)
    ("Tetraspanins" . SPARSER::PROTEIN)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("viral envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD81/CLDN1" . SPARSER::COLLECTION) ("infectious foci" . SPARSER::PROTEIN)
    ("co- receptors" . SPARSER::PROTEIN) ("R − E" . SPARSER::PROTEIN)
    ("SR-B1" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("NS4B" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("F-H" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("claudin1" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("IFITM1" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("Rep2" . SPARSER::PROTEIN) ("IFI27" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("IFN-α2b" . SPARSER::PROTEIN) ("claudin 1" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CLDN1" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("IFI6" . SPARSER::PROTEIN) ("protein 6" . SPARSER::PROTEIN)
    ("interferon-α" . SPARSER::DRUG)
    ("Cry2 and Hausp, and Cry2" . SPARSER::COLLECTION)
    ("Hausp, and Cry2" . SPARSER::COLLECTION)
    ("Cry2-Hausp" . SPARSER::COLLECTION) ("mg132" . SPARSER::PROTEIN)
    ("an associated protein" . SPARSER::PROTEIN) ("HAUSP" . SPARSER::PROTEIN)
    ("complex and transcript" . SPARSER::COLLECTION)
    ("Rad23b" . SPARSER::PROTEIN) ("Gadd45a and Rrm2b" . SPARSER::COLLECTION)
    ("possible direct targets" . SPARSER::TARGET-PROTEIN)
    ("transcriptional repressors and the observed degradation of Cry2"
     . SPARSER::COLLECTION)
    ("Gadd45a or Puma" . SPARSER::COLLECTION)
    ("Gadd45a and Puma" . SPARSER::COLLECTION)
    ("some sequence-specific DNA binding transcription factor"
     . SPARSER::PROTEIN)
    ("Fbxl3 and Hausp" . SPARSER::COLLECTION)
    ("Cry1 and Cr2" . SPARSER::COLLECTION) ("Cr2" . SPARSER::PROTEIN)
    ("which targets Crys" . SPARSER::PROTEIN) ("Crys" . SPARSER::PROTEIN)
    ("circadian proteins" . SPARSER::PROTEIN) ("TQ" . SPARSER::DRUG)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE) ("letter" . SPARSER::MOLECULE)
    ("Cry1, Cry2, and Hausp" . SPARSER::COLLECTION)
    ("the Cry1- and Cry2-associated protein" . SPARSER::COLLECTION)
    ("Cry2-associated protein" . SPARSER::PROTEIN)
    ("RNA binding and RNA" . SPARSER::COLLECTION) ("Clock" . SPARSER::PROTEIN)
    ("Cry1-" . SPARSER::PROTEIN) ("arrhythmic Cry1  −/−" . SPARSER::PROTEIN)
    ("the circadian transcriptional repressors Cry1 and Cry2"
     . SPARSER::COLLECTION)
    ("Cry2  −/− and Cry1  −/−" . SPARSER::COLLECTION)
    ("Rrm2b" . SPARSER::PROTEIN)
    ("Cry1 and/or Cry2 ( xref )" . SPARSER::COLLECTION)
    ("Cdkn1a" . SPARSER::PROTEIN) ("Cry1 or Cry2" . SPARSER::COLLECTION)
    ("SQ" . SPARSER::MOLECULE) ("phosphorylatable" . SPARSER::PROTEIN)
    ("Hausp and Cry2" . SPARSER::COLLECTION)
    ("Hausp–Cry1" . SPARSER::COLLECTION) ("Cry1–Hausp" . SPARSER::COLLECTION)
    ("a circadian promoter" . SPARSER::PROMOTER)
    ("Per2::Luc" . SPARSER::BIO-COMPLEX)
    ("Per2-Luciferase" . SPARSER::COLLECTION)
    ("Hausp and Cry1" . SPARSER::COLLECTION)
    ("Fbxl3 and Fbxl21" . SPARSER::COLLECTION)
    ("Cry1 and Hausp" . SPARSER::COLLECTION)
    ("Mdm2/MdmX" . SPARSER::COLLECTION) ("Mdm2 and MdmX" . SPARSER::COLLECTION)
    ("MdmX" . SPARSER::PROTEIN) ("Fbxl3 and SCF" . SPARSER::COLLECTION)
    ("Fbxl21" . SPARSER::PROTEIN) ("USPs" . SPARSER::PROTEIN)
    ("prokaryotic light-activated DNA repair enzymes" . SPARSER::ENZYME)
    ("Cry1 and/or Cry2" . SPARSER::COLLECTION)
    ("the glucocorticoid receptor ( xref ) and the CRE-responsive element binding protein (CREB) ( xref )"
     . SPARSER::COLLECTION)
    ("element binding protein (CREB)" . SPARSER::PROTEIN)
    ("FBXL3 or FBXL21" . SPARSER::COLLECTION) ("CRY" . SPARSER::PROTEIN)
    ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("Per1 , Per2 , and Per3" . SPARSER::COLLECTION)
    ("PERs and CRYs" . SPARSER::COLLECTION)
    ("CLOCK and BMAL1" . SPARSER::COLLECTION) ("PERs" . SPARSER::PROTEIN)
    ("BMAL1 and CLOCK" . SPARSER::COLLECTION) ("CLOCK" . SPARSER::PROTEIN)
    ("clock—" . SPARSER::PROTEIN) ("this circadian clock" . SPARSER::PROTEIN)
    ("the circadian clock" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("Cry1 and Cry2" . SPARSER::COLLECTION) ("Cry1/Cry2" . SPARSER::COLLECTION)
    ("Fbxl3" . SPARSER::PROTEIN) ("Usp7" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN) ("Hausp" . SPARSER::PROTEIN)
    ("bacterial light-activated DNA repair enzymes" . SPARSER::ENZYME)
    ("Cry2" . SPARSER::PROTEIN) ("Cry1" . SPARSER::PROTEIN)
    ("Rad23" . SPARSER::PROTEIN-FAMILY) ("CRY2" . SPARSER::PROTEIN)
    ("KL001" . SPARSER::DRUG) ("USP7" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("TX-100" . SPARSER::DRUG)
    ("PS1" . SPARSER::PROTEIN) ("p19" . SPARSER::PROTEIN)
    ("Xrcc1" . SPARSER::PROTEIN) ("p16ink4a" . SPARSER::PROTEIN)
    ("Gadd45a" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("S18" . SPARSER::PROTEIN) ("PPM1G" . SPARSER::PROTEIN)
    ("CT2" . SPARSER::PROTEIN) ("Vmw110" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN)
    ("FBXL21" . SPARSER::PROTEIN) ("FBXL3" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("Per3" . SPARSER::PROTEIN)
    ("Per2" . SPARSER::PROTEIN) ("Per1" . SPARSER::PROTEIN)
    ("BMAL1" . SPARSER::PROTEIN) ("gp120 and CD4" . SPARSER::COLLECTION)
    ("Galectins" . SPARSER::PROTEIN) ("JNK, p38 and ERK" . SPARSER::COLLECTION)
    ("CCL19 and CXCL12" . SPARSER::COLLECTION)
    ("IL-12p70, IL-10, IL-6, TNF-α, IL-1β and IL-23" . SPARSER::COLLECTION)
    ("β1-" . SPARSER::PROTEIN)
    ("cytokines or chemokines" . SPARSER::COLLECTION)
    ("Tim-3 and Gal-9" . SPARSER::COLLECTION)
    ("Tim-3, PDI and CD44" . SPARSER::COLLECTION)
    ("NGC and the PL046" . SPARSER::COLLECTION) ("NGC" . SPARSER::PROTEIN)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("p52 and RelB" . SPARSER::COLLECTION) ("p52/RelB" . SPARSER::COLLECTION)
    ("c-Rel, p65 and p50" . SPARSER::COLLECTION)
    ("MCP-2 or IFN-α" . SPARSER::COLLECTION)
    ("neither ERK inhibitor PD98059 (Fig. xref ) nor JNK inhibitor SP600125 (Fig. xref )"
     . SPARSER::COLLECTION)
    ("IL-18, IL-23 and IL-27" . SPARSER::COLLECTION)
    ("IFN-α, TNF-α, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("CD80, CD83, CD86 and HLA-DR" . SPARSER::COLLECTION)
    ("Gal-9-Tim-3" . SPARSER::COLLECTION)
    ("CCL19 or CCL21" . SPARSER::COLLECTION) ("attractant" . SPARSER::PROTEIN)
    ("protein disulphide isomerase (PDI) or CD44" . SPARSER::COLLECTION)
    ("Tim-3, protein disulphide isomerase (PDI) or CD44" . SPARSER::COLLECTION)
    ("isomerase (PDI)" . SPARSER::ISOMERASE) ("disulphide" . SPARSER::MOLECULE)
    ("Tim-3 and other potential receptors" . SPARSER::COLLECTION)
    ("Gal-9 and Tim-3" . SPARSER::COLLECTION) ("PL" . SPARSER::PROTEIN)
    ("IL-1α, IL-1β and IFN-γ" . SPARSER::COLLECTION)
    ("-IL-6" . SPARSER::COLLECTION)
    ("a positive pro-inflammatory regulator" . SPARSER::REGULATOR)
    ("MRL" . SPARSER::PROTEIN-FAMILY) ("interferon" . SPARSER::PROTEIN)
    ("Gal-9 and its ligand" . SPARSER::COLLECTION)
    ("galactoside" . SPARSER::MOLECULE) ("galectins" . SPARSER::PROTEIN)
    ("CCL19 and CCL21" . SPARSER::COLLECTION)
    ("kinase or extracellular signal-regulated kinase (ERK)"
     . SPARSER::COLLECTION)
    ("kinase or extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("Gal-1 or Gal-3" . SPARSER::COLLECTION) ("DV" . SPARSER::MOLECULE)
    ("interferon-γ and interleukin (IL)" . SPARSER::COLLECTION)
    ("interferon-γ and interleukin" . SPARSER::COLLECTION)
    ("gp120" . SPARSER::DRUG) ("sphingosine kinase" . SPARSER::PROTEIN)
    ("IL-12 receptor" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Poly I:C" . SPARSER::MOLECULE) ("1-1" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("IL-27" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN)
    ("transforming growth factor-beta1" . SPARSER::PROTEIN)
    ("MCP-2" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein" . SPARSER::PROTEIN)
    ("MIP-1β" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("TLR-3" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD83" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("Tim-3" . SPARSER::PROTEIN) ("Galectin-1" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN) ("CCL21" . SPARSER::PROTEIN)
    ("CCL19" . SPARSER::PROTEIN) ("Gal-3" . SPARSER::PROTEIN)
    ("Gal-1" . SPARSER::PROTEIN) ("Gal-9" . SPARSER::PROTEIN)
    ("Galectin-9" . SPARSER::PROTEIN)
    ("the mutated p53 variants that facilitate somatic cell reprogramming and increase"
     . SPARSER::COLLECTION)
    ("the mutated p53 variants" . SPARSER::VARIANT)
    ("the topoisomerase II inhibitor etoposide" . SPARSER::DRUG)
    ("NANOG , SOX2 , and OCT3/4" . SPARSER::COLLECTION)
    ("Topoisomerase II inhibitors" . SPARSER::INHIBITOR)
    ("SOX2 , NANOG , and OCT3/4" . SPARSER::COLLECTION)
    ("Isoform" . SPARSER::ISOFORM)
    ("C-MYC, SOX 2, OCT 3/4, and NANOG" . SPARSER::COLLECTION)
    ("Isoforms" . SPARSER::ISOFORM)
    ("SOX2 , OCT3/4 , and  NANOG" . SPARSER::COLLECTION)
    ("TA and Δ40" . SPARSER::COLLECTION)
    ("at least 12 different physiological isoforms" . SPARSER::ISOFORM)
    ("TA and Δ133" . SPARSER::COLLECTION) ("iPS" . SPARSER::PROTEIN)
    ("CD24/CD44" . SPARSER::COLLECTION)
    ("a major tumor suppressor gene" . SPARSER::PROTEIN)
    ("SOX2 , OCT3/4 , and NANOG" . SPARSER::COLLECTION)
    ("G–3" . SPARSER::PROTEIN) ("OCT 3" . SPARSER::PROTEIN)
    ("SOX 2" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("OCT3" . SPARSER::PROTEIN) ("the heterocyclic part" . SPARSER::COMPONENT)
    ("CDK-2 and GSK-3β" . SPARSER::COLLECTION)
    ("ligand and oxygen" . SPARSER::COLLECTION)
    ("another energetically favorable conformation"
     . SPARSER::BIO-CONFORMATION)
    ("PHE" . SPARSER::AMINO-ACID) ("CDK-2 or GSK-3β" . SPARSER::COLLECTION)
    ("CDK-2 and −10.1 kcal/mol" . SPARSER::COLLECTION)
    ("GLU" . SPARSER::AMINO-ACID) ("VAL" . SPARSER::AMINO-ACID)
    ("LEU" . SPARSER::AMINO-ACID) ("GUA" . SPARSER::MOLECULE)
    ("indirubin and its analogs [ xref , xref , xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 2 (CDK-2) and glycogen synthase kinase-3 (GSK-3β)"
     . SPARSER::COLLECTION)
    ("natural indirubin" . SPARSER::DRUG)
    ("cyclin-dependent kinases (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Indirubins" . SPARSER::DRUG) ("indirubins" . SPARSER::DRUG)
    ("mitochondrial ATPase" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("-oxime" . SPARSER::MOLECULE) ("oxime" . SPARSER::MOLECULE)
    ("indirubin" . SPARSER::DRUG) ("triazole" . SPARSER::MOLECULE)
    ("derivatives and analogs" . SPARSER::COLLECTION)
    ("Indirubin" . SPARSER::DRUG) ("GSK3B" . SPARSER::PROTEIN)
    ("GSK 3β" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN) ("CDK-2" . SPARSER::PROTEIN)
    ("H -1" . SPARSER::PROTEIN) ("INSR/p85" . SPARSER::COLLECTION)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("sXBP1 and ATF6" . SPARSER::COLLECTION)
    ("ATF6 and XBP1" . SPARSER::COLLECTION)
    ("INSR, p85α or XBP1" . SPARSER::COLLECTION)
    ("These results shed new light" . SPARSER::PROTEIN)
    ("ATF6, ATF4 and sXBP1" . SPARSER::COLLECTION)
    ("nuclear ATF6 (50 kDa) and CHOP" . SPARSER::COLLECTION)
    ("diabetic INSR flox/Wt x Pod Cre" . SPARSER::PROTEIN)
    ("INSR-p85-sXBP1" . SPARSER::COLLECTION)
    ("Cre and p85β" . SPARSER::COLLECTION)
    ("p85α (p85α flox/flox x Pod Cre ) and p85β (p85β −/− )"
     . SPARSER::COLLECTION)
    ("the INSR, p85α (p85α flox/flox x Pod Cre ) and p85β (p85β −/− )"
     . SPARSER::COLLECTION)
    ("lack spontaneous proteinuria" . SPARSER::PROTEIN)
    ("flox/Wt" . SPARSER::COLLECTION) ("proteinuria" . SPARSER::PROTEIN)
    ("p85α/p85β" . SPARSER::COLLECTION) ("INSR-p85" . SPARSER::COLLECTION)
    ("p85α and p85β" . SPARSER::COLLECTION) ("p85α" . SPARSER::PROTEIN)
    ("p85α-sXBP1 and p85β-sXBP1" . SPARSER::COLLECTION)
    ("p85β-sXBP1" . SPARSER::COLLECTION) ("p85α-sXBP1" . SPARSER::COLLECTION)
    ("p85–XBP1" . SPARSER::COLLECTION)
    ("total-XBP1 and sXBP1" . SPARSER::COLLECTION)
    ("INSR—p85" . SPARSER::COLLECTION) ("sXBP1" . SPARSER::PROTEIN)
    ("p85-sXBP1" . SPARSER::PROTEIN-PAIR) ("Doxycycline" . SPARSER::DRUG)
    ("β -galactosidase and ATF6" . SPARSER::COLLECTION)
    ("Tet-ATF6" . SPARSER::COLLECTION) ("Pod" . SPARSER::PROTEIN)
    ("nuclear ATF6 (50 kDa) and CHOP" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("IRE1-XBP1" . SPARSER::COLLECTION)
    ("tunicamycin or thapsigargin" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE) ("tunicamycin" . SPARSER::MOLECULE)
    ("mannitol" . SPARSER::PROTEIN)
    ("ATF6 (50 kDa) and CHOP" . SPARSER::COLLECTION)
    ("sodium–glucose" . SPARSER::PROTEIN) ("dapagliflozin" . SPARSER::DRUG)
    ("Edem1" . SPARSER::PROTEIN) ("Ero1b" . SPARSER::PROTEIN)
    ("ATF6 and CHOP" . SPARSER::COLLECTION)
    ("PERK and eIF2α" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("increased nuclear ATF6 (50 kDa) and CHOP" . SPARSER::COLLECTION)
    ("STZ-model" . SPARSER::DRUG)
    ("ATF6 (active form; 50 kDa) and CHOP" . SPARSER::COLLECTION)
    ("lipid and insulin" . SPARSER::COLLECTION)
    ("IRE1/XBP1" . SPARSER::COLLECTION) ("Inositol" . SPARSER::PROTEIN)
    ("TUDCA" . SPARSER::DRUG)
    ("insulin receptor, p85, and XBP1" . SPARSER::COLLECTION)
    ("the insulin receptor or the regulatory subunits phosphatidylinositol 3-kinase (PI3K) p85α or p85β"
     . SPARSER::COLLECTION)
    ("protein (CHOP)" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("NPHS2" . SPARSER::PROTEIN) ("Beta galactosidase" . SPARSER::PROTEIN)
    ("Lamin A/C" . SPARSER::PROTEIN) ("P85" . SPARSER::PROTEIN)
    ("PI3Kinase" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("SGLT2" . SPARSER::PROTEIN) ("PDIA4" . SPARSER::PROTEIN)
    ("DNAJC3" . SPARSER::PROTEIN) ("DNAJB9" . SPARSER::PROTEIN)
    ("IRE1α" . SPARSER::PROTEIN)
    ("double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("tauroursodeoxycholic acid" . SPARSER::DRUG) ("p85β" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("X-box binding protein-1" . SPARSER::PROTEIN)
    ("HATs or genes" . SPARSER::COLLECTION)
    ("several other inflammatory cytokines" . SPARSER::PROTEIN)
    ("miR-146a" . SPARSER::COLLECTION) ("SIRT1 or p300" . SPARSER::COLLECTION)
    ("Endothelin 1 and TGF-β1" . SPARSER::COLLECTION)
    ("ET-1 and FN" . SPARSER::COLLECTION)
    ("mesangial expansion etc ." . SPARSER::PROTEIN)
    ("collagen and FN" . SPARSER::COLLECTION)
    ("ET-1 or TGF-β1" . SPARSER::COLLECTION)
    ("diabetes-induced increased FN protein" . SPARSER::PROTEIN)
    ("micro-albumin" . SPARSER::PROTEIN) ("Streptozotocin" . SPARSER::DRUG)
    ("siRNA or p300" . SPARSER::COLLECTION)
    ("p300 and SIRT1" . SPARSER::COLLECTION)
    ("ET-1 and TGF-β1" . SPARSER::COLLECTION)
    ("siRNA and p300" . SPARSER::COLLECTION)
    ("SIRT1 and p300" . SPARSER::COLLECTION)
    ("mRNA and enzyme" . SPARSER::COLLECTION) ("STZ" . SPARSER::DRUG)
    ("ET-1 and TGF-β1 and" . SPARSER::COLLECTION)
    ("NFκB and AP-1" . SPARSER::COLLECTION)
    ("one vital regulator" . SPARSER::REGULATOR)
    ("Endothelin 1 (ET-1) and transforming growth factor β1 (TGF-β1)"
     . SPARSER::COLLECTION)
    ("fibronectin (FN) and collagen" . SPARSER::COLLECTION)
    ("p300, ET-1 and TGF-β1" . SPARSER::COLLECTION)
    ("streptozotocin" . SPARSER::DRUG) ("retinas" . SPARSER::DRUG)
    ("ET-1, TGF-β1, SIRT1, p300 and collagen" . SPARSER::COLLECTION)
    ("25 mmol/l glucose (HG) and 5 mmol/l glucose (NG)" . SPARSER::COLLECTION)
    ("glucose (NG)" . SPARSER::MOLECULE) ("glucose (HG)" . SPARSER::MOLECULE)
    ("SIRT1 or histone" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("ET-1 and TGF-β1" . SPARSER::COLLECTION)
    ("endothelin 1 (ET-1) and transforming growth factor beta 1 (TGF-β1)"
     . SPARSER::COLLECTION)
    ("146a" . SPARSER::PROTEIN) ("SMAD7" . SPARSER::PROTEIN)
    ("Endothelin 1" . SPARSER::PROTEIN) ("ET-1" . SPARSER::PROTEIN)
    ("endothelin 1" . SPARSER::PROTEIN) ("HC-associated HR" . SPARSER::PROTEIN)
    ("CtIP/MRE11" . SPARSER::COLLECTION) ("ATRi" . SPARSER::MOLECULE)
    ("DSBs" . SPARSER::PROTEIN) ("ATM and ATR" . SPARSER::COLLECTION)
    ("Olaparib" . SPARSER::DRUG) ("ATM and PARP" . SPARSER::COLLECTION)
    ("DSB" . SPARSER::PROTEIN) ("triamcinolone" . SPARSER::DRUG)
    ("DSRed" . SPARSER::PROTEIN) ("HC-DSBs" . SPARSER::PROTEIN-PAIR)
    ("the residual RAD51 foci" . SPARSER::PROTEIN)
    ("residual RAD51 foci" . SPARSER::PROTEIN)
    ("Ku55933 and Mirin" . SPARSER::COLLECTION)
    ("only 12 foci" . SPARSER::PROTEIN)
    ("an almost four times fewer RPA foci" . SPARSER::PROTEIN)
    ("either ATM inhibitor and/or MRE11 inhibitor" . SPARSER::COLLECTION)
    ("ATM or MRE11" . SPARSER::COLLECTION) ("Mirin" . SPARSER::DRUG)
    ("ATM and MRE11" . SPARSER::COLLECTION)
    ("residual RAD51 and yH2AX foci" . SPARSER::PROTEIN)
    ("RAD51 and yH2AX" . SPARSER::COLLECTION)
    ("CtIP, MRE11, EXO1 and BLM" . SPARSER::COLLECTION)
    ("BRCA2 and RAD54" . SPARSER::COLLECTION)
    ("MRE11 and CtIP" . SPARSER::COLLECTION)
    ("nucleolytic enzymes" . SPARSER::ENZYME)
    ("mitomycin C ( xref ) and topotecan ( xref )" . SPARSER::COLLECTION)
    ("-Polymerase" . SPARSER::COLLECTION) ("topotecan" . SPARSER::DRUG)
    ("ATM or siRNA-mediated" . SPARSER::COLLECTION)
    ("BRCA1, BLM, NBS1, MRE11 and CtIP" . SPARSER::COLLECTION)
    ("BLM" . SPARSER::PROTEIN) ("PIKK" . SPARSER::KINASE)
    ("phosphatidyl" . SPARSER::MOLECULE)
    ("residual RAD51/γH2AX foci" . SPARSER::PROTEIN)
    ("RAD51/γH2AX" . SPARSER::COLLECTION) ("SCE" . SPARSER::PROTEIN)
    ("CtIP and MRE11" . SPARSER::COLLECTION)
    ("ATPase activity" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("KAP-1" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("peak 2" . SPARSER::PROTEIN) ("Ku55933" . SPARSER::DRUG)
    ("ICR1" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("VE-821" . SPARSER::DRUG) ("KU55933" . SPARSER::DRUG)
    ("EXO1" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("inositol 3-kinase" . SPARSER::PROTEIN) ("-MAPK" . SPARSER::COLLECTION)
    ("KRAS and c-Myc" . SPARSER::COLLECTION)
    ("RAS-MAPK-ERK" . SPARSER::COLLECTION) ("cis-trans" . SPARSER::COLLECTION)
    ("SCF-SKP2" . SPARSER::COLLECTION) ("-MAPK kinase" . SPARSER::COLLECTION)
    ("the only peptidyl-prolyl cis/trans isomerase" . SPARSER::COLLECTION)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("KRAS and TP53" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("ERK/FBW7/c-Myc" . SPARSER::COLLECTION)
    ("FBW7 and c-Myc" . SPARSER::COLLECTION)
    ("cyclin E, c-Jun, Notch-1, SREBP1, PGC-1α, KLF5 and Mcl-1"
     . SPARSER::COLLECTION)
    ("wild-type FBW7 and a T205A phospho-deficient mutant"
     . SPARSER::COLLECTION)
    ("-fused" . SPARSER::COLLECTION)
    ("MEK1 (MEK1-CA) or ERK1 kinase" . SPARSER::COLLECTION)
    ("p-FBW7" . SPARSER::COLLECTION)
    ("phospho-Threonine-Proline" . SPARSER::COLLECTION)
    ("TP" . SPARSER::PROTEIN) ("Proline" . SPARSER::AMINO-ACID)
    ("endogenous FBW7 and vice versa ( xref and xref )" . SPARSER::COLLECTION)
    ("Flag-FBW7" . SPARSER::COLLECTION) ("ERK1 and FBW7" . SPARSER::COLLECTION)
    ("HA-ERK1" . SPARSER::COLLECTION) ("FBW7 and ERK1" . SPARSER::COLLECTION)
    ("MAPK-ERK" . SPARSER::COLLECTION)
    ("UO126, AZD6244, trametinib and SCH772984" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION) ("p-Erk" . SPARSER::COLLECTION)
    ("FBW7 and p-ERK" . SPARSER::COLLECTION)
    ("FBW7 and phospho-ERK" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("p53, Pin1, Hes-5 and Numb4" . SPARSER::COLLECTION)
    ("Numb" . SPARSER::PROTEIN)
    ("cyclin E, c-Myc, c-Jun, Notch-1, SREBP1 and Mcl-1" . SPARSER::COLLECTION)
    ("p53 or DPC4" . SPARSER::COLLECTION)
    ("p53 , DPC4 and BRCA2" . SPARSER::COLLECTION)
    ("KRAS and loss-of-function" . SPARSER::COLLECTION)
    ("SMAD4 and BRCA2" . SPARSER::COLLECTION) ("c-nu" . SPARSER::PROTEIN)
    ("p-RSK" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("Ink4a" . SPARSER::PROTEIN) ("KLF-5" . SPARSER::PROTEIN)
    ("NEDD4-1" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN)
    ("Ral guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("peptidyl-prolyl cis-trans isomerase" . SPARSER::PROTEIN)
    ("p-Thr" . SPARSER::PROTEIN)
    ("phospho-Threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("UO126" . SPARSER::DRUG) ("hCDC4" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("Hes-5" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN) ("FBW7" . SPARSER::PROTEIN)
    ("WD repeat domain" . SPARSER::PROTEIN)
    ("mRNA and lncRNA" . SPARSER::COLLECTION)
    ("RNA polymerase II and enhancer" . SPARSER::COLLECTION)
    ("classical mitogenic and proinflammatory genes" . SPARSER::GENE)
    ("accessible chromatin" . SPARSER::PROTEIN)
    ("soluble FoxA1" . SPARSER::PROTEIN)
    ("E2, TNFα, or E2+ TNFα" . SPARSER::COLLECTION)
    ("E2- and TNFα-treated MCF-7 cells" . SPARSER::COLLECTION)
    ("E2-" . SPARSER::MOLECULE)
    ("POU3F1, EFNA1 , and B4GALT1" . SPARSER::COLLECTION)
    ("PTGER3, GALNTL4 , and PPP1R3C" . SPARSER::COLLECTION)
    ("NF-κB or FoxA1" . SPARSER::COLLECTION)
    ("p65 or FoxA1" . SPARSER::COLLECTION)
    ("p65, FoxA1, and ERα" . SPARSER::COLLECTION)
    ("Enhancers" . SPARSER::PROTEIN) ("TNFα or TNFα" . SPARSER::COLLECTION)
    ("H3K27ac and CBP" . SPARSER::COLLECTION)
    ("p65 (for TNFα alone; xref , top right ) or ERα and p65 (for E2 + TNFα; xref , top )"
     . SPARSER::COLLECTION)
    ("TNFα or E2 + TNFα" . SPARSER::COLLECTION)
    ("ERα and p65" . SPARSER::COLLECTION)
    ("distal enhancers" . SPARSER::PROTEIN)
    ("RELA and ESR1" . SPARSER::COLLECTION)
    ("ERα (a transcription factor mediator of the estrogen signaling pathway) and the p65 subunit"
     . SPARSER::COLLECTION)
    ("E2 or TNFα" . SPARSER::COLLECTION)
    ("mRNA genes and long non-coding RNA (lncRNA) genes" . SPARSER::COLLECTION)
    ("E2 and TNFα" . SPARSER::COLLECTION) ("seq" . SPARSER::PROTEIN)
    ("estrogen and TNFα" . SPARSER::COLLECTION)
    ("ERα and NF-κB" . SPARSER::COLLECTION)
    ("TNFα-activated NF-κB and estrogen-activated ERα" . SPARSER::COLLECTION)
    ("estrogens and TNFα" . SPARSER::COLLECTION)
    ("chemokines, cytokines, and growth factors" . SPARSER::COLLECTION)
    ("estrogens" . SPARSER::MOLECULE)
    ("chromatin looping and target gene transcription ( xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("coregulatory proteins and chromatin-modifying enzymes"
     . SPARSER::COLLECTION)
    ("coregulatory proteins" . SPARSER::PROTEIN)
    ("FoxA1 or AP2γ" . SPARSER::COLLECTION)
    ("NF-κB and FoxA1" . SPARSER::COLLECTION) ("NF-κB-" . SPARSER::PROTEIN)
    ("estradiol (E2) and TNFα" . SPARSER::COLLECTION)
    ("GRO-seq" . SPARSER::COLLECTION) ("GRO" . SPARSER::PROTEIN)
    ("SNRP70" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("PPP1R3C" . SPARSER::PROTEIN) ("GALNTL4" . SPARSER::PROTEIN)
    ("PTGER3" . SPARSER::PROTEIN) ("P2RY2" . SPARSER::PROTEIN)
    ("B4GALT1" . SPARSER::PROTEIN) ("EFNA1" . SPARSER::PROTEIN)
    ("POU3F1" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("H3K4" . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("FoxA1" . SPARSER::PROTEIN) ("PKC-α and P53" . SPARSER::COLLECTION)
    ("his" . SPARSER::AMINO-ACID) ("P53-P63-Dicer" . SPARSER::COLLECTION)
    ("the Dicer and the PKC-α" . SPARSER::COLLECTION)
    ("the Dicer's" . SPARSER::PROTEIN) ("PKC-α-Dicer" . SPARSER::COLLECTION)
    ("the PKC-α and the Dicer" . SPARSER::COLLECTION)
    ("SV" . SPARSER::MOLECULE) ("Dicer and PKC-α" . SPARSER::COLLECTION)
    ("caspase-3-PARP" . SPARSER::COLLECTION)
    ("PKC-α and Dicer" . SPARSER::COLLECTION) ("DNase" . SPARSER::PROTEIN)
    ("the ribonuclease III enzymes" . SPARSER::ENZYME)
    ("ribonuclease" . SPARSER::PROTEIN)
    ("the caspase-3 or the PARP" . SPARSER::COLLECTION)
    ("PKC-α or Dicer" . SPARSER::COLLECTION) ("P63" . SPARSER::PROTEIN)
    ("116 kD" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("TAZ and Yki" . SPARSER::COLLECTION) ("angiomotin" . SPARSER::PROTEIN)
    ("AICAR, metformin, and A769662" . SPARSER::COLLECTION)
    ("AICAR-" . SPARSER::PROTEIN) ("AICAR or A769662" . SPARSER::COLLECTION)
    ("AICAR or metformin" . SPARSER::COLLECTION) ("Yki" . SPARSER::PROTEIN)
    ("drosophila" . SPARSER::PROTEIN) ("YAP-S94 forms" . SPARSER::FORM)
    ("alanine or glutamate" . SPARSER::COLLECTION)
    ("TSC2 and ULK1" . SPARSER::COLLECTION)
    ("AICAR and metformin" . SPARSER::COLLECTION)
    ("Lats2-KR" . SPARSER::COLLECTION)
    ("Metformin and AICAR" . SPARSER::COLLECTION)
    ("ribonucleotide (AICAR)" . SPARSER::MOLECULE)
    ("TEAD-luciferase" . SPARSER::COLLECTION)
    ("AMPKα1 or AMPKα2" . SPARSER::COLLECTION) ("PPase" . SPARSER::PROTEIN)
    ("ATP and AMP" . SPARSER::COLLECTION) ("MST" . SPARSER::PROTEIN)
    ("CTGF and CYR61" . SPARSER::COLLECTION) ("sorbitol" . SPARSER::PROTEIN)
    ("low-glucose" . SPARSER::PROTEIN)
    ("a nonmetabolizable glucose analog" . SPARSER::ANALOG)
    ("MST1/2 and Lats1/2 kinases and their downstream effectors"
     . SPARSER::COLLECTION)
    ("AMPK α1" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("YAP2" . SPARSER::PROTEIN) ("AMPKα 1" . SPARSER::PROTEIN)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY) ("Phos-tag" . SPARSER::DRUG)
    ("AMOTL1" . SPARSER::PROTEIN) ("RUNX2" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("AMPKα1" . SPARSER::PROTEIN)
    ("CYR61" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("phos-tag" . SPARSER::DRUG)
    ("microtubule-associated serine threonine kinase-like"
     . SPARSER::PROTEIN-FAMILY)
    ("securin or cyclin B1" . SPARSER::COLLECTION)
    ("catenanes" . SPARSER::DRUG) ("MASTL or ESPL1" . SPARSER::COLLECTION)
    ("TOP2A or ESPL1" . SPARSER::COLLECTION)
    ("case residual cyclin B1" . SPARSER::PROTEIN)
    ("CCNA2 or CCNB1" . SPARSER::COLLECTION)
    ("APC10 and Cdc20" . SPARSER::COLLECTION)
    ("Cdc20 and APC10" . SPARSER::COLLECTION) ("D-box" . SPARSER::PROTEIN)
    ("Checkpoint-sensitive APC/C Cdc20 substrates" . SPARSER::SUBSTRATE)
    ("PP2A and cyclin B1" . SPARSER::COLLECTION)
    ("a clear elongation" . SPARSER::PROTEIN) ("Topo" . SPARSER::PROTEIN)
    ("other mitotic regulators" . SPARSER::REGULATOR)
    ("shugoshin" . SPARSER::PROTEIN) ("CDC20 or MASTL" . SPARSER::COLLECTION)
    ("Cdc20–D-box" . SPARSER::PROTEIN-PAIR)
    ("cyclin B1-APC/C" . SPARSER::COLLECTION)
    ("cyclin B1 and the APC/C" . SPARSER::COLLECTION)
    ("MCCs" . SPARSER::PROTEIN) ("MASTL and Cdc20" . SPARSER::COLLECTION)
    ("APC3, APC4, APC10, or Cdc20" . SPARSER::COLLECTION)
    ("mitotic APC/C" . SPARSER::PROTEIN) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("Nek2A, Cdc20 or Mad2" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN) ("cyclin B1 or Nek2A" . SPARSER::COLLECTION)
    ("nocodazole-" . SPARSER::DRUG) ("the mitotic APC/C" . SPARSER::PROTEIN)
    ("APC/C" . SPARSER::PROTEIN) ("APC/C-Cdc20" . SPARSER::COLLECTION)
    ("securin and geminin" . SPARSER::COLLECTION)
    ("securin or geminin" . SPARSER::COLLECTION)
    ("CDC20 , CDH1 , and MASTL" . SPARSER::COLLECTION)
    ("Securin and geminin" . SPARSER::COLLECTION)
    ("Securin" . SPARSER::PROTEIN) ("Cyclin B1-Cdk1" . SPARSER::COLLECTION)
    ("CKS1B and CKS2" . SPARSER::COLLECTION)
    ("a Cdk1 inhibitor (RO-3306) or an Aurora B inhibitor (AZD1152)"
     . SPARSER::COLLECTION)
    ("MASTL and PPP2CA" . SPARSER::COLLECTION)
    ("cyclin B1-Cdk1" . SPARSER::COLLECTION)
    ("a pure fraction" . SPARSER::COMPONENT)
    ("cyclin B1 and securin" . SPARSER::COLLECTION)
    ("geminin and securin" . SPARSER::COLLECTION)
    ("geminin" . SPARSER::PROTEIN)
    ("phospho-serine and phospho-threonine" . SPARSER::COLLECTION)
    ("that Gwl's" . SPARSER::PROTEIN) ("GWL" . SPARSER::PROTEIN)
    ("Endosulfines" . SPARSER::PROTEIN-FAMILY)
    ("These two small homologous proteins" . SPARSER::PROTEIN)
    ("Arpp" . SPARSER::PROTEIN) ("Endosulfine" . SPARSER::PROTEIN-FAMILY)
    ("also known as microtubule-associated serine/threonine kinase-like (MASTL)"
     . SPARSER::PROTEIN-FAMILY)
    ("kinase-like (MASTL)" . SPARSER::PROTEIN-FAMILY)
    ("Gwl" . SPARSER::PROTEIN) ("Greatwall" . SPARSER::PROTEIN)
    ("PP2A-B55" . SPARSER::COLLECTION)
    ("other mitotic kinases" . SPARSER::KINASE) ("NEB" . SPARSER::PROTEIN)
    ("kinases and their counteracting phosphatases" . SPARSER::COLLECTION)
    ("separase" . SPARSER::PROTEIN) ("securin" . SPARSER::PROTEIN)
    ("MASTL" . SPARSER::PROTEIN) ("Cdk1 and Cks" . SPARSER::COLLECTION)
    ("Cks" . SPARSER::PROTEIN)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN) ("APC2" . SPARSER::PROTEIN)
    ("Nek2A" . SPARSER::PROTEIN) ("α at" . SPARSER::PROTEIN)
    ("Phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Nek2" . SPARSER::PROTEIN) ("anti-Histone" . SPARSER::PROTEIN)
    ("Emi1" . SPARSER::PROTEIN) ("APC10" . SPARSER::PROTEIN)
    ("APC8" . SPARSER::PROTEIN) ("APC4" . SPARSER::PROTEIN)
    ("APC3" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("SGOL1" . SPARSER::PROTEIN) ("PPP2CA" . SPARSER::PROTEIN)
    ("PP2A-C" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("CKS1" . SPARSER::PROTEIN) ("CKS1B" . SPARSER::PROTEIN)
    ("CDC20" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("ICRF-193" . SPARSER::DRUG) ("4-OHT" . SPARSER::DRUG)
    ("envelope protein" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("cAMP-regulated phosphoprotein 19" . SPARSER::PROTEIN)
    ("B55" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("S2 and Figures S1" . SPARSER::COLLECTION)
    ("a new biomarker" . SPARSER::MOLECULE)
    ("c-Fos and Fra-1" . SPARSER::COLLECTION)
    ("Fra-1 and c-Fos" . SPARSER::COLLECTION)
    ("IL-6 or STAT3" . SPARSER::COLLECTION)
    ("Snail, Slug and ZEB1" . SPARSER::COLLECTION)
    ("vimentin ( xref ) and pro-EMT microRNAs ( xref )" . SPARSER::COLLECTION)
    ("IDO and cyclin D1" . SPARSER::COLLECTION) ("IDO" . SPARSER::PROTEIN)
    ("TGF-β, EGF and OSM" . SPARSER::COLLECTION)
    ("Akt or ERK" . SPARSER::COLLECTION)
    ("TGF-β, VEGF and TNFα" . SPARSER::COLLECTION)
    ("chemokines, cytokines and growth factors" . SPARSER::COLLECTION)
    ("ZEB1, Snail, Slug, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("LEF1, TCF3 and MMP1" . SPARSER::COLLECTION)
    ("STAT3 and Fra-1" . SPARSER::COLLECTION)
    ("Fra-1-siRNA" . SPARSER::COLLECTION) ("Fra-1-Luc" . SPARSER::COLLECTION)
    ("the JAK2 inhibitor AG490 and the histone acetyltransferases inhibitor anacardic acid"
     . SPARSER::COLLECTION)
    ("trichostatin" . SPARSER::MOLECULE)
    ("acetyltransferases and histone" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("U0126 or LY294002" . SPARSER::COLLECTION)
    ("MEK and PI3K" . SPARSER::COLLECTION) ("stattic" . SPARSER::DRUG)
    ("possible upstream molecules" . SPARSER::MOLECULE)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("cytoplasmic mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("membranous epithelial marker E-cadherin" . SPARSER::PROTEIN)
    ("spindly" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine IL-6" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokine IL-6" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-6 (IL-6) and its intracellular signaling molecule signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("STAT3 or Fra-1" . SPARSER::COLLECTION)
    ("ZEB1, Snail, Slug, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The pro-inflammatory cytokine interleukin-6" . SPARSER::PROTEIN)
    ("annexin A1" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("Fra-1" . SPARSER::PROTEIN) ("radiation-induced DNA" . SPARSER::DNA)
    ("DNA-PKcs, PARP-1 and TNSK1BP1" . SPARSER::COLLECTION)
    ("CAFs" . SPARSER::PROTEIN) ("DNA-PKcs/Ku70/Ku86" . SPARSER::COLLECTION)
    ("basic chromatin proteins" . SPARSER::PROTEIN)
    ("residual γH2AX foci" . SPARSER::PROTEIN)
    ("PARP-1 and DNA-PK" . SPARSER::COLLECTION)
    ("DNA-PK, TNKS1BP1 and PARP-1" . SPARSER::COLLECTION)
    ("TNKS1BP1 and PARP-1" . SPARSER::COLLECTION)
    ("DNA-PKcs and TNKS1BP1" . SPARSER::COLLECTION)
    ("the TNKS1BP1-interacted complex" . SPARSER::BIO-COMPLEX)
    ("Ku70/Ku80/DNA-PKcs" . SPARSER::COLLECTION)
    ("DNA-PKcs and PARP-1" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("Myc-TNKS1BP1" . SPARSER::COLLECTION)
    ("IR, HeLa-shTNKS1BP1 and HeLa-NC" . SPARSER::COLLECTION)
    ("HeLa-NC and HepG2-NC" . SPARSER::COLLECTION) ("rays" . SPARSER::PROTEIN)
    ("PARP-1/DNA-PKcs" . SPARSER::COLLECTION)
    ("DNA-PKcs, Ku70, Ku86, and PARP-1" . SPARSER::COLLECTION)
    ("TAB182" . SPARSER::PROTEIN)
    ("DNA-PKcs and Ku70/Ku80 heterodimer [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("At least three PARP molecules" . SPARSER::MOLECULE)
    ("PARP-1, PARP-2 and PARP-3" . SPARSER::COLLECTION)
    ("polymerases (PARP)" . SPARSER::PROTEIN)
    ("polynucleotide kinase/phosphatase (PNKP)" . SPARSER::PROTEIN)
    ("Artemis, XRCC4, DNA ligase IV, XLF, Werner (WRN) and other DNA damage response proteins"
     . SPARSER::COLLECTION)
    ("PNKP" . SPARSER::PROTEIN) ("XLF" . SPARSER::PROTEIN)
    ("Artemis" . SPARSER::PROTEIN) ("Ku70/Ku86" . SPARSER::COLLECTION)
    ("a particularly hazardous type" . TYPE)
    ("genotoxic chemicals" . SPARSER::MOLECULE)
    ("PARP-1 and DNA-PKcs" . SPARSER::COLLECTION)
    ("DNA-dependent protein kinase (DNA-PKcs) and poly(ADP-ribose) polymerase"
     . SPARSER::COLLECTION)
    ("DAP1" . SPARSER::PROTEIN) ("HP1" . SPARSER::PROTEIN)
    ("XAV939" . SPARSER::DRUG) ("Nu7026" . SPARSER::DRUG)
    ("G 2 /M" . SPARSER::PROTEIN) ("TNKS1BP 1" . SPARSER::PROTEIN)
    ("tankyrase 1 binding protein 1" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("TNKS1" . SPARSER::PROTEIN)
    ("Tankyrase 1" . SPARSER::PROTEIN) ("PARP-3" . SPARSER::PROTEIN)
    ("PARP-2" . SPARSER::PROTEIN) ("DNA ligase IV" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("Ku86" . SPARSER::PROTEIN)
    ("kinase-like" . SPARSER::PROTEIN-FAMILY) ("PI-3" . SPARSER::PROTEIN)
    ("DNA dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("tankyrase 1" . SPARSER::PROTEIN) ("TNKS1BP1" . SPARSER::PROTEIN)
    ("tumor suppressor and its inactivation" . SPARSER::COLLECTION)
    ("Akt, SGK and FOXO1, and re-sensitized" . SPARSER::COLLECTION)
    ("FOXO1, and re-sensitized" . SPARSER::COLLECTION)
    ("S6K (ribosomal S6 kinase) and 4E-BP1 (4E binding protein 1)"
     . SPARSER::COLLECTION)
    ("PKC-α (protein kinase C-α) and SGK1 (serum-glucocorticoid-induced protein kinase-1)"
     . SPARSER::COLLECTION)
    ("(Thr24) in the tissues" . SPARSER::PROTEIN)
    ("PYM and/or cDDP" . SPARSER::COLLECTION)
    ("Akt and SGK1" . SPARSER::COLLECTION)
    ("PYM and cDDP" . SPARSER::COLLECTION) ("si-2" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("pMir-Mut" . SPARSER::COLLECTION) ("pMir-Wt" . SPARSER::COLLECTION)
    ("Mut" . SPARSER::PROTEIN) ("PYM or cDDP" . SPARSER::COLLECTION)
    ("PYM-" . SPARSER::PROTEIN) ("PYM and cisplatin" . SPARSER::COLLECTION)
    ("cDDP" . SPARSER::DRUG) ("PYM" . SPARSER::PROTEIN)
    ("both tumor suppressors and tumor promoters in cancer [ xref ]"
     . SPARSER::COLLECTION)
    ("p-FOXO1" . SPARSER::COLLECTION) ("p-SGK1" . SPARSER::COLLECTION)
    ("protein kinase-1" . SPARSER::PROTEIN) ("PKC-α" . SPARSER::PROTEIN)
    ("KU-0063794" . SPARSER::DRUG) ("BMI1" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("COX2 and PGE 2" . SPARSER::COLLECTION)
    ("ERK/MAP kinase" . SPARSER::COLLECTION)
    ("EGFR and β-catenin" . SPARSER::COLLECTION)
    ("most apoptotic inducers" . SPARSER::MOLECULE) ("PGES" . SPARSER::PROTEIN)
    ("an agonist of EP2 and not L902,688" . SPARSER::COLLECTION)
    ("Butaprost" . SPARSER::DRUG) ("EP2 and EP4" . SPARSER::COLLECTION)
    ("Olig2, GFAP and β-tubulin" . SPARSER::COLLECTION)
    ("nestin and β-tubulin" . SPARSER::COLLECTION)
    ("Olig2 and GFAP" . SPARSER::COLLECTION) ("nestin" . SPARSER::PROTEIN)
    ("ICCM" . SPARSER::PROTEIN) ("media (ICCM)" . SPARSER::PROTEIN)
    ("EP1, EP3 and EP4" . SPARSER::COLLECTION) ("EP1" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN) ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("receptors and kinase" . SPARSER::COLLECTION) ("olig2" . SPARSER::PROTEIN)
    ("MRP4" . SPARSER::PROTEIN) ("activated protein kinase" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("EP4" . SPARSER::PROTEIN)
    ("EP3" . SPARSER::PROTEIN) ("Cox2" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("EP2" . SPARSER::PROTEIN) ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("Prostaglandin E2" . SPARSER::MOLECULE)
    ("a secretive matrix protein" . SPARSER::PROTEIN)
    ("E-cadherin, beta-catenin, and MMPs" . SPARSER::COLLECTION)
    ("Marfan syndrome and Weill-Marchesani" . SPARSER::COLLECTION)
    ("p53 and SLUG" . SPARSER::COLLECTION)
    ("p53 and BRCA2" . SPARSER::COLLECTION)
    ("FBN1 or SLUG" . SPARSER::COLLECTION)
    ("p53, E-cadherin, and β-catenin" . SPARSER::COLLECTION)
    ("SLUG (simplified as S) or FBN1 (simplified as F)" . SPARSER::COLLECTION)
    ("FBN1, or SLUG" . SPARSER::COLLECTION)
    ("Aurora-A, FBN1 or SLUG and BRCA2" . SPARSER::COLLECTION)
    ("SLUG and BRCA2" . SPARSER::COLLECTION)
    ("Aurora-A, FBN1, SLUG or BRCA2" . SPARSER::COLLECTION)
    ("BRCA2, and FBN1" . SPARSER::COLLECTION)
    ("BRCA2, SLUG, and FBN1" . SPARSER::COLLECTION)
    ("FBN1, SLUG and p53" . SPARSER::COLLECTION)
    ("Aurora-A, FBN1, SLUG or p53" . SPARSER::COLLECTION)
    ("FBN1, SLUG or p53" . SPARSER::COLLECTION)
    ("SLUG, FBN1, or p53" . SPARSER::COLLECTION)
    ("BRCA2 and FBN1" . SPARSER::COLLECTION)
    ("SLUG and p53" . SPARSER::COLLECTION)
    ("BRCA2, p53, SLUG and FBN1" . SPARSER::COLLECTION)
    ("BRCA2, SLUG, FBN1, and p53" . SPARSER::COLLECTION)
    ("BRCA2, Aurora-A, SLUG, FBN1 or p53" . SPARSER::COLLECTION)
    ("SLUG, FBN1, and p53" . SPARSER::COLLECTION) ("mm3" . SPARSER::PROTEIN)
    ("shRNA and OVCA420/Aur" . SPARSER::COLLECTION)
    ("SLUG/FBN1" . SPARSER::COLLECTION) ("shRNA/p53" . SPARSER::COLLECTION)
    ("siRNA and OVCA420/BRCA2" . SPARSER::COLLECTION)
    ("FBN1 directly effects E-cadherin and β-cantenin" . SPARSER::COLLECTION)
    ("E-cadherin and β-cantenin" . SPARSER::COLLECTION)
    ("siRNA, and OVCA420/BRCA2" . SPARSER::COLLECTION)
    ("shRNA/FBN1" . SPARSER::COLLECTION)
    ("FBN1 and SLUG" . SPARSER::COLLECTION)
    ("p53, E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("MMP2, MMP9, and MMP13" . SPARSER::COLLECTION)
    ("shRNA or OVCA429/BRCA2" . SPARSER::COLLECTION)
    ("shRNA and OVCA420/BRCA2" . SPARSER::COLLECTION)
    ("shRNA or BRCA2" . SPARSER::COLLECTION)
    ("BRCA2, FBN1, SLUG, or p53" . SPARSER::COLLECTION)
    ("intricate lattice protein" . SPARSER::PROTEIN)
    ("the cytoskeletal regulatory protein SRC" . SPARSER::PROTEIN)
    ("SLUG or FBN1" . SPARSER::COLLECTION)
    ("BRCA2 or Aur" . SPARSER::COLLECTION)
    ("FBN1 and MMP9" . SPARSER::COLLECTION)
    ("SLUG and FBN1" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("SLUG, FBN1, and MMP2" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin, and p53" . SPARSER::COLLECTION)
    ("l-glutamine" . SPARSER::MOLECULE) ("beta-catenin" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("gremlin-1" . SPARSER::PROTEIN)
    ("Marfan syndrome" . SPARSER::PROTEIN) ("Fibrillin-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN) ("FBN1" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN)
    ("a unique molecular target" . SPARSER::TARGET-PROTEIN)
    ("ZEB" . SPARSER::PROTEIN) ("ER−" . SPARSER::PROTEIN)
    ("IGF1R/IR" . SPARSER::COLLECTION) ("IGF-I/IGF1R" . SPARSER::COLLECTION)
    ("vimentin, ZEB1, and pFAK" . SPARSER::COLLECTION)
    ("both PF228 and PF878 treatments" . SPARSER::COLLECTION)
    ("PF228 and PF878" . SPARSER::COLLECTION)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("0.5 μM PF228 or PF878" . SPARSER::COLLECTION)
    ("both PF228 and PF878 caused a decrease in vimentin"
     . SPARSER::COLLECTION)
    ("vimentin and ZEB-1" . SPARSER::COLLECTION)
    ("E-cadherin, claudin-1, and ZO-1" . SPARSER::COLLECTION)
    ("Snail-1" . SPARSER::COLLECTION) ("IGF1R-KD" . SPARSER::COLLECTION)
    ("EMT, invasion, and metastatic processes" . SPARSER::COLLECTION)
    ("FAK and IGF1R" . SPARSER::COLLECTION)
    ("regulators of cell polarity events like lamellipodia formation and Golgi reorientation"
     . SPARSER::COLLECTION)
    ("Rac, Rho, and cdc42" . SPARSER::COLLECTION)
    ("Src and PI3K" . SPARSER::COLLECTION)
    ("human monoclonal antibodies" . SPARSER::ANTIBODY)
    ("IGF1R/FAK" . SPARSER::COLLECTION) ("IGF1R and FAK" . SPARSER::COLLECTION)
    ("PF573228" . SPARSER::DRUG)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("PF228" . SPARSER::DRUG) ("ZEB-1" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("19a" . SPARSER::PROTEIN) ("E2F1 and MYC" . SPARSER::COLLECTION)
    ("a classical oncogene" . SPARSER::ONCOGENE)
    ("HER2 and Src" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("PTK6-KD" . SPARSER::COLLECTION) ("S1P/PTK6" . SPARSER::COLLECTION)
    ("PTK6 and ERK1/2" . SPARSER::COLLECTION)
    ("shRNA-PTK6-KD" . SPARSER::COLLECTION)
    ("siRNA-PTK6" . SPARSER::COLLECTION)
    ("The polycistronic microRNA" . SPARSER::RNA)
    ("kinase (BRK)" . SPARSER::KINASE) ("sphingolipid" . SPARSER::MOLECULE)
    ("PTK6 or ERK1/2" . SPARSER::COLLECTION)
    ("induced PTK6 and its downstream signal component (ERK1/2)"
     . SPARSER::COLLECTION)
    ("Ha-Ras" . SPARSER::PROTEIN) ("b-1" . SPARSER::PROTEIN)
    ("c-Src kinase" . SPARSER::PROTEIN)
    ("Protein tyrosine kinase 6" . SPARSER::PROTEIN)
    ("S1P 1" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("PTK6" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG)
    ("pathogenic single-chain PV antibodies" . SPARSER::ANTIBODY)
    ("caspase-3 and p38MAPK" . SPARSER::COLLECTION)
    ("cyclins, c-Myc and N-Myc" . SPARSER::COLLECTION)
    ("extracellular metalloproteases" . SPARSER::PROTEIN)
    ("plakoglobin, plakophilin and desmoplakin" . SPARSER::COLLECTION)
    ("desmoplakin" . SPARSER::PROTEIN) ("plakophilin" . SPARSER::PROTEIN)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("these pro-proliferative mediators" . SPARSER::PROTEIN)
    ("caspases-8, -9 and -12" . SPARSER::COLLECTION)
    ("EGFR and c-Myc" . SPARSER::COLLECTION)
    ("all currently available experimental PV" . SPARSER::PROTEIN)
    ("c-Myc and N-Myc" . SPARSER::COLLECTION)
    ("the pan-caspase inhibitor or caspase-3 inhibitor III"
     . SPARSER::COLLECTION)
    ("Triton X-100 soluble epidermal protein" . SPARSER::PROTEIN)
    ("mIgG" . SPARSER::PROTEIN)
    ("Desmosomal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-8, -9 and -12" . SPARSER::COLLECTION)
    ("classical apoptotic pathway components" . SPARSER::COMPONENT)
    ("Caspase-8, -9 and -12" . SPARSER::COLLECTION)
    ("a pan-caspase and two caspase-3 inhibitors" . SPARSER::COLLECTION)
    ("Ac-DEVD-CMK" . SPARSER::COLLECTION) ("CMK" . SPARSER::PROTEIN)
    ("FMK" . SPARSER::PROTEIN)
    ("full-length PARP and no cleaved PARP" . SPARSER::COLLECTION)
    ("Cytoskeletal actin" . SPARSER::PROTEIN)
    ("the pathogenic antibody AK23 or mouse (m)IgG"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pan-caspase and caspase-3" . SPARSER::COLLECTION)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("TdT" . SPARSER::PROTEIN)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("cis- or trans-adhesion" . SPARSER::COLLECTION)
    ("cis-" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("caspase-3 and metalloproteases" . SPARSER::COLLECTION)
    ("desmosomal cadherins and adhesive components" . SPARSER::COLLECTION)
    ("desmosomal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trans- or cis-adhesion" . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("Dsg3 and Dsg1" . SPARSER::COLLECTION)
    ("auto-antibodies" . SPARSER::ANTIBODY) ("Dsg" . SPARSER::DRUG)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PV" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("hsp27" . SPARSER::PROTEIN)
    ("p120 RasGAP" . SPARSER::PROTEIN) ("granzyme B" . SPARSER::PROTEIN)
    ("caspases-1" . SPARSER::PROTEIN) ("caspases-8" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("75 kD" . SPARSER::PROTEIN)
    ("100 kD" . SPARSER::PROTEIN) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("CPP32" . SPARSER::PROTEIN) ("keratin 14" . SPARSER::PROTEIN)
    ("caspase-12" . SPARSER::PROTEIN) ("Z-LEHD-FMK" . SPARSER::DRUG)
    ("Z-IETD-FMK" . SPARSER::DRUG) ("desmoglein 3" . SPARSER::PROTEIN)
    ("Dsg1" . SPARSER::PROTEIN) ("Dsg3" . SPARSER::PROTEIN)
    ("normal adipocytes" . SPARSER::PROTEIN)
    ("enough exogenous IGFBP-2" . SPARSER::PROTEIN)
    ("these mature adipocytes" . SPARSER::PROTEIN)
    ("exogenous IGFBP-2" . SPARSER::PROTEIN)
    ("IGFBP-2, IL-6sR, IL-8, leptin, MIF, and TGF-β" . SPARSER::COLLECTION)
    ("the adjacent adipocytes" . SPARSER::PROTEIN) ("KL" . SPARSER::PROTEIN)
    ("cancer-associated adipocytes (CAA)" . SPARSER::PROTEIN)
    ("human mature adipocytes and co-cultured" . SPARSER::COLLECTION)
    ("adipocytes and co-cultured" . SPARSER::COLLECTION)
    ("pre-adipocytes" . SPARSER::PROTEIN)
    ("hematoxylin and eosin" . SPARSER::COLLECTION)
    ("mRNA, and siRNA" . SPARSER::COLLECTION)
    ("PDGF-BB (210 pg/ml), IL-6sR (110 pg/ml) and TNF-a (529 pg/ml)"
     . SPARSER::COLLECTION)
    ("IGFBP-2, PDGF-BB, IL-6sR and TNF-a" . SPARSER::COLLECTION)
    ("activation normal T-cell" . SPARSER::PROTEIN)
    ("IGFBP-2 and PDGF-BB" . SPARSER::COLLECTION)
    ("interleukin-6 soluble receptor" . SPARSER::RECEPTOR)
    ("MIF" . SPARSER::PROTEIN)
    ("hormone-sensitive lipase (HSL)" . SPARSER::PROTEIN)
    ("HSL" . SPARSER::PROTEIN)
    ("several metastasis-associated genes" . SPARSER::GENE)
    ("palmitate" . SPARSER::PROTEIN) ("interleukin (IL)" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-11 and pro-inflammatory" . SPARSER::COLLECTION)
    ("IL-1β and IL-8" . SPARSER::COLLECTION)
    ("metastasis-associated proteins" . SPARSER::PROTEIN)
    ("stromal adipocytes" . SPARSER::PROTEIN) ("FFAs" . SPARSER::PROTEIN)
    ("Adipocytes" . SPARSER::PROTEIN)
    ("human mature adipocytes" . SPARSER::PROTEIN)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("co-cultured human mature adipocytes" . SPARSER::PROTEIN)
    ("MCP-3" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 3" . SPARSER::PROTEIN)
    ("ENA-78" . SPARSER::PROTEIN) ("angiopoietin-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("ANGPTL4" . SPARSER::PROTEIN) ("angiopoietin like 4" . SPARSER::PROTEIN)
    ("hormone-sensitive lipase" . SPARSER::PROTEIN)
    ("TNF-a" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-11" . SPARSER::PROTEIN)
    ("MMP-11" . SPARSER::PROTEIN) ("IGFBP-2" . SPARSER::PROTEIN)
    ("x" . SPARSER::PROTEIN) ("CD4:CD8" . SPARSER::BIO-COMPLEX)
    ("inhibitor (CKI)" . SPARSER::INHIBITOR) ("CKI" . SPARSER::PROTEIN)
    ("KIR-HLA" . SPARSER::COLLECTION) ("KIR" . SPARSER::PROTEIN)
    ("a major viral coreceptor" . SPARSER::PROTEIN)
    ("coreceptor" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("ODC1" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("TAP2" . SPARSER::PROTEIN) ("APOBEC3G" . SPARSER::PROTEIN)
    ("TRIM5α" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("cell permeable inhibitor" . SPARSER::INHIBITOR)
    ("GEF-H1, Rho/ROCK, and MLC phosphorylation" . SPARSER::COLLECTION)
    ("Rho/ROCK" . SPARSER::COLLECTION)
    ("the neuronal proteins MAP2 and tau" . SPARSER::COLLECTION)
    ("MAP2 and tau" . SPARSER::COLLECTION) ("tau" . SPARSER::PROTEIN)
    ("MAPs" . SPARSER::PROTEIN) ("MLCK and Rho" . SPARSER::COLLECTION)
    ("LPS- or TNF-α" . SPARSER::COLLECTION)
    ("MAP4 (Ala) and MKK6 (Glu)" . SPARSER::COLLECTION)
    ("polymeric tubulin" . SPARSER::PROTEIN)
    ("the pivotal kinase" . SPARSER::KINASE)
    ("inflammation-induced ALI" . SPARSER::PROTEIN)
    ("LPS (1.21- and 2.23-fold reduction at S696 and S787, respectively) or TNF-α (1.67- and 1.55-fold reduction at S696 and S787, respectively)"
     . SPARSER::COLLECTION)
    ("a phosphor-specific p38/MAPK antibody" . SPARSER::ANTIBODY)
    ("P38/MAPK" . SPARSER::COLLECTION) ("LPS-" . SPARSER::PROTEIN)
    ("polymer" . SPARSER::MOLECULE)
    ("polymerised tubulin and free tubulin" . SPARSER::COLLECTION)
    ("VDAC and GAPDH" . SPARSER::COLLECTION) ("VDAC" . SPARSER::PROTEIN)
    ("LPS or TNF-α" . SPARSER::COLLECTION) ("MTs" . SPARSER::PROTEIN)
    ("LPS and TNF-α" . SPARSER::COLLECTION) ("p38/MAPK" . SPARSER::COLLECTION)
    ("Porin 31HL" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 6" . SPARSER::PROTEIN)
    ("p-P38" . SPARSER::PROTEIN) ("GEF-H1" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("assembly/disassembly" . SPARSER::PROTEIN) ("MAP4" . SPARSER::PROTEIN)
    ("Microtubule-associated protein 4" . SPARSER::PROTEIN)
    ("untreated primary PCa" . SPARSER::PROTEIN)
    ("PCa [ xref ] and certain single-nucleotide polymorphisms"
     . SPARSER::COLLECTION)
    ("CRPC" . SPARSER::PROTEIN) ("19 metastasized PCa" . SPARSER::PROTEIN)
    ("131 primary PCa" . SPARSER::PROTEIN)
    ("GAPDH and Actin" . SPARSER::COLLECTION) ("snoRNA" . SPARSER::RNA)
    ("PSA and PCAT18" . SPARSER::COLLECTION)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("pure testosterone" . SPARSER::MOLECULE)
    ("AR and PCGEM1/PRNCR1" . SPARSER::COLLECTION)
    ("PCa (CRPC)" . SPARSER::PROTEIN)
    ("aggressive PCa [ xref ] and PCA3" . SPARSER::COLLECTION)
    ("aggressive PCa" . SPARSER::PROTEIN)
    ("metastasized PCa" . SPARSER::PROTEIN) ("primary PCa" . SPARSER::PROTEIN)
    ("micro-RNA" . SPARSER::MICRO-RNA) ("MALAT1" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("RNA 1" . SPARSER::PROTEIN-FAMILY) ("PCA3" . SPARSER::RNA)
    ("SChLAP1" . SPARSER::PROTEIN) ("PHD" . SPARSER::PROTEIN)
    ("an active HIF-1 heterodimer" . SPARSER::HETERODIMER)
    ("p53 or Wnt" . SPARSER::COLLECTION)
    ("the peroxisome proliferator-activated receptor (PPAR) family and SREBP"
     . SPARSER::COLLECTION)
    ("family and SREBP" . SPARSER::COLLECTION)
    ("DAG, substrate and product" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine (PE) and phosphatidylcholine (PC)"
     . SPARSER::COLLECTION)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("DAG" . SPARSER::DAG)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("neutral triglycerides" . SPARSER::MOLECULE)
    ("an essential lipogenic enzyme" . SPARSER::ENZYME)
    ("FASN" . SPARSER::PROTEIN) ("ARNT and DNA" . SPARSER::COLLECTION)
    ("HIF-1α and lipin-1" . SPARSER::COLLECTION)
    ("HIF-1α or lipin-1" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION) ("HIF-1-" . SPARSER::PROTEIN)
    ("CK1δ-HIF-1α-lipin-1" . SPARSER::COLLECTION)
    ("HIF-1 and lipin-1" . SPARSER::COLLECTION)
    ("lipin-2" . SPARSER::COLLECTION) ("lipin" . SPARSER::PROTEIN-FAMILY)
    ("b and c" . SPARSER::COLLECTION)
    ("a recently identified hypoxia and HIF-1 regulated gene" . SPARSER::GENE)
    ("hypoxia and HIF-1" . SPARSER::COLLECTION)
    ("the phosphodeficient S247A mutant" . SPARSER::MUTANT)
    ("fraction and residence" . SPARSER::COLLECTION)
    ("bound fraction (defined as the fraction of molecules that are bound at any given time) and residence time (defined as the time a molecule spends on average in the bound state)"
     . SPARSER::COLLECTION)
    ("Wild-type HIF-1α and its phosphomimetic mutant (S247D)"
     . SPARSER::COLLECTION)
    ("its phosphomimetic mutant" . SPARSER::MUTANT)
    ("GFP-HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α or ARNT" . SPARSER::COLLECTION) ("CK1δ" . SPARSER::PROTEIN)
    ("pcDNA3.1-CK1δ" . SPARSER::PROTEIN-PAIR)
    ("HIF-1α and ARNT" . SPARSER::COLLECTION) ("Kaempferol" . SPARSER::DRUG)
    ("anti-HIF-1α and anti-ARNT" . SPARSER::COLLECTION)
    ("HIF-1α/ARNT" . SPARSER::COLLECTION)
    ("HIF-1/lipin-1" . SPARSER::COLLECTION)
    ("complex and poorly understood xref" . SPARSER::COLLECTION)
    ("seven distinct mammalian isoforms (α, β, γ1, γ2, γ3, δ and ε) and their splice variants"
     . SPARSER::COLLECTION)
    ("GSK3, PLK3 and CDK1" . SPARSER::COLLECTION)
    ("NF-κB, PI3-K, MAPK and STAT3" . SPARSER::COLLECTION)
    ("HSP90, RACK1 and MgcRacGAP" . SPARSER::COLLECTION)
    ("MgcRacGAP" . SPARSER::PROTEIN)
    ("an active DNA-binding heterodimer" . SPARSER::HETERODIMER)
    ("PHDs" . SPARSER::PROTEIN)
    ("the regulatory HIFα subunits and the constitutively expressed HIFβ (or aryl hydrocarbon receptor nuclear translocator; ARNT) subunit"
     . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN) ("HIF-1α-" . SPARSER::PROTEIN)
    ("FRAP" . SPARSER::PROTEIN) ("PLA" . SPARSER::PROTEIN)
    ("ARNT" . SPARSER::PROTEIN) ("alpha subunit" . SPARSER::PROTEIN)
    ("CK1α" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("a 37 " . SPARSER::PROTEIN)
    ("T-1" . SPARSER::PROTEIN) ("PLK3" . SPARSER::PROTEIN)
    ("RACK1" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("lipid droplet" . SPARSER::PROTEIN) ("lipin-1" . SPARSER::PROTEIN)
    ("Hypoxia Inducible Factor-1" . SPARSER::PROTEIN)
    ("Gluc" . SPARSER::PROTEIN) ("TGF-β-Smad" . SPARSER::COLLECTION)
    ("TGF-β/Smad3" . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β-Smad3" . SPARSER::COLLECTION) ("TGFβ1" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("DAXX or ATRX" . SPARSER::COLLECTION)
    ("particular ZNRF3" . SPARSER::PROTEIN)
    ("NOTCH1 and NR5A1" . SPARSER::COLLECTION) ("ACC" . SPARSER::PROTEIN)
    ("LINC" . SPARSER::PROTEIN) ("CNA" . SPARSER::PROTEIN)
    ("a homozygous reference allele (R) or a homozygous mutant (M) allele"
     . SPARSER::COLLECTION)
    ("a homozygous mutant (M) allele" . SPARSER::ALLELE)
    ("a homozygous reference allele" . SPARSER::ALLELE)
    ("AI" . SPARSER::PROTEIN) ("the maternal allele" . SPARSER::ALLELE)
    ("a paternally expressed fetal growth factor" . SPARSER::GROWTH-FACTOR)
    ("available parental DNA" . SPARSER::DNA) ("UPD" . SPARSER::PROTEIN)
    ("the entire chromosome 17" . SPARSER::PROTEIN)
    ("DAXX or TERT" . SPARSER::COLLECTION) ("SVs" . SPARSER::MOLECULE)
    ("cisplatin, doxorubicin, etoposide and mitotane" . SPARSER::COLLECTION)
    ("LFS and BWS" . SPARSER::COLLECTION) ("LFS" . SPARSER::PROTEIN)
    ("TP53 and ATRX" . SPARSER::COLLECTION)
    ("ATRX and CTNNB1" . SPARSER::COLLECTION)
    ("major capsid protein" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("ZNRF3" . SPARSER::PROTEIN)
    ("Steroidogenic Factor-1" . SPARSER::PROTEIN) ("NR5A1" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN) ("CDKN1 C" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("Chromosome 17" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("TPX2" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("ESPL1" . SPARSER::PROTEIN) ("PTTG1" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("an anti-apoptotic protein and important target" . SPARSER::COLLECTION)
    ("BCL2, an anti-apoptotic protein and important target"
     . SPARSER::COLLECTION)
    ("CCND1 and CCNE1" . SPARSER::COLLECTION)
    ("BCL2, CCND1 and WNT3A" . SPARSER::COLLECTION)
    ("CCND3, CDK6 and p-Rb" . SPARSER::COLLECTION) ("HFE" . SPARSER::PROTEIN)
    ("anit" . SPARSER::MOLECULE)
    ("CCND3, CCNE1, Ki-67 and MMP3" . SPARSER::COLLECTION)
    ("CCND3, CCNE1, CDK6 and p-Rb" . SPARSER::COLLECTION)
    ("The associated cell cycle regulators" . SPARSER::REGULATOR)
    ("immortalized gastric epithelium cell lines GES-1" . SPARSER::PROTEIN)
    ("ILK [ xref ] and let-7" . SPARSER::COLLECTION)
    ("VASP" . SPARSER::PROTEIN) ("Yin" . SPARSER::PROTEIN)
    ("tumor suppressor genes and mismatch repair genes" . SPARSER::COLLECTION)
    ("six 4" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("RPL29" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("WNT3A" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("p-Rb" . SPARSER::PROTEIN)
    ("CCND3" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("beta-Galactosidase" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("STMN1" . SPARSER::PROTEIN) ("Stathmin 1" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("BCL6B" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN)
    ("the homologous recombination repair gene polymorphism"
     . SPARSER::PROTEIN)
    ("GCA" . SPARSER::PROTEIN)
    ("homologous recombination repair genes and the risk"
     . SPARSER::COLLECTION)
    ("homologous recombination repair genes" . SPARSER::GENE)
    ("estrogen receptor, progesterone receptor and HER-2"
     . SPARSER::COLLECTION)
    ("XRCC2 and RAD51" . SPARSER::COLLECTION)
    ("G/T and T/T" . SPARSER::COLLECTION) ("DNA and DNA" . SPARSER::COLLECTION)
    ("estrogen, progesterone and HER-2" . SPARSER::COLLECTION)
    ("receptor-2" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("The homozygous T/T genotype" . SPARSER::PROTEIN)
    ("genotype and TNBC" . SPARSER::COLLECTION)
    ("RAD51 and XRCC2" . SPARSER::COLLECTION)
    ("the most dangerous DNA" . SPARSER::DNA) ("HER-2" . SPARSER::PROTEIN)
    ("G/T" . SPARSER::PROTEIN) ("XRCC2" . SPARSER::PROTEIN)
    ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("SMAD4 , JAK1, RB1 , TP53 , APC, ARID1A, GNAS, MLL3, PTEN, CTNNB1 , BRAF, ATM, BAP1, PALB2, RNF43, TSC2 , and MSH2"
     . SPARSER::COLLECTION)
    ("FAT genes and their apparent contribution to a phenotype of human cancer"
     . SPARSER::COLLECTION)
    ("FAT1 or FAT3" . SPARSER::COLLECTION)
    ("FAT1, FAT2, FAT3 , and FAT4" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the allelic state" . SPARSER::BIO-STATE)
    ("functional BRCA2" . SPARSER::PROTEIN) ("ACC-2" . SPARSER::PROTEIN)
    ("FAT1, FAT3, and FAT4" . SPARSER::COLLECTION)
    ("protocadherin" . SPARSER::PROTEIN-FAMILY)
    ("BRCA2, FAT1, FAT3 , or FAT4" . SPARSER::COLLECTION)
    ("FAT1 and FAT3" . SPARSER::COLLECTION)
    ("FAT1, FAT3 , and FAT4" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, FAT1 , and FAT4" . SPARSER::COLLECTION)
    ("CpG, and GpC" . SPARSER::COLLECTION) ("GpC" . SPARSER::PROTEIN)
    ("JAK1, RB1 , and TP53" . SPARSER::COLLECTION)
    ("APC, ARID1A, GNAS, MLL3, PTEN, FAT4 , and CTNNB1" . SPARSER::COLLECTION)
    ("BRAF, ATM, BAP1, BRCA2, PALB2, RNF43, FAT2, TSC2 , and MSH2"
     . SPARSER::COLLECTION)
    ("cisplatinum" . SPARSER::DRUG)
    ("FAT1 , FAT3 , and FAT4" . SPARSER::COLLECTION)
    ("BRCA2 and FAT" . SPARSER::COLLECTION) ("FAT" . SPARSER::PROTEIN)
    ("TM 2" . SPARSER::PROTEIN-FAMILY) ("mitomycin-C" . SPARSER::DRUG)
    ("chr13" . SPARSER::PROTEIN) ("hydroxyl radical" . SPARSER::MOLECULE)
    ("CPT-11" . SPARSER::DRUG) ("S-1" . SPARSER::PROTEIN)
    ("Fat 4" . SPARSER::PROTEIN) ("Fat 3" . SPARSER::PROTEIN)
    ("RNF43" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("FAT4" . SPARSER::PROTEIN)
    ("FAT3" . SPARSER::PROTEIN) ("FAT1" . SPARSER::PROTEIN)
    ("novel diagnostic or predictive biomarkers" . SPARSER::MOLECULE)
    ("a promising prognostic biomarker" . SPARSER::MOLECULE)
    ("SPRY40-IT1" . SPARSER::PROTEIN-PAIR) ("pCDNA" . SPARSER::PROTEIN)
    ("si-ZNF703" . SPARSER::COLLECTION) ("pCDNA-ZNF703" . SPARSER::COLLECTION)
    ("SPRY4-IT1-siRNA" . SPARSER::COLLECTION)
    ("the top five upregulated genes (AMZ2, ZYX, NOL6, TCEB1, and IQSEC1) and the top five downregulated genes (TMEM185B, ZNF703, HSP90B3P, GSDMB, and SKA2)"
     . SPARSER::COLLECTION)
    ("TMEM185B, ZNF703, HSP90B3P, GSDMB, and SKA2" . SPARSER::COLLECTION)
    ("GSDMB" . SPARSER::PROTEIN) ("ZYX" . SPARSER::PROTEIN)
    ("SPRY" . SPARSER::PROTEIN) ("si-NC" . SPARSER::COLLECTION)
    ("si-SPRY4-IT1" . SPARSER::COLLECTION) ("pcDNA3.1-" . SPARSER::PROTEIN)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("p " . SPARSER::PROTEIN) ("HTR-8" . SPARSER::PROTEIN)
    ("HOTAIR" . SPARSER::PROTEIN)
    ("a diagnostic cancer biomarker" . SPARSER::MOLECULE)
    ("diagnostic or prognostic cancer biomarkers" . SPARSER::MOLECULE)
    ("ncRNAs" . SPARSER::RNA) ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("a novel prognostic biomarker and a potential therapeutic candidate"
     . SPARSER::COLLECTION)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("SPRY4-IT1" . SPARSER::COLLECTION) ("lncRNA" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA) ("bcl-2" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("SKA2" . SPARSER::PROTEIN) ("TMEM185B" . SPARSER::PROTEIN)
    ("IQSEC1" . SPARSER::PROTEIN) ("TCEB1" . SPARSER::PROTEIN)
    ("NOL6" . SPARSER::PROTEIN)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("GAS5" . SPARSER::PROTEIN) ("ZNF703" . SPARSER::PROTEIN)
    ("IT1" . SPARSER::PROTEIN) ("SPRY4" . SPARSER::PROTEIN)
    ("MACC1 and KRAS" . SPARSER::COLLECTION)
    ("MSS and KRAS or BRAF" . SPARSER::COLLECTION)
    ("MACC1 or KRAS" . SPARSER::COLLECTION)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("Serrated" . SPARSER::PROTEIN)
    ("prognostic biomarker" . SPARSER::MOLECULE) ("MACC1" . SPARSER::PROTEIN)
    ("SNAI2 (SLUG)" . SPARSER::PROTEIN) ("ER-" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("EMT and CSC-like" . SPARSER::COLLECTION)
    ("TTF" . SPARSER::PROTEIN) ("Representative examples" . SPARSER::EXAMPLE)
    ("ER and CK5/6" . SPARSER::COLLECTION)
    ("basal CKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunohistochemical biomarker" . SPARSER::MOLECULE)
    ("responding group" . SPARSER::MOLECULE)
    ("pre-operative trastuzumab" . SPARSER::DRUG)
    ("CKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A predictive biomarker" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("HER2 protein and basal cytokeratin markers CK5/6" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("responders" . SPARSER::PROTEIN)
    ("the most commonly inactivated tumor suppressor gene" . SPARSER::PROTEIN)
    ("the Spanish Urological Club" . SPARSER::PROTEIN)
    ("Club" . SPARSER::PROTEIN) ("RFS, and p53" . SPARSER::COLLECTION)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and RFS" . SPARSER::COLLECTION) ("intravesical BCG" . SPARSER::DRUG)
    ("cyclin D1, Rb, p16, p21, p27, and p53" . SPARSER::COLLECTION)
    ("poor RFS" . SPARSER::PROTEIN) ("BCG" . SPARSER::DRUG)
    ("= 10" . SPARSER::PROTEIN)
    ("Nanog , Oct-4 , and E-cadherin" . SPARSER::COLLECTION)
    ("which releases Gli1" . SPARSER::PROTEIN) ("SuFu" . SPARSER::PROTEIN)
    ("Smo" . SPARSER::PROTEIN) ("PTCH" . SPARSER::PROTEIN)
    ("Gli1 and p-p70S6K" . SPARSER::COLLECTION)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("vismodegib and mTOR" . SPARSER::COLLECTION)
    ("Nanog, Oct-4, and E-cadherin" . SPARSER::COLLECTION)
    ("SK-ChA-1" . SPARSER::COLLECTION) ("SK" . SPARSER::PROTEIN)
    ("Vismodegib" . SPARSER::DRUG) ("CellTiter-Glo" . SPARSER::COLLECTION)
    ("Glo" . SPARSER::PROTEIN)
    ("vismodegib and rapamycin" . SPARSER::COLLECTION)
    ("p70S6K and Gli1" . SPARSER::COLLECTION)
    ("gene and protein" . SPARSER::COLLECTION) ("cyclopamine" . SPARSER::DRUG)
    ("p-Gli1" . SPARSER::COLLECTION) ("p-p70S6K" . SPARSER::COLLECTION)
    ("Nanog and Oct-4" . SPARSER::COLLECTION)
    ("Sk-ChA-1" . SPARSER::COLLECTION)
    ("Rapamycin and vismodegib" . SPARSER::COLLECTION)
    ("p70S6k and Gli1" . SPARSER::COLLECTION)
    ("The respective signalling inhibitors rapamycin and vismodegib"
     . SPARSER::COLLECTION)
    ("rapamycin and vismodegib" . SPARSER::COLLECTION)
    ("vismodegib" . SPARSER::DRUG) ("p70 S6K" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN) ("Gli1" . SPARSER::PROTEIN)
    ("RAS or PIK3CA" . SPARSER::COLLECTION)
    ("temsirolimus and liposomal doxorubicin" . SPARSER::COLLECTION)
    ("liposomal doxorubicin" . SPARSER::PROTEIN)
    ("VEGF and HIF-1" . SPARSER::COLLECTION)
    ("bevacizumab and single-agent fluorouracil" . SPARSER::COLLECTION)
    ("panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("IFL" . SPARSER::PROTEIN) ("ITT" . SPARSER::MOLECULE)
    ("bevacizumab, and RAS" . SPARSER::COLLECTION)
    ("CB or CBM" . SPARSER::COLLECTION)
    ("KRAS , NRAS and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("EGFR and VEGF" . SPARSER::COLLECTION)
    ("KRAS exon 2 and BRAF mutation status ( xref )" . SPARSER::COLLECTION)
    ("VEGF and EGFR" . SPARSER::COLLECTION) ("MAbs" . SPARSER::DRUG)
    ("irinotecan-" . SPARSER::DRUG) ("MAb" . SPARSER::DRUG)
    ("the epithelial growth factor receptor (EGFR) and the vascular endothelial growth factor-A (VEGF-A)"
     . SPARSER::COLLECTION)
    ("mCRC" . SPARSER::PROTEIN) ("RAS and PIK3CA" . SPARSER::COLLECTION)
    ("p110 α" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("Class 1A" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT/mTOR" . SPARSER::COLLECTION)
    ("ATM mRNA ( xref ; xref ; xref ) or protein ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("mRNA and ATM" . SPARSER::COLLECTION)
    ("10 normal breast tissue RNAs and 454 unilateral invasive primary breast tumour RNAs"
     . SPARSER::COLLECTION)
    ("454 unilateral invasive primary breast tumour RNAs" . SPARSER::RNA)
    ("ATM and miR-203 expression status" . SPARSER::COLLECTION)
    ("ATM-" . SPARSER::PROTEIN)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("Rad50 ( P =0.0064) and TP53BP1 ( P =0.026)" . SPARSER::COLLECTION)
    ("H2AX ( P <0.0000001), XRCC5 ( P <0.0000001), NBN ( P <0.0000001), Mre11 ( P =0.0000029), Rad50 ( P =0.0064) and TP53BP1 ( P =0.026)"
     . SPARSER::COLLECTION)
    ("H2AX, XRCC5, NBN, Mre11, Rad50 and TP53BP1" . SPARSER::COLLECTION)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("HR/ERBB2" . SPARSER::COLLECTION)
    ("ATM and Ki67" . SPARSER::COLLECTION)
    ("HR (ER α and PR) and ERBB2 status" . SPARSER::COLLECTION)
    ("ER α and PR" . SPARSER::COLLECTION) ("HR−" . SPARSER::PROTEIN)
    ("ERBB2−" . SPARSER::PROTEIN) ("SBR" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("NBN" . SPARSER::PROTEIN)
    ("ATM and 14 proteins" . SPARSER::COLLECTION) ("P-MEK1" . SPARSER::PROTEIN)
    ("Reducing Agent" . SPARSER::MOLECULE) ("miR-181a" . SPARSER::MOLECULE)
    ("miR-106a" . SPARSER::MOLECULE) ("RPLP0" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN)
    ("TATA box-binding protein" . SPARSER::PROTEIN) ("ER α" . SPARSER::PROTEIN)
    ("TP53BP1" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("XRCC5" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("myotonic dystrophy type 1" . SPARSER::PROTEIN)
    ("hybrid heterodimeric receptors" . SPARSER::PROTEIN)
    ("glucose and HbA1c" . SPARSER::COLLECTION)
    ("glucose (r = -0.25, p = 0.088) and HbA1c" . SPARSER::COLLECTION)
    ("NGT and T2DM" . SPARSER::COLLECTION) ("NGT" . SPARSER::PROTEIN)
    ("neonatal hepatocytes" . SPARSER::PROTEIN)
    ("insulin-like growth factor II (IGF-II) and proinsulin"
     . SPARSER::COLLECTION)
    ("proinsulin" . SPARSER::PROTEIN)
    ("insulin receptor (INSR)" . SPARSER::PROTEIN)
    ("-exon" . SPARSER::COLLECTION) ("INSR" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("Insulin receptor" . SPARSER::PROTEIN) ("PcDNA3.1" . SPARSER::PROTEIN)
    ("HbA1" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("insulin-like growth factor II" . SPARSER::PROTEIN)
    ("PCK1" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("TGFB1 and CTGF" . SPARSER::COLLECTION) ("perinatal" . SPARSER::PROTEIN)
    ("Similarly phosphorylated STAT3" . SPARSER::PROTEIN)
    ("STAT3 and Jak" . SPARSER::COLLECTION)
    ("STAT3 and Tyk2" . SPARSER::COLLECTION)
    ("another nearby causal polymorphism" . SPARSER::PROTEIN)
    ("The causative variants" . SPARSER::VARIANT)
    ("hyper-IgE" . SPARSER::COLLECTION) ("cis-eQTL" . SPARSER::PROTEIN-PAIR)
    ("STAT3(Y705) or STAT3(S727) amino acids" . SPARSER::COLLECTION)
    ("TGFB1 and COL1A1" . SPARSER::COLLECTION)
    ("SOCS3 and COL1A1" . SPARSER::COLLECTION)
    ("TNBS-colitis" . SPARSER::MOLECULE)
    ("TGFB1 , COL1A1 and CTGF" . SPARSER::COLLECTION)
    ("TGF-β1and CTGF" . SPARSER::COLLECTION)
    ("COL1A1 and CTGF" . SPARSER::COLLECTION)
    ("TGF-β1, COL1A1 and CTGF" . SPARSER::COLLECTION)
    ("exogenous IL-6" . SPARSER::PROTEIN)
    ("dominant negative STAT3(S727A) or STAT3(Y705F)" . SPARSER::COLLECTION)
    ("STAT3(S727) and STAT3(Y705)" . SPARSER::COLLECTION)
    ("phospho-STAT3(S727) and phospho-STAT3(Y705)" . SPARSER::COLLECTION)
    ("MPO" . SPARSER::PROTEIN) ("myeloperoxidase" . SPARSER::PROTEIN)
    ("immunoreactive collagen" . SPARSER::PROTEIN)
    ("immunoreactive IL-6" . SPARSER::PROTEIN)
    ("their specific cytokine receptors and/or the common gp130 receptor"
     . SPARSER::COLLECTION)
    ("IL-6, IL-10, IL-12, IL-13, IL-17a and TNF-α" . SPARSER::COLLECTION)
    ("TGFB1, COL1A1 and Connective tissue growth factor" . SPARSER::COLLECTION)
    ("TT(N4)AA and TT(N5)AA" . SPARSER::MOLECULE)
    ("AA and TT" . SPARSER::COLLECTION)
    ("STAT3(K140) and/or STAT3(K685)" . SPARSER::COLLECTION)
    ("STAT3(Y705) and STAT3(S727)" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR) ("Transducers" . SPARSER::PROTEIN)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("TGF-β1 and collagen" . SPARSER::COLLECTION)
    ("Smooth muscle" . SPARSER::PROTEIN)
    ("TGF-β1 or collagen" . SPARSER::COLLECTION)
    ("the fibrogenic cytokine" . SPARSER::PROTEIN)
    ("IL-6, IL-10, IL-12, IL-13, and IL-17a and TNF-α" . SPARSER::COLLECTION)
    ("IL-17a and TNF-α" . SPARSER::COLLECTION) ("IL-17a" . SPARSER::PROTEIN)
    ("TGF-β1, collagen and CTGF" . SPARSER::COLLECTION)
    ("ileal" . SPARSER::PROTEIN) ("TNBS" . SPARSER::MOLECULE)
    ("autocrine IL-6" . SPARSER::PROTEIN)
    ("Stattic or dnSTAT3(S727A)" . SPARSER::COLLECTION)
    ("TGF-β1, COL1A1, and CTGF" . SPARSER::COLLECTION)
    ("high STAT3(S727) and low STAT3(Y705)" . SPARSER::COLLECTION)
    ("TGF-β1, Collagen1α1 and CTGF" . SPARSER::COLLECTION)
    ("STAT3 and SOCS3" . SPARSER::COLLECTION)
    ("STAT3-TGFB1" . SPARSER::COLLECTION) ("Collagen" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("Non-muscle" . SPARSER::PROTEIN)
    ("Connective tissue growth factor" . SPARSER::PROTEIN)
    ("N5" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("glycoprotein 130" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-12" . SPARSER::PROTEIN)
    ("Suppressor of Cytokine Signaling" . SPARSER::PROTEIN)
    ("IL-23R" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("Class B" . SPARSER::PROTEIN) ("COL1A1" . SPARSER::PROTEIN)
    ("STAT-3" . SPARSER::PROTEIN) ("ERα or FOXK2" . SPARSER::COLLECTION)
    ("Cycline" . SPARSER::PROTEIN-FAMILY)
    ("TFF1 , SDF-1 , Cyclin D1 and GREB1" . SPARSER::COLLECTION)
    ("BARD1 and ERα" . SPARSER::COLLECTION)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("ERα and its E3 ligases" . SPARSER::COLLECTION)
    ("Ubiquitin" . SPARSER::PROTEIN) ("protein or gene" . SPARSER::COLLECTION)
    ("HoxA" . SPARSER::PROTEIN)
    ("a valuable predictive and prognostic biomarker" . SPARSER::MOLECULE)
    ("Cyclin D1 and GREB1" . SPARSER::COLLECTION)
    ("Cyclin D1-luc" . SPARSER::COLLECTION)
    ("a classical ERα-targeted gene" . SPARSER::GENE)
    ("EREs" . SPARSER::PROTEIN) ("ERE-luc" . SPARSER::PROTEIN-PAIR)
    ("HA-BARD1" . SPARSER::COLLECTION) ("ERα and BARD1" . SPARSER::COLLECTION)
    ("ERα-FOXK2-BARD1" . SPARSER::COLLECTION)
    ("BARD1 and FOXK2" . SPARSER::COLLECTION)
    ("anti-FOXK2 or anti-BARD1" . SPARSER::COLLECTION)
    ("FOXK2 and BARD1" . SPARSER::COLLECTION)
    ("FOXK2 and MDM2" . SPARSER::COLLECTION)
    ("FOXK2 and the ubiquitin E3 ligases" . SPARSER::COLLECTION)
    ("Flag-tagged full-length FOXK2 (FOXK2 FL) or mutant FOXK2 (FOXK2 Δ1 contained FHA and FOX domains, FOXK2 Δ2 contained FHA domain, FOXK2 Δ3 contained FOX domain and FOXK2 Δ4 contained C-terminal tail domain)"
     . SPARSER::COLLECTION)
    ("pACT–FOXK2" . SPARSER::COLLECTION) ("pBIND–ERα" . SPARSER::COLLECTION)
    ("pACT" . SPARSER::PROTEIN) ("Flag-ERα" . SPARSER::COLLECTION)
    ("EGFP-FOXK2" . SPARSER::COLLECTION)
    ("anti-FOXK2 or anti-ERα" . SPARSER::COLLECTION)
    ("FOXK2 and ERα" . SPARSER::COLLECTION)
    ("ERα and FOXK2" . SPARSER::COLLECTION)
    ("FOXA1 and FOXO3a" . SPARSER::COLLECTION)
    ("G/T-mismatch" . SPARSER::PROTEIN-PAIR)
    ("CDK1/Cyclin" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("pol" . SPARSER::PROTEIN)
    ("Hsc70-interacting protein (CHIP)" . SPARSER::PROTEIN)
    ("/BRCA1-associated RING domain protein 1" . SPARSER::COLLECTION)
    ("only E3 ubiquitin ligases" . SPARSER::LIGASE)
    ("enzyme (E1), ubiquitin conjugating enzyme (E2), and ubiquitin ligases (E3)"
     . SPARSER::COLLECTION)
    ("ERα and ERβ" . SPARSER::COLLECTION)
    ("FOXK2 and BRCA1/BARD1" . SPARSER::COLLECTION)
    ("BRCA1/BARD1" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("FOXO1A" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("Bcap-37" . SPARSER::PROTEIN) ("ILF1" . SPARSER::PROTEIN)
    ("Forkhead box K2" . SPARSER::PROTEIN) ("RNF31" . SPARSER::PROTEIN)
    ("ring finger protein" . SPARSER::PROTEIN)
    ("BRCA1-associated RING domain protein 1" . SPARSER::PROTEIN)
    ("Breast cancer type 1 susceptibility protein" . SPARSER::PROTEIN)
    ("Hsc70-interacting protein" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("ER-α" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("FOXK2" . SPARSER::PROTEIN)
    ("pro-apoptotic genes and down-regulation of anti-apoptotic genes with Aurora B inhibition in glioblastoma"
     . SPARSER::COLLECTION)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("a previously reported therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("UW426" . SPARSER::PROTEIN)
    ("UW228-Myc and UW426-Myc" . SPARSER::COLLECTION)
    ("UW426-Myc" . SPARSER::COLLECTION)
    ("cyclophosphamide, cisplatin, and vincristine" . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG) ("WNT and G3MB" . SPARSER::COLLECTION)
    ("AURKA and AURKB" . SPARSER::COLLECTION) ("AURKB" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN) ("Group" . SPARSER::MOLECULE)
    ("Serum Albumin" . SPARSER::PROTEIN) ("VX-680" . SPARSER::DRUG)
    ("Nuak1" . SPARSER::PROTEIN) ("MED8" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 1" . SPARSER::PROTEIN)
    ("AZD1152" . SPARSER::DRUG) ("Aurora kinase B" . SPARSER::PROTEIN)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and a valid molecular target" . SPARSER::COLLECTION)
    ("a valid molecular target" . SPARSER::TARGET-PROTEIN)
    ("MDM2 or targets other upstream regulators" . SPARSER::COLLECTION)
    ("directly target MDM2" . SPARSER::PROTEIN)
    ("approximately 72% KD" . SPARSER::PROTEIN)
    ("Myc-MDM2" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("MDM2 or an MDM2 mutant (C464A)" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("MCF-10A and HMLE" . SPARSER::COLLECTION)
    ("human breast epithelial MCF-10A" . SPARSER::PROTEIN)
    ("sesquiterpenoids" . SPARSER::MOLECULE)
    ("specifically target MDM2" . SPARSER::PROTEIN)
    ("eudesmanolide" . SPARSER::DRUG) ("sesquiterpenoid" . SPARSER::MOLECULE)
    ("AMG" . SPARSER::PROTEIN) ("RITA" . SPARSER::PROTEIN)
    ("p53 and BRCA" . SPARSER::COLLECTION)
    ("MDM2 and NFAT1" . SPARSER::COLLECTION) ("MEF2" . SPARSER::PROTEIN)
    ("IL18" . SPARSER::PROTEIN) ("SAR405838" . SPARSER::DRUG)
    ("MI-219" . SPARSER::DRUG) ("NFAT1" . SPARSER::PROTEIN)
    ("EGFR and AChR" . SPARSER::COLLECTION)
    ("UNC50 and EGFR" . SPARSER::COLLECTION)
    ("protein and EGFR" . SPARSER::COLLECTION)
    ("Very few Golgi apparatus–related proteins" . SPARSER::PROTEIN)
    ("total cellular EGFR" . SPARSER::PROTEIN)
    ("UNC50 , CCND1 , EGF , MMP7 , AKR1B10 , MUC1 , and GAST"
     . SPARSER::COLLECTION)
    ("gastrin ( GAST )" . SPARSER::PROTEIN) ("levamisole" . SPARSER::MOLECULE)
    ("cell surface–associated mucin 1" . SPARSER::PROTEIN)
    ("GAST" . SPARSER::PROTEIN) ("gastrin" . SPARSER::PROTEIN)
    ("cytometry, and tetrazolium" . SPARSER::COLLECTION)
    ("nicotinic receptor" . SPARSER::RECEPTOR) ("COG8" . SPARSER::PROTEIN)
    ("GP73" . SPARSER::PROTEIN) ("EGFR antibody" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("mucin 1" . SPARSER::PROTEIN) ("AKR1B10" . SPARSER::PROTEIN)
    ("aldose reductase-like 1" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-7" . SPARSER::PROTEIN)
    ("UNC50" . SPARSER::PROTEIN)
    ("the seemingly non-functional polymorphisms" . SPARSER::PROTEIN)
    ("migraine" . SPARSER::PROTEIN) ("NOTCH1 and NOTCH2" . SPARSER::COLLECTION)
    ("retina" . SPARSER::DRUG) ("HR " . SPARSER::PROTEIN)
    ("the crude HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymorphism and 684AA" . SPARSER::COLLECTION)
    ("684GA polymorphism (64.8%) and 684AA polymorphism (65.1%)"
     . SPARSER::COLLECTION)
    ("OPN and NF-kb" . SPARSER::COLLECTION) ("OPN" . SPARSER::PROTEIN)
    ("Genotypes" . SPARSER::PROTEIN)
    ("NOTCH ligands, NOTCH receptors, and transcription factors"
     . SPARSER::COLLECTION)
    ("T type" . SPARSER::PROTEIN) ("ALOX5AP" . SPARSER::PROTEIN)
    ("NF-kb" . SPARSER::PROTEIN)
    ("the sequence-specific chemically modified miR-10b oligonucleotide inhibitors"
     . SPARSER::INHIBITOR)
    ("FBXW7 and SMAD3" . SPARSER::COLLECTION)
    ("DBF4 and other critical cell cycle substrates [ xref ]"
     . SPARSER::COLLECTION)
    ("FBXW7, and FBXW7" . SPARSER::COLLECTION)
    ("E2F1, LSH, KI67, Cyclin A2 and Cyclin E2" . SPARSER::COLLECTION)
    ("two E2F1-driven promoters" . SPARSER::PROMOTER)
    ("secondary miRNAs" . SPARSER::PROTEIN) ("Repressor" . SPARSER::REPRESSOR)
    ("Polycomb" . SPARSER::PROTEIN)
    ("KI67 and proliferating cell nuclear antigen" . SPARSER::COLLECTION)
    ("single direct target and key tumor suppressor gene CDKN1A/p21"
     . SPARSER::COLLECTION)
    ("Cdk4/6" . SPARSER::PROTEIN) ("p16/CDKN1A" . SPARSER::COLLECTION)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("principal miRNA regulators" . SPARSER::REGULATOR)
    ("E2F1, LSH, Ki67, Cyclin A2, and Cyclin E2" . SPARSER::COLLECTION)
    ("LSH" . SPARSER::PROTEIN) ("miR-15b, or miR-16" . SPARSER::COLLECTION)
    ("miR-10b and miR-15/16" . SPARSER::COLLECTION)
    ("miR-10b and E2F1" . SPARSER::COLLECTION)
    ("p21-E2F1" . SPARSER::COLLECTION)
    ("miR-10b or control" . SPARSER::COLLECTION)
    ("p21 and E2F1" . SPARSER::COLLECTION)
    ("Rb1 and p21" . SPARSER::COLLECTION) ("Rb1" . SPARSER::PROTEIN)
    ("mature mRNA" . SPARSER::PROTEIN) ("E2F1 and E2F1" . SPARSER::COLLECTION)
    ("mRNAs and miRNAs" . SPARSER::COLLECTION)
    ("several pro-apoptotic E2F1 target genes" . SPARSER::GENE)
    ("ethinyl-uridine" . SPARSER::COLLECTION) ("uridine" . SPARSER::PROTEIN)
    ("barely detectable p21" . SPARSER::PROTEIN)
    ("E2F2 or E2F3" . SPARSER::COLLECTION) ("MOE" . SPARSER::PROTEIN)
    ("p21-" . SPARSER::PROTEIN) ("E2F-" . SPARSER::PROTEIN-FAMILY)
    ("p21/CDKN1A" . SPARSER::COLLECTION)
    ("helicases, and ligases" . SPARSER::COLLECTION)
    ("E2 and CDKs" . SPARSER::COLLECTION) ("EED" . SPARSER::PROTEIN)
    ("polycomb" . SPARSER::PROTEIN) ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("miR-10b sequence-specific inhibitors" . SPARSER::INHIBITOR)
    ("BIM, TFAP2C, and TP53" . SPARSER::COLLECTION)
    ("CDKN2A/p16" . SPARSER::COLLECTION) ("CDKN1A/p21" . SPARSER::COLLECTION)
    ("MiRNA" . SPARSER::PROTEIN) ("oligonucleotides (ASO)" . SPARSER::MOLECULE)
    ("epigenetic modulators, and miRNAs" . SPARSER::COLLECTION)
    ("modulators, and miRNAs" . SPARSER::COLLECTION)
    ("p21WAF1/Cip1" . SPARSER::COLLECTION) ("beta-Actin" . SPARSER::PROTEIN)
    ("miR-10" . SPARSER::PROTEIN) ("DBF4" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("CDC4" . SPARSER::PROTEIN)
    ("CCPG1" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("miR-15b" . SPARSER::MOLECULE)
    ("Retinoblastoma Protein" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("MiR-10b" . SPARSER::MOLECULE) ("miR-10b" . SPARSER::MOLECULE)
    ("TRAF4, ΔR, ΔZn and ΔTRAF" . SPARSER::COLLECTION)
    ("TRAF4 and TRAF4" . SPARSER::COLLECTION)
    ("p70s6k and TRAF2" . SPARSER::COLLECTION)
    ("mTOR, p70s6k, TRAF4 and TRAF2" . SPARSER::COLLECTION)
    ("TRAF2 or TRAF4" . SPARSER::COLLECTION)
    ("TRAF2 and TRAF4" . SPARSER::COLLECTION)
    ("siRNA-TRAF4" . SPARSER::COLLECTION)
    ("p70s6k and mTOR" . SPARSER::COLLECTION)
    ("TRAF4, p70s6k and mTOR" . SPARSER::COLLECTION)
    ("p70s6k and TRAF4" . SPARSER::COLLECTION)
    ("mTOR and p70s6k" . SPARSER::COLLECTION)
    ("p-p70S6k" . SPARSER::COLLECTION)
    ("TRAF4, ΔR and ΔT" . SPARSER::COLLECTION)
    ("wild-type TRAF4 and domain-deleted mutants" . SPARSER::COLLECTION)
    ("domain-deleted mutants" . SPARSER::MUTANT)
    ("kinase (RSK)" . SPARSER::KINASE) ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("p70s6k and Flag" . SPARSER::COLLECTION)
    ("TRAF4 and p-p70s6k/p-S6 in breast cancer cells MCF7 and MDA-MB-231"
     . SPARSER::COLLECTION)
    ("p-p70s6k/p-S6" . SPARSER::COLLECTION)
    ("p70s6k and the phosphorylation status" . SPARSER::COLLECTION)
    ("P70s6k" . SPARSER::PROTEIN)
    ("TRAF4 and p-p70s6k (T389) in normal breast tissue(NBT) ( n = 16) and breast cancer tissue (BCT) ( n = 80)"
     . SPARSER::COLLECTION)
    ("p-p70s6k" . SPARSER::COLLECTION)
    ("TRAF4 and TRAF2" . SPARSER::COLLECTION)
    ("mTOR/p70s6k" . SPARSER::COLLECTION)
    ("Numerous mitogens such as growth factors and hormones"
     . SPARSER::COLLECTION)
    ("phosphoinosmde-3-kinase/protein kinase B/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("receptors and interleukin" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("TRAFs" . SPARSER::PROTEIN)
    ("TNFa" . SPARSER::PROTEIN) ("TRAF4 and p70s6k" . SPARSER::COLLECTION)
    ("TRAF4 and 70 kDa ribosomal protein S6 kinase (p70s6k)"
     . SPARSER::COLLECTION)
    ("p70s6k" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("laminB1" . SPARSER::PROTEIN) ("LaminB1" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("TGF-b" . SPARSER::PROTEIN)
    ("p90S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Zinc finger" . SPARSER::PROTEIN)
    ("P70" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("s6k" . SPARSER::PROTEIN) ("TRAF4" . SPARSER::PROTEIN)
    ("factor 4" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN) ("KIBRA" . SPARSER::PROTEIN)
    ("WTIP" . SPARSER::PROTEIN) ("Jub" . SPARSER::PROTEIN)
    ("Ajuba" . SPARSER::PROTEIN) ("the vital effectors" . SPARSER::EFFECTOR)
    ("SCH" . SPARSER::PROTEIN) ("Gli2 and BIRC5" . SPARSER::COLLECTION)
    ("Trametinib or DMSO" . SPARSER::COLLECTION)
    ("GSK1120212 [ xref ] or the ERK inhibitor FR180204" . SPARSER::COLLECTION)
    ("pyrimidin-1" . SPARSER::COLLECTION) ("cyclopropyl" . SPARSER::MOLECULE)
    ("ERK1/2 siRNA or YAP siRNA" . SPARSER::COLLECTION)
    ("CTGF , Gli2 and BIRC5" . SPARSER::COLLECTION)
    ("ERK1 or ERK2" . SPARSER::COLLECTION)
    ("cycloheximide and non-targeting" . SPARSER::COLLECTION)
    ("-2-hydroxyethyl" . SPARSER::PROTEIN-PAIR)
    ("pyridazin" . SPARSER::MOLECULE) ("carboxamide" . SPARSER::MOLECULE)
    ("small interfering RNA (siRNA) or small-molecular inhibitors"
     . SPARSER::COLLECTION)
    ("Hippo downstream genes and YAP protein expression after ERK1/2 knockdown by using small interfering RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("Salvador" . SPARSER::PROTEIN) ("Raf or MEK" . SPARSER::COLLECTION)
    ("kinases, and phosphatases" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK" . SPARSER::COLLECTION)
    ("siRNA or small-molecular inhibitors" . SPARSER::COLLECTION)
    ("small-molecular inhibitors" . SPARSER::INHIBITOR)
    ("CTGF , Gli2 , and BIRC5" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION) ("EGFR/ERK" . SPARSER::COLLECTION)
    ("p44 MAPK" . SPARSER::PROTEIN) ("p42 MAPK" . SPARSER::PROTEIN)
    ("Wilms tumor protein" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("SCH772984" . SPARSER::DRUG)
    ("Mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("FR180204" . SPARSER::DRUG)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular signal regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIRC5" . SPARSER::PROTEIN) ("connexin" . SPARSER::PROTEIN-FAMILY)
    ("ARF6 and ARF1" . SPARSER::COLLECTION)
    ("ARF1, and ARF1" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("GEFs and GTPases" . SPARSER::COLLECTION)
    ("ARNO, and ARNO" . SPARSER::COLLECTION)
    ("IpgD and SecinH3-sensitive GEFs" . SPARSER::COLLECTION)
    ("BTK" . SPARSER::PROTEIN)
    ("two splice variants—ARNO 2G and ARNO 3G—that" . SPARSER::COLLECTION)
    ("ARNO and GRP1" . SPARSER::COLLECTION)
    ("GEP100/BRAG2" . SPARSER::COLLECTION)
    ("IpgD and IpgD" . SPARSER::COLLECTION) ("ipgD" . SPARSER::PROTEIN-FAMILY)
    ("Rac1 and Cdc42, and IpgB2" . SPARSER::COLLECTION)
    ("Cdc42, and IpgB2" . SPARSER::COLLECTION) ("IpaJ" . SPARSER::PROTEIN)
    ("the uropathogenic Escherichia coli afimbrial adhesin" . SPARSER::PROTEIN)
    ("adhesin" . SPARSER::PROTEIN) ("ARF6-HA" . SPARSER::COLLECTION)
    ("phenylindole" . SPARSER::MOLECULE) ("ARF6 or ARF6" . SPARSER::COLLECTION)
    ("ARF6 and ARNO" . SPARSER::COLLECTION) ("inositol" . SPARSER::PROTEIN)
    ("the GEFs ARF nucleotide binding site opener (ARNO) and DOCK180/ELMO complex ( xref  xref  xref )"
     . SPARSER::COLLECTION)
    ("phosphoinositide and lipid" . SPARSER::COLLECTION)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION) ("Actin" . SPARSER::PROTEIN)
    ("ipaA" . SPARSER::PROTEIN) ("vinculin" . SPARSER::PROTEIN)
    ("IpaA" . SPARSER::PROTEIN) ("SS" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("ARF nucleotide binding site opener (ARNO)" . SPARSER::PROTEIN)
    ("ARNO" . SPARSER::PROTEIN) ("GEF" . SPARSER::GEF)
    ("IpgD" . SPARSER::PROTEIN-FAMILY)
    ("the human bacterial pathogens Shigella spp" . SPARSER::PROTEIN)
    ("spp" . SPARSER::PROTEIN) ("PSCD2" . SPARSER::PROTEIN)
    ("Tiam1" . SPARSER::PROTEIN) ("Rab-11" . SPARSER::PROTEIN)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARNO 3" . SPARSER::PROTEIN) ("Cytohesin-1" . SPARSER::PROTEIN)
    ("SecinH3" . SPARSER::DRUG) ("cytohesin-3" . SPARSER::PROTEIN)
    ("GRP1" . SPARSER::PROTEIN) ("cytohesin-2" . SPARSER::PROTEIN)
    ("cytohesin-1" . SPARSER::PROTEIN) ("EFA6" . SPARSER::PROTEIN)
    ("BRAG2" . SPARSER::PROTEIN) ("GEP100" . SPARSER::PROTEIN)
    ("ARF1" . SPARSER::PROTEIN) ("GGA3" . SPARSER::PROTEIN)
    ("ARF binding protein 3" . SPARSER::PROTEIN) ("Arf6" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("PIP5K" . SPARSER::PROTEIN) ("DOCK180" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("ARF nucleotide binding site opener" . SPARSER::PROTEIN)
    ("ARF6" . SPARSER::PROTEIN)
    ("ADP-ribosylation factor 6" . SPARSER::PROTEIN)
    ("the NRAS and WT cohorts" . SPARSER::COLLECTION)
    ("=10" . SPARSER::PROTEIN) ("=15" . SPARSER::PROTEIN)
    ("poor responders" . SPARSER::PROTEIN)
    ("previously received BRAF and/or MEK inhibitors" . SPARSER::COLLECTION)
    ("previously received BRAF" . SPARSER::PROTEIN)
    ("anti-PD-1 or anti-PD-L1" . SPARSER::COLLECTION)
    ("NRAS-" . SPARSER::PROTEIN)
    ("BRAF and/or MEK inhibitors" . SPARSER::COLLECTION)
    ("BRAF or MEK" . SPARSER::COLLECTION) ("CR or PR" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("imiquimod" . SPARSER::DRUG)
    ("fotemustine" . SPARSER::DRUG)
    ("ipilimumab and nivolumab" . SPARSER::COLLECTION)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("NRAS and non-NRAS" . SPARSER::COLLECTION) ("CBR" . SPARSER::PROTEIN)
    ("immune-suppressive cytokines" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("pembrolizumab" . SPARSER::DRUG)
    ("nivolumab" . SPARSER::DRUG) ("Ipilimumab" . SPARSER::DRUG)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("specifically target NRAS" . SPARSER::PROTEIN)
    ("a distinct cohort" . SPARSER::MOLECULE)
    ("BRAF , NRAS , and CKIT" . SPARSER::COLLECTION)
    ("CKIT" . SPARSER::PROTEIN) ("anti-PD-1/PD-L1" . SPARSER::COLLECTION)
    ("PD-1/PD-L1" . SPARSER::COLLECTION) ("ipilimumab" . SPARSER::DRUG)
    ("PDL1" . SPARSER::PROTEIN) ("GNA11" . SPARSER::PROTEIN)
    ("MPDL3280A" . SPARSER::DRUG) ("CTLA-4" . SPARSER::PROTEIN)
    ("antigen-4" . SPARSER::PROTEIN) ("Interleukin-2" . SPARSER::PROTEIN)
    ("PD-L1" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-2" . SPARSER::PROTEIN)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("alcohol or nutrient" . SPARSER::COLLECTION)
    ("hypoxic and low NAD +" . SPARSER::MOLECULE)
    ("transferrin or DFX" . SPARSER::COLLECTION)
    ("Mcp-1 and Col1a1" . SPARSER::COLLECTION)
    ("mononucleotide" . SPARSER::MOLECULE) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("Mcp-1" . SPARSER::PROTEIN) ("STAM" . SPARSER::PROTEIN)
    ("NAD + and CXCL10" . SPARSER::COLLECTION)
    ("nicotinamide adenine dinucleotide and silent information regulator 1"
     . SPARSER::COLLECTION)
    ("DFX" . SPARSER::PROTEIN) ("chelator" . SPARSER::MOLECULE)
    ("NAD + and NADH" . SPARSER::COLLECTION) ("Alcohol" . SPARSER::DRUG)
    ("Glucose and alcohol" . SPARSER::COLLECTION)
    ("nicotinamide nucleotide adenylyltransferase 1 (NMNAT1) and nicotinamide phosphoribosyltransferase (NAMPT)"
     . SPARSER::COLLECTION)
    ("NAMPT" . SPARSER::PROTEIN)
    ("histones and several proteins" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("ASH" . SPARSER::PROTEIN)
    ("CXCL10 and MCP-1" . SPARSER::COLLECTION) ("Col1a1" . SPARSER::PROTEIN)
    ("Histone H3K" . SPARSER::PROTEIN)
    ("Nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("CYP2E1" . SPARSER::PROTEIN) ("NMNAT1" . SPARSER::PROTEIN)
    ("nicotinamide nucleotide adenylyltransferase 1" . SPARSER::PROTEIN)
    ("PGC1" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("FANCF , BRCA1 , and BRCA2" . SPARSER::COLLECTION)
    ("FANCF" . SPARSER::PROTEIN) ("fatal DNA" . SPARSER::DNA)
    ("CDDP or mitomycin C" . SPARSER::COLLECTION)
    ("GEM, and CDDP" . SPARSER::COLLECTION)
    ("FANCD2 staining in the nucleus and CD24 staining in the cytoplasm"
     . SPARSER::COLLECTION)
    ("BRCA2 , FANCD2 and RAD51c" . SPARSER::COLLECTION)
    ("KMCH1-GR and CCLP1-GR" . SPARSER::COLLECTION)
    ("GEM and CDDP" . SPARSER::COLLECTION) ("nucleoprotein" . SPARSER::PROTEIN)
    ("GEM (NC, 183.8 ng/mL; si FANCD2 , 57.1 ng/mL, P  < 0.001; si BRCA2 , 38.4 ng/mL, P  < 0.001; si RAD51c , 48.8 ng/mL, P  < 0.001; Fig. xref , left) and CDDP (NC, 4.67 μg/mL; si FANCD2 , 0.69 μg/mL, P  < 0.001; si BRCA2 , 0.11 μg/mL, P  < 0.001; si RAD51c ; 0.77 μg/mL, P  < 0.001; Fig. xref , right)"
     . SPARSER::COLLECTION)
    ("PARP1 and DNA-dependent protein kinase catalytic subunit"
     . SPARSER::COLLECTION)
    ("BRCA2 and FANCD2" . SPARSER::COLLECTION)
    ("gemcitabine or cisplatin" . SPARSER::COLLECTION)
    ("CCLP1-GR and KMCH1-GR" . SPARSER::COLLECTION)
    ("BRCA2, FANCD2 and RAD51c" . SPARSER::COLLECTION)
    ("BRCA2 , FANCD2 , FANCI and RAD51c" . SPARSER::COLLECTION)
    ("FANCI" . SPARSER::PROTEIN) ("mRNA and proteins" . SPARSER::COLLECTION)
    ("MzChA1-GR, KMCH1-GR and CCLP1-GR" . SPARSER::COLLECTION)
    ("directly repairs DNA" . SPARSER::DNA)
    ("DDR and CD24" . SPARSER::COLLECTION) ("RAD51c" . SPARSER::PROTEIN)
    ("ERCC1 , RAD21 , MGMT , PARP1 , PARP2 , BRCA1 , BRCA2 , MSH2 , MSH6 , FAN1 and XRCC1"
     . SPARSER::COLLECTION)
    ("elongation and ribonucleotide" . SPARSER::COLLECTION)
    ("nucleoside" . SPARSER::MOLECULE) ("Gemcitabine" . SPARSER::DRUG)
    ("GEM and/or CDDP" . SPARSER::COLLECTION)
    ("siRNA and RAD51" . SPARSER::COLLECTION)
    ("GEM or CDDP" . SPARSER::COLLECTION)
    ("GEM and cisplatin" . SPARSER::COLLECTION)
    ("FANCD2 and CD24" . SPARSER::COLLECTION) ("BRCA/FA" . SPARSER::COLLECTION)
    ("GEM" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("BRCA/Fanconi anemia" . SPARSER::COLLECTION)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("RRM1" . SPARSER::PROTEIN) ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("FAN1" . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("RAD21" . SPARSER::PROTEIN) ("MIG6 and mutant" . SPARSER::COLLECTION)
    ("EGFR and LAMP1" . SPARSER::COLLECTION)
    ("mutant EGFR and WT EGFR" . SPARSER::COLLECTION)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("undetectable MIG6 protein" . SPARSER::PROTEIN)
    ("a classic tumor suppressor" . SPARSER::SUPPRESSOR)
    ("rtTA or mutant" . SPARSER::COLLECTION)
    ("rtTA and mutant" . SPARSER::COLLECTION)
    ("EGFR and rtTA" . SPARSER::COLLECTION)
    ("Ttf-1 and EGFR" . SPARSER::COLLECTION) ("Ttf-1" . SPARSER::PROTEIN)
    ("MIG6 and miR200c" . SPARSER::COLLECTION)
    ("MIG6/EGFR" . SPARSER::COLLECTION)
    ("mouse wild-type Egfr and human mutant EGFR" . SPARSER::COLLECTION)
    ("the kinase activity nearly full length mutant EGFR" . SPARSER::PROTEIN)
    ("WT EGFR and no endogenous MIG6" . SPARSER::COLLECTION)
    ("a lysosomotropic inhibitor" . SPARSER::INHIBITOR)
    ("WT EGFR or L858R EGFR ( xref )" . SPARSER::COLLECTION)
    ("EGF and cycloheximide" . SPARSER::COLLECTION)
    ("EGFR and mutant" . SPARSER::COLLECTION)
    ("WT EGFR or L858R EGFR" . SPARSER::COLLECTION)
    ("pTyr and FLAG" . SPARSER::COLLECTION)
    ("both WT EGFR and L858R EGFR" . SPARSER::COLLECTION)
    ("MIG6 and other proteins ( xref )" . SPARSER::COLLECTION)
    ("EGFR and MIG6" . SPARSER::COLLECTION) ("EBR" . SPARSER::PROTEIN)
    ("MIG6 and EGFR" . SPARSER::COLLECTION)
    ("arginine and lysine" . SPARSER::COLLECTION) ("Sftpc" . SPARSER::PROTEIN)
    ("Egfr" . SPARSER::PROTEIN) ("p-4EBP" . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN)
    ("anti-Ttf1 and anti-EGFR" . SPARSER::COLLECTION)
    ("Ki67 and pErk" . SPARSER::COLLECTION) ("antisera" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Ttf1 and EGFR" . SPARSER::COLLECTION) ("Erk/Mapk" . SPARSER::COLLECTION)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki67, and pErk" . SPARSER::COLLECTION) ("Ttf1" . SPARSER::PROTEIN)
    ("pErk" . SPARSER::PROTEIN)
    ("forCCSP-rtTA/TetO-EGFR" . SPARSER::COLLECTION)
    ("ofCCSP-rtTA/TetO-EGFR" . SPARSER::COLLECTION) ("TetO" . SPARSER::PROTEIN)
    ("the mutant EGFRs inMig6 +/+ ,Mig6 +/− ," . SPARSER::PROTEIN)
    ("inMig6" . SPARSER::PROTEIN) ("transgenes" . SPARSER::PROTEIN)
    ("hyper-" . SPARSER::PROTEIN) ("EGFR transgenes" . SPARSER::PROTEIN)
    ("/EGFR" . SPARSER::COLLECTION) ("/Mig6" . SPARSER::COLLECTION)
    ("resultingtetO-EGFR" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("EGFRs and MIG6" . SPARSER::COLLECTION)
    ("a haploinsufficient tumor suppressor" . SPARSER::SUPPRESSOR)
    ("EGFR and ERBB2" . SPARSER::COLLECTION) ("RALT" . SPARSER::PROTEIN)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("BRAF ( xref ) and HER2 ( xref )" . SPARSER::COLLECTION)
    ("CRKL" . SPARSER::PROTEIN) ("Arginine" . SPARSER::AMINO-ACID)
    ("an inhibitor of ERBB signaling and a potential tumor suppressor"
     . SPARSER::COLLECTION)
    ("ERBB" . SPARSER::PROTEIN) ("Rho-GDI" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN) ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("4EBP" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("CC10" . SPARSER::PROTEIN) ("ERBB2" . SPARSER::PROTEIN)
    ("immediate early response" . SPARSER::PROTEIN)
    ("ERRFI1" . SPARSER::PROTEIN) ("Mig6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MIG6" . SPARSER::PROTEIN)
    ("cytotoxic IR or DSB-inducing anticancer drugs" . SPARSER::COLLECTION)
    ("PARP1, IKKγ and PIASy" . SPARSER::COLLECTION)
    ("genotoxic cues" . SPARSER::PROTEIN-FAMILY)
    ("ATM and PARP1" . SPARSER::COLLECTION) ("cue" . SPARSER::PROTEIN-FAMILY)
    ("LRP16-Ku70/Ku80" . SPARSER::COLLECTION)
    ("LRP16, Ku70 and Ku80" . SPARSER::COLLECTION)
    ("LRP16, PARP1 and Ku80" . SPARSER::COLLECTION)
    ("Ku70 or Ku80" . SPARSER::COLLECTION)
    ("LRP16 and/or PARP1 and IKKγ" . SPARSER::COLLECTION)
    ("type or types" . SPARSER::COLLECTION)
    ("PARP1 and PAR-PARP1" . SPARSER::COLLECTION)
    ("GST-IKKγ" . SPARSER::COLLECTION) ("GST-LRP16" . SPARSER::COLLECTION)
    ("LRP16, IKKγ and PARP1" . SPARSER::COLLECTION)
    ("PARP1-siRNAs" . SPARSER::COLLECTION) ("benzamide" . SPARSER::DRUG)
    ("LRP16-IKKγ" . SPARSER::COLLECTION) ("PARP1-IKKγ" . SPARSER::COLLECTION)
    ("IKKγ-PARP1" . SPARSER::COLLECTION)
    ("IKKγ and PIASy" . SPARSER::COLLECTION)
    ("PIASy-IKKγ" . SPARSER::COLLECTION) ("LRP16-siRNAs" . SPARSER::COLLECTION)
    ("the first 106 amino acids of IKKγ" . SPARSER::PROTEIN)
    ("LRP16 and IKKγ" . SPARSER::COLLECTION)
    ("FLAG-IKKγ" . SPARSER::COLLECTION) ("LRP16-PARP1" . SPARSER::COLLECTION)
    ("anti-PARP1 or anti-IKKγ" . SPARSER::COLLECTION)
    ("doxorubicin (DOX) and camptothecin (CPT) (Figure xref , Supplementary Figure S1A, and Figure xref )"
     . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("FLAG-LRP16" . SPARSER::COLLECTION)
    ("IKKγ and PARP1" . SPARSER::COLLECTION)
    ("ATM and PIASy" . SPARSER::COLLECTION)
    ("Ku80 or Ku70" . SPARSER::COLLECTION)
    ("Ku70 and Ku80" . SPARSER::COLLECTION)
    ("LRP16, PARP1 and IKKγ" . SPARSER::COLLECTION)
    ("an essential cofactor" . SPARSER::MOLECULE)
    ("Leukemia" . SPARSER::PROTEIN) ("ATM-p53" . SPARSER::COLLECTION)
    ("MRE11, Rad50 and NBS1" . SPARSER::COLLECTION)
    ("an inactive dimeric form" . SPARSER::FORM)
    ("Ataxia Telangiectasia Mutated (ATM), DNA-PKs and Poly (ADP-ribose) Polymerase"
     . SPARSER::COLLECTION)
    ("Polymerase" . SPARSER::PROTEIN) ("Ku70/Ku80" . SPARSER::COLLECTION)
    ("PARP1, IKKγ, and PIASy" . SPARSER::COLLECTION)
    ("PARP1 and IKKγ" . SPARSER::COLLECTION)
    ("PIASy and ATM" . SPARSER::COLLECTION) ("PIASy" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("A-F" . SPARSER::PROTEIN)
    ("A-V" . SPARSER::MOLECULE) ("ADP-riboses" . SPARSER::MOLECULE)
    ("O-acetyl-ADP-riboses" . SPARSER::MOLECULE)
    ("O-Acetyl-ADP-ribose" . SPARSER::MOLECULE) ("L–S" . SPARSER::PROTEIN)
    ("s2" . SPARSER::MOLECULE) ("p-1" . SPARSER::PROTEIN)
    ("P-1" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("TRITON X-100" . SPARSER::MOLECULE) ("SUMO-1" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("PJ-34" . SPARSER::DRUG)
    ("Rad50" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LRP16" . SPARSER::PROTEIN)
    ("the GG allele and GT/TT allele" . SPARSER::COLLECTION)
    ("MDM2 G/G genotype and other genotypes (T/G and T/T)"
     . SPARSER::COLLECTION)
    ("GT" . SPARSER::PROTEIN)
    ("polymorphisms and TP53 and MDM2" . SPARSER::COLLECTION)
    ("TP53 and MDM2" . SPARSER::COLLECTION)
    ("PDAC and CP" . SPARSER::COLLECTION)
    ("functional and nonfunctional TP53" . SPARSER::PROTEIN)
    ("an essential part" . SPARSER::COMPONENT)
    ("Pro/Pro" . SPARSER::COLLECTION)
    ("TP53 and MDM2 protein" . SPARSER::COLLECTION)
    ("TP53 (codon 72, rs1042522) and MDM2 promoter (SNP 309, rs2279744)"
     . SPARSER::COLLECTION)
    ("K-ras" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("tumor protein p53" . SPARSER::PROTEIN) ("SNP 309" . SPARSER::PROTEIN)
    ("NF-κB and IL-8" . SPARSER::COLLECTION)
    ("IκBα and NF-κB" . SPARSER::COLLECTION)
    ("CXCL1 and other typical NF-κB target genes" . SPARSER::COLLECTION)
    ("other typical NF-κB target genes" . SPARSER::GENE)
    ("Tnfα, c-Myc and Il-6" . SPARSER::COLLECTION)
    ("Short hairpin-mediated IL-8" . SPARSER::PROTEIN)
    ("the publically available AC patient cohort" . SPARSER::MOLECULE)
    ("a haploinsufficient tumour suppressor" . SPARSER::SUPPRESSOR)
    ("all Caucasian AC" . SPARSER::PROTEIN)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("cancer type or the specific tumour microenvironment"
     . SPARSER::COLLECTION)
    ("STAT3–NF-κB–CXCL1" . SPARSER::COLLECTION)
    ("STAT3 and the NF-κB subunit p65" . SPARSER::COLLECTION)
    ("promoter and co-stimulation" . SPARSER::COLLECTION)
    ("RE2" . SPARSER::PROTEIN)
    ("the human CXCL1 and the mouse Cxcl1 promoter" . SPARSER::COLLECTION)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("Tnfα , c-Myc, Il-6 and Cxcl1" . SPARSER::COLLECTION)
    ("Ccnd1 and Ccl5" . SPARSER::COLLECTION) ("Ccl5" . SPARSER::PROTEIN)
    ("Ccnd1" . SPARSER::PROTEIN) ("Ccl" . SPARSER::DRUG)
    ("CXCL1/IL-8" . SPARSER::COLLECTION)
    ("IL-8 and STAT3" . SPARSER::COLLECTION)
    ("LSL-G12D/+ animals" . SPARSER::PROTEIN-PAIR)
    ("IL-8 and CXCL1" . SPARSER::COLLECTION)
    ("OSM or IL-6" . SPARSER::COLLECTION)
    ("OSM, IL-6 and EGF" . SPARSER::COLLECTION)
    ("STAT3 and IL-8" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokine CXCL1" . SPARSER::PROTEIN)
    ("the alveolar type 2 cell-specific marker SP-C" . SPARSER::PROTEIN)
    ("CXCL1 and IL-8" . SPARSER::COLLECTION) ("Cxcl1" . SPARSER::PROTEIN)
    ("Granulocyte–macrophage colony-stimulating factor and IL-6"
     . SPARSER::COLLECTION)
    ("IL-2, IL-12p40, IL-4 and IL-17" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("CD31 or VEGF and P-STAT3 or STAT3" . SPARSER::COLLECTION)
    ("VEGF and P-STAT3 or STAT3" . SPARSER::COLLECTION)
    ("/CD8" . SPARSER::COLLECTION) ("PDGFA" . SPARSER::PROTEIN)
    ("differentially expressed genes" . SPARSER::GENE)
    ("invasive ACs" . SPARSER::PROTEIN) ("Lep" . SPARSER::PROTEIN)
    ("G12D /+" . SPARSER::PROTEIN) ("G12D/+" . SPARSER::PROTEIN)
    ("LSL-G12D/+" . SPARSER::COLLECTION)
    ("EGF, OSM and IL-6" . SPARSER::COLLECTION)
    ("the pro-angiogenic chemokine ligand" . SPARSER::MOLECULE)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("oncostatin-M (OSM) and epidermal growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("interleukin-6 (IL-6), oncostatin-M (OSM) and epidermal growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("OSM" . SPARSER::PROTEIN)
    ("kirsten rat sarcoma viral oncogene ( KRAS)" . SPARSER::ONCOGENE)
    ("ACs" . SPARSER::PROTEIN) ("STAT3–NF-κB–IL-8" . SPARSER::COLLECTION)
    ("AC" . SPARSER::PROTEIN) ("HSC-70" . SPARSER::PROTEIN)
    ("TUBA1A" . SPARSER::PROTEIN) ("lithium chloride" . SPARSER::DRUG)
    ("Na 3 Vo 4" . SPARSER::MOLECULE) ("CD32" . SPARSER::PROTEIN)
    ("CD16" . SPARSER::PROTEIN) ("FSP1" . SPARSER::PROTEIN)
    ("NKp46" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("member 1" . SPARSER::PROTEIN) ("Il-6" . SPARSER::PROTEIN)
    ("Tnfα" . SPARSER::DRUG) ("SB225002" . SPARSER::DRUG)
    ("surfactant protein C" . SPARSER::PROTEIN) ("SP-C" . SPARSER::PROTEIN)
    ("Granulocyte–macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("Ly6G" . SPARSER::PROTEIN)
    ("Ly6C" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("von Willebrand Factor" . SPARSER::PROTEIN) ("CXCR2" . SPARSER::PROTEIN)
    ("oncostatin-M" . SPARSER::PROTEIN) ("RAD51 and RPA" . SPARSER::COLLECTION)
    ("HR/FA" . SPARSER::COLLECTION)
    ("a specific chromatin or topological context" . SPARSER::COLLECTION)
    ("Both aberrant RIs" . SPARSER::MOLECULE)
    ("Saccharomyces" . SPARSER::PROTEIN) ("PARPs" . SPARSER::MOLECULE)
    ("the minichromosome maintenance–associated FA factor FANCD2"
     . SPARSER::PROTEIN)
    ("the genotoxic drugs" . SPARSER::DRUG)
    ("CPT, MMC, or HU" . SPARSER::COLLECTION)
    ("MMC and CPT" . SPARSER::COLLECTION) ("RPA32-S4" . SPARSER::PROTEIN-PAIR)
    ("HU and CPT" . SPARSER::COLLECTION)
    ("HU, MMC, and CPT" . SPARSER::COLLECTION) ("olaparib" . SPARSER::DRUG)
    ("MMC and HU" . SPARSER::COLLECTION)
    ("RECQ1 and PARP" . SPARSER::COLLECTION)
    ("APH and ETP" . SPARSER::COLLECTION) ("ATR or ATM" . SPARSER::COLLECTION)
    ("ATM/KAP1" . SPARSER::COLLECTION) ("S4/S8" . SPARSER::PROTEIN)
    ("ATM, KAP1, and RPA32-S4/S8" . SPARSER::COLLECTION)
    ("RPA32-S4/S8" . SPARSER::PROTEIN-PAIR)
    ("ATM and its target KAP1" . SPARSER::COLLECTION)
    ("CPT and UV" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("EdU" . SPARSER::DRUG) ("ethynyl" . SPARSER::MOLECULE)
    ("ETP, DOX, MMC, CDDP, and APH" . SPARSER::COLLECTION)
    ("CPT and H 2 O 2" . SPARSER::COLLECTION)
    ("RI-enrichment" . SPARSER::MOLECULE) ("RI" . SPARSER::MOLECULE)
    ("RIs" . SPARSER::MOLECULE) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("psoralen" . SPARSER::DRUG) ("ATR and ATM" . SPARSER::COLLECTION)
    ("different cancer chemotherapeutic drugs" . SPARSER::DRUG)
    ("CPT, ETP, and DOX" . SPARSER::COLLECTION)
    ("MMC and CDDP" . SPARSER::COLLECTION) ("APH and HU" . SPARSER::COLLECTION)
    ("H 2 O 2 , and UV-C" . SPARSER::COLLECTION)
    ("PARP and RECQ1" . SPARSER::COLLECTION)
    ("replisome" . SPARSER::BIO-COMPLEX)
    ("MRE11, NBS1, and CtIP" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("biochemical reconstitution—including RECQ helicases" . SPARSER::PROTEIN)
    ("proteins, and FANCM" . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("FANCM" . SPARSER::PROTEIN)
    ("Sucrose" . SPARSER::MOLECULE) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("RECQ" . SPARSER::PROTEIN-FAMILY)
    ("poly (ADP-ribose) polymerase (PARP) and RECQ1" . SPARSER::COLLECTION)
    ("mild Top1 poisoning" . SPARSER::MOLECULE)
    ("oxidative DNA" . SPARSER::DNA) ("FA" . SPARSER::PROTEIN)
    ("mitomycin C (MMC) and cisplatin (or cis-diamminedichloroplatinum [CDDP])"
     . SPARSER::COLLECTION)
    ("CDDP" . SPARSER::DRUG) ("aphidicolin (APH)" . SPARSER::MOLECULE)
    ("APH" . SPARSER::PROTEIN) ("antimetabolites" . SPARSER::DRUG)
    ("DOX" . SPARSER::PROTEIN)
    ("etoposide (ETP) and doxorubicin (DOX)" . SPARSER::COLLECTION)
    ("both potent chemotherapeutic drugs" . SPARSER::DRUG)
    ("Topoisomerase II (Top2) inhibitors" . SPARSER::INHIBITOR)
    ("Top2" . SPARSER::PROTEIN) ("ETP" . SPARSER::PROTEIN)
    ("the central homologous recombination factor RAD51" . SPARSER::PROTEIN)
    ("poisons" . SPARSER::MOLECULE) ("Topoisomerase" . SPARSER::PROTEIN)
    ("poisoning" . SPARSER::MOLECULE) ("TFIIH p89" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("RecQ1" . SPARSER::PROTEIN)
    ("glycine)" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("XRCC3" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("RPE-1" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN)
    ("cis-diamminedichloroplatinum" . SPARSER::DRUG)
    ("Top1" . SPARSER::PROTEIN) ("RECQ1" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DBC1 and DBC1ΔLZ" . SPARSER::COLLECTION)
    ("DBC1 and DBC1" . SPARSER::COLLECTION)
    ("full length DBC1 and deletion mutants" . SPARSER::COLLECTION)
    ("SIRT1 or p53" . SPARSER::COLLECTION) ("Nutlin" . SPARSER::DRUG)
    ("MDM2-p53" . SPARSER::COLLECTION) ("DBC1-p53" . SPARSER::COLLECTION)
    ("DBC1 and p53" . SPARSER::COLLECTION)
    ("p53 and DBC1" . SPARSER::COLLECTION)
    ("DBC1 and MDM2" . SPARSER::COLLECTION)
    ("p53 and vice versa ( xref )" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("PKA and AMPK" . SPARSER::COLLECTION) ("DBC1-SIRT1" . SPARSER::COLLECTION)
    ("Nin" . SPARSER::PROTEIN) ("p120 and p66" . SPARSER::COLLECTION)
    ("EF" . SPARSER::PROTEIN) ("p53 and MDM2" . SPARSER::COLLECTION)
    ("a pivotal tumor suppressor and one of the most mutated genes in human cancer"
     . SPARSER::COLLECTION)
    ("a pivotal tumor suppressor" . SPARSER::SUPPRESSOR)
    ("either a tumor suppressor or an oncogene" . SPARSER::COLLECTION)
    ("an important negative regulator of SIRT1 and cellular stress response"
     . SPARSER::COLLECTION)
    ("CCAR2 or KIAA1967" . SPARSER::COLLECTION) ("DBC1" . SPARSER::PROTEIN)
    ("alpha tubulin" . SPARSER::PROTEIN) ("Ing1" . SPARSER::PROTEIN)
    ("AA1" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("p66" . SPARSER::PROTEIN) ("p120" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("KIAA1967" . SPARSER::PROTEIN)
    ("CCAR2" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoinoside-3-kinase-Akt" . SPARSER::COLLECTION)
    ("PTK-PTP" . SPARSER::COLLECTION) ("Gab1/Gab2" . SPARSER::COLLECTION)
    ("Shp2 and Erk1/2" . SPARSER::COLLECTION)
    ("Shp2CSDA and Gab1" . SPARSER::COLLECTION)
    ("No mouse-specific Shp2 tryptic peptide" . SPARSER::PEPTIDE)
    ("Shp2 (on Y62 and Y580 of the human Shp2CSDA) and Mpzl1 (on Y263)"
     . SPARSER::COLLECTION)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("Gab1 or Gab2" . SPARSER::COLLECTION)
    ("less associated tyrosine phosphorylated proteins and Gab1"
     . SPARSER::COLLECTION)
    ("proteins and Gab1" . SPARSER::COLLECTION)
    ("pAkt and pStat3" . SPARSER::COLLECTION)
    ("pErk1/2 and pSrc" . SPARSER::COLLECTION) ("pSrc" . SPARSER::PROTEIN)
    ("tetO-EGFR" . SPARSER::COLLECTION)
    ("CCSP-rtTA/tetO-Shp2CSDA/tetO-EGFR" . SPARSER::COLLECTION)
    ("EL" . SPARSER::PROTEIN) ("rtTA" . SPARSER::PROTEIN)
    ("CCSP-rtTA" . SPARSER::PROTEIN-PAIR)
    ("CCSP-rtTA/tetO-Shp2CSDA" . SPARSER::COLLECTION)
    ("a cell permeable Shp2 inhibitor" . SPARSER::INHIBITOR)
    ("a Shp2-binding defective Gab1Y627F/Y659F mutant (Gab1FF) and a Shp2 PTP-inactive mutant (Shp2CSDA)"
     . SPARSER::COLLECTION)
    ("EGFR and Gab1" . SPARSER::COLLECTION)
    ("erlotinib or WZ4002" . SPARSER::COLLECTION)
    ("Shp2CSDA" . SPARSER::PROTEIN) ("tetO-Shp2CSDA" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("a rat Clara cell secretory protein (CCSP) promoter" . SPARSER::PROMOTER)
    ("CCSP-rtTA/tetO-EGFR" . SPARSER::COLLECTION)
    ("EGFR and Ras" . SPARSER::COLLECTION)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1/2 and Src" . SPARSER::COLLECTION)
    ("Gab1-Shp2" . SPARSER::COLLECTION) ("CCSP" . SPARSER::PROTEIN)
    ("tetO" . SPARSER::PROTEIN) ("PTP" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("pCDNA3.1" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("Mpzl1" . SPARSER::PROTEIN)
    ("Gab2" . SPARSER::PROTEIN) ("10 C" . SPARSER::PROTEIN)
    ("WZ4002" . SPARSER::DRUG) ("pErk1/2" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PLCγ-PKC" . SPARSER::COLLECTION) ("Src-JAK-STATs" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK-MAPK" . SPARSER::COLLECTION)
    ("known typical EGFR-TKIs" . SPARSER::COLLECTION)
    ("Gefitinib and Erlotinib" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("PC-9-luc" . SPARSER::COLLECTION) ("luc" . SPARSER::PROTEIN)
    ("PARP and Caspase-3" . SPARSER::COLLECTION)
    ("p21, Bcl-2, Cyclin D1 and Cyclin D3" . SPARSER::COLLECTION)
    ("these typical proteins" . SPARSER::PROTEIN)
    ("p21, Bcl-2, Bax, Cyclin D1, and Cyclin D3" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("WT EGFR and L858R-mutated EGFR" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("Bank, and Autodock4.2" . SPARSER::COLLECTION)
    ("x-ray" . SPARSER::PROTEIN-PAIR) ("type and mutant" . SPARSER::COLLECTION)
    ("still no effective TKI" . SPARSER::PROTEIN)
    ("Erlotinib and Afatinib" . SPARSER::COLLECTION)
    ("Afatinib" . SPARSER::DRUG) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("JG" . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("MAPK, Akt, ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG)
    ("EGFR, AKT, and ERK1/2" . SPARSER::COLLECTION)
    ("etc ." . SPARSER::PROTEIN) ("PI3K-AKT-mTOR" . SPARSER::PROTEIN)
    ("integrin/matrix" . SPARSER::COLLECTION)
    ("a known integrin regulator and Src and Matriptase substrate [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("The cell-associated Matriptase" . SPARSER::PROTEIN)
    ("an associated molecule" . SPARSER::MOLECULE)
    ("new mRNA" . SPARSER::PROTEIN) ("LBD" . SPARSER::MUTANT)
    ("mutant (LBD)" . SPARSER::MUTANT)
    ("Casodex and RU486" . SPARSER::COLLECTION)
    ("AR, Src, and Matriptase" . SPARSER::COLLECTION)
    ("Src and Matriptase" . SPARSER::COLLECTION)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION) ("AR/Src" . SPARSER::COLLECTION)
    ("MAPK, PI-3K, EGFR, and Src" . SPARSER::COLLECTION)
    ("other Src-related tyrosine kinases as well as some receptor kinases"
     . SPARSER::COLLECTION)
    ("Full-length CDCP1 (140 kDa) and its cleaved form (72 kDa)"
     . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Cell-associated cleaved Matriptase" . SPARSER::PROTEIN)
    ("cleaved cell-associated Matriptase" . SPARSER::PROTEIN)
    ("The active transmembrane-associated protein" . SPARSER::PROTEIN)
    ("AR and Src" . SPARSER::COLLECTION)
    ("PC3-Puro or PC3-AR" . SPARSER::COLLECTION)
    ("RU486 or Casodex" . SPARSER::COLLECTION)
    ("LNCaP or C4–2" . SPARSER::COLLECTION) ("-Src" . SPARSER::COLLECTION)
    ("integrins, α3 and α6" . SPARSER::COLLECTION)
    ("LNCaP and C4–2" . SPARSER::COLLECTION)
    ("Casodex or RU486" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PC3-Puro and PC3-AR" . SPARSER::COLLECTION) ("Puro" . SPARSER::PROTEIN)
    ("AR or Src" . SPARSER::COLLECTION) ("ER and AR" . SPARSER::COLLECTION)
    ("AR or PR" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("NMAR/PELP" . SPARSER::COLLECTION) ("PELP" . SPARSER::PROTEIN)
    ("cortactin" . SPARSER::PROTEIN) ("Src and Lyn" . SPARSER::COLLECTION)
    ("family (SFK)" . SPARSER::PROTEIN-FAMILY) ("aka" . SPARSER::PROTEIN)
    ("enzalutamide" . SPARSER::DRUG)
    ("a classical nuclear steroid receptor" . SPARSER::RECEPTOR)
    ("Matriptase and Src" . SPARSER::COLLECTION)
    ("Matriptase" . SPARSER::PROTEIN) ("laminin" . SPARSER::PROTEIN)
    ("exogenous androgen" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("phenol red" . SPARSER::DRUG)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Actinomycin D" . SPARSER::MOLECULE) ("C4–2" . SPARSER::PROTEIN)
    ("RU486" . SPARSER::DRUG) ("ILK1" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("MDV3100" . SPARSER::DRUG) ("CDCP1" . SPARSER::PROTEIN)
    ("Apo" . SPARSER::PROTEIN) ("GALNT1 and GALNT2" . SPARSER::COLLECTION)
    ("inflammatory cytokine" . SPARSER::PROTEIN)
    ("EGF and EGF" . SPARSER::COLLECTION)
    ("LRP5, GRM5, and IAPP" . SPARSER::COLLECTION)
    ("VAV1 and DENND2A" . SPARSER::COLLECTION) ("IAPP" . SPARSER::PROTEIN)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("WNT3 and KIF26B" . SPARSER::COLLECTION)
    ("MDM2 and RHOQ" . SPARSER::COLLECTION) ("RHOQ" . SPARSER::PROTEIN)
    ("neurotrophin" . SPARSER::PROTEIN)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFRs" . SPARSER::PROTEIN)
    ("O-glycans and sialic acids" . SPARSER::COLLECTION)
    ("EEA1 and LAMP1" . SPARSER::COLLECTION)
    ("chemoattractants" . SPARSER::PROTEIN) ("SF" . SPARSER::PROTEIN)
    ("GALNT1 and GALNT7" . SPARSER::COLLECTION)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diverse glycosyltransferases" . SPARSER::PROTEIN)
    ("The resultant short core region O-glycans" . SPARSER::MOLECULE)
    ("glycosyltransferases" . SPARSER::PROTEIN)
    ("acetylgalactosaminyltransferase" . SPARSER::PROTEIN)
    ("Actin beta" . SPARSER::PROTEIN) ("C-III" . SPARSER::PROTEIN)
    ("EA2" . SPARSER::PROTEIN) ("O-glycan" . SPARSER::MOLECULE)
    ("VAV1" . SPARSER::PROTEIN) ("GRM5" . SPARSER::PROTEIN)
    ("LRP5" . SPARSER::PROTEIN) ("SPTBN1" . SPARSER::PROTEIN)
    ("KIF26B" . SPARSER::PROTEIN) ("WNT3" . SPARSER::PROTEIN)
    ("sialic acids" . SPARSER::MOLECULE)
    ("early endosome antigen 1" . SPARSER::PROTEIN) ("p-Y" . SPARSER::PROTEIN)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("PLC5" . SPARSER::PROTEIN)
    ("GALNT7" . SPARSER::PROTEIN) ("GALNT14" . SPARSER::PROTEIN)
    ("GALNT3" . SPARSER::PROTEIN) ("GALNT2" . SPARSER::PROTEIN)
    ("O-glycans" . SPARSER::MOLECULE) ("GALNT1" . SPARSER::PROTEIN)
    ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("HCC and the selective COX-2 inhibitor" . SPARSER::COLLECTION)
    ("food" . SPARSER::MOLECULE)
    ("polymorphisms and HCC" . SPARSER::COLLECTION)
    ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("-CTCTTAAGGCCATTGCTCCA-3" . SPARSER::COLLECTION)
    ("-CATCCCTTCCTCCCTCTTTC-3" . SPARSER::COLLECTION)
    ("-TTCTCTGGTGACAGTATTGACTTG-3" . SPARSER::COLLECTION)
    ("MEMO" . SPARSER::PROTEIN) ("CD25 and Annexin A1" . SPARSER::COLLECTION)
    ("Annexin A1, CD20, CD22, CD11c, CD103, and CD25" . SPARSER::COLLECTION)
    ("four HCL-c, two HCL-v, and four SMZL" . SPARSER::COLLECTION)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD25" . SPARSER::PROTEIN)
    ("CD103" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("CD22" . SPARSER::PROTEIN) ("Annexin A1" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("IGHV4-34" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN)
    ("a full transcriptionally active NR-coactivator complex"
     . SPARSER::BIO-COMPLEX)
    ("antibodies or co-activators" . SPARSER::COLLECTION)
    ("SRC-3-p300" . SPARSER::COLLECTION) ("p300 and ERα" . SPARSER::COLLECTION)
    ("SRC-1:SRC-3 and SRC-2:SRC-3" . SPARSER::COLLECTION)
    ("ERα- or AR-" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERα-" . SPARSER::PROTEIN)
    ("SRC-2:SRC-3" . SPARSER::BIO-COMPLEX)
    ("SRC-1:SRC-3" . SPARSER::BIO-COMPLEX)
    ("ERα and p300" . SPARSER::COLLECTION)
    ("VP16, p53 and c-Myc" . SPARSER::COLLECTION)
    ("this ER and coactivator core complex" . SPARSER::COLLECTION)
    ("no structural homology" . SPARSER::PROTEIN)
    ("ERα and SRC-3b" . SPARSER::COLLECTION)
    ("ERα and SRC" . SPARSER::COLLECTION)
    ("possibly using two consecutive NR" . SPARSER::PROTEIN)
    ("NR and SRC" . SPARSER::COLLECTION)
    ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("a transcriptionally active ER-coactivator complex"
     . SPARSER::BIO-COMPLEX)
    ("ER/SRC-3/p300" . SPARSER::COLLECTION)
    ("secure one molecule" . SPARSER::MOLECULE)
    ("the conformational state" . SPARSER::BIO-STATE)
    ("p300 conformation and its HAT activity" . SPARSER::COLLECTION)
    ("SRC-3 and ERα" . SPARSER::COLLECTION)
    ("nearby histones" . SPARSER::PROTEIN)
    ("many chromatin-associated proteins" . SPARSER::PROTEIN)
    ("bromodomain" . SPARSER::PROTEIN)
    ("fragments and full-length" . SPARSER::COLLECTION)
    ("GST-SRC-3" . SPARSER::COLLECTION) ("Ab2" . SPARSER::PROTEIN)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("only one antibody" . SPARSER::ANTIBODY)
    ("a previous cryo-EM map" . SPARSER::PROTEIN)
    ("RXR/VDR" . SPARSER::COLLECTION) ("RXR" . SPARSER::PROTEIN)
    ("SRC-3 monomer (160 kDa) and the ERα dimer (132 kDa)"
     . SPARSER::COLLECTION)
    ("p300-Ab2" . SPARSER::PROTEIN-PAIR)
    ("the smaller component" . SPARSER::COMPONENT)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("a smaller component" . SPARSER::COMPONENT)
    ("the largest component" . SPARSER::COMPONENT) ("tilt" . SPARSER::DRUG)
    ("cryo" . SPARSER::PROTEIN) ("SRC-3 or p300" . SPARSER::COLLECTION)
    ("ERα/SRC-3/p300" . SPARSER::COLLECTION)
    ("presumptive target genes" . SPARSER::GENE)
    ("estrogen and steroid hormone" . SPARSER::COLLECTION)
    ("ERα and SRC-3" . SPARSER::COLLECTION)
    ("a biologically relevant ER-coactivator complex" . SPARSER::BIO-COMPLEX)
    ("ERα and coactivators" . SPARSER::COLLECTION)
    ("an active protein complex" . SPARSER::BIO-COMPLEX)
    ("ERα, SRC-3 and p300" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a nuclear receptor and coactivator complex (~720 kDa)"
     . SPARSER::COLLECTION)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SRC-3 and p300" . SPARSER::COLLECTION)
    ("the ER/SRC/p300 minimal complex" . SPARSER::BIO-COMPLEX)
    ("ER/SRC/p300" . SPARSER::COLLECTION)
    ("other secondary coactivators" . SPARSER::PROTEIN)
    ("NR and p300" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("ER and SRCs, ER and p300, and SRCs and p300" . SPARSER::COLLECTION)
    ("SRCs, ER and p300, and SRCs and p300" . SPARSER::COLLECTION)
    ("p300, and SRCs and p300" . SPARSER::COLLECTION)
    ("SRCs and p300" . SPARSER::COLLECTION) ("SRCs" . SPARSER::PROTEIN)
    ("a minimal receptor-coactivator complex" . SPARSER::BIO-COMPLEX)
    ("multiple secondary coactivators" . SPARSER::PROTEIN)
    ("SRC-1/2/3" . SPARSER::COLLECTION) ("cryo-EM" . SPARSER::COLLECTION)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("e2" . SPARSER::MOLECULE)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EP300" . SPARSER::PROTEIN)
    ("A 3D" . SPARSER::PROTEIN) ("SRC-2" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("SRC-1" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("iron and HSPB1" . SPARSER::COLLECTION) ("Iron" . SPARSER::MOLECULE)
    ("intracellular iron ( xref ) and growth inhibition ( xref ) following erastin treatment"
     . SPARSER::COLLECTION)
    ("WASP" . SPARSER::PROTEIN) ("further confirming HSPB1" . SPARSER::PROTEIN)
    ("HSP70 ( xref ) and HSPB1 ( xref )" . SPARSER::COLLECTION)
    ("cyclophilin" . SPARSER::PROTEIN) ("CsA" . SPARSER::PROTEIN)
    ("deferoxamine" . SPARSER::MOLECULE)
    ("a soluble cytosolic enzyme" . SPARSER::ENZYME)
    ("staurosporine (an inducer for apoptosis) or hydrogen peroxide (H 2 O 2 , an inducer for necrosis)"
     . SPARSER::COLLECTION)
    ("cellular iron" . SPARSER::MOLECULE)
    ("HSF1 ( xref ) and HSPB1 ( xref )" . SPARSER::COLLECTION)
    ("alamarBlue" . SPARSER::DRUG) ("HSP90 and HSP70" . SPARSER::COLLECTION)
    ("the most highly-induced gene" . SPARSER::GENE)
    ("HSP90, HSP70, HSP60, HSP40, and HSPB1" . SPARSER::COLLECTION)
    ("HSFs" . SPARSER::PROTEIN) ("genes or proteins" . SPARSER::COLLECTION)
    ("smaller cell size and smaller mitochondria" . SPARSER::PROTEIN)
    ("antiporters" . SPARSER::PROTEIN) ("cystine" . SPARSER::MOLECULE)
    ("anion" . SPARSER::MOLECULE) ("Scott" . SPARSER::PROTEIN)
    ("HSF1-HSPB1" . SPARSER::COLLECTION)
    ("HSF1 and HSPB1" . SPARSER::COLLECTION) ("erastin" . SPARSER::DRUG)
    ("Erastin" . SPARSER::DRUG) ("ClN 4" . SPARSER::PROTEIN)
    ("s 5a" . SPARSER::PROTEIN) ("CCL-2" . SPARSER::PROTEIN)
    ("cGMP-dependent" . SPARSER::PROTEIN) ("MAPKAPK-2" . SPARSER::PROTEIN)
    ("KRIBB3" . SPARSER::DRUG) ("WAVE2" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN)
    ("Wiskott-Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("cytochalasin D" . SPARSER::DRUG) ("S15A" . SPARSER::PROTEIN)
    ("cyclosporin A" . SPARSER::MOLECULE) ("Nec-1" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("chelating agent" . SPARSER::MOLECULE)
    ("FTH1" . SPARSER::PROTEIN) ("ferritin heavy chain 1" . SPARSER::PROTEIN)
    ("TFR1" . SPARSER::PROTEIN)
    ("transferrin receptor protein 1" . SPARSER::PROTEIN)
    ("HSP25" . SPARSER::PROTEIN) ("HSP60" . SPARSER::PROTEIN)
    ("glutathione peroxidase 4" . SPARSER::PROTEIN)
    ("heat shock protein beta-1" . SPARSER::PROTEIN)
    ("a bulkier amino acid such as an alanine" . SPARSER::AMINO-ACID)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("at least one second-generation TKI" . SPARSER::PROTEIN)
    ("CD74-ROS1" . SPARSER::COLLECTION)
    ("even three new drugs" . SPARSER::DRUG)
    ("alectinib and ceritinib" . SPARSER::COLLECTION)
    ("the most difficult ALK mutant and much effort" . SPARSER::COLLECTION)
    ("the peculiar fusion protein" . SPARSER::PROTEIN)
    ("clinically relevant second-generation ALK inhibitors"
     . SPARSER::INHIBITOR)
    ("only EA C1156Y mutant" . SPARSER::MUTANT) ("RR " . SPARSER::MOLECULE)
    ("alectinib, and ceritinib" . SPARSER::COLLECTION)
    ("aims" . SPARSER::PROTEIN)
    ("crizotinib and all available second-generation ALK inhibitors"
     . SPARSER::COLLECTION)
    ("all available second-generation ALK inhibitors" . SPARSER::INHIBITOR)
    ("the mutated forms" . SPARSER::FORM) ("6 mutated forms" . SPARSER::FORM)
    ("all clinically relevant second-generation ALK inhibitors"
     . SPARSER::INHIBITOR)
    ("NPM-ALK" . SPARSER::COLLECTION) ("Alectinib" . SPARSER::DRUG)
    ("an aggressive form" . SPARSER::FORM)
    ("six mutated forms" . SPARSER::FORM) ("ASP" . SPARSER::PROTEIN)
    ("ALK/c-MET/ROS" . SPARSER::COLLECTION) ("-ALK" . SPARSER::COLLECTION)
    ("CD74" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("A20" . SPARSER::PROTEIN) ("LDK378" . SPARSER::DRUG)
    ("PF-2341066" . SPARSER::DRUG) ("pro-B" . SPARSER::DRUG)
    ("interleukin-3" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Src/p-Src" . SPARSER::COLLECTION) ("p-Src and Src" . SPARSER::COLLECTION)
    ("Src and p-Src" . SPARSER::COLLECTION)
    ("Src and phospho-Src" . SPARSER::COLLECTION) ("p-Src" . SPARSER::PROTEIN)
    ("mini-gene constructs containing only one exon" . SPARSER::PROTEIN)
    ("Asp1778Asn variant and the c" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN) ("exon–intron" . SPARSER::COLLECTION)
    ("ovarian cancer genes BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("ethidium" . SPARSER::MOLECULE) ("781 unique variants" . SPARSER::VARIANT)
    ("ENIGMA" . SPARSER::PROTEIN) ("MIM" . SPARSER::PROTEIN)
    ("MDM2/ARF" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("p53-MDM2-ARF" . SPARSER::COLLECTION)
    ("ARF and ARFT8A" . SPARSER::COLLECTION)
    ("MG132 and ARF" . SPARSER::COLLECTION)
    ("the phospho-mimetic T8D mutant" . SPARSER::MUTANT)
    ("si-ctr" . SPARSER::COLLECTION) ("ctr" . SPARSER::PROTEIN)
    ("PKC α specific siRNA or control siRNA" . SPARSER::COLLECTION)
    ("NES" . SPARSER::PROTEIN) ("p14ARF and the ARF" . SPARSER::COLLECTION)
    ("p14ARF and MDM2" . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN)
    ("p53 and/or MDM2" . SPARSER::COLLECTION)
    ("ARF and Mdm2" . SPARSER::COLLECTION)
    ("a multifunctional component" . SPARSER::COMPONENT)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("ARF and MDM2" . SPARSER::COLLECTION) ("lamin A/C" . SPARSER::PROTEIN)
    ("I-19" . SPARSER::PROTEIN) ("TBP1" . SPARSER::PROTEIN)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("p19 ARF" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("ARF 1" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("alpha)" . SPARSER::PROTEIN)
    ("REG γ" . SPARSER::PROTEIN) ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBP-1" . SPARSER::PROTEIN)
    ("Alternative Reading Frame" . SPARSER::PROTEIN)
    ("p19ARF" . SPARSER::PROTEIN)
    ("ROCK1 (~80%) and ZIPK (~50%)" . SPARSER::COLLECTION)
    ("IL-6 (FC = -1.26) and ROCK1 (FC = -1.006)" . SPARSER::COLLECTION)
    ("the two major pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("growth factors and cell adhesion molecules" . SPARSER::COLLECTION)
    ("diverse cytokines" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA) and cyclin D1 [ xref ]"
     . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE)
    ("either ZIPK- or ROCK1-knockdown SMC" . SPARSER::COLLECTION)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("COX2, vEGF, ICAM, SOCS3 and ILK" . SPARSER::COLLECTION)
    ("ILK" . SPARSER::PROTEIN) ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("vEGF" . SPARSER::PROTEIN)
    ("ROCK1- and ZIPK-knockdown SMC" . SPARSER::COLLECTION)
    ("ROCK or ZIPK" . SPARSER::COLLECTION)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("ZIPK-" . SPARSER::PROTEIN)
    ("three pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6, IL-1β and MCP1" . SPARSER::COLLECTION) ("SMCs" . SPARSER::PROTEIN)
    ("PPARG and VDR" . SPARSER::COLLECTION) ("VDR" . SPARSER::PROTEIN)
    ("PPARG" . SPARSER::PROTEIN)
    ("the ROCK1- and ZIPK-knockdown datasets" . SPARSER::COLLECTION)
    ("cellular ZIPK" . SPARSER::PROTEIN) ("BrDU" . SPARSER::DRUG)
    ("HDAC1, CDC25A, and CCNE2" . SPARSER::COLLECTION)
    ("ZIPK and ROCK1" . SPARSER::COLLECTION)
    ("ROCK1-siRNA" . SPARSER::COLLECTION) ("ZIPK-siRNA" . SPARSER::COLLECTION)
    ("5 genes and down-regulation of 4 genes" . SPARSER::COLLECTION)
    ("only two genes" . SPARSER::GENE)
    ("growth factors, phosphatases and ion channels" . SPARSER::COLLECTION)
    ("Differentially" . SPARSER::PROTEIN)
    ("ROCK1 or ZIPK" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("ROCK and ZIPK" . SPARSER::COLLECTION)
    ("smooth muscle and non-muscle" . SPARSER::COLLECTION)
    ("DAPK1 [ xref ] and ROCK1 [ xref ]" . SPARSER::COLLECTION)
    ("myosin II regulatory light" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("DAPK3 (ZIPK)" . SPARSER::PROTEIN)
    ("DRAK1 and DRAK2" . SPARSER::COLLECTION) ("DAPK" . SPARSER::PROTEIN)
    ("vimentin and LIM (Lin11, Isl1 and Mec3)-kinase [ xref ]"
     . SPARSER::COLLECTION)
    ("adducin, vimentin and LIM (Lin11, Isl1 and Mec3)-kinase [ xref ]"
     . SPARSER::COLLECTION)
    ("-kinase" . SPARSER::KINASE)
    ("ezrin-radixin-moesin" . SPARSER::COLLECTION)
    ("adducin" . SPARSER::PROTEIN-FAMILY) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("ERM" . SPARSER::PROTEIN) ("vascular SMC" . SPARSER::PROTEIN)
    ("only two cytokine genes" . SPARSER::GENE)
    ("Only 76 differentially" . SPARSER::PROTEIN)
    ("receptors, growth factors, phosphatases and ion channels"
     . SPARSER::COLLECTION)
    ("ROCK1 and ZIPK" . SPARSER::COLLECTION) ("SMC" . SPARSER::PROTEIN)
    ("kinase (ZIPK)" . SPARSER::KINASE)
    ("Rho-associated kinase (ROCK)" . SPARSER::KINASE)
    ("ZIPK" . SPARSER::PROTEIN) ("MCM 3" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("α-actin" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("GROα" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("I-TAC" . SPARSER::PROTEIN) ("IP-10" . SPARSER::PROTEIN)
    ("17-kDa protein" . SPARSER::PROTEIN) ("CPI-17" . SPARSER::PROTEIN)
    ("LC 20" . SPARSER::PROTEIN)
    ("apoptosis-inducing protein" . SPARSER::PROTEIN)
    ("DRAK2" . SPARSER::PROTEIN) ("DRAK1" . SPARSER::PROTEIN)
    ("DAPK3" . SPARSER::PROTEIN) ("DAPK2" . SPARSER::PROTEIN)
    ("DAPK1" . SPARSER::PROTEIN)
    ("death-associated protein" . SPARSER::PROTEIN) ("Isl1" . SPARSER::PROTEIN)
    ("Lin11" . SPARSER::PROTEIN) ("ROCK1 protein" . SPARSER::PROTEIN)
    ("ALK or ROS1" . SPARSER::COLLECTION)
    ("FISH and RNA" . SPARSER::COLLECTION)
    ("RET and ROS1" . SPARSER::COLLECTION) ("the ALK01" . SPARSER::PROTEIN)
    ("-gene" . SPARSER::GENE) ("extensive homology" . SPARSER::PROTEIN)
    ("tyrosine kinase (LTK)" . SPARSER::PROTEIN)
    ("EML4-ALK4" . SPARSER::COLLECTION) ("EML4 and ALK" . SPARSER::COLLECTION)
    ("CLTC" . SPARSER::PROTEIN) ("LMNA" . SPARSER::PROTEIN)
    ("ATIC" . SPARSER::PROTEIN)
    ("both a strong constitutive promoter and an oligomerization domain  xref"
     . SPARSER::COLLECTION)
    ("both a strong constitutive promoter" . SPARSER::PROMOTER)
    ("nucleophosmin" . SPARSER::PROTEIN) ("TKs" . SPARSER::PROTEIN)
    ("TPM3 or TPM4" . SPARSER::COLLECTION) ("VCL" . SPARSER::PROTEIN)
    ("NPM" . SPARSER::PROTEIN)
    ("the kinases investigated suggesting alternative pathogenesis"
     . SPARSER::PROTEIN)
    ("ROS1 (2 cases) or RET (1 case)" . SPARSER::COLLECTION)
    ("either ALK (12 cases), ROS1 (2 cases) or RET (1 case)"
     . SPARSER::COLLECTION)
    ("PDGFRB, NTRK1 and LTK" . SPARSER::COLLECTION)
    ("component and fibro-myxoid" . SPARSER::COLLECTION)
    ("HPFs" . SPARSER::PROTEIN) ("-type" . TYPE)
    ("a 7.0 cm right upper lobe" . SPARSER::PROTEIN)
    ("ALK, ROS1 or PDGFRB" . SPARSER::COLLECTION)
    ("RANBP2-ALK" . SPARSER::COLLECTION) ("perinuclear ALK" . SPARSER::PROTEIN)
    ("-receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("TFG-ROS1" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("actionable kinases" . SPARSER::KINASE)
    ("ALK, ROS1, PDGFRB, NTRK1 and RET" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN) ("ALK4" . SPARSER::PROTEIN)
    ("SEC31A" . SPARSER::PROTEIN) ("PRKAR1A" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("Anaplastic Lymphoma Kinase" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IgG4" . SPARSER::PROTEIN)
    ("RANBP2" . SPARSER::PROTEIN) ("TPM4" . SPARSER::PROTEIN)
    ("TPM3" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("protein and ~4-fold" . SPARSER::COLLECTION)
    ("protein and telomerase activity" . SPARSER::COLLECTION)
    ("ETS or c-MYC" . SPARSER::COLLECTION)
    ("c-MYC or WNT" . SPARSER::COLLECTION) ("SIMs" . SPARSER::PROTEIN)
    ("HA-mSLX4" . SPARSER::COLLECTION) ("SUMO–SIM" . SPARSER::PROTEIN-PAIR)
    ("the nucleoplasmic fraction" . SPARSER::COMPONENT)
    ("NBS1-mCherry" . SPARSER::COLLECTION)
    ("wild-type SLX4 and the ΔSIM mutant" . SPARSER::COLLECTION)
    ("XPF-" . SPARSER::PROTEIN) ("mSLX4-ΔSIM" . SPARSER::COLLECTION)
    ("EME1-MUS81" . SPARSER::COLLECTION) ("ERCC1-XPF" . SPARSER::COLLECTION)
    ("XPF" . SPARSER::PROTEIN) ("ΔSIM" . SPARSER::PROTEIN)
    ("PML " . SPARSER::PROTEIN) ("Cajal" . SPARSER::PROTEIN)
    ("SLX4-ΔSIM" . SPARSER::PROTEIN-PAIR) ("GFP-SLX4-wt" . SPARSER::COLLECTION)
    ("GFP-mSLX4-wt" . SPARSER::COLLECTION) ("mSLX4" . SPARSER::PROTEIN)
    ("GFP-mSLX4" . SPARSER::COLLECTION) ("ICLs" . SPARSER::PROTEIN)
    ("alanines" . SPARSER::AMINO-ACID) ("hydroxyurea (HU)" . SPARSER::DRUG)
    ("CPT" . SPARSER::PROTEIN) ("HIS" . SPARSER::AMINO-ACID)
    ("mitomycin C (MMC)" . SPARSER::DRUG) ("MMC" . SPARSER::PROTEIN)
    ("ICL" . SPARSER::PROTEIN) ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("MDC1, 53BP1, BRCA1, PCNA and RNF168" . SPARSER::COLLECTION)
    ("Examples" . SPARSER::EXAMPLE) ("PIAS1 and PIAS4" . SPARSER::COLLECTION)
    ("SUMOs" . SPARSER::PROTEIN) ("laser-induced DNA" . SPARSER::DNA)
    ("MUS81" . SPARSER::PROTEIN) ("EME1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("USP25" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("RNF168" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("PIAS4" . SPARSER::PROTEIN)
    ("PIAS1" . SPARSER::PROTEIN) ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SLX4" . SPARSER::PROTEIN) ("much longer CA-SSR1" . SPARSER::PROTEIN)
    ("Alleles" . SPARSER::ALLELE) ("Polymorphism" . SPARSER::PROTEIN)
    ("antibacterials" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("Cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("KRAS, NRAS, or BRAF" . SPARSER::COLLECTION)
    ("a human–mouse chimeric mAb" . SPARSER::DRUG) ("mAb" . SPARSER::DRUG)
    ("Erbitux" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("p  " . SPARSER::PROTEIN) ("dinucleotide" . SPARSER::MOLECULE)
    ("SSR1" . SPARSER::PROTEIN) ("ErbB-1" . SPARSER::PROTEIN)
    ("TNFα , FB1 , PTGS2 and PTGS1" . SPARSER::COLLECTION)
    ("EWSR1-FLI1" . SPARSER::COLLECTION) ("Polypeptide" . SPARSER::PEPTIDE)
    ("HATs and HDAC" . SPARSER::COLLECTION)
    ("HAT and histone deacetylase" . SPARSER::COLLECTION)
    ("TGFB1 and MGC4093" . SPARSER::COLLECTION) ("CREBBP" . SPARSER::PROTEIN)
    ("TGFB1 and IgE" . SPARSER::COLLECTION)
    ("an immunoregulatory cytokine" . SPARSER::PROTEIN)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("the major pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("MHC" . SPARSER::PROTEIN) ("TNFα and TGFB1" . SPARSER::COLLECTION)
    ("MGC4093 and AIF" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("AIF" . SPARSER::PROTEIN) ("SNAP" . SPARSER::PROTEIN)
    ("Genotype" . SPARSER::PROTEIN) ("Allele" . SPARSER::ALLELE)
    ("HDI, MDI and TDI" . SPARSER::COLLECTION)
    ("NAG1/GDF15" . SPARSER::COLLECTION)
    ("PTGS1 , PTGS2 , ADAM33 and ALOX5 genes and allergic asthma"
     . SPARSER::COLLECTION)
    ("PTGS1 , PTGS2 , ADAM33 and ALOX5" . SPARSER::COLLECTION)
    ("leukotrienes" . SPARSER::PROTEIN)
    ("essential mediators" . SPARSER::PROTEIN)
    ("ALOX5 (arachidonate 5-lipoxygenase) and NAG-1/GDF15 (non-steroidal anti-inflammatory drug-activated gene)"
     . SPARSER::COLLECTION)
    ("ADAM33 (ADAM metallopeptidase domain 33), PTGS1 (prostaglandin-endoperoxide synthase-1, previously COX1 ), PTGS2 (previously COX2 ), ALOX5 (arachidonate 5-lipoxygenase) and NAG-1/GDF15 (non-steroidal anti-inflammatory drug-activated gene)"
     . SPARSER::COLLECTION)
    ("IL10 , TNFα and transforming growth factor-" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokine genes" . SPARSER::GENE)
    ("both T-helper (T H )-1 and T H 2 cytokines" . SPARSER::COLLECTION)
    ("human proteins and these protein" . SPARSER::COLLECTION)
    ("MDI" . SPARSER::MOLECULE) ("TDI" . SPARSER::MOLECULE)
    ("low-molecular weight reactive chemicals" . SPARSER::MOLECULE)
    ("TNFα , TGFB1 , PTGS1 and PTGS2" . SPARSER::COLLECTION)
    ("polymorphisms (SNP)" . SPARSER::PROTEIN) ("nuclease" . SPARSER::PROTEIN)
    ("confirmed DA (DA + , n = 95) and asymptomatic exposed workers (AW, n = 142)"
     . SPARSER::COLLECTION)
    ("TNFα , IL1α , IL1β , IL1RN , IL10 , TGFB1 , ADAM33 , ALOX -5, PTGS1 , PTGS2 and NAG -1/"
     . SPARSER::COLLECTION)
    ("FB1" . SPARSER::PROTEIN) ("RNA-Binding Protein" . SPARSER::PROTEIN)
    ("Transcription Factor AP-2 Gamma" . SPARSER::PROTEIN)
    ("TFAP2C" . SPARSER::PROTEIN) ("AP-2 alpha" . SPARSER::PROTEIN)
    ("TFAP2A" . SPARSER::PROTEIN) ("CREB binding protein" . SPARSER::PROTEIN)
    ("CCCTC-binding factor" . SPARSER::PROTEIN) ("POLR2A" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("5-lipoxygenase" . SPARSER::PROTEIN)
    ("Allograft Inflammatory Factor 1" . SPARSER::PROTEIN)
    ("AIF1" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("MGC4093" . SPARSER::PROTEIN) ("NAG1" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclo-oxygenases" . SPARSER::PROTEIN) ("NAG-1" . SPARSER::PROTEIN)
    ("arachidonate 5-lipoxygenase" . SPARSER::PROTEIN)
    ("ALOX5" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("COX1" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase-1" . SPARSER::PROTEIN)
    ("ADAM metallopeptidase domain 33" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-1" . SPARSER::PROTEIN)
    ("hexamethylene diisocyanate" . SPARSER::MOLECULE)
    ("Toluene diisocyanate" . SPARSER::MOLECULE) ("GDF15" . SPARSER::PROTEIN)
    ("NAG -1" . SPARSER::PROTEIN) ("PTGS1" . SPARSER::PROTEIN)
    ("ALOX -5" . SPARSER::PROTEIN) ("ADAM33" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN) ("IL1RN" . SPARSER::PROTEIN)
    ("IL1α" . SPARSER::PROTEIN) ("CUL1:FBXW7" . SPARSER::BIO-COMPLEX)
    ("MTHFD2, HMGB1 and ITGB3BP" . SPARSER::COLLECTION)
    ("HSF1 and Cyclin E" . SPARSER::COLLECTION)
    ("metastatic foci" . SPARSER::PROTEIN)
    ("a critical substrate of FBXW7 and its accumulation"
     . SPARSER::COLLECTION)
    ("the BRAF inhibitor Vemurafenib and the MEK inhibitor Trametinib"
     . SPARSER::COLLECTION)
    ("BRAF/MEK" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("targets and mRNAs" . SPARSER::COLLECTION) ("FBXW7 α" . SPARSER::PROTEIN)
    ("FBXW7:HSF1" . SPARSER::BIO-COMPLEX)
    ("Previously characterized HSF1" . SPARSER::PROTEIN)
    ("HSPD1 , HSPE1 , HSPH1 and CKS2" . SPARSER::COLLECTION)
    ("increased survival compared toFbxw7 flox/flox" . SPARSER::COLLECTION)
    ("proteotoxic drugs" . SPARSER::DRUG) ("flox/flox" . SPARSER::COLLECTION)
    ("flox" . SPARSER::PROTEIN) ("FBXW7-HSF1" . SPARSER::COLLECTION)
    ("the proteasome inhibitor MG132 and the HSP90 inhibitor Radicicol"
     . SPARSER::COLLECTION)
    ("Radicicol" . SPARSER::DRUG)
    ("HSPH1 , HSPB1 and HSPE1" . SPARSER::COLLECTION)
    ("the heat-shock-inducible HSPA6 gene" . SPARSER::GENE)
    ("a GSK3 inhibitor (GSK3i IX and XVI) or a MEK inhibitor (U0126)"
     . SPARSER::COLLECTION)
    ("down-modulating HSF1's" . SPARSER::PROTEIN)
    ("down-modulating HSF1" . SPARSER::PROTEIN) ("FBXW7α" . SPARSER::PROTEIN)
    ("FBXW7 and HSF1" . SPARSER::COLLECTION)
    ("GSK3β and ERK1" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("e-5" . SPARSER::PROTEIN)
    ("m 1" . SPARSER::MOLECULE) ("IL-2R" . SPARSER::PROTEIN)
    ("ADAM22" . SPARSER::PROTEIN) ("ADAM17" . SPARSER::PROTEIN)
    ("DNAJB1" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("GSK1120212" . SPARSER::DRUG) ("PLX4032" . SPARSER::DRUG)
    ("L-15" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("IP2" . SPARSER::PROTEIN) ("NaVO3" . SPARSER::MOLECULE)
    ("CUL1" . SPARSER::PROTEIN) ("ITGB3BP" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("MTHFD2" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("FBXW7 protein" . SPARSER::PROTEIN)
    ("CKS2" . SPARSER::PROTEIN) ("Fbxw7" . SPARSER::PROTEIN)
    ("HSP90AB1" . SPARSER::PROTEIN) ("HSPD1" . SPARSER::PROTEIN)
    ("CCT6A" . SPARSER::PROTEIN) ("EIF4A2" . SPARSER::PROTEIN)
    ("HSPE1" . SPARSER::PROTEIN) ("HSPB1" . SPARSER::PROTEIN)
    ("HSPH1" . SPARSER::PROTEIN) ("HSPA6" . SPARSER::PROTEIN)
    ("Cullin 1" . SPARSER::PROTEIN) ("Cul1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("HSF1" . SPARSER::PROTEIN) ("AG1478 and Bay11-7082" . SPARSER::COLLECTION)
    ("EGFR, JAK–STAT and PI3K–AKT" . SPARSER::COLLECTION)
    ("JAK–STAT and PI3K–AKT" . SPARSER::COLLECTION)
    ("JNK1/2 and ERK1/2" . SPARSER::COLLECTION) ("rhein" . SPARSER::DRUG)
    ("magnolol" . SPARSER::DRUG)
    ("JAK–STAT, PI3K–AKT and MAPKs" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclins" . SPARSER::COLLECTION)
    ("IκB-α and inactivated NF-κB" . SPARSER::COLLECTION)
    ("cyclin D1 and Bcl-xL" . SPARSER::COLLECTION)
    ("RelB and c-Rel" . SPARSER::COLLECTION) ("NF-kB2" . SPARSER::PROTEIN)
    ("lupeol and bromelain" . SPARSER::COLLECTION) ("lupeol" . SPARSER::DRUG)
    ("Bax–Bcl-2" . SPARSER::COLLECTION)
    ("caspase-9–caspase-3" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("Apaf-1 (apoptotic protease activating factor 1) and pro-caspase-9 [ xref ]"
     . SPARSER::COLLECTION)
    ("cytochrome c , Apaf-1 (apoptotic protease activating factor 1) and pro-caspase-9 [ xref ]"
     . SPARSER::COLLECTION)
    ("cyclin–CDK" . SPARSER::COLLECTION) ("type " . TYPE)
    ("Helenalin (1 μM) and the EGFR inhibitor AG1478 (1 μM)"
     . SPARSER::COLLECTION)
    ("anticipated AG1478 (1 μM, an EGFR inhibitor) and Bay11-7082 (5 μM, a NF-κB inhibitor)"
     . SPARSER::COLLECTION)
    ("EGFR and NF-κB" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION)
    ("EGFR, STAT3 and Akt" . SPARSER::COLLECTION)
    ("STAT3, Akt and Erk" . SPARSER::COLLECTION)
    ("MAPK–Erk" . SPARSER::COLLECTION) ("NF-κB–p65" . SPARSER::COLLECTION)
    ("Blot" . SPARSER::PROTEIN)
    ("cyclins, Bax and Bcl-2" . SPARSER::COLLECTION)
    ("NF-κB and NF-κB" . SPARSER::COLLECTION)
    ("both 10 μM shikonin and 100 μM Z–Asp–CH2–DCB" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("procaspase-9 and procaspase-3 " . SPARSER::COLLECTION)
    ("procaspase-9, procaspase-3, Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("Annexin-V–PI" . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("KIP1–p27" . SPARSER::COLLECTION) ("WAF1–p21" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN)
    ("EGFR and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("the EGFR and its downstream targets" . SPARSER::COLLECTION)
    ("SCCs" . SPARSER::PROTEIN)
    ("growth factor receptors or their downstream effectors"
     . SPARSER::COLLECTION)
    ("-NF-κB" . SPARSER::COLLECTION) ("EGFR–NF-κB" . SPARSER::COLLECTION)
    ("Helenalin and the EGFR inhibitor AG1478" . SPARSER::COLLECTION)
    ("LY294002 and STAT3" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("Helenalin" . SPARSER::DRUG)
    ("anticipated AG1478 (EGFR inhibitor) and Bay11-7082 (NF-κB inhibitor)"
     . SPARSER::COLLECTION)
    ("DCB" . SPARSER::PROTEIN-FAMILY)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("shikonin" . SPARSER::DRUG) ("naphthoquinone" . SPARSER::MOLECULE)
    ("Shikonin" . SPARSER::DRUG) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor 1" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN) ("PI3K–Akt" . SPARSER::PROTEIN)
    ("JAK–STAT" . SPARSER::PROTEIN) ("-3 " . SPARSER::PROTEIN)
    ("CDK 2" . SPARSER::PROTEIN) ("KIP1" . SPARSER::PROTEIN)
    ("IκB-α" . SPARSER::PROTEIN) ("p27KIP1" . SPARSER::PROTEIN)
    ("Bay11-7082" . SPARSER::DRUG) ("CH2" . SPARSER::PROTEIN)
    ("urinary EGFR and UBC" . SPARSER::COLLECTION)
    ("EGFR and UBC" . SPARSER::COLLECTION)
    ("full-length and ectodomain" . SPARSER::COLLECTION)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("a potential urinary biomarker" . SPARSER::MOLECULE)
    ("high EGFR and low EpCAM" . SPARSER::COLLECTION)
    ("EGFR and EPCAM" . SPARSER::COLLECTION) ("EPCAM" . SPARSER::PROTEIN)
    ("EGFR (HR=6.69, 95% CI 3.41–13.12, P <0.001) and EpCAM (HR=2.13, 95% CI 1.19–3.82, P =0.011)"
     . SPARSER::COLLECTION)
    ("EpCAM or EGFR" . SPARSER::COLLECTION)
    ("urinary EpCAM and EGFR" . SPARSER::COLLECTION)
    ("EpCAM and EGFR" . SPARSER::COLLECTION)
    ("elevated urinary EGFR" . SPARSER::PROTEIN)
    ("the predominant form" . SPARSER::FORM)
    ("EGFR, and peptides" . SPARSER::COLLECTION)
    ("‘soluble' EGFR" . SPARSER::PROTEIN)
    ("pTa, pT1 and pT2+" . SPARSER::COLLECTION)
    ("urinary EGFR" . SPARSER::PROTEIN) ("pT1 or pT2+" . SPARSER::COLLECTION)
    ("creatinine" . SPARSER::PROTEIN) ("pg" . SPARSER::MOLECULE)
    ("the total cellular EGFR" . SPARSER::PROTEIN) ("CLS" . SPARSER::PROTEIN)
    ("Both ‘light' and ‘heavy' EGFR peptides" . SPARSER::COLLECTION)
    ("‘light'" . SPARSER::PROTEIN) ("Tryptic peptides" . SPARSER::PEPTIDE)
    ("EGFR, glucose-6-phosphate dehydrogenase, peroxiredoxin 6, LY6/PLAUR domain containing 3 and fibulin 1"
     . SPARSER::COLLECTION)
    ("urinary biomarkers" . SPARSER::MOLECULE)
    ("2078 unique proteins" . SPARSER::PROTEIN)
    ("soluble urinary EpCAM" . SPARSER::PROTEIN)
    ("soluble urinary EGFR" . SPARSER::PROTEIN)
    ("pTa/pT1/pTis" . SPARSER::COLLECTION) ("pTis" . SPARSER::PROTEIN)
    ("pTa" . SPARSER::PROTEIN) ("UBC" . SPARSER::PROTEIN)
    ("urinary EGFR and EpCAM" . SPARSER::COLLECTION)
    ("both urinary EGFR and EpCAM" . SPARSER::COLLECTION)
    ("EGFR and EpCAM" . SPARSER::COLLECTION) ("EpCAM" . SPARSER::PROTEIN)
    ("Urinary EGFR" . SPARSER::PROTEIN) ("Soluble EGFR" . SPARSER::PROTEIN)
    ("shotgun" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("fibulin 1" . SPARSER::PROTEIN)
    ("LY6/PLAUR domain containing 3" . SPARSER::PROTEIN)
    ("peroxiredoxin 6" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN)
    ("An excellent example" . SPARSER::EXAMPLE) ("rituximab" . SPARSER::DRUG)
    ("this study sheds new light" . SPARSER::PROTEIN)
    ("GITR" . SPARSER::PROTEIN) ("MS4A4 or SMAP1" . SPARSER::COLLECTION)
    ("MS4A4 and SMAP1" . SPARSER::COLLECTION)
    ("neoplastic KIT" . SPARSER::PROTEIN)
    ("PLCγ1 and phosphatidylinositol-3-kinases" . SPARSER::COLLECTION)
    ("MEK1 partner (MP1) and p14 proteins ( xref )" . SPARSER::COLLECTION)
    ("p14-MP1-MEK1" . SPARSER::COLLECTION)
    ("AKT and PLCγ1" . SPARSER::COLLECTION)
    ("endocytic receptor" . SPARSER::RECEPTOR)
    ("Lyn and PLCγ1" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("particular PLCγ1" . SPARSER::PROTEIN)
    ("MS4A4 and caveolin-1" . SPARSER::COLLECTION)
    ("MS4A4 and clathrin" . SPARSER::COLLECTION)
    ("Rab5 and EEA1" . SPARSER::COLLECTION) ("Rab9" . SPARSER::PROTEIN)
    ("MS4A4 and Rab11" . SPARSER::COLLECTION)
    ("MS4A4 and Rab7" . SPARSER::COLLECTION) ("Rab5-" . SPARSER::PROTEIN)
    ("Rab5 and colocalizes" . SPARSER::COLLECTION)
    ("KIT and EEA1" . SPARSER::COLLECTION)
    ("MS4A4 or KIT" . SPARSER::COLLECTION)
    ("MS4A4 and the constitutively active Rab5 (Q79L)" . SPARSER::COLLECTION)
    ("MS4A4 and WT Rab5 (Supplemental Figure S4A)" . SPARSER::COLLECTION)
    ("MS4A4 and Rab5" . SPARSER::COLLECTION)
    ("dominant-negative Rab5 (S34N) and MS4A4" . SPARSER::COLLECTION)
    ("both wild-type Rab5 ( xref , left) and constitutively active Rab5 (Q79L; xref , middle)"
     . SPARSER::COLLECTION)
    ("fluorescent protein–tagged MS4A4 and various Rab proteins and their variants"
     . SPARSER::COLLECTION)
    ("various Rab proteins and their variants" . SPARSER::COLLECTION)
    ("fluorescent protein–tagged MS4A4" . SPARSER::PROTEIN)
    ("Rab family proteins and their effector proteins" . SPARSER::COLLECTION)
    ("MS4A4 and EEA1" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("MS4A4 and Sec61B" . SPARSER::COLLECTION) ("Sec61B" . SPARSER::PROTEIN)
    ("SCF, MS4A4 and KIT" . SPARSER::COLLECTION)
    ("MS4A4 and KIT" . SPARSER::COLLECTION)
    ("AKT (Ser-473) and ERK (Thr-202/Tyr-204)" . SPARSER::COLLECTION)
    ("shMS" . SPARSER::DRUG)
    ("at least three known MS4A4 splice variants" . SPARSER::VARIANT)
    ("an essential receptor" . SPARSER::RECEPTOR)
    ("stem cell factor receptor (KIT)" . SPARSER::PROTEIN)
    ("IgE" . SPARSER::PROTEIN) ("MS4A4 and MS4A6" . SPARSER::COLLECTION)
    ("MS4A1 (encoding CD20) and MS4A2 (encoding the β subunit of the high-affinity immunoglobulin E receptor FceRI)"
     . SPARSER::COLLECTION)
    ("FceRI" . SPARSER::PROTEIN) ("tetraspanins" . SPARSER::PROTEIN-FAMILY)
    ("mast cell" . SPARSER::PROTEIN) ("Akt and PLCγ1" . SPARSER::COLLECTION)
    ("PLCg1" . SPARSER::PROTEIN) ("KIT" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("SP8" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("SMAP1" . SPARSER::PROTEIN)
    ("ARF GTPase-activating protein 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-MET" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("MP1" . SPARSER::PROTEIN) ("MEK1 partner" . SPARSER::PROTEIN)
    ("Ms4a" . SPARSER::PROTEIN-FAMILY) ("Rab family" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("B–D" . SPARSER::PROTEIN)
    ("Sec61" . SPARSER::PROTEIN) ("CD54" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("KIT ligand" . SPARSER::PROTEIN) ("MS4A4A" . SPARSER::PROTEIN)
    ("stem cell factor receptor" . SPARSER::PROTEIN)
    ("MS4A6" . SPARSER::PROTEIN) ("MS4A2" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("MS4A1" . SPARSER::PROTEIN)
    ("MS4A" . SPARSER::PROTEIN-FAMILY) ("PLCγ1" . SPARSER::PROTEIN)
    ("MS4A family" . SPARSER::PROTEIN-FAMILY) ("MS4A4" . SPARSER::PROTEIN)
    ("NRF2 and p62" . SPARSER::COLLECTION)
    ("accumulated ubiquitinated NRF2 and total NRF2 protein"
     . SPARSER::COLLECTION)
    ("NAC" . SPARSER::PROTEIN) ("atm" . SPARSER::PROTEIN)
    ("KLF4, NANOG, SOX2, and OCT4" . SPARSER::COLLECTION)
    ("NRF2 and ABC transporters" . SPARSER::COLLECTION)
    ("MRP3 and MRP6" . SPARSER::COLLECTION)
    ("MDR1 and BCRP" . SPARSER::COLLECTION)
    ("h-doxorubicin" . SPARSER::COLLECTION)
    ("Differential transporter" . SPARSER::PROTEIN)
    ("MRP2 and BCRP" . SPARSER::COLLECTION)
    ("BCRP and MRP2" . SPARSER::COLLECTION) ("diacetate" . SPARSER::MOLECULE)
    ("HO-1 and AKR1c1" . SPARSER::COLLECTION) ("GSR" . SPARSER::PROTEIN)
    ("AKR1c1, NQO1 , and HO-1" . SPARSER::COLLECTION)
    ("KLF4 and NANOG" . SPARSER::COLLECTION)
    ("GCLC, GCLM, HO-1, AKR1c1, and NQO-1" . SPARSER::COLLECTION)
    ("GCLM" . SPARSER::PROTEIN) ("AKR1c1 and MRP2" . SPARSER::COLLECTION)
    ("p62 and NRF2" . SPARSER::COLLECTION) ("p62-" . SPARSER::PROTEIN)
    ("ODC" . SPARSER::PROTEIN) ("NRF2 and KLF4" . SPARSER::COLLECTION)
    ("ligase ( GCLC )" . SPARSER::LIGASE) ("AKR1c1" . SPARSER::PROTEIN)
    ("MRP2 and MRP3" . SPARSER::COLLECTION)
    ("multidrug resistance proteins ( MRPs ; ABCCs ) and breast cancer resistance protein ( BCRP ; ABCG2 )"
     . SPARSER::COLLECTION)
    ("BCRP" . SPARSER::PROTEIN) ("ABCCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-polymerase" . SPARSER::COLLECTION) ("/CD24" . SPARSER::COLLECTION)
    ("KLF4, NANOG, and SOX2" . SPARSER::COLLECTION)
    ("transporters and detoxifying/antioxidant" . SPARSER::COLLECTION)
    ("proteins and drug" . SPARSER::COLLECTION) ("GSCs" . SPARSER::PROTEIN)
    ("NRF2-KEAP1" . SPARSER::COLLECTION) ("p62 and p21" . SPARSER::COLLECTION)
    ("glutathione (GSH) generation enzymes, and GSH peroxidase ( GPx ) as well as drug efflux transporters [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("NAD(P)H quinine oxidoreductase ( NQO-1 ), heme oxygenase-1 ( HO-1 ), glutathione (GSH) generation enzymes, and GSH peroxidase ( GPx ) as well as drug efflux transporters [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("enzymes, and GSH" . SPARSER::COLLECTION) ("GPx" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN) ("oxidoreductase" . SPARSER::PROTEIN)
    ("quinine" . SPARSER::DRUG) ("striatum" . SPARSER::PROTEIN)
    ("Notch-1 and Wnt" . SPARSER::COLLECTION)
    ("transporters and antioxidant" . SPARSER::COLLECTION)
    ("peptidase activity" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("Musashi-1" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG)
    ("butylated hydroxyanisole" . SPARSER::MOLECULE)
    ("MRP6" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("H 2 DCFDA" . SPARSER::DRUG) ("PSMB7" . SPARSER::PROTEIN)
    ("PSMB5" . SPARSER::PROTEIN) ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("aldo-keto reductase" . SPARSER::PROTEIN) ("MRP3" . SPARSER::PROTEIN)
    ("MRP2" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("Cullin 3" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("that Bevacizumab's" . SPARSER::DRUG)
    ("an eIF4E inhibitor (RBV) (RPMI-8226, CAG) and an inhibitor"
     . SPARSER::COLLECTION)
    ("inhibitor (RBV)" . SPARSER::INHIBITOR) ("EGI" . SPARSER::PROTEIN)
    ("si" . SPARSER::PROTEIN) ("GADD153/CHOP" . SPARSER::COLLECTION)
    ("GRP78/BiP" . SPARSER::COLLECTION)
    ("media and drug" . SPARSER::COLLECTION) ("trypan" . SPARSER::DRUG)
    ("Media" . SPARSER::PROTEIN) ("regular media" . SPARSER::PROTEIN)
    ("RBV-competitive" . SPARSER::DRUG) ("RBV" . SPARSER::DRUG)
    ("Ribavirin" . SPARSER::DRUG) ("KD and ER-stress" . SPARSER::COLLECTION)
    ("MiRs" . SPARSER::PROTEIN) ("30–50 possible microRNAs" . SPARSER::RNA)
    ("NFkB" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("si-eIF4G" . SPARSER::PROTEIN-PAIR) ("si-eIF4E" . SPARSER::PROTEIN-PAIR)
    ("often tumor suppressors or oncogenes" . SPARSER::COLLECTION)
    ("eIF4E or eIF4GI" . SPARSER::COLLECTION)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("RPMI 8226" . SPARSER::PROTEIN)
    ("the traditional eIF4F" . SPARSER::PROTEIN)
    ("eukaryotic initiation complex eIF4F" . SPARSER::PROTEIN)
    ("eIF4G, and RNA" . SPARSER::COLLECTION)
    ("eIF4E and eIF4GI" . SPARSER::COLLECTION) ("eIF4GI" . SPARSER::PROTEIN)
    ("microRNAs and phenotype" . SPARSER::COLLECTION)
    ("Avastin" . SPARSER::DRUG)
    ("microRNAs, and phenotype" . SPARSER::COLLECTION)
    ("The eukaryotic translation initiation complex eIF4F" . SPARSER::PROTEIN)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("small nucleolar RNA" . SPARSER::RNA) ("PPM1E" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("ASS1" . SPARSER::PROTEIN)
    ("SESN2" . SPARSER::PROTEIN) ("PIM1" . SPARSER::PROTEIN)
    ("HOXB9" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("FBXO32" . SPARSER::PROTEIN) ("TRIB2" . SPARSER::PROTEIN)
    ("LSP1" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("IL23A" . SPARSER::PROTEIN) ("SERPINI1" . SPARSER::PROTEIN)
    ("ARAP1" . SPARSER::PROTEIN) ("DOCK4" . SPARSER::PROTEIN)
    ("AGPAT1" . SPARSER::PROTEIN) ("SMAD5" . SPARSER::PROTEIN)
    ("ARP1" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("GADD153" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN) ("mRNA and TERT" . SPARSER::COLLECTION)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("tamoxifen" . SPARSER::MOLECULE) ("delTA" . SPARSER::PROTEIN)
    ("mucinous and nonmucinous subtypes" . SPARSER::PROTEIN)
    ("a special type" . TYPE) ("histologic type" . TYPE)
    ("MIA" . SPARSER::PROTEIN) ("Histological type" . TYPE)
    ("direct DNA sequencing or amplification refractory mutation system-PCR"
     . SPARSER::COLLECTION)
    ("BAX and BAK1-deficient MEFs" . SPARSER::COLLECTION)
    ("BCL2, BCL2L1, or MCL1" . SPARSER::COLLECTION)
    ("BECN1 and either BCL2 or BCL2L1" . SPARSER::COLLECTION)
    ("Bax , Bak1, and Mcl1" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN)
    ("BCL2, BCL2L2, and BCL2L1" . SPARSER::COLLECTION)
    ("genotype" . SPARSER::PROTEIN) ("MEFs or Bax" . SPARSER::COLLECTION)
    ("both rapamycin and ABT-737-induced autophagy" . SPARSER::COLLECTION)
    ("BECN1-BCL2" . SPARSER::COLLECTION) ("SQSTM1/p62" . SPARSER::COLLECTION)
    ("/Baf" . SPARSER::COLLECTION) ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCL1 and the proapoptotic molecules" . SPARSER::COLLECTION)
    ("Bak1" . SPARSER::PROTEIN) ("viral BCL2-like proteins" . SPARSER::PROTEIN)
    ("BH3-only proteins or BH3 peptidomimetic drugs" . SPARSER::COLLECTION)
    ("BH3 peptidomimetic drugs" . SPARSER::DRUG)
    ("BCL2 and BCL2L1" . SPARSER::COLLECTION)
    ("BCL2 or BCL2L1" . SPARSER::COLLECTION)
    ("protein and organelle" . SPARSER::COLLECTION)
    ("BECN1/Beclin 1" . SPARSER::COLLECTION)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG)
    ("BCL2-BECN1" . SPARSER::COLLECTION) ("BAX and BAK1" . SPARSER::COLLECTION)
    ("BCL2L1/BCL-X" . SPARSER::COLLECTION) ("RB 2" . SPARSER::PROTEIN)
    ("IRE2" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("BCL2L2" . SPARSER::PROTEIN)
    ("bafilomycin A 1" . SPARSER::DRUG) ("ABT-737-" . SPARSER::DRUG)
    ("JNK1" . SPARSER::PROTEIN) ("MAPK8" . SPARSER::PROTEIN)
    ("ATG14" . SPARSER::PROTEIN) ("VPS34" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("BAK1" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("Rank" . SPARSER::PROTEIN)
    ("TGT" . SPARSER::PROTEIN) ("GAT" . SPARSER::PROTEIN)
    ("GGT" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor, and insulin-like growth factor"
     . SPARSER::COLLECTION)
    ("guanosine triphosphate (GTP)" . SPARSER::MOLECULE)
    ("guanosine" . SPARSER::MOLECULE)
    ("tumor suppressor genes (APC, p16, p53, and DCC) and mismatch repair genes"
     . SPARSER::COLLECTION)
    ("APC, p16, p53, and DCC" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("PMS2 and hMSH6" . SPARSER::COLLECTION) ("MLH1" . SPARSER::PROTEIN)
    ("wild KRAS gene" . SPARSER::GENE) ("tissue type" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("G3 - 4" . SPARSER::PROTEIN)
    ("G1 - 3" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE) ("hMSH6" . SPARSER::PROTEIN)
    ("the largest cohort" . SPARSER::MOLECULE) ("Iodine" . SPARSER::MOLECULE)
    ("RFS or DSS" . SPARSER::COLLECTION) ("RFS, and DSS" . SPARSER::COLLECTION)
    ("DSS" . SPARSER::PROTEIN) ("RFS" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN)
    ("thyroid stimulating hormone" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN)
    ("anti-BRAF and anti-MEK" . SPARSER::COLLECTION)
    ("IL-6 and IL-3" . SPARSER::COLLECTION)
    ("which harnesses AKT and related PI3K components" . SPARSER::COLLECTION)
    ("which harnesses AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("epithelial mesenchymal transition (EMT)-related genes" . SPARSER::GENE)
    ("ZEB1 and MMP3" . SPARSER::COLLECTION) ("Dct" . SPARSER::PROTEIN)
    ("Integrin" . SPARSER::PROTEIN) ("MITF" . SPARSER::PROTEIN)
    ("DCT and TYR" . SPARSER::COLLECTION) ("TYR" . SPARSER::AMINO-ACID)
    ("several pigmentation genes ( DCT, PMEL, MelanA ) and elevation of number of cytokines"
     . SPARSER::COLLECTION)
    ("MelanA" . SPARSER::PROTEIN) ("PMEL" . SPARSER::PROTEIN)
    ("DCT" . SPARSER::PROTEIN)
    ("tuberin, mTOR and GSK3β" . SPARSER::COLLECTION)
    ("mTOR and GSK3" . SPARSER::COLLECTION)
    ("PDK1 and PI3K" . SPARSER::COLLECTION) ("AKT/PDK1" . SPARSER::COLLECTION)
    ("genotypes" . SPARSER::PROTEIN)
    ("AKT, FOXO3a, PRAS40 and GSK3β" . SPARSER::COLLECTION)
    ("bortezomib and PDK1" . SPARSER::COLLECTION)
    ("ATF4 and CHOP" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("the pan PI3K inhibitor BKM120 and the proteasome inhibitors bortezomib and carfilzomib ( xref and xref )"
     . SPARSER::COLLECTION)
    ("bortezomib and carfilzomib" . SPARSER::COLLECTION)
    ("carfilzomib" . SPARSER::DRUG) ("bortezomib" . SPARSER::DRUG)
    ("BRAF, HRAS and NRAS" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("often more potent inhibitors" . SPARSER::INHIBITOR)
    ("synergizes" . SPARSER::PROTEIN) ("SGK3 and PDK1" . SPARSER::COLLECTION)
    ("PDK1 or SGK3" . SPARSER::COLLECTION)
    ("SGK3 or PDK1" . SPARSER::COLLECTION)
    ("FOXO3a and PRAS40" . SPARSER::COLLECTION)
    ("the SGK inhibitor (SGKi) GSK650394 ( xref ) or the PDK1 inhibitor (PDK1i) GSK2334470 ( xref )"
     . SPARSER::COLLECTION)
    ("PDK1 and SGK" . SPARSER::COLLECTION)
    ("Sgk3 KD (70% inhibition) and Sgk1 KD (55% inhibition; xref )"
     . SPARSER::COLLECTION)
    ("Pdk1 or Sgk3" . SPARSER::COLLECTION)
    ("an independent Sgk3- specfic shRNA" . SPARSER::PROTEIN)
    ("SGK3 and p70S6K" . SPARSER::COLLECTION)
    ("p70S6K, FOXO3a, PRAS40 and 4EBP1, and KD" . SPARSER::COLLECTION)
    ("4EBP1, and KD" . SPARSER::COLLECTION)
    ("P70S6K, and 4EBP1" . SPARSER::COLLECTION)
    ("Pdk1 , Sgk1 and Sgk3" . SPARSER::COLLECTION)
    ("AKT, FOXO3a and PRAS40" . SPARSER::COLLECTION)
    ("SGK1 or SGK3" . SPARSER::COLLECTION)
    ("Pdk1 , Sgk1 , or Sgk3" . SPARSER::COLLECTION)
    ("SBM-A3" . SPARSER::COLLECTION) ("SBM-A2" . SPARSER::COLLECTION)
    ("Sgk3" . SPARSER::PROTEIN) ("Sgk1" . SPARSER::PROTEIN)
    ("AKT or SGK" . SPARSER::COLLECTION)
    ("hyperproliferative foci" . SPARSER::PROTEIN)
    ("::Pdk1" . SPARSER::BIO-COMPLEX) ("Pdk1" . SPARSER::PROTEIN)
    ("::Pten" . SPARSER::BIO-COMPLEX) ("PDK1/SGK" . SPARSER::COLLECTION)
    ("SGK1 and SGK3" . SPARSER::COLLECTION)
    ("kinases, SGK1, SGK2, and SGK3" . SPARSER::COLLECTION)
    ("a sizable fraction" . SPARSER::COMPONENT)
    ("PDK1 and PTEN" . SPARSER::COLLECTION)
    ("an immediate downstream effector" . SPARSER::EFFECTOR)
    ("PKA, AKT, PKC, p70S6k, and SGK" . SPARSER::COLLECTION)
    ("p70S6k" . SPARSER::PROTEIN) ("Phosphoinositide" . SPARSER::PROTEIN)
    ("cytokines and inflammatory genes" . SPARSER::COLLECTION)
    ("PDK1/PI3K" . SPARSER::COLLECTION) ("PDK1 and SGK3" . SPARSER::COLLECTION)
    ("Braf::Pten" . SPARSER::BIO-COMPLEX) ("Pten" . SPARSER::PROTEIN)
    ("Braf" . SPARSER::PROTEIN) ("4-EBP1" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("E-4" . SPARSER::PROTEIN)
    ("Serpin2" . SPARSER::PROTEIN) ("Serpin1" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("TIF2" . SPARSER::PROTEIN)
    ("BKM120" . SPARSER::DRUG) ("ATF4" . SPARSER::PROTEIN)
    ("PI3K inhibitor BKM120" . SPARSER::DRUG) ("STF-083010" . SPARSER::DRUG)
    ("GSK650394" . SPARSER::DRUG) ("GGTI-298" . SPARSER::DRUG)
    ("EX 527" . SPARSER::DRUG) ("Brefeldin A" . SPARSER::MOLECULE)
    ("BKM-120" . SPARSER::DRUG) ("BI-D1870" . SPARSER::MOLECULE)
    ("AZD-6244" . SPARSER::DRUG) ("Mmp3" . SPARSER::PROTEIN)
    ("H3.3A" . SPARSER::PROTEIN) ("GSK2334470" . SPARSER::DRUG)
    ("S100" . SPARSER::PROTEIN) ("pS6K" . SPARSER::PROTEIN)
    ("4-Hydroxytamoxifen" . SPARSER::DRUG) ("SGK2" . SPARSER::PROTEIN)
    ("SGK3" . SPARSER::PROTEIN) ("emtansine" . SPARSER::DRUG)
    ("ado" . SPARSER::PROTEIN) ("pertuzumab" . SPARSER::DRUG)
    ("cisplatin and a fluoropyrimidine (capecitabine or 5-fluorouracil)"
     . SPARSER::COLLECTION)
    ("capecitabine or 5-fluorouracil" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG) ("fluoropyrimidine" . SPARSER::DRUG)
    ("trastuzumab" . SPARSER::DRUG) ("HER2:HER3" . SPARSER::BIO-COMPLEX)
    ("HER2:HER2" . SPARSER::BIO-COMPLEX)
    ("the most active signaling complex" . SPARSER::BIO-COMPLEX)
    ("CISH" . SPARSER::PROTEIN) ("T-DM1" . SPARSER::PROTEIN)
    ("an excellent example" . SPARSER::EXAMPLE)
    ("E2F4 and two target genes" . SPARSER::COLLECTION)
    ("repressive E2F4/p130" . SPARSER::COLLECTION)
    ("the repressive pRB/E2F3/HDAC1 complex" . SPARSER::BIO-COMPLEX)
    ("pRB/E2F3/HDAC1" . SPARSER::COLLECTION)
    ("E2F3 instead of E2F4 ( xref )" . SPARSER::COLLECTION)
    ("repressive E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("the only relevant activator" . SPARSER::ACTIVATOR)
    ("ATAD2 and RAD51" . SPARSER::COLLECTION)
    ("which contrasts EWS-FLI1 binding promoters" . SPARSER::PROMOTER)
    ("Supplementary Figures S5 and S6" . SPARSER::COLLECTION)
    ("ATAD2 or RAD51" . SPARSER::COLLECTION)
    ("E2F3 , and E2F3" . SPARSER::COLLECTION)
    ("E2F3 proteins independently target genes" . SPARSER::GENE)
    ("git" . SPARSER::PROTEIN)
    ("the statistical modeling part" . SPARSER::COMPONENT)
    ("b-actin" . SPARSER::COLLECTION)
    ("a physical complex" . SPARSER::BIO-COMPLEX)
    ("E2F4/E2F3" . SPARSER::COLLECTION)
    ("oncoprotein and E2F" . SPARSER::COLLECTION)
    ("E2F4 and p130" . SPARSER::COLLECTION)
    ("the repressive E2F4/p130 complex" . SPARSER::BIO-COMPLEX)
    ("pRB and p130" . SPARSER::COLLECTION)
    ("EWS-FLI1/E2F" . SPARSER::COLLECTION)
    ("pRB and E2F4" . SPARSER::COLLECTION)
    ("constitutively expressed repressive E2F4" . SPARSER::PROTEIN)
    ("E2F3 and RAD51" . SPARSER::COLLECTION)
    ("E2F3, ATAD2 and RAD51" . SPARSER::COLLECTION)
    ("CDKN1C/KIP2" . SPARSER::COLLECTION) ("E2F3/E2F4" . SPARSER::COLLECTION)
    ("repressive E2F4" . SPARSER::PROTEIN)
    ("MKI67 and RAD54L" . SPARSER::COLLECTION)
    ("the ATAD2 (Figure xref and  xref ) and RAD51 (Figure xref and  xref ) promoters"
     . SPARSER::COLLECTION)
    ("ETS and E2F" . SPARSER::COLLECTION)
    ("doxycycline controllable EWS-FLI1 shRNA" . SPARSER::PROTEIN)
    ("ETS/E2F" . SPARSER::COLLECTION) ("hg" . SPARSER::MOLECULE)
    ("Mio" . SPARSER::PROTEIN) ("E2F3 and E2F4" . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("ETS and E2F3" . SPARSER::COLLECTION)
    ("polypeptide (DP)" . SPARSER::PROTEIN) ("DP" . SPARSER::PROTEIN)
    ("p130 and p107, and E2F5" . SPARSER::COLLECTION)
    ("p107, and E2F5" . SPARSER::COLLECTION)
    ("p130 and pRB" . SPARSER::COLLECTION)
    ("transcriptional activators (E2F1–3A, B) and transcriptional repressors (E2F4-8)"
     . SPARSER::COLLECTION)
    ("Promoters" . SPARSER::PROMOTER)
    ("The resultant oncogenic transcription factor" . SPARSER::PROTEIN)
    ("a synergistic complex" . SPARSER::BIO-COMPLEX)
    ("longitudinal E2F target" . SPARSER::TARGET-PROTEIN)
    ("EWS-FLI1/E2F3" . SPARSER::COLLECTION)
    ("constitutively expressed repressive E2F4/p130" . SPARSER::COLLECTION)
    ("EWS-FLI1" . SPARSER::COLLECTION) ("E2F4/p130" . SPARSER::COLLECTION)
    ("E2F3/pRB" . SPARSER::COLLECTION) ("EWS" . SPARSER::PROTEIN)
    ("Cdc6" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("KIP2" . SPARSER::PROTEIN)
    ("CDKN1C" . SPARSER::PROTEIN) ("p57" . SPARSER::PROTEIN)
    ("RAD54L" . SPARSER::PROTEIN) ("MKI67" . SPARSER::PROTEIN)
    ("M  2" . SPARSER::MOLECULE) ("M  1" . SPARSER::MOLECULE)
    ("k  2" . SPARSER::PROTEIN) ("k  1" . SPARSER::PROTEIN)
    ("ATAD2" . SPARSER::PROTEIN) ("E 2 F 3" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("Transcription Factor" . SPARSER::PROTEIN)
    ("E2F7" . SPARSER::PROTEIN) ("E2F6" . SPARSER::PROTEIN)
    ("E2F5" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("EWSR1" . SPARSER::PROTEIN) ("FLI1" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("MEK1 or B-Raf" . SPARSER::COLLECTION)
    ("containing 2 μg/mL bovine serum albumin" . SPARSER::PROTEIN)
    ("acetone" . SPARSER::MOLECULE) ("ERK or MEK1" . SPARSER::COLLECTION)
    ("mercaptoethanol" . SPARSER::MOLECULE) ("EGTA" . SPARSER::MOLECULE)
    ("protein and LicoA" . SPARSER::COLLECTION)
    ("MEK1, B-Raf, and C-Raf" . SPARSER::COLLECTION) ("PIP" . SPARSER::PROTEIN)
    ("oxalate" . SPARSER::MOLECULE) ("methanol" . SPARSER::MOLECULE)
    ("chloroform" . SPARSER::MOLECULE) ("Lipids" . SPARSER::LIPID)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("dithiothreitol (DTT)" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE) ("FBS/MEM" . SPARSER::COLLECTION)
    ("trypsinized" . SPARSER::PROTEIN) ("FBS–MEM" . SPARSER::COLLECTION)
    ("MEM" . SPARSER::PROTEIN)
    ("an HRP-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("HRP" . SPARSER::PROTEIN) ("PVDF" . SPARSER::DRUG)
    ("Ramat-Gan" . SPARSER::COLLECTION) ("-2-" . SPARSER::PROTEIN)
    ("Gan" . SPARSER::PROTEIN) ("FBS-MEM" . SPARSER::PROTEIN-PAIR)
    ("5% FBS and 200 μg/mL" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("Phosphatidylinositol" . SPARSER::PROTEIN)
    ("B-Raf, and active" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("Sigma-Aldrich" . SPARSER::PROTEIN-PAIR)
    ("ERK1/2/p90RSK" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("PI3K, MEK1, B-Raf, and C-Raf" . SPARSER::COLLECTION)
    ("MEK1 and Raf" . SPARSER::COLLECTION)
    ("sunitinib and sorafenib" . SPARSER::COLLECTION)
    ("JNK1/2 or p38" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("ERKs/p90RSK" . SPARSER::COLLECTION)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("TPA" . SPARSER::DRUG)
    ("flavones, flavans, chalcones, and isoflavonoids" . SPARSER::COLLECTION)
    ("isoflavonoids" . SPARSER::MOLECULE) ("chalcones" . SPARSER::MOLECULE)
    ("flavans" . SPARSER::MOLECULE) ("flavones" . SPARSER::DRUG)
    ("Glycyrrhiza" . SPARSER::DRUG) ("mineralocorticoid" . SPARSER::MOLECULE)
    ("12-O-Tetradecanoylphorbol-13-acetate (TPA)" . SPARSER::DRUG)
    ("anthracene" . SPARSER::DRUG) ("hydrocortisone" . SPARSER::DRUG)
    ("triterpenoids" . SPARSER::MOLECULE)
    ("the principal biologically active component" . SPARSER::COMPONENT)
    ("PI3K ( xref B) and B-Raf ( xref F)" . SPARSER::COLLECTION)
    ("Sepharose" . SPARSER::MOLECULE)
    ("a widely-used commercial PI3K inhibitor" . SPARSER::INHIBITOR)
    ("PI3K, MEK1, and Raf" . SPARSER::COLLECTION)
    ("proteins and C-Raf" . SPARSER::COLLECTION)
    ("Akt or MEK" . SPARSER::COLLECTION) ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("Akt/ mammalian target of rapamycin mTOR ( xref A) and ERKs/p90 ribosomal protein S6 kinase (RSK) ( xref B)"
     . SPARSER::COLLECTION)
    ("ERKs/p90" . SPARSER::COLLECTION)
    ("a well-known commercial COX-2 inhibitor" . SPARSER::INHIBITOR)
    ("a potent direct physical inhibitor" . SPARSER::INHIBITOR)
    ("MAPKs and PI3K/Akt" . SPARSER::COLLECTION)
    ("Raf and MAPK/" . SPARSER::COLLECTION)
    ("ERKs, PI3K and Akt" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK and PI3K/Akt" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase (PI3K)"
     . SPARSER::COLLECTION)
    ("an essential enzyme" . SPARSER::ENZYME)
    ("aldosterone" . SPARSER::PROTEIN) ("rennin" . SPARSER::PROTEIN)
    ("triterpenes" . SPARSER::MOLECULE) ("polyamines" . SPARSER::MOLECULE)
    ("polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("a traditional herbal medicine and one of the most commonly prescribed botanicals"
     . SPARSER::COLLECTION)
    ("medicine and one of the most commonly prescribed botanicals"
     . SPARSER::COLLECTION)
    ("a traditional herbal medicine" . SPARSER::DRUG)
    ("PI3K and B-Raf" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase kinase (MEK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K, MEK1, and B-Raf" . SPARSER::COLLECTION)
    ("Akt/ mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinases (ERK)1/2/p90 ribosomal protein S6 kinase (RSK)"
     . SPARSER::COLLECTION)
    ("ribosomal protein S6 kinase (RSK)" . SPARSER::PROTEIN)
    ("cyclooxygenase (COX)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("sUV" . SPARSER::PROTEIN)
    ("chalcone" . SPARSER::MOLECULE) ("licorice" . SPARSER::DRUG)
    ("phytochemical" . SPARSER::DRUG) ("triterpene" . SPARSER::MOLECULE)
    ("a traditional botanical medicine" . SPARSER::DRUG)
    ("Licorice" . SPARSER::DRUG) ("p81" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("12-O-Tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("Licorice root extract" . SPARSER::DRUG)
    ("licorice root extract" . SPARSER::DRUG) ("C-Raf" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Raf-1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("seven different homologous proteins" . SPARSER::PROTEIN)
    ("TGF- β 1 and TGFR" . SPARSER::COLLECTION)
    ("fibronectin and TGF- β" . SPARSER::COLLECTION)
    ("EMT or EndMT" . SPARSER::COLLECTION)
    ("RAGE-ERK1/2" . SPARSER::COLLECTION)
    ("RSV or EX527" . SPARSER::COLLECTION)
    ("activator or inhibitor" . SPARSER::COLLECTION)
    ("CD 31 and FSP-1" . SPARSER::COLLECTION)
    ("RSV or EX527 and RSV" . SPARSER::COLLECTION)
    ("EX527 and RSV" . SPARSER::COLLECTION)
    ("RSV and EX527" . SPARSER::COLLECTION) ("RSV" . SPARSER::PROTEIN)
    ("activator and inhibitor" . SPARSER::COLLECTION)
    ("Sirt 1 and Sirt 2" . SPARSER::COLLECTION)
    ("BSA- or AGE-BSA-treated" . SPARSER::COLLECTION)
    ("BSA-" . SPARSER::PROTEIN) ("RAGE" . SPARSER::PROTEIN)
    ("FSP-1 or collagen" . SPARSER::COLLECTION)
    ("FSP-1, α -SMA, or collagen" . SPARSER::COLLECTION)
    ("TGF- β and Sirt 1" . SPARSER::COLLECTION)
    ("FSP-1, α -SMA, and collagen" . SPARSER::COLLECTION)
    ("fibronectin and TGF- β 1" . SPARSER::COLLECTION)
    ("TGF- β [ xref ] as well as several small molecule inhibitors"
     . SPARSER::COLLECTION)
    ("/Snail" . SPARSER::COLLECTION) ("a special part" . SPARSER::COMPONENT)
    ("hyperglycemia, hyperinsulinemia, and dyslipidemia" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN)
    ("Sir 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("Sirt 2" . SPARSER::PROTEIN)
    ("Ex527" . SPARSER::DRUG) ("F-12 " . SPARSER::PROTEIN)
    ("TGF- β 1" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("EX527" . SPARSER::DRUG) ("Sirt 1" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α -SMA" . SPARSER::PROTEIN)
    ("FSP-1" . SPARSER::PROTEIN) ("CD 31" . SPARSER::PROTEIN)
    ("meanwhile drinkers carrying homozygous mutant (AA)" . SPARSER::MUTANT)
    ("homozygous mutant (AA)" . SPARSER::MUTANT)
    ("polymorphism and EC" . SPARSER::COLLECTION) ("CGT" . SPARSER::PROTEIN)
    ("The heterozygous genotype TC" . SPARSER::PROTEIN)
    ("TC or CC, and allele" . SPARSER::COLLECTION)
    ("complexes and residues" . SPARSER::COLLECTION)
    ("XRCC1 promoter and a transcription inhibitory factor"
     . SPARSER::COLLECTION)
    ("Hao" . SPARSER::PROTEIN) ("placental DNA" . SPARSER::DNA)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("formamidopyrimidines" . SPARSER::MOLECULE)
    ("endonuclease 1" . SPARSER::PROTEIN) ("APE1" . SPARSER::PROTEIN)
    ("DNA polymerase beta" . SPARSER::PROTEIN)
    ("X-ray repair cross complementing 1" . SPARSER::PROTEIN)
    ("dioxin" . SPARSER::MOLECULE) ("epigen" . SPARSER::PROTEIN)
    ("p38, B-Raf, and NF-κB" . SPARSER::COLLECTION)
    ("EGCG (epigallocatechin-3-gallate) or apomorphine, and flavone derivatives as well as components"
     . SPARSER::COLLECTION)
    ("apomorphine, and flavone derivatives as well as components"
     . SPARSER::COLLECTION)
    ("apomorphine, and flavone" . SPARSER::COLLECTION)
    ("flavone" . SPARSER::DRUG) ("apomorphine" . SPARSER::DRUG)
    ("EGCG" . SPARSER::DRUG) ("Mrp1" . SPARSER::PROTEIN)
    ("eotaxin-1/CCL11" . SPARSER::COLLECTION) ("eotaxin" . SPARSER::PROTEIN)
    ("a natural chemokine" . SPARSER::PROTEIN)
    ("Eotaxin-1/CCL11" . SPARSER::COLLECTION) ("Eotaxin" . SPARSER::PROTEIN)
    ("TGIF" . SPARSER::PROTEIN) ("Curcumin" . SPARSER::DRUG)
    ("hormonal signaling molecules" . SPARSER::MOLECULE)
    ("SFN or trichostan" . SPARSER::COLLECTION)
    ("Keap1-Cul3" . SPARSER::COLLECTION) ("glutathione" . SPARSER::DRUG)
    ("collagen, elastin, hyaluronic acid, or glycosaminoglycans"
     . SPARSER::COLLECTION)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("Nrf2-Maf" . SPARSER::COLLECTION) ("bacterial toxins" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("PERK" . SPARSER::PROTEIN)
    ("Bach1—protein" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Keap1-Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and protein" . SPARSER::COLLECTION)
    ("the harmful ROS" . SPARSER::PROTEIN) ("tyrosinase" . SPARSER::PROTEIN)
    ("active transcription complex" . SPARSER::BIO-COMPLEX)
    ("AhR and forms" . SPARSER::COLLECTION) ("Ketoconazole" . SPARSER::DRUG)
    ("dithiole" . SPARSER::MOLECULE) ("Keap1 cysteine’s" . SPARSER::MOLECULE)
    ("sterols" . SPARSER::MOLECULE)
    ("the Keap1 conformation and its inhibitory properties"
     . SPARSER::COLLECTION)
    ("quercetin or kaempferol" . SPARSER::COLLECTION)
    ("kaempferol" . SPARSER::DRUG) ("quercetin" . SPARSER::MOLECULE)
    ("Many chemopreventive phytochemicals" . SPARSER::DRUG)
    ("phytochemicals" . SPARSER::DRUG) ("dinitrochlorobenzene" . SPARSER::DRUG)
    ("Xenobiotics" . SPARSER::MOLECULE) ("AhR" . SPARSER::PROTEIN)
    ("electrophilic chemicals and metal ions, and Nrf2" . SPARSER::COLLECTION)
    ("electrophilic chemicals" . SPARSER::MOLECULE)
    ("ions, and Nrf2" . SPARSER::COLLECTION) ("ACD" . SPARSER::PROTEIN)
    ("uncontrolled Nrf2" . SPARSER::PROTEIN) ("Maf-Nrf2" . SPARSER::COLLECTION)
    ("HO-1, NQO1, and GST" . SPARSER::COLLECTION)
    ("allergens" . SPARSER::MOLECULE)
    ("IL-6, IL-1β, and GM-CSF" . SPARSER::COLLECTION)
    ("the harmful chemicals" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("Keratinocytes" . SPARSER::PROTEIN)
    ("KGF—Keratinocyte Growth Factor" . SPARSER::COLLECTION)
    ("KGF" . SPARSER::PROTEIN) ("a reactive 15d-PGJ2" . SPARSER::MOLECULE)
    ("cyclooxygenases (COX)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PGE2, PGD2, PGF2α, TXA2, and prostacyclin" . SPARSER::COLLECTION)
    ("prostacyclin" . SPARSER::MOLECULE) ("isomerases" . SPARSER::ISOMERASE)
    ("HNE" . SPARSER::PROTEIN)
    ("HO-1, GCLC, Gαi2, and IL-8" . SPARSER::COLLECTION)
    ("GCLC" . SPARSER::PROTEIN) ("NFκB-p65" . SPARSER::COLLECTION)
    ("NFκB and downstream proinflammatory cytokines [ xref ]"
     . SPARSER::COLLECTION)
    ("downstream proinflammatory cytokines" . SPARSER::PROTEIN)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("Keap1/Cul3" . SPARSER::COLLECTION)
    ("NFκB and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and NFκB" . SPARSER::COLLECTION)
    ("transcription factor—NFκB" . SPARSER::COLLECTION)
    ("cooperative proteins" . SPARSER::PROTEIN)
    ("antioxidants" . SPARSER::DRUG) ("stimulant" . SPARSER::DRUG)
    ("ferritin" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("glutathione S-transferase (GST)" . SPARSER::PROTEIN)
    ("ligase (GCL)" . SPARSER::LIGASE) ("hydrolase (EPHX)" . SPARSER::PROTEIN)
    ("mainly antioxidant enzymes" . SPARSER::ENZYME)
    ("TrxR" . SPARSER::PROTEIN) ("EPHX" . SPARSER::PROTEIN)
    ("hydrolase" . SPARSER::PROTEIN) ("UGT" . SPARSER::PROTEIN)
    ("glucuronosyltransferases" . SPARSER::PROTEIN)
    ("-TGACnnnGCA-3" . SPARSER::COLLECTION)
    ("at least four molecules" . SPARSER::MOLECULE)
    ("Nrf2-Keap1-Cul3" . SPARSER::COLLECTION)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("Leucine" . SPARSER::AMINO-ACID)
    ("bZip" . SPARSER::PROTEIN-FAMILY) ("CNC" . SPARSER::PROTEIN)
    ("cytoprotectional genes" . SPARSER::GENE) ("labile" . SPARSER::PROTEIN)
    ("the cellular macromolecules" . SPARSER::MOLECULE)
    ("xenobiotics" . SPARSER::MOLECULE) ("stimulants" . SPARSER::DRUG)
    ("ketoconazole" . SPARSER::DRUG) ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins or interleukins, and multidrug" . SPARSER::COLLECTION)
    ("interleukins, and multidrug" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN) ("Sprr2d" . SPARSER::PROTEIN)
    ("proline-rich protein" . SPARSER::PROTEIN)
    ("secretory leukocyte peptidase inhibitor" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN) ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("CCL11" . SPARSER::PROTEIN) ("ERRα" . SPARSER::PROTEIN)
    ("HA14-1" . SPARSER::DRUG) ("Bcl - 2" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE) ("m-RNA" . SPARSER::RNA)
    ("Nrf2 " . SPARSER::PROTEIN) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("MC-1R" . SPARSER::PROTEIN) ("α-MSH" . SPARSER::PROTEIN)
    ("H-1" . SPARSER::PROTEIN) ("SKH-1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin-8" . SPARSER::PROTEIN)
    ("Keratinocyte Growth Factor" . SPARSER::PROTEIN)
    ("15d-PGJ2" . SPARSER::MOLECULE) ("TXA2" . SPARSER::MOLECULE)
    ("PGF2α" . SPARSER::MOLECULE) ("PGD2" . SPARSER::PROTEIN)
    ("PGH2" . SPARSER::MOLECULE) ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN) ("UDP-" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN)
    ("the antifibrotic mediator adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("explanted dermal fibroblasts SIRT1" . SPARSER::PROTEIN)
    ("cellular nicotinamide" . SPARSER::PROTEIN)
    ("hypoxia, and ROS" . SPARSER::COLLECTION) ("acetylase" . SPARSER::PROTEIN)
    ("acetyltransferases and deacetylases" . SPARSER::COLLECTION)
    ("histones and nonhistone" . SPARSER::COLLECTION)
    ("F4/80-positive dermal macrophages" . SPARSER::PROTEIN)
    ("SIRT1 and α-SMA" . SPARSER::COLLECTION)
    ("resveratrol and bleomycin" . SPARSER::COLLECTION)
    ("collagen, α-SMA, and Fn" . SPARSER::COLLECTION)
    ("exogenous ligand" . SPARSER::LIGAND) ("cellular p300" . SPARSER::PROTEIN)
    ("-Luc" . SPARSER::COLLECTION)
    ("a selective pharmacologic antagonist" . SPARSER::MOLECULE)
    ("collagen, α-SMA, and fibronectin" . SPARSER::COLLECTION)
    ("cellular SIRT1" . SPARSER::PROTEIN)
    ("AMP kinase and other enzymes" . SPARSER::COLLECTION)
    ("a naturally occurring SIRT1 activator" . SPARSER::ACTIVATOR)
    ("prolonged hypoxia (1.5% O 2 for 24 hours) or H 2 O 2"
     . SPARSER::COLLECTION)
    ("healthy fibroblasts SIRT1" . SPARSER::PROTEIN)
    ("SIRT1/CD68" . SPARSER::COLLECTION)
    ("a cell-autonomous negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("TGFβ/Smad" . SPARSER::COLLECTION)
    ("histone and nonhistone" . SPARSER::COLLECTION)
    ("fibrotic genes" . SPARSER::GENE)
    ("hypoxia or platelet-derived growth factor" . SPARSER::COLLECTION)
    ("receptor type" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("nova2" . SPARSER::PROTEIN) ("COL1A2" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("thymidine kinase" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("TGFβ2" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("sirtuin 1" . SPARSER::PROTEIN)
    ("BRAF-" . SPARSER::PROTEIN) ("Lupin" . SPARSER::PROTEIN)
    ("BRAF and MEK" . SPARSER::COLLECTION)
    ("both BRAF V600E and non-V600E" . SPARSER::COLLECTION)
    ("non-V600E" . SPARSER::PROTEIN)
    ("proteins, CDK2, p21 and p27" . SPARSER::COLLECTION)
    ("BRAF-non-V600E" . SPARSER::PROTEIN-PAIR)
    ("BIM and MCL-1" . SPARSER::COLLECTION)
    ("proteins, p21 and p27" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("the intermediary CDC25C" . SPARSER::PROTEIN)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("DMSO or vemurafenib" . SPARSER::COLLECTION)
    ("BCL-2, BCL-xl, MCL-1, BAX and BAK" . SPARSER::COLLECTION)
    ("pro-apoptotic protein" . SPARSER::PROTEIN)
    ("CDK2 or p21 and p27" . SPARSER::COLLECTION)
    ("CDK2, p21 or p27" . SPARSER::COLLECTION)
    ("trametinib and the combination" . SPARSER::COLLECTION)
    ("trametinib and the combination ( xref )" . SPARSER::COLLECTION)
    ("MEK inhibitor and BRAF inhibitor" . SPARSER::COLLECTION)
    ("Trametinib and vemurafenib" . SPARSER::COLLECTION)
    ("ERK-AKT" . SPARSER::COLLECTION)
    ("vemurafenib and no significant synergy" . SPARSER::COLLECTION)
    ("vemurafenib and the combination" . SPARSER::COLLECTION)
    ("BRAF and EGFR" . SPARSER::COLLECTION)
    ("erlotinib and vemurafenib" . SPARSER::COLLECTION)
    ("Erlotinib and vemurafenib" . SPARSER::COLLECTION)
    ("Drugs" . SPARSER::DRUG) ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("-AKT" . SPARSER::COLLECTION) ("AKT/MTOR" . SPARSER::COLLECTION)
    ("RAF/MAPK" . SPARSER::COLLECTION)
    ("vemurafenib or trametinib" . SPARSER::COLLECTION)
    ("trametinib and vemurafenib" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("vemurafenib or dabrafenib" . SPARSER::COLLECTION)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("an orally available MEK inhibitor" . SPARSER::INHIBITOR)
    ("a BRAF inhibitor (dabrafenib) and MEK inhibitor (trametinib)"
     . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("traditional platinum" . SPARSER::MOLECULE)
    ("Iressa" . SPARSER::DRUG)
    ("Erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG) ("p-AKT" . SPARSER::COLLECTION)
    ("vemurafenib and trametinib" . SPARSER::COLLECTION)
    ("Trametinib" . SPARSER::DRUG) ("Vemurafenib" . SPARSER::DRUG)
    ("vemurafenib and erlotinib" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("Oncogene" . SPARSER::ONCOGENE) ("p-ERK 1" . SPARSER::PROTEIN)
    ("Dimethyl Sulfoxide" . SPARSER::MOLECULE)
    ("v-Raf murine sarcoma viral oncogene homolog B1" . SPARSER::PROTEIN)
    ("dense LD mapping" . SPARSER::PROTEIN)
    ("TC and LDLC" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("G allele (OR = 2.21, 95% CI = 1.13–4.31, P  c = 0.040, xref ) or the combined CG/GG genotype (OR = 2.27, 95% CI = 1.13–4.55, P  c = 0.042, xref )"
     . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION) ("HDLC" . SPARSER::MOLECULE)
    ("LDLC" . SPARSER::PROTEIN) ("triglycerides" . SPARSER::MOLECULE)
    ("Resveratrol" . SPARSER::PROTEIN) ("Ota" . SPARSER::MOLECULE)
    ("polymorphic variants" . SPARSER::VARIANT) ("Han" . SPARSER::PROTEIN)
    ("SIRT 1" . SPARSER::PROTEIN) ("glucose oxidase" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sirtuin1" . SPARSER::PROTEIN)
    ("constitutively activated Stat3 and proinflammatory cytokine IL-17"
     . SPARSER::COLLECTION)
    ("late clinical stage CRC" . SPARSER::PROTEIN) ("BK" . SPARSER::PROTEIN)
    ("Stat3 and IL-17" . SPARSER::COLLECTION)
    ("strong active p-Stat3" . SPARSER::COLLECTION)
    ("Overactive p-Stat3" . SPARSER::COLLECTION)
    ("Constitutively Overactive p-Stat3" . SPARSER::COLLECTION)
    ("ANT and CRA" . SPARSER::COLLECTION) ("CRC and ANT" . SPARSER::COLLECTION)
    ("CRA" . SPARSER::PROTEIN)
    ("prevalent HPV-associated CRC" . SPARSER::PROTEIN)
    ("promoter or antitumor" . SPARSER::COLLECTION)
    ("an essential proinflammatory cytokine" . SPARSER::PROTEIN)
    ("regulating downstream proinflammatory cytokines" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("p-Stat3" . SPARSER::COLLECTION)
    ("ANT" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("-TKIs" . SPARSER::COLLECTION)
    ("EGFR tyrosine kinase inhibitors (TKI) or ALK inhibitor"
     . SPARSER::COLLECTION)
    ("previously uncharacterized EML4-ALK variants" . SPARSER::VARIANT)
    ("wild-type EGFR ( P = 0.00 McNemar test) and KRAS ( P = 0.00 McNemar test)"
     . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("chimeric tyrosine kinase" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("histological types" . TYPE)
    ("EML4-ALK" . SPARSER::COLLECTION)
    ("echinoderm microtubule-associated protein-like 4 ( EML4 ) and anaplastic lymphoma kinase ( ALK )"
     . SPARSER::COLLECTION)
    ("EML4" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("CRC or IBD" . SPARSER::COLLECTION)
    ("PTGS2 T8473C (P int ; fruit = 0.03) and PTGS2 A-1195G (P int ;fibre 0.020 and current smoking = 0.046)"
     . SPARSER::COLLECTION)
    ("fish" . SPARSER::PROTEIN)
    ("the pro-inflammatory p65/p50 heterodimer" . SPARSER::HETERODIMER)
    ("p50/p65 heterodimers and p50 homodimers" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION) ("p65/p50" . SPARSER::COLLECTION)
    ("p65, p50, p105, C-rel and relB" . SPARSER::COLLECTION)
    ("relB" . SPARSER::PROTEIN) ("p50/p105" . SPARSER::COLLECTION)
    ("polymorphisms and CRC" . SPARSER::COLLECTION)
    ("a prospective cohort" . SPARSER::MOLECULE)
    ("TLR4 and NF-κB" . SPARSER::COLLECTION)
    ("dietary components" . SPARSER::COMPONENT)
    ("CRC and the SNP [ xref – xref ]" . SPARSER::COLLECTION)
    ("IBD [ xref – xref ] and CRC [ xref – xref ]" . SPARSER::COLLECTION)
    ("aggressive human colon cancer" . SPARSER::PROTEIN)
    ("A functional SNP" . SPARSER::PROTEIN)
    ("IBD and CRC" . SPARSER::COLLECTION) ("IBD" . SPARSER::PROTEIN)
    ("IL-1β and COX-2" . SPARSER::COLLECTION)
    ("NF-κB and epidermal growth factor" . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::RECEPTOR) ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("butyrate" . SPARSER::PROTEIN) ("SCFA" . SPARSER::MOLECULE)
    ("starch" . SPARSER::MOLECULE) ("SCFAs" . SPARSER::MOLECULE)
    ("ins" . SPARSER::PROTEIN) ("IRR" . SPARSER::PROTEIN)
    ("NFKB1 and TLR4" . SPARSER::COLLECTION)
    ("polymorphisms" . SPARSER::PROTEIN) ("PTGS2" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("C-rel" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("factor—κB" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("factor–κB" . SPARSER::PROTEIN)
    ("toll-like receptor 4" . SPARSER::PROTEIN)
    ("RBL2/p130" . SPARSER::COLLECTION)
    ("Rb-inactivating viral oncoproteins" . SPARSER::PROTEIN)
    ("DNMTs and consequent INK4/p16 silencing through methylation"
     . SPARSER::COLLECTION)
    ("consequent INK4/p16" . SPARSER::COLLECTION)
    ("a soluble form" . SPARSER::FORM) ("naïve" . SPARSER::PROTEIN)
    ("a soluble effector" . SPARSER::EFFECTOR)
    ("many proteins and viral microRNAs" . SPARSER::COLLECTION)
    ("the pocket protein family (pRb, p107, p130) and/or the p53 tumor suppressor [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("viral oncogenes" . SPARSER::ONCOGENE)
    ("BSP and MSP" . SPARSER::COLLECTION) ("MSP and BSP" . SPARSER::COLLECTION)
    ("BSP" . SPARSER::PROTEIN) ("MSP" . SPARSER::PROTEIN)
    ("gene and microRNA" . SPARSER::COLLECTION) ("b" . SPARSER::PROTEIN)
    ("b-c" . SPARSER::PROTEIN-PAIR) ("hsa-miR-148b" . SPARSER::PROTEIN-PAIR)
    ("hsa" . SPARSER::PROTEIN) ("TP53 and RB1" . SPARSER::COLLECTION)
    ("INK4/p16" . SPARSER::COLLECTION)
    ("cytokines and their receptors [ xref – xref ]" . SPARSER::COLLECTION)
    ("gene and miRNA expression in host cells [ xref ]" . SPARSER::COLLECTION)
    ("its encoded proteins and/or viral microRNAs (miRNAs)"
     . SPARSER::COLLECTION)
    ("viral microRNAs" . SPARSER::RNA)
    ("genes and microRNAs" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pRb/E2F" . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN) ("DNMT3a and DNMT3b" . SPARSER::COLLECTION)
    ("DNMT" . SPARSER::PROTEIN) ("RBL2" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("T-antigens" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("miR-29b" . SPARSER::MOLECULE) ("miR-29" . SPARSER::PROTEIN)
    ("DNA Methyltransferase 1" . SPARSER::PROTEIN)
    ("interleukins-6" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE) ("DNMT3b" . SPARSER::PROTEIN)
    ("DNMT3a" . SPARSER::PROTEIN) ("DNMT1" . SPARSER::PROTEIN)
    ("a pleiotropic adipokine" . SPARSER::PROTEIN-FAMILY)
    ("MMP-9 and MMP-13" . SPARSER::COLLECTION)
    ("DRAM1 and p62" . SPARSER::COLLECTION) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("a pivotal part" . SPARSER::COMPONENT)
    ("FoxO3A and autophagy related genes" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("LC3B and apoptotic proteins" . SPARSER::COLLECTION)
    ("Atg5, Beclin-1, LC3B and apoptotic proteins" . SPARSER::COLLECTION)
    ("Bax, Calpain, and Caspases" . SPARSER::COLLECTION)
    ("Caspases" . SPARSER::PROTEIN)
    ("beclin-1, Atg5 and LC3II" . SPARSER::COLLECTION)
    ("MAPKs and PI3K" . SPARSER::COLLECTION)
    ("leptin/leptin receptor" . SPARSER::COLLECTION)
    ("endocrine" . SPARSER::PROTEIN) ("adenine" . SPARSER::NUCLEOBASE)
    ("eGFP-LC3" . SPARSER::COLLECTION) ("an essential Atg" . SPARSER::DRUG)
    ("p53-FoxO3A" . SPARSER::COLLECTION)
    ("p53 and FoxO3A" . SPARSER::COLLECTION)
    ("sestrins" . SPARSER::PROTEIN-FAMILY)
    ("chloroquine or 3-methyladenine" . SPARSER::COLLECTION)
    ("chloroquine" . SPARSER::PROTEIN) ("typical example" . SPARSER::EXAMPLE)
    ("LC3/Atg8" . SPARSER::COLLECTION)
    ("Atg13 and Atg17" . SPARSER::COLLECTION) ("Atg17" . SPARSER::PROTEIN)
    ("Atgs" . SPARSER::DRUG) ("adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinase and PI3 kinase" . SPARSER::COLLECTION)
    ("adipokine" . SPARSER::PROTEIN-FAMILY) ("BALB/c" . SPARSER::COLLECTION)
    ("p53 or FoxO3A" . SPARSER::COLLECTION)
    ("p53/FoxO3A" . SPARSER::COLLECTION)
    ("beclin-1, Atg5 and LC3" . SPARSER::COLLECTION)
    ("Atg5" . SPARSER::PROTEIN) ("leptin" . SPARSER::PROTEIN)
    ("Leptin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("Ac-DEVD-pNA" . SPARSER::DRUG) ("Glo 3" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("DRAM1" . SPARSER::PROTEIN)
    ("HIPK3" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase 3" . SPARSER::PROTEIN)
    ("Beclin-1" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("forkhead box O3" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("Atg12" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("FoxO3A" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("beclin-1" . SPARSER::PROTEIN)
    ("HDAC2 and its sumoylation status" . SPARSER::COLLECTION)
    ("p53 or RSK1" . SPARSER::COLLECTION)
    ("the chemotherapeutic doxorubicin" . SPARSER::PROTEIN)
    ("p53 or p65" . SPARSER::COLLECTION) ("HDAC1/HDAC2" . SPARSER::COLLECTION)
    ("HDAC2 and NF-κB" . SPARSER::COLLECTION)
    ("HDAC1 or HDAC2" . SPARSER::COLLECTION)
    ("HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("p53/NF-κB" . SPARSER::COLLECTION)
    ("doxorubicin and inhibitors" . SPARSER::COLLECTION)
    ("CAPE or YM155" . SPARSER::COLLECTION)
    ("tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("numerous classical NF-κB target genes" . SPARSER::GENE)
    ("dNTP" . SPARSER::MOLECULE) ("ribonucleotide" . SPARSER::MOLECULE)
    ("LMB" . SPARSER::MOLECULE) ("p65-GFP" . SPARSER::COLLECTION)
    ("p65 and p53" . SPARSER::COLLECTION) ("p53 or p53" . SPARSER::COLLECTION)
    ("HDAC2 K462R or GFP" . SPARSER::COLLECTION)
    ("ABCD" . SPARSER::PROTEIN-FAMILY) ("p65/HDAC2" . SPARSER::COLLECTION)
    ("Tp53" . SPARSER::PROTEIN) ("NF-κB and survivin" . SPARSER::COLLECTION)
    ("the NF-κB inhibitor caffeic acid phenethyl ester (CAPE)"
     . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE) ("CAPE" . SPARSER::PROTEIN)
    ("numerous other classical NF-κB target genes" . SPARSER::GENE)
    ("HDAC2 and HDAC2" . SPARSER::COLLECTION)
    ("The mutants HDAC2 V461A and HDAC2 E464A" . SPARSER::COLLECTION)
    ("Hdac2" . SPARSER::PROTEIN) ("HDAC2 or HDAC2" . SPARSER::COLLECTION)
    ("further epigenetic regulators control NF-κB" . SPARSER::PROTEIN)
    ("HATs" . SPARSER::PROTEIN) ("p53 and IKKs" . SPARSER::COLLECTION)
    ("NF-κB/p53" . SPARSER::COLLECTION) ("conjugase" . SPARSER::PROTEIN)
    ("small ubiquitin-related modifier (SUMO)" . SPARSER::PROTEIN)
    ("HDAC1, HDAC2, HDAC4, and SIRT1" . SPARSER::COLLECTION)
    ("HDAC" . SPARSER::PROTEIN) ("KDACs/HDACs" . SPARSER::COLLECTION)
    ("The apical stress sensor kinase ATM" . SPARSER::PROTEIN)
    ("IKKγ/NEMO" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("RelB, and c-Rel" . SPARSER::COLLECTION)
    ("p100/p52" . SPARSER::COLLECTION) ("p105/p50" . SPARSER::COLLECTION)
    ("p65/RelA" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("genotoxin" . SPARSER::MOLECULE) ("survivin" . SPARSER::PROTEIN)
    ("p53 and RSK1" . SPARSER::COLLECTION)
    ("the ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("RPL13A" . SPARSER::PROTEIN) ("alpha-Tubulin" . SPARSER::PROTEIN)
    ("Bcl-x" . SPARSER::PROTEIN) ("C-21" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("IκBε" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("H-4" . SPARSER::PROTEIN)
    ("F-8" . SPARSER::PROTEIN) ("A -V" . SPARSER::MOLECULE)
    ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-GAL" . SPARSER::PROTEIN)
    ("Leptomycin B" . SPARSER::MOLECULE)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("HDAC3" . SPARSER::PROTEIN)
    ("P 53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SUMO1" . SPARSER::PROTEIN)
    ("YM155" . SPARSER::DRUG)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("IKKγ" . SPARSER::PROTEIN)
    ("IKKε" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("RSK1" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("types and stages" . SPARSER::COLLECTION)
    ("subunit 4, and TAp73" . SPARSER::COLLECTION)
    ("Sirt1, AMPKa2, and LKB1" . SPARSER::COLLECTION)
    ("p53 and its family members p63 and p73" . SPARSER::COLLECTION)
    ("AMPK-p53" . SPARSER::COLLECTION)
    ("AKT-1 and ABL-1" . SPARSER::COLLECTION)
    ("glucose and oxygen" . SPARSER::COLLECTION) ("Metformin" . SPARSER::DRUG)
    ("Tigar" . SPARSER::PROTEIN)
    ("Acad11 and other p53 target genes" . SPARSER::COLLECTION)
    ("Acad11 and Hmgcll1" . SPARSER::COLLECTION)
    ("serine and glycine" . SPARSER::COLLECTION) ("CG" . SPARSER::PROTEIN)
    ("a previously undescribed p53 target gene" . SPARSER::GENE)
    ("Acad11, Hmgcll1, Cpt1c, and Lpin1" . SPARSER::COLLECTION)
    ("doxorubicin-treated wild-type MEFs" . SPARSER::PROTEIN)
    ("Cpt1c and site #1" . SPARSER::COLLECTION)
    ("Cpt1c and 1A" . SPARSER::COLLECTION)
    ("Acad11, Cpt1c and Lpin1" . SPARSER::COLLECTION)
    ("previously using wild-type MEFs" . SPARSER::PROTEIN)
    ("Acad11, Hmgcll1, and Cpt1c" . SPARSER::COLLECTION)
    ("Acad11, Cpt1c and Hmgcll1" . SPARSER::COLLECTION)
    ("LSL-wt/LSL-wt" . SPARSER::COLLECTION)
    ("p53 -null MEFs" . SPARSER::PROTEIN)
    ("Acad11, Hmgcll1 and Cpt1c" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("wild-type p53 and p53 -null MEFs" . SPARSER::PROTEIN)
    ("the transcriptionally-dead p53 25,26,53,54 mutant" . SPARSER::MUTANT)
    ("Hmgcll1, Cpt1c and Lpin1" . SPARSER::COLLECTION)
    ("Acad11, Hmgcll1, Cpt1c and Lpin1" . SPARSER::COLLECTION)
    ("an extramitochondrial hydroxymethylglutaryl-CoA lyase (HMGCL)"
     . SPARSER::PROTEIN)
    ("lyase (HMGCL)" . SPARSER::PROTEIN) ("Hmgcll1" . SPARSER::PROTEIN)
    ("ketone" . SPARSER::MOLECULE) ("HMGCL" . SPARSER::PROTEIN)
    ("lyase" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("p53 and p53" . SPARSER::COLLECTION)
    ("Cpt1c and Lpin1" . SPARSER::COLLECTION) ("Lpin1" . SPARSER::PROTEIN)
    ("NADH and FADH 2" . SPARSER::COLLECTION) ("NADH" . SPARSER::MOLECULE)
    ("coenzyme" . SPARSER::MOLECULE) ("50 unique genes" . SPARSER::GENE)
    ("SAM" . SPARSER::MOLECULE)
    ("the most relevant p53 target genes" . SPARSER::GENE)
    ("Lox-Stop-Lox" . SPARSER::COLLECTION) ("LSL" . SPARSER::PROTEIN)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("essential p53 transcriptional targets" . SPARSER::TARGET-PROTEIN)
    ("both normal and low glucose" . SPARSER::PROTEIN)
    ("normal and low glucose" . SPARSER::PROTEIN) ("etomoxir" . SPARSER::DRUG)
    ("Seahorse" . SPARSER::PROTEIN) ("Hras" . SPARSER::PROTEIN)
    ("deoxyglucose" . SPARSER::MOLECULE) ("primary MEFs" . SPARSER::PROTEIN)
    ("direct metabolism-associated p53 target genes" . SPARSER::GENE)
    ("NADPH" . SPARSER::PROTEIN) ("Pentose" . SPARSER::MOLECULE)
    ("p53 E177R or p53 3KR" . SPARSER::COLLECTION)
    ("GPX1 , ALDH4 , and TP53INP1" . SPARSER::COLLECTION)
    ("whose encoded protein" . SPARSER::PROTEIN)
    ("fructose-2" . SPARSER::COLLECTION) ("TIGAR" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("subunit 4" . SPARSER::PROTEIN)
    ("COX4" . SPARSER::PROTEIN) ("AMPKa2" . SPARSER::PROTEIN)
    ("ABL-1" . SPARSER::PROTEIN) ("AKT-1" . SPARSER::PROTEIN)
    ("CEP-1" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("Lipin 1" . SPARSER::PROTEIN)
    ("carnitine palmitoyltransferase 1C" . SPARSER::PROTEIN)
    ("Cpt1c" . SPARSER::PROTEIN) ("Acyl-CoA" . SPARSER::MOLECULE)
    ("H/R" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("acyl-CoA" . SPARSER::MOLECULE) ("TP53INP1" . SPARSER::PROTEIN)
    ("ALDH4" . SPARSER::PROTEIN) ("GPX1" . SPARSER::PROTEIN)
    ("Acad11" . SPARSER::PROTEIN)
    ("relatively few deacetylation substrates" . SPARSER::SUBSTRATE)
    ("glycine" . SPARSER::AMINO-ACID) ("CobB" . SPARSER::PROTEIN)
    ("malonyl, succinyl, and glutaryl" . SPARSER::COLLECTION)
    ("SIRT6 (preferentially a defatty-acylase in vitro ) and SIRT7"
     . SPARSER::COLLECTION)
    ("other long-chain fatty acyl substrates" . SPARSER::SUBSTRATE)
    ("octanoyl" . SPARSER::MOLECULE)
    ("SIRT1, SIRT2 and SIRT3" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT3" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT1" . SPARSER::COLLECTION)
    ("SIRT2 and SIRT6" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT6" . SPARSER::COLLECTION)
    ("group and SIRT2" . SPARSER::COLLECTION) ("PKK" . SPARSER::PROTEIN)
    ("apo SIRT2 and other sirtuins" . SPARSER::COLLECTION)
    ("SIRT2/BHJH-TM1" . SPARSER::COLLECTION)
    ("substrate or analog" . SPARSER::COLLECTION)
    ("BHJH-TM1" . SPARSER::COLLECTION) ("TM1" . SPARSER::PROTEIN)
    ("acetyl and myristoyl H3K9 peptides" . SPARSER::COLLECTION)
    ("long-chain fatty acyl peptides" . SPARSER::PEPTIDE)
    ("histone H3 Lys9 (H3K9) xref ( xref ) peptides" . SPARSER::PEPTIDE)
    ("defatty-acylase" . SPARSER::COLLECTION) ("acylase" . SPARSER::PROTEIN)
    ("an Arg and a Tyr" . SPARSER::COLLECTION) ("malonyl" . SPARSER::PROTEIN)
    ("SIRT1, SIRT3, and SIRT6" . SPARSER::COLLECTION)
    ("weak deacetylase activity" . SPARSER::PROTEIN)
    ("lysine and palmitoyl" . SPARSER::COLLECTION)
    ("very weak in vitro deacetylase activity" . SPARSER::PROTEIN)
    ("efficient deacetylase activity" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("A1 at" . SPARSER::DRUG)
    ("Ulp1" . SPARSER::PROTEIN) ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("H2BK" . SPARSER::PROTEIN) ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lys9" . SPARSER::PROTEIN)
    ("Nicotinamide Adenine Dinucleotide" . SPARSER::MOLECULE)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("MLL" . SPARSER::PROTEIN)
    ("an active CDK/CyclinD complex" . SPARSER::BIO-COMPLEX)
    ("naive T cells wherein both CDK6 and CyclinD3" . SPARSER::COLLECTION)
    ("CyclinD3/CDK6" . SPARSER::COLLECTION)
    ("5-FU or IFN" . SPARSER::COLLECTION) ("CyclinD-CDK" . SPARSER::COLLECTION)
    ("SD" . SPARSER::PROTEIN) ("LUC/GFP" . SPARSER::COLLECTION)
    ("pre-existent CDK6" . SPARSER::PROTEIN) ("LUC" . SPARSER::PROTEIN)
    ("CDK4-CDK6" . SPARSER::COLLECTION)
    ("CDK6 and CyclinD" . SPARSER::COLLECTION)
    ("CDK/CyclinD" . SPARSER::COLLECTION)
    ("CDK6 and CyclinD3" . SPARSER::COLLECTION)
    ("almost all ST-HSCs" . SPARSER::COLLECTION)
    ("CDK6, CyclinD1, and CyclinD3" . SPARSER::COLLECTION)
    ("CyclinD-CDK6" . SPARSER::COLLECTION)
    ("an active complex" . SPARSER::BIO-COMPLEX)
    ("neither one expressed CyclinD1 nor CyclinD3" . SPARSER::COLLECTION)
    ("CyclinD1 and CyclinD3" . SPARSER::COLLECTION)
    ("CDK6/CyclinD" . SPARSER::COLLECTION) ("CyclinD" . SPARSER::PROTEIN)
    ("LT- and ST-HSC" . SPARSER::COLLECTION)
    ("cytokine and nutrient" . SPARSER::COLLECTION)
    ("576 single LT- and ST-HSCs" . SPARSER::COLLECTION)
    ("GMPs" . SPARSER::GMP)
    ("a possible differential G 1 arrest state" . SPARSER::BIO-STATE)
    ("LT- and ST-HSCs" . SPARSER::COLLECTION)
    ("phenotypic ST-HSCs" . SPARSER::COLLECTION)
    ("phenotypic LT-" . SPARSER::PROTEIN)
    ("phenotypic human LT-" . SPARSER::PROTEIN)
    ("LT- and ST-HSC-enriched" . SPARSER::COLLECTION)
    ("LT-" . SPARSER::PROTEIN) ("ST-HSCs" . SPARSER::COLLECTION)
    ("MPPs" . SPARSER::PROTEIN) ("ST" . SPARSER::PROTEIN)
    ("-HSCs" . SPARSER::COLLECTION) ("LT" . SPARSER::PROTEIN)
    ("B-10" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("IL7" . SPARSER::PROTEIN) ("Flt3L" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("CD7" . SPARSER::PROTEIN)
    ("Ink4" . SPARSER::PROTEIN) ("miR-126" . SPARSER::PROTEIN)
    ("D–4" . SPARSER::PROTEIN) ("CyclinD3" . SPARSER::PROTEIN)
    ("S-G2" . SPARSER::PROTEIN) ("S-G 2" . SPARSER::PROTEIN)
    ("− 2" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("specific drugs and target glycogenic flux" . SPARSER::COLLECTION)
    ("AMPK/glycogen" . SPARSER::COLLECTION)
    ("mature glycogen molecules" . SPARSER::MOLECULE)
    ("monosaccharides" . SPARSER::MOLECULE)
    ("only three metabolites" . SPARSER::MOLECULE)
    ("glycosphingolipid" . SPARSER::MOLECULE)
    ("significantly knockdown GYS1" . SPARSER::PROTEIN)
    ("FLT3-ITD" . SPARSER::COLLECTION)
    ("metformin and resveratrol" . SPARSER::COLLECTION)
    ("AICAR" . SPARSER::PROTEIN) ("PIM" . SPARSER::PROTEIN)
    ("their respective inhibitory sites S 21" . SPARSER::PROTEIN)
    ("GSK3α and GSKβ" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("the AMPK pathway activators and anti-diabetic small molecule drugs resveratrol and metformin  xref  (  xref  )"
     . SPARSER::COLLECTION)
    ("resveratrol and metformin" . SPARSER::COLLECTION)
    ("resveratrol" . SPARSER::PROTEIN) ("GYS1 and GBE1" . SPARSER::COLLECTION)
    ("GYS1, GYS2 or GBE1" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE) ("dTTP" . SPARSER::MOLECULE)
    ("deoxythymidine" . SPARSER::MOLECULE)
    ("BCR-ABL (KU812) and JAK2V617F (HEL)" . SPARSER::COLLECTION)
    ("Hyper" . SPARSER::PROTEIN)
    ("a strong allosteric activator" . SPARSER::ACTIVATOR)
    ("catabolism" . SPARSER::PROTEIN)
    ("glycogen synthase (GYS)" . SPARSER::PROTEIN-FAMILY)
    ("GYS" . SPARSER::PROTEIN) ("Glycogen" . SPARSER::PROTEIN)
    ("the glycogenic precursor UDP-D-glucose" . SPARSER::MOLECULE)
    ("glycogen" . SPARSER::PROTEIN) ("type 4" . SPARSER::PROTEIN)
    ("HIF1" . SPARSER::PROTEIN) ("AMPK β" . SPARSER::PROTEIN)
    ("A769662" . SPARSER::DRUG)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("MK-2206" . SPARSER::MOLECULE) ("S 21" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN) ("anti-diabetic" . SPARSER::DRUG)
    ("1,4-alpha-glucan-branching enzyme" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("FLT3" . SPARSER::PROTEIN)
    ("gag-pol" . SPARSER::PROTEIN) ("Glucose-6-phosphate" . SPARSER::MOLECULE)
    ("glucose-6-phosphate" . SPARSER::MOLECULE) ("GYS2" . SPARSER::PROTEIN)
    ("6-bisphosphatase 3" . SPARSER::PROTEIN) ("PFKFB3" . SPARSER::PROTEIN)
    ("glycogen branching enzyme" . SPARSER::PROTEIN)
    ("GBE1" . SPARSER::PROTEIN) ("GYS1" . SPARSER::PROTEIN)
    ("glycogen synthase 1" . SPARSER::PROTEIN)
    ("UDP-D-glucose" . SPARSER::MOLECULE)
    ("anti-EGFR or anti-AKT1" . SPARSER::COLLECTION)
    ("anti-EGFR and anti-AKT1" . SPARSER::COLLECTION)
    ("the dual tyrosine kinase inhibitor lapatinib" . SPARSER::DRUG)
    ("lapatinib" . SPARSER::DRUG)
    ("erlotinib and other targeted drugs" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and other targeted drugs" . SPARSER::COLLECTION)
    ("estrogen receptor and progesterone receptor" . SPARSER::COLLECTION)
    ("discrete and robust FISH" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor and AKT1" . SPARSER::COLLECTION)
    ("gene " . SPARSER::GENE) ("EGFR/PI3K" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("COX" . SPARSER::PROTEIN)
    ("EGFR/AKT1" . SPARSER::COLLECTION) ("EGFR and AKT1" . SPARSER::COLLECTION)
    ("PI3" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("P11" . SPARSER::PROTEIN) ("K24" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4, 5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular miRNAs" . SPARSER::PROTEIN)
    ("DICER1 or LIN28" . SPARSER::COLLECTION)
    ("cyclin D1 and p53" . SPARSER::COLLECTION)
    ("the traditional oncogenes" . SPARSER::ONCOGENE)
    ("Tumour suppressive let-7" . SPARSER::RNA)
    ("p53 and cyclin D1" . SPARSER::COLLECTION)
    ("N3 and Tax-induced" . SPARSER::COLLECTION) ("TRE" . SPARSER::PROTEIN)
    ("increased p53 inhibited both cyclin D1 and DICER1" . SPARSER::COLLECTION)
    ("exogenous cyclin D1 and DICER1" . SPARSER::COLLECTION)
    ("cyclin D1 and DICER1" . SPARSER::COLLECTION)
    ("cyclin D1 and let-7" . SPARSER::COLLECTION)
    ("Tetracycline" . SPARSER::DRUG) ("TET" . SPARSER::PROTEIN)
    ("mature let-7 miRNAs" . SPARSER::PROTEIN)
    ("the mature let-7 miRNAs" . SPARSER::PROTEIN)
    ("miRNAs and their targeted genes" . SPARSER::COLLECTION)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("let-7 and cyclin D1 form" . SPARSER::COLLECTION)
    ("Nutlin-3 and TAX-induced let-7 expression" . SPARSER::COLLECTION)
    ("endoribonuclease" . SPARSER::PROTEIN) ("LIN28" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("PMD2" . SPARSER::MOLECULE)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("Bach1 and Abraxas" . SPARSER::COLLECTION)
    ("Abraxas/CCDC98" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Asp and +2" . SPARSER::COLLECTION)
    ("Gln, Thr and Val" . SPARSER::COLLECTION) ("Gln" . SPARSER::AMINO-ACID)
    ("PPII" . SPARSER::PROTEIN) ("polyproline" . SPARSER::PROTEIN)
    ("phi" . SPARSER::PROTEIN) ("PDBs" . SPARSER::MOLECULE)
    ("a phosphorylated Thr instead of Ser of Bach1" . SPARSER::PROTEIN)
    ("a phosphorylated Thr instead of Ser" . SPARSER::COLLECTION)
    ("tetrapeptide" . SPARSER::MOLECULE)
    ("the phosphorylated Ser (position 0) and the Phe (position +3)"
     . SPARSER::COLLECTION)
    ("BRCA1-Bach1" . SPARSER::COLLECTION) ("anchors" . SPARSER::ANCHOR)
    ("sulphur" . SPARSER::MOLECULE)
    ("DNA ( xref , xref ) and poly(ADP-ribose) (PAR)" . SPARSER::COLLECTION)
    ("this 1863-amino-acid BRCA1 protein" . SPARSER::PROTEIN)
    ("CA1-" . SPARSER::PROTEIN) ("CA1" . SPARSER::PROTEIN)
    ("Chk1, Chk2 and MK2" . SPARSER::COLLECTION)
    ("strong anchor" . SPARSER::ANCHOR) ("phosphoprotein" . SPARSER::PROTEIN)
    ("CCDC98" . SPARSER::PROTEIN) ("Topbp1" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("Bach1" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("C - T" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("the Thoracic Oncology group" . SPARSER::MOLECULE)
    ("carboplatin and etoposide" . SPARSER::COLLECTION)
    ("a right upper lobe" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("TKI-naïve" . SPARSER::PROTEIN-PAIR)
    ("the clinically-available TKIs gefitinib, erlotinib and afatinib"
     . SPARSER::COLLECTION)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("hypoxia or nutrient" . SPARSER::COLLECTION)
    ("SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT5 and SIRT4" . SPARSER::COLLECTION)
    ("excessive ammonia" . SPARSER::MOLECULE)
    ("KO and Sirt5" . SPARSER::COLLECTION)
    ("BNIP3 as well as PINK1 and PARK2 ( xref )" . SPARSER::COLLECTION)
    ("CO 2 and HCO3" . SPARSER::COLLECTION) ("Mitochondria" . SPARSER::PROTEIN)
    ("BNIP3, PINK1, and PARK2" . SPARSER::COLLECTION)
    ("−1 and +1" . SPARSER::COLLECTION) ("GK" . SPARSER::PROTEIN)
    ("long-lived protein" . SPARSER::PROTEIN)
    ("the most abundant nonessential amino acid" . SPARSER::AMINO-ACID)
    ("PEG" . SPARSER::PROTEIN)
    ("Almost no red mitochondria" . SPARSER::PROTEIN)
    ("MFN2 and OPA1" . SPARSER::COLLECTION)
    ("PINK1 and PARK2" . SPARSER::COLLECTION)
    ("ubiquitinases" . SPARSER::UBIQUITINASE)
    ("the mitochondria and the autophagy marker MAP1LC3B"
     . SPARSER::COLLECTION)
    ("NH 4 Cl and glutamine withdrawal ( xref )" . SPARSER::COLLECTION)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("MAP1LC3B and GABARAP" . SPARSER::COLLECTION)
    ("potentially dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("fluorescent long-lived proteins" . SPARSER::PROTEIN)
    ("a fluorescent alkyne group" . SPARSER::MOLECULE)
    ("alkyne" . SPARSER::MOLECULE) ("-methionine" . SPARSER::COLLECTION)
    ("azide" . SPARSER::MOLECULE) ("AHA" . SPARSER::MOLECULE)
    ("LC3-II, GABARAPL2, and GABARAP" . SPARSER::COLLECTION)
    ("LC3-II, GABARAPL2, GABARAP, and SQSTM1" . SPARSER::COLLECTION)
    ("exogenous ammonia" . SPARSER::MOLECULE)
    ("GABARAP and GABARAPL2" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN)
    ("GABARAP (GABA[A] receptor-associated protein) and GABARAPL2 (GABA[A] receptor-associated protein-like 2)"
     . SPARSER::COLLECTION)
    ("autophagic markers MAP1LC3B, GABARAP (GABA[A] receptor-associated protein) and GABARAPL2 (GABA[A] receptor-associated protein-like 2)"
     . SPARSER::COLLECTION)
    ("autophagic markers MAP1LC3B" . SPARSER::PROTEIN)
    ("GABA" . SPARSER::MOLECULE) ("ATG" . SPARSER::DRUG)
    ("SIRT5 and human GLS" . SPARSER::COLLECTION)
    ("tetramer" . SPARSER::TETRAMER) ("Hex" . SPARSER::PROTEIN)
    ("GLUD1 and SIRT5" . SPARSER::COLLECTION)
    ("GLUD1-SIRT3" . SPARSER::COLLECTION) ("SIRT5-GLS" . SPARSER::COLLECTION)
    ("GLS and SIRT5" . SPARSER::COLLECTION)
    ("SIRT5 inhibitor and not SIRT5-silenced cells in our immunoprecipitation experiments"
     . SPARSER::COLLECTION)
    ("SIRT5 and GLS" . SPARSER::COLLECTION)
    ("a nonessential amino acid" . SPARSER::AMINO-ACID)
    ("GLUL and GLS" . SPARSER::COLLECTION) ("GLUL" . SPARSER::PROTEIN)
    ("Glutamine" . SPARSER::AMINO-ACID)
    ("a monoclonal anti-succinyl lysine antibody" . SPARSER::ANTIBODY)
    ("Ammonia" . SPARSER::MOLECULE) ("mitochondrial GLS" . SPARSER::PROTEIN)
    ("GLS" . SPARSER::PROTEIN)
    ("glutaminase and glutamine" . SPARSER::COLLECTION)
    ("MTOR and ULK1" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4, and SIRT5" . SPARSER::COLLECTION)
    ("NAD" . SPARSER::MOLECULE)
    ("PIK3R4 (phosphoinositide-3-kinase, regulatory subunit 4) and PIK3C3 (phosphatidylinositol 3-kinase, catalytic subunit type 3)"
     . SPARSER::COLLECTION)
    ("BECN1 (Beclin 1, autophagy-related), AMBRA1 (autophagy/Beclin 1 regulator 1), PIK3R4 (phosphoinositide-3-kinase, regulatory subunit 4) and PIK3C3 (phosphatidylinositol 3-kinase, catalytic subunit type 3)"
     . SPARSER::COLLECTION)
    ("MAP1LC3B, GABARAP, and GABARAPL2" . SPARSER::COLLECTION)
    ("PINK1-PARK2" . SPARSER::COLLECTION) ("GABARAP" . SPARSER::PROTEIN)
    ("SIRT5 and glutaminase" . SPARSER::COLLECTION)
    ("glutaminase" . SPARSER::PROTEIN) ("glutamine" . SPARSER::AMINO-ACID)
    ("ammonia" . SPARSER::MOLECULE) ("JC1" . SPARSER::MOLECULE)
    ("18 h" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("COX4I1" . SPARSER::PROTEIN) ("Ammonium chloride" . SPARSER::MOLECULE)
    ("Bafilomycin A 1" . SPARSER::DRUG)
    ("CREB-regulated transcription coactivator 1" . SPARSER::PROTEIN)
    ("CRTC1" . SPARSER::PROTEIN) ("sirt3" . SPARSER::PROTEIN)
    ("sirt5" . SPARSER::PROTEIN) ("HCO3" . SPARSER::MOLECULE)
    ("JC-1" . SPARSER::MOLECULE) ("mitofusin 2" . SPARSER::PROTEIN)
    ("MFN2" . SPARSER::PROTEIN)
    ("parkin RBR E3 ubiquitin protein ligase" . SPARSER::PROTEIN)
    ("PTEN induced putative kinase 1" . SPARSER::PROTEIN)
    ("proton pump" . SPARSER::PROTEIN) ("sequestosome 1" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN)
    ("receptor-associated protein" . SPARSER::PROTEIN)
    ("GLUD1" . SPARSER::PROTEIN)
    ("glutamate-ammonia ligase" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("glutaminase activity" . SPARSER::PROTEIN)
    ("glutaminase 2" . SPARSER::PROTEIN) ("GLS2" . SPARSER::PROTEIN)
    ("mitochondrial)" . SPARSER::PROTEIN)
    ("carbamoyl-phosphate synthase 1" . SPARSER::PROTEIN)
    ("forkhead box O1" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("ATG7" . SPARSER::PROTEIN) ("SIRT4" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("SIRT7" . SPARSER::PROTEIN) ("sirtuin1" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN)
    ("unc-51 like autophagy activating kinase 1" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("ATG16L1" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("autophagy related 12" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("PtdIns3K" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("PIK3C3" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3R4" . SPARSER::PROTEIN) ("AMBRA1" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("PARK2" . SPARSER::PROTEIN)
    ("PINK1" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("GABARAPL2" . SPARSER::PROTEIN) ("MAP1LC3B" . SPARSER::PROTEIN)
    ("CPS1" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("exclusively targets PDGFRα" . SPARSER::PROTEIN)
    ("Inhibitors" . SPARSER::INHIBITOR)
    ("rapamycin and PDGFR" . SPARSER::COLLECTION)
    ("TGF-β, TGF-βR1, and TIMP2" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN)
    ("Raf, VEGFRs, and PDGFRα/β" . SPARSER::COLLECTION)
    ("normal c-KIT" . SPARSER::PROTEIN)
    ("imatinib, sunitinib, and sorafenib" . SPARSER::COLLECTION)
    ("multi-TKIs" . SPARSER::COLLECTION) ("Receptors" . SPARSER::RECEPTOR)
    ("PDGF-A and PDGFRA" . SPARSER::COLLECTION) ("fluke" . SPARSER::PROTEIN)
    ("phospho-PDGFRα and phospho-AKT" . SPARSER::COLLECTION)
    ("a poorly differentiated mesenchymal state" . SPARSER::BIO-STATE)
    ("HCC-associated EMT" . SPARSER::PROTEIN)
    ("multi-TKI" . SPARSER::COLLECTION)
    ("Ras-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRV" . SPARSER::PROTEIN)
    ("Prx" . SPARSER::PROTEIN) ("peroxiredoxin" . SPARSER::PROTEIN)
    ("which forms part" . SPARSER::COMPONENT)
    ("E-cadherin/β-catenin junctional complexes" . SPARSER::BIO-COMPLEX)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog (PTEN) and glucose-regulated protein"
     . SPARSER::COLLECTION)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::PROTEIN-FAMILY) ("major PDGFRα" . SPARSER::PROTEIN)
    ("PDGF-C and PDGFRα" . SPARSER::COLLECTION)
    ("β-catenin-p65" . SPARSER::COLLECTION)
    ("tumori-genesis" . SPARSER::COLLECTION)
    ("NF-κB/PDGFRα" . SPARSER::COLLECTION)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("this group's" . SPARSER::MOLECULE)
    ("PDGF-A or PDGF-B" . SPARSER::COLLECTION)
    ("PDGF-A as well as PDGF-B" . SPARSER::COLLECTION)
    ("these profibrogenic mediators" . SPARSER::PROTEIN)
    ("pathologic angio-genesis" . SPARSER::COLLECTION)
    ("Ras-transformed hepatocytes" . SPARSER::PROTEIN)
    ("VEGFRs and PDGFRs" . SPARSER::COLLECTION) ("VEGFRs" . SPARSER::PROTEIN)
    ("PDGFR and VEGFR" . SPARSER::COLLECTION) ("VEGFA" . SPARSER::PROTEIN)
    ("MiR-146a" . SPARSER::PROTEIN-PAIR) ("PDGFRA" . SPARSER::PROTEIN)
    ("the most well-documented PDGF receptor" . SPARSER::PROTEIN)
    ("traditional VEGFR inhibitors" . SPARSER::INHIBITOR)
    ("potential alternative targets" . SPARSER::TARGET-PROTEIN)
    ("both EGFR and the hepatocyte growth factor receptor Met—"
     . SPARSER::COLLECTION)
    ("Met—" . SPARSER::AMINO-ACID) ("TAA" . SPARSER::MOLECULE)
    ("decorin" . SPARSER::PROTEIN) ("proteoglycan" . SPARSER::PROTEIN)
    ("PDGFRα, PDGFRβ, and VEGF" . SPARSER::COLLECTION)
    ("Olaratumab" . SPARSER::DRUG)
    ("PDGF-AA and PDGF-CC" . SPARSER::COLLECTION)
    ("molecules and growth factors" . SPARSER::COLLECTION)
    ("PDGF-A and PDGF-C" . SPARSER::COLLECTION)
    ("Hepatocytes" . SPARSER::PROTEIN)
    ("pericentral hepatocytes" . SPARSER::PROTEIN)
    ("PDGFRα/PDGF-A" . SPARSER::COLLECTION)
    ("media, and PDGF-AA or PDGF-BB" . SPARSER::COLLECTION)
    ("PDGF-AA or PDGF-BB" . SPARSER::COLLECTION)
    ("liver sinusoidal EC (LSEC)" . SPARSER::PROTEIN)
    ("PECAM" . SPARSER::PROTEIN) ("thioacetamide" . SPARSER::MOLECULE)
    ("some sinusoidal EC and EC" . SPARSER::COLLECTION)
    ("EC and EC" . SPARSER::COLLECTION)
    ("functional PDGFRβ" . SPARSER::PROTEIN)
    ("PDGF-A and PDGFRα" . SPARSER::COLLECTION)
    ("PDGF-AA (increased) and PDGFRα (decreased)" . SPARSER::COLLECTION)
    ("mitochondrial ROS" . SPARSER::PROTEIN) ("Ligand" . SPARSER::LIGAND)
    ("the latter form" . SPARSER::FORM) ("monomeric PDGFRα" . SPARSER::PROTEIN)
    ("a recent study sheds new light" . SPARSER::PROTEIN)
    ("TGF-β/PDGFRα" . SPARSER::COLLECTION)
    ("myofibroblasts sheds new light" . SPARSER::PROTEIN)
    ("PDGF-BB/PDGFRβ" . SPARSER::COLLECTION)
    ("mRNA and total/phosphorylated" . SPARSER::COLLECTION)
    ("antiserum" . SPARSER::PROTEIN)
    ("PDGFRβ and PDGFRα" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND) ("heterodimer" . SPARSER::HETERODIMER)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("PDGF-B and PDGF-D" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("BDL" . SPARSER::PROTEIN)
    ("quiescent HSCs" . SPARSER::PROTEIN) ("mito" . SPARSER::DRUG)
    ("HGF and ligands" . SPARSER::COLLECTION) ("mitogens" . SPARSER::MITOGEN)
    ("PDGFRα and EGFR" . SPARSER::COLLECTION)
    ("EGFR and Met" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and hepatocyte growth factor (HGF) receptor Met"
     . SPARSER::COLLECTION)
    ("albumin-cre" . SPARSER::COLLECTION) ("cre" . SPARSER::PROTEIN)
    ("nonproliferative states" . SPARSER::BIO-STATE)
    ("exogenous PDGF-AA and PDGF-BB" . SPARSER::COLLECTION)
    ("PDGF-AA and PDGF-BB" . SPARSER::COLLECTION)
    ("Dlk-1 and PDGFRα" . SPARSER::COLLECTION) ("Dlk-1" . SPARSER::PROTEIN)
    ("Dlk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGFRα or PDGFRβ" . SPARSER::COLLECTION)
    ("mediators and tyrosine" . SPARSER::COLLECTION)
    ("PI3K, MAPK, PLCγ, Src, and Shp-2" . SPARSER::COLLECTION)
    ("Shc" . SPARSER::PROTEIN) ("PDGFRα, and PDGFRαb" . SPARSER::COLLECTION)
    ("Ras and Erk2" . SPARSER::COLLECTION) ("homodimers" . SPARSER::HOMODIMER)
    ("Crk" . SPARSER::PROTEIN) ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION)
    ("other kinases as well as nonenzymatic adaptor molecules"
     . SPARSER::COLLECTION)
    ("nonenzymatic adaptor molecules" . SPARSER::MOLECULE)
    ("dimeric PDGF ligands" . SPARSER::LIGAND) ("PDGFRs" . SPARSER::PROTEIN)
    ("BB" . SPARSER::MOLECULE)
    ("multireceptor TKIs and PDGFRα-specific inhibitors" . SPARSER::COLLECTION)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN)
    ("alcohol" . SPARSER::DRUG)
    ("autocrine growth factors and inflammatory chemokines"
     . SPARSER::COLLECTION)
    ("resident macrophages" . SPARSER::PROTEIN)
    ("inflammatory chemokines" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("multireceptor tyrosine kinase inhibitors and PDGFRα-specific inhibitors"
     . SPARSER::COLLECTION)
    ("various pathologic states" . SPARSER::BIO-STATE)
    ("cirrhosis" . SPARSER::PROTEIN) ("PDGFR" . SPARSER::PROTEIN)
    ("Monoclonal Antibody" . SPARSER::DRUG) ("TIMP2" . SPARSER::PROTEIN)
    ("TGF-βR" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("STI-571" . SPARSER::DRUG) ("GRP78" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("N-nitrosodiethylamine" . SPARSER::MOLECULE)
    ("HIF-1 α" . SPARSER::PROTEIN) ("ephrinB2" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("PDGF receptor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("K19" . SPARSER::PROTEIN) ("TGF-β 1" . SPARSER::PROTEIN)
    ("SMAD-2" . SPARSER::PROTEIN) ("TβRII" . SPARSER::PROTEIN)
    ("TβRI" . SPARSER::PROTEIN) ("SMAD2" . SPARSER::PROTEIN)
    ("PDGF-C" . SPARSER::PROTEIN) ("PDGF-A" . SPARSER::PROTEIN)
    ("PDGF-D" . SPARSER::PROTEIN) ("PDGF-B" . SPARSER::PROTEIN)
    ("PDGFRαa" . SPARSER::PROTEIN) ("α-SMA" . SPARSER::PROTEIN)
    ("PDGF-AB" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("CK8" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("PDGF-AA" . SPARSER::PROTEIN)
    ("Shp-2" . SPARSER::PROTEIN) ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("PDGFRαb" . SPARSER::PROTEIN-FAMILY) ("PDGFRβ" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("prion" . SPARSER::PROTEIN-FAMILY)
    ("protein (proteostasis) or ribonucleoprotein/RNA" . SPARSER::COLLECTION)
    ("SOD1 , OPTN , TARDBP , VCP , SPG11 , and TBK1" . SPARSER::COLLECTION)
    ("other possible ALS genes" . SPARSER::GENE)
    ("TBK1 and OPTN" . SPARSER::COLLECTION) ("ENAH" . SPARSER::PROTEIN)
    ("NEK1 and two widely expressed proteins" . SPARSER::COLLECTION)
    ("RAB" . SPARSER::PROTEIN) ("NIMA" . SPARSER::PROTEIN-FAMILY)
    ("the strongly associated genes" . SPARSER::GENE)
    ("VAPB" . SPARSER::PROTEIN) ("OPTN and TBK1" . SPARSER::COLLECTION)
    ("any other variants or other risk factors" . SPARSER::COLLECTION)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("OPTN , SQSTM1 , or TBK1" . SPARSER::COLLECTION)
    ("NF-κB and IRF3" . SPARSER::COLLECTION)
    ("the transcription factor IRF3( xref – xref ) and the critical innate immunity signaling components MAVS and STING( xref )"
     . SPARSER::COLLECTION)
    ("MAVS and STING" . SPARSER::COLLECTION) ("STING" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("OPTN, SQSTM1 and TBK1" . SPARSER::COLLECTION)
    ("some cases apparently sparing other neuronal cell types" . TYPE)
    ("sparing other neuronal cell types" . TYPE)
    ("OPTN, SQSTM1, VCP and TBK1" . SPARSER::COLLECTION)
    ("ribonucleoprotein" . SPARSER::PROTEIN) ("PARKIN" . SPARSER::PROTEIN)
    ("the essential autophagosome protein LC3" . SPARSER::PROTEIN)
    ("OPTN and SQSTM1" . SPARSER::COLLECTION)
    ("SQSTM1 and OPTN" . SPARSER::COLLECTION)
    ("SOD1 , TARDBP and FUS" . SPARSER::COLLECTION)
    ("anti-SQSTM1 and OPTN" . SPARSER::COLLECTION)
    ("most known pathogenic variants" . SPARSER::VARIANT)
    ("242 sporadic ALS" . SPARSER::PROTEIN)
    ("SOD1 and SPG11" . SPARSER::COLLECTION)
    ("other previously reported ALS genes" . SPARSER::GENE)
    ("TUBA4A, MATR3, GLE1, SS18L1, and CHCHD10" . SPARSER::COLLECTION)
    ("the ALS pathogenic TARDBP" . SPARSER::PROTEIN)
    ("PolyPhen-2" . SPARSER::COLLECTION)
    ("sporadic ALS (SALS)" . SPARSER::PROTEIN) ("DAO" . SPARSER::PROTEIN)
    ("dominant not benign variants" . SPARSER::VARIANT)
    ("HLA-B , ZNF729 , SIRPA , and TP53" . SPARSER::COLLECTION)
    ("This pathological TARDBP" . SPARSER::PROTEIN) ("VCP" . SPARSER::PROTEIN)
    ("GRN" . SPARSER::PROTEIN) ("FUS" . SPARSER::PROTEIN)
    ("TARDBP" . SPARSER::PROTEIN)
    ("Protein and protein/RNA" . SPARSER::COLLECTION)
    ("Approximately 20 genes" . SPARSER::GENE)
    ("autosomal dominant, autosomal recessive, or X-linked"
     . SPARSER::COLLECTION)
    ("optineurin (OPTN) and p62 (SQSTM1/sequestosome)" . SPARSER::COLLECTION)
    ("OPTN" . SPARSER::PROTEIN) ("optineurin" . SPARSER::PROTEIN)
    ("ALS" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("DNMT3A" . SPARSER::PROTEIN) ("NEK1" . SPARSER::PROTEIN)
    ("interferon-β" . SPARSER::DRUG) ("IRF3" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("SS18L1" . SPARSER::PROTEIN) ("GLE1" . SPARSER::PROTEIN)
    ("MATR3" . SPARSER::PROTEIN) ("TUBA4A" . SPARSER::PROTEIN)
    ("SPG11" . SPARSER::PROTEIN) ("D-amino acid oxidase" . SPARSER::PROTEIN)
    ("ZNF729" . SPARSER::PROTEIN) ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NIPA1" . SPARSER::PROTEIN) ("UBQLN2" . SPARSER::PROTEIN)
    ("C9orf72" . SPARSER::PROTEIN) ("TDP-43" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("TANK-Binding Kinase 1" . SPARSER::PROTEIN)
    ("NOTCH1 and/or NOTCH3" . SPARSER::COLLECTION)
    ("receptors and downstream effectors" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG)
    ("NOTCH1 and NOTCH3" . SPARSER::COLLECTION)
    ("human airway epithelial ALI" . SPARSER::PROTEIN)
    ("HEYL and SCGB1A1" . SPARSER::COLLECTION)
    ("HEY1 and MUC5AC" . SPARSER::COLLECTION)
    ("HEY1 and HEYL" . SPARSER::COLLECTION)
    ("NICD1 and NICD3" . SPARSER::COLLECTION) ("Effector" . SPARSER::EFFECTOR)
    ("NICD2 and NICD4" . SPARSER::COLLECTION)
    ("KRT5, MUC5AC and SCGB1A1" . SPARSER::COLLECTION)
    ("NICD3 or NICD4" . SPARSER::COLLECTION) ("NICD4" . SPARSER::PROTEIN)
    ("NICD2" . SPARSER::PROTEIN) ("NICD1-4" . SPARSER::PROTEIN)
    ("NICD1 or NICD3" . SPARSER::COLLECTION)
    ("Lenti-NICD4" . SPARSER::COLLECTION) ("Lenti-NICD2" . SPARSER::COLLECTION)
    ("Lenti-NICD1-4" . SPARSER::COLLECTION)
    ("HES5 (44.4-fold Lenti-NICD1 and 17.7-fold Lenti-NICD3) and HEYL (39.1-fold Lenti-NICD1 and 22.4-fold Lenti-NICD3)"
     . SPARSER::COLLECTION)
    ("HEY2 (p<0.02) and HEYL (p<0.04)" . SPARSER::COLLECTION)
    ("HES5 (p<0.02), HEY1 (p<0.02), HEY2 (p<0.02) and HEYL (p<0.04)"
     . SPARSER::COLLECTION)
    ("NICD3" . SPARSER::PROTEIN) ("NICD1" . SPARSER::PROTEIN)
    ("Lenti-NICD1" . SPARSER::COLLECTION) ("Lenti-NICD3" . SPARSER::COLLECTION)
    ("Lenti" . SPARSER::PROTEIN) ("HES2 and HES6" . SPARSER::COLLECTION)
    ("Lenti-GFP" . SPARSER::COLLECTION)
    ("MUC5AC (secretory cell) and SCGB1A1 (secretory cell)"
     . SPARSER::COLLECTION)
    ("the respective genes" . SPARSER::GENE)
    ("the secretory cell marker SCGB1A1" . SPARSER::PROTEIN)
    ("KRT5 and TP63" . SPARSER::COLLECTION)
    ("the secretory cell markers MUC5AC and SCGB1A1" . SPARSER::COLLECTION)
    ("MUC5AC and SCGB1A1" . SPARSER::COLLECTION) ("ALI" . SPARSER::PROTEIN)
    ("HEYL" . SPARSER::PROTEIN)
    ("DLL1, DLL4, JAG1 and JAG2" . SPARSER::COLLECTION)
    ("receptors and downstream effectors ( xref )" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT)
    ("an active transcriptional complex" . SPARSER::BIO-COMPLEX)
    ("RBPJK" . SPARSER::PROTEIN) ("NICD" . SPARSER::PROTEIN)
    ("Notch2" . SPARSER::PROTEIN) ("B-1" . SPARSER::PROTEIN)
    ("EF1α" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("PA1" . SPARSER::PROTEIN) ("TEKT1" . SPARSER::PROTEIN)
    ("SCGB1A1" . SPARSER::PROTEIN) ("MUC5AC" . SPARSER::PROTEIN)
    ("t-butyl" . SPARSER::MOLECULE) ("γ-Secretase" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("HEY2" . SPARSER::PROTEIN)
    ("HEY1" . SPARSER::PROTEIN) ("HES7" . SPARSER::PROTEIN)
    ("HES6" . SPARSER::PROTEIN) ("HES5" . SPARSER::PROTEIN)
    ("HES2" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("NOTCH4" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("JAG2" . SPARSER::PROTEIN) ("DLL4" . SPARSER::PROTEIN)
    ("DLL3" . SPARSER::PROTEIN) ("DLL1" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("KRT5" . SPARSER::PROTEIN)
    ("jagged 1" . SPARSER::PROTEIN) ("NOTCH2" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("GSK3β and p38" . SPARSER::COLLECTION)
    ("MAPK and calpain" . SPARSER::COLLECTION)
    ("Drosha or Dicer" . SPARSER::COLLECTION)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("p68 or DGCR8" . SPARSER::COLLECTION)
    ("TGFβ/BMP-SMADs" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("BMP" . SPARSER::PROTEIN)
    ("additional accessory proteins" . SPARSER::PROTEIN)
    ("p68 and p72" . SPARSER::COLLECTION)
    ("miRNA biogenic associated proteins" . SPARSER::PROTEIN)
    ("a fluorescent substrate" . SPARSER::SUBSTRATE)
    ("wt or mt5 Drosha" . SPARSER::COLLECTION)
    ("MAPK/MKK6" . SPARSER::COLLECTION) ("mature miRNAs" . SPARSER::PROTEIN)
    ("Northern blot" . SPARSER::PROTEIN) ("TRIzol" . SPARSER::DRUG)
    ("calpain and p38" . SPARSER::COLLECTION)
    ("Calpain II cleaved full length and ΔN220 Drosha" . SPARSER::PROTEIN)
    ("Calpain" . SPARSER::PROTEIN)
    ("a cell permeable calpain inhibitor calpeptin" . SPARSER::MOLECULE)
    ("calpeptin" . SPARSER::MOLECULE) ("the key proteases" . SPARSER::PROTEIN)
    ("Drosha and ΔN390" . SPARSER::COLLECTION)
    ("MAPK and MKK6" . SPARSER::COLLECTION)
    ("wt and mt5 Drosha" . SPARSER::COLLECTION)
    ("SB203580 or p38 (AF)" . SPARSER::COLLECTION)
    ("SB203580 or p38" . SPARSER::COLLECTION)
    ("SB203580 or leptomycin B" . SPARSER::COLLECTION)
    ("DGCR8 and DDX17" . SPARSER::COLLECTION)
    ("relatively clean cytoplasmic and nuclear fractions" . SPARSER::COMPONENT)
    ("wt or mt5 Drosha-FLAG" . SPARSER::COLLECTION)
    ("p38/MKK6" . SPARSER::COLLECTION) ("GST-DGCR8" . SPARSER::COLLECTION)
    ("p38 (AF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Drosha-DGCR8" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("Drosha and DGCR8" . SPARSER::COLLECTION)
    ("Full phospho Ser substrate" . SPARSER::SUBSTRATE)
    ("wt" . SPARSER::PROTEIN)
    ("p38 MAPK and its activator MKK6" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Drosha or 1-390aa" . SPARSER::COLLECTION)
    ("Drosha-FLAG" . SPARSER::COLLECTION)
    ("GST-p38 MAPK and its activator MKK3 (mitogen-activated protein kinase kinase 3)"
     . SPARSER::COLLECTION)
    ("p38 and Drosha" . SPARSER::COLLECTION) ("GST-p38" . SPARSER::COLLECTION)
    ("p38 MAPK and full length Drosha" . SPARSER::COLLECTION)
    ("GST specifically pulls down p38 MAPK" . SPARSER::PROTEIN)
    ("MAPK and Drosha" . SPARSER::COLLECTION)
    ("GST-Drosha" . SPARSER::COLLECTION)
    ("miRNAs and proteins" . SPARSER::COLLECTION)
    ("miRNA-protein" . SPARSER::COLLECTION)
    ("the ~22 nucleotide mature miRNAs" . SPARSER::PROTEIN)
    ("the long primary miRNAs" . SPARSER::PROTEIN)
    ("calpain" . SPARSER::PROTEIN) ("Drosha" . SPARSER::PROTEIN)
    ("argonaute 2" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("p72" . SPARSER::PROTEIN) ("H2O2" . SPARSER::DRUG)
    ("pri-miRNA" . SPARSER::RNA) ("pre-miRNA" . SPARSER::RNA)
    ("calpain inhibitor" . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE) ("CRM1" . SPARSER::PROTEIN)
    ("DDX17" . SPARSER::PROTEIN) ("MKK6" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 3" . SPARSER::PROTEIN)
    ("MKK3" . SPARSER::PROTEIN) ("MeCP2" . SPARSER::PROTEIN)
    ("Methyl-CpG binding protein" . SPARSER::PROTEIN)
    ("p68" . SPARSER::PROTEIN) ("Argonaute 2" . SPARSER::PROTEIN)
    ("MAPK-activated protein kinase 2" . SPARSER::PROTEIN)
    ("exportin-5" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("DGCR8" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("pri-miRNAs" . SPARSER::RNA) ("RNase III" . SPARSER::PROTEIN)
    ("RNAPII and DRIP" . SPARSER::COLLECTION)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION) ("-mutant" . SPARSER::MUTANT)
    ("proteins (APOBEC)" . SPARSER::PROTEIN) ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("AID" . SPARSER::PROTEIN) ("cytosine" . SPARSER::NUCLEOBASE)
    ("endonucleases" . SPARSER::PROTEIN) ("flap" . SPARSER::PROTEIN)
    ("certain R-loop-associated TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("holoenzyme" . SPARSER::PROTEIN) ("these special DNA" . SPARSER::DNA)
    ("HBD" . SPARSER::PROTEIN) ("proteins and R-loops" . SPARSER::COLLECTION)
    ("β-actin , Gemin7 , and ENSA" . SPARSER::COLLECTION)
    ("R-loop-associated TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Precise mapping" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("SBM" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("− 1" . SPARSER::PROTEIN)
    ("RH" . SPARSER::MOLECULE) ("DRIP" . SPARSER::PROTEIN)
    ("the relevant genes" . SPARSER::GENE) ("p " . SPARSER::PROTEIN)
    ("whose filtered TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-loop-associated TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a genomic TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("764 distinct BRCA1" . SPARSER::PROTEIN)
    ("numerous fragile genomic sequences prone" . SPARSER::PROTEIN-FAMILY)
    ("alkaline" . SPARSER::PROTEIN)
    ("local R-loop-associated DNA" . SPARSER::DNA)
    ("local γH2AX" . SPARSER::PROTEIN)
    ("ENSA and Gemin7" . SPARSER::COLLECTION) ("ENSA" . SPARSER::PROTEIN)
    ("BRCA1-" . SPARSER::PROTEIN) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("helicases" . SPARSER::PROTEIN) ("BRCA1 or SETX" . SPARSER::COLLECTION)
    ("BJ-hTERT" . SPARSER::PROTEIN-PAIR)
    ("Irrelevant IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abs" . SPARSER::PROTEIN)
    ("co-transcriptional R-loop-associated DNA" . SPARSER::DNA)
    ("BRCA1 and SETX" . SPARSER::COLLECTION)
    ("R-loop-associated DNA" . SPARSER::DNA) ("RNAPII" . SPARSER::PROTEIN)
    ("meiotic" . SPARSER::DRUG) ("BRCA1/protein" . SPARSER::COLLECTION)
    ("TAP" . SPARSER::PROTEIN) ("BRCA1/SETX" . SPARSER::COLLECTION)
    ("TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-loop-driven DNA" . SPARSER::DNA) ("SETX" . SPARSER::PROTEIN)
    ("senataxin" . SPARSER::PROTEIN) ("apolipoprotein B" . SPARSER::PROTEIN)
    ("C–6" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("WT/WT" . SPARSER::PROTEIN) ("2-P" . SPARSER::PROTEIN)
    ("S2P" . SPARSER::PROTEIN) ("α-amanitin" . SPARSER::MOLECULE)
    ("cyclinB1" . SPARSER::PROTEIN) ("Gemin7" . SPARSER::PROTEIN)
    ("RNaseH1" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN) ("p220" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN)
    ("progesterone and estrogen" . SPARSER::COLLECTION)
    ("VEGF-A and EGF" . SPARSER::COLLECTION) ("VEGF-" . SPARSER::PROTEIN)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("E-cadherin and an inducer" . SPARSER::COLLECTION)
    ("antibody or mTOR" . SPARSER::COLLECTION)
    ("Rapamycin and anti-EGFR" . SPARSER::COLLECTION)
    ("possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("EGF and EGFR" . SPARSER::COLLECTION)
    ("tuberin or hamartin" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stat and phosphatidylinositol-3" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("lymph-specific receptor" . SPARSER::RECEPTOR)
    ("hyaluronan" . SPARSER::PROTEIN) ("LVD" . SPARSER::MOLECULE)
    ("Tsc2" . SPARSER::PROTEIN) ("Estrogen" . SPARSER::MOLECULE)
    ("mTOR and biomarker" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("antibody and rapamycin" . SPARSER::COLLECTION)
    ("actin (ASM)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-smooth muscle" . SPARSER::COLLECTION) ("PKH" . SPARSER::PROTEIN)
    ("HSD " . SPARSER::PROTEIN) ("receptors and Snail" . SPARSER::COLLECTION)
    ("EGFR and EGF" . SPARSER::COLLECTION) ("CKO" . SPARSER::PROTEIN)
    ("EGF and hepatocytes" . SPARSER::COLLECTION)
    ("tuberin, and TSC2" . SPARSER::COLLECTION) ("ASM" . SPARSER::PROTEIN)
    ("Tuberin and hamartin" . SPARSER::COLLECTION)
    ("TSC2 and TSC1" . SPARSER::COLLECTION) ("Tuberin" . SPARSER::PROTEIN)
    ("estrogen receptor (ER) and progesterone receptors (PR)"
     . SPARSER::COLLECTION)
    ("receptors (PR)" . SPARSER::RECEPTOR)
    ("phosphatidylinositol 3-kinase-AKT" . SPARSER::COLLECTION)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("pulmonary nodules anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN)
    ("EGF and monoclonal anti-EGFR antibodies" . SPARSER::COLLECTION)
    ("monoclonal anti-EGFR antibodies" . SPARSER::ANTIBODY)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX) ("TSC" . SPARSER::PROTEIN)
    ("HER" . SPARSER::PROTEIN) ("VEGF-D" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fra1" . SPARSER::PROTEIN)
    ("PI3 K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LYVE 1" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("α -Actin" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("PKH26" . SPARSER::DRUG) ("LYVE-1" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α -actin" . SPARSER::PROTEIN) ("TSC 2" . SPARSER::PROTEIN)
    ("its hypo-phosphorylated state" . SPARSER::BIO-STATE)
    ("cyclin D-CDK-p21 CIP1" . SPARSER::COLLECTION)
    ("pRb-protein" . SPARSER::COLLECTION)
    ("at least 2 independent shRNAs" . SPARSER::RNA)
    ("the CDKs had little" . SPARSER::PROTEIN)
    ("their regulatory cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the respective kinases" . SPARSER::KINASE)
    ("S3A and S3B" . SPARSER::COLLECTION)
    ("binary complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin D1, CDK4 and p21 CIP1" . SPARSER::COLLECTION)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("cyclin D1 and p21 CIP1" . SPARSER::COLLECTION)
    ("cyclin D1 or p21 CIP1" . SPARSER::COLLECTION)
    ("cyclin D–CDK" . SPARSER::COLLECTION)
    ("Cyclin D-CDK" . SPARSER::COLLECTION)
    ("a previously validated shRNA" . SPARSER::PROTEIN)
    ("normal HFs" . SPARSER::PROTEIN)
    ("pRb, p53 and p21 CIP1" . SPARSER::COLLECTION)
    ("p53 and Chk2" . SPARSER::COLLECTION) ("TERT" . SPARSER::PROTEIN)
    ("a temperature-sensitive (ts) allele" . SPARSER::ALLELE)
    ("TIG3" . SPARSER::PROTEIN)
    ("cyclin D1-CDK4-p21 CIP1" . SPARSER::COLLECTION)
    ("simian virus 40 large tumor antigen" . SPARSER::DRUG)
    ("cyclin D-CDK" . SPARSER::COLLECTION) ("CIP/KIP" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN) ("CIP" . SPARSER::PROTEIN)
    ("the ternary complexes" . SPARSER::BIO-COMPLEX)
    ("senescent HFs" . SPARSER::PROTEIN)
    ("its active hypo-phosphorylated state" . SPARSER::BIO-STATE)
    ("cyclins, CDK4 and p21 CIP1" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("p21 CIP1 and p16 INK4a" . SPARSER::COLLECTION) ("HFs" . SPARSER::PROTEIN)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("cyclin D-CDK4-p21" . SPARSER::COLLECTION)
    ("a hypo-phosphorylated state" . SPARSER::BIO-STATE)
    ("cyclin D-CDK4" . SPARSER::COLLECTION)
    ("pRb and p53" . SPARSER::COLLECTION)
    ("p16 INK4a and p21 CIP1" . SPARSER::COLLECTION)
    ("OPA1" . SPARSER::PROTEIN) ("amino acid transporter" . SPARSER::PROTEIN)
    ("T-antigen" . SPARSER::PROTEIN) ("PD0332991" . SPARSER::DRUG)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("p27 KIP1" . SPARSER::PROTEIN) ("T-Ag" . SPARSER::PROTEIN)
    ("large T-antigen" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4a" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("particularly aggressive form" . SPARSER::FORM)
    ("curcumin" . SPARSER::DRUG) ("Jak/STAT3" . SPARSER::COLLECTION)
    ("receptor and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("-2 and c-Src" . SPARSER::COLLECTION) ("Jak/STAT" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras/Erk1/2" . SPARSER::COLLECTION) ("ectogenic genes" . SPARSER::GENE)
    ("exogenous SOCS3" . SPARSER::PROTEIN)
    ("ectogenic SOCS3 gene" . SPARSER::GENE)
    ("retinal ischemia" . SPARSER::PROTEIN)
    ("hypoxia and nutrient" . SPARSER::COLLECTION)
    ("wortmannin and CPA-7" . SPARSER::COLLECTION)
    ("CD34 and VEGF" . SPARSER::COLLECTION) ("Wortmannin" . SPARSER::PROTEIN)
    ("JAK/STAT3" . SPARSER::COLLECTION) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("JAK/STAT" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("VEGF-A and CD34" . SPARSER::COLLECTION)
    ("Ad5-SOCS3" . SPARSER::COLLECTION)
    ("SOCS3 and HIF-1α" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS2" . SPARSER::COLLECTION)
    ("VEGF-A and interleukin-6" . SPARSER::COLLECTION)
    ("the angiogenic factor VEGF-A" . SPARSER::PROTEIN)
    ("upregu-lated" . SPARSER::COLLECTION) ("lated" . SPARSER::PROTEIN)
    ("Ad5-SOCS3-GFP transfection group and Ad5-GFP transfection group"
     . SPARSER::COLLECTION)
    ("Ad5-GFP" . SPARSER::COLLECTION) ("Ad5-SOCS3-GFP" . SPARSER::COLLECTION)
    ("aza" . SPARSER::DRUG) ("Akt and STAT3" . SPARSER::COLLECTION)
    ("a peptide, which inhibits the binding between HIF-1α and the coactivator p300/CBP ( xref )"
     . SPARSER::COLLECTION)
    ("angio-genesis" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("type 5" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor-A" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("farnesyl transferase inhibitors (FTIs) or Raf/Mek/Erk inhibitors"
     . SPARSER::COLLECTION)
    ("Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FTIs" . SPARSER::DRUG)
    ("NRAS and KRAS" . SPARSER::COLLECTION) ("Ras-MAPK" . SPARSER::COLLECTION)
    ("proangiogenic cytokines and prostaglandins" . SPARSER::COLLECTION)
    ("cytokines and prostaglandins" . SPARSER::COLLECTION)
    ("VEGF and Flk-1" . SPARSER::COLLECTION)
    ("additional heterozygous HRAS mutations c" . SPARSER::PROTEIN)
    ("HRAS" . SPARSER::PROTEIN) ("a heterozygous c" . SPARSER::PROTEIN)
    ("40 archival PG" . SPARSER::PROTEIN)
    ("secondary somatic variants or regions" . SPARSER::COLLECTION)
    ("variants or regions" . SPARSER::COLLECTION)
    ("GLMN, VEGRF3, FOXC2, SOX18, ACVRLK1, MADH4, and ENG"
     . SPARSER::COLLECTION)
    ("CCM1/2/3" . SPARSER::COLLECTION) ("ENG" . SPARSER::PROTEIN)
    ("GLMN" . SPARSER::PROTEIN) ("TEK" . SPARSER::PROTEIN)
    ("a heterozygous NRAS c" . SPARSER::PROTEIN)
    ("A heterozygous KRAS c" . SPARSER::PROTEIN)
    ("prednisone and propranolol" . SPARSER::COLLECTION)
    ("propranolol" . SPARSER::DRUG) ("prednisone" . SPARSER::DRUG)
    ("bright" . SPARSER::PROTEIN) ("Vascular malformations" . SPARSER::PROTEIN)
    ("β-blockers" . SPARSER::DRUG)
    ("RAS p21 protein activator" . SPARSER::PROTEIN)
    ("Flk-1" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("P34" . SPARSER::PROTEIN) ("G15" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("MADH4" . SPARSER::PROTEIN)
    ("ACVRLK1" . SPARSER::PROTEIN) ("SOX18" . SPARSER::PROTEIN)
    ("FOXC2" . SPARSER::PROTEIN) ("CCM1" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("p65 and c-Rel" . SPARSER::COLLECTION)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("an immediate caspase" . SPARSER::PROTEIN)
    ("Bcl2, c-IAP、XIAP, c-FLIP, p53, and c-myc" . SPARSER::COLLECTION)
    ("c" . SPARSER::PROTEIN)
    ("the potential downstream death genes" . SPARSER::GENE)
    ("p53 and c-myc" . SPARSER::COLLECTION) ("c-IAP" . SPARSER::PROTEIN-PAIR)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FLICE" . SPARSER::PROTEIN)
    ("FADD and caspase-8" . SPARSER::COLLECTION)
    ("agonistic anti-Fas antibody" . SPARSER::ANTIBODY)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("z-LETD-fmk" . SPARSER::COLLECTION) ("fmk" . SPARSER::PROTEIN)
    ("PARP, caspase-8 and-3" . SPARSER::COLLECTION)
    ("caspase-4 and other caspases" . SPARSER::COLLECTION)
    ("Cas4" . SPARSER::PROTEIN) ("BMS" . SPARSER::DRUG)
    ("Smac" . SPARSER::PROTEIN) ("neurotoxin" . SPARSER::PROTEIN)
    ("The prototypical NF-κB" . SPARSER::PROTEIN)
    ("Fas/FasL" . SPARSER::COLLECTION) ("Fas and FasL" . SPARSER::COLLECTION)
    ("caspase-3 and poly (ADP-ribose) polymerase (PARP)" . SPARSER::COLLECTION)
    ("its downstream effectors, caspase-3 and poly (ADP-ribose) polymerase (PARP)"
     . SPARSER::COLLECTION)
    ("Fas ligand (FasL) or its agonistic antibody" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("Fas-associated death domain adaptor protein (FADD)" . SPARSER::PROTEIN)
    ("adaptor protein (FADD)" . SPARSER::PROTEIN)
    ("its agonistic antibody" . SPARSER::PROTEIN)
    ("DISC" . SPARSER::BIO-COMPLEX) ("FasL" . SPARSER::PROTEIN)
    ("receptor (TNFR)" . SPARSER::RECEPTOR) ("TNFR" . SPARSER::PROTEIN)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("its dominant negative (DN) form" . SPARSER::FORM)
    ("RelA" . SPARSER::PROTEIN)
    ("IκBα (DN-IκBα) or an IκB kinase-specific inhibitor"
     . SPARSER::COLLECTION)
    ("agonistic Fas antibody" . SPARSER::ANTIBODY)
    ("SH-EP1" . SPARSER::PROTEIN) ("CAS4" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("caspase-1" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("Caspase-4" . SPARSER::PROTEIN) ("BMS-345541" . SPARSER::DRUG)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("caspase-2" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("caspase-4" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("AR, EGFR, or BRCA1" . SPARSER::COLLECTION)
    ("inhibitor (HDI)" . SPARSER::INHIBITOR) ("HDI" . SPARSER::MOLECULE)
    ("-carboplatin" . SPARSER::DRUG) ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("other therapeutic target receptors (e.g., VEGFR and folate receptor) and novel inhibitors (e.g., inhibitor of mTOR and histone deacetylase)"
     . SPARSER::COLLECTION)
    ("VEGFR and folate" . SPARSER::COLLECTION)
    ("mTOR and histone deacetylase" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE) ("docetaxel" . SPARSER::DRUG)
    ("poison" . SPARSER::MOLECULE)
    ("MUC1, and MUC1 and EGFR" . SPARSER::COLLECTION)
    ("MUC1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and neoadjuvant" . SPARSER::COLLECTION)
    ("identifying possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("EGFR and PDGFR β and AR" . SPARSER::COLLECTION)
    ("PDGFR β and AR" . SPARSER::COLLECTION)
    ("Erk1/2, EGFR, and PDGFR β" . SPARSER::COLLECTION)
    ("antiandrogen" . SPARSER::DRUG) ("UK" . SPARSER::PROTEIN)
    ("fix" . SPARSER::PROTEIN) ("AR and BRCA1" . SPARSER::COLLECTION)
    ("androgen and androgen receptor (AR)" . SPARSER::COLLECTION)
    ("ER or PR" . SPARSER::COLLECTION)
    ("androgen and androgen receptor" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("bicalutamide" . SPARSER::DRUG)
    ("ATR/BRCA" . SPARSER::COLLECTION) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("LAR" . SPARSER::PROTEIN) ("appropriate biomarkers" . SPARSER::MOLECULE)
    ("which lacks known common therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("unique biomarkers" . SPARSER::MOLECULE)
    ("AR and EGFR" . SPARSER::COLLECTION) ("RR" . SPARSER::MOLECULE)
    ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("AR, EGFR, and BRCA1" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("PDGFR β" . SPARSER::PROTEIN)
    ("BL2" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CSF" . SPARSER::PROTEIN) ("recent MRI" . SPARSER::PROTEIN)
    ("MSF1, MSF2, and MSF4" . SPARSER::COLLECTION)
    ("only three DNA" . SPARSER::DNA) ("ALCAM" . SPARSER::PROTEIN)
    ("the HLA-DRA and HLA-DRB genes" . SPARSER::COLLECTION)
    ("heterodimeric protein" . SPARSER::PROTEIN)
    ("HLA-DRB" . SPARSER::COLLECTION) ("DR" . SPARSER::MOLECULE)
    ("phenformin" . SPARSER::DRUG)
    ("metformin and H 2 O 2" . SPARSER::COLLECTION)
    ("Cre-recombinase" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("CNPase-Cre" . SPARSER::COLLECTION)
    ("CNPase" . SPARSER::PROTEIN) ("Polymorphisms" . SPARSER::PROTEIN)
    ("CD3 and CD28" . SPARSER::COLLECTION) ("DRB" . SPARSER::PROTEIN)
    ("MSF1 and MSF2" . SPARSER::COLLECTION)
    ("the major ancestral C allele" . SPARSER::ALLELE)
    ("harbored both the STK11-SNP" . SPARSER::COLLECTION)
    ("SNP" . SPARSER::PROTEIN) ("polymorphism (SNP)" . SPARSER::PROTEIN)
    ("polymorphism" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("at least 14 other protein kinases" . SPARSER::PROTEIN)
    ("family (MSF)" . SPARSER::PROTEIN-FAMILY) ("CIS" . SPARSER::PROTEIN)
    ("MSF" . SPARSER::PROTEIN) ("HLA" . SPARSER::PROTEIN)
    ("STK11-SNP" . SPARSER::COLLECTION) ("CD24" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("HLA-DRA" . SPARSER::PROTEIN)
    ("RIP2" . SPARSER::PROTEIN) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("IL-10" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("CD3 " . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("MSF1" . SPARSER::PROTEIN) ("Par-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HLA-DRB1" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("-substrates" . SPARSER::SUBSTRATE) ("Chaperone" . SPARSER::PROTEIN)
    ("BAG" . SPARSER::PROTEIN-FAMILY) ("PMP22/Ub" . SPARSER::COLLECTION)
    ("duo" . SPARSER::PROTEIN)
    ("a noncompetitive inhibitor" . SPARSER::INHIBITOR)
    ("pharmacologically treated MEFs" . SPARSER::PROTEIN)
    ("Rab7 and HSP70" . SPARSER::COLLECTION)
    ("Atf6, BiP, or CHOP" . SPARSER::COLLECTION)
    ("Wt or HSP70.1/3" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("Atf6" . SPARSER::PROTEIN) ("BiP" . SPARSER::PROTEIN)
    ("The mature TrJ protein" . SPARSER::PROTEIN)
    ("constitutive (HSC70) HSP70 (designated as HSP70*) and anti-HA ( xref )"
     . SPARSER::COLLECTION)
    ("anti-HA and anti-LAMP1" . SPARSER::COLLECTION)
    ("TrJ-HA" . SPARSER::COLLECTION) ("ConA" . SPARSER::DRUG)
    ("HA3" . SPARSER::PROTEIN) ("TrJ-HA3" . SPARSER::COLLECTION)
    ("carbohydrate" . SPARSER::MOLECULE) ("TrJ" . SPARSER::PROTEIN)
    ("the normal MEFs" . SPARSER::PROTEIN) ("myc-PMP22" . SPARSER::COLLECTION)
    ("Wt and HSP70.1/3" . SPARSER::COLLECTION)
    ("The exogenous myc-tagged PMP22" . SPARSER::PROTEIN)
    ("Wt" . SPARSER::PROTEIN) ("Wt-Myc3" . SPARSER::COLLECTION)
    ("Wt-PMP22" . SPARSER::COLLECTION) ("mannosidase" . SPARSER::PROTEIN)
    ("sugar" . SPARSER::MOLECULE) ("TrJ-PMP22" . SPARSER::COLLECTION)
    ("well-defined PMP22-" . SPARSER::PROTEIN) ("PMP22-" . SPARSER::PROTEIN)
    ("PMP22 and other Ub-positive proteasome substrates" . SPARSER::COLLECTION)
    ("pUb-reactive proteins" . SPARSER::PROTEIN)
    ("DMSO and BIIB021" . SPARSER::COLLECTION)
    ("the representative blot" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("PMP22 and Ub" . SPARSER::COLLECTION)
    ("Lc-treated Wt MEFs" . SPARSER::PROTEIN) ("mUb" . SPARSER::PROTEIN)
    ("Essentially all PMP22-containing protein" . SPARSER::PROTEIN)
    ("HSP70, HSP70.1 and HSP70" . SPARSER::COLLECTION)
    ("HSP90, HSP27, and αB-Crystallin" . SPARSER::COLLECTION)
    ("applicable chaperones" . SPARSER::PROTEIN)
    ("Ub-GFP" . SPARSER::COLLECTION)
    ("The stress-inducible form" . SPARSER::FORM)
    ("HSP70, HSP40, and αB-crystallin" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN) ("tetraspan" . SPARSER::PROTEIN)
    ("Rab7" . SPARSER::PROTEIN) ("Chaperones" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("Activating transcription factor 6" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("N-glycan" . SPARSER::MOLECULE)
    ("BIIB021 " . SPARSER::DRUG) ("HSP27" . SPARSER::PROTEIN)
    ("Myc3" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIIB021" . SPARSER::DRUG) ("myelin protein zero" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSP40" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("HSP70.1" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("PMP22" . SPARSER::PROTEIN)
    ("peripheral myelin protein 22" . SPARSER::PROTEIN)
    ("Rab2 and PKCι" . SPARSER::COLLECTION)
    ("Rabs and atypical PKCs" . SPARSER::COLLECTION)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab13 and Rab14" . SPARSER::COLLECTION) ("Rab13" . SPARSER::PROTEIN)
    ("occludin and JAM-A" . SPARSER::COLLECTION)
    ("occludin and claudin-2" . SPARSER::COLLECTION)
    ("ZO-1 ( xref ) and occludin ( xref ; xref )" . SPARSER::COLLECTION)
    ("claudins" . SPARSER::PROTEIN)
    ("regulator Rab14 and the polarity protein PKCι" . SPARSER::COLLECTION)
    ("PKCι and the apical marker podocalyxin" . SPARSER::COLLECTION)
    ("the apical marker podocalyxin" . SPARSER::PROTEIN)
    ("podocalyxin" . SPARSER::PROTEIN)
    ("Rab14 (PKCι KD) or PKCι (Rab14 KD)" . SPARSER::COLLECTION)
    ("PKCι or Rab14" . SPARSER::COLLECTION) ("Rab14-GFP" . SPARSER::COLLECTION)
    ("HEK" . SPARSER::PROTEIN) ("nonhydrolyzable GTP" . SPARSER::NUCLEOTIDE)
    ("the lysosomotropic amine NH 4 Cl" . SPARSER::MOLECULE)
    ("amine" . SPARSER::MOLECULE) ("ZIP" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("occludin and claudin-1" . SPARSER::COLLECTION)
    ("claudin-2 and claudin-4" . SPARSER::COLLECTION)
    ("claudin-1, occludin, ZO-1, and E-cadherin" . SPARSER::COLLECTION)
    ("fluorescein" . SPARSER::MOLECULE)
    ("Supplemental Figure S1B" . SPARSER::PROTEIN)
    ("occludin, claudin-1, and ZO-1" . SPARSER::COLLECTION)
    ("at least 10 times more PKCι mRNA" . SPARSER::PROTEIN)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCι and PKCζ" . SPARSER::COLLECTION) ("PKCι-" . SPARSER::PROTEIN)
    ("PKCι or PKCζ" . SPARSER::COLLECTION) ("calcium" . SPARSER::CALCIUM)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("a selectively permeable barrier" . SPARSER::PROTEIN)
    ("ions" . SPARSER::MOLECULE) ("Rab14 and aPKC" . SPARSER::COLLECTION)
    ("PKCι and Rab14" . SPARSER::COLLECTION)
    ("Rab14 and PKCι" . SPARSER::COLLECTION) ("TGN" . SPARSER::PROTEIN)
    ("aPKC" . SPARSER::PROTEIN)
    ("claudin-1, ZO-1, and occludin" . SPARSER::COLLECTION)
    ("GTPγs" . SPARSER::PROTEIN) ("p -nitrophenyl" . SPARSER::MOLECULE)
    ("β -actin" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("Rab25" . SPARSER::PROTEIN) ("ammonium chloride" . SPARSER::MOLECULE)
    ("Claudin-2" . SPARSER::PROTEIN)
    ("lysosome-associated membrane protein 1" . SPARSER::PROTEIN)
    ("claudin-4" . SPARSER::PROTEIN) ("β-COP" . SPARSER::PROTEIN)
    ("Rab2" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("Rab34" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("JAM-A" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("Atypical protein kinase" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("claudin-1" . SPARSER::PROTEIN) ("Rab14" . SPARSER::PROTEIN)
    ("claudin-2" . SPARSER::PROTEIN) ("PKCι" . SPARSER::PROTEIN)
    ("trimeric PCNA" . SPARSER::PROTEIN)
    ("PCNA and Polη-mediated" . SPARSER::COLLECTION)
    ("NBS1 and Polη" . SPARSER::COLLECTION)
    ("PCNA and Ub" . SPARSER::COLLECTION)
    ("CHK1-Claspin" . SPARSER::COLLECTION)
    ("Spartan/C1orf124/DVC1" . SPARSER::COLLECTION)
    ("Claspin" . SPARSER::PROTEIN) ("PTIP" . SPARSER::PROTEIN)
    ("Spartan" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("unmodifiable PCNA" . SPARSER::PROTEIN)
    ("both endogenous PCNA and exogenous PCNA[KR]" . SPARSER::COLLECTION)
    ("at least one ubiquitinated monomer" . SPARSER::MONOMER)
    ("dCMP" . SPARSER::DCMP) ("GFP-Polη" . SPARSER::COLLECTION)
    ("Polη-" . SPARSER::PROTEIN) ("exogenous HA-PCNA" . SPARSER::COLLECTION)
    ("Polη or RAD18" . SPARSER::COLLECTION) ("Polη" . SPARSER::PROTEIN)
    ("RAD18 or Polη" . SPARSER::COLLECTION)
    ("FLAG-RAD18" . SPARSER::COLLECTION) ("FLAG-Polη" . SPARSER::PROTEIN-PAIR)
    ("RAD18 [ xref ] or Polη [ xref ]" . SPARSER::COLLECTION)
    ("multiple modification-susceptible PCNA trimers" . SPARSER::TRIMER)
    ("HA-PCNA" . SPARSER::COLLECTION)
    ("monomers and endogenous PCNA monomers" . SPARSER::COLLECTION)
    ("His-Ub-modified PCNA molecules" . SPARSER::MOLECULE)
    ("exogenous PCNA" . SPARSER::PROTEIN)
    ("unmodifiable PCNA molecules" . SPARSER::MOLECULE)
    ("The larger protein" . SPARSER::PROTEIN)
    ("larger molecules" . SPARSER::MOLECULE)
    ("anti-Ub or anti-PCNA" . SPARSER::COLLECTION)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("RAD6" . SPARSER::PROTEIN)
    ("FLAG, HA, and His" . SPARSER::COLLECTION)
    ("FLAG-tagged modifiable WT PCNA" . SPARSER::PROTEIN)
    ("-Ub" . SPARSER::COLLECTION) ("Ub-fused" . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("RAD6-RAD18" . SPARSER::COLLECTION)
    ("SUMO" . SPARSER::PROTEIN)
    ("yeast) or HLTF and SHPRH" . SPARSER::COLLECTION)
    ("HLTF and SHPRH" . SPARSER::COLLECTION) ("SHPRH" . SPARSER::PROTEIN)
    ("HLTF" . SPARSER::PROTEIN) ("Ub-PCNA" . SPARSER::COLLECTION)
    ("a ring-shaped homo-trimer complex that interacts with many proteins and plays crucial roles in DNA replication"
     . SPARSER::COLLECTION)
    ("TS" . SPARSER::PROTEIN) ("Exogenous PCNA" . SPARSER::PROTEIN)
    ("trimers" . SPARSER::TRIMER) ("trimer" . SPARSER::TRIMER)
    ("Pol" . SPARSER::PROTEIN) ("DDT" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("ELG1" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("DVC1" . SPARSER::PROTEIN)
    ("C1orf124" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("CRL4" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("RAD6A" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C20" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("Rad5" . SPARSER::PROTEIN) ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("RAD18" . SPARSER::PROTEIN)
    ("eGFR" . SPARSER::PROTEIN) ("ROS and ADMA" . SPARSER::COLLECTION)
    ("/eNOS" . SPARSER::COLLECTION) ("PPAR-γ and Nrf2" . SPARSER::COLLECTION)
    ("PPAR-γ and eNOS" . SPARSER::COLLECTION)
    ("DDAH-1 and DDAH-2" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("HO-1 and NQO-1" . SPARSER::COLLECTION)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("DDAH-1 or -2" . SPARSER::COLLECTION)
    ("eNOS and p-eNOS ser" . SPARSER::COLLECTION)
    ("eNOS, DDAH-1 and DDAH-2" . SPARSER::COLLECTION)
    ("p-eNOS" . SPARSER::COLLECTION) ("tBHQ-" . SPARSER::DRUG)
    ("Nrf2-p" . SPARSER::COLLECTION)
    ("DDAH-1 (−1016/−1008) and ARE2" . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN)
    ("almost halved medium ADMA" . SPARSER::MOLECULE)
    ("dimethylarginine (ADMA)" . SPARSER::DRUG)
    ("dimethylarginine" . SPARSER::DRUG)
    ("Nitric oxide (NO)" . SPARSER::MOLECULE)
    ("cytoprotective genes" . SPARSER::GENE) ("GST-1" . SPARSER::COLLECTION)
    ("superoxide" . SPARSER::MOLECULE) ("oxygenase" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("/Akt" . SPARSER::COLLECTION)
    ("Nrf2-Keap1" . SPARSER::COLLECTION)
    ("naturally occurring substances" . SPARSER::SUBSTANCE)
    ("sulforaphane" . SPARSER::PROTEIN) ("cystein" . SPARSER::MOLECULE)
    ("its inhibitor Kelch-like ECH-associated protein (Keap)-1"
     . SPARSER::PROTEIN)
    ("Cytoplamic Nrf2" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the HO-1 and other genes" . SPARSER::COLLECTION)
    ("ADMA and PPAR-γ" . SPARSER::COLLECTION)
    ("NOS and DDAH" . SPARSER::COLLECTION) ("tBHQ" . SPARSER::DRUG)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("eNOS" . SPARSER::PROTEIN)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("ADMA" . SPARSER::MOLECULE) ("DDAH" . SPARSER::PROTEIN)
    ("Dimethylarginine" . SPARSER::DRUG) ("Nrf-2" . SPARSER::PROTEIN)
    ("NQO-1" . SPARSER::PROTEIN) ("ARE2" . SPARSER::PROTEIN)
    ("ARE-2" . SPARSER::PROTEIN) ("DDAH-2" . SPARSER::PROTEIN)
    ("- 2" . SPARSER::PROTEIN) ("SOD2" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN)
    ("peroxisome proliferator activated receptor gamma" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("Keap-1" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("bardoxolone methyl" . SPARSER::DRUG)
    ("Keap 1" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG) ("PPAR- γ" . SPARSER::PROTEIN)
    ("DDAH-1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("PKCα and β-catenin" . SPARSER::COLLECTION)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("protein (HBX)" . SPARSER::PROTEIN)
    ("GSK3β and Wnt5a" . SPARSER::COLLECTION)
    ("siRNA or LiCl" . SPARSER::COLLECTION)
    ("p16 Ink4a , p21 Cip1 , and p27 Kip1" . SPARSER::COLLECTION)
    ("β-catenin and PKCα" . SPARSER::COLLECTION)
    ("kinase, MEK1/2, p38, and JNK" . SPARSER::COLLECTION)
    ("p38, and c-Jun" . SPARSER::COLLECTION) ("Regulator" . SPARSER::REGULATOR)
    ("wild-type β-catenin or the S33F" . SPARSER::COLLECTION)
    ("normal glucose" . SPARSER::PROTEIN)
    ("β-catenin and GSK3β" . SPARSER::COLLECTION)
    ("cell-permeable proteasome inhibitor" . SPARSER::INHIBITOR)
    ("β-catenin and LC3-II" . SPARSER::COLLECTION)
    ("β-catenin and LC3" . SPARSER::COLLECTION)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("β-catenin mRNA and/or protein" . SPARSER::COLLECTION)
    ("phospho-mTOR and phospho-p70S6K" . SPARSER::COLLECTION)
    ("phospho-Rb, CDK2, CDK4, and cyclin" . SPARSER::COLLECTION)
    ("Glc" . SPARSER::MOLECULE) ("Regulators" . SPARSER::REGULATOR)
    ("Wnt5a" . SPARSER::PROTEIN) ("TCF" . SPARSER::PROTEIN)
    ("Groucho" . SPARSER::PROTEIN)
    ("complex, casein kinase 1α and GSK3β" . SPARSER::COLLECTION)
    ("transducin" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("palmitic acid" . SPARSER::MOLECULE) ("p27 Kip1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 Ink4a" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("MLN4924" . SPARSER::DRUG) ("d -glucose" . SPARSER::MOLECULE)
    ("β-Catenin" . SPARSER::PROTEIN) ("S33" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("Go6976" . SPARSER::DRUG)
    ("Lithium chloride" . SPARSER::DRUG) ("Wnt5" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("a largely nonfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the BUM (beta-uniform mixture" . SPARSER::MOLECULE)
    ("GOF" . SPARSER::PROTEIN) ("p21 and apoptotioc" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("MDM2 and Noxa" . SPARSER::COLLECTION)
    ("classical wtp53 responsive target genes" . SPARSER::GENE)
    ("p21, MDM2, and Noxa" . SPARSER::COLLECTION)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 or p21" . SPARSER::COLLECTION) ("AA" . SPARSER::MOLECULE)
    ("p 53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("–2 µ" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("/Cyclin D3" . SPARSER::COLLECTION) ("mapping" . SPARSER::PROTEIN)
    ("receptor (PXR)" . SPARSER::RECEPTOR) ("PXR" . SPARSER::PROTEIN)
    ("GRs" . SPARSER::PROTEIN)
    ("the zinc-finger protein CTCF and the lineage-specific transcription factor Runx2"
     . SPARSER::COLLECTION)
    ("the lineage-specific transcription factor Runx2" . SPARSER::PROTEIN)
    ("FoxI1" . SPARSER::PROTEIN) ("forkhead" . SPARSER::PROTEIN)
    ("CTCF" . SPARSER::PROTEIN)
    ("RNA polymerases and sequence-specific DNA binding proteins and histone"
     . SPARSER::COLLECTION)
    ("sequence-specific DNA binding proteins and histone"
     . SPARSER::COLLECTION)
    ("proteins and histone" . SPARSER::COLLECTION)
    ("a highly condensed state and global transcription during mitosis"
     . SPARSER::COLLECTION)
    ("a highly condensed state" . SPARSER::BIO-STATE)
    ("mitotic chromatin" . SPARSER::PROTEIN) ("COS" . SPARSER::MOLECULE)
    ("exogenous GFP-tagged AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("media and androgen" . SPARSER::COLLECTION) ("FACs" . SPARSER::PROTEIN)
    ("cyclin/cdk2" . SPARSER::COLLECTION) ("Receptor (TR)" . SPARSER::RECEPTOR)
    ("Glucocorticoid Receptor (GR)" . SPARSER::PROTEIN)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Thyroid" . SPARSER::PROTEIN)
    ("CDK5 or CDK9" . SPARSER::COLLECTION) ("Mitotic C4-2" . SPARSER::PROTEIN)
    ("Mitotic LNCaP" . SPARSER::PROTEIN) ("Hormone" . SPARSER::MOLECULE)
    ("AR and DNA" . SPARSER::COLLECTION)
    ("beta2-adrenergic receptor and DNA" . SPARSER::COLLECTION)
    ("the characteristic DNA condensation" . SPARSER::PROTEIN-FAMILY)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("LNCaP and C4-2" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("PRO" . SPARSER::AMINO-ACID)
    ("mitotic cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SGK, SNAI2, and TMPRSS2" . SPARSER::COLLECTION)
    ("SGK1 and SNAI2" . SPARSER::COLLECTION) ("DHT" . SPARSER::PROTEIN)
    ("TMPRSS2, SGK1, and SNAI2" . SPARSER::COLLECTION)
    ("LNCaP" . SPARSER::PROTEIN)
    ("phospho-S308-specific and anti-total AR antibodies" . SPARSER::ANTIBODY)
    ("CycD/CDK4" . SPARSER::COLLECTION) ("CycE" . SPARSER::PROTEIN)
    ("CycD" . SPARSER::PROTEIN) ("hypo-phosphorylated RB" . SPARSER::PROTEIN)
    ("Enzalutamide" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("AR and phospho-S308" . SPARSER::COLLECTION)
    ("Androgen Receptor (AR)" . SPARSER::PROTEIN)
    ("Cyclin D3" . SPARSER::PROTEIN) ("p58" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK11" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE) ("cdk2" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("Glucocorticoid Receptor" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("beta2-adrenergic receptor" . SPARSER::PROTEIN)
    ("Histone-H3" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("beta type" . SPARSER::PROTEIN) ("PSMB6" . SPARSER::PROTEIN)
    ("UBE2C" . SPARSER::PROTEIN) ("C4-2" . SPARSER::PROTEIN)
    ("AF-1" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("CYP17" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("oncogenic viral and cellular proteins" . SPARSER::PROTEIN)
    ("the pro-apoptotic genes" . SPARSER::GENE)
    ("EBNA3C, AK-B and p53" . SPARSER::COLLECTION)
    ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the p53 S215A and S315A mutants" . SPARSER::COLLECTION)
    ("p21 and pTEN" . SPARSER::COLLECTION) ("pTEN" . SPARSER::PROTEIN)
    ("AK-B, EBNA3C and p53" . SPARSER::COLLECTION)
    ("Wild type AK-B and the K 207 R mutant" . SPARSER::COLLECTION)
    ("the wild type AK-B and its kinase-dead mutants" . SPARSER::COLLECTION)
    ("exogenously-expressed ETS-1 and EBNA3C" . SPARSER::COLLECTION)
    ("ETS-1 and EBNA3C" . SPARSER::COLLECTION)
    ("p53 and ETS-1" . SPARSER::COLLECTION)
    ("EBNA3C and p53" . SPARSER::COLLECTION)
    ("EBNA3C and other EBV lytic genes [ xref ]" . SPARSER::COLLECTION)
    ("EBNA3C, p53 and AK-B" . SPARSER::COLLECTION)
    ("p53 as well as E2F1, pRB, BubR1, and H2AX [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("E2F1, pRB, BubR1, and H2AX" . SPARSER::COLLECTION)
    ("pRB" . SPARSER::PROTEIN) ("centromeric proteins" . SPARSER::PROTEIN)
    ("AK-B and p53" . SPARSER::COLLECTION)
    ("Bcl2, APAF-1, and Bax1" . SPARSER::COLLECTION)
    ("Bcl2, p73, APAF-1 and BAX1" . SPARSER::COLLECTION)
    ("substrate, and 32 P" . SPARSER::COLLECTION)
    ("p53-GST" . SPARSER::COLLECTION)
    ("wild type AK-B and four mutants" . SPARSER::COLLECTION)
    ("A mutant or wild type p53" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("wild type p53 or the S315 mutant (Fig. xref )" . SPARSER::COLLECTION)
    ("p53, EBNA3C, and AK-B" . SPARSER::COLLECTION)
    ("EBNA3C and AK-B" . SPARSER::COLLECTION)
    ("AK-B and ETS-1" . SPARSER::COLLECTION)
    ("ETS-1 and AK-B" . SPARSER::COLLECTION)
    ("ETS-1, AK-B and p53" . SPARSER::COLLECTION)
    ("p53, or p53 and EBNA3C" . SPARSER::COLLECTION)
    ("p53 and EBNA3C" . SPARSER::COLLECTION) ("sh-p53" . SPARSER::COLLECTION)
    ("delta" . SPARSER::PROTEIN)
    ("an essential EBV latent protein" . SPARSER::PROTEIN)
    ("p53 and AK-B" . SPARSER::COLLECTION)
    ("HDAC1, CtBP, SMN, DP103, p300, prothymosin alpha, Sin3A, and NcoR"
     . SPARSER::COLLECTION)
    ("NcoR" . SPARSER::PROTEIN) ("SMN" . SPARSER::PROTEIN)
    ("CtBP" . SPARSER::PROTEIN) ("Gal4 and Sp1" . SPARSER::COLLECTION)
    ("Gal4" . SPARSER::PROTEIN) ("Gal" . SPARSER::PROTEIN)
    ("BIM, FLNA, CD21, JAG1, NCALD, TCL1A, ITGA4, p16, IRF4, AK-B, and H2AX"
     . SPARSER::COLLECTION)
    ("NCALD" . SPARSER::PROTEIN) ("FLNA" . SPARSER::PROTEIN)
    ("Necdin" . SPARSER::PROTEIN) ("RBPJ/CSL" . SPARSER::COLLECTION)
    ("RBPJ" . SPARSER::PROTEIN)
    ("EBNA2, EBNA3A, EBNA3C, EBNA-LP, and LMP1" . SPARSER::COLLECTION)
    ("three viral membrane proteins" . SPARSER::PROTEIN)
    ("p53 and its homolog p73" . SPARSER::COLLECTION)
    ("AK-B and EBNA3C" . SPARSER::COLLECTION) ("AK" . SPARSER::PROTEIN)
    ("Bcl 2" . SPARSER::PROTEIN) ("Apaf1" . SPARSER::PROTEIN)
    ("Sh-RNA" . SPARSER::RNA) ("BA1" . SPARSER::PROTEIN)
    ("LCL2" . SPARSER::PROTEIN) ("Aurora-B" . SPARSER::PROTEIN)
    ("pGL3B" . SPARSER::MOLECULE) ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl2" . SPARSER::PROTEIN) ("P53 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LCL1" . SPARSER::PROTEIN)
    ("Sin3A" . SPARSER::PROTEIN) ("prothymosin alpha" . SPARSER::PROTEIN)
    ("DP103" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("ITGA4" . SPARSER::PROTEIN) ("TCL1A" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("Nm23-H1" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("EBNA-LP" . SPARSER::PROTEIN) ("EBNA3A" . SPARSER::PROTEIN)
    ("EBNA2" . SPARSER::PROTEIN) ("EBNA-1" . SPARSER::PROTEIN)
    ("ETS-1" . SPARSER::PROTEIN) ("AK-B" . SPARSER::PROTEIN)
    ("EBNA3C" . SPARSER::PROTEIN)
    ("Oregovomab and Abagovomab that are met" . SPARSER::COLLECTION)
    ("brefeldin" . SPARSER::PROTEIN) ("brefeldin A (BFA)" . SPARSER::MOLECULE)
    ("Oregovomab" . SPARSER::DRUG) ("GO" . SPARSER::PROTEIN)
    ("Lmo2 and NANOG" . SPARSER::COLLECTION) ("mesothelin" . SPARSER::PROTEIN)
    ("a passive biomarker" . SPARSER::MOLECULE)
    ("transmembrane mucins" . SPARSER::PROTEIN)
    ("primary and metastatic PC" . SPARSER::PROTEIN) ("Luc" . SPARSER::PROTEIN)
    ("luciferase-eGFP" . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("MUC16-Cter-JAK2-LMO2/NANOG" . SPARSER::COLLECTION)
    ("intact Jak2" . SPARSER::PROTEIN) ("Lmo2 and Nanog" . SPARSER::COLLECTION)
    ("Lmo2" . SPARSER::PROTEIN) ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("commercial antibody" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("JAK2 and HA-tag" . SPARSER::COLLECTION) ("Ig" . SPARSER::MOLECULE)
    ("punctate" . SPARSER::PROTEIN) ("FLAG and HA-" . SPARSER::COLLECTION)
    ("NP" . SPARSER::PROTEIN)
    ("the functional cell-associated MUC16" . SPARSER::PROTEIN)
    ("the smallest fragment" . SPARSER::FRAGMENT)
    ("dual-tagged 114 amino acids of carboxyl-terminal MUC16"
     . SPARSER::PROTEIN)
    ("114 amino acids of carboxyl-terminal MUC16 in PC cells"
     . SPARSER::PROTEIN)
    ("metastatic PC" . SPARSER::PROTEIN)
    ("LMO2 [ xref ] and NANOG [ xref ]" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("Das" . SPARSER::DRUG)
    ("the largest known transmembrane mucin" . SPARSER::PROTEIN)
    ("successful mucin" . SPARSER::PROTEIN)
    ("these predominant mucins" . SPARSER::PROTEIN)
    ("the best characterized transmembrane mucin" . SPARSER::PROTEIN)
    ("MUC1-Cter" . SPARSER::COLLECTION)
    ("these transmembrane mucins" . SPARSER::PROTEIN)
    ("protein, Enterokinase and Agrin" . SPARSER::COLLECTION)
    ("Agrin" . SPARSER::PROTEIN) ("Enterokinase" . SPARSER::PROTEIN)
    ("SEA" . SPARSER::PROTEIN) ("a special class" . CLASS)
    ("mesenchymal type" . TYPE) ("CPCs" . SPARSER::PROTEIN)
    ("eGFP-Luciferase" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("using Jak2 +/+ and Jak2 −/− cells" . SPARSER::COLLECTION)
    ("LMO2 and NANOG" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("Cter" . SPARSER::PROTEIN) ("FLAG-" . SPARSER::PROTEIN-FAMILY)
    ("MUC16-Cter" . SPARSER::COLLECTION)
    ("a type-I transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("C-HA" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("phospho-Tyrosine" . SPARSER::MOLECULE) ("β-Actin" . SPARSER::PROTEIN)
    ("Protein-G" . SPARSER::PROTEIN) ("Protein-A" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE) ("HP1α" . SPARSER::PROTEIN)
    ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("TG101209" . SPARSER::DRUG)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MUC1" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("LMO2" . SPARSER::PROTEIN)
    ("CA125" . SPARSER::DRUG) ("MUC16" . SPARSER::PROTEIN)
    ("efficiently target RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("crizotinib and KRAS" . SPARSER::COLLECTION)
    ("either wild type KRAS or constitutively active KRAS or NRAS"
     . SPARSER::COLLECTION)
    ("the anti-EGFR monoclonal antibodies cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("KRAS or NRAS" . SPARSER::COLLECTION)
    ("ALK and ROS1" . SPARSER::COLLECTION)
    ("KRAS , BRAF and NRAS" . SPARSER::COLLECTION)
    ("MAPK or AKT" . SPARSER::COLLECTION)
    ("KRAS or NRAS, or wt" . SPARSER::COLLECTION)
    ("NRAS, or wt" . SPARSER::COLLECTION)
    ("KRAS, BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("U0126 and MK2206" . SPARSER::COLLECTION)
    ("crizotinib and foretinib" . SPARSER::COLLECTION)
    ("foretinib" . SPARSER::DRUG)
    ("the previously described mutational hot" . SPARSER::PROTEIN)
    ("NRAS , BRAF and PIK3CA" . SPARSER::COLLECTION) ("hot" . SPARSER::PROTEIN)
    ("KRAS , NRAS , BRAF , and PIK3CA" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("AKT, MAPK and S6 kinase" . SPARSER::COLLECTION)
    ("A representative example" . SPARSER::EXAMPLE)
    ("example" . SPARSER::EXAMPLE) ("RoS1" . SPARSER::PROTEIN)
    ("DFG" . SPARSER::PROTEIN) ("RoS" . SPARSER::PROTEIN)
    ("Crizotinib" . SPARSER::DRUG) ("ALK and LTK" . SPARSER::COLLECTION)
    ("LTK" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("ALK , RET and ROS1" . SPARSER::COLLECTION)
    ("KRAS/NRAS" . SPARSER::COLLECTION) ("SLC34A2-ROS1" . SPARSER::COLLECTION)
    ("G10" . SPARSER::PROTEIN) ("Ribosomal Protein" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("Mk2206" . SPARSER::DRUG)
    ("CEP4" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS family" . SPARSER::PROTEIN) ("SLC34A2" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("Lysine" . SPARSER::AMINO-ACID)
    ("PML" . SPARSER::PROTEIN) ("myc-H3.3S31A" . SPARSER::PROTEIN)
    ("myc" . SPARSER::PROTEIN) ("telomeric foci" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE) ("Nocodazole" . SPARSER::DRUG)
    ("an external DNA" . SPARSER::DNA)
    ("canonical H3 histone" . SPARSER::PROTEIN)
    ("Threonine" . SPARSER::AMINO-ACID) ("both pericentric DNA" . SPARSER::DNA)
    ("Colcemid" . SPARSER::DRUG) ("pericentric DNA" . SPARSER::DNA)
    ("RA" . SPARSER::PROTEIN) ("Serine" . SPARSER::AMINO-ACID)
    ("chaperones" . SPARSER::PROTEIN) ("ATM and CHK2" . SPARSER::COLLECTION)
    ("the pericentric heterochromatin" . SPARSER::PROTEIN)
    ("ATRX-DNMT3-DNMT3L" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("H3.3S31A" . SPARSER::PROTEIN)
    ("pericentric satellite DNA" . SPARSER::DNA)
    ("ATRX/DAXX" . SPARSER::COLLECTION) ("ATRX and DAXX" . SPARSER::COLLECTION)
    ("DAXX" . SPARSER::PROTEIN) ("ATRX" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myc- tagged" . SPARSER::PROTEIN) ("H3 histone" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("SB218078" . SPARSER::DRUG)
    ("UCN-01" . SPARSER::DRUG) ("NBP1" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("H3.2" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("DNMT3L" . SPARSER::PROTEIN)
    ("DNMT3" . SPARSER::PROTEIN)
    ("Death-associated protein" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN) ("Mental Retardation" . SPARSER::PROTEIN)
    ("FU" . SPARSER::PROTEIN) ("ABCB5 and c-MYC" . SPARSER::COLLECTION)
    ("Annexin V-" . SPARSER::PROTEIN)
    ("transporters, ABCC5 and ABCG2" . SPARSER::COLLECTION)
    ("DMSO or 10058-F4" . SPARSER::COLLECTION)
    ("c-MYC-MAX" . SPARSER::COLLECTION) ("MAX" . SPARSER::PROTEIN)
    ("a possible c-MYC target gene" . SPARSER::GENE)
    ("ABCB5 , ABCC4 , and ABCC5" . SPARSER::COLLECTION)
    ("ABCB5 , ABCC4 and ABCC5" . SPARSER::COLLECTION)
    ("MDR1 and MRP1" . SPARSER::COLLECTION)
    ("MDR1 , MRP1 , ABCB5 , ABCC4 and ABCC5" . SPARSER::COLLECTION)
    ("siRNA or c-MYC" . SPARSER::COLLECTION)
    ("c-MYC-ABCB5" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN)
    ("a new potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("5-FU and 10058-F4" . SPARSER::COLLECTION)
    ("5-FU or 10058-F4" . SPARSER::COLLECTION)
    ("exogenous c-MYC" . SPARSER::PROTEIN) ("SP6" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("ABCC4" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("F-2" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("MRP5" . SPARSER::PROTEIN) ("ABCC5" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("ABCB5" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN)
    ("autophagic flux inhibitors" . SPARSER::INHIBITOR)
    ("Bcl-2 and Beclin 1" . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN) ("LC-3-" . SPARSER::PROTEIN)
    ("strong inhibitors" . SPARSER::INHIBITOR)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("Fluos" . SPARSER::PROTEIN)
    ("Annexin-V-Fluos and PI" . SPARSER::COLLECTION)
    ("Annexin-V-Fluos" . SPARSER::COLLECTION)
    ("ATG3 and ATG4B" . SPARSER::COLLECTION)
    ("c-Myc and Sp1" . SPARSER::COLLECTION)
    ("the anti-apoptotic Bcl-2 and the pro-apoptotic BAX"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic BAX" . SPARSER::PROTEIN)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("Sp1 and c-Myc" . SPARSER::COLLECTION)
    ("CASP3 ( caspase-3 ) and NF-kB1" . SPARSER::COLLECTION)
    ("Sp1 , c-Myc , Beclin 1 , ATG3 , BCL2 ( Bcl-2 ), LC3 , ATG4B , BAX , CASP3 ( caspase-3 ) and NF-kB1"
     . SPARSER::COLLECTION)
    ("the mitotic Histone H3pS10 variant" . SPARSER::VARIANT)
    ("Histone" . SPARSER::PROTEIN) ("BafA" . SPARSER::PROTEIN)
    ("Trypan" . SPARSER::DRUG) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LC3 and Beclin 1" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN)
    ("monomeric anthracyclines" . SPARSER::MOLECULE)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("hypoxia or DNA" . SPARSER::COLLECTION)
    ("anthracycline" . SPARSER::MOLECULE) ("bis" . SPARSER::PROTEIN)
    ("PC-3" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("c- Myc" . SPARSER::PROTEIN) ("LC-3" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("CASP3" . SPARSER::PROTEIN)
    ("ATG4B" . SPARSER::PROTEIN) ("ATG3" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("bafilomycin A1" . SPARSER::DRUG) ("acridine orange" . SPARSER::MOLECULE)
    ("D-glucose" . SPARSER::MOLECULE) ("CRC and KRAS" . SPARSER::COLLECTION)
    ("primary CRC" . SPARSER::PROTEIN) ("metastatic CRC" . SPARSER::PROTEIN)
    ("CRC and thoracic LNI ( P =0.001 and 0.04, respectively)"
     . SPARSER::COLLECTION)
    ("an elevated preoperative CEA" . SPARSER::PROTEIN)
    ("LRR and the type" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("the Food and Drug Administration" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("oxaliplatin" . SPARSER::DRUG) ("the primary CRC" . SPARSER::PROTEIN)
    ("preoperative CEA" . SPARSER::PROTEIN) ("neo" . SPARSER::PROTEIN)
    ("pT1 and pT2" . SPARSER::COLLECTION)
    ("the mutant KRAS ( mKRAS ) and mutant BRAF ( mBRAF )"
     . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("paired primary and metastatic CRC" . SPARSER::PROTEIN)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CEA" . SPARSER::PROTEIN)
    ("carcinoembryonic" . SPARSER::PROTEIN) ("fluorouracil" . SPARSER::DRUG)
    ("OS 3" . SPARSER::PROTEIN) ("3–1" . SPARSER::PROTEIN)
    ("pT1" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("5-FU" . SPARSER::PROTEIN)
    ("herbimycin" . SPARSER::PROTEIN) ("geldanamycin" . SPARSER::DRUG)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("lymphoid" . SPARSER::PROTEIN) ("hyper" . SPARSER::PROTEIN)
    ("Foxo3a and Spred1" . SPARSER::COLLECTION)
    ("Ras-ERK" . SPARSER::COLLECTION)
    ("imatinib or Spred2" . SPARSER::COLLECTION)
    ("CD235a and GATA1" . SPARSER::COLLECTION)
    ("imatinib and Spred2" . SPARSER::COLLECTION)
    ("CD235a ( xref ) and GATA1 ( xref )" . SPARSER::COLLECTION)
    ("Ad5/F11p-Spred2" . SPARSER::COLLECTION)
    ("Spreds" . SPARSER::PROTEIN-FAMILY)
    ("membrane-associated negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("RAS-ERK" . SPARSER::COLLECTION) ("myeloid" . SPARSER::PROTEIN)
    ("imatinib and dasatinib" . SPARSER::COLLECTION)
    ("dasatinib" . SPARSER::DRUG)
    ("Chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("BCR/ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("BCR" . SPARSER::PROTEIN) ("Imatinib" . SPARSER::DRUG)
    ("Spred2" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("Spred" . SPARSER::PROTEIN-FAMILY) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("ara-C" . SPARSER::DRUG) ("Spred-2" . SPARSER::PROTEIN)
    ("Spred1" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("18h" . SPARSER::PROTEIN) ("transcription factor 1" . SPARSER::PROTEIN)
    ("spred1" . SPARSER::PROTEIN) ("GATA1" . SPARSER::PROTEIN)
    ("Phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("CD11b" . SPARSER::PROTEIN) ("CD235a" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony stimulating factor" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("IL-3" . SPARSER::PROTEIN)
    ("Flt-3L" . SPARSER::PROTEIN) ("BCR-ABL" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("FGR" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN) ("FGFR3 and EGFR" . SPARSER::COLLECTION)
    ("DTT and formaldehyde" . SPARSER::COLLECTION)
    ("the pathogenic
A391E dimer"
     . SPARSER::DIMER)
    ("the shorter linker" . SPARSER::LINKER)
    ("the dimeric form" . SPARSER::FORM)
    ("GpA and FGFR3" . SPARSER::COLLECTION) ("anchor" . SPARSER::ANCHOR)
    ("the shortest linker" . SPARSER::LINKER) ("GpA-" . SPARSER::PROTEIN)
    ("GpA" . SPARSER::PROTEIN) ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("the
fluorescent proteins"
     . SPARSER::PROTEIN)
    ("formaldehyde and DTT" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("fluorescent proteins" . SPARSER::PROTEIN) ("TM-" . SPARSER::PROTEIN)
    ("the dimeric
fraction"
     . SPARSER::COMPONENT)
    ("acceptors" . SPARSER::MOLECULE)
    ("the fluorescent proteins" . SPARSER::PROTEIN) ("lnK" . SPARSER::PROTEIN)
    ("dimeric fractions" . SPARSER::COMPONENT)
    ("dimeric
fractions"
     . SPARSER::COMPONENT)
    ("the
dimeric receptor fraction"
     . SPARSER::COMPONENT)
    ("acceptor" . SPARSER::MOLECULE) ("-mCherry" . SPARSER::COLLECTION)
    ("-YFP" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("this
15-residue flexible linker"
     . SPARSER::LINKER)
    ("a fluorescent protein" . SPARSER::PROTEIN)
    ("-YFP/mCherry" . SPARSER::COLLECTION) ("GGS" . SPARSER::PROTEIN)
    ("an unliganded dimeric state" . SPARSER::BIO-STATE)
    ("liganded" . SPARSER::MOLECULE)
    ("ligand, and ligand" . SPARSER::COLLECTION)
    ("the unliganded dimeric state" . SPARSER::BIO-STATE)
    ("dimer" . SPARSER::DIMER) ("TM" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphorylated ATR and downstream targets" . SPARSER::COLLECTION)
    ("CDC25A, CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("-negative forms" . SPARSER::FORM) ("CMF" . SPARSER::PROTEIN)
    ("the phosphorylated form or subcellular localisation"
     . SPARSER::COLLECTION)
    ("CHK1 and the nuclear transport protein KPNA2" . SPARSER::COLLECTION)
    ("functional DDR" . SPARSER::PROTEIN)
    ("an essential tumour suppressor gene" . SPARSER::GENE)
    ("PI3K and HER2" . SPARSER::COLLECTION)
    ("KPNA2 and cytoplasmic/nuclear" . SPARSER::COLLECTION)
    ("the cytoplasmic homologous recombination marker BARD1"
     . SPARSER::PROTEIN)
    ("ATM, RAD51 and BRCA1" . SPARSER::COLLECTION)
    ("p53, CK5, AKT and PI3K" . SPARSER::COLLECTION)
    ("ER and PgR" . SPARSER::COLLECTION)
    ("ER, PgR, AR, GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("PgR" . SPARSER::PROTEIN) ("p53 or Mdm2" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("CHK1/CHK2" . SPARSER::COLLECTION)
    ("ATR-CHK1" . SPARSER::PROTEIN-PAIR)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("Cdc25A, Cdc25B and p53" . SPARSER::COLLECTION)
    ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("p53 and E2F1" . SPARSER::COLLECTION)
    ("the distal transducers" . SPARSER::PROTEIN)
    ("proximal transducers" . SPARSER::PROTEIN)
    ("transducers" . SPARSER::PROTEIN) ("DDR" . SPARSER::PROTEIN)
    ("cyclophosphamide" . SPARSER::DRUG)
    ("UBC9 and PIAS γ" . SPARSER::COLLECTION)
    ("KU70/KU80" . SPARSER::COLLECTION)
    ("KI67, p53, AKT and PI3K" . SPARSER::COLLECTION)
    ("KI67 and PI3K" . SPARSER::COLLECTION) ("CDC25C" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("CdK1" . SPARSER::PROTEIN) ("CK18" . SPARSER::PROTEIN)
    ("CK17" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("CHK 1" . SPARSER::PROTEIN)
    ("Cdc5" . SPARSER::PROTEIN) ("Tousled like kinase1" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("Cdc25B" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("Checkpoint Kinase 1" . SPARSER::PROTEIN)
    ("KPNA2" . SPARSER::PROTEIN) ("PIAS γ" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("KU80" . SPARSER::PROTEIN) ("KU70" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("Checkpoint kinase1" . SPARSER::PROTEIN)
    ("attractive drugs" . SPARSER::DRUG)
    ("mucins and its associated signaling molecules" . SPARSER::COLLECTION)
    ("its associated signaling molecules" . SPARSER::MOLECULE)
    ("EGFR or HER2" . SPARSER::COLLECTION)
    ("bur reversible TKI" . SPARSER::PROTEIN)
    ("Irreversible TKI" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("c-Jun NH2-terminal kinase (JNK) and p38" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("MAPKs" . SPARSER::PROTEIN)
    ("AKT and FAK" . SPARSER::COLLECTION)
    ("FAK, AKT and ERK" . SPARSER::COLLECTION) ("CyclinA" . SPARSER::PROTEIN)
    ("EGFR and MUC4" . SPARSER::COLLECTION) ("p-STAT1" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3 receptors and their cognate ligands"
     . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("EGFR, HER2 and MUC4" . SPARSER::COLLECTION)
    ("their respective total proteins" . SPARSER::PROTEIN)
    ("MUC4, pEGFR, pHER2 and phospho-STAT1" . SPARSER::COLLECTION)
    ("FAK and AKT" . SPARSER::COLLECTION)
    ("HER2, MUC4 and pFAK" . SPARSER::COLLECTION) ("FAK" . SPARSER::PROTEIN)
    ("Cyclin D1 and Cyclin A" . SPARSER::COLLECTION)
    ("STAT1 and MUC4" . SPARSER::COLLECTION)
    ("small molecule irreversible and reversible TKIs" . SPARSER::PROTEIN)
    ("reversible TKI" . SPARSER::PROTEIN)
    ("irreversible TKI" . SPARSER::PROTEIN)
    ("EGFR and phospho-STAT1" . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID) ("MUC4 and HER2" . SPARSER::COLLECTION)
    ("HER3 and HER4" . SPARSER::COLLECTION)
    ("afatinib and erlotinib" . SPARSER::COLLECTION)
    ("canertinib, afatinib and erlotinib" . SPARSER::COLLECTION)
    ("Canertinib and afatinib" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("an irreversible TKI" . SPARSER::PROTEIN) ("Canertinib" . SPARSER::DRUG)
    ("TKIs, reversible TKIs that binds to the active sites of EGFR kinase domain and irreversible TKIs that binds to cysteine residues"
     . SPARSER::COLLECTION)
    ("irreversible TKIs" . SPARSER::PROTEIN)
    ("reversible TKIs" . SPARSER::PROTEIN) ("Herceptin" . SPARSER::DRUG)
    ("a transmembrane mucin" . SPARSER::PROTEIN)
    ("HER1/EGFR" . SPARSER::COLLECTION) ("mucin" . SPARSER::PROTEIN)
    ("mucins" . SPARSER::PROTEIN) ("-paclitaxel" . SPARSER::DRUG)
    ("paclitaxel" . SPARSER::DRUG) ("albumin" . SPARSER::PROTEIN)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("anti-VEGF and farnesyl transferrase inhibitors" . SPARSER::COLLECTION)
    ("various anti-epidermal growth factor receptor (EGFR) monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("anti-epidermal growth factor receptor (EGFR)" . SPARSER::ANTIBODY)
    ("MUC4 and EGFR" . SPARSER::COLLECTION)
    ("canertinib and afatinib" . SPARSER::COLLECTION)
    ("canertinib or afatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("canertinib" . SPARSER::DRUG)
    ("MUC4, EGFR and HER2" . SPARSER::COLLECTION) ("Texas red" . SPARSER::DRUG)
    ("NH2" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Muc4" . SPARSER::PROTEIN) ("e 7" . SPARSER::PROTEIN-FAMILY)
    ("HER4" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("BIBW2992" . SPARSER::DRUG) ("CI 1033" . SPARSER::DRUG)
    ("HER1" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("MUC4" . SPARSER::PROTEIN) ("p62-KO" . SPARSER::COLLECTION)
    ("only one Htt gene" . SPARSER::GENE)
    ("ULK1 and ULK2" . SPARSER::COLLECTION)
    ("Htt, ULK1 and p62" . SPARSER::COLLECTION)
    ("the Htt’s" . SPARSER::PROTEIN) ("Htt and mTOR" . SPARSER::COLLECTION)
    ("UKL1/mTOR" . SPARSER::COLLECTION) ("p62, and Htt" . SPARSER::COLLECTION)
    ("p62 and Ub-K63-modified" . SPARSER::COLLECTION)
    ("at least three types" . TYPE) ("ULK1 and p62" . SPARSER::COLLECTION)
    ("this cargo receptor and its Ub-K63-modified substrates"
     . SPARSER::COLLECTION)
    ("its Ub-K63-modified substrates" . SPARSER::SUBSTRATE)
    ("mTORC1/ULK1" . SPARSER::COLLECTION) ("Myc-mTOR" . SPARSER::COLLECTION)
    ("FLAG-ULK1-KD" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("ULK1 and Htt" . SPARSER::COLLECTION)
    ("Htt, ULK1 and mTOR" . SPARSER::COLLECTION)
    ("ULK1/mTOR" . SPARSER::COLLECTION) ("ULK1/Htt" . SPARSER::COLLECTION)
    ("ULK1-KO" . SPARSER::COLLECTION) ("mTOR or Raptor" . SPARSER::COLLECTION)
    ("mTOR and Raptor" . SPARSER::COLLECTION)
    ("Htt, mTOR, and Raptor" . SPARSER::COLLECTION)
    ("mTOR/Raptor/ULK1" . SPARSER::COLLECTION)
    ("Htt/ULK1" . SPARSER::COLLECTION)
    ("a stable quaternary complex" . SPARSER::BIO-COMPLEX)
    ("FIP200, Atg13 and Atg101" . SPARSER::COLLECTION)
    ("Atg101" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("Atg13" . SPARSER::PROTEIN) ("AMPK and ULK1" . SPARSER::COLLECTION)
    ("MBP" . SPARSER::PROTEIN) ("mTOR/ULK1" . SPARSER::COLLECTION)
    ("Huntingtin/ULK1" . SPARSER::COLLECTION)
    ("p62 and LC3" . SPARSER::COLLECTION)
    ("Ub-K63-modified proteins" . SPARSER::PROTEIN)
    ("Ub-K63" . SPARSER::COLLECTION) ("Myc-p62" . SPARSER::COLLECTION)
    ("HA-p62" . SPARSER::COLLECTION) ("LIR" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN) ("PB1" . SPARSER::PROTEIN)
    ("cellular p62" . SPARSER::PROTEIN) ("insoluble p62" . SPARSER::PROTEIN)
    ("soluble p62" . SPARSER::PROTEIN) ("detergent" . SPARSER::MOLECULE)
    ("a tertiary complex" . SPARSER::BIO-COMPLEX)
    ("Htt and p62" . SPARSER::COLLECTION) ("Atg1" . SPARSER::PROTEIN)
    ("Htt and the autophagy components" . SPARSER::COLLECTION)
    ("p62 and ULK1" . SPARSER::COLLECTION)
    ("mCherry-GFP-LC3" . SPARSER::COLLECTION) ("Htt-KO" . SPARSER::COLLECTION)
    ("GFP-Htt" . SPARSER::COLLECTION) ("at least three different types" . TYPE)
    ("oleic acid or FCCP" . SPARSER::COLLECTION)
    ("lipids or mitochondria" . SPARSER::COLLECTION)
    ("LC3 and MitoTracker" . SPARSER::COLLECTION)
    ("CMXRos" . SPARSER::MOLECULE) ("Bodipy" . SPARSER::DRUG)
    ("Lipid" . SPARSER::LIPID) ("Atg7" . SPARSER::PROTEIN)
    ("GST-BHMT" . SPARSER::COLLECTION) ("BHMT" . SPARSER::PROTEIN)
    ("depolarizing agent FCCP" . SPARSER::MOLECULE)
    ("FCCP" . SPARSER::MOLECULE) ("a larger fraction" . SPARSER::COMPONENT)
    ("EM" . SPARSER::PROTEIN) ("proteins and p62" . SPARSER::COLLECTION)
    ("endo-lysosomal" . SPARSER::COLLECTION) ("transferrin" . SPARSER::PROTEIN)
    ("endo" . SPARSER::PROTEIN) ("peptidase" . SPARSER::PROTEIN)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("toxic proteins" . SPARSER::PROTEIN)
    ("mCherry-Atg8" . SPARSER::COLLECTION) ("Fat" . SPARSER::PROTEIN)
    ("atg8a and indhtt" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("mCherry" . SPARSER::PROTEIN) ("atg7 and atg13" . SPARSER::COLLECTION)
    ("atg13" . SPARSER::PROTEIN) ("atg7" . SPARSER::PROTEIN)
    ("atg1" . SPARSER::PROTEIN) ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("atg" . SPARSER::DRUG) ("ko" . SPARSER::PROTEIN)
    ("htt" . SPARSER::PROTEIN) ("huntingtin" . SPARSER::PROTEIN)
    ("the mTOR-ULK1 complex and subsequent initiation of selective autophagy"
     . SPARSER::COLLECTION)
    ("mTOR-ULK1" . SPARSER::COLLECTION) ("-K63" . SPARSER::COLLECTION)
    ("Ub" . SPARSER::PROTEIN) ("Htt" . SPARSER::PROTEIN)
    ("scaffolds" . SPARSER::SCAFFOLD) ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("which releases ULK1" . SPARSER::PROTEIN)
    ("lysine-63-linked ubiquitin-modified substrates" . SPARSER::SUBSTRATE)
    ("Huntingtin" . SPARSER::PROTEIN) ("NBR1" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("UKL1" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("GST-4" . SPARSER::PROTEIN)
    ("FIP200" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("bafilomycin-A1" . SPARSER::DRUG) ("oleic acid" . SPARSER::MOLECULE)
    ("LC3-II" . SPARSER::PROTEIN) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("atg8a" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("Atg11" . SPARSER::PROTEIN-FAMILY)
    ("SQSTM1" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN) ("p62" . SPARSER::PROTEIN)
    ("Alexa Fluor 488 goat anti-mouse and Alexa Fluor 594 goat anti-rabbit secondary antibodies"
     . SPARSER::ANTIBODY)
    ("goat" . SPARSER::PROTEIN) ("Fluor" . SPARSER::MOLECULE)
    ("anti-mouse secondary antibody" . SPARSER::PROTEIN)
    ("PMSF" . SPARSER::MOLECULE) ("cFN-EDA" . SPARSER::PROTEIN-PAIR)
    ("glyceraldehyde" . SPARSER::PROTEIN)
    ("exogenous FN-EDA" . SPARSER::COLLECTION) ("bleomycin" . SPARSER::DRUG)
    ("up1" . SPARSER::PROTEIN) ("collagen" . SPARSER::PROTEIN)
    ("postnatal malformations" . SPARSER::PROTEIN)
    ("FN-EDA" . SPARSER::COLLECTION) ("The latter form" . SPARSER::FORM)
    ("cellular fibronectin" . SPARSER::PROTEIN) ("EDA" . SPARSER::PROTEIN)
    ("glycosaminoglycans and fibrin" . SPARSER::COLLECTION)
    ("αvβ3, and Toll1like" . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE) ("FN" . SPARSER::PROTEIN)
    ("extracellular connective tissue matrices (ECM)"
     . SPARSER::PROTEIN-FAMILY)
    ("matrices (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("Fibronectins" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("FN1" . SPARSER::PROTEIN)
    ("wt/wt" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1like" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("rapamycin and its analogs" . SPARSER::COLLECTION)
    ("the clinically available antidiabetic drug metformin" . SPARSER::DRUG)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("RAD001 or AP23573" . SPARSER::COLLECTION) ("mIAS" . SPARSER::PROTEIN)
    ("myelin" . SPARSER::PROTEIN) ("SCs" . SPARSER::PROTEIN)
    ("CCI-779 or metformin" . SPARSER::COLLECTION)
    ("metformin" . SPARSER::DRUG)
    ("the dual mTOR inhibitor Torin 1" . SPARSER::DRUG)
    ("the lateral part" . SPARSER::COMPONENT)
    ("mTOR and other components" . SPARSER::COLLECTION)
    ("ramps" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adjuvant (CFA)" . SPARSER::DRUG)
    ("other nociceptive and algogenic substances" . SPARSER::SUBSTANCE)
    ("CFA" . SPARSER::PROTEIN) ("spinal mTOR" . SPARSER::PROTEIN)
    ("rapamycin and its analogous CCI-779 (thus mTOR inhibition)"
     . SPARSER::COLLECTION)
    ("its analogous CCI-779" . SPARSER::DRUG) ("sham" . SPARSER::DRUG)
    ("anisomycin" . SPARSER::DRUG) ("morphine" . SPARSER::MOLECULE)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION) ("CCI" . SPARSER::PROTEIN)
    ("CGRP and S6K1" . SPARSER::COLLECTION) ("SNL" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("carrageenan" . SPARSER::MOLECULE)
    ("capsaicin" . SPARSER::DRUG)
    ("ribosomal protein, and phospho-4E-BP1" . SPARSER::COLLECTION)
    ("TSA-" . SPARSER::PROTEIN) ("TSA" . SPARSER::PROTEIN)
    ("mTOR and mTORC1" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("mTOR and its downstream targets" . SPARSER::COLLECTION)
    ("mTOR and S6K1" . SPARSER::COLLECTION)
    ("active mTORC1 and its downstream phosphorylated targets (4E-BP1 and the S6 ribosomal protein)"
     . SPARSER::COLLECTION)
    ("CGRP" . SPARSER::PROTEIN) ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("dual PI3K/mTORC inhibitors" . SPARSER::INHIBITOR)
    ("Dual mTORC1/mTORC2 inhibitors" . SPARSER::INHIBITOR)
    ("PI3K/mTORC" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION) ("mTORC" . SPARSER::PROTEIN)
    ("Dual mTOR/PI3K inhibitors" . SPARSER::INHIBITOR)
    ("SF1126, and PKI-587" . SPARSER::COLLECTION)
    ("mTOR and PI3K" . SPARSER::COLLECTION)
    ("mTORC1 or PI3K" . SPARSER::COLLECTION)
    ("mTOR/PI3K dual inhibitors" . SPARSER::INHIBITOR)
    ("mTOR/PI3K" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("mTORC1 and AKT" . SPARSER::COLLECTION)
    ("immunosuppressant" . SPARSER::DRUG) ("prodrug" . SPARSER::DRUG)
    ("ridaforolimus or deforolimus" . SPARSER::COLLECTION)
    ("ridaforolimus" . SPARSER::DRUG) ("mTOR and FKBP12" . SPARSER::COLLECTION)
    ("analogs" . SPARSER::ANALOG)
    ("mTOR and the immunophilin" . SPARSER::COLLECTION)
    ("a trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("immunophilin" . SPARSER::PROTEIN) ("sirolimus" . SPARSER::DRUG)
    ("Rapamycin" . SPARSER::DRUG) ("Rapa" . SPARSER::DRUG)
    ("paxillin and Rho" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("AKT (i.e., mTORC1) and an important upstream regulator"
     . SPARSER::COLLECTION)
    ("PKC-" . SPARSER::PROTEIN) ("pentose" . SPARSER::MOLECULE)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("the ribosomal S6 protein" . SPARSER::PROTEIN)
    ("4E-BP1 and the ACG-family protein" . SPARSER::COLLECTION)
    ("mTORC1, 4E-BP1 and the ACG-family protein" . SPARSER::COLLECTION)
    ("ACG" . SPARSER::PROTEIN) ("arginine and leucine" . SPARSER::COLLECTION)
    ("Rag" . SPARSER::PROTEIN) ("leucine" . SPARSER::AMINO-ACID)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IKK-" . SPARSER::PROTEIN) ("kinase-" . SPARSER::KINASE)
    ("IKK" . SPARSER::PROTEIN) ("PKB/AKT" . SPARSER::COLLECTION)
    ("PI3K and Ras" . SPARSER::COLLECTION)
    ("GTPase-activating protein (GAP)" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tuberous sclerosis 1 (TSC1, also known as hamartin) and TSC2 (also known as tuberin)"
     . SPARSER::COLLECTION)
    ("tuberin" . SPARSER::PROTEIN) ("hamartin" . SPARSER::PROTEIN)
    ("PROTOR" . SPARSER::PROTEIN-FAMILY)
    ("the eukaryotic initiation factor-4E-binding protein 1"
     . SPARSER::PROTEIN)
    ("Raptor" . SPARSER::PROTEIN)
    ("the regulatory-associated protein of mTOR (raptor) and the inhibitory protein PRAS40 (proline-rich AKT substrate of 40 KDa)"
     . SPARSER::COLLECTION)
    ("KDa" . SPARSER::PROTEIN)
    ("the inhibitory protein DEPTOR and the adaptor protein mLST8/G β L (mammalian LST8/G-protein β -subunit like protein)"
     . SPARSER::COLLECTION)
    ("-subunit" . SPARSER::FRAGMENT) ("LST8/G-protein" . SPARSER::COLLECTION)
    ("mLST8/G β L" . SPARSER::COLLECTION) ("DEPTOR" . SPARSER::PROTEIN)
    ("TOR" . SPARSER::PROTEIN) ("local anesthetics" . SPARSER::DRUG)
    ("analgesics" . SPARSER::DRUG) ("opioid" . SPARSER::PROTEIN)
    ("anesthetics" . SPARSER::DRUG) ("antidepressants" . SPARSER::DRUG)
    ("pronociceptive mediators" . SPARSER::PROTEIN)
    ("glial" . SPARSER::PROTEIN)
    ("substance P and calcitonin gene-related peptide" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("receptors, enzymes, and voltage-dependent" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN)
    ("the mammalian target of rapamycin (mTOR) kinase and downstream effectors"
     . SPARSER::COLLECTION)
    ("RAD001" . SPARSER::DRUG) ("Torin 1" . SPARSER::DRUG)
    ("TRPV1" . SPARSER::PROTEIN) ("1–L" . SPARSER::PROTEIN)
    ("A-beta" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("PKI-587" . SPARSER::DRUG) ("SF1126" . SPARSER::DRUG)
    ("NVP-BEZ235" . SPARSER::DRUG) ("AP23573" . SPARSER::DRUG)
    ("PPIase FKBP1A" . SPARSER::PROTEIN)
    ("FK506-binding protein" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("PKC α" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("insulin receptor" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("I κ B" . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("tuberous sclerosis 1" . SPARSER::PROTEIN) ("mSIN1" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("4E-binding protein 1" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("LST8" . SPARSER::PROTEIN) ("G β L" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("calcitonin gene-related peptide" . SPARSER::PROTEIN)
    ("substance P" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("voltage-dependent" . SPARSER::PROTEIN)
    ("monomeric state" . SPARSER::BIO-STATE)
    ("a noncanonical anti-apoptotic BH4" . SPARSER::PROTEIN-FAMILY)
    ("Alanine" . SPARSER::AMINO-ACID) ("BH4-BAX" . SPARSER::COLLECTION)
    ("/BAX" . SPARSER::COLLECTION)
    ("the α-helical BH4 peptide" . SPARSER::PEPTIDE)
    ("spin" . SPARSER::PROTEIN) ("nitroxide" . SPARSER::MOLECULE)
    ("monomeric forms" . SPARSER::FORM)
    ("the BH4 and BH3 helices" . SPARSER::COLLECTION)
    ("crosslinker" . SPARSER::PROTEIN) ("benzophenone" . SPARSER::DRUG)
    ("BAX, and liposomes" . SPARSER::COLLECTION)
    ("monomeric BAX" . SPARSER::PROTEIN)
    ("individual BAX peptic fragments" . SPARSER::FRAGMENT)
    ("BCL-2 and BAX" . SPARSER::COLLECTION) ("staurosporine" . SPARSER::DRUG)
    ("BCL-2 and BCL-2" . SPARSER::COLLECTION)
    ("peptide sequence-specific inhibitors" . SPARSER::INHIBITOR)
    ("liposomes" . SPARSER::PROTEIN) ("DPX" . SPARSER::PROTEIN)
    ("aa" . SPARSER::MOLECULE) ("BAX and BCL-2" . SPARSER::COLLECTION)
    ("BID, BIM, and PUMA" . SPARSER::COLLECTION) ("BID" . SPARSER::PROTEIN)
    ("α-helical peptides" . SPARSER::PEPTIDE)
    ("BCL-2/BCL-X" . SPARSER::COLLECTION)
    ("α-Helical BCL-2 BH4 Domain Peptides" . SPARSER::PEPTIDE)
    ("pro-apoptotic BAX" . SPARSER::PROTEIN)
    ("the full-length BAX/BCL-2 heterodimeric complexes"
     . SPARSER::BIO-COMPLEX)
    ("BAX/BCL-2" . SPARSER::COLLECTION)
    ("short α-helical peptides" . SPARSER::PEPTIDE)
    ("their native and bioactive α-helical state" . SPARSER::BIO-STATE)
    ("homo-oligomers" . SPARSER::PROTEIN) ("oligomers" . SPARSER::MOLECULE)
    ("BAK" . SPARSER::PROTEIN) ("homologous proteins" . SPARSER::PROTEIN)
    ("hairpins" . SPARSER::PROTEIN-FAMILY) ("deuterium" . SPARSER::MOLECULE)
    ("aa 1" . SPARSER::PROTEIN) ("ABT-199" . SPARSER::DRUG)
    ("P130" . SPARSER::PROTEIN) ("P43" . SPARSER::PROTEIN)
    ("H- 15" . SPARSER::PROTEIN) ("Y28" . SPARSER::PROTEIN)
    ("I19" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("BCL-X" . SPARSER::PROTEIN) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("PI3K, p27 and STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3/p27" . SPARSER::COLLECTION)
    ("a tripartite p27/JAK2/STAT3 complex" . SPARSER::BIO-COMPLEX)
    ("STAT3 and STAT3" . SPARSER::COLLECTION)
    ("p27/JAK2/STAT3" . SPARSER::COLLECTION)
    ("a repressive complex" . SPARSER::BIO-COMPLEX)
    ("p130 and E2F4" . SPARSER::COLLECTION)
    ("TWIST1-luciferase" . SPARSER::COLLECTION)
    ("total and phosphorylated STAT3" . SPARSER::PROTEIN)
    ("Twist1, Snail and Slug" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("TWIST1 and EMT" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("PI3K, p70pT389, p90pT359, S6pS235 and S6pS240" . SPARSER::COLLECTION)
    ("TCPA" . SPARSER::PROTEIN-FAMILY) ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-cadherin and Twist1" . SPARSER::COLLECTION)
    ("a trimeric JAK2/p27CK-DD/STAT3 complex" . SPARSER::BIO-COMPLEX)
    ("associated STAT3" . SPARSER::PROTEIN)
    ("STAT3 and p27" . SPARSER::COLLECTION)
    ("total and activated STAT3" . SPARSER::PROTEIN)
    ("Janus kinase 2-STAT3" . SPARSER::COLLECTION)
    ("the TWIST1 promoter and TWIST1 activation" . SPARSER::COLLECTION)
    ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("protein and STAT3" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin and Twist1" . SPARSER::COLLECTION)
    ("vimentin and Twist1" . SPARSER::COLLECTION)
    ("cellular p27" . SPARSER::PROTEIN)
    ("AKT, SGK and PDK1" . SPARSER::COLLECTION) ("SGK" . SPARSER::PROTEIN)
    ("Slug" . SPARSER::PROTEIN) ("hTert" . SPARSER::PROTEIN)
    ("EMT, and p27" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("p27 and p27CK-DD" . SPARSER::COLLECTION) ("CK−" . SPARSER::PROTEIN)
    ("each single phosphomimetic p27 mutant" . SPARSER::MUTANT)
    ("matrigel" . SPARSER::PROTEIN) ("cyclins or CDKs" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::PROTEIN) ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("cyclin and CDK" . SPARSER::COLLECTION) ("RhoGEF" . SPARSER::PROTEIN)
    ("p53 or p16" . SPARSER::COLLECTION)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("TWIST1 , SNAI1 and ZEB1" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("pPDK1" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("LuL2" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("homeobox 1" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("ERK and p38" . SPARSER::COLLECTION)
    ("HIF-1α and AMPK" . SPARSER::COLLECTION)
    ("MAPK and Smad" . SPARSER::COLLECTION)
    ("TGF-β1 and H 2 O 2" . SPARSER::COLLECTION)
    ("NF-κB, Smad, and p38" . SPARSER::COLLECTION)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("HIF-1α and AMP-activated" . SPARSER::COLLECTION)
    ("pyruvate" . SPARSER::PROTEIN) ("AMPK" . SPARSER::PROTEIN)
    ("Smad3 inhibitor and p38 MAPK inhibitor" . SPARSER::COLLECTION)
    ("MAPK, and ERK" . SPARSER::COLLECTION) ("lactate" . SPARSER::LACTATE)
    ("TGF-β1 or TGF-β1/H 2 O 2" . SPARSER::COLLECTION)
    ("p21 and p16" . SPARSER::COLLECTION)
    ("Smad and p38" . SPARSER::COLLECTION)
    ("p16 and p21" . SPARSER::COLLECTION)
    ("ERK and Smad" . SPARSER::COLLECTION)
    ("Transforming growth factor-β1" . SPARSER::COLLECTION)
    ("-β1" . SPARSER::COLLECTION) ("HOCl" . SPARSER::MOLECULE)
    ("c-Fos" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("β-Gal" . SPARSER::PROTEIN) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("SIS3" . SPARSER::MOLECULE) ("SP600125" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("p16" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("Sirtuin 6" . SPARSER::PROTEIN) ("our group’s" . SPARSER::MOLECULE)
    ("Ceritinib and alectinib" . SPARSER::COLLECTION)
    ("Ceritinib" . SPARSER::DRUG)
    ("ceritinib and alectinib" . SPARSER::COLLECTION)
    ("alectinib" . SPARSER::DRUG) ("ceritinib" . SPARSER::DRUG)
    ("upfront EGFR TKI" . SPARSER::PROTEIN)
    ("Most available TKIs" . SPARSER::PROTEIN)
    ("gefitinib, erlotinib, and crizotinib" . SPARSER::COLLECTION)
    ("TKIs" . SPARSER::PROTEIN) ("EGFR/KRAS/ALK" . SPARSER::COLLECTION)
    ("ALK-" . SPARSER::PROTEIN) ("crizotinib" . SPARSER::DRUG)
    ("-gefitinib, erlotinib, or dacomitinib" . SPARSER::COLLECTION)
    ("-gefitinib" . SPARSER::DRUG) ("dacomitinib" . SPARSER::DRUG)
    ("TKI" . SPARSER::PROTEIN) ("tobacco" . SPARSER::DRUG)
    ("EGFR and ALK" . SPARSER::COLLECTION)
    ("The complete cohort" . SPARSER::MOLECULE)
    ("EGFR/ALK" . SPARSER::COLLECTION) ("CRR" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("only human VEGF-A" . SPARSER::PROTEIN)
    ("ARHGEF16 and CXCL16" . SPARSER::COLLECTION)
    ("THY-1, TIMP-4 and SERPIN" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION)
    ("-methylguanine-DNA methyltransferase" . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alkylator" . SPARSER::MOLECULE)
    ("proteins, AKT and NDRG1" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION) ("PTEN-" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE) ("RTCA" . SPARSER::PROTEIN)
    ("FITC-dextran that had been perfused" . SPARSER::MOLECULE)
    ("FITC-dextran" . SPARSER::MOLECULE) ("CD1" . SPARSER::PROTEIN)
    ("tissue inhibitor of metalloproteinase (TIMP)-4 and SERPIN F1"
     . SPARSER::COLLECTION)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("chemokine (C-X-C motif) ligand (CXCL)16 and Rho guanine nucleotide exchange factor (ARHGEF)16 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Rho guanine nucleotide exchange factor (ARHGEF)" . SPARSER::PROTEIN)
    ("ligand (CXCL)" . SPARSER::MOLECULE) ("chemotaxis" . SPARSER::PROTEIN)
    ("gene (NDRG)" . SPARSER::GENE) ("NDRG" . SPARSER::PROTEIN-FAMILY)
    ("p-p65" . SPARSER::COLLECTION) ("RELA" . SPARSER::PROTEIN)
    ("whose target genes" . SPARSER::GENE)
    ("the only transcription factor complex" . SPARSER::BIO-COMPLEX)
    ("TMZ" . SPARSER::DRUG) ("Cediranib" . SPARSER::DRUG)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("exogenous VEGF" . SPARSER::PROTEIN)
    ("VEGFR-2, p90RSK and AKT" . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("VEGFR-2 and PTEN" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("MET/VEGFR-2" . SPARSER::COLLECTION)
    ("VEGF/VEGFR-2" . SPARSER::COLLECTION) ("MET" . SPARSER::PROTEIN)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("AKT/PKB" . SPARSER::COLLECTION)
    ("the monoclonal anti-VEGF-directed antibody bevacizumab (BEV)"
     . SPARSER::DRUG)
    ("bevacizumab (BEV)" . SPARSER::DRUG) ("/VEGF" . SPARSER::COLLECTION)
    ("temozolomide or bevacizumab" . SPARSER::COLLECTION)
    ("temozolomide" . SPARSER::DRUG) ("bevacizumab" . SPARSER::DRUG)
    ("Bevacizumab" . SPARSER::DRUG) ("raptor" . SPARSER::PROTEIN)
    ("VEGFR" . SPARSER::PROTEIN) ("TIMP-4" . SPARSER::PROTEIN)
    ("CXCL16" . SPARSER::PROTEIN) ("ARHGEF16" . SPARSER::PROTEIN)
    ("methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("HGF receptor" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("THY-1" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("N-myc" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("v-myc myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("AZD2171" . SPARSER::DRUG) ("CCI-779" . SPARSER::DRUG)
    ("p90" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG)
    ("N-myc downstream regulated gene 1" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN)
    ("renal medullary PRR and PGs" . SPARSER::COLLECTION)
    ("PRR and PGs" . SPARSER::COLLECTION)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("EP 1 , EP 2 , EP 3 and EP 4" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE) ("EP 1" . SPARSER::PROTEIN)
    ("exogenous PGE 2" . SPARSER::DRUG)
    ("PGE 2 , PGF 2α , PGD 2 , PGI 2 , and thromboxane A 2"
     . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE)
    ("chronic salt loading [ xref ] and intramedullary delivery"
     . SPARSER::COLLECTION)
    ("chronic salt" . SPARSER::MOLECULE)
    ("renal medullary COX-2" . SPARSER::PROTEIN) ("EP" . SPARSER::PROTEIN)
    ("metabolites" . SPARSER::PROTEIN) ("COX-2/EP 4" . SPARSER::COLLECTION)
    ("vasa" . SPARSER::PROTEIN) ("PRR or COX-2" . SPARSER::COLLECTION)
    ("renal COX-2" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("-Ang II" . SPARSER::COLLECTION)
    ("juxtaglomerular renin" . SPARSER::PROTEIN)
    ("systemic RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paracrine tubular RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiotensinogen" . SPARSER::PROTEIN) ("PGs" . SPARSER::MOLECULE)
    ("renal medullary PRR" . SPARSER::PROTEIN)
    ("local RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRR and COX-2" . SPARSER::COLLECTION)
    ("intrarenal RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("renin" . SPARSER::PROTEIN) ("PRR" . SPARSER::PROTEIN)
    ("antihypertensive" . SPARSER::DRUG) ("EP 1 receptor" . SPARSER::PROTEIN)
    ("EP 3" . SPARSER::PROTEIN) ("EP 2" . SPARSER::PROTEIN)
    ("thromboxane A 2" . SPARSER::MOLECULE) ("PGI 2" . SPARSER::PROTEIN)
    ("PGD 2" . SPARSER::PROTEIN) ("PGF 2α" . SPARSER::MOLECULE)
    ("EP 4" . SPARSER::PROTEIN) ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NS-398" . SPARSER::DRUG) ("immediate early" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("AT 1" . SPARSER::PROTEIN)
    ("Ang II" . SPARSER::PROTEIN) ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("K1" . SPARSER::PROTEIN) ("AT1" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("EP 4 receptor" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("renin receptor" . SPARSER::PROTEIN) ("Angiotensin II" . SPARSER::PROTEIN)
    ("Pik3ca" . SPARSER::PROTEIN) ("Pik" . SPARSER::BIO-COMPLEX)
    ("fit" . SPARSER::PROTEIN-FAMILY)
    ("embryonic vasculature" . SPARSER::PROTEIN)
    ("other vascular malformations" . SPARSER::PROTEIN)
    ("LMs" . SPARSER::MOLECULE) ("microcystic LM" . SPARSER::MOLECULE)
    ("Hospital comprising affected tissue DNA" . SPARSER::DNA)
    ("amplimer" . SPARSER::PROTEIN)
    ("water and healthy control DNA" . SPARSER::COLLECTION)
    ("healthy control DNA" . SPARSER::DNA)
    ("healthy control genomic DNA" . SPARSER::DNA)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lymphatic malformations (LM)" . SPARSER::PROTEIN)
    ("growth factor, fibroblast growth factor, and insulin-like growth factor"
     . SPARSER::COLLECTION)
    ("the enzyme’s" . SPARSER::ENZYME)
    ("had isolated LM (16/17) or LM" . SPARSER::COLLECTION)
    ("LM" . SPARSER::MOLECULE) ("SLC12A7" . SPARSER::PROTEIN)
    ("PPP3CC" . SPARSER::PROTEIN) ("PPP3CB" . SPARSER::PROTEIN)
    ("PPP3CA" . SPARSER::PROTEIN) ("PIK3R3" . SPARSER::PROTEIN)
    ("PIK3R2" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("PIK3CG" . SPARSER::PROTEIN) ("PIK3CB" . SPARSER::PROTEIN)
    ("NOS3" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("NFATC1" . SPARSER::PROTEIN) ("KCNK5" . SPARSER::PROTEIN)
    ("KCNH2" . SPARSER::PROTEIN) ("KCNH1" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("FKBP1A" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("histological type and TNM stage" . SPARSER::COLLECTION)
    ("histological type" . TYPE)
    ("deforolimus, everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("everolimus" . SPARSER::DRUG)
    ("deforolimus" . SPARSER::DRUG)
    ("histological type and number" . SPARSER::COLLECTION)
    ("type and number" . SPARSER::COLLECTION)
    ("HR and 95%CI" . SPARSER::COLLECTION) ("ADC" . SPARSER::PROTEIN)
    ("parts" . SPARSER::COMPONENT)
    ("the scientific design part" . SPARSER::COMPONENT)
    ("bene" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("homolog 1/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/v-akt" . SPARSER::COLLECTION)
    ("akt" . SPARSER::PROTEIN)
    ("HER2[ xref ] and KRAS[ xref ]" . SPARSER::COLLECTION)
    ("EGFR[ xref ], HER2[ xref ] and KRAS[ xref ]" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR/p-mTOR" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("HR 2" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("4EBP1" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("m-TOR" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("/PAI-1" . SPARSER::COLLECTION)
    ("viral surface glycoproteins" . SPARSER::PROTEIN)
    ("Mucins and surfactant" . SPARSER::COLLECTION)
    ("surfactant" . SPARSER::PROTEIN) ("Mucins" . SPARSER::PROTEIN)
    ("SERPIN" . SPARSER::PROTEIN)
    ("possibly reflecting PAI-1’s" . SPARSER::PROTEIN)
    ("latent TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tip" . SPARSER::PROTEIN)
    ("protease-protease" . SPARSER::COLLECTION)
    ("IL-6, IL-1, TGF-β, and TNF-α" . SPARSER::COLLECTION)
    ("the only previously known airway protease inhibitor"
     . SPARSER::INHIBITOR)
    ("inhibitor (MPI)" . SPARSER::INHIBITOR) ("MPI" . SPARSER::PROTEIN)
    ("aprotinin" . SPARSER::DRUG) ("Leupeptin" . SPARSER::DRUG)
    ("morpholinos or peptide mimetic protease inhibitors" . SPARSER::INHIBITOR)
    ("Less pathogenic IAV HAs" . SPARSER::PROTEIN)
    ("Highly pathogenic avian H5 and H7 HAs" . SPARSER::PROTEIN)
    ("HAs" . SPARSER::PROTEIN)
    ("a given protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Furin and PC5/6" . SPARSER::COLLECTION) ("subtilisin" . SPARSER::PROTEIN)
    ("Furin" . SPARSER::PROTEIN)
    ("its own protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("disulfide" . SPARSER::MOLECULE)
    ("HAT, and TMPRSS2" . SPARSER::COLLECTION)
    ("chymotrypsin" . SPARSER::PROTEIN) ("smooth muscle" . SPARSER::PROTEIN)
    ("a 50 kDa glycoprotein and the main physiological inhibitor"
     . SPARSER::COLLECTION)
    ("uPA/tPA" . SPARSER::COLLECTION) ("tPA" . SPARSER::PROTEIN)
    ("at least one rs6092 allele" . SPARSER::ALLELE)
    ("given PAI-1’s" . SPARSER::PROTEIN) ("given PAI-1" . SPARSER::PROTEIN)
    ("mRNA and mPAI-1" . SPARSER::COLLECTION) ("mPAI-1" . SPARSER::COLLECTION)
    ("VSV" . SPARSER::PROTEIN) ("PAI-1-furin" . SPARSER::COLLECTION)
    ("trypsin- and TMPRSS2-treated HA" . SPARSER::COLLECTION)
    ("TMPRSS2-treated HA" . SPARSER::PROTEIN) ("trypsin-" . SPARSER::PROTEIN)
    ("either exogenous trypsin" . SPARSER::PROTEIN)
    ("the extracellular airway proteases transmembrane protease serine 2 (TMPRSS2) and HAT"
     . SPARSER::COLLECTION)
    ("PAI-1 and trypsin" . SPARSER::COLLECTION)
    ("glycoprotein, and Sendai" . SPARSER::COLLECTION)
    ("SeV" . SPARSER::PROTEIN) ("PAI-1 and furin" . SPARSER::COLLECTION)
    ("furin" . SPARSER::PROTEIN)
    ("human tryptase and human airway trypsin (HAT)" . SPARSER::COLLECTION)
    ("trypsin (HAT)" . SPARSER::PROTEIN) ("tryptase" . SPARSER::PROTEIN)
    ("PAI-1-trypsin" . SPARSER::COLLECTION)
    ("PAI-1 and a prototype chymotrypsin-like serine protease ( xref )"
     . SPARSER::COLLECTION)
    ("TPCK" . SPARSER::MOLECULE) ("uPA" . SPARSER::PROTEIN)
    ("Proteases" . SPARSER::PROTEIN) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("extracellular PAI-1" . SPARSER::PROTEIN) ("rPAI-1" . SPARSER::COLLECTION)
    ("ISG15 , IFITM3 , and BST2" . SPARSER::COLLECTION)
    ("the viral hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XAF1 , MAFF , and SERPINE1" . SPARSER::COLLECTION)
    ("MAFF" . SPARSER::PROTEIN) ("TRAIL" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("RANTES" . SPARSER::PROTEIN)
    ("hpi" . SPARSER::PROTEIN)
    ("therapeutic small molecules (influenza A virus [IAV] neuraminidase inhibitors; HIV-1 protease inhibitors) and intrinsic ISGs such as tetherin ( xref ) or viperin ( xref )"
     . SPARSER::COLLECTION)
    ("tetherin ( xref ) or viperin ( xref )" . SPARSER::COLLECTION)
    ("viperin" . SPARSER::PROTEIN) ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neuraminidase" . SPARSER::PROTEIN) ("IFNs" . SPARSER::DRUG)
    ("IFN" . SPARSER::DRUG) ("glycoprotein" . SPARSER::PROTEIN)
    ("the antiviral state" . SPARSER::BIO-STATE)
    ("Interferon" . SPARSER::PROTEIN) ("Hprt1" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE)
    ("RNA polymerase I" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("PB2" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("inhibitor 1" . SPARSER::PROTEIN)
    ("PAI-039" . SPARSER::DRUG) ("RPS-11" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("Serpine 1" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("TMPRSS13" . SPARSER::PROTEIN) ("PC5" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("E–6" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("Serpine1" . SPARSER::PROTEIN) ("serine 2" . SPARSER::PROTEIN)
    ("transmembrane protease" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN) ("B–2" . SPARSER::PROTEIN)
    ("ISG15" . SPARSER::PROTEIN) ("A–S2" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("SERPIN family" . SPARSER::PROTEIN)
    ("H3N2" . SPARSER::MOLECULE) ("E1" . SPARSER::MOLECULE)
    ("XAF1" . SPARSER::PROTEIN) ("TNFSF10" . SPARSER::PROTEIN)
    ("CRY1" . SPARSER::PROTEIN) ("SCO2" . SPARSER::PROTEIN)
    ("PMM2" . SPARSER::PROTEIN) ("ELF1" . SPARSER::PROTEIN)
    ("MAP3K14" . SPARSER::PROTEIN) ("BST2" . SPARSER::PROTEIN)
    ("IFITM3" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("IFNLR1" . SPARSER::PROTEIN) ("IL28RA" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("IRF2" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("IFIH1" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("DDX58" . SPARSER::PROTEIN)
    ("α-HA" . SPARSER::MOLECULE) ("N1" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN)
    ("PTEN, FAS, PAPSS2 and PSA" . SPARSER::COLLECTION)
    ("PTEN, FAS, and PAPSS2" . SPARSER::COLLECTION) ("WA" . SPARSER::MOLECULE)
    ("all experimental CEL" . SPARSER::PROTEIN) ("CEL" . SPARSER::PROTEIN)
    ("topographical maps" . SPARSER::PROTEIN)
    ("Post-surgical serum PSA" . SPARSER::PROTEIN)
    ("PTEN and its neighboring genes" . SPARSER::COLLECTION)
    ("inorganic sulfate" . SPARSER::MOLECULE) ("APS" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE) ("DHEA" . SPARSER::DRUG)
    ("dehydroepiandrosterone" . SPARSER::MOLECULE)
    ("kinase/Akt" . SPARSER::COLLECTION) ("Fas" . SPARSER::PROTEIN)
    ("PTEN , FAS and PAPSS2" . SPARSER::COLLECTION)
    ("PAPSS2 , ATAD1 , KLLN , PTEN , RNLS , ANKRD22 , LIPF , LIPK , LIPM , LIPN , ACTA2 , FAS and STAMBPL1"
     . SPARSER::COLLECTION)
    ("prostatic" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("ACTA2 , ANKRD22 , ATAD1 , CH25H , FAS , IFIT1 , IFIT1B , IFIT2 , IFIT3 , IFIT5 , KIF20B , KLLN , LIPA , LIPF , LIPJ , LIPK , LIPM , LIPN , MIR107 , PANK1 , PTEN , RNLS , SLC16A12 and STAMBPL1"
     . SPARSER::COLLECTION)
    ("SLC16A12" . SPARSER::PROTEIN) ("RNLS" . SPARSER::PROTEIN)
    ("LIPN" . SPARSER::PROTEIN) ("LIPM" . SPARSER::PROTEIN)
    ("LIPK" . SPARSER::PROTEIN) ("LIPJ" . SPARSER::PROTEIN)
    ("LIPF" . SPARSER::PROTEIN) ("p12" . SPARSER::PROTEIN)
    ("QC" . SPARSER::PROTEIN)
    ("43 fresh frozen tumor foci and 10 non-tumor" . SPARSER::COLLECTION)
    ("43 fresh frozen tumor foci" . SPARSER::PROTEIN)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("androgen" . SPARSER::PROTEIN)
    ("androgens" . SPARSER::DRUG)
    ("PTEN, FAS and PAPSS2" . SPARSER::COLLECTION)
    ("PTEN and FAS" . SPARSER::COLLECTION) ("FAS" . SPARSER::PROTEIN)
    ("unique genes" . SPARSER::GENE) ("PSA" . SPARSER::PROTEIN)
    ("forty-three fresh frozen PCa tissue foci" . SPARSER::PROTEIN)
    ("specific prognostic biomarker" . SPARSER::MOLECULE)
    ("PCa" . SPARSER::PROTEIN)
    ("3'-phosphoadenosine 5'-phosphosulfate synthase 2" . SPARSER::PROTEIN)
    ("FAS ligand" . SPARSER::PROTEIN)
    ("Fatty acid synthase" . SPARSER::PROTEIN) ("NKX3-1" . SPARSER::PROTEIN)
    ("STAMBPL1" . SPARSER::PROTEIN) ("16A" . SPARSER::PROTEIN)
    ("PANK1" . SPARSER::PROTEIN) ("MIR107" . SPARSER::PROTEIN)
    ("KIF20B" . SPARSER::PROTEIN) ("IFIT5" . SPARSER::PROTEIN)
    ("IFIT3" . SPARSER::PROTEIN) ("IFIT2" . SPARSER::PROTEIN)
    ("IFIT1B" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("CH25H" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("PAPSS2" . SPARSER::PROTEIN) ("EGF/CXCR4" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("Kras" . SPARSER::PROTEIN)
    ("the single-positive group ( P <0.001 for both DFS and OS) or the both-negative group ( P = 0.005 and <0.001 for DFS and OS, respectively)"
     . SPARSER::COLLECTION)
    ("the single-positive group and the both-negative group ( P = 0.720 and 0.545 for DFS and OS, respectively)"
     . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::PROTEIN)
    ("a single-positive group (either CXCR4+ or EGFR+) or a both-negative group (CXCR4− and EGFR-)"
     . SPARSER::COLLECTION)
    ("an EGFR/CXCR4 coexpression group (CXCR4+ and EGFR+), a single-positive group (either CXCR4+ or EGFR+) or a both-negative group (CXCR4− and EGFR-)"
     . SPARSER::COLLECTION)
    ("EGFR-" . SPARSER::PROTEIN)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("CXCL12/CXCR4" . SPARSER::COLLECTION)
    ("potentially relevant biomarkers" . SPARSER::MOLECULE)
    ("CXCR4 and EGFR" . SPARSER::COLLECTION)
    ("EGFR or CXCR4" . SPARSER::COLLECTION)
    ("EGFR/CXCR4" . SPARSER::COLLECTION)
    ("EGFR and CXCR4" . SPARSER::COLLECTION)
    ("EGFR and G-protein-coupled chemokine receptor CXCR4"
     . SPARSER::COLLECTION)
    ("PDAC" . SPARSER::MOLECULE) ("VEGF-C" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("CXCL8, IL-6, and CRP" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("Cigarette" . SPARSER::DRUG) ("CRP" . SPARSER::PROTEIN)
    ("dexamethasone and/or GW856553 (both at 10 −6 M)" . SPARSER::COLLECTION)
    ("dexamethasone and GW856553" . SPARSER::COLLECTION)
    ("CXCL8 and IL-6" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38α, p38β, p38γ, and p38δ" . SPARSER::COLLECTION)
    ("TNF-α, IL-1β, CXCL8, and IL-6" . SPARSER::COLLECTION)
    ("CXCL8 and GM-CSF" . SPARSER::COLLECTION) ("CS (ICS)" . SPARSER::PROTEIN)
    ("dexamethasone-" . SPARSER::PROTEIN)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN) ("dexamethasone" . SPARSER::PROTEIN)
    ("AF1" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("GM-CSF" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CXCL8" . SPARSER::PROTEIN)
    ("GW856553" . SPARSER::DRUG) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VCAM-1 and VAP-1" . SPARSER::COLLECTION)
    ("RhoC or ROCKs" . SPARSER::COLLECTION)
    ("indeed ROCK inhibitors" . SPARSER::INHIBITOR)
    ("RhoC or Cdc42" . SPARSER::COLLECTION)
    ("metallo-proteinases" . SPARSER::COLLECTION)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("integrin, and α5β1" . SPARSER::COLLECTION) ("cava" . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN) ("YFP" . SPARSER::PROTEIN)
    ("RhoC, ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("RhoC/ROCK" . SPARSER::COLLECTION) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("ROCK1-" . SPARSER::PROTEIN)
    ("ROCKs, ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("proteins, RhoA, RhoB and RhoC" . SPARSER::COLLECTION)
    ("RhoB" . SPARSER::PROTEIN)
    ("any inflammatory cytokines" . SPARSER::PROTEIN)
    ("ICAM-1 or VCAM-1" . SPARSER::COLLECTION)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("secondary tumour foci" . SPARSER::PROTEIN)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION) ("VAP-1" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("myosin light chain" . SPARSER::PROTEIN)
    ("D–G" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("chemo-attractant" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("MLC2" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("C-16" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("USP8 and/or EGFR" . SPARSER::COLLECTION)
    ("ErbB3 and C-Met" . SPARSER::COLLECTION)
    ("EGFR-MAPK" . SPARSER::COLLECTION) ("GH or PRL" . SPARSER::COLLECTION)
    ("midnight serum cortisol and 24-h urinary free cortisol" . SPARSER::DRUG)
    ("cortisol and 24-h" . SPARSER::COLLECTION) ("UFC" . SPARSER::PROTEIN)
    ("a clinically available EGFR inhibitor" . SPARSER::INHIBITOR)
    ("USP8 and EGFR" . SPARSER::COLLECTION)
    ("prolactin (PRL)" . SPARSER::PROTEIN)
    ("growth hormone (GH)" . SPARSER::PROTEIN) ("PRL" . SPARSER::PROTEIN)
    ("prolactin" . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("any previously reported genes" . SPARSER::GENE)
    ("GNAS or PRKACA" . SPARSER::COLLECTION) ("PRKACA" . SPARSER::PROTEIN)
    ("gefitinib" . SPARSER::DRUG) ("GNAS or AIP" . SPARSER::COLLECTION)
    ("PA" . SPARSER::PROTEIN) ("AIP" . SPARSER::PROTEIN)
    ("subunit ( GNAS )" . SPARSER::FRAGMENT) ("GNAS" . SPARSER::PROTEIN)
    ("Brg1 and histone deacetylase 2" . SPARSER::COLLECTION)
    ("Brg1" . SPARSER::PROTEIN) ("proopiomelanocortin" . SPARSER::PROTEIN)
    ("Adrenocorticotropic hormone (ACTH)" . SPARSER::PROTEIN)
    ("USP8 or EGFR" . SPARSER::COLLECTION) ("POMC" . SPARSER::PROTEIN)
    ("USP8 and 14-3-3" . SPARSER::COLLECTION)
    ("adrenocorticotropic hormone (ACTH)" . SPARSER::PROTEIN)
    ("corticotrophin" . SPARSER::PROTEIN) ("cortisol" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("C-Met" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("NR3C1" . SPARSER::PROTEIN)
    ("DICER1" . SPARSER::PROTEIN) ("DAX-1" . SPARSER::PROTEIN)
    ("histone deacetylase 2" . SPARSER::PROTEIN)
    ("Adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("USP8" . SPARSER::PROTEIN)
    ("adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("DMBA" . SPARSER::MOLECULE) ("p16 INK4A or p21" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION)
    ("CDK2 and Cyclin D1" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("PP1 and PP2A" . SPARSER::COLLECTION)
    ("CDK2 or CDK4/6" . SPARSER::COLLECTION)
    ("Cyclin A, Cyclin D1 or Cyclin E" . SPARSER::COLLECTION)
    ("Pin1 and Rb" . SPARSER::COLLECTION)
    ("Pin1(W34A) or Pin1(R68/69A)" . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("Pin1 or GFP" . SPARSER::COLLECTION) ("hydroxyurea" . SPARSER::DRUG)
    ("aphidicolin" . SPARSER::PROTEIN) ("hyper-pRb" . SPARSER::PROTEIN-PAIR)
    ("DHFR-Luc" . SPARSER::PROTEIN-PAIR) ("DHFR" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("Cyclin E/CDK2" . SPARSER::COLLECTION) ("MCF-10A" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN)
    ("S-phase Cyclin-associated kinases" . SPARSER::KINASE)
    ("Cyclin D1, Cyclin E or Cyclin A" . SPARSER::COLLECTION)
    ("Cyclin/CDK" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION) ("RbLP" . SPARSER::PROTEIN)
    ("pS/T-P" . SPARSER::COLLECTION) ("pS" . SPARSER::PROTEIN)
    ("Roscovitine" . SPARSER::DRUG) ("roscovitine" . SPARSER::DRUG)
    ("Rb-Pin1" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("Pin1–Rb" . SPARSER::COLLECTION) ("GST-Pin1-PPIase" . SPARSER::COLLECTION)
    ("GST-Pin1" . SPARSER::COLLECTION) ("PPIase" . SPARSER::PROTEIN)
    ("prolyl" . SPARSER::PROTEIN) ("isomerase" . SPARSER::ISOMERASE)
    ("Cyclin/Cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RB" . SPARSER::PROTEIN)
    ("X-Gal" . SPARSER::MOLECULE) ("C-11" . SPARSER::PROTEIN)
    ("Na3VO4" . SPARSER::MOLECULE) ("MgCL2" . SPARSER::MOLECULE)
    ("pSM2" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("raf-1" . SPARSER::PROTEIN) ("Pim-1" . SPARSER::PROTEIN)
    ("Thr-Pro" . SPARSER::MOLECULE) ("small t antigen" . SPARSER::PROTEIN)
    ("as 2 " . SPARSER::PROTEIN) ("β -Gal" . SPARSER::PROTEIN)
    ("β -Galactosidase" . SPARSER::PROTEIN)
    ("dihydrofolate reductase" . SPARSER::PROTEIN) ("T-P" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("antiangiogenesis-induced intratumoral hypoxia" . SPARSER::PROTEIN)
    ("intratumoral hypoxia" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN)
    ("antiangiogenic tyrosine kinase inhibitors" . SPARSER::INHIBITOR)
    ("Mani" . SPARSER::PROTEIN) ("Lv" . SPARSER::MOLECULE)
    ("Snail" . SPARSER::PROTEIN) ("Klotho/VEGFR2/PAK1" . SPARSER::COLLECTION)
    ("Mgat5" . SPARSER::PROTEIN) ("HBX/PAK1" . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE) ("Chen" . SPARSER::PROTEIN)
    ("Klotho" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("CD73 ( P =0.013) and CD 146" . SPARSER::COLLECTION)
    ("IL-6 ( P =0.006), CD73 ( P =0.013) and CD 146" . SPARSER::COLLECTION)
    ("IL-6, CD73 and CD146" . SPARSER::COLLECTION)
    ("IPA3 or IL-6" . SPARSER::COLLECTION)
    ("IPA3 or sunitinib" . SPARSER::COLLECTION)
    ("PAK1/NF -κ B/IL-6" . SPARSER::COLLECTION)
    ("PAK1/NF- κ B/IL-6" . SPARSER::COLLECTION)
    ("PDTC or IL-6" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("inhibitor (PDTC)" . SPARSER::INHIBITOR) ("PDTC" . SPARSER::DRUG)
    ("Sunitinib" . SPARSER::DRUG) ("PAK1 or PAK1" . SPARSER::COLLECTION)
    ("a shRNA-resistant wild-type PAK1 or a PAK1 T423E mutant"
     . SPARSER::COLLECTION)
    ("RAF1 (S338) and MEK1 (S298)" . SPARSER::COLLECTION)
    ("MEK1 (see Frost et al.   xref  and Beeser et al.   xref  ) and RAF1 (see Jin et al.   xref  )"
     . SPARSER::COLLECTION)
    ("PAK1 and PAK1" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("p-PAK1" . SPARSER::COLLECTION) ("Kinase (JNK)" . SPARSER::KINASE)
    ("anoikis" . SPARSER::PROTEIN) ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDC42 and RAC1" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("sunitinib and sorafinib" . SPARSER::COLLECTION)
    ("sorafinib" . SPARSER::DRUG) ("NF- κ B/IL-6" . SPARSER::COLLECTION)
    ("antibody and IPA3" . SPARSER::COLLECTION)
    ("/interleukin-6" . SPARSER::COLLECTION)
    ("PAK1 mutant K299R and IPA3" . SPARSER::COLLECTION)
    ("PAK1 shRNA, PAK1 mutant K299R and IPA3" . SPARSER::COLLECTION)
    ("sunitinib" . SPARSER::DRUG)
    ("dead kinase PAK1 mutant K299R or allosteric inhibitor IPA3"
     . SPARSER::COLLECTION)
    ("SU11248" . SPARSER::DRUG) ("p-MEK1" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("CD133" . SPARSER::PROTEIN)
    ("RSK4" . SPARSER::PROTEIN) ("TTBK2" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("p34cdc2" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rho GTPase" . SPARSER::PROTEIN) ("CD 146" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("CD73" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("factor- κ B" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("CDC42" . SPARSER::PROTEIN)
    ("cell division cycle 42" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN) ("IFN- α" . SPARSER::PROTEIN)
    ("interferon- α" . SPARSER::DRUG) ("interleukin 2" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("NF -κ B" . SPARSER::PROTEIN)
    ("factor -κ B" . SPARSER::PROTEIN) ("IPA3" . SPARSER::MOLECULE)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("BRMS1-iASPP-p300/CBP-TAp73" . SPARSER::COLLECTION)
    ("methyltransferases" . SPARSER::PROTEIN) ("HDACs" . SPARSER::PROTEIN)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION) ("MAPK-" . SPARSER::PROTEIN)
    ("ASPP and other regulatory proteins" . SPARSER::COLLECTION)
    ("ASPP and p300" . SPARSER::COLLECTION)
    ("BRMS1 and p300" . SPARSER::COLLECTION)
    ("ASPP1 and ASPP2" . SPARSER::COLLECTION)
    ("CBP, or TAp73" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("essential cofactors" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 and its cousin TAp73" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::MOLECULE) ("cisplatin-treated Lox" . SPARSER::PROTEIN)
    ("Lox" . SPARSER::PROTEIN) ("iASPP and BRMS1" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION) ("CBP and iASPP" . SPARSER::COLLECTION)
    ("p300 and iASPP" . SPARSER::COLLECTION)
    ("a pro-apoptotic cofactor" . SPARSER::MOLECULE)
    ("iASPP and CBP" . SPARSER::COLLECTION)
    ("CBP and BRMS1" . SPARSER::COLLECTION)
    ("BRMS1 and p300/CBP in cisplatin-treated HCT116 cells"
     . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("TAp73/p300" . SPARSER::COLLECTION)
    ("TAp73 or iASPP" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("pro-apoptotic p73 target genes" . SPARSER::GENE)
    ("pro-apoptotic target genes" . SPARSER::GENE)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("BBC3/Puma" . SPARSER::COLLECTION)
    ("chromatin-associated p300 and TAp73" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("Cycloheximide" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION)
    ("dacarbazine (DTIC)" . SPARSER::DRUG) ("dacarbazine" . SPARSER::DRUG)
    ("p300, CBP, and TAp73" . SPARSER::COLLECTION) ("TAp73" . SPARSER::PROTEIN)
    ("p300-TAp73" . SPARSER::PROTEIN-PAIR) ("iASPP-p300" . SPARSER::COLLECTION)
    ("p300 or TAp73" . SPARSER::COLLECTION)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("iASPP and TAp73" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION) ("ankyrin" . SPARSER::PROTEIN)
    ("p53, TAp73, and TAp63" . SPARSER::COLLECTION)
    ("cisplatin or etoposide" . SPARSER::COLLECTION)
    ("ASPP2 and ASPP1" . SPARSER::COLLECTION)
    ("ASPP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p300/CBP" . SPARSER::COLLECTION)
    ("BRMS1 and CBP" . SPARSER::COLLECTION)
    ("pro-apoptotic TAp73 target genes" . SPARSER::GENE)
    ("p300 and TAp73" . SPARSER::COLLECTION)
    ("the histone acetyltransferase p300 and its homolog CBP"
     . SPARSER::COLLECTION)
    ("p300 and CBP" . SPARSER::COLLECTION) ("iASPP" . SPARSER::PROTEIN)
    ("The p53 family and its cofactors" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN) ("Lamin B1" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("PARP1" . SPARSER::PROTEIN)
    ("β -Actin" . SPARSER::PROTEIN) ("B-6" . SPARSER::PROTEIN)
    ("HSC70" . SPARSER::PROTEIN) ("beta-glycerophosphate" . SPARSER::DRUG)
    ("DNase I" . SPARSER::PROTEIN) ("pcDNA3.1" . SPARSER::PROTEIN)
    ("or 2 " . SPARSER::MOLECULE) ("p14ARF" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("CD95" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("KAT3" . SPARSER::PROTEIN) ("ASPP1" . SPARSER::PROTEIN)
    ("ASPP2" . SPARSER::PROTEIN) ("BRMS1" . SPARSER::PROTEIN)
    ("apoptosis-stimulating protein of p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("multiple associated proteins" . SPARSER::PROTEIN)
    ("ER and HBXIP and XIAP" . SPARSER::COLLECTION)
    ("HBXIP and XIAP" . SPARSER::COLLECTION)
    ("caspase-9 and the bound c-Abl" . SPARSER::COLLECTION)
    ("XIAP/caspase-9" . SPARSER::COLLECTION)
    ("the triple protein complex" . SPARSER::BIO-COMPLEX)
    ("TUCAN" . SPARSER::PROTEIN) ("HBXIP" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("proteins, APAF-1 and cytochrome c" . SPARSER::COLLECTION)
    ("Cysteine-tryptophan" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::AMINO-ACID)
    ("MTH2 and PCNA" . SPARSER::COLLECTION)
    ("PCNA and MutT homolog2 (MTH2)" . SPARSER::COLLECTION)
    ("TPI and PGK1" . SPARSER::COLLECTION)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("dihydroxyacetone" . SPARSER::MOLECULE) ("TPI" . SPARSER::PROTEIN)
    ("electrons" . SPARSER::MOLECULE) ("oxidase" . SPARSER::PROTEIN)
    ("MAP" . SPARSER::PROTEIN) ("mitogen" . SPARSER::MITOGEN)
    ("Thioredoxin" . SPARSER::PROTEIN) ("a causative gene" . SPARSER::GENE)
    ("approximately 200 proteins" . SPARSER::PROTEIN)
    ("PDI, Drp-1, Prx-2, XIAP, and parkin" . SPARSER::COLLECTION)
    ("PDI" . SPARSER::PROTEIN) ("proteins and form" . SPARSER::COLLECTION)
    ("nitrated" . SPARSER::MOLECULE) ("ester" . SPARSER::MOLECULE)
    ("nitrite" . SPARSER::MOLECULE) ("parkin" . SPARSER::PROTEIN)
    ("PCNA and casepase-9" . SPARSER::COLLECTION)
    ("pcDNA3.1-PCNA" . SPARSER::PROTEIN-PAIR) ("DTT" . SPARSER::MOLECULE)
    ("exogenous cytochrome c" . SPARSER::PROTEIN)
    ("caspase-9 and APAF-1" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX) ("nickel" . SPARSER::MOLECULE)
    ("alanine" . SPARSER::AMINO-ACID) ("the Western blot" . SPARSER::PROTEIN)
    ("caspase-9 and PCNA" . SPARSER::COLLECTION)
    ("a key caspase" . SPARSER::PROTEIN)
    ("heat shock protein 90, peroxiredoxin-6, and 14–3–3"
     . SPARSER::COLLECTION)
    ("PCNA and DAPI" . SPARSER::COLLECTION) ("DAPI" . SPARSER::DRUG)
    ("PCNA and aldose reductase" . SPARSER::COLLECTION)
    ("were fractioned" . SPARSER::BIO-FRACTION)
    ("fractioned" . SPARSER::BIO-FRACTION) ("leukocytes" . SPARSER::PROTEIN)
    ("avidin" . SPARSER::PROTEIN) ("PCNA, PGK1, and TRX" . SPARSER::COLLECTION)
    ("TRX" . SPARSER::PROTEIN) ("ascorbate" . SPARSER::MOLECULE)
    ("thiols" . SPARSER::MOLECULE) ("reagent" . SPARSER::MOLECULE)
    ("phosphatidylserine" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("FITC" . SPARSER::MOLECULE) ("DAF-FM" . SPARSER::COLLECTION)
    ("DA" . SPARSER::MOLECULE) ("FM" . SPARSER::PROTEIN)
    ("thiol" . SPARSER::MOLECULE) ("XIAP and caspases" . SPARSER::COLLECTION)
    ("neuronal nitric oxide synthase" . SPARSER::PROTEIN)
    ("NOS" . SPARSER::PROTEIN) ("NMDA" . SPARSER::MOLECULE)
    ("oxidized glutathione (GSH)" . SPARSER::DRUG)
    ("superoxide anion, hydroxyl radicals, and hydrogen peroxide"
     . SPARSER::COLLECTION)
    ("GSH" . SPARSER::DRUG) ("ROS" . SPARSER::PROTEIN)
    ("pesticide" . SPARSER::MOLECULE) ("Rotenone" . SPARSER::PROTEIN)
    ("adrenergic" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("BIR" . SPARSER::PROTEIN) ("Dynamin" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE)
    ("peroxynitrite" . SPARSER::MOLECULE) ("nNOS" . SPARSER::PROTEIN)
    ("6-OHDA and LPS or rotenone" . SPARSER::COLLECTION)
    ("LPS or rotenone" . SPARSER::COLLECTION) ("iNOS" . SPARSER::PROTEIN)
    ("a highly diffusible gaseous state" . SPARSER::BIO-STATE)
    ("radical" . SPARSER::MOLECULE) ("caspases" . SPARSER::PROTEIN)
    ("SNpc" . SPARSER::PROTEIN) ("PCNA and caspase-9" . SPARSER::COLLECTION)
    ("cysteine" . SPARSER::AMINO-ACID)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("rotenone" . SPARSER::PROTEIN) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("that nitric oxide (NO) or its derivatives" . SPARSER::COLLECTION)
    ("nitric oxide (NO)" . SPARSER::MOLECULE) ("ERK2" . SPARSER::PROTEIN)
    ("procaspase-9" . SPARSER::PROTEIN) ("MTH2" . SPARSER::PROTEIN)
    ("homolog2" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("Phosphoglycerate kinase 1" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate" . SPARSER::MOLECULE)
    ("Triosephosphate isomerase" . SPARSER::PROTEIN)
    ("Subunit 5" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating Kinase 1" . SPARSER::PROTEIN)
    ("DJ-1" . SPARSER::PROTEIN) ("Prx-2" . SPARSER::PROTEIN)
    ("Drp-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("L-NAME" . SPARSER::MOLECULE)
    ("APAF-1" . SPARSER::PROTEIN) ("14–3–3" . SPARSER::PROTEIN)
    ("peroxiredoxin-6" . SPARSER::PROTEIN)
    ("heat shock protein 90" . SPARSER::PROTEIN)
    ("aldose reductase" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("PGK1" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("L-NMMA" . SPARSER::MOLECULE)
    ("L-arginine" . SPARSER::MOLECULE) ("TRX2" . SPARSER::PROTEIN)
    ("Thioredoxin2" . SPARSER::PROTEIN) ("caspases-3" . SPARSER::PROTEIN)
    ("voltage dependent" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN)
    ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("hydroxyl radicals" . SPARSER::MOLECULE)
    ("superoxide anion" . SPARSER::MOLECULE) ("complex I" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("Siah1" . SPARSER::PROTEIN) ("Prx2" . SPARSER::PROTEIN)
    ("peroxiredoxin 2" . SPARSER::PROTEIN) ("Drp1" . SPARSER::PROTEIN)
    ("dynamin-related protein 1" . SPARSER::PROTEIN)
    ("S-nitrosothiols" . SPARSER::MOLECULE) ("6-OHDA" . SPARSER::MOLECULE)
    ("Nitric oxide" . SPARSER::MOLECULE) ("nitric oxide" . SPARSER::MOLECULE)
    ("thrombin or plasmin" . SPARSER::COLLECTION) ("t" . SPARSER::PROTEIN)
    ("TAFI" . SPARSER::INHIBITOR)
    ("Thrombin activatable fibrinolysis inhibitor (TAFI)" . SPARSER::INHIBITOR)
    ("inhibitor (TAFI)" . SPARSER::INHIBITOR)
    ("C4a, and C5a" . SPARSER::COLLECTION)
    ("arginine or lysine" . SPARSER::COLLECTION) ("C4a" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("carboxy" . SPARSER::MOLECULE)
    ("kinins" . SPARSER::PROTEIN-FAMILY)
    ("peptides and proteins" . SPARSER::COLLECTION)
    ("t-PA, plasminogen and plasmin" . SPARSER::COLLECTION)
    ("local plasmin" . SPARSER::PROTEIN) ("Anticoagulant" . SPARSER::DRUG)
    ("sub endothelial tissue factor (TF)" . SPARSER::PROTEIN)
    ("proinflammatory cytokines ( xref ) and complement ( xref )"
     . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("α v β 3 and vitronectin" . SPARSER::COLLECTION)
    ("-integrins" . SPARSER::COLLECTION) ("vitronectin" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::PROTEIN) ("vasculature" . SPARSER::PROTEIN)
    ("PAI-1 and pregnancy zone protein (spot #31)" . SPARSER::COLLECTION)
    ("anticoagulant" . SPARSER::DRUG)
    ("viral N proteins and glycoproteins" . SPARSER::COLLECTION)
    ("proteins and glycoproteins" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("flu" . SPARSER::PROTEIN)
    ("whose disease state" . SPARSER::BIO-STATE)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("citrate" . SPARSER::PROTEIN)
    ("dL" . SPARSER::MOLECULE) ("thromboplastin" . SPARSER::PROTEIN)
    ("Prothrombin" . SPARSER::DRUG) ("Complement" . SPARSER::PROTEIN)
    ("elastin" . SPARSER::PROTEIN)
    ("an acute phase proteinase inhibitor" . SPARSER::INHIBITOR)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apolipoprotein" . SPARSER::MOLECULE)
    ("dehydrogenase, and haptoglobin" . SPARSER::COLLECTION)
    ("haptoglobin" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("prothrombin" . SPARSER::DRUG) ("hemopexin" . SPARSER::PROTEIN)
    ("antitrypsin" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("pro-inflammatory and anti-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1α, IL-1β, IL-6, TNF-α, IFN-γ, IL-2, IL-4 and TNFβ"
     . SPARSER::COLLECTION)
    ("Rac1, Rap1 and RhoA" . SPARSER::COLLECTION)
    ("the viral RNA" . SPARSER::RNA)
    ("viral S-segment RNA proteins" . SPARSER::PROTEIN)
    ("soluble DAF" . SPARSER::PROTEIN)
    ("a prothrombotic state" . SPARSER::BIO-STATE)
    ("thrombin and thrombin" . SPARSER::COLLECTION)
    ("thrombin-" . SPARSER::PROTEIN) ("PAR-1 and PAR-4" . SPARSER::COLLECTION)
    ("Plasmin" . SPARSER::PROTEIN)
    ("platelets and a variety" . SPARSER::COLLECTION)
    ("PAR-1, PAR-3 and PAR-4" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("hirudin" . SPARSER::PROTEIN)
    ("argatroban" . SPARSER::DRUG) ("fibrin" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("Thrombin and plasmin" . SPARSER::COLLECTION)
    ("Thrombin" . SPARSER::PROTEIN) ("at least two types" . TYPE)
    ("states" . SPARSER::BIO-STATE) ("Da" . SPARSER::MOLECULE)
    ("Cysteine" . SPARSER::AMINO-ACID) ("Fit" . SPARSER::PROTEIN-FAMILY)
    ("Peptide" . SPARSER::PEPTIDE)
    ("angiotensin and ACTH" . SPARSER::COLLECTION) ("ACTH" . SPARSER::PROTEIN)
    ("angiotensin" . SPARSER::PROTEIN) ("TFA" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE) ("trypsin" . SPARSER::PROTEIN)
    ("Vac" . SPARSER::PROTEIN) ("acetonitrile" . SPARSER::MOLECULE)
    ("hydrate" . SPARSER::MOLECULE) ("CDF" . SPARSER::PROTEIN)
    ("max" . SPARSER::PROTEIN) ("MAD" . SPARSER::PROTEIN)
    ("asX" . SPARSER::AMINO-ACID) ("PG" . SPARSER::PROTEIN)
    ("NC" . SPARSER::PROTEIN)
    ("carbonic anhydrase (29,000) and lysozyme (14,000)" . SPARSER::COLLECTION)
    ("catalase (60,000), actin (43,000), carbonic anhydrase (29,000) and lysozyme (14,000)"
     . SPARSER::COLLECTION)
    ("carbonic anhydrase" . SPARSER::PROTEIN) ("lysozyme" . SPARSER::PROTEIN)
    ("anhydrase" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("phosphorylase" . SPARSER::PROTEIN) ("Chemical" . SPARSER::MOLECULE)
    ("slab" . SPARSER::PROTEIN) ("acrylamide" . SPARSER::MOLECULE)
    ("tris" . SPARSER::MOLECULE) ("SDS" . SPARSER::PROTEIN)
    ("dithiothreitol" . SPARSER::PROTEIN) ("glycerol" . SPARSER::PROTEIN)
    ("tropomyosin" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("RPM" . SPARSER::PROTEIN) ("Albumin and IgG" . SPARSER::COLLECTION)
    ("Albumin/IgG" . SPARSER::COLLECTION) ("Albumin" . SPARSER::PROTEIN)
    ("secondary antibody" . SPARSER::PROTEIN)
    ("either anti ZO1 (rabbit polyclonal from Abcam, 1:100 dilution in blocking buffer) or occludin (mouse monoclonal antibody from Invitrogen, 1:200 dilution in blocking buffer)"
     . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN) ("Triton" . SPARSER::MOLECULE)
    ("paraformaldehyde" . SPARSER::DRUG)
    ("occludin or ZO1" . SPARSER::COLLECTION) ("occludin" . SPARSER::PROTEIN)
    ("San" . SPARSER::PROTEIN) ("Prism" . SPARSER::PROTEIN)
    ("Cytokines" . SPARSER::PROTEIN) ("Reopro" . SPARSER::DRUG)
    ("excess soluble DAF" . SPARSER::PROTEIN)
    ("spurious environmental cues" . SPARSER::PROTEIN-FAMILY)
    ("monkey kidney cells form more robust cell-cell barrier"
     . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("fibronectin" . SPARSER::PROTEIN)
    ("EBM" . SPARSER::PROTEIN) ("ciprofloxacin" . SPARSER::DRUG)
    ("streptomycin" . SPARSER::DRUG)
    ("TRIS (10 mM or 25 mM Tris, 150 mM NaCl, pH 7.5) and HHB (30 mM HEPES, 110 mM NaCl, 10 mM KCl, 1 mM MgCl 2 6H 2 O and 10 mM glucose, pH 7.4) buffer"
     . SPARSER::COLLECTION)
    ("Solution (HBSS)" . SPARSER::MOLECULE)
    ("sterile" . SPARSER::PROTEIN-FAMILY) ("Solution" . SPARSER::MOLECULE)
    ("KCl" . SPARSER::MOLECULE) ("HEPES" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("TRIS" . SPARSER::MOLECULE) ("Sephadex" . SPARSER::DRUG)
    ("VA" . SPARSER::MOLECULE) ("PBS" . SPARSER::PROTEIN)
    ("Secondary antibodies" . SPARSER::ANTIBODY) ("DAF" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN) ("EDTA" . SPARSER::MOLECULE)
    ("plasminogen" . SPARSER::PROTEIN)
    ("an increasing prothrombotic state" . SPARSER::BIO-STATE)
    ("thrombin and plasmin" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("monolayers" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("t-PA" . SPARSER::PROTEIN)
    ("C5b" . SPARSER::PROTEIN) ("C5a" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("α v β 3" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN) ("C4b" . SPARSER::PROTEIN)
    ("neutrophil elastase" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("component C" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("TNFβ" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("PAR-4" . SPARSER::PROTEIN)
    ("PAR-3" . SPARSER::PROTEIN) ("PAR-1" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::MOLECULE) ("ZO1" . SPARSER::PROTEIN)
    ("Tight junction" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("MnCl 2" . SPARSER::DRUG) ("MgSO 4" . SPARSER::DRUG)
    ("CO 3" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("PAI-1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("N-RAS (N-RASQ61) and MEK (exons 3 and 6)" . SPARSER::COLLECTION)
    ("receptor, and G protein-coupled receptor" . SPARSER::COLLECTION)
    ("metastatic PTC" . SPARSER::PROTEIN)
    ("B-RAF/MEK/MAPK" . SPARSER::COLLECTION) ("Sorafenib" . SPARSER::DRUG)
    ("B-RAF or COT" . SPARSER::COLLECTION) ("TPO" . SPARSER::PROTEIN)
    ("BRAF and/or COT" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("commercially available anti-A-RAF and anti-C-RAF antibodies"
     . SPARSER::ANTIBODY)
    ("anti-A-RAF and anti-C-RAF" . SPARSER::COLLECTION)
    ("RAF or MEK" . SPARSER::COLLECTION)
    ("C-RAF, COT1, or mutant" . SPARSER::COLLECTION)
    ("N-RAS , MEK1 , or AKT1" . SPARSER::COLLECTION)
    ("receptor, beta polypeptide, insulin-like growth factor 1 receptor, and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("IK" . SPARSER::PROTEIN) ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNM, and B-RAF" . SPARSER::COLLECTION) ("formalin" . SPARSER::MOLECULE)
    ("BRAF and COT" . SPARSER::COLLECTION)
    ("BRAF V600E -negative PTC" . SPARSER::PROTEIN)
    ("primary PTC" . SPARSER::PROTEIN) ("COT or MEK" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("NRAS" . SPARSER::PROTEIN) ("RAF and MEK" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION) ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RET" . SPARSER::PROTEIN)
    ("RAS-RAF-mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("iodine" . SPARSER::MOLECULE)
    ("C-RAF, and COT" . SPARSER::COLLECTION)
    ("B-RAF-RAS" . SPARSER::COLLECTION) ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNM" . SPARSER::MOLECULE) ("B-RAF and COT" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase kinase kinase 8 (COT)"
     . SPARSER::PROTEIN)
    ("COT" . SPARSER::PROTEIN) ("NIMA-interacting 1" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("erbB-2" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("beta polypeptide" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("SB590885" . SPARSER::DRUG)
    ("factor-κB" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("TLR8" . SPARSER::PROTEIN) ("toll-like receptor 8" . SPARSER::PROTEIN)
    ("CCA-3" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("toll-like receptor 7" . SPARSER::PROTEIN) ("CXCL11" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("CD247" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("AG-3" . SPARSER::PROTEIN) ("AT-3" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("ARRY-142886" . SPARSER::DRUG) ("AZD6244" . SPARSER::DRUG)
    ("RAS-binding" . SPARSER::PROTEIN) ("MEK-1" . SPARSER::PROTEIN)
    ("A-RAF" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK kinase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T-cell receptor" . SPARSER::PROTEIN) ("C-RAF" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("MAP3K8" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 8" . SPARSER::PROTEIN)
    ("Cancer Osaka Thyroid Oncogene" . SPARSER::PROTEIN)
    ("Nat" . SPARSER::PROTEIN)
    ("Sirt2-SirReal1-OTC complex () and the Sirt2-ADPR-NCA () complex"
     . SPARSER::COLLECTION)
    ("Sirt2-ADPR-NCA" . SPARSER::COLLECTION)
    ("synthesized SirReal inhibitors" . SPARSER::INHIBITOR)
    ("previously published Sirt2 inhibitors" . SPARSER::INHIBITOR)
    ("neither the indole inhibitors nor SRT1720 or any of the inhibitors"
     . SPARSER::COLLECTION)
    ("SRT1720 or any of the inhibitors" . SPARSER::COLLECTION)
    ("The only other isotype-selective sirtuin inhibitors"
     . SPARSER::INHIBITOR)
    ("indole" . SPARSER::DRUG) ("a rigid form" . SPARSER::FORM)
    ("the SirReal inhibitors" . SPARSER::INHIBITOR) ("Class" . CLASS)
    ("SirReal2 or NCA" . SPARSER::COLLECTION)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cys" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID)
    ("Sirt1 (Sirt1-HM) and Sirt3 (Sirt3-HM)" . SPARSER::COLLECTION)
    ("Sirt1 and Sirt3" . SPARSER::COLLECTION)
    ("Sirt1, Sirt3, Sirt4, Sirt5 and Sirt6" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE)
    ("several SirReal derivatives" . SPARSER::DERIVATIVE)
    ("disable Sirt2" . SPARSER::PROTEIN)
    ("Both SirReal inhibitors" . SPARSER::INHIBITOR)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("valine" . SPARSER::AMINO-ACID)
    ("zinc-binding and NAD +" . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("NAD + or Carba-NAD +" . SPARSER::COLLECTION)
    ("the available sirtuin structures lacking inhibitors"
     . SPARSER::INHIBITOR)
    ("Sirt2–SirReal complexes" . SPARSER::BIO-COMPLEX)
    ("OTC" . SPARSER::PROTEIN)
    ("Sirt2 and a different acetyl-lysine peptide substrate"
     . SPARSER::COLLECTION)
    ("a rigid conformation" . SPARSER::BIO-CONFORMATION)
    ("pyrimidine" . SPARSER::DRUG) ("amide" . SPARSER::MOLECULE)
    ("NAD + , Phe131, Leu134, Ile169, Ile232, Val233 and Phe234"
     . SPARSER::COLLECTION)
    ("van" . SPARSER::PROTEIN) ("the available Sirt2" . SPARSER::PROTEIN)
    ("aminothiazole" . SPARSER::DRUG) ("EC" . SPARSER::PROTEIN)
    ("phenylalanines" . SPARSER::AMINO-ACID) ("lysines" . SPARSER::AMINO-ACID)
    ("Sirt2 and ADPR" . SPARSER::COLLECTION)
    ("Sirt2–apo" . SPARSER::COLLECTION) ("ADPR" . SPARSER::PROTEIN)
    ("apo-Sirt2" . SPARSER::PROTEIN-PAIR) ("Sirt2–ADPR" . SPARSER::COLLECTION)
    ("apo" . SPARSER::PROTEIN) ("cofactor" . SPARSER::MOLECULE)
    ("zinc-binding" . SPARSER::PROTEIN) ("monomer" . SPARSER::MONOMER)
    ("SirReal2 and the cosubstrate NAD + (structure termed Sirt2–SirReal2–NAD + )"
     . SPARSER::COLLECTION)
    ("SirReal2 and an acetyl-lysine peptide" . SPARSER::COLLECTION)
    ("SirReal2" . SPARSER::PROTEIN)
    ("either NAD + or a peptidic acetyl-lysine substrate ( xref )"
     . SPARSER::COLLECTION)
    ("a peptidic acetyl-lysine substrate" . SPARSER::SUBSTRATE)
    ("Sirt2–SirReal2" . SPARSER::COLLECTION)
    ("Sirt2–ADPR–NCA" . SPARSER::COLLECTION) ("NCA" . SPARSER::PROTEIN)
    ("nicotinamide" . SPARSER::PROTEIN)
    ("Sirt1 (22% inhibition at 100 μM) and Sirt6 (19% inhibition at 200 μM)"
     . SPARSER::COLLECTION)
    ("non-labelled peptidic substrates" . SPARSER::SUBSTRATE)
    ("melting" . SPARSER::DRUG) ("Sirt1 or Sirt3" . SPARSER::COLLECTION)
    ("Sirt1" . SPARSER::PROTEIN) ("aminothiazoles" . SPARSER::DRUG)
    ("acetyl" . SPARSER::MOLECULE) ("SirReal inhibitors" . SPARSER::INHIBITOR)
    ("a potent macrocyclic peptidic inhibitor" . SPARSER::INHIBITOR)
    ("modulators" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("cytoplasmatic proteins" . SPARSER::PROTEIN) ("ADP" . SPARSER::ADP)
    ("deacetylases" . SPARSER::PROTEIN) ("a unique class" . CLASS)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY) ("tubulin" . SPARSER::PROTEIN)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY) ("−2" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE) ("PEG 10" . SPARSER::PROTEIN)
    ("Bis–Tris" . SPARSER::MOLECULE) ("HDAC8" . SPARSER::PROTEIN)
    ("Sirt7" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("RP18" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("ml −1" . SPARSER::PROTEIN) ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("Q8N6T7" . SPARSER::PROTEIN) ("Q96EB6" . SPARSER::PROTEIN)
    ("Q8IXJ6" . SPARSER::PROTEIN) ("SRT1720" . SPARSER::DRUG)
    ("EX-527" . SPARSER::DRUG) ("nitrogen atom" . SPARSER::MOLECULE)
    ("Sirt5" . SPARSER::PROTEIN) ("Sirt4" . SPARSER::PROTEIN)
    ("Sir2Tm" . SPARSER::PROTEIN) ("ID 2" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("ID 4" . SPARSER::PROTEIN)
    ("S2" . SPARSER::MOLECULE) ("ID 1" . SPARSER::PROTEIN)
    ("ID 3" . SPARSER::PROTEIN) ("Sirt6" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN) ("AGK2" . SPARSER::PROTEIN)
    ("Sirtuin 2" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Sirt2" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("delivering plasmid DNA" . SPARSER::DNA)
    ("a tumour-targeted CPP" . SPARSER::MOLECULE)
    ("other cancer-associated genes" . SPARSER::GENE) ("types " . TYPE)
    ("CPP–cargo" . SPARSER::MOLECULE)
    ("the CPP and its cargo (hTERT siRNA) successfully entered hepatoma cells"
     . SPARSER::COLLECTION)
    ("polyanionic peptides" . SPARSER::PEPTIDE) ("linker" . SPARSER::LINKER)
    ("oxide" . SPARSER::MOLECULE) ("iron" . SPARSER::MOLECULE)
    ("dextran" . SPARSER::DEXTRAN) ("methotrexate" . SPARSER::DRUG)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cancer-associated proteases" . SPARSER::PROTEIN)
    ("siRNA and GFP" . SPARSER::COLLECTION)
    ("small nucleic acid fragments" . SPARSER::FRAGMENT)
    ("the most well-known proteases" . SPARSER::PROTEIN)
    ("proteases" . SPARSER::PROTEIN) ("solution" . SPARSER::MOLECULE)
    ("polyanions" . SPARSER::MOLECULE)
    ("antibody derivatives or targeting peptides that recognize receptors or intracellular enzymes specifically"
     . SPARSER::COLLECTION)
    ("receptors or intracellular enzymes" . SPARSER::COLLECTION)
    ("typically 5–30 amino acids" . SPARSER::AMINO-ACID)
    ("substances" . SPARSER::SUBSTANCE) ("gene and G 1" . SPARSER::COLLECTION)
    ("a matrix metalloproteinase-2 (MMP2)-activatable cell-penetrating peptide"
     . SPARSER::PEPTIDE)
    ("CPP" . SPARSER::MOLECULE) ("CPPs" . SPARSER::MOLECULE)
    ("delivering hTERT siRNA" . SPARSER::PROTEIN) ("aCPP" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN)
    ("Activatable cell-penetrating peptides" . SPARSER::PEPTIDE)
    ("aCPPs" . SPARSER::PROTEIN) ("peptides" . SPARSER::PEPTIDE)
    ("tissue factor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN) ("telomerase activity" . SPARSER::PROTEIN)
    ("Telomerase activity" . SPARSER::PROTEIN) ("MPP2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("FAD104/FNDC3B" . SPARSER::COLLECTION)
    ("zinc-dependent enzymes" . SPARSER::ENZYME)
    ("cAMP-responsive element-binding (CREB) protein and activator protein-2α"
     . SPARSER::COLLECTION)
    ("protein and activator protein-2α" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("STAT (PIAS)" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("phosphatases" . SPARSER::PHOSPHATASE)
    ("mask" . SPARSER::PROTEIN) ("FBS" . SPARSER::PROTEIN)
    ("STAT" . SPARSER::PROTEIN) ("Myc-FAD104" . SPARSER::COLLECTION)
    ("FLAG-STAT3" . SPARSER::COLLECTION) ("FAD104-" . SPARSER::PROTEIN)
    ("FAD104 or LacZ" . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("MEFs" . SPARSER::PROTEIN)
    ("fndc3a , b and c" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID)
    ("fad49 , fad158 , peg10 and fad104" . SPARSER::COLLECTION)
    ("peg10" . SPARSER::PROTEIN) ("FNDC3B" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("Mmp2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("activator protein-2" . SPARSER::PROTEIN) ("ATF-1" . SPARSER::PROTEIN)
    ("tenascin-C" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("cucurbitacin I" . SPARSER::DRUG) ("JSI-124" . SPARSER::DRUG)
    ("βgal" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nonidet P-40" . SPARSER::DRUG) ("K 2" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("mmp2" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("fndc3b" . SPARSER::PROTEIN) ("fndc3a" . SPARSER::PROTEIN)
    ("Fad104" . SPARSER::PROTEIN) ("fibronectin type III" . SPARSER::PROTEIN)
    ("fad49" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("FAD104" . SPARSER::PROTEIN) ("fad104" . SPARSER::PROTEIN)
    ("Bank" . SPARSER::PROTEIN)
    ("conformation or dynamics" . SPARSER::COLLECTION)
    ("Gly" . SPARSER::AMINO-ACID) ("Substrates" . SPARSER::SUBSTRATE)
    ("palindromic EBS" . SPARSER::PROTEIN)
    ("Ets-2 and Ets-1" . SPARSER::COLLECTION)
    ("stromelysin" . SPARSER::PROTEIN) ("viral Ets-1" . SPARSER::PROTEIN)
    ("Lys" . SPARSER::AMINO-ACID) ("Asp" . SPARSER::AMINO-ACID)
    ("β1" . SPARSER::PROTEIN) ("Asn" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID) ("Arg" . SPARSER::AMINO-ACID)
    ("salt" . SPARSER::MOLECULE) ("solvent" . SPARSER::MOLECULE)
    ("Pro" . SPARSER::AMINO-ACID)
    ("predominantly branched chain amino acids" . SPARSER::AMINO-ACID)
    ("Trp" . SPARSER::AMINO-ACID) ("β1-β2" . SPARSER::COLLECTION)
    ("Form" . SPARSER::FORM) ("DNA and protein" . SPARSER::COLLECTION)
    ("map" . SPARSER::PROTEIN) ("FEV" . SPARSER::PROTEIN)
    ("Ets-2 and three 10-bp DNA duplexes" . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("both ERG ( xref ) and CDK10 ( xref )" . SPARSER::COLLECTION)
    ("ERG" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("maps" . SPARSER::PROTEIN) ("electron" . SPARSER::MOLECULE)
    ("PDB" . SPARSER::MOLECULE) ("monomers" . SPARSER::MONOMER)
    ("the wider Ets family proteins" . SPARSER::PROTEIN)
    ("EBS" . SPARSER::PROTEIN) ("protein-protein" . SPARSER::COLLECTION)
    ("polypeptide" . SPARSER::PEPTIDE)
    ("Ets-1, Ets-2, Etv-4, Etv-5, and Etv-6" . SPARSER::COLLECTION)
    ("Etv-1" . SPARSER::COLLECTION) ("Pu-1" . SPARSER::COLLECTION)
    ("Tel" . SPARSER::PROTEIN) ("classes" . CLASS) ("GGA" . SPARSER::MOLECULE)
    ("metazoan" . SPARSER::PROTEIN-FAMILY) ("homologue" . SPARSER::PROTEIN)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ets-1 and Ets-2" . SPARSER::COLLECTION) ("ETS" . SPARSER::PROTEIN)
    ("H1–2" . SPARSER::PROTEIN) ("branched chain" . SPARSER::PROTEIN)
    ("l -arginine" . SPARSER::MOLECULE)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("iminodiacetic acid" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("d -1" . SPARSER::PROTEIN) ("CDK10" . SPARSER::PROTEIN)
    ("stromelysin-1" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("Ets-2" . SPARSER::PROTEIN)
    ("mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("GPCR-Rho" . SPARSER::COLLECTION) ("ECM" . SPARSER::PROTEIN)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("Arkadia" . SPARSER::PROTEIN)
    ("AMOT" . SPARSER::PROTEIN) ("ITCH" . SPARSER::PROTEIN)
    ("Hect" . SPARSER::PROTEIN) ("Lats2 and CK1ɛ" . SPARSER::COLLECTION)
    ("/Axin/GSK-3" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("a strong antitumorigenic barrier" . SPARSER::PROTEIN)
    ("TEAD and NCoR1" . SPARSER::COLLECTION) ("TEAD/TAZ" . SPARSER::COLLECTION)
    ("TAZ-TEAD" . SPARSER::COLLECTION) ("/CRL1" . SPARSER::COLLECTION)
    ("TAZ and TAZS89A" . SPARSER::COLLECTION)
    ("-integrin" . SPARSER::COLLECTION) ("integrin" . SPARSER::PROTEIN)
    ("the accessory molecules Sav" . SPARSER::PROTEIN)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("GST-TAZ" . SPARSER::COLLECTION)
    ("exogenous substrates" . SPARSER::SUBSTRATE)
    ("–TAZ" . SPARSER::COLLECTION) ("vimentin" . SPARSER::PROTEIN)
    ("TAZ-acini" . SPARSER::COLLECTION)
    ("the three-dimensional (3D) Matrigel" . SPARSER::PROTEIN)
    ("acinus" . SPARSER::PROTEIN) ("Mutant" . SPARSER::MUTANT)
    ("CTGF" . SPARSER::PROTEIN)
    ("a short hairpin RNA (shRNA) or two small interfering RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("HA-Mer" . SPARSER::COLLECTION) ("Mer" . SPARSER::PROTEIN)
    ("NDR1 and NDR2" . SPARSER::COLLECTION)
    ("associated proteins" . SPARSER::PROTEIN)
    ("Myc-Lats2" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lats1, and Lats2" . SPARSER::COLLECTION)
    ("STK38 or NDR1" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("LATS" . SPARSER::PROTEIN) ("a Ski-associated protein" . SPARSER::PROTEIN)
    ("Proteins" . SPARSER::PROTEIN)
    ("Ski-associated proteins" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("thrombin, and epinephrine" . SPARSER::COLLECTION)
    ("epinephrine" . SPARSER::DRUG) ("thrombin" . SPARSER::PROTEIN)
    ("guanine" . SPARSER::PROTEIN) ("TEAD/TEF" . SPARSER::COLLECTION)
    ("TEF" . SPARSER::PROTEIN) ("Sav1" . SPARSER::PROTEIN)
    ("Sav" . SPARSER::PROTEIN) ("Lats1 or Lats2" . SPARSER::COLLECTION)
    ("Mst1" . SPARSER::PROTEIN) ("molecules or pathways" . SPARSER::COLLECTION)
    ("the functional heteromeric Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TEAD-TAZ" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("coactivators" . SPARSER::PROTEIN) ("TAZ" . SPARSER::PROTEIN)
    ("/Smad" . SPARSER::COLLECTION)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("TEAD4" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("LATS2" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("TEAD1" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("R-Smad" . SPARSER::PROTEIN-FAMILY)
    ("AIP4" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("CRL1" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("STK38L" . SPARSER::PROTEIN)
    ("NDR2" . SPARSER::PROTEIN) ("NDR1" . SPARSER::PROTEIN)
    ("serine/threonine kinase 38" . SPARSER::PROTEIN)
    ("STK38" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("G protein" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("Mob1" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("Lats1" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("NCoR1" . SPARSER::PROTEIN) ("Lats2" . SPARSER::PROTEIN)
    ("transforming protein" . SPARSER::PROTEIN) ("trap" . SPARSER::PROTEIN)
    ("p53 and Gli2" . SPARSER::COLLECTION)
    ("p73 or p53BP2" . SPARSER::COLLECTION) ("Forkhead" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN)
    ("YAP1, 14-3-3σ, and p21" . SPARSER::COLLECTION)
    ("TGF-β/Smad" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("p-Smad2 and p-Smad3" . SPARSER::COLLECTION)
    ("p-Smad3" . SPARSER::COLLECTION) ("p-Smad2" . SPARSER::COLLECTION)
    ("both endogenous Gli2 and ectopically expressed Myc-tagged Gli2"
     . SPARSER::COLLECTION)
    ("TGF-β/Smad/Gli2" . SPARSER::COLLECTION)
    ("IL-11 or Jagged-1" . SPARSER::COLLECTION)
    ("PTHrP, IL-11, and Jagged-1" . SPARSER::COLLECTION)
    ("TRAP" . SPARSER::PROTEIN) ("mature osteoclasts" . SPARSER::PROTEIN)
    ("osteoclasts" . SPARSER::PROTEIN) ("RANKL" . SPARSER::PROTEIN)
    ("GFP and luciferase" . SPARSER::COLLECTION) ("ray" . SPARSER::PROTEIN)
    ("GFP-" . SPARSER::PROTEIN) ("BLI" . SPARSER::PROTEIN)
    ("GFP and Luciferase" . SPARSER::COLLECTION)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("TESS" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("Aza" . SPARSER::DRUG)
    ("p53-MDM2" . SPARSER::COLLECTION) ("SFN" . SPARSER::PROTEIN)
    ("p53 ( xref ) or FOXO3a ( xref )" . SPARSER::COLLECTION)
    ("p21 protein and mRNA" . SPARSER::COLLECTION)
    ("a key effector of TGF-β’s" . SPARSER::EFFECTOR)
    ("p27/Kip1" . SPARSER::COLLECTION)
    ("fresh media containing TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPPA" . SPARSER::PROTEIN)
    ("atypical ductal hyperplasia (ADH)-like acini" . SPARSER::PROTEIN)
    ("ADH" . SPARSER::PROTEIN) ("normal acini" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN)
    ("the polyoma viral middle T antigen" . SPARSER::MOLECULE)
    ("Tgfbr2" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("EMT" . SPARSER::PROTEIN) ("Gli2" . SPARSER::PROTEIN)
    ("PTHrP" . SPARSER::PROTEIN) ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("6.3" . SPARSER::PROTEIN) ("p53BP2" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("14-3-3s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Zinc finger protein" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN)
    ("parathyroid hormone-related protein" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("YAP1" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("T antigen" . SPARSER::MOLECULE) ("Smad4" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("TGFβR" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("active genes" . SPARSER::GENE)
    ("c-Myc, cyclin D1, and cyclin D2" . SPARSER::COLLECTION)
    ("DMSO or tylophorine" . SPARSER::COLLECTION)
    ("polysomes, P-bodies and stress granules" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("mRNA and cyclins" . SPARSER::COLLECTION) ("tylophorine-" . SPARSER::DRUG)
    ("mRNA, and cyclins" . SPARSER::COLLECTION)
    ("viral RNP complexes" . SPARSER::BIO-COMPLEX)
    ("RNA and protein" . SPARSER::COLLECTION) ("snRNPs" . SPARSER::BIO-COMPLEX)
    ("hnRNP" . SPARSER::PROTEIN) ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("RNPs" . SPARSER::PROTEIN)
    ("c-Myc, cyclin D2, and cyclin D1" . SPARSER::COLLECTION)
    ("tylophorine and DBQ 33b" . SPARSER::COLLECTION)
    ("cyclin A2, cyclin B1, SERBP1, PRDX3, and POLR3G" . SPARSER::COLLECTION)
    ("GADD45A, and THBS1" . SPARSER::COLLECTION)
    ("alkaloids" . SPARSER::MOLECULE) ("Dcp1a" . SPARSER::PROTEIN)
    ("GLS1 and LDHA" . SPARSER::COLLECTION) ("nutrient" . SPARSER::MOLECULE)
    ("dehydrogenase" . SPARSER::PROTEIN) ("Lactate" . SPARSER::LACTATE)
    ("LDHA" . SPARSER::PROTEIN) ("Glutaminase" . SPARSER::PROTEIN)
    ("pRb, cyclin A2 and cyclin B1" . SPARSER::COLLECTION)
    ("the caprin-1 and c-Myc mRNA-associated RNP complex"
     . SPARSER::BIO-COMPLEX)
    ("even ectopically expressed c-Myc" . SPARSER::PROTEIN)
    ("caprin-1 and c-Myc" . SPARSER::COLLECTION)
    ("a c-Myc target and another upstream effector" . SPARSER::COLLECTION)
    ("either cyclin D2 (Fig. xref -upper panel) or cyclin D1 (Fig. xref -lower panel)"
     . SPARSER::COLLECTION)
    ("the pRb's" . SPARSER::PROTEIN)
    ("G3BP1 protein (Fig. xref ) and mRNAs" . SPARSER::COLLECTION)
    ("c-Myc and cyclinD1/D2" . SPARSER::COLLECTION)
    ("TAMRA" . SPARSER::MOLECULE) ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("either cyclin D1 or D2 mRNAs" . SPARSER::COLLECTION)
    ("the caprin-1, G3BP1, and c-Myc mRNA-associated RNP complex"
     . SPARSER::BIO-COMPLEX)
    ("caprin-1, G3BP1, and c-Myc" . SPARSER::COLLECTION)
    ("polysomal fractions" . SPARSER::COMPONENT)
    ("caprin-1 and G3BP1" . SPARSER::COLLECTION)
    ("mRNA and cyclin D2" . SPARSER::COLLECTION)
    ("α-actinin-4, G3BP1, and p-S6" . SPARSER::COLLECTION)
    ("peptidyl-tRNA" . SPARSER::COLLECTION) ("tRNA" . SPARSER::PROTEIN)
    ("TATA-binding protein-associated factor 2N isoform 1" . SPARSER::PROTEIN)
    ("splicing factor (PSF)" . SPARSER::PROTEIN) ("TAF" . SPARSER::PROTEIN)
    ("PSF" . SPARSER::PROTEIN) ("nucleolin" . SPARSER::PROTEIN)
    ("The potential tylophorine-interacting proteins" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("streptavidin" . SPARSER::PROTEIN)
    ("traditional pentacyclic tylophorine" . SPARSER::DRUG)
    ("the two major phenanthrene" . SPARSER::DRUG)
    ("quinolizidine" . SPARSER::MOLECULE) ("tylocrebrine" . SPARSER::DRUG)
    ("valuable novel drug" . SPARSER::DRUG)
    ("mRNA, and Cyclin D2" . SPARSER::COLLECTION)
    ("c-Myc or cyclin D2" . SPARSER::COLLECTION)
    ("caprin-1/G3BP1" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN) ("Active" . SPARSER::ACTIVE)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("active cyclin D-Cdk4/6 complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin D-Cdk4" . SPARSER::PROTEIN-PAIR) ("pRb" . SPARSER::PROTEIN)
    ("cyclin D1, cyclin D2, and cyclin D3" . SPARSER::COLLECTION)
    ("its associated RNP" . SPARSER::PROTEIN) ("RNP" . SPARSER::PROTEIN)
    ("cyclin D-Cdk" . SPARSER::COLLECTION) ("mRNP" . SPARSER::BIO-COMPLEX)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and cyclins" . SPARSER::COLLECTION)
    ("the polysomal fractions" . SPARSER::COMPONENT)
    ("fractions" . SPARSER::COMPONENT)
    ("mRNA, and cyclin D2" . SPARSER::COLLECTION)
    ("tylophorine" . SPARSER::DRUG) ("Tylophorine" . SPARSER::DRUG)
    ("SP5" . SPARSER::PROTEIN) ("DCP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-3" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("Asp-Tyr" . SPARSER::MOLECULE)
    ("housekeeping gene" . SPARSER::PROTEIN) ("DU 145" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN) ("N 5" . SPARSER::PROTEIN)
    ("CD 3" . SPARSER::PROTEIN) ("Cl 2" . SPARSER::PROTEIN)
    ("CH 2" . SPARSER::MOLECULE) ("SO 4" . SPARSER::PROTEIN)
    ("tert-butyl" . SPARSER::MOLECULE) ("THBS1" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("POLR3G" . SPARSER::PROTEIN)
    ("PRDX3" . SPARSER::PROTEIN) ("SERBP1" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("Dcp1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 1" . SPARSER::PROTEIN) ("GLS1" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("G3BP-1" . SPARSER::PROTEIN)
    ("ribosomal protein S3" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("isoform 1" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein M" . SPARSER::PROTEIN)
    ("PABP-1" . SPARSER::PROTEIN)
    ("polyadenylate-binding protein" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("α-actinin-4" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN)
    ("Ras GTPase-activating protein-binding protein 1" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("cyclin A2" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D3" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caprin-1" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("cyclin D2" . SPARSER::PROTEIN) ("G3BP1" . SPARSER::PROTEIN)
    ("caprin-1" . SPARSER::PROTEIN) ("COX-2 and AP-2α" . SPARSER::COLLECTION)
    ("p53, GATA-1, p50 and p65" . SPARSER::COLLECTION)
    ("AP-2α, and AP-2α" . SPARSER::COLLECTION)
    ("p300 and AP-2α" . SPARSER::COLLECTION)
    ("a predominant isoform" . SPARSER::ISOFORM)
    ("trans-activating factor" . SPARSER::COLLECTION)
    ("NF-κB and/or AP-2 nuclear protein" . SPARSER::COLLECTION)
    ("AP-2α or the siRNA" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("IL-1, PMA and LPS" . SPARSER::COLLECTION)
    ("the potential binding proteins" . SPARSER::PROTEIN)
    ("anti-p300 or anti-AP-2α" . SPARSER::COLLECTION)
    ("agarose" . SPARSER::MOLECULE)
    ("both p300 (green) and AP-2α (red)" . SPARSER::COLLECTION)
    ("AP-2α and p300" . SPARSER::COLLECTION)
    ("SP1, NF-κB and AP-2" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AP-2α and the other trans-activators" . SPARSER::COLLECTION)
    ("SP1 and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and AP-2α" . SPARSER::COLLECTION)
    ("the COX-2 proximal promoter" . SPARSER::PROMOTER)
    ("SP1" . SPARSER::PROTEIN) ("CB" . SPARSER::PROTEIN)
    ("LacZ" . SPARSER::PROTEIN) ("nanoparticles" . SPARSER::MOLECULE)
    ("COX-2 mRNA (Fig. xref , right panel ) and proteins (Fig. xref , right panel)"
     . SPARSER::COLLECTION)
    ("COX-2 mRNA (Fig. xref , left panel) and proteins (Fig. xref , left panel)"
     . SPARSER::COLLECTION)
    ("siAP-2" . SPARSER::COLLECTION) ("media" . SPARSER::PROTEIN)
    ("the internal control GAPDH or β-actin" . SPARSER::COLLECTION)
    ("AP-2α or COX-2" . SPARSER::COLLECTION)
    ("GAPDH or β-actin" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("SUNE-1" . SPARSER::COLLECTION)
    ("the potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("enhancers" . SPARSER::PROTEIN) ("GGC" . SPARSER::PROTEIN)
    ("GC" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("AP-2α, AP-2β, AP-2γ, AP-2δ and AP-2ε" . SPARSER::COLLECTION)
    ("IIB (TFIIB)" . SPARSER::PROTEIN) ("TFIIB" . SPARSER::PROTEIN)
    ("IIB" . SPARSER::PROTEIN) ("P300 and CBP" . SPARSER::COLLECTION)
    ("CBP" . SPARSER::PROTEIN) ("AMP" . SPARSER::AMP)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRE and C/EBP" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("CRE" . SPARSER::PROTEIN) ("PMA" . SPARSER::PROTEIN)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("an immediate and early response gene" . SPARSER::GENE)
    ("growth factors, cytokines, and oncogenes" . SPARSER::COLLECTION)
    ("esters" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)"
     . SPARSER::COLLECTION)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thromboxane" . SPARSER::MOLECULE) ("prostaglandin" . SPARSER::PROTEIN)
    ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("HAT" . SPARSER::PROTEIN) ("acetyltransferase" . SPARSER::PROTEIN)
    ("AP-2α/COX-2" . SPARSER::COLLECTION)
    ("COX-2 and PGE2" . SPARSER::COLLECTION)
    ("AP-2α and COX-2" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("NPCs" . SPARSER::MOLECULE) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("de-" . SPARSER::MOLECULE)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("NH4 Cl" . SPARSER::MOLECULE) ("monoclonal antibody" . SPARSER::DRUG)
    ("P40" . SPARSER::PROTEIN) ("DUAL-luciferase" . SPARSER::PROTEIN)
    ("GATA-1" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("SP-1" . SPARSER::PROTEIN)
    ("C646" . SPARSER::MOLECULE) ("p65" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG) ("1-C" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN) ("AP-2ε" . SPARSER::PROTEIN)
    ("AP-2δ" . SPARSER::PROTEIN) ("AP-2γ" . SPARSER::PROTEIN)
    ("AP-2β" . SPARSER::PROTEIN)
    ("AP-2 transcription factor" . SPARSER::PROTEIN)
    ("P300" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("COX-1" . SPARSER::PROTEIN)
    ("cyclooxygenase-1" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("PGE2" . SPARSER::DRUG) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("AP-2α" . SPARSER::PROTEIN)
    ("Activating enhancer-binding protein-2" . SPARSER::PROTEIN)
    ("MYC and FBXW7" . SPARSER::COLLECTION) ("leukemia" . SPARSER::PROTEIN)
    ("the most frequently mutated genes (approximately 30% of cases [ xref ]) and mouse models"
     . SPARSER::COLLECTION)
    ("MYC, CyclinE, NOTCH1, and c-JUN" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("only four MYC-SL candidate genes" . SPARSER::GENE)
    ("estrogen and faithfully models MYC deregulation [ xref ]"
     . SPARSER::COLLECTION)
    ("siRNA and shRNA" . SPARSER::COLLECTION)
    ("FBXW7, LAMA2, PRMT8, and ZNF614" . SPARSER::COLLECTION)
    ("MYC or CDC45" . SPARSER::COLLECTION)
    ("PARP, and PUMA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("ATR or Chk2" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("ATR" . SPARSER::PROTEIN) ("alleles" . SPARSER::ALLELE)
    ("c-Jun, NOTCH1, CyclinE, and mTOR" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN) ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("luminal" . SPARSER::DRUG) ("Luminal" . SPARSER::DRUG)
    ("FBXW7 and MYC" . SPARSER::COLLECTION) ("ON/MYC" . SPARSER::COLLECTION)
    ("live cell flow cytometry" . SPARSER::PROTEIN)
    ("GFP or RFP" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("antibiotic" . SPARSER::DRUG)
    ("MYC and other oncoproteins [ xref ]" . SPARSER::COLLECTION)
    ("MYC-SL" . SPARSER::COLLECTION) ("SL" . SPARSER::PROTEIN)
    ("fructose and mannose" . SPARSER::COLLECTION)
    ("mannose" . SPARSER::MOLECULE) ("fructose" . SPARSER::PROTEIN)
    ("ON" . SPARSER::PROTEIN) ("FC" . SPARSER::PROTEIN)
    ("−1" . SPARSER::PROTEIN)
    ("complementary oligonucleotide" . SPARSER::MOLECULE)
    ("fluorescent nucleotides" . SPARSER::NUCLEOTIDE)
    ("oligonucleotide" . SPARSER::MOLECULE)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("essential genes" . SPARSER::GENE)
    ("foci" . SPARSER::PROTEIN) ("thymidine" . SPARSER::PROTEIN)
    ("hormone" . SPARSER::MOLECULE)
    ("78 potential synthetic lethal targets" . SPARSER::TARGET-PROTEIN)
    ("the WRN helicase [ xref , xref ], the AuroraA/B [ xref ] and CDK [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("kinases, and Chk1/2" . SPARSER::COLLECTION)
    ("helicase" . SPARSER::PROTEIN) ("WRN" . SPARSER::PROTEIN)
    ("several additional oncoproteins and master regulator molecules"
     . SPARSER::COLLECTION)
    ("CyclinE, NOTCH1, mTOR, SREBP, and c-JUN" . SPARSER::COLLECTION)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("CyclinE" . SPARSER::PROTEIN-FAMILY)
    ("Fbw7" . SPARSER::PROTEIN) ("hAgo" . SPARSER::PROTEIN)
    ("At least 4 different ubiquitin ligase complexes" . SPARSER::BIO-COMPLEX)
    ("transcriptional activator and repressor" . SPARSER::COLLECTION)
    ("bHLH-LZ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("bHLH" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("Cdc45" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("RNAse A" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("c-Myb" . SPARSER::PROTEIN)
    ("KLF5" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("NRF1" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("ZNF614" . SPARSER::PROTEIN) ("PRMT8" . SPARSER::PROTEIN)
    ("LAMA2" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("GSK3-β" . SPARSER::PROTEIN) ("UBE2I" . SPARSER::PROTEIN)
    ("4OHT" . SPARSER::DRUG) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("CSNK1E" . SPARSER::PROTEIN) ("SAE1" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("hCdc4" . SPARSER::PROTEIN) ("Sel-10" . SPARSER::PROTEIN)
    ("CDC45" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("NCCN" . SPARSER::MOLECULE) ("vascular malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("FTC" . SPARSER::DRUG)
    ("PTC" . SPARSER::PROTEIN) ("KLLN and AR" . SPARSER::COLLECTION)
    ("KLLN and PTEN" . SPARSER::COLLECTION)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and KLLN" . SPARSER::COLLECTION) ("cryptic" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("three benign CS" . SPARSER::PROTEIN) ("benign CS" . SPARSER::PROTEIN)
    ("CpG" . SPARSER::PROTEIN) ("SIR" . SPARSER::PROTEIN)
    ("bisulfite" . SPARSER::MOLECULE) ("rank" . SPARSER::PROTEIN)
    ("CS/CSL" . SPARSER::COLLECTION) ("CS and CSL" . SPARSER::COLLECTION)
    ("KLLN/PTEN" . SPARSER::COLLECTION) ("classic CS" . SPARSER::PROTEIN)
    ("CSL" . SPARSER::PROTEIN)
    ("particular malignant and benign CS" . SPARSER::PROTEIN)
    ("thyroid" . SPARSER::PROTEIN)
    ("benign and malignant CS" . SPARSER::PROTEIN) ("CS" . SPARSER::PROTEIN)
    ("KLLN" . SPARSER::PROTEIN) ("Exonuclease 1" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN)
    ("adenomatous polyposis coli( APC ) gene" . SPARSER::GENE)
    ("APC" . SPARSER::PROTEIN) ("Hyperactive Notch3" . SPARSER::PROTEIN)
    ("a distinctive biomarker" . SPARSER::MOLECULE)
    ("Notch3 and AFP" . SPARSER::COLLECTION)
    ("lenti-shRNA" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("β-catenin and increase Nanog" . SPARSER::COLLECTION)
    ("Myc and Oct4" . SPARSER::COLLECTION)
    ("Myc, Oct4 and Nanog" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("Notch3 and β-catenin" . SPARSER::COLLECTION)
    ("AFP and Notch 3" . SPARSER::COLLECTION)
    ("AFP and Notch3" . SPARSER::COLLECTION)
    ("Notch3 and Hes1" . SPARSER::COLLECTION)
    ("the Notch-related genes" . SPARSER::GENE) ("ALDH" . SPARSER::PROTEIN)
    ("Nanog" . SPARSER::PROTEIN) ("ki67" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Aldehyde dehydrogenase" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("Notch 3" . SPARSER::PROTEIN) ("notch 3" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("Jagged2" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("T-ICs" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("pemetrexed and platinum-based chemotherapy regimens"
     . SPARSER::COLLECTION)
    ("a reliable and robust prognostic and predictive biomarker"
     . SPARSER::MOLECULE)
    ("more
aggressive MPM"
     . SPARSER::MOLECULE)
    ("substance" . SPARSER::SUBSTANCE) ("ID" . SPARSER::PROTEIN)
    ("a newly developed, potent and
selective MDM2 inhibitor"
     . SPARSER::INHIBITOR)
    ("MDM2–P53" . SPARSER::COLLECTION) ("-imidazoline" . SPARSER::MOLECULE)
    ("imidazoline" . SPARSER::MOLECULE) ("cis" . SPARSER::PROTEIN)
    ("two unique proteins" . SPARSER::PROTEIN)
    ("protein and mRNA" . SPARSER::COLLECTION) ("platinum" . SPARSER::MOLECULE)
    ("MDM2
and P53"
     . SPARSER::COLLECTION)
    ("reliable, predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("DNA-repair" . SPARSER::DNA)
    ("cisplatin or
carboplatin"
     . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("Male" . SPARSER::MOLECULE)
    ("the investigated patients received cisplatin" . SPARSER::DRUG)
    ("–1" . SPARSER::PROTEIN) ("-mRNA" . SPARSER::COLLECTION)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HR" . SPARSER::PROTEIN)
    ("reliable predictive biomarkers" . SPARSER::MOLECULE)
    ("biphasic MPM" . SPARSER::MOLECULE) ("antifolates" . SPARSER::MOLECULE)
    ("asbestos" . SPARSER::MOLECULE) ("MPMs" . SPARSER::MOLECULE)
    ("robust
prognostic and predictive biomarker"
     . SPARSER::MOLECULE)
    ("P14/ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("cisplatin and pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("MPM" . SPARSER::MOLECULE)
    ("RO5045337" . SPARSER::DRUG) ("Nutlin-3A" . SPARSER::DRUG)
    ("P16" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("MDM2
protein"
     . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("l −1" . SPARSER::PROTEIN) ("IF2" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("P14" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the c-Abl inhibitor imatinib or the c-Abl knockdown ( xref and xref )"
     . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("etoposide, doxorubicin, cisplatin, camptothecin, nocodazole, and taxol"
     . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG)
    ("a pathophysiologically relevant downstream target"
     . SPARSER::TARGET-PROTEIN)
    ("functional IER3" . SPARSER::PROTEIN)
    ("BAX, NOXA, and NIS" . SPARSER::COLLECTION) ("NIS" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("p73 and E6" . SPARSER::COLLECTION)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("E6-associated protein" . SPARSER::PROTEIN)
    ("ligase, and forms" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("imatinib ( xref ) and c-Abl knockdown ( xref )" . SPARSER::COLLECTION)
    ("Gleevec" . SPARSER::DRUG) ("imatinib" . SPARSER::DRUG)
    ("Etoposide" . SPARSER::PROTEIN)
    ("nocodazole, camptothecin, doxorubicin, etoposide, and cisplatin"
     . SPARSER::COLLECTION)
    ("cisplatin" . SPARSER::DRUG) ("camptothecin" . SPARSER::DRUG)
    ("nocodazole" . SPARSER::DRUG)
    ("IER3 protein and its mRNA" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("Luciferase" . SPARSER::PROTEIN)
    ("neither p53 nor TAp63" . SPARSER::COLLECTION)
    ("E6 or E7" . SPARSER::COLLECTION)
    ("p53, p63, and p73" . SPARSER::COLLECTION)
    ("IER3 and TAp73β" . SPARSER::COLLECTION)
    ("MCL-1, and IER3" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION)
    ("functional BIM" . SPARSER::PROTEIN)
    ("the pivotal regulator" . SPARSER::REGULATOR) ("BIM" . SPARSER::PROTEIN)
    ("p53, Sp1, c-Myc, and NF-κB" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("p22/PRG-1" . SPARSER::COLLECTION)
    ("Dif-2" . SPARSER::PROTEIN) ("gly" . SPARSER::AMINO-ACID)
    ("Dif" . SPARSER::PROTEIN) ("p22" . SPARSER::PROTEIN)
    ("TP73 (p73) and p63" . SPARSER::COLLECTION)
    ("Viral E6 and E7" . SPARSER::COLLECTION)
    ("E6 and E7" . SPARSER::COLLECTION) ("oncoproteins" . SPARSER::PROTEIN)
    ("etoposide" . SPARSER::PROTEIN) ("p53 and TAp63" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("Caspase 7" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("E6AP" . SPARSER::PROTEIN) ("STI571" . SPARSER::DRUG)
    ("Caspase 8" . SPARSER::PROTEIN) ("Caspase 9" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("BCL-xL" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("PRG-1" . SPARSER::PROTEIN) ("IEX-1" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN)
    ("Immediate early response" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("c-Ab1" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("TAp63" . SPARSER::PROTEIN) ("IER3" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokinetic substrates" . SPARSER::SUBSTRATE)
    ("centromeres" . SPARSER::PROTEIN) ("INCENP" . SPARSER::PROTEIN)
    ("MyoGEF" . SPARSER::PROTEIN) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("the potential substrate" . SPARSER::SUBSTRATE)
    ("condensin" . SPARSER::PROTEIN-FAMILY)
    ("a third kinase or another form" . SPARSER::COLLECTION)
    ("the resultant stable transfectants" . SPARSER::PROTEIN)
    ("transfectants" . SPARSER::PROTEIN) ("HA-" . SPARSER::PROTEIN)
    ("HA" . SPARSER::PROTEIN) ("Plk1 and" . SPARSER::PROTEIN)
    ("GST-tagged WT Ataxin-10 or the S12A mutant" . SPARSER::COLLECTION)
    ("GST-Plk1 and" . SPARSER::PROTEIN-PAIR)
    ("GST-Ataxin-10-S12A" . SPARSER::COLLECTION)
    ("S12A and Plk1" . SPARSER::COLLECTION) ("HA-Plk1" . SPARSER::PROTEIN-PAIR)
    ("BI, and Ataxin-10" . SPARSER::COLLECTION)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("which targets Plk1" . SPARSER::PROTEIN) ("BI" . SPARSER::PROTEIN)
    ("S12A" . SPARSER::PROTEIN) ("Ataxin-10-S12A" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN)
    ("serines or threonines" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID) ("serines" . SPARSER::AMINO-ACID)
    ("Ala" . SPARSER::AMINO-ACID) ("IVK" . SPARSER::KINASE)
    ("His" . SPARSER::AMINO-ACID) ("GST-Ataxin-10" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN) ("Noc" . SPARSER::PROTEIN)
    ("FLAG-Ataxin-10" . SPARSER::COLLECTION)
    ("a key mitotic kinase" . SPARSER::KINASE) ("PCNA" . SPARSER::PROTEIN)
    ("OGT" . SPARSER::PROTEIN) ("The toxic RNA" . SPARSER::RNA)
    ("mitochondria" . SPARSER::PROTEIN) ("epilepsy" . SPARSER::PROTEIN)
    ("ataxia" . SPARSER::PROTEIN) ("Ataxin-10 and Plk1" . SPARSER::COLLECTION)
    ("Ataxin-10 and polo-like kinase 1" . SPARSER::COLLECTION)
    ("MS2" . SPARSER::PROTEIN) ("Glu-C" . SPARSER::PROTEIN)
    ("Asp-N" . SPARSER::PROTEIN) ("32 P" . SPARSER::|32P|)
    ("MgCl 2" . SPARSER::MOLECULE)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("CAP-D2" . SPARSER::PROTEIN) ("MYPT1" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("kinase activity" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("ZM447439" . SPARSER::DRUG)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PKC δ" . SPARSER::PROTEIN)
    ("hnRNP K" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("Plk1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("Ataxin-10" . SPARSER::PROTEIN)
    ("ATXN10" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("cigarette" . SPARSER::DRUG)
    ("naproxen and ibuprofen" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("naproxen" . SPARSER::DRUG) ("NSAIDs" . SPARSER::DRUG)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("nonsteroidal anti-inflammatory drug celecoxib" . SPARSER::DRUG)
    ("neutrophil" . SPARSER::PROTEIN) ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFR1, ERK1/2, Src, nitric oxide synthase, and glucocorticoid"
     . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN) ("clathrin" . SPARSER::PROTEIN)
    ("monocytes" . SPARSER::PROTEIN) ("nonfunctional CFTR" . SPARSER::PROTEIN)
    ("miR-199a-5p and CAV1" . SPARSER::COLLECTION) ("HD" . SPARSER::PROTEIN)
    ("celecoxib or vehicle" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("neutrophils (PMN)" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("BAL" . SPARSER::PROTEIN) ("emphysema" . SPARSER::PROTEIN)
    ("smoke" . SPARSER::MOLECULE) ("Celecoxib" . SPARSER::DRUG)
    ("PTEN-KO" . SPARSER::COLLECTION) ("KO" . SPARSER::PROTEIN)
    ("AKT1-KO" . SPARSER::COLLECTION) ("AKT3/PKBγ" . SPARSER::COLLECTION)
    ("AKT1/PKBα" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("/protein kinase B (AKT)" . SPARSER::COLLECTION)
    ("MAC1" . SPARSER::PROTEIN)
    ("EGFP and puromycin-resistance genes" . SPARSER::COLLECTION)
    ("puromycin" . SPARSER::DRUG) ("RV-" . SPARSER::MOLECULE)
    ("CTR" . SPARSER::PROTEIN) ("EGFP" . SPARSER::PROTEIN)
    ("RV" . SPARSER::MOLECULE) ("a-1 and a-2" . SPARSER::COLLECTION)
    ("a-2" . SPARSER::PROTEIN) ("a-1" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("arm" . SPARSER::PROTEIN)
    ("The miR-199a-5p and miR-199a-3p mature miRNA" . SPARSER::PROTEIN)
    ("miR-199a-5p and miR-199a-3p" . SPARSER::COLLECTION)
    ("Grp78" . SPARSER::PROTEIN) ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("flagellin" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("functional CFTR" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("miRs" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("MiRNAs" . SPARSER::PROTEIN) ("dysfunctional CFTR" . SPARSER::PROTEIN)
    ("CAV1/HO-1" . SPARSER::COLLECTION) ("redox" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("CFTR" . SPARSER::PROTEIN) ("drug (NSAID)" . SPARSER::DRUG)
    ("NSAID" . SPARSER::PROTEIN)
    ("other pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("celecoxib" . SPARSER::DRUG) ("FDA" . SPARSER::PROTEIN)
    ("scaffold" . SPARSER::SCAFFOLD) ("LPS" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("6B" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD14" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("let7" . SPARSER::RNA) ("IGF-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("cAMP-dependent chloride channel" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("PKBγ" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("PKBα" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAC-1" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("CAV-1" . SPARSER::PROTEIN) ("b-5" . SPARSER::PROTEIN)
    ("miR-199a-3p" . SPARSER::MOLECULE) ("ATF6" . SPARSER::PROTEIN)
    ("α1-antitrypsin" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("TLR5" . SPARSER::PROTEIN) ("MiR-199a-5p" . SPARSER::MOLECULE)
    ("Hif-1α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1alpha" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("messenger RNAs" . SPARSER::RNA) ("HO-1" . SPARSER::PROTEIN)
    ("heme-oxygenase 1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("Toll like receptor 4" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("TLR4" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("intact MMR" . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("PNI" . SPARSER::PROTEIN) ("p53, DCC, and KRAS" . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN) ("DCC" . SPARSER::PROTEIN)
    ("MMR" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("Mismatch" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("Nodal" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN)
    ("CCND1 or 11q13" . SPARSER::COLLECTION)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("T1-2 and T3-4" . SPARSER::COLLECTION)
    ("a diagnostic biomarker" . SPARSER::MOLECULE)
    ("New diagnostic biomarkers" . SPARSER::MOLECULE)
    ("PPV" . SPARSER::MOLECULE) ("CGH" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN) ("bad" . SPARSER::PROTEIN)
    ("met" . SPARSER::AMINO-ACID)
    ("Myo, Miyamoto, and Michikawa" . SPARSER::COLLECTION)
    ("Myo" . SPARSER::PROTEIN)
    ("several potential driver genes" . SPARSER::GENE)
    ("CCND1 , CTTN , FADD , FGF19 , and ORAOV1" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("CTTN" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN)
    ("a larger homogeneous cohort" . SPARSER::MOLECULE)
    ("CCND1 and protein" . SPARSER::COLLECTION) ("nodal" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN) ("ORAOV1" . SPARSER::PROTEIN)
    ("FGF19" . SPARSER::PROTEIN) ("T1-2" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("proto-oncogene and ERα" . SPARSER::COLLECTION)
    ("multi" . SPARSER::PROTEIN) ("CtBP1 and HDAC1/2" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION)
    ("CDKN2B and CDK6" . SPARSER::COLLECTION)
    ("MAPK13 and CYP26B1" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("a global gene" . SPARSER::GENE)
    ("the tumor suppressor CDKN2B and its target CDK6" . SPARSER::COLLECTION)
    ("normal water" . SPARSER::MOLECULE)
    ("mice either received normal drinking water or water-containing 2 mg/mL doxycycline"
     . SPARSER::COLLECTION)
    ("water" . SPARSER::MOLECULE) ("estradiol" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN)
    ("the mainly anti-proliferative NRs RAR and PPAR" . SPARSER::COLLECTION)
    ("the pro-proliferative type I NRs ERα and PR" . SPARSER::COLLECTION)
    ("ERα and PR" . SPARSER::COLLECTION) ("RAR and PPAR" . SPARSER::COLLECTION)
    ("CDK2 , CCNB1 , CCNE2 , and E2F1" . SPARSER::COLLECTION)
    ("CDK/cyclin D" . SPARSER::COLLECTION)
    ("cyclin-dependent protein kinases (CDKs) and cyclins"
     . SPARSER::COLLECTION)
    ("INK4 and Cip/Kip" . SPARSER::COLLECTION)
    ("families" . SPARSER::PROTEIN-FAMILY) ("Cip" . SPARSER::PROTEIN)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKs" . SPARSER::PROTEIN)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-proliferative type I NRs" . SPARSER::PROTEIN)
    ("type I and type II" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("NR" . SPARSER::PROTEIN)
    ("receptor (RAR)" . SPARSER::RECEPTOR)
    ("receptor (PPAR)" . SPARSER::RECEPTOR) ("RAR" . SPARSER::PROTEIN)
    ("PPAR" . SPARSER::PROTEIN) ("peroxisome" . SPARSER::PROTEIN)
    ("NRs" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("adjuvant" . SPARSER::DRUG) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("differentially" . SPARSER::PROTEIN) ("PIM - 1" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC1" . SPARSER::PROTEIN)
    ("CtBP1" . SPARSER::PROTEIN) ("ZNF217" . SPARSER::PROTEIN)
    ("zinc-finger protein" . SPARSER::PROTEIN) ("CYP26B1" . SPARSER::PROTEIN)
    ("MAPK13" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("HPRT1" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("17β-estradiol" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("S-M" . SPARSER::PROTEIN)
    ("p15ink4b" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("vitamin D3" . SPARSER::MOLECULE) ("retinoic acid" . SPARSER::MOLECULE)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("zinc finger protein 366" . SPARSER::PROTEIN)
    ("CDKN2B" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("ZNF366" . SPARSER::PROTEIN) ("ERα" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("epoxide" . SPARSER::MOLECULE)
    ("pyrene" . SPARSER::PROTEIN) ("Ren" . SPARSER::PROTEIN)
    ("Van" . SPARSER::PROTEIN) ("miR-494-3p" . SPARSER::PROTEIN)
    ("U87-miR-494-3p" . SPARSER::PROTEIN-PAIR)
    ("Caspase-3 and Caspase-9" . SPARSER::COLLECTION)
    ("BCL2, Caspase-3, and Caspase-9" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("PTEN and miR-494-3P" . SPARSER::COLLECTION)
    ("antioncogenes" . SPARSER::PROTEIN) ("antisense" . SPARSER::PROTEIN)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U87 and U251" . SPARSER::COLLECTION) ("polymerase" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("HRP-3" . SPARSER::PROTEIN)
    ("caspase9" . SPARSER::PROTEIN) ("caspase3" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("mutagen" . SPARSER::MOLECULE) ("mutagens" . SPARSER::MOLECULE)
    ("Cdc25b" . SPARSER::PROTEIN)
    ("FoxM1 and its downstream target Skp2" . SPARSER::COLLECTION)
    ("p53 and its downstream targets p21 and p27" . SPARSER::COLLECTION)
    ("Mdm2 and FoxM1" . SPARSER::COLLECTION)
    ("PB or other CAR activators" . SPARSER::COLLECTION)
    ("spontaneous HCC" . SPARSER::PROTEIN)
    ("at least 10 known or candidate β-catenin" . SPARSER::PROTEIN)
    ("LEF1 and TCF7" . SPARSER::COLLECTION) ("repressor" . SPARSER::REPRESSOR)
    ("HCCs" . SPARSER::PROTEIN) ("TC and TC" . SPARSER::COLLECTION)
    ("Mdm2, FoxM1 and Skp2" . SPARSER::COLLECTION)
    ("CyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("Igf2, AFP and Sox4" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("GS as well as HCC marker alpha-fetoprotein (AFP)" . SPARSER::COLLECTION)
    ("alpha-fetoprotein (AFP)" . SPARSER::PROTEIN)
    ("TC and Ad-Cre" . SPARSER::COLLECTION)
    ("c-Myc or CyclinD1" . SPARSER::COLLECTION) ("allele" . SPARSER::ALLELE)
    ("FoxM1-Skp2" . SPARSER::COLLECTION)
    ("FoxM1 and Skp2" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("such primary CAR" . SPARSER::PROTEIN)
    ("chemotaxin" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("Apc" . SPARSER::PROTEIN)
    ("p21, Mcp1, Cxcl10 and Csf" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("Csf1, Mcp1, Cxcl10 and Icam" . SPARSER::COLLECTION)
    ("Cxcl10" . SPARSER::PROTEIN) ("Mcp1" . SPARSER::PROTEIN)
    ("Icam" . SPARSER::PROTEIN-FAMILY) ("Csf" . SPARSER::PROTEIN)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("Birc5 and Ccne1" . SPARSER::COLLECTION)
    ("Cre and Cre" . SPARSER::COLLECTION) ("Ccne1" . SPARSER::PROTEIN)
    ("Birc5" . SPARSER::PROTEIN) ("Igf2 and Sox4" . SPARSER::COLLECTION)
    ("AFP" . SPARSER::PROTEIN) ("Cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("refs" . SPARSER::PROTEIN) ("β-catenin and CAR" . SPARSER::COLLECTION)
    ("Cyp2b10 and Gadd45β" . SPARSER::COLLECTION)
    ("GS and Axin2" . SPARSER::COLLECTION) ("GS" . SPARSER::PROTEIN)
    ("TC or Ad-Cre" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("β-catenin and its downstream transcriptional targets Glutamine Synthetase (GS) and Axin2 ( xref )"
     . SPARSER::COLLECTION)
    ("its downstream transcriptional targets Glutamine Synthetase (GS) and Axin2 ( xref )"
     . SPARSER::COLLECTION)
    ("Glutamine Synthetase (GS)" . SPARSER::PROTEIN)
    ("TC or PB" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("adenoviral Cre" . SPARSER::PROTEIN) ("ctnnb1" . SPARSER::PROTEIN)
    ("exon" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("male" . SPARSER::MOLECULE) ("enzymes" . SPARSER::ENZYME)
    ("CAR and β-catenin" . SPARSER::COLLECTION)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("promoters" . SPARSER::PROMOTER) ("Bis" . SPARSER::PROTEIN)
    ("TCPOBOP" . SPARSER::DRUG) ("PB" . SPARSER::PROTEIN)
    ("activators" . SPARSER::ACTIVATOR)
    ("p53 and trigger" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("standard chemotherapeutic approaches makes HCC" . SPARSER::PROTEIN)
    ("sorafenib" . SPARSER::DRUG) ("States" . SPARSER::BIO-STATE)
    ("phenobarbital" . SPARSER::DRUG)
    ("either β-catenin or the nuclear xenobiotic receptor CAR"
     . SPARSER::COLLECTION)
    ("CAR" . SPARSER::PROTEIN) ("xenobiotic" . SPARSER::MOLECULE)
    ("hepatocytes" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("glutamine synthetase" . SPARSER::PROTEIN) ("Ad5" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H-ras" . SPARSER::PROTEIN) ("TCF7" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("TBX3" . SPARSER::PROTEIN)
    ("ephrin receptor" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("Lect2" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("Sox4" . SPARSER::PROTEIN)
    ("Igf2" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cyp2b10" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("Axin2" . SPARSER::PROTEIN) ("Glutamine Synthetase" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("NR1I3" . SPARSER::PROTEIN)
    ("Constitutive Androstane Receptor" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("receptor, EGFR, and TrkA/B" . SPARSER::COLLECTION)
    ("TrkA" . SPARSER::PROTEIN) ("IGF" . SPARSER::PROTEIN)
    ("Src or MMP" . SPARSER::COLLECTION)
    ("tyrosine kinase and MMP-2" . SPARSER::COLLECTION)
    ("MAPK and Src" . SPARSER::COLLECTION) ("ligand" . SPARSER::LIGAND)
    ("Akt or ERK1/2" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("one herbal medicine" . SPARSER::DRUG)
    ("MMP-2 and BiPs" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN) ("metalloproteases" . SPARSER::PROTEIN)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("TGF" . SPARSER::DRUG)
    ("heparin" . SPARSER::PROTEIN) ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src and MMP-2" . SPARSER::COLLECTION)
    ("Akt and/or ERK1/2" . SPARSER::COLLECTION) ("Phe" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("Ile" . SPARSER::AMINO-ACID)
    ("Leu" . SPARSER::AMINO-ACID) ("mutants" . SPARSER::MUTANT)
    ("forskolin" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("Molecule" . SPARSER::MOLECULE) ("PI3K and ERK1/2" . SPARSER::COLLECTION)
    ("wortmannin or U0126" . SPARSER::COLLECTION)
    ("wortmannin (100 nmol/L) and U0126 (1 μmol/L)" . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("somas" . SPARSER::DRUG) ("MAPK, Akt, and JNK" . SPARSER::COLLECTION)
    ("a typical RTK" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RTKs" . SPARSER::PROTEIN)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK" . SPARSER::PROTEIN) ("Oxygen" . SPARSER::MOLECULE)
    ("cyclopentyl" . SPARSER::MOLECULE)
    ("cerebral ischemia" . SPARSER::PROTEIN)
    ("a potential neuroprotective agent" . SPARSER::DRUG)
    ("antioxidant" . SPARSER::PROTEIN) ("analgesic" . SPARSER::DRUG)
    ("medicine" . SPARSER::DRUG) ("MMP-2/MMP-9" . SPARSER::COLLECTION)
    ("BiPs" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION) ("EGFR" . SPARSER::PROTEIN)
    ("wortmannin or MEK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("wortmannin" . SPARSER::PROTEIN)
    ("Akt and ERK1/2" . SPARSER::COLLECTION) ("paeoniflorin" . SPARSER::DRUG)
    ("Receptor" . SPARSER::RECEPTOR) ("MTT" . SPARSER::MOLECULE)
    ("oxygen-glucose" . SPARSER::PROTEIN) ("OGD" . SPARSER::PROTEIN)
    ("middle cerebral artery occlusion-induced ischemia" . SPARSER::PROTEIN)
    ("ischemia" . SPARSER::PROTEIN) ("Paeoniflorin" . SPARSER::DRUG)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("pro-HB-EGF" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("HB-EGF" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("N 2" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("PP3" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("adenosine A 1 receptor" . SPARSER::PROTEIN)
    ("neuroprotective agent" . SPARSER::DRUG) ("MMP-9" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("Src kinase" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("U0126" . SPARSER::DRUG)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a tumor-suppressive protein" . SPARSER::PROTEIN)
    ("an important intracellular fatty acids carrier protein"
     . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG) ("adipocytes" . SPARSER::PROTEIN)
    ("glucose, lipids, and lipoprotein" . SPARSER::COLLECTION)
    ("lipoprotein" . SPARSER::PROTEIN) ("lipids" . SPARSER::LIPID)
    ("FABP4 and TG" . SPARSER::COLLECTION)
    ("PTEN and FABP4" . SPARSER::COLLECTION)
    ("TC and LDL-C" . SPARSER::COLLECTION) ("TC" . SPARSER::PROTEIN)
    ("FABP4, TG, and PTEN" . SPARSER::COLLECTION)
    ("glucose (FPG)" . SPARSER::MOLECULE) ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("TG" . SPARSER::PROTEIN) ("triglyceride" . SPARSER::MOLECULE)
    ("FABP4, and PTEN" . SPARSER::COLLECTION) ("HOMA-IR" . SPARSER::COLLECTION)
    ("lipid" . SPARSER::LIPID) ("FABP4 and PTEN" . SPARSER::COLLECTION)
    ("PTEN" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("PI3K-AKT" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::PROTEIN)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE)
    ("lipid-binding protein" . SPARSER::PROTEIN)
    ("fatty acid-binding protein 4" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("HDL-C" . SPARSER::PROTEIN)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("FABP4" . SPARSER::PROTEIN)
    ("fatty acid binding protein 4" . SPARSER::PROTEIN)
    ("a tumour suppressor gene and its connection" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE) ("p53 and p73" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("p53-A2B" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION) ("crmA" . SPARSER::PROTEIN)
    ("TA-p73" . SPARSER::COLLECTION) ("type" . TYPE)
    ("p73 and ADORA2B" . SPARSER::COLLECTION)
    ("cancer makes targeting p73 and its downstream signalling components"
     . SPARSER::COLLECTION)
    ("adriamycin and NECA" . SPARSER::COLLECTION)
    ("pro-apoptotic Bak, Bax and Noxa" . SPARSER::COLLECTION)
    ("Bak, Bax and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic mitochondrial proteins" . SPARSER::PROTEIN)
    ("the ectopically expressed viral protein" . SPARSER::PROTEIN)
    ("the cowpox viral protein CrmA" . SPARSER::PROTEIN)
    ("CrmA" . SPARSER::PROTEIN) ("A2B and p73" . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("PARP" . SPARSER::PROTEIN) ("A2B" . SPARSER::PROTEIN)
    ("p73-A2B" . SPARSER::COLLECTION) ("antagonist" . SPARSER::MOLECULE)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("cytometry" . SPARSER::PROTEIN) ("NECA" . SPARSER::DRUG)
    ("several p53-responsive pro-apoptotic genes" . SPARSER::GENE)
    ("p53 and TAp73" . SPARSER::COLLECTION) ("homology" . SPARSER::PROTEIN)
    ("an alternative internal promoter" . SPARSER::PROMOTER)
    ("isoform" . SPARSER::ISOFORM) ("TA" . SPARSER::PROTEIN)
    ("doxycycline" . SPARSER::DRUG) ("a strong inducer" . SPARSER::PROTEIN)
    ("tet" . SPARSER::PROTEIN) ("extracellular adenosine" . SPARSER::PROTEIN)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("Extracellular adenosine" . SPARSER::PROTEIN)
    ("the internal P2 promoter" . SPARSER::PROMOTER)
    ("trigger" . SPARSER::PROTEIN) ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paralogue" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug adriamycin" . SPARSER::DRUG)
    ("doxorubicin" . SPARSER::PROTEIN) ("adriamycin" . SPARSER::DRUG)
    ("caspase-" . SPARSER::PROTEIN) ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("adenosine" . SPARSER::PROTEIN) ("potassium chloride" . SPARSER::MOLECULE)
    ("Cytochrome c" . SPARSER::PROTEIN) ("IP 3 " . SPARSER::IP3)
    ("FL-1" . SPARSER::PROTEIN) ("FL-2" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("Val-Ala" . SPARSER::MOLECULE) ("caspase 8" . SPARSER::PROTEIN)
    ("PSB603" . SPARSER::DRUG) ("Mcl-1" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("caspases-9" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("zVAD-fmk" . SPARSER::DRUG)
    ("PSB 603" . SPARSER::DRUG) ("p21" . SPARSER::PROTEIN)
    ("ADORA2B" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-protein" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p73" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("activator" . SPARSER::ACTIVATOR)
    ("receptors or Rac" . SPARSER::COLLECTION) ("GTPases" . SPARSER::GTPASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P-Rex1, VAV2 and DOCK1" . SPARSER::COLLECTION)
    ("variants" . SPARSER::VARIANT) ("GEFs and GAPs" . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GDP" . SPARSER::NUCLEOTIDE)
    ("drug or vehicle" . SPARSER::COLLECTION)
    ("mammary fat" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("DT" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("HER2 and HACE1" . SPARSER::COLLECTION)
    ("HRG and EGF" . SPARSER::COLLECTION)
    ("DOCK1, PREX1 and VAV2" . SPARSER::COLLECTION)
    ("inhibitor or vehicle" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("GTPase" . SPARSER::GTPASE) ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligases" . SPARSER::LIGASE) ("Matrigel" . SPARSER::PROTEIN)
    ("actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGF and HRG" . SPARSER::COLLECTION)
    ("HA-tagged wild-type Rac1 as well as a K147R mutant"
     . SPARSER::COLLECTION)
    ("mutant" . SPARSER::MUTANT) ("lysine" . SPARSER::AMINO-ACID)
    ("inactive" . SPARSER::INACTIVE) ("polyubiquitination" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF) and heregulin (HRG)" . SPARSER::COLLECTION)
    ("ligands" . SPARSER::LIGAND) ("HRG" . SPARSER::PROTEIN)
    ("heregulin" . SPARSER::PROTEIN) ("EGF" . SPARSER::PROTEIN)
    ("GEFs" . SPARSER::PROTEIN) ("ubiquitin" . SPARSER::PROTEIN)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("shRNAs" . SPARSER::RNA)
    ("Exon" . SPARSER::PROTEIN) ("caspase-9 and genes" . SPARSER::COLLECTION)
    ("RACE" . SPARSER::PROTEIN) ("HECT and Ankyrin" . SPARSER::COLLECTION)
    ("Ankyrin" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("a strong promoter" . SPARSER::PROMOTER)
    ("novel cancer-associated genes as well as validating known cancer genes"
     . SPARSER::COLLECTION)
    ("novel cancer-associated genes" . SPARSER::GENE)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTP" . SPARSER::NUCLEOTIDE)
    ("HER2 cooperative tumor suppressor gene" . SPARSER::PROTEIN)
    ("ligase" . SPARSER::LIGASE) ("neu" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("Anti-" . SPARSER::ANTIBODY)
    ("pMD2" . SPARSER::MOLECULE) ("sodium bicarbonate" . SPARSER::DRUG)
    ("Rac1b" . SPARSER::PROTEIN) ("P-Rex1" . SPARSER::PROTEIN)
    ("VAV2" . SPARSER::PROTEIN) ("PREX1" . SPARSER::PROTEIN)
    ("DOCK1" . SPARSER::PROTEIN) ("RAC1" . SPARSER::PROTEIN)
    ("EHT1864" . SPARSER::DRUG) ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("SLC25A43" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("HACE1" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("Target" . SPARSER::TARGET-PROTEIN)
    ("variant" . SPARSER::VARIANT) ("RhoC/MMP9" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα and IL1β" . SPARSER::COLLECTION) ("oncogene" . SPARSER::ONCOGENE)
    ("PRKCA" . SPARSER::PROTEIN) ("Tinagl1" . SPARSER::PROTEIN)
    ("Tinagl" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("RhoC or TNF α" . SPARSER::COLLECTION)
    ("RhoC and TNF α" . SPARSER::COLLECTION) ("biomarker" . SPARSER::MOLECULE)
    ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("TNFα or ectopically expressing TNF±" . SPARSER::COLLECTION)
    ("TNF" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("Cytokine" . SPARSER::PROTEIN)
    ("a strong barrier" . SPARSER::PROTEIN) ("cytokines" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("TN" . SPARSER::PROTEIN) ("LNA" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN)
    ("potential RhoC-targeting microRNA" . SPARSER::RNA)
    ("potential target genes" . SPARSER::GENE) ("IL2R" . SPARSER::PROTEIN)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("NOD" . SPARSER::PROTEIN)
    ("BrM" . SPARSER::PROTEIN) ("comprehensive microRNA" . SPARSER::RNA)
    ("Gene" . SPARSER::GENE) ("GSEA" . SPARSER::PROTEIN)
    ("cohort" . SPARSER::MOLECULE) ("two essential genes" . SPARSER::GENE)
    ("attractive biomarkers" . SPARSER::MOLECULE)
    ("cohorts" . SPARSER::MOLECULE) ("seven" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("microRNAs" . SPARSER::RNA)
    ("TWF1 and IL-11" . SPARSER::COLLECTION) ("estrogen" . SPARSER::MOLECULE)
    ("ER" . SPARSER::PROTEIN) ("cyclin D, MYC and H-RAS" . SPARSER::COLLECTION)
    ("MYC" . SPARSER::PROTEIN) ("oncogenes" . SPARSER::ONCOGENE)
    ("miRNAs" . SPARSER::PROTEIN) ("RNAs" . SPARSER::RNA)
    ("miRNA" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("Most chemotherapeutic drugs" . SPARSER::DRUG)
    ("RhoC-TNFα" . SPARSER::COLLECTION)
    ("TNFα and RhoC-induced MMP9" . SPARSER::COLLECTION)
    ("RhoC and TNFα" . SPARSER::COLLECTION) ("BBB" . SPARSER::PROTEIN)
    ("RhoC" . SPARSER::PROTEIN) ("cytokine" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA) ("miR" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA) ("most chemotherapeutic drugs" . SPARSER::DRUG)
    ("barrier" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("α-tubulin" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("L-glutamine" . SPARSER::MOLECULE)
    ("-2" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("miR-7" . SPARSER::PROTEIN)
    ("Sec23" . SPARSER::PROTEIN-FAMILY)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("TNF α" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL2" . SPARSER::PROTEIN) ("IL-11" . SPARSER::PROTEIN)
    ("TWF1" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("SATB1" . SPARSER::PROTEIN) ("H-RAS" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("Let-7" . SPARSER::RNA)
    ("MMP9" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("ABCE1-translin" . SPARSER::COLLECTION) ("fraction" . SPARSER::COMPONENT)
    ("translin and C3PO" . SPARSER::COLLECTION)
    ("ds-siRNA" . SPARSER::COLLECTION) ("ss-siRNA" . SPARSER::COLLECTION)
    ("endonuclease" . SPARSER::PROTEIN) ("heterochromatin" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN) ("effector" . SPARSER::EFFECTOR)
    ("substrates" . SPARSER::SUBSTRATE)
    ("even more target molecules" . SPARSER::MOLECULE)
    ("dsRNAs" . SPARSER::RNA) ("RdRP" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("RdRPs" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("a well-characterized viral RNA" . SPARSER::RNA)
    ("weaker" . SPARSER::PROTEIN) ("exogenous ULK3" . SPARSER::PROTEIN)
    ("DNA" . SPARSER::DNA) ("class" . CLASS)
    ("viral proteins" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("complexes" . SPARSER::BIO-COMPLEX) ("V5-tagged ABCE1" . SPARSER::PROTEIN)
    ("novel ABCE1-associated proteins" . SPARSER::PROTEIN)
    ("human ABCE1 or its orthologs" . SPARSER::COLLECTION)
    ("different ribosomal proteins" . SPARSER::PROTEIN)
    ("orthologs" . SPARSER::PROTEIN)
    ("the ERI-1 or the ABCE1" . SPARSER::COLLECTION)
    ("whereby GFP fused" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("siRNA(X) and pFLuc" . SPARSER::COLLECTION)
    ("V5-tagged ABCE1 and P19" . SPARSER::COLLECTION)
    ("ABCE1 and P19" . SPARSER::COLLECTION) ("antibody" . SPARSER::ANTIBODY)
    ("western blot" . SPARSER::PROTEIN) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("pULK" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("Unc" . SPARSER::PROTEIN) ("siRNA" . SPARSER::PROTEIN)
    ("strong GFP" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("particularly 24 nt long siRNAs" . SPARSER::PROTEIN)
    ("pBin61-GFP/pBin61-AtRLI2" . SPARSER::COLLECTION)
    ("AtRLI2" . SPARSER::PROTEIN) ("pBin61-GFP/pBin61" . SPARSER::COLLECTION)
    ("pBin61-AtRLI2" . SPARSER::COLLECTION)
    ("pBin61-GFP/pBin61-ABCE1" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("pBin61" . SPARSER::PROTEIN)
    ("systemic RNA" . SPARSER::RNA) ("ABCE1 or AtRLI2" . SPARSER::COLLECTION)
    ("pBin61-ABCE1" . SPARSER::COLLECTION)
    ("pBin61-GFP" . SPARSER::PROTEIN-PAIR) ("mixture" . SPARSER::MOLECULE)
    ("dpi" . SPARSER::PROTEIN) ("inducer" . SPARSER::MOLECULE)
    ("transgene" . SPARSER::PROTEIN) ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("several potential interactors" . SPARSER::PROTEIN)
    ("RISC" . SPARSER::PROTEIN) ("interactors" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN) ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("ribosomal subunits" . SPARSER::PROTEIN) ("subunits" . SPARSER::FRAGMENT)
    ("mRNA and single-stranded RNA" . SPARSER::COLLECTION)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("HP" . SPARSER::PROTEIN)
    ("kDa" . SPARSER::PROTEIN) ("Drosophila" . SPARSER::PROTEIN)
    ("siRNAs" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("RNase" . SPARSER::PROTEIN)
    ("these proteins and so far endogenous regulators" . SPARSER::COLLECTION)
    ("viral suppressors" . SPARSER::SUPPRESSOR)
    ("highly diverse multifunctional proteins" . SPARSER::PROTEIN)
    ("the viral suppressors" . SPARSER::SUPPRESSOR)
    ("suppressors" . SPARSER::SUPPRESSOR) ("TRAX" . SPARSER::PROTEIN)
    ("translin" . SPARSER::PROTEIN)
    ("potential ABCE1-interacting proteins" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("Ago2" . SPARSER::PROTEIN) ("RNA-specific" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("C . elegans )" . SPARSER::PROTEIN) ("muscle specific" . SPARSER::PROTEIN)
    ("Sonic hedgehog" . SPARSER::PROTEIN) ("Lys-C" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("M2" . SPARSER::MOLECULE)
    ("AS3" . SPARSER::PROTEIN) ("myo-2" . SPARSER::PROTEIN)
    ("AS2" . SPARSER::PROTEIN) ("rol-6" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("eri-1" . SPARSER::PROTEIN)
    ("myo-3" . SPARSER::PROTEIN) ("ERI-1" . SPARSER::PROTEIN)
    ("ULK3" . SPARSER::PROTEIN) ("pP19" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("P19" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("single-stranded RNA" . SPARSER::RNA)
    ("interferon-induced" . SPARSER::PROTEIN)
    ("iron-sulfur" . SPARSER::MOLECULE) ("yeast)" . SPARSER::PROTEIN)
    ("Rli1" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("ABCE1" . SPARSER::PROTEIN)
    ("ATP-binding cassette sub-family E member 1" . SPARSER::PROTEIN)
    ("a potential molecular target" . SPARSER::TARGET-PROTEIN)
    ("mTOR and p70S6K, and VEGF" . SPARSER::COLLECTION)
    ("p70S6K, and VEGF" . SPARSER::COLLECTION)
    ("mTOR, p70S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("eIF" . SPARSER::PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("ribosomal p70S6 kinase" . SPARSER::KINASE)
    ("HIF-1a and suppreses" . SPARSER::COLLECTION)
    ("Glut1 and EPO" . SPARSER::COLLECTION) ("promoter" . SPARSER::PROMOTER)
    ("VEGF, Glut1, and EPO" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN)
    ("HIF-1α, phospho-mTOR, and phospho-p70S6K" . SPARSER::COLLECTION)
    ("MVD" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::MOLECULE)
    ("Hemoglobin" . SPARSER::MOLECULE)
    ("mTOR, p70S6K, and RPS6" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG)
    ("mTOR, p70S6K, RPS6, and 4E-BP1" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("proteasomal" . SPARSER::PROTEIN) ("normoxia" . SPARSER::PROTEIN)
    ("methionine" . SPARSER::AMINO-ACID)
    ("using Western blot" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("CHX" . SPARSER::PROTEIN) ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("cycloheximide" . SPARSER::PROTEIN) ("erythropoietin" . SPARSER::PROTEIN)
    ("transporter" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("Tubulin" . SPARSER::PROTEIN)
    ("HIF-2α and HIF-1β" . SPARSER::COLLECTION) ("Hypoxia" . SPARSER::PROTEIN)
    ("VEGF, Glut-1, and EPO" . SPARSER::COLLECTION)
    ("Glut-1" . SPARSER::PROTEIN) ("EPO" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("Bax" . SPARSER::PROTEIN)
    ("phenanthrene-quinone" . SPARSER::PROTEIN) ("quinone" . SPARSER::PROTEIN)
    ("phenanthrene" . SPARSER::DRUG) ("derivative" . SPARSER::DERIVATIVE)
    ("types" . TYPE) ("heterodimers" . SPARSER::HETERODIMER)
    ("proteasomes" . SPARSER::PROTEIN) ("genes" . SPARSER::GENE)
    ("oxygen" . SPARSER::MOLECULE)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("tumor cells usually causes hypoxia" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN) ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (mTOR) and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("p70S6K" . SPARSER::PROTEIN) ("effectors" . SPARSER::EFFECTOR)
    ("mTOR" . SPARSER::PROTEIN) ("Tanshinone" . SPARSER::DRUG)
    ("VEGF" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("MG-132" . SPARSER::DRUG) ("RPS6" . SPARSER::PROTEIN)
    ("CO 2" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("serum albumin" . SPARSER::PROTEIN) ("protein A" . SPARSER::PROTEIN)
    ("Glut1" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("β-actin" . SPARSER::PROTEIN) ("HIF-2α" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("HIF-1" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("p70S6" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("vascular endothelial" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("these relevant kinases" . SPARSER::KINASE)
    ("commercial inhibitors" . SPARSER::INHIBITOR)
    ("tyrosine kinase/PI3K/Akt" . SPARSER::COLLECTION)
    ("active" . SPARSER::ACTIVE) ("variety" . SPARSER::VARIETY)
    ("complemented" . SPARSER::PROTEIN)
    ("GSK-3 and eEF2K" . SPARSER::COLLECTION) ("Thr" . SPARSER::AMINO-ACID)
    ("BDNF" . SPARSER::PROTEIN)
    ("The NF-κB inhibitors BAY 11–7082 and BAY 11–7085" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("form" . SPARSER::FORM)
    ("JNK, Cdk4, and PKC" . SPARSER::COLLECTION) ("pro" . SPARSER::AMINO-ACID)
    ("kinases (JNK)" . SPARSER::PROTEIN)
    ("the diverse MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AP-1" . SPARSER::PROTEIN) ("Wee1 and PKC" . SPARSER::COLLECTION)
    ("JNK, Cdk4, NF-κB, and eEF2K" . SPARSER::COLLECTION)
    ("receptors" . SPARSER::RECEPTOR) ("tyrosine" . SPARSER::AMINO-ACID)
    ("prolines" . SPARSER::AMINO-ACID) ("PI3K-Akt-GSK3" . SPARSER::COLLECTION)
    ("antidepressant" . SPARSER::DRUG) ("ATP" . SPARSER::ATP)
    ("oxidant" . SPARSER::PROTEIN) ("stabilizer" . SPARSER::MOLECULE)
    ("platelets" . SPARSER::PROTEIN) ("serine/threonine" . SPARSER::COLLECTION)
    ("neurotransmitter" . SPARSER::MOLECULE) ("isoforms" . SPARSER::ISOFORM)
    ("family" . SPARSER::PROTEIN-FAMILY)
    ("a strong inhibitor" . SPARSER::INHIBITOR) ("SCF" . SPARSER::PROTEIN)
    ("kinase and PKC" . SPARSER::COLLECTION) ("run" . SPARSER::PROTEIN-FAMILY)
    ("PKA and PKC" . SPARSER::COLLECTION) ("linkers" . SPARSER::LINKER)
    ("Ser" . SPARSER::AMINO-ACID) ("PKA" . SPARSER::PROTEIN)
    ("Nav1.2" . SPARSER::PROTEIN)
    ("this macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("PKC and Wee1" . SPARSER::COLLECTION)
    ("PI3K/Akt/GSK3" . SPARSER::COLLECTION) ("group" . SPARSER::MOLECULE)
    ("Nav1.6 and FGF14" . SPARSER::COLLECTION) ("IPA" . SPARSER::MOLECULE)
    ("the inhibitors and their targeting kinases that associate"
     . SPARSER::COLLECTION)
    ("inhibitors and kinases" . SPARSER::COLLECTION)
    ("JNK, Akt, and Cdk4" . SPARSER::COLLECTION)
    ("Wee1, eEF2K, and Syk" . SPARSER::COLLECTION)
    ("NF-kB, MLCK, Cdk1, PIKfyve and IP3K" . SPARSER::COLLECTION)
    ("hydrochloride and Syk" . SPARSER::COLLECTION)
    ("Inhibitor" . SPARSER::INHIBITOR) ("component" . SPARSER::COMPONENT)
    ("Akt/PI3K" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("suppressor" . SPARSER::SUPPRESSOR) ("JNK/CDK4/PKC" . SPARSER::COLLECTION)
    ("Akt/PI3K/PIKfyve" . SPARSER::COLLECTION)
    ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("triciribine and NSC" . SPARSER::COLLECTION)
    ("Ro 3306 and Go 6983" . SPARSER::COLLECTION)
    ("partial" . SPARSER::PROTEIN)
    ("BAY 11–7082 and BAY 11–7085" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("agonist" . SPARSER::AGONIST)
    ("FGF14:Nav" . SPARSER::BIO-COMPLEX) ("Nav" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE) ("receptor" . SPARSER::RECEPTOR)
    ("antagonists" . SPARSER::MOLECULE) ("agonists" . SPARSER::AGONIST)
    ("drug" . SPARSER::DRUG) ("IV, and Wee1" . SPARSER::COLLECTION)
    ("II" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("XVI" . SPARSER::PROTEIN) ("TX" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE) ("Triciribine" . SPARSER::MOLECULE)
    ("Three representative examples" . SPARSER::EXAMPLE)
    ("hydrochloride" . SPARSER::MOLECULE) ("triciribine" . SPARSER::MOLECULE)
    ("examples" . SPARSER::EXAMPLE) ("DMSO" . SPARSER::MOLECULE)
    ("Chemicals" . SPARSER::MOLECULE) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("EMD" . SPARSER::PROTEIN) ("chemical" . SPARSER::MOLECULE)
    ("Akt, Cdk1, Cdk4, eEF2K, PI3K, JNK, MLCK, NF-kB, PIKfyve, PKC, Syk and Wee1"
     . SPARSER::COLLECTION)
    ("Syk" . SPARSER::PROTEIN) ("PIKfyve" . SPARSER::PROTEIN)
    ("MLCK" . SPARSER::PROTEIN) ("JNK" . SPARSER::PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN)
    ("the FGF14 and Nav1.6-C-tail complex (  xref  )" . SPARSER::COLLECTION)
    ("CLuc-FGF14" . SPARSER::COLLECTION)
    ("expressible proteins" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT) ("Protein" . SPARSER::PROTEIN)
    ("signalosome" . SPARSER::PROTEIN)
    ("chemically-diverse inhibitors" . SPARSER::INHIBITOR)
    ("the original HTS" . SPARSER::PROTEIN)
    ("FGF14-Nav" . SPARSER::PROTEIN-PAIR) ("HTS" . SPARSER::PROTEIN)
    ("FGF14 and Nav1.6" . SPARSER::COLLECTION) ("light" . SPARSER::PROTEIN)
    ("Nav1.6" . SPARSER::PROTEIN) ("gene" . SPARSER::GENE)
    ("forms" . SPARSER::FORM)
    ("a multivalent accessory protein" . SPARSER::PROTEIN)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("accessory and regulatory proteins" . SPARSER::PROTEIN)
    ("its macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("proteins" . SPARSER::PROTEIN) ("substrate" . SPARSER::SUBSTRATE)
    ("subunit" . SPARSER::FRAGMENT)
    ("their relevant molecular targets" . SPARSER::TARGET-PROTEIN)
    ("state" . SPARSER::BIO-STATE) ("biomarkers" . SPARSER::MOLECULE)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("a multifunctional kinase" . SPARSER::KINASE)
    ("the first psychotropic drugs" . SPARSER::DRUG)
    ("potential new therapeutics" . SPARSER::THERAPEUTICS)
    ("inhibitor" . SPARSER::INHIBITOR) ("drugs" . SPARSER::DRUG)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("Kinase" . SPARSER::KINASE)
    ("molecule" . SPARSER::MOLECULE)
    ("structurally-diverse kinase inhibitors" . SPARSER::INHIBITOR)
    ("kinase, and protein" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitors" . SPARSER::INHIBITOR)
    ("its multivalent accessory protein" . SPARSER::PROTEIN)
    ("regulators" . SPARSER::REGULATOR) ("enzyme" . SPARSER::ENZYME)
    ("fragments" . SPARSER::FRAGMENT) ("LCA" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("part" . SPARSER::COMPONENT) ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("protein" . SPARSER::PROTEIN) ("kinases" . SPARSER::PROTEIN)
    ("complex" . SPARSER::BIO-COMPLEX) ("Kinases" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("eEF2" . SPARSER::PROTEIN)
    ("elongation factor 2" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-protein coupled" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("PI3K-Akt" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("PI3Kγ" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("β-TrCP" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("K+" . SPARSER::MOLECULE) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("CHIR99021" . SPARSER::MOLECULE) ("full-length" . SPARSER::PROTEIN)
    ("IP3K" . SPARSER::PROTEIN) ("Go 6976" . SPARSER::DRUG)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("Go 6983" . SPARSER::DRUG)
    ("Gö 6983" . SPARSER::DRUG) ("YM201636" . SPARSER::DRUG)
    ("Ro 3306" . SPARSER::DRUG) ("GSK690693" . SPARSER::DRUG)
    ("BAY 11–7082" . SPARSER::DRUG) ("LY294002" . SPARSER::MOLECULE)
    ("ML-7" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("eEF2K" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("CH3" . SPARSER::MOLECULE) ("MgCl2" . SPARSER::MOLECULE)
    ("Tween 20" . SPARSER::MOLECULE) ("Triton X-100" . SPARSER::MOLECULE)
    ("HD2" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("5–2" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("cytosine arabinoside" . SPARSER::DRUG) ("N2" . SPARSER::PROTEIN)
    ("2–4" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG) ("CO2" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("SCA27" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("Wee1" . SPARSER::PROTEIN)
    (NIL . SPARSER::GROWTH-FACTOR) ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGF14" . SPARSER::PROTEIN)
    ("fibroblast growth factor 14" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY) ("Nav1" . SPARSER::PROTEIN)
    ("sodium channel" . SPARSER::PROTEIN) ("voltage-gated" . SPARSER::PROTEIN)))